data_1p9k_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1p9k _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.551 ' HB1' ' CG1' ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.456 -0.174 0 CA-C-O 120.687 0.28 . . . . 0.0 111.095 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.3 123.23 26.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.895 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.472 ' CE1' ' HB3' ' A' ' 29' ' ' LEU . 50.0 t80 -100.87 152.82 20.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.911 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.83 153.46 21.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.101 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.3 mt -129.32 -40.16 1.47 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.785 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.44 -111.54 3.63 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.73 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.86 57.4 1.35 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.114 0.483 . . . . 0.0 110.624 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.64 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 2.3 m-70 -110.04 165.84 11.9 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.567 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.64 ' HD2' ' HB3' ' A' ' 18' ' ' HIS . 31.2 Cg_endo -62.64 -41.25 32.53 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.098 1.866 . . . . 0.0 111.863 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.553 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 21.5 p80 171.38 -170.36 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.721 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.6 m -145.78 158.99 12.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.236 0.541 . . . . 0.0 112.365 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.535 ' HG3' ' HA ' ' A' ' 59' ' ' ARG . 8.2 tt0 -88.78 139.21 30.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.848 178.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.442 HD22 ' O ' ' A' ' 57' ' ' ARG . 4.1 pp -42.45 -30.48 0.34 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.781 0.324 . . . . 0.0 111.404 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.5 t -72.47 -40.17 67.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.977 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.401 ' N ' ' O ' ' A' ' 22' ' ' GLU . 1.9 m-20 -65.74 -53.73 36.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.938 0.399 . . . . 0.0 110.702 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.524 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 10.1 tt -54.75 -48.72 72.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.825 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.577 HD13 ' HG2' ' A' ' 45' ' ' GLU . 8.9 mp -65.76 -63.03 1.18 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.648 -178.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.0 tmmm? -43.84 -59.43 2.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.023 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.472 ' HB3' ' CE1' ' A' ' 13' ' ' PHE . 0.5 OUTLIER -56.13 -47.5 78.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.226 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.524 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 2.3 mm-40 -62.11 -15.21 43.84 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.681 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.04 24.68 14.34 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.321 -0.942 . . . . 0.0 113.253 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.618 ' HZ2' ' HB ' ' A' ' 75' ' ' VAL . 7.8 m0 -79.09 -63.88 1.32 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.248 0.524 . . . . 0.0 109.988 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.9 t -106.72 135.37 48.37 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.778 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.41 -33.36 71.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.827 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.7 p -104.67 -40.46 5.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.493 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 121.83 -30.74 5.2 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.027 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -138.31 5.93 2.53 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.701 0.259 . . . . 0.0 111.701 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.408 ' C ' ' H ' ' A' ' 40' ' ' LYS . 21.5 tp60 -54.91 -74.69 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.859 0.362 . . . . 0.0 110.952 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.62 15.68 0.34 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.77 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.41 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 37.4 mttm 64.48 24.57 13.15 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 120.961 0.41 . . . . 0.0 110.073 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.553 ' HA ' ' CE2' ' A' ' 70' ' ' PHE . 16.9 mt -63.71 -18.92 23.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.708 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.11 -79.14 0.09 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.93 0.395 . . . . 0.0 110.663 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 29.4 mm -46.61 -45.01 6.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.674 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.524 ' HB3' ' CE1' ' A' ' 70' ' ' PHE . . . -54.33 -68.14 0.21 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.91 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.601 ' HA ' ' HB2' ' A' ' 70' ' ' PHE . 6.6 tp10 -32.66 -45.14 0.12 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.604 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 55' ' ' GLU . . . -57.84 -74.37 0.35 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 119.875 -1.155 . . . . 0.0 110.637 178.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.557 ' CA ' ' HB ' ' A' ' 56' ' ' THR . 14.6 pt20 -46.33 -14.62 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.452 HG21 ' CD1' ' A' ' 70' ' ' PHE . 56.0 t -74.92 -88.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.116 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.427 ' HG2' ' O ' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -172.84 128.87 0.5 Allowed 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.828 0.346 . . . . 0.0 111.019 179.221 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.424 ' O ' ' N ' ' A' ' 52' ' ' GLY . 44.7 t -124.29 149.48 28.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.591 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -55.66 85.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.132 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 106.78 -6.15 37.62 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.115 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -133.75 135.42 43.92 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 117.148 0.474 . . . . 0.0 111.267 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.41 HG21 ' O ' ' A' ' 54' ' ' VAL . 12.1 p -125.42 38.13 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.306 178.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' A' ' 46' ' ' GLY . 7.6 mt-10 -106.94 -151.39 0.46 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.211 -0.449 . . . . 0.0 112.171 -178.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.557 ' HB ' ' CA ' ' A' ' 47' ' ' GLN . 3.5 t -166.96 57.3 0.08 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.927 0.394 . . . . 0.0 111.469 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.442 ' O ' HD22 ' A' ' 23' ' ' LEU . 2.2 mtt-85 -86.29 175.29 8.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.019 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.21 -47.53 27.82 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.535 ' HA ' ' HG3' ' A' ' 22' ' ' GLU . 3.8 mtm180 -115.21 153.09 31.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.237 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -125.68 137.22 53.84 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.928 0.394 . . . . 0.0 111.231 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.491 ' HG3' ' CD2' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -99.98 77.59 2.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.441 179.485 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.3 mt -133.9 144.49 35.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.42 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.548 ' CG1' ' HA ' ' A' ' 20' ' ' HIS . 6.5 m -150.28 175.64 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.183 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 74.4 -150.39 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.082 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.634 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -84.93 77.74 2.08 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.319 -0.467 . . . . 0.0 112.963 -178.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 18.3 mm100 -122.09 158.71 28.66 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.859 0.361 . . . . 0.0 110.979 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.505 HG23 ' O ' ' A' ' 75' ' ' VAL . 26.9 m -117.15 154.64 30.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.141 0.496 . . . . 0.0 112.251 -178.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.591 HG12 ' CH2' ' A' ' 32' ' ' TRP . 0.7 OUTLIER -127.37 143.25 41.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.44 178.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 36.8 m -136.66 132.82 35.5 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -178.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.601 ' HB2' ' HA ' ' A' ' 45' ' ' GLU . 1.4 t80 -141.95 122.77 14.39 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.336 178.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 46.67 -87.01 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.687 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -126.66 -6.06 5.69 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.858 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.403 ' O ' ' CH2' ' A' ' 32' ' ' TRP . 1.0 OUTLIER -90.61 103.59 16.27 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.793 0.33 . . . . 0.0 111.042 -179.464 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.3 m -114.65 125.57 53.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.602 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.618 ' HB ' ' HZ2' ' A' ' 32' ' ' TRP . 47.0 t -145.59 153.58 13.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.23 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.499 ' HG3' HG23 ' A' ' 67' ' ' THR . 3.1 mp0 -112.25 158.28 19.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.813 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.634 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 46.9 t -129.2 152.22 36.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.813 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.2 m -130.89 148.97 33.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.921 0.391 . . . . 0.0 111.53 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.077 179.682 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.411 ' CB ' HG12 ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.456 -0.132 0 CA-C-O 120.898 0.38 . . . . 0.0 111.166 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.64 132.26 48.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.592 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.584 ' CD2' HD13 ' A' ' 26' ' ' LEU . 77.8 t80 -110.04 148.57 31.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.923 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.5 146.9 30.02 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.809 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 27.8 mt -114.23 -40.45 3.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.921 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.65 -103.75 2.89 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.585 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.06 56.62 0.9 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.995 0.426 . . . . 0.0 111.011 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.417 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 1.0 OUTLIER -113.36 167.33 9.49 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.578 179.863 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.583 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 19.4 Cg_endo -59.8 -33.55 96.12 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.3 2.0 . . . . 0.0 111.665 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.583 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 14.1 p80 163.01 -164.32 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.989 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.9 m -142.92 153.91 17.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.139 0.495 . . . . 0.0 112.004 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.437 ' HG3' ' CB ' ' A' ' 59' ' ' ARG . 0.7 OUTLIER -83.53 138.34 33.46 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.907 179.019 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.408 HD12 ' N ' ' A' ' 24' ' ' CYS . 4.6 pp -41.03 -33.27 0.31 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.764 0.316 . . . . 0.0 111.478 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.408 ' N ' HD12 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -71.3 -39.15 71.63 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.988 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 22' ' ' GLU . 78.8 m-20 -62.73 -52.27 63.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.05 0.452 . . . . 0.0 110.442 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.584 HD13 ' CD2' ' A' ' 13' ' ' PHE . 8.4 tp -58.23 -46.5 85.8 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.893 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.504 HD11 ' HG3' ' A' ' 45' ' ' GLU . 5.6 mp -67.33 -60.69 2.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.651 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -46.53 -65.26 0.58 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.752 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.57 -41.61 63.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.212 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 2.9 mm-40 -72.27 -15.3 61.91 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.19 26.26 12.71 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.475 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.544 ' CH2' HG12 ' A' ' 68' ' ' VAL . 9.4 m95 -76.39 -66.04 0.85 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 117.094 0.447 . . . . 0.0 110.079 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.0 t -101.0 149.29 24.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.315 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.32 -34.08 36.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.04 0.448 . . . . 0.0 110.489 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.78 -31.95 8.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.585 179.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 126.08 -60.22 0.65 Allowed Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.346 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -129.32 7.59 5.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.789 0.328 . . . . 0.0 111.281 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -54.21 -64.38 0.85 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.872 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.19 15.08 0.35 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.1 mmmt 72.24 14.14 5.58 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.622 0.249 . . . . 0.0 111.206 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.422 ' HA ' ' CE2' ' A' ' 70' ' ' PHE . 6.8 mt -65.5 -14.99 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-O 120.969 0.414 . . . . 0.0 110.739 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.21 -79.81 0.07 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.047 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 19.8 mm -52.33 -33.13 16.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.985 0.421 . . . . 0.0 110.51 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.436 ' O ' ' HG3' ' A' ' 47' ' ' GLN . . . -63.09 -72.18 0.14 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.683 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.594 ' HG2' ' HB2' ' A' ' 70' ' ' PHE . 3.6 tm-20 -35.35 -41.09 0.16 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.838 0.352 . . . . 0.0 111.157 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.437 ' C ' ' H ' ' A' ' 48' ' ' VAL . . . -63.04 -73.8 0.49 Allowed Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.277 -0.964 . . . . 0.0 110.928 178.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.436 ' HG3' ' O ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -47.96 -9.52 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -179.62 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.485 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 57.4 t -74.66 -90.67 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.644 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.596 ' HD3' ' HB ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -167.02 119.37 0.95 Allowed 'General case' 0 CA--C 1.527 0.08 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.73 179.694 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.529 ' HB ' ' O ' ' A' ' 53' ' ' ALA . 19.2 t -113.62 154.98 14.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.549 ' HB2' ' H ' ' A' ' 67' ' ' THR . 16.8 t0 -44.7 98.2 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.017 0.437 . . . . 0.0 111.611 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.93 21.43 61.18 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.339 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.529 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -145.79 79.87 1.57 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.021 0.439 . . . . 0.0 111.766 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.596 ' HB ' ' HD3' ' A' ' 49' ' ' LYS . 14.9 p -88.21 62.76 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.926 0.393 . . . . 0.0 111.044 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.42 178.4 4.65 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.297 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.8 t -139.31 40.59 2.08 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.801 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -86.91 174.39 8.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.693 0.282 . . . . 0.0 111.01 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.1 mttp -75.18 -50.27 16.8 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.965 0.412 . . . . 0.0 110.806 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.437 ' CB ' ' HG3' ' A' ' 22' ' ' GLU . 0.3 OUTLIER -106.4 136.88 45.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.27 179.402 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -100.04 115.58 30.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.949 0.404 . . . . 0.0 111.031 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.482 ' HA ' ' CG ' ' A' ' 20' ' ' HIS . 4.7 mtmt -87.12 76.01 9.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.881 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.5 mm -133.44 142.39 41.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.981 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.452 ' CG1' ' HA ' ' A' ' 20' ' ' HIS . 1.4 m -146.85 175.2 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.724 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.448 ' O ' ' HA ' ' A' ' 78' ' ' VAL . . . 74.48 -155.01 0.05 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.313 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.457 ' HA2' ' HA ' ' A' ' 78' ' ' VAL . . . -84.73 81.13 1.77 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 121.329 -0.462 . . . . 0.0 112.515 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -122.05 156.46 33.49 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.111 0.481 . . . . 0.0 111.264 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.549 ' H ' ' HB2' ' A' ' 51' ' ' ASP . 0.8 OUTLIER -113.55 152.9 29.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.752 -179.109 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.544 HG12 ' CH2' ' A' ' 32' ' ' TRP . 0.8 OUTLIER -127.34 147.07 32.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.645 179.237 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.4 m -143.16 137.8 29.31 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -178.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.594 ' HB2' ' HG2' ' A' ' 45' ' ' GLU . 1.6 t80 -144.91 121.66 11.2 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.084 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 48.72 -85.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.689 0.28 . . . . 0.0 111.347 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -126.77 -5.72 5.75 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.786 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.416 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 1.1 m-70 -88.39 104.4 16.74 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.888 0.344 . . . . 0.0 111.084 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -116.9 106.72 13.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.838 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.521 ' HB ' ' HZ2' ' A' ' 32' ' ' TRP . 38.6 t -126.17 155.94 36.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.017 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.456 ' HA ' HG21 ' A' ' 67' ' ' THR . 1.3 mt-30 -112.33 158.02 20.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.012 0.434 . . . . 0.0 111.058 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.457 HG23 ' CD1' ' A' ' 26' ' ' LEU . 29.0 t -140.39 148.0 22.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.329 -179.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.457 ' HA ' ' HA2' ' A' ' 65' ' ' GLY . 17.0 m -139.92 178.03 3.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.707 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.073 -179.902 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.552 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.452 -0.34 0 CA-C-O 120.754 0.312 . . . . 0.0 111.036 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.5 112.23 7.88 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.474 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.418 ' CD1' ' HG2' ' A' ' 30' ' ' GLU . 73.8 t80 -98.67 144.13 28.28 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.002 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.4 m -107.02 135.72 48.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.478 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.445 ' CD1' ' HA ' ' A' ' 63' ' ' VAL . 0.5 OUTLIER -84.91 -33.18 22.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.849 0.357 . . . . 0.0 110.529 179.698 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.59 33.07 28.83 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.291 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 25.5 mttm 58.73 56.14 4.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.069 0.461 . . . . 0.0 110.764 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.492 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 12.9 m170 -115.36 166.14 12.68 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.867 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.571 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 23.8 Cg_endo -60.97 -36.94 80.48 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.386 2.057 . . . . 0.0 112.151 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.571 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 22.4 p80 168.14 -174.6 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.406 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.761 HG21 HD13 ' A' ' 26' ' ' LEU . 2.5 m -140.96 160.44 23.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.189 0.519 . . . . 0.0 111.975 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.42 ' O ' ' N ' ' A' ' 25' ' ' ASP . 0.5 OUTLIER -94.26 141.76 28.19 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.038 179.351 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.491 ' HB2' ' O ' ' A' ' 58' ' ' LYS . 8.1 mt -38.08 -39.28 0.39 Allowed 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.418 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -73.4 -37.59 65.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.387 -179.396 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 22' ' ' GLU . 56.6 m-20 -61.62 -54.52 41.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.06 0.457 . . . . 0.0 111.074 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.761 HD13 HG21 ' A' ' 21' ' ' VAL . 0.4 OUTLIER -60.06 -43.31 95.52 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.658 -179.546 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.592 ' N ' HD13 ' A' ' 27' ' ' LEU . 6.7 mp -68.33 -56.87 7.05 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.701 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -56.95 -55.87 29.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.859 0.362 . . . . 0.0 111.216 -179.597 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 29' ' ' LEU . 81.9 mt -53.41 -37.73 62.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.685 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.418 ' HG2' ' CD1' ' A' ' 13' ' ' PHE . 8.7 mm-40 -79.08 -11.33 59.99 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.12 22.9 23.92 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.366 -0.921 . . . . 0.0 113.226 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.491 ' HZ2' ' HB ' ' A' ' 75' ' ' VAL . 11.9 m95 -73.97 -63.21 1.27 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.008 0.432 . . . . 0.0 109.96 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.444 ' CB ' HD13 ' A' ' 41' ' ' ILE . 4.1 t -106.95 135.19 48.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.915 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -74.43 -34.69 63.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.022 0.439 . . . . 0.0 110.247 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.0 p -106.4 -44.76 4.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.268 178.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 112.74 -21.82 17.94 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.987 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -128.63 -1.24 5.47 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 111.709 0.262 . . . . 0.0 111.709 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.4 tp60 -61.11 -79.42 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.79 0.329 . . . . 0.0 110.611 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.32 11.28 2.47 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.562 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.539 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 19.3 mttm 59.44 29.81 19.42 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 120.798 0.332 . . . . 0.0 110.297 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.512 ' HA ' ' CE2' ' A' ' 70' ' ' PHE . 8.0 mt -60.06 -17.67 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.613 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.4 -79.09 0.09 Allowed 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.822 0.344 . . . . 0.0 111.111 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 44.2 mm -47.38 -36.54 4.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.97 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.539 ' HB1' ' O ' ' A' ' 40' ' ' LYS . . . -61.81 -67.24 0.43 Allowed 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.346 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.631 ' HA ' ' HB2' ' A' ' 70' ' ' PHE . 12.3 tp10 -33.62 -42.08 0.1 Allowed 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 120.902 0.382 . . . . 0.0 110.466 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.1 -77.4 0.18 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 119.936 -1.126 . . . . 0.0 110.938 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.512 ' HG3' ' O ' ' A' ' 44' ' ' ALA . 0.6 OUTLIER -48.26 -10.88 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -179.645 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.498 ' CG1' ' HA ' ' A' ' 70' ' ' PHE . 47.5 t -75.33 -96.66 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.033 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -164.86 120.96 1.45 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 118.404 0.547 . . . . 0.0 111.576 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.56 ' HB ' ' O ' ' A' ' 53' ' ' ALA . 16.5 t -114.05 150.39 16.09 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -44.79 97.05 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.972 0.415 . . . . 0.0 111.441 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.98 16.7 70.87 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.759 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.56 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -145.91 81.14 1.59 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.122 0.487 . . . . 0.0 112.09 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.477 HG11 ' O ' ' A' ' 54' ' ' VAL . 7.0 p -90.3 71.95 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.126 0.488 . . . . 0.0 110.309 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 47' ' ' GLN . 8.2 mt-10 -99.34 -173.14 2.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.817 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 t -147.29 46.19 1.14 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.908 0.385 . . . . 0.0 111.62 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 19.0 mtt-85 -98.02 174.54 6.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.535 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.491 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 1.7 mptp? -75.2 -38.12 60.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.012 0.434 . . . . 0.0 110.08 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -127.72 158.29 38.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.064 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -133.96 115.8 14.81 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.388 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.471 ' HG2' ' CD2' ' A' ' 20' ' ' HIS . 31.4 mtmt -74.14 94.53 2.44 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.499 HD11 HG21 ' A' ' 62' ' ' ILE . 5.8 mm -133.49 144.89 34.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.328 -178.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.56 HG12 ' HA ' ' A' ' 20' ' ' HIS . 14.3 m -148.4 174.45 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.807 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 72.69 -151.27 0.07 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.64 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -88.87 81.26 1.54 Allowed Glycine 0 C--N 1.337 0.585 0 C-N-CA 121.472 -0.394 . . . . 0.0 112.6 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -122.05 156.06 34.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.135 0.493 . . . . 0.0 111.414 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 40.3 m -118.65 147.69 43.51 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.233 -178.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.457 HG12 ' CH2' ' A' ' 32' ' ' TRP . 0.7 OUTLIER -124.21 148.23 28.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.031 178.986 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.411 ' O ' HG11 ' A' ' 48' ' ' VAL . 58.1 m -141.7 138.46 32.44 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.631 ' HB2' ' HA ' ' A' ' 45' ' ' GLU . 2.8 t80 -152.16 127.08 9.64 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.614 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 47.55 -85.85 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.334 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -128.2 -7.92 4.29 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.039 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.452 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 1.9 m-70 -89.22 108.77 19.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.145 0.472 . . . . 0.0 111.391 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -118.99 107.45 13.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.171 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.552 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 22.0 t -130.5 152.95 38.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.039 0.447 . . . . 0.0 111.944 -178.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.544 ' N ' HG11 ' A' ' 75' ' ' VAL . 28.6 mt-30 -111.87 164.29 13.26 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.427 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.64 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 21.3 t -136.52 148.73 26.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.547 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.404 ' N ' HG13 ' A' ' 77' ' ' VAL . 27.2 m -131.63 160.05 42.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.947 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.291 -0.861 . . . . 0.0 111.144 179.978 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.446 ' O ' HG11 ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.456 -0.141 0 CA-C-O 120.758 0.313 . . . . 0.0 111.045 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.462 ' HA ' HG11 ' A' ' 75' ' ' VAL . 72.1 p -137.0 129.04 29.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.185 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.631 ' HB3' HG23 ' A' ' 77' ' ' VAL . 41.6 t80 -98.36 154.48 17.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.006 0.431 . . . . 0.0 110.749 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.7 m -106.42 155.53 19.46 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.107 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.598 ' CD1' ' HA ' ' A' ' 63' ' ' VAL . 6.7 mt -122.2 -31.51 3.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.545 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.19 -111.7 3.42 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.023 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -149.84 54.72 0.94 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.306 0.574 . . . . 0.0 110.16 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.678 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 16.2 m-70 -118.98 168.6 9.5 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.766 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.678 ' HD2' ' HB3' ' A' ' 18' ' ' HIS . 7.7 Cg_endo -48.36 -44.45 29.46 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.742 2.295 . . . . 0.0 112.62 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.552 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 3.9 p80 162.75 -165.65 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.091 0.556 . . . . 0.0 109.929 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.575 HG13 HD23 ' A' ' 15' ' ' LEU . 15.5 m -134.77 147.23 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 120.959 0.409 . . . . 0.0 111.888 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.577 ' HA ' ' H ' ' A' ' 60' ' ' CYS . 1.2 mt-10 -83.93 143.54 29.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.634 179.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.519 HD13 ' N ' ' A' ' 60' ' ' CYS . 2.5 mp -39.82 -36.45 0.44 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.83 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 9.2 t -76.31 -35.51 58.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.329 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' A' ' 22' ' ' GLU . 30.1 m-20 -64.29 -62.03 1.87 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.969 0.414 . . . . 0.0 110.691 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.505 HD23 HG22 ' A' ' 68' ' ' VAL . 9.7 tt -55.05 -44.98 75.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.338 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.572 ' N ' HD11 ' A' ' 27' ' ' LEU . 5.8 mp -62.23 -54.35 42.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.698 -178.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.9 -48.89 79.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.635 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.451 HD13 ' CZ ' ' A' ' 13' ' ' PHE . 45.7 mt -58.35 -48.13 81.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.267 -0.424 . . . . 0.0 112.012 -179.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.497 ' CG ' ' HB2' ' A' ' 13' ' ' PHE . 7.4 mm-40 -70.75 -12.25 61.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.55 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.96 23.26 30.56 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.846 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.519 ' CZ3' ' HB2' ' A' ' 73' ' ' HIS . 23.1 m95 -64.63 -73.52 0.12 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.8 0.333 . . . . 0.0 110.334 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.518 ' HB2' HG21 ' A' ' 41' ' ' ILE . 24.6 t -92.91 147.27 22.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.787 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -76.75 -33.32 58.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.684 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.445 ' OG ' ' HB3' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -105.42 -28.8 10.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.112 179.71 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 115.79 -72.71 0.26 Allowed Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.445 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -120.41 -2.96 9.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.771 0.32 . . . . 0.0 111.042 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.445 ' HB3' ' OG ' ' A' ' 35' ' ' SER . 3.9 tp60 -52.63 -62.85 1.38 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.914 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.415 ' HB3' HG12 ' A' ' 41' ' ' ILE . . . -73.87 15.05 0.32 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.797 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.8 mttt 68.61 15.95 9.07 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.695 0.283 . . . . 0.0 111.046 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.518 HG21 ' HB2' ' A' ' 33' ' ' SER . 45.5 mm -58.54 -20.93 17.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.023 0.439 . . . . 0.0 110.926 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.05 -76.4 0.12 Allowed 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.93 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.6 mm -47.85 -42.52 9.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.772 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.56 ' HB3' ' CZ ' ' A' ' 70' ' ' PHE . . . -57.94 -66.6 0.45 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.383 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' A' ' 44' ' ' ALA . 9.3 tp10 -30.94 -44.83 0.06 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.56 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.93 -74.56 0.36 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.169 -1.015 . . . . 0.0 110.892 178.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.412 ' HA ' ' O ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -47.57 -11.58 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -179.787 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.471 ' CG2' ' CD1' ' A' ' 70' ' ' PHE . 39.7 t -75.32 -99.61 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 O-C-N 122.137 -0.352 . . . . 0.0 111.668 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.671 ' HD3' ' HB ' ' A' ' 54' ' ' VAL . 8.2 mmtp -161.0 138.64 9.29 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.702 0.683 . . . . 0.0 111.839 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.649 ' HB ' ' O ' ' A' ' 53' ' ' ALA . 44.1 t -127.58 147.91 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.706 ' HB2' ' HB ' ' A' ' 67' ' ' THR . 12.9 t0 -44.03 87.01 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -177.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 101.87 -19.13 50.83 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.739 -0.743 . . . . 0.0 114.821 177.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.649 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -146.77 136.68 23.31 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 118.41 1.105 . . . . 0.0 113.041 -178.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.671 ' HB ' ' HD3' ' A' ' 49' ' ' LYS . 11.3 p -107.43 108.68 25.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.238 178.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.412 ' O ' ' HA ' ' A' ' 47' ' ' GLN . 47.3 mt-10 -102.98 -170.28 1.77 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.642 0.258 . . . . 0.0 110.845 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.6 t -164.0 30.27 0.08 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.354 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.17 169.99 9.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.947 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.1 ttpp -75.86 -43.83 43.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.594 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.428 ' HA ' ' HG2' ' A' ' 22' ' ' GLU . 0.3 OUTLIER -102.31 142.63 33.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.747 179.854 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . 0.577 ' H ' ' HA ' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -100.08 116.58 32.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.805 -179.789 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.3 mtmt -103.74 78.75 1.59 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.173 0.511 . . . . 0.0 109.875 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.0 mt -138.95 148.92 23.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.172 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.598 ' HA ' ' CD1' ' A' ' 15' ' ' LEU . 1.3 m -151.11 175.09 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.698 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 78.76 -138.45 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.562 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -104.41 84.25 0.42 Allowed Glycine 0 C--N 1.339 0.695 0 C-N-CA 121.041 -0.599 . . . . 0.0 113.624 -178.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 61.9 mm-40 -122.05 163.19 19.85 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.757 0.313 . . . . 0.0 111.145 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.706 ' HB ' ' HB2' ' A' ' 51' ' ' ASP . 8.9 m -119.11 139.87 51.06 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.247 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.505 HG22 HD23 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -110.68 137.16 44.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.36 179.558 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.46 ' O ' HG11 ' A' ' 48' ' ' VAL . 2.6 m -132.0 128.18 37.83 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.919 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.56 ' CZ ' ' HB3' ' A' ' 44' ' ' ALA . 4.1 t80 -175.68 130.38 0.26 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.351 179.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.452 ' N ' ' CD1' ' A' ' 70' ' ' PHE . . . 56.99 44.91 22.08 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.393 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 70.16 1.6 35.23 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.791 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.519 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 8.3 m-70 -94.55 98.16 10.64 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.877 0.338 . . . . 0.0 111.111 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.96 101.77 11.79 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.549 ' O ' HG21 ' A' ' 67' ' ' THR . 40.8 t -120.37 147.55 24.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.569 -178.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.494 ' HG3' ' OG1' ' A' ' 67' ' ' THR . 2.0 mp0 -111.94 145.65 39.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.667 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.631 HG23 ' HB3' ' A' ' 13' ' ' PHE . 8.0 t -120.62 145.66 26.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.333 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.8 m -128.59 157.53 41.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.947 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.294 -0.86 . . . . 0.0 111.04 179.882 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.523 ' O ' HG12 ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.452 -0.356 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.62 135.85 40.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.94 0.4 . . . . 0.0 110.773 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.72 ' CE2' ' HA ' ' A' ' 26' ' ' LEU . 31.7 t80 -103.98 143.11 33.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.557 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.447 ' O ' ' CE1' ' A' ' 13' ' ' PHE . 0.4 OUTLIER -106.84 132.63 52.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.389 179.471 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 63' ' ' VAL . 0.5 OUTLIER -75.51 -37.23 60.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.82 0.343 . . . . 0.0 110.845 179.868 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.66 29.48 26.62 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.306 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.19 43.18 20.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.053 0.454 . . . . 0.0 110.722 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.454 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.9 OUTLIER -114.67 168.6 7.8 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.845 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.48 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 8.8 Cg_endo -50.38 -43.68 42.92 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.694 2.263 . . . . 0.0 112.215 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.48 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 6.3 p80 172.85 -163.79 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.839 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.8 m -142.05 153.58 18.72 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.474 ' HG2' ' CB ' ' A' ' 59' ' ' ARG . 14.6 mt-10 -100.64 153.8 19.11 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.135 178.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.67 ' HB2' ' O ' ' A' ' 58' ' ' LYS . 1.5 mp -40.23 -54.85 2.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.732 0.301 . . . . 0.0 111.42 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.568 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -57.63 -33.75 68.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.748 179.791 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -72.31 -55.07 7.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.884 0.373 . . . . 0.0 110.975 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.72 ' HA ' ' CE2' ' A' ' 13' ' ' PHE . 7.6 tt -57.79 -47.93 81.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.406 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.625 ' HG ' ' CE3' ' A' ' 32' ' ' TRP . 7.5 mp -64.45 -59.14 4.69 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.568 ' HB2' ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -51.49 -59.21 4.51 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.263 -178.723 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.47 -50.62 69.4 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -178.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.532 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 2.0 mm-40 -61.85 -15.26 40.74 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.05 23.04 13.79 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.319 -0.943 . . . . 0.0 113.443 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.625 ' CE3' ' HG ' ' A' ' 27' ' ' LEU . 7.7 m0 -73.53 -66.48 0.69 Allowed 'General case' 0 C--O 1.232 0.165 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.2 t -106.83 143.25 35.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.185 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -70.24 -34.15 72.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.852 0.358 . . . . 0.0 110.692 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.469 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -105.73 -52.14 2.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.443 179.307 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 139.07 -31.82 2.33 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.432 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.98 8.7 2.1 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.469 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 3.2 tp-100 -55.25 -71.11 0.09 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.703 0.287 . . . . 0.0 111.155 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.56 15.5 0.47 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 71.44 19.44 5.21 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.045 0.45 . . . . 0.0 110.35 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.576 ' HA ' ' CE2' ' A' ' 70' ' ' PHE . 9.9 mt -61.13 -22.86 28.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.293 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.64 -77.75 0.08 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.997 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.4 ' CD1' ' HG2' ' A' ' 58' ' ' LYS . 37.1 mm -51.61 -41.78 28.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.928 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.528 ' HA ' HE21 ' A' ' 47' ' ' GLN . . . -57.74 -71.19 0.11 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.623 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.515 ' HG3' HD11 ' A' ' 27' ' ' LEU . 1.6 tm-20 -33.46 -40.13 0.06 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.013 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.454 ' C ' ' H ' ' A' ' 48' ' ' VAL . . . -60.09 -75.35 0.28 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.289 -0.957 . . . . 0.0 110.986 178.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.528 HE21 ' HA ' ' A' ' 44' ' ' ALA . 23.7 pt20 -49.15 -8.17 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.517 HG13 ' H ' ' A' ' 71' ' ' ALA . 97.7 t -75.33 -98.71 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.144 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.427 ' HG2' ' O ' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -161.87 126.15 3.29 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.973 -179.303 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.515 HG12 ' O ' ' A' ' 67' ' ' THR . 21.4 t -121.73 149.2 24.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.479 ' HB2' ' HB ' ' A' ' 67' ' ' THR . 22.2 t0 -44.96 102.48 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.864 0.364 . . . . 0.0 111.224 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 63.52 20.78 64.0 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.172 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.484 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -146.19 74.6 1.38 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.981 0.42 . . . . 0.0 111.657 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.5 p -86.25 63.72 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.983 0.42 . . . . 0.0 110.263 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.415 ' O ' ' HA ' ' A' ' 47' ' ' GLN . 21.6 mt-10 -102.29 -170.21 1.78 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.506 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.524 ' OG1' ' HB3' ' A' ' 47' ' ' GLN . 3.1 t -142.89 47.67 1.53 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.553 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 45.3 mtp85 -98.53 174.22 6.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.962 0.41 . . . . 0.0 111.3 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.67 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 24.0 mttm -79.61 -38.67 33.35 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.924 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.474 ' CB ' ' HG2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -128.34 159.36 35.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.856 -179.759 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -140.67 115.79 9.85 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.218 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.74 96.88 2.1 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.479 ' CG2' ' HG3' ' A' ' 66' ' ' GLN . 13.1 mt -133.47 136.01 55.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.809 -178.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.455 ' O ' ' HB3' ' A' ' 64' ' ' ALA . 31.1 m -141.72 175.6 5.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.535 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.455 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 71.19 -136.52 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.635 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.567 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -106.37 86.04 0.46 Allowed Glycine 0 C--N 1.339 0.702 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.192 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.479 ' HG3' ' CG2' ' A' ' 62' ' ' ILE . 8.4 mm-40 -122.05 172.25 8.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.716 0.293 . . . . 0.0 111.47 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 4.9 m -130.31 152.13 50.06 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.443 HG23 ' CD1' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -135.52 152.64 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.385 179.795 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.615 ' HA ' ' O ' ' A' ' 73' ' ' HIS . 0.4 OUTLIER -146.25 137.63 24.63 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -179.643 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.576 ' CE2' ' HA ' ' A' ' 41' ' ' ILE . 1.8 t80 -137.12 118.7 14.89 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.619 178.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.517 ' H ' HG13 ' A' ' 48' ' ' VAL . . . 38.2 30.01 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 116.39 -6.63 18.76 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.365 -0.921 . . . . 0.0 113.563 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.615 ' O ' ' HA ' ' A' ' 69' ' ' SER . 1.4 m-70 -88.13 82.98 7.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.317 0.558 . . . . 0.0 111.145 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.6 119.81 29.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.749 0.309 . . . . 0.0 110.71 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.533 ' HB ' ' HZ2' ' A' ' 32' ' ' TRP . 43.1 t -142.57 152.75 17.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.09 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.532 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 7.7 mt-30 -112.61 164.23 13.58 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.7 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.567 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 6.7 t -131.9 142.8 42.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.225 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 64' ' ' ALA . 28.1 m -138.44 169.15 18.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.184 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.118 -0.944 . . . . 0.0 111.212 179.956 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.42 ' O ' HG13 ' A' ' 75' ' ' VAL . . . . . . . . 0 CA--C 1.523 -0.089 0 CA-C-O 120.89 0.376 . . . . 0.0 110.705 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.44 131.93 43.93 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.376 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.459 ' HB3' ' CG2' ' A' ' 77' ' ' VAL . 40.8 t80 -110.39 165.3 11.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.557 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.27 140.71 35.19 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.943 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.41 ' HB2' ' CG1' ' A' ' 77' ' ' VAL . 0.4 OUTLIER -142.3 -36.03 0.42 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.944 -179.37 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.436 ' N ' ' HA ' ' A' ' 79' ' ' ALA . . . -48.58 -30.06 8.17 Favored Glycine 0 C--N 1.329 0.153 0 C-N-CA 120.98 -0.629 . . . . 0.0 113.164 -179.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.73 -34.33 65.06 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.837 0.351 . . . . 0.0 110.839 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.604 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 3.9 m-70 -117.45 163.88 21.78 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.893 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.604 ' HD2' ' HB3' ' A' ' 18' ' ' HIS . 15.8 Cg_endo -56.13 -35.14 94.69 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.569 2.179 . . . . 0.0 111.985 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.476 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 2.5 p80 174.98 -176.37 0.09 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.431 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.436 HG11 ' O ' ' A' ' 20' ' ' HIS . 13.6 m -145.32 164.21 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.422 ' CB ' ' HB3' ' A' ' 59' ' ' ARG . 1.5 pt-20 -99.83 153.17 19.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.2 178.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.1 mt -41.13 -41.84 1.87 Allowed 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 40.9 t -70.8 -38.72 73.36 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.638 0.256 . . . . 0.0 111.547 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -63.35 -60.96 2.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.947 0.403 . . . . 0.0 110.841 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.453 HD11 ' CG2' ' A' ' 77' ' ' VAL . 0.7 OUTLIER -50.86 -42.18 58.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.04 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.557 ' HG ' ' CE3' ' A' ' 32' ' ' TRP . 4.4 mp -68.01 -64.74 0.8 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.78 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.9 tmmm? -43.34 -61.45 1.35 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.66 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.412 ' HB3' ' CZ ' ' A' ' 13' ' ' PHE . 0.5 OUTLIER -54.49 -40.56 68.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.77 -179.426 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.447 ' HG2' ' CD1' ' A' ' 13' ' ' PHE . 8.7 mm-40 -69.43 -14.54 62.95 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.46 20.78 21.47 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.28 -0.962 . . . . 0.0 112.92 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.633 ' CZ3' ' HB2' ' A' ' 73' ' ' HIS . 8.3 m0 -75.63 -66.52 0.77 Allowed 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.468 ' OG ' HD12 ' A' ' 41' ' ' ILE . 30.1 t -106.86 137.03 45.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.595 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -70.75 -33.82 71.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.039 0.447 . . . . 0.0 110.295 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.485 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 0.1 OUTLIER -105.74 -55.4 2.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.314 179.223 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.403 ' N ' ' OG ' ' A' ' 33' ' ' SER . . . 126.68 -33.53 3.39 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.303 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -123.04 -5.49 8.45 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.485 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 0.8 OUTLIER -52.52 -76.34 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.839 0.352 . . . . 0.0 111.029 -179.728 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.449 ' HB3' HD13 ' A' ' 41' ' ' ILE . . . -77.15 15.77 0.67 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.249 -0.432 . . . . 0.0 112.14 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 4.5 mmtt 68.53 24.26 7.07 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.068 0.461 . . . . 0.0 110.098 -179.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.594 ' HA ' ' CE2' ' A' ' 70' ' ' PHE . 3.9 mp -57.86 -24.86 24.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.449 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.92 -77.35 0.13 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.259 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.3 mm -48.96 -42.24 14.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-O 121.017 0.437 . . . . 0.0 110.644 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.472 ' O ' ' C ' ' A' ' 45' ' ' GLU . . . -57.64 -69.05 0.18 Allowed 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.446 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.555 ' HB2' HD21 ' A' ' 27' ' ' LEU . 9.0 tp10 -29.81 -44.13 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.011 0.434 . . . . 0.0 110.672 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 55' ' ' GLU . . . -59.61 -74.89 0.31 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.115 -1.041 . . . . 0.0 110.621 178.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.528 ' N ' ' HA ' ' A' ' 56' ' ' THR . 2.3 pt20 -48.64 -12.94 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.462 HG23 ' CD1' ' A' ' 70' ' ' PHE . 47.5 t -75.06 -98.17 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.933 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -165.98 122.71 1.37 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 118.37 0.532 . . . . 0.0 111.921 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.46 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 31.7 t -117.33 152.29 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.53 ' HB2' ' O ' ' A' ' 67' ' ' THR . 3.7 t0 -44.72 101.29 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.909 0.385 . . . . 0.0 111.492 -179.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 62.63 21.89 63.3 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.415 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.46 ' HB1' ' HB ' ' A' ' 50' ' ' VAL . . . -145.83 75.57 1.43 Allowed 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 121.037 0.446 . . . . 0.0 111.67 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.1 p -87.13 67.37 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.961 0.41 . . . . 0.0 110.485 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.447 ' O ' ' O ' ' A' ' 46' ' ' GLY . 0.2 OUTLIER -102.56 -166.25 1.26 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.062 -179.356 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.528 ' HA ' ' N ' ' A' ' 47' ' ' GLN . 3.4 t -145.8 37.99 1.09 Allowed 'General case' 0 C--O 1.232 0.154 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.09 174.79 7.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.825 0.345 . . . . 0.0 111.041 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.4 tttt -78.68 -41.6 30.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.738 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.422 ' HB3' ' CB ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -124.49 154.59 40.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.62 179.796 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -136.74 115.38 12.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.394 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.6 mttt -69.48 99.09 1.19 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 17.1 mt -133.46 144.04 37.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.633 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.411 HG12 ' O ' ' A' ' 19' ' ' PRO . 7.8 m -149.5 175.3 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.862 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.453 ' HA ' ' HB2' ' A' ' 79' ' ' ALA . . . 72.31 -149.73 0.07 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 178.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.562 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -92.33 81.3 1.16 Allowed Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 116.298 -0.41 . . . . 0.0 112.953 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.92 157.47 31.13 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.208 0.528 . . . . 0.0 111.378 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.611 HG21 ' O ' ' A' ' 75' ' ' VAL . 2.9 m -113.72 150.86 32.71 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.836 -178.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.515 HG11 ' CH2' ' A' ' 32' ' ' TRP . 1.2 t -128.27 145.15 35.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.023 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.527 ' HA ' ' O ' ' A' ' 73' ' ' HIS . 1.1 m -136.07 132.21 35.86 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.594 ' CE2' ' HA ' ' A' ' 41' ' ' ILE . 2.6 t80 -147.14 123.34 10.86 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.232 178.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.409 ' N ' ' CD1' ' A' ' 70' ' ' PHE . . . 41.57 30.66 0.15 Allowed 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.2 -4.06 38.06 Favored Glycine 0 C--N 1.329 0.171 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.422 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.633 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 2.7 m-70 -90.47 98.53 11.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.853 0.327 . . . . 0.0 110.829 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -108.99 114.16 27.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.853 0.359 . . . . 0.0 111.424 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.611 ' O ' HG21 ' A' ' 67' ' ' THR . 17.6 t -138.21 156.32 30.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.761 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 9.5 mt-30 -112.6 165.61 12.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.136 0.493 . . . . 0.0 111.709 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.562 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 21.3 t -141.4 150.4 19.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.587 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.42 ' N ' HG13 ' A' ' 77' ' ' VAL . 18.2 m -130.52 166.13 28.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.886 0.374 . . . . 0.0 111.759 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.453 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . . . . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.238 -0.887 . . . . 0.0 111.096 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.177 0 CA-C-O 120.78 0.324 . . . . 0.0 110.826 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.55 119.03 22.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.865 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.506 ' CD2' HD13 ' A' ' 26' ' ' LEU . 29.5 t80 -98.66 149.9 22.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.542 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.3 m -105.33 147.69 27.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.979 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.6 mt -127.44 -36.28 2.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.955 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.09 -111.67 3.49 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.688 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.9 tttt -136.72 52.89 1.93 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.875 0.369 . . . . 0.0 110.903 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -103.89 155.62 36.79 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.972 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.618 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 8.1 Cg_endo -50.56 -44.56 39.42 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.789 2.326 . . . . 0.0 112.235 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.618 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 12.6 p80 164.64 -166.98 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.491 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.482 ' O ' ' O ' ' A' ' 60' ' ' CYS . 14.9 m -143.58 155.92 16.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.474 ' HG2' ' HA ' ' A' ' 59' ' ' ARG . 1.4 mt-10 -87.01 141.07 28.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.03 178.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.426 HD13 ' N ' ' A' ' 24' ' ' CYS . 4.1 pp -40.94 -38.35 0.95 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.716 0.293 . . . . 0.0 111.381 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.426 ' N ' HD13 ' A' ' 23' ' ' LEU . 3.7 t -69.37 -39.51 78.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.89 0.376 . . . . 0.0 110.742 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 22' ' ' GLU . 87.8 m-20 -61.03 -59.21 5.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.629 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.506 HD13 ' CD2' ' A' ' 13' ' ' PHE . 8.2 tp -50.3 -46.99 55.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.616 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.464 ' HG ' ' CE3' ' A' ' 32' ' ' TRP . 6.8 mp -66.45 -60.91 2.31 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.865 -179.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -50.92 -55.47 17.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.317 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.78 -42.39 71.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.716 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.43 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 1.5 mm-40 -74.36 -13.83 60.79 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.0 24.75 14.23 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.251 -0.976 . . . . 0.0 113.281 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.586 ' HZ2' ' HB ' ' A' ' 75' ' ' VAL . 9.7 m95 -74.68 -63.42 1.25 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 117.003 0.401 . . . . 0.0 110.07 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 39.4 t -106.85 142.92 35.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.344 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -77.94 -34.48 51.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.837 0.351 . . . . 0.0 110.739 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.415 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 31.0 p -106.07 -41.72 5.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.309 178.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 115.82 -33.94 4.98 Favored Glycine 0 CA--C 1.52 0.36 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.771 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -129.56 8.55 5.41 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.415 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 10.4 tp60 -60.48 -74.57 0.07 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.909 0.385 . . . . 0.0 110.541 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.7 15.16 1.43 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.725 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 64.61 27.54 13.27 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.994 0.426 . . . . 0.0 110.201 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.6 mp -62.67 -16.87 17.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.085 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.68 -80.68 0.05 Allowed 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.456 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 36.4 mm -52.05 -34.31 17.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.859 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.433 ' HB1' ' CE1' ' A' ' 70' ' ' PHE . . . -61.33 -72.31 0.12 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.62 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.597 ' HA ' ' HB2' ' A' ' 70' ' ' PHE . 4.9 tm-20 -35.08 -41.17 0.14 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.263 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.433 ' C ' ' H ' ' A' ' 48' ' ' VAL . . . -60.91 -74.16 0.41 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.177 -1.011 . . . . 0.0 110.972 178.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -48.49 -9.35 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.452 HG23 ' CD1' ' A' ' 70' ' ' PHE . 58.2 t -74.66 -89.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.352 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.41 ' HG2' ' O ' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -170.31 120.97 0.62 Allowed 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 120.011 -0.676 . . . . 0.0 112.534 179.763 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.588 ' HB ' ' O ' ' A' ' 53' ' ' ALA . 40.9 t -114.29 147.47 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.457 ' N ' HG12 ' A' ' 50' ' ' VAL . 3.3 t70 -44.99 98.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.053 0.454 . . . . 0.0 111.498 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.44 15.71 73.09 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.727 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.588 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -145.86 78.03 1.52 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.976 0.417 . . . . 0.0 112.004 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.9 p -88.57 62.39 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.977 0.418 . . . . 0.0 110.465 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -99.8 -170.77 1.94 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.063 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.7 t -150.85 36.81 0.63 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.427 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.7 mtt180 -81.08 168.79 18.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.519 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.1 -44.93 44.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.046 0.451 . . . . 0.0 109.924 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.474 ' HA ' ' HG2' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -103.66 150.43 24.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.77 179.615 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . 0.482 ' O ' ' O ' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -116.95 118.13 31.59 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.01 0.433 . . . . 0.0 111.434 -179.43 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.3 mttm -96.11 71.51 2.87 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.037 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.415 ' CG2' ' HG3' ' A' ' 66' ' ' GLN . 33.2 mt -136.05 147.4 28.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.702 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.489 HG12 ' HA ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -152.51 175.14 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.776 179.52 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 77.96 -149.2 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.916 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.508 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -84.93 78.27 2.02 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 121.285 -0.484 . . . . 0.0 112.578 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.415 ' HG3' ' CG2' ' A' ' 62' ' ' ILE . 20.6 mm-40 -121.66 155.62 34.77 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.066 0.46 . . . . 0.0 111.108 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 59.3 m -116.79 152.91 33.41 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.585 -178.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.469 ' CG1' ' CH2' ' A' ' 32' ' ' TRP . 1.1 t -127.9 145.58 34.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.668 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 49' ' ' LYS . 22.2 m -143.05 135.87 27.8 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.597 ' HB2' ' HA ' ' A' ' 45' ' ' GLU . 2.2 t80 -148.48 124.06 10.41 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.195 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 51.99 -85.12 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.353 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -129.97 -3.22 4.98 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.912 -0.661 . . . . 0.0 113.012 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.453 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 2.1 m-70 -92.63 108.38 19.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.929 0.365 . . . . 0.0 111.44 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.91 102.66 8.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.338 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.586 ' HB ' ' HZ2' ' A' ' 32' ' ' TRP . 99.4 t -125.19 151.94 31.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.347 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.515 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 13.0 mt-30 -112.97 160.62 17.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.995 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.508 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 21.8 t -131.25 148.66 32.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.503 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.8 m -140.02 171.65 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.792 0.33 . . . . 0.0 111.497 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.506 -0.759 . . . . 0.0 111.059 179.933 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 -0.119 0 CA-C-O 120.848 0.356 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.53 134.14 39.14 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.405 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.511 ' CZ ' ' HB3' ' A' ' 29' ' ' LEU . 19.2 t80 -105.61 90.11 3.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.864 0.364 . . . . 0.0 110.827 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 38.6 t -73.38 95.14 2.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.904 0.383 . . . . 0.0 110.897 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.41 HD12 ' CG1' ' A' ' 21' ' ' VAL . 1.0 OUTLIER -55.63 -35.28 65.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.933 179.789 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.67 48.24 3.01 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.403 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.6 tttt 58.56 54.89 5.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.939 0.4 . . . . 0.0 110.934 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.66 166.79 10.71 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.157 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.5 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 28.2 Cg_endo -62.51 -48.8 6.78 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.617 2.211 . . . . 0.0 112.091 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.5 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 3.1 p80 173.86 -173.67 0.06 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.327 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.463 ' N ' ' ND1' ' A' ' 20' ' ' HIS . 4.1 m -142.12 158.3 20.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.441 0.639 . . . . 0.0 112.723 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.554 ' HG2' ' HG2' ' A' ' 59' ' ' ARG . 1.1 mp0 -100.81 149.96 23.3 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.002 178.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.477 HD23 ' CD ' ' A' ' 45' ' ' GLU . 0.1 OUTLIER -39.64 -53.65 2.13 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.232 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 37.5 t -60.93 -32.2 71.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.89 0.376 . . . . 0.0 110.77 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.574 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 0.9 OUTLIER -68.94 -58.83 3.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.98 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.501 HD13 ' CG2' ' A' ' 77' ' ' VAL . 3.2 tp -52.52 -48.09 66.24 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.882 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.579 HD22 ' HG3' ' A' ' 45' ' ' GLU . 4.1 mt -64.77 -58.75 5.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.699 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.72 -57.36 12.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.803 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.574 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.3 OUTLIER -50.81 -39.34 52.83 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.026 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.43 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 2.5 mm-40 -79.2 -8.09 58.74 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.75 25.28 32.87 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.313 -0.946 . . . . 0.0 113.168 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.735 ' CZ3' ' HB2' ' A' ' 73' ' ' HIS . 19.6 m95 -71.17 -65.52 0.73 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.869 0.366 . . . . 0.0 110.485 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.452 ' HB2' ' CG2' ' A' ' 41' ' ' ILE . 8.3 t -100.53 147.61 25.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.51 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -71.01 -34.81 71.68 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.668 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.3 p -106.68 -59.29 1.82 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.012 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 131.69 -19.28 4.76 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.406 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.46 -2.58 0.86 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.415 ' C ' ' H ' ' A' ' 40' ' ' LYS . 23.4 tp60 -60.13 -74.71 0.07 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.866 0.365 . . . . 0.0 110.41 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.41 14.11 0.37 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.497 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.415 ' H ' ' C ' ' A' ' 38' ' ' GLN . 3.7 mttt 66.92 20.18 10.54 Favored 'General case' 0 C--O 1.23 0.057 0 CA-C-O 120.776 0.322 . . . . 0.0 110.702 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.452 ' CG2' ' HB2' ' A' ' 33' ' ' SER . 48.0 mm -51.0 -29.62 8.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.753 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.38 -78.68 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.77 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.424 ' CD1' ' HG3' ' A' ' 58' ' ' LYS . 25.1 mm -49.81 -38.4 13.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.072 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.455 ' O ' ' HG2' ' A' ' 47' ' ' GLN . . . -61.21 -71.68 0.14 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.122 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.579 ' HG3' HD22 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -33.41 -40.48 0.07 Allowed 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 120.859 0.361 . . . . 0.0 110.594 -179.41 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.463 ' CA ' HD22 ' A' ' 23' ' ' LEU . . . -58.24 -76.12 0.23 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 119.718 -1.229 . . . . 0.0 110.531 177.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 44' ' ' ALA . 5.5 pt20 -50.24 -9.46 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.528 HG22 ' HA ' ' A' ' 45' ' ' GLU . 38.9 t -75.45 -101.24 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.007 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.5 ' HD3' ' HB ' ' A' ' 54' ' ' VAL . 1.5 mmtm -163.15 120.02 1.86 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 119.117 0.871 . . . . 0.0 112.657 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.502 ' HB ' ' O ' ' A' ' 53' ' ' ALA . 13.7 t -112.85 142.82 24.0 Favored 'Isoleucine or valine' 0 C--N 1.338 0.081 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.455 ' HB2' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -48.6 95.74 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.916 0.388 . . . . 0.0 111.023 -179.461 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.7 15.68 80.38 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.498 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.502 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -146.1 75.78 1.43 Allowed 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.078 0.465 . . . . 0.0 111.627 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.5 ' HB ' ' HD3' ' A' ' 49' ' ' LYS . 10.9 p -90.58 65.91 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.907 0.384 . . . . 0.0 110.74 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.442 ' O ' ' O ' ' A' ' 46' ' ' GLY . 44.1 mm-40 -102.08 -174.66 2.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.087 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.4 ' HA ' ' N ' ' A' ' 47' ' ' GLN . 1.7 t -143.95 41.4 1.41 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.945 0.402 . . . . 0.0 111.373 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.53 175.22 6.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.983 0.421 . . . . 0.0 110.808 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -81.04 -25.68 36.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.776 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.554 ' HG2' ' HG2' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -140.77 148.97 41.49 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.893 179.806 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -137.24 116.52 12.65 Favored 'General case' 0 CA--C 1.523 -0.078 0 CA-C-O 120.803 0.335 . . . . 0.0 110.892 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.5 mttm -74.66 102.89 4.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.526 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.4 mt -132.93 133.59 58.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.023 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.45 ' CG1' ' O ' ' A' ' 19' ' ' PRO . 35.4 m -140.46 174.96 7.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.696 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 72.27 -133.77 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.68 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.488 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -109.25 84.82 0.38 Allowed Glycine 0 C--N 1.338 0.691 0 C-N-CA 121.031 -0.604 . . . . 0.0 113.609 -178.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -122.92 167.23 13.83 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.599 0.238 . . . . 0.0 111.242 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.613 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 5.2 m -126.01 153.52 44.26 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.084 0.469 . . . . 0.0 111.866 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.641 HG12 ' CH2' ' A' ' 32' ' ' TRP . 1.2 t -132.23 147.11 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.978 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.404 ' O ' HG13 ' A' ' 48' ' ' VAL . 13.8 m -134.64 136.59 42.97 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.84 0.352 . . . . 0.0 111.703 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.482 ' CD1' ' CG2' ' A' ' 48' ' ' VAL . 6.2 t80 -176.13 137.21 0.31 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.632 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.48 ' N ' ' CD1' ' A' ' 70' ' ' PHE . . . 50.24 37.01 13.85 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.732 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.44 -4.74 66.74 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.434 -0.889 . . . . 0.0 112.823 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.735 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 5.0 m-70 -89.92 107.64 19.23 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.75 0.309 . . . . 0.0 111.189 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.17 103.81 12.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.214 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.541 ' HB ' ' HZ2' ' A' ' 32' ' ' TRP . 64.9 t -132.5 154.36 39.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.63 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.613 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 20.3 mt-30 -112.96 168.81 9.39 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.013 0.435 . . . . 0.0 111.161 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.501 ' CG2' HD13 ' A' ' 26' ' ' LEU . 20.4 t -124.34 137.81 55.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.674 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.4 m -126.84 147.87 31.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.876 0.37 . . . . 0.0 111.208 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.433 -179.586 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.507 ' O ' HG13 ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.454 -0.248 0 CA-C-O 120.838 0.352 . . . . 0.0 110.576 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.14 128.33 53.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.904 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.582 ' O ' HG11 ' A' ' 77' ' ' VAL . 34.2 t80 -108.05 95.94 6.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.762 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.03 104.7 1.82 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.847 0.356 . . . . 0.0 110.972 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.469 ' CD2' HG13 ' A' ' 21' ' ' VAL . 6.2 mt -72.9 -38.19 67.0 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.947 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.24 -82.46 0.31 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.519 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.4 53.47 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.951 0.405 . . . . 0.0 110.948 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.498 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 33.3 m170 -103.57 160.49 25.95 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.84 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.599 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 18.2 Cg_endo -58.83 -35.35 98.75 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.382 2.055 . . . . 0.0 111.875 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.599 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 4.5 p80 167.15 -173.57 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.117 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.475 HG23 ' CD1' ' A' ' 26' ' ' LEU . 2.8 m -146.03 164.17 10.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.255 0.55 . . . . 0.0 112.04 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.446 ' CB ' ' HB3' ' A' ' 59' ' ' ARG . 12.0 pt-20 -102.15 150.08 23.63 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.815 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.577 ' O ' HD11 ' A' ' 27' ' ' LEU . 96.0 mt -40.82 -45.64 2.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.818 0.342 . . . . 0.0 111.543 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 4.9 t -59.7 -36.26 76.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.553 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.52 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 14.8 m-20 -71.13 -63.12 1.17 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.778 0.323 . . . . 0.0 111.515 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.484 HD11 ' CG2' ' A' ' 77' ' ' VAL . 3.6 tp -46.65 -45.66 19.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.009 0.433 . . . . 0.0 111.374 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.705 ' HG ' ' CE3' ' A' ' 32' ' ' TRP . 9.7 mp -67.69 -66.63 0.54 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.28 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 24' ' ' CYS . 9.9 ttmt -50.1 -51.3 44.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.764 0.316 . . . . 0.0 111.222 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.52 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.1 OUTLIER -56.99 -34.9 68.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.203 -179.728 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 5.0 mm-40 -84.22 -8.77 58.95 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.91 22.95 24.3 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.272 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.705 ' CE3' ' HG ' ' A' ' 27' ' ' LEU . 8.6 m0 -74.99 -62.84 1.41 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.006 0.431 . . . . 0.0 109.909 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.461 ' CB ' HD13 ' A' ' 41' ' ' ILE . 0.3 OUTLIER -107.28 143.58 35.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.759 179.621 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.2 tp10 -78.28 -34.37 48.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.818 0.342 . . . . 0.0 111.261 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.423 ' OG ' ' CB ' ' A' ' 38' ' ' GLN . 42.2 p -105.72 -39.5 6.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.075 0.464 . . . . 0.0 110.525 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 108.15 -25.05 21.45 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.167 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.3 -15.43 2.51 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.423 ' CB ' ' OG ' ' A' ' 35' ' ' SER . 17.9 tp60 -52.52 -73.71 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.804 0.335 . . . . 0.0 111.362 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.12 14.96 0.18 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.39 23.38 12.93 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.803 0.335 . . . . 0.0 110.709 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.536 HG23 ' O ' ' A' ' 41' ' ' ILE . 1.9 mt -60.19 -19.6 18.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.884 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.29 -76.56 0.14 Allowed 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.82 0.343 . . . . 0.0 110.781 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 45.6 mm -47.33 -45.32 9.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-O 121.083 0.468 . . . . 0.0 110.618 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.472 ' O ' ' C ' ' A' ' 45' ' ' GLU . . . -55.39 -67.71 0.26 Allowed 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.877 178.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.472 ' C ' ' O ' ' A' ' 44' ' ' ALA . 11.5 tp10 -28.31 -47.75 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.089 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 55' ' ' GLU . . . -58.34 -74.14 0.38 Allowed Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.172 -1.014 . . . . 0.0 110.824 178.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.552 ' N ' ' HA ' ' A' ' 56' ' ' THR . 1.2 pt20 -44.57 -16.21 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.49 HG11 ' H ' ' A' ' 71' ' ' ALA . 46.6 t -76.01 -95.43 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.592 ' HD3' ' HB ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -162.82 120.08 1.97 Allowed 'General case' 0 C--N 1.339 0.149 0 O-C-N 122.1 -0.375 . . . . 0.0 111.866 -179.294 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.416 HG13 HG23 ' A' ' 68' ' ' VAL . 42.6 t -118.96 157.0 20.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.193 178.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.493 ' HB3' ' H ' ' A' ' 67' ' ' THR . 4.7 p-10 -43.62 99.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.015 0.436 . . . . 0.0 111.603 -178.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 59.76 24.35 59.94 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.175 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -145.79 76.48 1.47 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.592 ' HB ' ' HD3' ' A' ' 49' ' ' LYS . 7.6 p -84.88 58.08 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.151 0.501 . . . . 0.0 110.327 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.436 ' O ' ' O ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -100.42 -162.72 0.96 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.809 -179.547 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.552 ' HA ' ' N ' ' A' ' 47' ' ' GLN . 2.1 t -144.43 53.11 1.26 Allowed 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.525 ' HG3' ' O ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -99.25 172.66 7.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.903 0.382 . . . . 0.0 111.306 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -77.35 -48.47 17.26 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.795 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.525 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 0.3 OUTLIER -120.52 142.79 48.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.314 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . 0.507 ' HB3' HD13 ' A' ' 62' ' ' ILE . 3.3 t -124.26 118.53 27.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.975 0.417 . . . . 0.0 110.972 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.53 99.87 2.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.331 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.507 HD13 ' HB3' ' A' ' 60' ' ' CYS . 2.7 mp -138.34 142.45 35.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.769 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.566 HG13 ' O ' ' A' ' 19' ' ' PRO . 12.8 m -145.66 175.63 2.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.433 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 72.58 -138.17 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.741 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -106.32 84.75 0.41 Allowed Glycine 0 C--N 1.34 0.798 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.14 -178.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.484 ' HB3' ' CG ' ' A' ' 51' ' ' ASP . 56.5 mm-40 -123.02 167.48 13.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.975 0.417 . . . . 0.0 112.082 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.493 ' H ' ' HB3' ' A' ' 51' ' ' ASP . 3.5 m -118.18 140.84 49.2 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.076 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.605 HG12 ' CH2' ' A' ' 32' ' ' TRP . 1.2 t -123.49 146.53 28.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.794 178.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.58 ' HA ' ' O ' ' A' ' 73' ' ' HIS . 32.0 p -140.01 136.1 33.36 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -179.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.516 ' CE2' ' HA ' ' A' ' 41' ' ' ILE . 1.9 t80 -140.17 121.21 14.67 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.332 178.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.49 ' H ' HG11 ' A' ' 48' ' ' VAL . . . 40.82 28.23 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 179.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 113.16 -5.81 25.27 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.323 -0.941 . . . . 0.0 113.674 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.6 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 1.1 m-70 -88.01 91.33 8.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 117.166 0.483 . . . . 0.0 110.934 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -98.02 118.01 33.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.848 0.356 . . . . 0.0 111.443 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.594 ' HB ' ' HZ2' ' A' ' 32' ' ' TRP . 96.8 t -143.5 152.74 16.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.391 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.46 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 24.8 mt-30 -112.89 156.1 23.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.231 0.539 . . . . 0.0 111.609 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.741 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 38.3 t -121.5 145.05 28.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.129 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.8 m -134.18 165.94 30.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.872 0.367 . . . . 0.0 111.699 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.194 -179.873 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.493 ' HB1' ' CG1' ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.455 -0.191 0 CA-C-O 120.86 0.362 . . . . 0.0 111.135 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.87 129.04 37.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.537 ' HD2' ' HG2' ' A' ' 30' ' ' GLU . 56.5 t80 -102.48 149.23 24.59 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.855 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.93 123.33 48.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.394 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.74 -37.59 76.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.714 0.292 . . . . 0.0 110.958 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.29 26.79 13.11 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.832 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.3 mtmt 59.58 51.52 6.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.909 0.385 . . . . 0.0 110.833 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.426 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 2.9 m-70 -119.43 168.25 10.43 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.61 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.545 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 10.3 Cg_endo -52.64 -37.96 75.56 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.396 2.064 . . . . 0.0 111.741 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.545 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 5.6 p80 167.94 -168.5 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.009 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.484 ' O ' ' O ' ' A' ' 60' ' ' CYS . 28.8 m -143.58 157.04 16.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.898 0.38 . . . . 0.0 111.77 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.511 ' HA ' ' H ' ' A' ' 60' ' ' CYS . 1.5 pt-20 -103.48 152.21 21.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.583 178.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.432 HD13 ' HB2' ' A' ' 42' ' ' ALA . 0.2 OUTLIER -37.93 -46.54 0.98 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.919 -179.372 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.0 t -62.2 -38.4 89.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.606 0.241 . . . . 0.0 111.608 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -67.73 -58.81 3.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.119 0.485 . . . . 0.0 111.122 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.492 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 3.2 tp -55.27 -49.54 71.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.8 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.623 ' HG ' ' CE3' ' A' ' 32' ' ' TRP . 6.2 mp -62.61 -59.16 5.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.159 -179.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -50.28 -59.79 3.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.98 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.474 ' HB3' ' HE2' ' A' ' 13' ' ' PHE . 3.8 mm? -55.89 -43.31 77.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.482 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.542 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 0.1 OUTLIER -66.83 -15.7 63.79 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.045 -179.943 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.92 23.9 19.02 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.096 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.623 ' CE3' ' HG ' ' A' ' 27' ' ' LEU . 8.8 m0 -74.84 -66.05 0.8 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.202 0.525 . . . . 0.0 110.119 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.478 ' CB ' HD12 ' A' ' 41' ' ' ILE . 2.1 t -106.68 139.19 41.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.135 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -82.31 -33.48 29.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.574 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.418 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -105.16 -27.54 11.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.959 179.645 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.79 0.75 88.68 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.855 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.88 -15.32 0.31 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.681 0.277 . . . . 0.0 111.468 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.418 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 1.0 OUTLIER -54.29 -77.31 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.374 -179.682 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.96 15.05 1.56 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.3 mttt 61.71 26.53 16.16 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.98 0.419 . . . . 0.0 110.406 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.539 ' HA ' ' CE2' ' A' ' 70' ' ' PHE . 11.7 mt -58.1 -22.27 18.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.708 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.432 ' HB2' HD13 ' A' ' 23' ' ' LEU . . . -74.92 -77.67 0.12 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.099 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 44.3 mm -52.31 -36.81 21.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.778 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' ' 45' ' ' GLU . . . -59.62 -69.29 0.21 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.351 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.502 ' HG3' HD12 ' A' ' 27' ' ' LEU . 3.0 tm-20 -34.28 -42.05 0.13 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.839 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.428 ' C ' ' H ' ' A' ' 48' ' ' VAL . . . -59.14 -75.43 0.27 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.109 -1.044 . . . . 0.0 111.184 178.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.51 ' HA ' ' HB ' ' A' ' 56' ' ' THR . 20.7 pt20 -48.82 -9.37 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.475 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 68.7 t -75.02 -97.28 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.166 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 48' ' ' VAL . 1.9 mmtm -163.02 124.63 2.51 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.549 0.613 . . . . 0.0 112.269 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.59 ' HB ' ' O ' ' A' ' 53' ' ' ALA . 26.3 t -116.76 151.76 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.093 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 177.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.532 ' HB2' ' HB ' ' A' ' 67' ' ' THR . 0.9 OUTLIER -44.67 99.95 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.971 0.415 . . . . 0.0 110.937 -179.269 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 60.12 24.84 61.39 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.089 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.59 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -145.78 80.49 1.59 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.436 ' HB ' ' HD3' ' A' ' 49' ' ' LYS . 8.7 p -89.24 78.92 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.896 0.379 . . . . 0.0 110.425 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -113.13 -172.77 2.12 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.69 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.51 ' HB ' ' HA ' ' A' ' 47' ' ' GLN . 2.8 t -158.62 42.77 0.26 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.52 -179.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.9 172.81 8.21 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.814 0.34 . . . . 0.0 110.991 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.9 mmmm -75.35 -55.74 5.4 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.033 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.4 mtm180 -100.46 141.66 33.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.011 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . 0.511 ' H ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -106.59 131.62 53.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.1 0.476 . . . . 0.0 111.318 -178.957 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.414 ' HA ' ' CG ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -110.07 74.71 0.9 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.245 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.417 HG22 ' N ' ' A' ' 63' ' ' VAL . 12.6 mt -134.26 144.07 36.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.16 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.417 ' N ' HG22 ' A' ' 62' ' ' ILE . 8.0 m -146.97 175.41 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.254 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 78.18 -144.64 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.542 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.621 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -100.22 83.47 0.55 Allowed Glycine 0 C--N 1.335 0.499 0 C-N-CA 121.17 -0.538 . . . . 0.0 113.382 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -122.27 163.41 19.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.664 0.269 . . . . 0.0 111.037 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.532 ' HB ' ' HB2' ' A' ' 51' ' ' ASP . 86.3 m -119.89 150.72 40.01 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.053 0.454 . . . . 0.0 112.043 -178.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.564 HG12 ' CH2' ' A' ' 32' ' ' TRP . 1.1 t -129.99 149.08 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.102 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -137.78 133.69 34.34 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -178.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.539 ' CE2' ' HA ' ' A' ' 41' ' ' ILE . 5.0 t80 -138.42 115.22 10.72 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.384 179.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 36.47 32.95 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 178.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 116.77 -13.2 14.93 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.361 -0.923 . . . . 0.0 113.531 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.406 ' O ' ' CH2' ' A' ' 32' ' ' TRP . 2.2 m-70 -88.25 82.51 7.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.955 0.378 . . . . 0.0 110.952 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.8 m -95.2 101.0 12.71 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.942 0.401 . . . . 0.0 110.943 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.497 ' HB ' ' HZ2' ' A' ' 32' ' ' TRP . 46.5 t -120.27 155.71 23.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.721 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 25.5 mt-30 -111.57 161.21 16.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.94 0.4 . . . . 0.0 110.421 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.621 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 13.1 t -133.38 146.85 31.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.424 -178.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.0 m -131.47 157.24 43.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.985 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.253 -0.88 . . . . 0.0 111.147 -179.929 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.425 ' O ' HG12 ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.455 -0.204 0 CA-C-O 120.645 0.26 . . . . 0.0 110.394 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.46 132.47 29.49 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.85 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.419 ' CD2' ' CD1' ' A' ' 26' ' ' LEU . 36.8 t80 -102.33 147.49 26.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.896 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.8 m -106.25 147.89 28.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.399 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.0 mt -118.61 -38.12 3.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.063 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.13 -103.75 2.9 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.397 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.0 mttt -143.58 41.87 1.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.019 0.437 . . . . 0.0 110.894 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.4 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 8.0 m170 -95.5 163.91 20.3 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.446 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.591 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 17.9 Cg_endo -58.59 -43.02 48.53 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.322 2.015 . . . . 0.0 112.008 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.591 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 19.9 p80 166.08 -163.96 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.203 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.8 m -139.47 154.23 24.57 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-O 121.09 0.471 . . . . 0.0 112.144 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.491 ' HG2' ' CB ' ' A' ' 59' ' ' ARG . 13.8 mt-10 -90.81 148.09 22.76 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.593 178.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.465 HD12 ' O ' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -41.27 -50.34 3.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.795 0.331 . . . . 0.0 111.656 -179.656 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 17.9 t -65.64 -32.72 74.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.884 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 2.9 m-20 -64.57 -59.38 4.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.776 0.322 . . . . 0.0 110.323 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.599 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 12.5 tp -51.78 -40.48 60.43 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.891 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.477 HD23 ' CE3' ' A' ' 32' ' ' TRP . 12.6 mt -66.74 -67.87 0.42 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.111 0.482 . . . . 0.0 110.788 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.461 ' HE2' ' O ' ' A' ' 35' ' ' SER . 4.1 ttmt -50.15 -55.92 13.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.79 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.1 OUTLIER -53.83 -40.14 66.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.117 -178.991 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.599 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 1.1 mm-40 -80.35 -10.05 59.75 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.838 0.311 . . . . 0.0 111.838 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.68 25.13 21.56 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.249 -0.977 . . . . 0.0 113.342 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.701 ' CZ3' ' HB2' ' A' ' 73' ' ' HIS . 13.0 m95 -72.94 -61.99 1.62 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 117.133 0.466 . . . . 0.0 110.2 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.464 ' HB2' ' CB ' ' A' ' 41' ' ' ILE . 39.2 t -100.18 156.22 17.32 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.453 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -85.74 -35.15 20.97 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.186 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.461 ' O ' ' HE2' ' A' ' 28' ' ' LYS . 1.1 p -106.94 -46.21 3.99 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.524 178.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 120.81 -28.5 6.14 Favored Glycine 0 C--N 1.333 0.374 0 CA-C-N 115.745 -0.662 . . . . 0.0 112.882 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.98 1.74 3.31 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -60.91 -76.46 0.05 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.865 0.364 . . . . 0.0 111.105 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.15 15.4 0.57 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.928 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.3 mttp 66.1 24.93 10.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.983 0.421 . . . . 0.0 110.004 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.515 ' HA ' ' CE2' ' A' ' 70' ' ' PHE . 40.8 mm -52.99 -26.96 12.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.61 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.81 -78.33 0.08 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.928 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 34.4 mm -49.49 -34.34 8.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.856 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.605 ' O ' ' HG3' ' A' ' 47' ' ' GLN . . . -63.5 -72.23 0.15 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.718 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.496 ' HA ' ' HB2' ' A' ' 70' ' ' PHE . 0.6 OUTLIER -32.79 -41.71 0.07 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.95 0.405 . . . . 0.0 110.879 -179.845 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.446 ' C ' ' H ' ' A' ' 48' ' ' VAL . . . -59.68 -77.02 0.19 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.268 -0.967 . . . . 0.0 110.848 178.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.605 ' HG3' ' O ' ' A' ' 44' ' ' ALA . 1.4 pt20 -46.52 -10.42 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.481 HG23 ' CD1' ' A' ' 70' ' ' PHE . 58.4 t -74.9 -92.86 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.906 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' A' ' 48' ' ' VAL . 0.1 OUTLIER -168.12 125.73 1.13 Allowed 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.894 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.8 t -122.15 158.01 26.2 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -44.05 101.75 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.053 0.454 . . . . 0.0 111.71 -178.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 57.29 23.13 46.76 Favored Glycine 0 C--N 1.333 0.386 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.489 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -146.15 82.64 1.61 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.869 0.366 . . . . 0.0 111.787 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.442 ' O ' HG12 ' A' ' 54' ' ' VAL . 10.7 p -88.39 61.47 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.073 0.463 . . . . 0.0 110.824 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -101.14 -164.41 1.1 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.221 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.486 ' HB ' ' HA ' ' A' ' 47' ' ' GLN . 9.7 t -153.18 45.15 0.65 Allowed 'General case' 0 C--O 1.232 0.164 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.465 ' O ' HD12 ' A' ' 23' ' ' LEU . 52.3 mtt180 -87.77 174.98 8.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.067 0.46 . . . . 0.0 111.104 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -85.35 -38.72 18.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.086 179.395 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.491 ' CB ' ' HG2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -120.65 134.06 55.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.822 179.664 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -119.9 115.39 23.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.875 0.369 . . . . 0.0 110.73 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.477 ' HG3' ' CD2' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -74.15 89.85 2.01 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.033 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.531 HG21 ' HG3' ' A' ' 66' ' ' GLN . 6.9 mm -133.11 138.22 51.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.207 0.527 . . . . 0.0 112.153 -178.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.5 m -146.26 175.29 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.125 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.466 ' HA ' ' HB2' ' A' ' 79' ' ' ALA . . . 76.52 -143.14 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.64 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -99.91 83.44 0.57 Allowed Glycine 0 C--N 1.336 0.546 0 C-N-CA 121.308 -0.472 . . . . 0.0 112.129 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.531 ' HG3' HG21 ' A' ' 62' ' ' ILE . 6.1 mm100 -122.36 159.63 27.08 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.887 0.375 . . . . 0.0 111.753 -178.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 7.3 m -120.37 144.46 47.87 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.458 -178.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.612 HG11 ' CH2' ' A' ' 32' ' ' TRP . 1.2 t -118.67 143.14 30.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.451 178.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -134.07 133.37 41.09 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.516 ' CE1' ' HB3' ' A' ' 44' ' ' ALA . 1.4 t80 -146.19 122.48 10.91 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.611 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.469 ' H ' HG13 ' A' ' 48' ' ' VAL . . . 49.52 -85.47 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.343 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -129.14 -5.6 4.67 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.722 -0.751 . . . . 0.0 113.026 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.701 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 0.9 OUTLIER -90.61 113.07 25.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.967 0.384 . . . . 0.0 111.441 -179.269 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 72.1 m -120.48 115.54 23.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.178 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.576 ' HB ' ' HZ2' ' A' ' 32' ' ' TRP . 59.4 t -138.59 155.23 27.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.803 0.335 . . . . 0.0 111.328 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.508 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 2.8 mt-30 -112.78 169.96 8.53 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.104 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.64 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 21.6 t -136.36 146.0 29.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.82 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.96 150.49 34.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.952 0.406 . . . . 0.0 111.665 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.466 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.336 -0.84 . . . . 0.0 110.964 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.518 ' HB3' HG12 ' A' ' 75' ' ' VAL . . . . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.597 0.237 . . . . 0.0 111.037 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.58 121.55 16.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.999 0.428 . . . . 0.0 111.168 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.53 ' CD2' HD12 ' A' ' 26' ' ' LEU . 37.1 t80 -99.02 155.28 17.52 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.945 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.5 m -106.63 148.73 27.97 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.272 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.1 mt -117.92 -28.74 5.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.851 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.09 40.06 62.34 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.972 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 56.93 68.46 0.86 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.974 0.416 . . . . 0.0 110.829 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.486 ' O ' HG13 ' A' ' 63' ' ' VAL . 1.8 m170 -115.28 170.02 6.08 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.903 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.464 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 32.7 Cg_endo -64.86 -51.5 1.68 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.406 2.07 . . . . 0.0 112.356 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.559 ' HA ' HG11 ' A' ' 63' ' ' VAL . 7.4 p80 177.94 -179.72 0.28 Allowed 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.333 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.464 HG23 HD11 ' A' ' 26' ' ' LEU . 4.5 m -142.11 161.01 20.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -179.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.468 ' HG2' ' HA ' ' A' ' 59' ' ' ARG . 8.3 mt-10 -98.89 144.42 28.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.192 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 58' ' ' LYS . 0.9 OUTLIER -39.7 -38.02 0.59 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.629 -0.259 . . . . 0.0 111.561 -179.67 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 48.9 t -73.38 -39.71 64.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.606 0.241 . . . . 0.0 111.189 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -62.86 -57.42 10.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.069 0.461 . . . . 0.0 110.358 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.53 HD12 ' CD2' ' A' ' 13' ' ' PHE . 12.6 tp -55.27 -45.97 76.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.268 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.555 ' HB3' ' HB2' ' A' ' 32' ' ' TRP . 4.0 mp -66.73 -59.95 3.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.885 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -49.31 -56.12 10.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.446 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.3 -38.42 71.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.089 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.449 ' CG ' ' HB2' ' A' ' 13' ' ' PHE . 5.2 mm-40 -79.87 -10.95 59.83 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.82 24.02 18.9 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.257 -0.973 . . . . 0.0 113.155 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.594 ' HZ2' ' HB ' ' A' ' 75' ' ' VAL . 11.2 m95 -75.92 -62.55 1.56 Allowed 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.5 t -106.38 138.54 42.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.339 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.67 -34.41 60.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.963 0.411 . . . . 0.0 110.408 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.9 -48.12 3.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.057 178.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.401 ' O ' ' HB3' ' A' ' 42' ' ' ALA . . . 118.63 -22.85 9.18 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.231 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.47 -1.78 3.12 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -59.3 -77.95 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.611 0.243 . . . . 0.0 111.249 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.423 ' HB3' HG13 ' A' ' 41' ' ' ILE . . . -75.15 15.13 0.45 Allowed 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.425 ' O ' ' HB3' ' A' ' 44' ' ' ALA . 34.9 mttt 61.85 25.34 15.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.765 0.317 . . . . 0.0 110.76 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.468 ' HA ' ' CE2' ' A' ' 70' ' ' PHE . 14.4 mt -61.37 -16.43 14.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.608 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . -72.68 -79.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.314 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 43.4 mm -53.9 -33.72 24.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.806 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.456 ' HB2' ' CE1' ' A' ' 70' ' ' PHE . . . -61.0 -72.2 0.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.232 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.533 ' HA ' ' HB2' ' A' ' 70' ' ' PHE . 2.4 tm-20 -34.76 -40.97 0.12 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.22 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.19 -73.93 0.4 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.156 -1.021 . . . . 0.0 110.628 178.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.551 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 15.8 pt20 -48.9 -11.55 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.505 HG21 ' HA ' ' A' ' 45' ' ' GLU . 47.2 t -75.0 -90.92 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.102 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.428 ' HD3' ' HB ' ' A' ' 54' ' ' VAL . 6.4 mmtp -165.43 124.84 1.75 Allowed 'General case' 0 C--O 1.232 0.153 0 C-N-CA 120.193 -0.603 . . . . 0.0 112.284 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.523 ' HB ' ' O ' ' A' ' 53' ' ' ALA . 34.2 t -119.08 142.77 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 178.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.447 ' HB2' ' O ' ' A' ' 67' ' ' THR . 0.8 OUTLIER -45.29 97.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.924 0.392 . . . . 0.0 111.567 -179.102 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.25 11.02 85.76 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.976 -0.631 . . . . 0.0 113.001 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.523 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -146.03 82.44 1.61 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 117.073 0.436 . . . . 0.0 112.033 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.439 HG11 ' O ' ' A' ' 54' ' ' VAL . 7.4 p -86.99 56.2 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.075 0.464 . . . . 0.0 110.081 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -99.65 179.72 4.45 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.628 -178.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.551 ' HB ' ' HB3' ' A' ' 47' ' ' GLN . 1.7 p -134.39 36.97 3.16 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.684 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.38 171.23 12.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.873 0.368 . . . . 0.0 111.189 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.443 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 38.6 mttm -75.57 -46.46 31.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.682 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.468 ' HA ' ' HG2' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -116.61 137.65 52.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.633 179.862 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . 0.435 ' HB3' HD13 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -115.24 115.28 26.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.77 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.436 ' HG2' ' CD2' ' A' ' 20' ' ' HIS . 11.5 mtpt -78.46 82.26 4.74 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.369 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.467 ' CD1' HG11 ' A' ' 50' ' ' VAL . 26.8 mt -133.61 147.97 30.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.261 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.559 HG11 ' HA ' ' A' ' 20' ' ' HIS . 1.9 m -154.99 175.87 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.245 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 76.22 -150.66 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.301 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -83.9 78.54 2.0 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.292 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.401 ' HG3' ' CG2' ' A' ' 62' ' ' ILE . 10.0 mm100 -122.26 154.91 36.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.112 0.482 . . . . 0.0 110.956 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.617 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 87.6 m -114.46 156.28 24.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.375 -178.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.54 HG11 ' CH2' ' A' ' 32' ' ' TRP . 1.0 OUTLIER -133.01 148.97 31.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.672 179.34 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 76.8 p -143.12 139.86 30.6 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.533 ' HB2' ' HA ' ' A' ' 45' ' ' GLU . 2.3 t80 -150.82 124.36 9.02 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 114.902 -1.044 . . . . 0.0 110.323 179.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 49.52 -85.46 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.59 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -126.18 -6.99 5.61 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.972 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.499 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 1.7 m-70 -89.5 107.11 18.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.791 0.329 . . . . 0.0 111.54 -179.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.76 95.29 4.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.175 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.594 ' HB ' ' HZ2' ' A' ' 32' ' ' TRP . 97.0 t -123.23 155.32 29.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.517 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.617 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 3.2 mp0 -113.26 165.1 12.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.971 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.441 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 11.0 t -139.76 150.57 22.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.974 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.43 ' N ' HG12 ' A' ' 77' ' ' VAL . 34.0 m -129.17 165.5 28.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.973 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.215 -0.897 . . . . 0.0 111.191 179.892 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.431 ' O ' HG13 ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.458 -0.075 0 CA-C-O 120.68 0.276 . . . . 0.0 110.698 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.97 133.82 34.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.56 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.469 ' CD2' HD12 ' A' ' 26' ' ' LEU . 58.4 t80 -105.35 156.58 18.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.1 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.2 m -107.16 142.7 36.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.963 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.63 HD21 ' HB2' ' A' ' 18' ' ' HIS . 0.5 OUTLIER -104.67 -40.62 5.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.445 179.375 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.22 42.95 6.82 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.702 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 50.18 59.31 4.64 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.93 0.395 . . . . 0.0 111.248 179.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.63 ' HB2' HD21 ' A' ' 15' ' ' LEU . 30.7 m170 -115.66 165.27 14.88 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.398 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.647 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 18.3 Cg_endo -57.75 -38.43 93.06 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.557 2.171 . . . . 0.0 112.386 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.647 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 12.0 p80 164.38 -173.7 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.72 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.866 HG23 HD11 ' A' ' 26' ' ' LEU . 2.4 m -145.79 166.47 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.217 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.483 ' HG2' ' HB2' ' A' ' 59' ' ' ARG . 70.4 mt-10 -95.97 141.03 29.87 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.818 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.446 HD21 ' N ' ' A' ' 59' ' ' ARG . 2.0 pp -44.12 -30.59 0.78 Allowed 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 -178.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.584 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -69.63 -40.71 76.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.78 0.324 . . . . 0.0 110.396 179.361 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -63.44 -60.63 3.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.049 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.866 HD11 HG23 ' A' ' 21' ' ' VAL . 2.6 tp -49.46 -49.25 46.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.652 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.755 ' HG ' ' CE3' ' A' ' 32' ' ' TRP . 9.5 mp -65.1 -61.76 1.95 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.445 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.584 ' HB2' ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -48.82 -55.59 11.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.348 -179.718 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.2 mt -55.33 -42.49 73.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.533 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.448 ' CG ' ' HB2' ' A' ' 13' ' ' PHE . 1.3 mm-40 -71.19 -15.28 62.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.728 -0.214 . . . . 0.0 111.555 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.07 24.77 12.17 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.268 -0.968 . . . . 0.0 113.071 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.755 ' CE3' ' HG ' ' A' ' 27' ' ' LEU . 7.8 m0 -76.33 -66.28 0.82 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.959 0.38 . . . . 0.0 109.999 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 25.0 t -106.12 140.04 39.7 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.353 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -75.74 -34.96 60.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.898 0.38 . . . . 0.0 110.73 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.485 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 0.2 OUTLIER -106.45 -48.0 3.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.365 178.848 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.4 -26.25 8.72 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.201 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -127.58 -2.67 6.09 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.485 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 4.2 tp-100 -59.74 -76.56 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.674 0.273 . . . . 0.0 110.962 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.91 15.11 0.93 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.725 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.7 mttm 61.93 27.83 16.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.084 0.469 . . . . 0.0 110.401 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.44 ' HA ' ' CE2' ' A' ' 70' ' ' PHE . 12.7 mt -59.29 -25.0 29.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.554 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.07 -77.69 0.08 Allowed 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.144 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 31.6 mm -48.62 -36.29 7.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 120.896 0.379 . . . . 0.0 110.599 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.567 ' HB1' ' CE1' ' A' ' 70' ' ' PHE . . . -61.46 -67.06 0.44 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.519 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.521 ' HB2' HD21 ' A' ' 27' ' ' LEU . 5.9 tp10 -33.96 -45.73 0.21 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.852 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' A' ' 48' ' ' VAL . . . -59.23 -75.94 0.24 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.238 -0.982 . . . . 0.0 111.04 178.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.54 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 12.4 pt20 -44.5 -15.86 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.624 HG11 ' H ' ' A' ' 71' ' ' ALA . 93.6 t -75.05 -91.7 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 O-C-N 122.212 -0.305 . . . . 0.0 110.575 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -171.18 136.88 1.09 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.956 0.408 . . . . 0.0 111.146 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.485 ' O ' ' N ' ' A' ' 52' ' ' GLY . 58.5 t -131.7 144.95 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.951 179.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.461 ' HB3' ' H ' ' A' ' 67' ' ' THR . 37.6 t70 -60.61 77.23 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.055 0.455 . . . . 0.0 110.46 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 120.96 -12.46 9.89 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.408 -179.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.469 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . . . -132.37 133.69 44.27 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.892 0.377 . . . . 0.0 110.8 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.6 p -125.2 31.98 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.714 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -107.49 160.21 15.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.283 0.563 . . . . 0.0 112.433 -178.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.54 ' HB ' ' HB3' ' A' ' 47' ' ' GLN . 14.8 t -108.66 50.12 0.79 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.556 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 10.0 mtp180 -84.24 173.38 11.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.746 0.308 . . . . 0.0 111.018 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.1 ttmm -81.68 -0.69 43.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.991 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.483 ' HB2' ' HG2' ' A' ' 22' ' ' GLU . 0.3 OUTLIER -160.86 157.3 26.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.616 179.708 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.6 t -134.93 114.99 13.08 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.463 ' HG2' ' CD2' ' A' ' 20' ' ' HIS . 3.6 mttm -76.0 94.62 3.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.36 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.459 HD12 ' CG1' ' A' ' 50' ' ' VAL . 16.2 mt -135.41 141.17 43.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.696 -179.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.59 HG11 ' HA ' ' A' ' 20' ' ' HIS . 0.8 OUTLIER -144.24 175.18 3.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.927 179.3 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 66.21 -150.17 0.21 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.716 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.598 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -86.79 79.13 1.84 Allowed Glycine 0 C--N 1.336 0.565 0 C-N-CA 121.451 -0.404 . . . . 0.0 113.498 -178.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.515 ' HG3' ' O ' ' A' ' 63' ' ' VAL . 2.3 mm100 -122.18 158.95 28.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.935 0.397 . . . . 0.0 111.347 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.59 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 0.3 OUTLIER -114.53 157.66 22.69 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.529 -178.71 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.467 ' CG1' ' CH2' ' A' ' 32' ' ' TRP . 1.2 t -133.96 147.51 30.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.829 179.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.637 ' HA ' ' O ' ' A' ' 73' ' ' HIS . 0.5 OUTLIER -137.7 132.15 32.44 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -178.939 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.567 ' CE1' ' HB1' ' A' ' 44' ' ' ALA . 1.7 t80 -139.32 117.9 12.2 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.347 178.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.624 ' H ' HG11 ' A' ' 48' ' ' VAL . . . 38.01 30.0 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 117.17 -7.26 16.69 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.211 -0.995 . . . . 0.0 113.512 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.637 ' O ' ' HA ' ' A' ' 69' ' ' SER . 2.6 m-70 -87.9 89.79 8.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 117.242 0.521 . . . . 0.0 110.834 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 58.2 m -100.59 102.02 13.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.858 0.361 . . . . 0.0 111.008 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.554 ' HB ' ' HZ2' ' A' ' 32' ' ' TRP . 46.9 t -127.19 153.61 36.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.843 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.59 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -112.95 165.04 12.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.031 0.443 . . . . 0.0 111.122 179.538 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.598 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 45.3 t -138.11 154.86 28.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.48 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.483 ' O ' ' HB2' ' A' ' 15' ' ' LEU . 16.1 m -131.77 161.47 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.865 0.364 . . . . 0.0 111.417 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.321 -0.847 . . . . 0.0 111.429 179.624 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.425 ' HB1' ' HA ' ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.457 -0.098 0 CA-C-O 120.711 0.291 . . . . 0.0 111.141 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.62 109.42 6.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.781 0.324 . . . . 0.0 110.78 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.597 ' O ' HG11 ' A' ' 77' ' ' VAL . 28.2 t80 -98.64 170.59 8.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.975 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.9 m -106.82 138.1 43.62 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.356 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.837 ' HB2' HG12 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -131.49 -37.99 1.19 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.221 179.337 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -44.09 -27.69 1.14 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 121.213 -0.518 . . . . 0.0 113.002 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -55.46 -40.86 72.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.663 0.268 . . . . 0.0 111.257 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.575 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 42.4 m80 -119.64 163.06 29.48 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.319 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.575 ' HD2' ' HB3' ' A' ' 18' ' ' HIS . 18.2 Cg_endo -59.74 -27.87 85.96 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.658 2.239 . . . . 0.0 112.496 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.462 ' HA ' ' CG1' ' A' ' 63' ' ' VAL . 4.7 p80 177.05 178.17 0.27 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.12 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.426 HG11 ' O ' ' A' ' 20' ' ' HIS . 15.4 m -145.93 167.15 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.576 ' HG3' ' HA ' ' A' ' 59' ' ' ARG . 17.3 tt0 -100.35 144.2 29.64 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.08 178.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.45 ' HB2' ' OE1' ' A' ' 45' ' ' GLU . 1.6 pp -40.86 -46.84 2.83 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.655 0.264 . . . . 0.0 111.625 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 5.6 t -62.31 -38.05 87.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.751 0.31 . . . . 0.0 110.927 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -66.06 -57.61 7.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.885 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.2 tt -56.64 -42.05 78.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.053 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.613 HD11 ' HG3' ' A' ' 45' ' ' GLU . 6.7 mp -65.77 -62.29 1.59 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.972 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.04 -55.55 11.69 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.383 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 13' ' ' PHE . 6.6 mt -53.48 -40.16 65.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.265 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.48 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 0.4 OUTLIER -73.45 -15.17 61.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.605 -179.702 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.5 23.82 17.84 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.425 -0.893 . . . . 0.0 113.294 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.594 ' HZ2' ' HB ' ' A' ' 75' ' ' VAL . 9.3 m0 -72.62 -59.04 2.91 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 117.215 0.508 . . . . 0.0 110.137 179.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.0 t -104.87 138.72 40.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.426 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -69.28 -33.77 73.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.905 0.383 . . . . 0.0 110.761 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.9 p -105.16 -42.44 5.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.064 0.459 . . . . 0.0 110.573 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 128.67 -43.34 1.33 Allowed Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.107 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.52 4.37 3.95 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -53.07 -70.38 0.09 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.838 0.352 . . . . 0.0 110.831 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.31 15.49 0.44 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.967 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.2 mttt 64.35 23.3 12.99 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 120.913 0.387 . . . . 0.0 110.163 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.584 ' HA ' ' CE2' ' A' ' 70' ' ' PHE . 29.8 mt -61.83 -19.63 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.617 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.29 -78.92 0.09 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.916 0.389 . . . . 0.0 110.961 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 43.6 mm -52.41 -37.98 24.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.734 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.413 ' O ' ' C ' ' A' ' 45' ' ' GLU . . . -58.42 -69.38 0.19 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.155 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.613 ' HG3' HD11 ' A' ' 27' ' ' LEU . 12.3 tm-20 -34.53 -44.92 0.22 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.107 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.01 -73.14 0.44 Allowed Glycine 0 C--N 1.332 0.314 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.576 ' HG2' ' HB ' ' A' ' 56' ' ' THR . 0.0 OUTLIER -45.63 -15.44 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 179.614 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.517 HG23 ' HA ' ' A' ' 45' ' ' GLU . 46.2 t -74.92 -91.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 121.053 -0.259 . . . . 0.0 111.124 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 69' ' ' SER . 0.3 OUTLIER -175.74 130.13 0.25 Allowed 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.292 -0.563 . . . . 0.0 112.029 179.826 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.609 ' HB ' ' HB3' ' A' ' 53' ' ' ALA . 21.3 t -116.91 148.01 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.587 ' HB2' ' HB ' ' A' ' 67' ' ' THR . 14.0 t0 -44.85 99.21 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.934 0.397 . . . . 0.0 111.594 -179.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.37 17.67 70.68 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.225 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.609 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . . . -145.79 73.09 1.33 Allowed 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.249 0.547 . . . . 0.0 111.586 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.422 HG21 ' HG2' ' A' ' 49' ' ' LYS . 3.0 p -84.33 69.25 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.419 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.414 ' C ' HG21 ' A' ' 56' ' ' THR . 31.7 mm-40 -100.48 -178.62 3.86 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.83 -179.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.576 ' HB ' ' HG2' ' A' ' 47' ' ' GLN . 3.0 p -142.45 37.74 1.52 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.172 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.15 172.71 7.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.765 0.316 . . . . 0.0 111.256 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.412 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -75.3 -41.77 56.18 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.45 179.713 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.576 ' HA ' ' HG3' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -123.8 145.56 48.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.645 179.424 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . 0.411 ' HB3' HD12 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -130.85 116.16 17.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.926 0.393 . . . . 0.0 111.439 -179.469 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.24 86.46 1.09 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.278 179.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.539 ' O ' HG13 ' A' ' 63' ' ' VAL . 20.8 mt -133.37 139.94 47.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.224 -179.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.539 HG13 ' O ' ' A' ' 62' ' ' ILE . 34.4 m -148.83 175.88 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.92 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.62 ' HA ' ' HB2' ' A' ' 79' ' ' ALA . . . 76.96 -147.94 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 178.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.704 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -84.36 75.62 2.34 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.25 -179.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.426 ' OE1' ' HB3' ' A' ' 51' ' ' ASP . 16.7 mm-40 -122.17 152.73 39.64 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.099 0.476 . . . . 0.0 111.285 -179.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.623 HG23 ' O ' ' A' ' 75' ' ' VAL . 21.9 m -115.93 152.75 32.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.787 -178.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.423 ' CG1' ' CH2' ' A' ' 32' ' ' TRP . 0.8 OUTLIER -128.03 144.53 37.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.222 179.241 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' ' 49' ' ' LYS . 25.7 m -136.74 136.42 38.94 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.119 0.485 . . . . 0.0 112.246 -178.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.584 ' CE2' ' HA ' ' A' ' 41' ' ' ILE . 2.1 t80 -144.65 121.85 11.52 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.21 179.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 51.08 -81.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.981 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -131.75 -4.14 3.92 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.85 -0.69 . . . . 0.0 113.337 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.472 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 1.8 m-70 -91.48 112.62 24.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.087 0.444 . . . . 0.0 111.691 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.4 109.37 15.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.863 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.623 ' O ' HG23 ' A' ' 67' ' ' THR . 27.6 t -132.14 150.68 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 120.579 0.228 . . . . 0.0 111.468 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.601 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 1.5 mt-30 -112.29 172.4 6.93 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.008 0.432 . . . . 0.0 111.351 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.837 HG12 ' HB2' ' A' ' 15' ' ' LEU . 12.1 t -142.64 150.52 18.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.233 -178.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.1 m -127.49 158.78 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-O 120.746 0.307 . . . . 0.0 111.81 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.62 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.304 -0.855 . . . . 0.0 111.04 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.4 ' CB ' HG12 ' A' ' 75' ' ' VAL . . . . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.713 0.292 . . . . 0.0 111.021 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.55 135.24 53.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.28 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.516 ' CG ' HD12 ' A' ' 26' ' ' LEU . 1.1 t80 -101.07 95.59 6.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.309 179.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.05 111.26 8.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.855 0.359 . . . . 0.0 110.58 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.512 HD21 ' HB2' ' A' ' 18' ' ' HIS . 1.4 mt -82.46 -33.7 28.37 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.033 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.4 -73.86 0.67 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.715 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.44 52.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.129 0.49 . . . . 0.0 110.847 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.688 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 32.2 m170 -109.02 166.83 10.08 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.648 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.688 ' HD2' ' HB3' ' A' ' 18' ' ' HIS . 18.6 Cg_endo -57.97 -41.48 68.18 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.317 2.011 . . . . 0.0 111.831 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.595 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 9.0 p80 165.69 -164.71 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.256 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.426 ' CG1' HD22 ' A' ' 15' ' ' LEU . 22.6 m -142.73 156.91 18.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.354 0.597 . . . . 0.0 112.248 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.697 ' HG2' ' HA ' ' A' ' 59' ' ' ARG . 12.6 mt-10 -92.56 142.93 26.85 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.639 178.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -40.14 -40.05 1.02 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.726 0.298 . . . . 0.0 111.171 -179.61 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 54.0 t -67.1 -40.24 86.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.058 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -65.29 -57.15 9.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.023 179.667 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.516 HD12 ' CG ' ' A' ' 13' ' ' PHE . 9.9 tp -57.16 -47.77 80.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.436 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.525 ' HG ' ' CE3' ' A' ' 32' ' ' TRP . 4.6 mp -62.69 -57.34 11.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.785 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -50.76 -59.12 4.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.953 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 18.7 mt -56.83 -44.04 81.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.583 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 10.9 mm-40 -67.99 -14.99 63.4 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 121.117 -0.233 . . . . 0.0 111.165 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.24 22.54 26.97 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.359 -0.924 . . . . 0.0 113.209 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.551 ' HZ2' ' HB ' ' A' ' 75' ' ' VAL . 9.3 m0 -68.84 -64.08 0.94 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.71 152.63 23.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.016 178.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -70.38 -34.56 72.72 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.28 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.559 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -106.13 -57.23 2.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.103 0.478 . . . . 0.0 110.568 179.241 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 152.63 -33.88 0.82 Allowed Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.972 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.37 7.53 1.33 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.559 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 2.1 tp60 -54.36 -70.33 0.1 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.701 0.286 . . . . 0.0 110.902 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.72 15.35 0.2 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.575 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.601 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 0.0 OUTLIER 69.11 16.26 8.63 Favored 'General case' 0 CA--C 1.523 -0.067 0 CA-C-O 120.734 0.302 . . . . 0.0 110.723 -179.378 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.542 ' HA ' ' CE2' ' A' ' 70' ' ' PHE . 22.9 mm -56.34 -26.5 22.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.299 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.75 -79.43 0.06 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.407 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.2 mm -48.04 -42.77 10.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.689 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.601 ' HB2' ' O ' ' A' ' 40' ' ' LYS . . . -57.99 -64.21 0.99 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.506 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.521 ' HA ' ' HB2' ' A' ' 70' ' ' PHE . 3.1 tm-20 -35.94 -40.78 0.21 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.709 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' A' ' 48' ' ' VAL . . . -60.07 -75.07 0.3 Allowed Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 178.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.609 ' HG2' ' HB ' ' A' ' 56' ' ' THR . 0.0 OUTLIER -46.49 -12.59 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 179.891 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.49 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 57.7 t -74.99 -89.32 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.103 -179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 48' ' ' VAL . 5.8 mmmt -167.44 144.46 4.44 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.982 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.599 ' HB ' ' O ' ' A' ' 53' ' ' ALA . 14.0 t -131.04 145.7 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.5 ' HB2' ' HB ' ' A' ' 67' ' ' THR . 8.8 t0 -43.89 90.27 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -178.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 108.98 -31.93 7.31 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.712 -0.756 . . . . 0.0 114.03 178.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.599 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -147.58 145.59 29.08 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 117.851 0.825 . . . . 0.0 112.549 -179.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.412 ' CG2' ' O ' ' A' ' 48' ' ' VAL . 4.8 p -109.38 101.5 12.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.053 178.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -99.75 -165.05 1.18 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.966 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.609 ' HB ' ' HG2' ' A' ' 47' ' ' GLN . 5.2 t -165.24 31.06 0.06 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.775 0.322 . . . . 0.0 111.371 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.3 mtt180 -89.07 167.85 12.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.023 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 58.3 mmtt -78.32 -35.61 47.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.237 0.542 . . . . 0.0 109.953 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.697 ' HA ' ' HG2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -106.93 135.08 49.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.563 179.592 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . 0.41 ' H ' ' HA ' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -104.39 118.29 36.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.879 0.371 . . . . 0.0 110.793 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.423 ' HA ' ' CD2' ' A' ' 20' ' ' HIS . 5.4 mtmt -98.99 74.06 1.98 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.11 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.449 ' O ' ' HB2' ' A' ' 20' ' ' HIS . 29.6 mt -137.88 145.26 29.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.657 -179.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.443 ' CG1' ' HA ' ' A' ' 20' ' ' HIS . 0.5 OUTLIER -151.26 175.39 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.867 179.696 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 74.88 -148.89 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.424 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.435 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -85.13 74.76 2.43 Favored Glycine 0 C--N 1.335 0.513 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.732 -179.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.421 ' O ' ' N ' ' A' ' 77' ' ' VAL . 27.9 mm-40 -122.35 150.0 42.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.955 0.407 . . . . 0.0 110.8 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 77.1 m -114.83 150.38 35.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.384 -178.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.504 HG13 ' CH2' ' A' ' 32' ' ' TRP . 0.7 OUTLIER -125.77 145.57 32.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.523 178.774 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 28.4 p -139.32 138.8 37.0 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -178.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.577 ' O ' ' N ' ' A' ' 72' ' ' GLY . 1.9 t80 -143.04 122.2 12.93 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.21 179.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.443 ' H ' HG12 ' A' ' 48' ' ' VAL . . . 48.04 -81.38 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.796 0.332 . . . . 0.0 111.396 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -130.7 -1.29 5.11 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.877 -0.678 . . . . 0.0 113.053 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -93.41 98.93 11.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.134 0.467 . . . . 0.0 111.624 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.3 m -109.82 108.28 18.55 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.405 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.551 ' HB ' ' HZ2' ' A' ' 32' ' ' TRP . 25.1 t -128.55 156.44 40.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.819 -179.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.507 ' N ' HG13 ' A' ' 75' ' ' VAL . 2.7 mp0 -112.05 161.55 16.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.815 0.34 . . . . 0.0 110.716 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.435 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 23.2 t -125.7 141.14 46.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.059 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.3 m -129.77 152.23 37.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.866 0.365 . . . . 0.0 111.124 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.279 -0.867 . . . . 0.0 111.236 -179.776 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.779 0.323 . . . . 0.0 111.38 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -139.62 132.83 29.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.792 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.445 ' CE1' ' HB3' ' A' ' 29' ' ' LEU . 19.1 t80 -107.54 149.28 28.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.927 0.394 . . . . 0.0 111.294 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.63 150.63 26.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.738 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.5 mt -128.08 -40.47 1.67 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.144 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.91 -100.49 2.65 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.671 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.3 tppt? -148.83 53.62 0.98 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.992 0.425 . . . . 0.0 111.003 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.589 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 69.6 m-70 -106.12 163.95 15.98 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.898 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.589 ' HD2' ' HB3' ' A' ' 18' ' ' HIS . 18.3 Cg_endo -57.74 -45.18 34.87 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.615 2.21 . . . . 0.0 112.277 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.546 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 13.8 p80 170.91 -166.67 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.941 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.41 ' O ' ' O ' ' A' ' 60' ' ' CYS . 19.5 m -147.08 159.03 9.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.408 ' O ' ' N ' ' A' ' 25' ' ' ASP . 1.2 mt-10 -88.56 139.29 30.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.959 178.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.469 ' HB2' ' OE1' ' A' ' 45' ' ' GLU . 0.9 OUTLIER -43.47 -32.5 0.9 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.884 0.374 . . . . 0.0 111.28 -179.653 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 26.3 t -73.1 -38.23 66.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.816 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.408 ' N ' ' O ' ' A' ' 22' ' ' GLU . 6.5 m-20 -62.5 -55.31 28.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.743 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.406 HD11 ' CG2' ' A' ' 77' ' ' VAL . 0.4 OUTLIER -54.89 -44.22 73.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.143 -179.913 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.556 ' HG ' ' CE3' ' A' ' 32' ' ' TRP . 5.2 mp -62.16 -64.31 0.97 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.45 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.6 ttmm -47.66 -52.46 18.08 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.974 -179.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.445 ' HB3' ' CE1' ' A' ' 13' ' ' PHE . 3.5 mm? -58.96 -46.51 87.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.322 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -70.52 -14.93 62.71 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.53 26.03 14.43 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.39 -0.91 . . . . 0.0 113.498 179.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.579 ' CH2' HG11 ' A' ' 68' ' ' VAL . 9.6 m0 -74.39 -64.89 0.93 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.015 0.436 . . . . 0.0 110.15 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.9 t -106.31 138.51 42.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.663 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.23 -33.66 37.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.707 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.42 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -105.33 -33.79 8.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.529 179.621 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.32 -20.42 50.34 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.792 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.97 -8.18 3.07 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.42 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 63.8 tp60 -55.51 -76.06 0.03 OUTLIER 'General case' 0 C--O 1.232 0.134 0 CA-C-O 120.724 0.297 . . . . 0.0 111.277 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.32 15.0 2.63 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.75 29.65 19.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.041 0.448 . . . . 0.0 110.44 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.483 ' HA ' ' CE2' ' A' ' 70' ' ' PHE . 18.6 mt -60.49 -23.89 29.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.982 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.62 -78.67 0.07 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.242 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.9 mm -51.8 -40.8 28.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.954 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.36 -68.65 0.19 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.617 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.501 ' HA ' HG23 ' A' ' 48' ' ' VAL . 3.7 tm-20 -35.82 -44.57 0.35 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.909 0.385 . . . . 0.0 110.965 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.47 -76.38 0.19 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.13 -1.033 . . . . 0.0 110.912 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.46 ' HA ' ' HB ' ' A' ' 56' ' ' THR . 14.7 pt20 -47.5 -12.07 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.501 HG23 ' HA ' ' A' ' 45' ' ' GLU . 43.6 t -74.96 -90.83 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.285 -179.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -162.39 124.23 2.71 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 119.903 -0.719 . . . . 0.0 112.916 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.644 ' HB ' ' O ' ' A' ' 53' ' ' ALA . 45.2 t -117.13 148.1 20.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 177.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -44.68 96.1 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.912 0.387 . . . . 0.0 111.343 -179.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.34 17.86 74.66 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.627 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.644 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -146.03 82.56 1.61 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.017 0.437 . . . . 0.0 112.063 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.476 HG13 ' O ' ' A' ' 54' ' ' VAL . 12.5 p -86.85 59.08 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 0.0 110.874 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.16 -168.64 1.56 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.684 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.46 ' HB ' ' HA ' ' A' ' 47' ' ' GLN . 12.2 t -151.66 44.12 0.75 Allowed 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.607 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -87.52 165.08 15.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.91 0.386 . . . . 0.0 111.292 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.2 -40.07 59.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.791 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -111.67 134.38 53.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.918 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . 0.41 ' O ' ' O ' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -107.44 115.17 29.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.36 179.782 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.53 76.49 5.07 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.129 0.49 . . . . 0.0 109.754 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.437 ' CG2' ' HG3' ' A' ' 66' ' ' GLN . 46.5 mt -139.2 153.32 24.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.43 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.44 ' CG1' ' HA ' ' A' ' 20' ' ' HIS . 4.3 m -155.26 175.42 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.663 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 78.33 -150.52 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 178.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.707 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -84.87 77.41 2.11 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.939 -179.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.437 ' HG3' ' CG2' ' A' ' 62' ' ' ILE . 22.0 mm100 -122.18 157.72 30.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.913 0.387 . . . . 0.0 111.491 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 25.1 m -118.58 156.72 28.66 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.673 0.619 . . . . 0.0 112.673 -178.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.579 HG11 ' CH2' ' A' ' 32' ' ' TRP . 1.2 t -137.34 149.37 25.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.891 179.11 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.582 ' HA ' ' O ' ' A' ' 73' ' ' HIS . 43.2 p -140.57 138.08 34.21 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.483 ' CE2' ' HA ' ' A' ' 41' ' ' ILE . 2.4 t80 -138.4 115.58 11.02 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.701 178.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 38.29 31.6 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 179.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 116.67 -7.61 17.58 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.334 -0.936 . . . . 0.0 113.619 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.582 ' O ' ' HA ' ' A' ' 69' ' ' SER . 0.9 OUTLIER -88.14 83.83 6.95 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 117.252 0.526 . . . . 0.0 110.882 -179.427 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.2 m -92.58 111.47 23.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.979 0.419 . . . . 0.0 110.942 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.51 ' HB ' ' HZ2' ' A' ' 32' ' ' TRP . 64.5 t -131.65 151.07 34.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.485 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.536 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 49.3 mt-30 -112.0 171.45 7.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.463 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.707 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 2.8 t -144.13 146.76 20.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.162 -178.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.0 m -136.38 170.44 18.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.838 0.351 . . . . 0.0 111.01 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.117 0 CA-C-O 118.214 -0.898 . . . . 0.0 111.068 179.881 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.492 ' O ' HG13 ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.455 -0.209 0 CA-C-O 120.797 0.332 . . . . 0.0 111.042 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.55 130.55 51.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.146 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.541 ' HZ ' HD11 ' A' ' 29' ' ' LEU . 15.2 t80 -106.78 96.65 6.59 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.106 -179.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.403 ' HA ' ' CG2' ' A' ' 78' ' ' VAL . 7.7 t -70.95 110.56 5.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.94 0.4 . . . . 0.0 111.083 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.438 HD11 HG11 ' A' ' 77' ' ' VAL . 13.8 mt -83.27 -31.55 26.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.555 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.05 -88.66 0.63 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.892 -0.671 . . . . 0.0 111.897 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.02 71.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.011 0.434 . . . . 0.0 110.886 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.446 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -117.43 172.18 4.24 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.38 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.592 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 38.0 Cg_endo -66.92 -41.56 9.97 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.054 1.836 . . . . 0.0 111.789 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.776 ' HA ' HG12 ' A' ' 63' ' ' VAL . 7.0 p80 170.68 -178.22 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.057 179.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.47 HG12 ' O ' ' A' ' 20' ' ' HIS . 10.8 m -149.17 169.23 2.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.604 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -97.62 146.99 24.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.988 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.529 HD12 ' N ' ' A' ' 24' ' ' CYS . 4.3 pp -42.65 -34.0 0.81 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.46 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.529 ' N ' HD12 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -65.74 -43.58 88.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.85 0.357 . . . . 0.0 110.566 179.928 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.552 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 0.5 OUTLIER -61.82 -60.11 4.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.195 179.33 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.462 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 1.9 tp -50.08 -47.92 53.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.404 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.716 HD12 ' HG2' ' A' ' 45' ' ' GLU . 9.2 mp -67.5 -61.9 1.68 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.683 -179.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -50.45 -54.43 22.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.002 -179.714 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.552 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 2.2 mt -56.8 -34.65 67.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.192 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 7.4 mm-40 -78.83 -15.13 58.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.408 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.33 22.23 22.68 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.421 -0.895 . . . . 0.0 113.104 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.627 ' CZ3' ' HB2' ' A' ' 73' ' ' HIS . 9.2 m95 -72.81 -70.49 0.35 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 117.09 0.445 . . . . 0.0 109.896 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.6 t -95.05 138.9 32.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.956 178.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -75.7 -34.17 60.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.885 0.374 . . . . 0.0 110.792 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.3 -28.8 10.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.045 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.47 -37.5 3.79 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.49 179.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.32 5.27 2.97 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 43.4 tp60 -58.45 -72.6 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.712 0.292 . . . . 0.0 111.716 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.75 15.5 0.5 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.5 mtmm 64.49 24.53 13.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.053 0.454 . . . . 0.0 110.479 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.417 HG23 HD23 ' A' ' 27' ' ' LEU . 51.4 mt -59.56 -17.83 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.698 179.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.446 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . . . -76.0 -77.91 0.12 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.042 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 13.1 mm -45.33 -45.7 3.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 121.078 0.466 . . . . 0.0 110.724 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.659 ' O ' ' HG3' ' A' ' 47' ' ' GLN . . . -57.82 -61.12 2.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.839 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.716 ' HG2' HD12 ' A' ' 27' ' ' LEU . 9.9 tp10 -35.9 -35.6 0.07 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.143 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.459 ' O ' ' N ' ' A' ' 48' ' ' VAL . . . -72.16 -72.68 0.91 Allowed Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.24 -0.981 . . . . 0.0 111.743 178.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.662 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 0.0 OUTLIER -39.93 -18.96 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -178.905 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.615 HG22 ' HA ' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -75.34 -85.74 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.763 -179.55 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -176.56 130.55 0.2 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.467 -0.493 . . . . 0.0 112.112 179.723 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.429 ' O ' ' N ' ' A' ' 52' ' ' GLY . 49.6 t -125.04 150.83 30.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.721 178.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.486 ' HB2' ' H ' ' A' ' 67' ' ' THR . 1.2 m-20 -65.96 70.65 0.06 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.944 0.402 . . . . 0.0 110.601 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 135.92 -18.51 3.79 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.387 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.66 135.02 47.43 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.009 0.433 . . . . 0.0 111.123 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.4 p -124.43 29.95 2.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.273 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -115.04 158.05 22.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.206 0.527 . . . . 0.0 111.495 -179.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.662 ' HB ' ' HB3' ' A' ' 47' ' ' GLN . 13.3 t -99.65 58.23 1.04 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.445 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 57' ' ' ARG . 14.6 mtt180 -89.13 171.81 9.54 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.785 0.326 . . . . 0.0 111.214 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.407 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -76.19 -48.24 21.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.23 179.655 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -122.4 154.82 37.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.035 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -136.91 119.19 15.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.899 0.38 . . . . 0.0 111.472 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.488 ' HG2' ' CD2' ' A' ' 20' ' ' HIS . 18.6 mttt -68.61 86.9 0.32 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.93 179.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 25.6 mt -134.54 139.98 46.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.955 0.407 . . . . 0.0 111.695 -179.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.776 HG12 ' HA ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -152.58 176.29 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.191 -179.649 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.497 ' HB1' ' O ' ' A' ' 63' ' ' VAL . . . 75.26 -154.38 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.55 179.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.575 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -84.5 78.65 1.99 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.826 -178.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -122.3 157.07 32.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.092 0.472 . . . . 0.0 111.268 -179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.554 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 1.9 m -113.25 155.5 24.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.311 -178.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.401 ' CG1' ' CH2' ' A' ' 32' ' ' TRP . 0.9 OUTLIER -125.33 139.72 50.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.55 179.228 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.406 ' O ' ' HB ' ' A' ' 48' ' ' VAL . 0.7 OUTLIER -133.99 128.88 35.29 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.232 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.615 ' HA ' HG22 ' A' ' 48' ' ' VAL . 2.9 t80 -146.77 126.5 13.44 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.641 179.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 46.13 -87.1 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.301 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -127.02 -8.73 4.5 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.889 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.627 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 1.8 m-70 -89.64 109.02 20.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.941 0.371 . . . . 0.0 111.471 -179.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.1 m -120.32 117.28 27.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.356 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.492 HG13 ' O ' ' A' ' 11' ' ' ALA . 19.5 t -140.54 159.49 24.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.58 -179.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.554 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 19.5 mt-30 -112.66 163.15 14.89 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.028 0.442 . . . . 0.0 111.485 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.575 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 15.0 t -132.08 147.78 32.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.266 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.403 ' CG2' ' HA ' ' A' ' 14' ' ' SER . 24.5 m -129.12 162.45 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 CA-C-O 120.864 0.364 . . . . 0.0 111.291 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.299 -0.858 . . . . 0.0 111.079 179.901 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.412 ' HB2' ' CG1' ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.456 -0.167 0 N-CA-C 110.383 -0.229 . . . . 0.0 110.383 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.11 130.3 35.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.973 0.416 . . . . 0.0 111.046 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.484 ' HB2' ' CG ' ' A' ' 30' ' ' GLU . 13.6 t80 -107.07 144.66 33.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.312 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 74.7 m -106.82 149.82 26.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.46 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.464 ' HG ' HG13 ' A' ' 77' ' ' VAL . 55.2 mt -118.25 -40.06 2.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.833 0.349 . . . . 0.0 110.866 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.32 -102.93 2.99 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.245 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.7 pttt -143.1 43.65 1.55 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.964 0.411 . . . . 0.0 111.227 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.644 ' CG ' ' HD2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -101.64 154.45 37.27 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.194 179.536 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.644 ' HD2' ' CG ' ' A' ' 18' ' ' HIS . 9.3 Cg_endo -50.91 -32.4 37.67 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.581 2.187 . . . . 0.0 112.008 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.56 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 10.4 p80 159.62 -165.38 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.809 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.1 m -133.52 141.94 43.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.989 0.423 . . . . 0.0 111.233 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.619 ' HA ' ' H ' ' A' ' 60' ' ' CYS . 1.3 mp0 -81.28 148.07 29.61 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.822 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.485 ' O ' HD11 ' A' ' 27' ' ' LEU . 4.0 mp -38.7 -54.8 1.54 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.766 0.317 . . . . 0.0 111.39 -179.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.3 t -60.68 -29.06 69.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.417 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 22' ' ' GLU . 1.0 OUTLIER -72.74 -62.38 1.47 Allowed 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.76 0.314 . . . . 0.0 111.382 -179.716 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.441 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 4.9 tt -51.97 -48.84 64.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.266 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.526 HD12 ' HB3' ' A' ' 45' ' ' GLU . 5.4 mt -60.51 -57.76 11.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.556 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.6 ttpt -55.66 -54.46 43.99 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.769 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.25 -51.22 68.91 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -178.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.484 ' CG ' ' HB2' ' A' ' 13' ' ' PHE . 3.1 mm-40 -63.71 -15.44 58.49 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.56 25.54 15.47 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.267 -0.968 . . . . 0.0 113.341 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.599 ' CH2' HG12 ' A' ' 68' ' ' VAL . 12.4 m95 -74.14 -61.27 1.91 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-N 117.417 0.608 . . . . 0.0 109.552 178.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.0 t -106.79 140.52 39.51 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.495 179.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.61 -34.1 67.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.978 0.418 . . . . 0.0 110.171 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.54 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -105.77 -47.05 3.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.466 179.354 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 129.29 -30.82 3.57 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.303 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.96 6.7 3.4 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.54 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 19.1 tp60 -52.25 -75.01 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.857 0.361 . . . . 0.0 110.69 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.591 ' HB3' HD11 ' A' ' 41' ' ' ILE . . . -79.96 15.35 1.48 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.562 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.1 mmtt 64.61 29.4 13.06 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 121.142 0.496 . . . . 0.0 110.283 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.624 ' HA ' ' CE2' ' A' ' 70' ' ' PHE . 2.5 mp -63.4 -24.31 35.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.0 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.56 -78.97 0.05 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.383 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.4 mm -50.54 -42.64 22.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.946 0.403 . . . . 0.0 110.832 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.506 ' HA ' HE21 ' A' ' 47' ' ' GLN . . . -58.06 -68.86 0.21 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.165 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.526 ' HB3' HD12 ' A' ' 27' ' ' LEU . 1.6 tm-20 -33.88 -42.18 0.11 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.944 0.402 . . . . 0.0 111.087 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.451 ' C ' ' H ' ' A' ' 48' ' ' VAL . . . -60.15 -72.64 0.59 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.348 178.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.547 ' CA ' ' HB ' ' A' ' 56' ' ' THR . 9.3 pt20 -49.84 -8.57 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.515 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 60.0 t -74.87 -90.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.293 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.515 ' HG2' ' O ' ' A' ' 48' ' ' VAL . 0.5 OUTLIER -171.18 133.97 0.89 Allowed 'General case' 0 C--O 1.232 0.132 0 C-N-CA 120.432 -0.507 . . . . 0.0 111.744 179.559 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.516 HG22 HG23 ' A' ' 68' ' ' VAL . 21.9 t -130.41 147.44 33.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.819 178.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.413 ' HB2' ' H ' ' A' ' 67' ' ' THR . 0.5 OUTLIER -63.53 79.83 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.08 0.466 . . . . 0.0 110.51 -179.888 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 125.52 -13.68 7.33 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.583 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -135.96 135.45 39.58 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.965 0.412 . . . . 0.0 111.17 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.451 HG22 ' O ' ' A' ' 54' ' ' VAL . 10.5 p -125.55 31.19 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.886 178.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -104.71 -150.46 0.43 Allowed 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.799 -178.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.547 ' HB ' ' CA ' ' A' ' 47' ' ' GLN . 4.5 t -169.89 67.4 0.05 Allowed 'General case' 0 C--O 1.232 0.147 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.95 174.15 7.23 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.46 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -75.12 -46.43 34.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.014 0.435 . . . . 0.0 110.224 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.431 ' O ' ' HG2' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -101.87 131.9 47.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.045 179.167 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . 0.619 ' H ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -100.08 115.61 30.18 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.979 0.419 . . . . 0.0 111.217 -179.449 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.458 ' HG3' ' NE2' ' A' ' 20' ' ' HIS . 0.1 OUTLIER -94.55 74.86 3.78 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.783 179.207 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.402 HG22 ' N ' ' A' ' 63' ' ' VAL . 36.6 mt -133.65 142.09 42.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.061 0.458 . . . . 0.0 111.578 -178.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.429 HG11 ' O ' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -150.77 175.96 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.606 -179.908 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.416 ' CB ' ' O ' ' A' ' 63' ' ' VAL . . . 81.09 -154.29 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.513 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -93.7 79.02 1.03 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.631 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -122.63 162.22 22.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.147 0.498 . . . . 0.0 111.34 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.651 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 25.8 m -113.85 156.57 23.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.851 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.599 HG12 ' CH2' ' A' ' 32' ' ' TRP . 0.9 OUTLIER -131.75 146.04 34.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.005 179.335 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 60.0 p -143.66 139.13 29.41 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 120.907 0.384 . . . . 0.0 111.727 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.624 ' CE2' ' HA ' ' A' ' 41' ' ' ILE . 0.8 OUTLIER -128.48 -86.24 0.56 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.28 179.983 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -139.63 88.56 2.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.743 0.306 . . . . 0.0 110.464 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.17 -25.5 6.93 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.441 -0.885 . . . . 0.0 111.444 -178.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.593 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 0.9 OUTLIER -93.06 109.02 20.49 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 120.791 0.329 . . . . 0.0 110.914 -179.758 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.9 m -120.23 98.48 6.08 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.579 ' HB ' ' HZ2' ' A' ' 32' ' ' TRP . 38.9 t -120.32 151.16 23.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.475 -178.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.651 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 30.0 mt-30 -112.45 164.38 13.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.642 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.464 HG13 ' HG ' ' A' ' 15' ' ' LEU . 10.7 t -132.47 146.52 32.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.065 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 17.9 m -139.89 169.5 16.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.886 0.374 . . . . 0.0 111.144 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.181 -0.914 . . . . 0.0 111.071 179.863 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.507 ' O ' HG12 ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.453 -0.275 0 CA-C-O 120.813 0.339 . . . . 0.0 110.65 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.69 135.46 53.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.464 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -124.83 98.57 5.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.886 0.374 . . . . 0.0 110.87 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.75 141.5 57.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.721 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -90.93 -36.89 13.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.633 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.26 -81.3 1.06 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.574 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.7 ttmm -171.44 39.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.887 0.375 . . . . 0.0 110.85 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.629 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 6.1 m-70 -98.67 165.1 15.7 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.713 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.629 ' HD2' ' HB3' ' A' ' 18' ' ' HIS . 42.2 Cg_endo -66.79 -37.3 21.07 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.272 1.982 . . . . 0.0 111.935 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.525 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 6.3 p80 172.71 -172.14 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.022 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.491 ' CG2' HD11 ' A' ' 26' ' ' LEU . 2.5 m -136.26 151.9 29.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.091 0.472 . . . . 0.0 112.255 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.423 ' O ' ' N ' ' A' ' 25' ' ' ASP . 2.5 mp0 -95.01 148.3 22.48 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.464 178.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.424 HD22 ' HA2' ' A' ' 46' ' ' GLY . 0.5 OUTLIER -40.7 -47.94 2.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.743 0.306 . . . . 0.0 111.636 -179.492 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -62.78 -34.72 77.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.877 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 22' ' ' GLU . 8.7 m-20 -64.75 -62.2 1.72 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.046 0.45 . . . . 0.0 110.433 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.633 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 0.9 OUTLIER -50.64 -46.0 58.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.148 179.909 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.491 ' HA ' ' CG ' ' A' ' 32' ' ' TRP . 9.8 mt -67.07 -59.37 3.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.915 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.18 -58.59 7.31 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.423 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.2 OUTLIER -53.9 -45.49 71.12 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.677 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.633 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 4.3 mm-40 -72.55 -14.62 61.68 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.09 25.34 12.93 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.192 -1.004 . . . . 0.0 113.332 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.627 ' CH2' HG12 ' A' ' 68' ' ' VAL . 12.4 m95 -73.47 -58.6 3.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.041 0.448 . . . . 0.0 110.013 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.415 ' HA ' HD13 ' A' ' 41' ' ' ILE . 2.1 t -106.1 133.7 50.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.513 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -64.67 -34.12 77.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.608 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.412 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 56.2 p -105.83 -49.2 3.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.734 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 133.91 -32.54 2.66 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.764 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.23 6.57 1.73 Allowed 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.412 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 69.7 tp60 -54.61 -71.83 0.07 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.956 0.408 . . . . 0.0 110.852 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.05 15.22 1.17 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.465 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.457 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 0.0 OUTLIER 65.38 20.84 11.86 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.629 -179.53 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.536 ' HA ' ' CE2' ' A' ' 70' ' ' PHE . 37.5 mt -54.88 -25.89 16.4 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-O 121.01 0.433 . . . . 0.0 110.712 179.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.479 ' HA ' ' CD1' ' A' ' 27' ' ' LEU . . . -67.72 -79.34 0.05 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.164 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 44.6 mm -51.2 -39.17 20.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.199 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.457 ' HB1' ' O ' ' A' ' 40' ' ' LYS . . . -58.04 -68.88 0.21 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.238 179.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.482 ' HA ' ' HB2' ' A' ' 70' ' ' PHE . 0.9 OUTLIER -33.42 -41.9 0.09 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.749 179.741 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.424 ' HA2' HD22 ' A' ' 23' ' ' LEU . . . -57.44 -74.72 0.31 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.034 -1.079 . . . . 0.0 110.553 178.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.51 ' HA ' HG21 ' A' ' 56' ' ' THR . 13.8 pt20 -48.06 -12.84 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.464 HG23 ' CD1' ' A' ' 70' ' ' PHE . 58.7 t -75.02 -93.63 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.969 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.468 ' HD3' ' HB ' ' A' ' 54' ' ' VAL . 4.6 mmtt -166.92 124.89 1.32 Allowed 'General case' 0 C--O 1.23 0.065 0 C-N-CA 120.151 -0.619 . . . . 0.0 112.368 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.494 ' HB ' ' O ' ' A' ' 53' ' ' ALA . 12.8 t -118.11 149.17 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 177.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -45.07 100.47 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.025 0.44 . . . . 0.0 111.534 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 66.95 17.3 67.43 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.857 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.494 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -145.98 82.71 1.62 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.922 0.391 . . . . 0.0 111.945 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.468 ' HB ' ' HD3' ' A' ' 49' ' ' LYS . 14.0 p -90.66 65.44 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.912 0.387 . . . . 0.0 110.582 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -99.83 -173.5 2.47 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.511 -179.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.51 HG21 ' HA ' ' A' ' 47' ' ' GLN . 0.8 OUTLIER -140.83 32.59 1.79 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.149 -179.708 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 19.4 mtp180 -84.74 169.13 14.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.062 0.458 . . . . 0.0 111.503 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.17 -32.01 55.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.915 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.2 mtt85 -131.76 146.54 52.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.654 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -129.51 115.89 18.13 Favored 'General case' 0 C--O 1.23 0.078 0 CA-C-O 120.89 0.376 . . . . 0.0 111.328 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.412 ' HG2' ' CD2' ' A' ' 20' ' ' HIS . 6.3 mttt -76.1 91.91 3.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.352 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 39.8 mt -133.77 139.72 48.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.265 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.476 HG11 ' O ' ' A' ' 19' ' ' PRO . 2.5 m -146.23 175.2 2.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.119 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 74.98 -143.51 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.965 178.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -93.13 80.49 1.08 Allowed Glycine 0 C--N 1.336 0.552 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.766 -179.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -121.92 175.17 6.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.819 0.342 . . . . 0.0 111.228 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.415 ' OG1' ' HG3' ' A' ' 76' ' ' GLN . 27.1 m -135.85 151.14 49.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.008 -178.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.627 HG12 ' CH2' ' A' ' 32' ' ' TRP . 1.2 t -130.5 144.13 38.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.309 179.135 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 67.8 m -140.99 141.23 34.4 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -178.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.536 ' CE2' ' HA ' ' A' ' 41' ' ' ILE . 1.9 t80 -146.08 122.28 10.85 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.273 179.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 49.78 -83.47 0.01 OUTLIER 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.481 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -127.46 -5.09 5.62 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.963 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.527 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 0.8 OUTLIER -89.46 113.79 25.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 117.01 0.405 . . . . 0.0 111.592 -179.027 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.61 111.35 17.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.285 178.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.568 ' HB ' ' HZ2' ' A' ' 32' ' ' TRP . 41.1 t -132.39 151.61 35.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.817 0.342 . . . . 0.0 111.488 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.415 ' HG3' ' OG1' ' A' ' 67' ' ' THR . 24.5 mp0 -113.2 159.53 19.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.423 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.452 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 6.3 t -125.07 138.7 53.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.084 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.1 m -133.88 154.54 38.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.014 0.435 . . . . 0.0 111.871 -179.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.058 179.948 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.15 0 CA-C-O 120.652 0.263 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.63 132.99 41.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.021 0.439 . . . . 0.0 110.902 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.521 ' CG ' HD13 ' A' ' 26' ' ' LEU . 16.8 t80 -99.72 98.24 9.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.967 179.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.411 ' HA ' HG21 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -77.18 98.98 5.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.764 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.9 mt -55.83 -34.14 65.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.985 0.421 . . . . 0.0 110.542 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.54 42.49 7.82 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.005 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt 61.3 39.38 15.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.981 0.419 . . . . 0.0 110.631 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.417 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 3.6 m170 -95.15 165.73 16.3 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.897 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.425 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 14.8 Cg_endo -56.99 -63.63 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.672 2.248 . . . . 0.0 112.612 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.425 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 8.5 p80 178.51 -174.05 0.16 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.241 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.579 HG22 HD12 ' A' ' 26' ' ' LEU . 17.8 m -149.93 167.07 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -103.71 153.39 20.72 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.253 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 81.6 mt -41.65 -45.55 3.44 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.0 t -65.37 -39.12 91.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.721 0.296 . . . . 0.0 111.671 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -62.12 -62.31 1.86 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.593 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.579 HD12 HG22 ' A' ' 21' ' ' VAL . 2.3 tp -53.69 -41.92 67.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.474 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.519 ' HG ' ' CE3' ' A' ' 32' ' ' TRP . 8.0 mp -66.81 -64.7 0.8 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.382 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -51.26 -57.0 10.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.988 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 24.9 mt -53.65 -31.02 45.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.079 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.45 ' HB2' ' CD1' ' A' ' 32' ' ' TRP . 2.4 mm-40 -84.05 -13.61 52.71 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.55 18.0 34.36 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.365 -0.922 . . . . 0.0 112.685 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.519 ' CE3' ' HG ' ' A' ' 27' ' ' LEU . 9.4 m0 -69.58 -60.81 2.09 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.1 t -106.83 134.04 50.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.99 179.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -63.95 -34.83 78.87 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.856 0.36 . . . . 0.0 111.048 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.536 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 79.0 p -106.25 -51.56 2.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.138 0.494 . . . . 0.0 110.225 178.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 139.29 -37.62 1.74 Allowed Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.3 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.03 11.25 3.33 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.536 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 3.4 tp-100 -63.11 -66.65 0.51 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.761 0.315 . . . . 0.0 110.777 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.29 14.41 0.94 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.727 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 46.0 mmtt 65.4 25.48 11.99 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.832 0.349 . . . . 0.0 110.745 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.506 ' HA ' ' CE2' ' A' ' 70' ' ' PHE . 5.3 mt -63.09 -27.12 42.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.267 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.84 -78.51 0.06 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.836 0.35 . . . . 0.0 110.577 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.6 mm -46.51 -35.81 2.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 121.104 0.478 . . . . 0.0 110.249 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.521 ' O ' ' HG3' ' A' ' 47' ' ' GLN . . . -63.8 -62.61 1.54 Allowed 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.657 178.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.464 ' HB2' ' CD2' ' A' ' 27' ' ' LEU . 16.3 tp10 -32.35 -41.84 0.06 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.823 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.8 -71.6 0.92 Allowed Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.355 -0.926 . . . . 0.0 111.743 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.521 ' HG3' ' O ' ' A' ' 44' ' ' ALA . 0.7 OUTLIER -43.69 -19.54 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.726 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.468 HG23 ' CD1' ' A' ' 70' ' ' PHE . 21.5 t -75.85 -85.05 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.945 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -170.36 133.17 1.05 Allowed 'General case' 0 C--O 1.23 0.055 0 CA-C-O 120.804 0.335 . . . . 0.0 111.138 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.428 ' O ' ' N ' ' A' ' 52' ' ' GLY . 4.4 t -134.62 144.19 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.056 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 67' ' ' THR . 6.0 t70 -48.74 91.25 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.75 0.31 . . . . 0.0 111.442 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 94.27 -7.4 72.3 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.875 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.0 131.33 47.39 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 117.323 0.562 . . . . 0.0 111.187 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.5 p -124.84 32.51 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.861 178.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -101.99 154.64 18.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.936 -178.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.504 ' HB ' ' HB3' ' A' ' 47' ' ' GLN . 12.1 t -92.88 46.84 1.24 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.643 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.68 169.98 17.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.187 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.09 -32.25 20.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.125 0.488 . . . . 0.0 109.819 178.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 36.2 mtm180 -128.38 151.94 48.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.991 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . 0.404 ' HB3' HD12 ' A' ' 62' ' ' ILE . 18.4 t -136.94 117.29 13.62 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.827 0.346 . . . . 0.0 111.105 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.02 99.0 2.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.394 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.404 HD12 ' HB3' ' A' ' 60' ' ' CYS . 1.5 mt -133.36 142.65 41.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.151 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.6 m -147.54 170.71 3.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.39 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 72.34 -155.5 0.09 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.387 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.547 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -87.17 82.96 1.59 Allowed Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 121.516 -0.373 . . . . 0.0 112.285 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.442 ' HB3' ' CB ' ' A' ' 51' ' ' ASP . 5.0 mm100 -121.48 160.91 23.21 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.972 0.415 . . . . 0.0 111.577 -178.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 0.2 OUTLIER -116.23 149.07 39.76 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.551 -178.498 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.46 HG12 ' CH2' ' A' ' 32' ' ' TRP . 1.1 t -125.88 142.47 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.651 179.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.2 m -138.14 133.53 33.47 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -178.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.52 ' O ' ' N ' ' A' ' 72' ' ' GLY . 1.9 t80 -144.05 122.57 12.45 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.1 178.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 47.21 -85.5 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.724 0.297 . . . . 0.0 111.535 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -127.31 -4.89 5.75 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.037 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.462 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 1.8 m-70 -92.75 110.1 21.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.025 0.413 . . . . 0.0 111.3 -179.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.0 m -120.69 125.16 46.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.278 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.0 t -147.23 160.64 8.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.808 0.337 . . . . 0.0 111.564 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.485 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 35.8 mt-30 -112.41 164.02 13.75 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.949 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.547 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 16.9 t -137.13 147.12 27.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.658 -179.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.417 ' N ' HG12 ' A' ' 77' ' ' VAL . 17.0 m -134.22 178.01 6.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 120.718 0.294 . . . . 0.0 110.624 178.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.331 -0.842 . . . . 0.0 111.098 -179.978 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.168 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.58 80.29 1.28 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.88 0.371 . . . . 0.0 110.736 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.1 ttt -168.58 72.91 0.1 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.309 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 34.8 pt -99.49 148.47 6.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.885 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 33.6 m80 -84.43 -174.88 5.52 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.725 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.46 ' C ' ' H ' ' A' ' 8' ' ' SER . 1.5 mtt180 -147.57 109.92 4.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.74 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 74.43 -31.32 0.21 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.294 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.46 ' H ' ' C ' ' A' ' 6' ' ' ARG . 0.6 OUTLIER 67.72 115.99 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.864 0.364 . . . . 0.0 110.9 179.667 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -108.75 83.88 1.84 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.868 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.57 71.78 2.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.037 0.446 . . . . 0.0 110.414 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.551 ' HB1' ' CG1' ' A' ' 75' ' ' VAL . . . -77.16 102.55 6.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.095 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.3 123.23 26.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.895 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.472 ' CE1' ' HB3' ' A' ' 29' ' ' LEU . 50.0 t80 -100.87 152.82 20.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.911 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.83 153.46 21.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.101 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.3 mt -129.32 -40.16 1.47 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.785 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.44 -111.54 3.63 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.73 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.86 57.4 1.35 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.114 0.483 . . . . 0.0 110.624 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.64 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 2.3 m-70 -110.04 165.84 11.9 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.567 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.64 ' HD2' ' HB3' ' A' ' 18' ' ' HIS . 31.2 Cg_endo -62.64 -41.25 32.53 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.098 1.866 . . . . 0.0 111.863 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.553 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 21.5 p80 171.38 -170.36 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.721 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.6 m -145.78 158.99 12.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.236 0.541 . . . . 0.0 112.365 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.535 ' HG3' ' HA ' ' A' ' 59' ' ' ARG . 8.2 tt0 -88.78 139.21 30.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.848 178.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.442 HD22 ' O ' ' A' ' 57' ' ' ARG . 4.1 pp -42.45 -30.48 0.34 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.781 0.324 . . . . 0.0 111.404 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.5 t -72.47 -40.17 67.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.977 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.401 ' N ' ' O ' ' A' ' 22' ' ' GLU . 1.9 m-20 -65.74 -53.73 36.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.938 0.399 . . . . 0.0 110.702 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.524 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 10.1 tt -54.75 -48.72 72.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.825 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.577 HD13 ' HG2' ' A' ' 45' ' ' GLU . 8.9 mp -65.76 -63.03 1.18 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.648 -178.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.0 tmmm? -43.84 -59.43 2.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.023 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.472 ' HB3' ' CE1' ' A' ' 13' ' ' PHE . 0.5 OUTLIER -56.13 -47.5 78.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.226 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.524 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 2.3 mm-40 -62.11 -15.21 43.84 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.681 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.04 24.68 14.34 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.321 -0.942 . . . . 0.0 113.253 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.618 ' HZ2' ' HB ' ' A' ' 75' ' ' VAL . 7.8 m0 -79.09 -63.88 1.32 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.248 0.524 . . . . 0.0 109.988 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.9 t -106.72 135.37 48.37 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.778 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.41 -33.36 71.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.827 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.7 p -104.67 -40.46 5.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.493 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 121.83 -30.74 5.2 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.027 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -138.31 5.93 2.53 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.701 0.259 . . . . 0.0 111.701 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.408 ' C ' ' H ' ' A' ' 40' ' ' LYS . 21.5 tp60 -54.91 -74.69 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.859 0.362 . . . . 0.0 110.952 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.62 15.68 0.34 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.77 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.41 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 37.4 mttm 64.48 24.57 13.15 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 120.961 0.41 . . . . 0.0 110.073 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.553 ' HA ' ' CE2' ' A' ' 70' ' ' PHE . 16.9 mt -63.71 -18.92 23.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.708 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.11 -79.14 0.09 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.93 0.395 . . . . 0.0 110.663 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 29.4 mm -46.61 -45.01 6.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.674 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.524 ' HB3' ' CE1' ' A' ' 70' ' ' PHE . . . -54.33 -68.14 0.21 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.91 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.601 ' HA ' ' HB2' ' A' ' 70' ' ' PHE . 6.6 tp10 -32.66 -45.14 0.12 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.604 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 55' ' ' GLU . . . -57.84 -74.37 0.35 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 119.875 -1.155 . . . . 0.0 110.637 178.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.557 ' CA ' ' HB ' ' A' ' 56' ' ' THR . 14.6 pt20 -46.33 -14.62 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.452 HG21 ' CD1' ' A' ' 70' ' ' PHE . 56.0 t -74.92 -88.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.116 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.427 ' HG2' ' O ' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -172.84 128.87 0.5 Allowed 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.828 0.346 . . . . 0.0 111.019 179.221 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.424 ' O ' ' N ' ' A' ' 52' ' ' GLY . 44.7 t -124.29 149.48 28.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.591 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -55.66 85.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.132 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 106.78 -6.15 37.62 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.115 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -133.75 135.42 43.92 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 117.148 0.474 . . . . 0.0 111.267 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.41 HG21 ' O ' ' A' ' 54' ' ' VAL . 12.1 p -125.42 38.13 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.306 178.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' A' ' 46' ' ' GLY . 7.6 mt-10 -106.94 -151.39 0.46 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.211 -0.449 . . . . 0.0 112.171 -178.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.557 ' HB ' ' CA ' ' A' ' 47' ' ' GLN . 3.5 t -166.96 57.3 0.08 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.927 0.394 . . . . 0.0 111.469 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.442 ' O ' HD22 ' A' ' 23' ' ' LEU . 2.2 mtt-85 -86.29 175.29 8.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.019 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.21 -47.53 27.82 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.535 ' HA ' ' HG3' ' A' ' 22' ' ' GLU . 3.8 mtm180 -115.21 153.09 31.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.237 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -125.68 137.22 53.84 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.928 0.394 . . . . 0.0 111.231 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.491 ' HG3' ' CD2' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -99.98 77.59 2.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.441 179.485 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.3 mt -133.9 144.49 35.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.42 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.548 ' CG1' ' HA ' ' A' ' 20' ' ' HIS . 6.5 m -150.28 175.64 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.183 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 74.4 -150.39 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.082 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.634 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -84.93 77.74 2.08 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.319 -0.467 . . . . 0.0 112.963 -178.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 18.3 mm100 -122.09 158.71 28.66 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.859 0.361 . . . . 0.0 110.979 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.505 HG23 ' O ' ' A' ' 75' ' ' VAL . 26.9 m -117.15 154.64 30.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.141 0.496 . . . . 0.0 112.251 -178.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.591 HG12 ' CH2' ' A' ' 32' ' ' TRP . 0.7 OUTLIER -127.37 143.25 41.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.44 178.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 36.8 m -136.66 132.82 35.5 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -178.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.601 ' HB2' ' HA ' ' A' ' 45' ' ' GLU . 1.4 t80 -141.95 122.77 14.39 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.336 178.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 46.67 -87.01 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.687 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -126.66 -6.06 5.69 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.858 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.403 ' O ' ' CH2' ' A' ' 32' ' ' TRP . 1.0 OUTLIER -90.61 103.59 16.27 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.793 0.33 . . . . 0.0 111.042 -179.464 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.3 m -114.65 125.57 53.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.602 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.618 ' HB ' ' HZ2' ' A' ' 32' ' ' TRP . 47.0 t -145.59 153.58 13.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.23 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.499 ' HG3' HG23 ' A' ' 67' ' ' THR . 3.1 mp0 -112.25 158.28 19.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.813 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.634 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 46.9 t -129.2 152.22 36.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.813 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.2 m -130.89 148.97 33.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.921 0.391 . . . . 0.0 111.53 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.077 179.682 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 112.554 -0.218 . . . . 0.0 112.554 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 63.43 103.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.828 0.347 . . . . 0.0 110.987 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.3 mtt -80.39 -48.42 12.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.721 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.7 mt 65.7 41.14 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.124 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 14.4 t-160 -71.54 -20.82 61.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.138 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.5 ttt180 61.65 94.51 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.827 0.346 . . . . 0.0 110.781 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -114.15 -69.43 0.86 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.881 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.7 t -105.61 104.63 14.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.015 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -88.72 154.33 20.37 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.911 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -71.56 156.39 39.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.665 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.411 ' CB ' HG12 ' A' ' 75' ' ' VAL . . . -98.73 134.28 41.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.166 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.64 132.26 48.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.592 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.584 ' CD2' HD13 ' A' ' 26' ' ' LEU . 77.8 t80 -110.04 148.57 31.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.923 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.5 146.9 30.02 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.809 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 27.8 mt -114.23 -40.45 3.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.921 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.65 -103.75 2.89 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.585 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.06 56.62 0.9 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.995 0.426 . . . . 0.0 111.011 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.417 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 1.0 OUTLIER -113.36 167.33 9.49 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.578 179.863 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.583 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 19.4 Cg_endo -59.8 -33.55 96.12 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.3 2.0 . . . . 0.0 111.665 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.583 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 14.1 p80 163.01 -164.32 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.989 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.9 m -142.92 153.91 17.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.139 0.495 . . . . 0.0 112.004 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.437 ' HG3' ' CB ' ' A' ' 59' ' ' ARG . 0.7 OUTLIER -83.53 138.34 33.46 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.907 179.019 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.408 HD12 ' N ' ' A' ' 24' ' ' CYS . 4.6 pp -41.03 -33.27 0.31 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.764 0.316 . . . . 0.0 111.478 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.408 ' N ' HD12 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -71.3 -39.15 71.63 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.988 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 22' ' ' GLU . 78.8 m-20 -62.73 -52.27 63.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.05 0.452 . . . . 0.0 110.442 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.584 HD13 ' CD2' ' A' ' 13' ' ' PHE . 8.4 tp -58.23 -46.5 85.8 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.893 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.504 HD11 ' HG3' ' A' ' 45' ' ' GLU . 5.6 mp -67.33 -60.69 2.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.651 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -46.53 -65.26 0.58 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.752 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.57 -41.61 63.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.212 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 2.9 mm-40 -72.27 -15.3 61.91 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.19 26.26 12.71 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.475 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.544 ' CH2' HG12 ' A' ' 68' ' ' VAL . 9.4 m95 -76.39 -66.04 0.85 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 117.094 0.447 . . . . 0.0 110.079 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.0 t -101.0 149.29 24.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.315 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.32 -34.08 36.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.04 0.448 . . . . 0.0 110.489 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.78 -31.95 8.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.585 179.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 126.08 -60.22 0.65 Allowed Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.346 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -129.32 7.59 5.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.789 0.328 . . . . 0.0 111.281 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -54.21 -64.38 0.85 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.872 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.19 15.08 0.35 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.1 mmmt 72.24 14.14 5.58 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.622 0.249 . . . . 0.0 111.206 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.422 ' HA ' ' CE2' ' A' ' 70' ' ' PHE . 6.8 mt -65.5 -14.99 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-O 120.969 0.414 . . . . 0.0 110.739 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.21 -79.81 0.07 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.047 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 19.8 mm -52.33 -33.13 16.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.985 0.421 . . . . 0.0 110.51 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.436 ' O ' ' HG3' ' A' ' 47' ' ' GLN . . . -63.09 -72.18 0.14 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.683 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.594 ' HG2' ' HB2' ' A' ' 70' ' ' PHE . 3.6 tm-20 -35.35 -41.09 0.16 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.838 0.352 . . . . 0.0 111.157 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.437 ' C ' ' H ' ' A' ' 48' ' ' VAL . . . -63.04 -73.8 0.49 Allowed Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.277 -0.964 . . . . 0.0 110.928 178.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.436 ' HG3' ' O ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -47.96 -9.52 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -179.62 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.485 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 57.4 t -74.66 -90.67 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.644 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.596 ' HD3' ' HB ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -167.02 119.37 0.95 Allowed 'General case' 0 CA--C 1.527 0.08 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.73 179.694 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.529 ' HB ' ' O ' ' A' ' 53' ' ' ALA . 19.2 t -113.62 154.98 14.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.549 ' HB2' ' H ' ' A' ' 67' ' ' THR . 16.8 t0 -44.7 98.2 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.017 0.437 . . . . 0.0 111.611 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.93 21.43 61.18 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.339 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.529 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -145.79 79.87 1.57 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.021 0.439 . . . . 0.0 111.766 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.596 ' HB ' ' HD3' ' A' ' 49' ' ' LYS . 14.9 p -88.21 62.76 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.926 0.393 . . . . 0.0 111.044 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.42 178.4 4.65 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.297 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.8 t -139.31 40.59 2.08 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.801 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -86.91 174.39 8.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.693 0.282 . . . . 0.0 111.01 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.1 mttp -75.18 -50.27 16.8 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.965 0.412 . . . . 0.0 110.806 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.437 ' CB ' ' HG3' ' A' ' 22' ' ' GLU . 0.3 OUTLIER -106.4 136.88 45.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.27 179.402 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -100.04 115.58 30.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.949 0.404 . . . . 0.0 111.031 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.482 ' HA ' ' CG ' ' A' ' 20' ' ' HIS . 4.7 mtmt -87.12 76.01 9.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.881 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.5 mm -133.44 142.39 41.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.981 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.452 ' CG1' ' HA ' ' A' ' 20' ' ' HIS . 1.4 m -146.85 175.2 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.724 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.448 ' O ' ' HA ' ' A' ' 78' ' ' VAL . . . 74.48 -155.01 0.05 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.313 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.457 ' HA2' ' HA ' ' A' ' 78' ' ' VAL . . . -84.73 81.13 1.77 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 121.329 -0.462 . . . . 0.0 112.515 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -122.05 156.46 33.49 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.111 0.481 . . . . 0.0 111.264 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.549 ' H ' ' HB2' ' A' ' 51' ' ' ASP . 0.8 OUTLIER -113.55 152.9 29.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.752 -179.109 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.544 HG12 ' CH2' ' A' ' 32' ' ' TRP . 0.8 OUTLIER -127.34 147.07 32.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.645 179.237 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.4 m -143.16 137.8 29.31 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -178.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.594 ' HB2' ' HG2' ' A' ' 45' ' ' GLU . 1.6 t80 -144.91 121.66 11.2 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.084 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 48.72 -85.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.689 0.28 . . . . 0.0 111.347 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -126.77 -5.72 5.75 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.786 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.416 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 1.1 m-70 -88.39 104.4 16.74 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.888 0.344 . . . . 0.0 111.084 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -116.9 106.72 13.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.838 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.521 ' HB ' ' HZ2' ' A' ' 32' ' ' TRP . 38.6 t -126.17 155.94 36.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.017 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.456 ' HA ' HG21 ' A' ' 67' ' ' THR . 1.3 mt-30 -112.33 158.02 20.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.012 0.434 . . . . 0.0 111.058 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.457 HG23 ' CD1' ' A' ' 26' ' ' LEU . 29.0 t -140.39 148.0 22.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.329 -179.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.457 ' HA ' ' HA2' ' A' ' 65' ' ' GLY . 17.0 m -139.92 178.03 3.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.707 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.073 -179.902 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.301 0 N-CA-C 112.565 -0.214 . . . . 0.0 112.565 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.7 m 65.68 -171.44 0.19 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.656 0.265 . . . . 0.0 110.786 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 8.3 ttt -67.05 152.7 45.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.138 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 23.5 mt 60.36 117.89 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.56 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -172.82 -60.45 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.831 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 16.8 mtt180 58.4 167.66 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.051 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 17.9 mmt 58.28 -172.3 0.1 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.612 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.3 m 67.55 161.59 0.18 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.878 0.37 . . . . 0.0 110.702 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -165.46 -62.38 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.475 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -95.72 -176.09 3.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.768 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.552 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . . . -92.71 83.34 4.83 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.754 0.312 . . . . 0.0 111.036 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.5 112.23 7.88 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.474 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.418 ' CD1' ' HG2' ' A' ' 30' ' ' GLU . 73.8 t80 -98.67 144.13 28.28 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.002 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.4 m -107.02 135.72 48.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.478 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.445 ' CD1' ' HA ' ' A' ' 63' ' ' VAL . 0.5 OUTLIER -84.91 -33.18 22.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.849 0.357 . . . . 0.0 110.529 179.698 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.59 33.07 28.83 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.291 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 25.5 mttm 58.73 56.14 4.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.069 0.461 . . . . 0.0 110.764 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.492 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 12.9 m170 -115.36 166.14 12.68 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.867 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.571 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 23.8 Cg_endo -60.97 -36.94 80.48 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.386 2.057 . . . . 0.0 112.151 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.571 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 22.4 p80 168.14 -174.6 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.406 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.761 HG21 HD13 ' A' ' 26' ' ' LEU . 2.5 m -140.96 160.44 23.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.189 0.519 . . . . 0.0 111.975 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.42 ' O ' ' N ' ' A' ' 25' ' ' ASP . 0.5 OUTLIER -94.26 141.76 28.19 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.038 179.351 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.491 ' HB2' ' O ' ' A' ' 58' ' ' LYS . 8.1 mt -38.08 -39.28 0.39 Allowed 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.418 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -73.4 -37.59 65.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.387 -179.396 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 22' ' ' GLU . 56.6 m-20 -61.62 -54.52 41.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.06 0.457 . . . . 0.0 111.074 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.761 HD13 HG21 ' A' ' 21' ' ' VAL . 0.4 OUTLIER -60.06 -43.31 95.52 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.658 -179.546 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.592 ' N ' HD13 ' A' ' 27' ' ' LEU . 6.7 mp -68.33 -56.87 7.05 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.701 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -56.95 -55.87 29.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.859 0.362 . . . . 0.0 111.216 -179.597 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 29' ' ' LEU . 81.9 mt -53.41 -37.73 62.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.685 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.418 ' HG2' ' CD1' ' A' ' 13' ' ' PHE . 8.7 mm-40 -79.08 -11.33 59.99 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.12 22.9 23.92 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.366 -0.921 . . . . 0.0 113.226 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.491 ' HZ2' ' HB ' ' A' ' 75' ' ' VAL . 11.9 m95 -73.97 -63.21 1.27 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.008 0.432 . . . . 0.0 109.96 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.444 ' CB ' HD13 ' A' ' 41' ' ' ILE . 4.1 t -106.95 135.19 48.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.915 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -74.43 -34.69 63.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.022 0.439 . . . . 0.0 110.247 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.0 p -106.4 -44.76 4.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.268 178.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 112.74 -21.82 17.94 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.987 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -128.63 -1.24 5.47 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 111.709 0.262 . . . . 0.0 111.709 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.4 tp60 -61.11 -79.42 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.79 0.329 . . . . 0.0 110.611 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.32 11.28 2.47 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.562 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.539 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 19.3 mttm 59.44 29.81 19.42 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 120.798 0.332 . . . . 0.0 110.297 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.512 ' HA ' ' CE2' ' A' ' 70' ' ' PHE . 8.0 mt -60.06 -17.67 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.613 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.4 -79.09 0.09 Allowed 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.822 0.344 . . . . 0.0 111.111 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 44.2 mm -47.38 -36.54 4.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.97 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.539 ' HB1' ' O ' ' A' ' 40' ' ' LYS . . . -61.81 -67.24 0.43 Allowed 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.346 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.631 ' HA ' ' HB2' ' A' ' 70' ' ' PHE . 12.3 tp10 -33.62 -42.08 0.1 Allowed 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 120.902 0.382 . . . . 0.0 110.466 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.1 -77.4 0.18 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 119.936 -1.126 . . . . 0.0 110.938 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.512 ' HG3' ' O ' ' A' ' 44' ' ' ALA . 0.6 OUTLIER -48.26 -10.88 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -179.645 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.498 ' CG1' ' HA ' ' A' ' 70' ' ' PHE . 47.5 t -75.33 -96.66 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.033 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -164.86 120.96 1.45 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 118.404 0.547 . . . . 0.0 111.576 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.56 ' HB ' ' O ' ' A' ' 53' ' ' ALA . 16.5 t -114.05 150.39 16.09 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -44.79 97.05 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.972 0.415 . . . . 0.0 111.441 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.98 16.7 70.87 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.759 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.56 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -145.91 81.14 1.59 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.122 0.487 . . . . 0.0 112.09 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.477 HG11 ' O ' ' A' ' 54' ' ' VAL . 7.0 p -90.3 71.95 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.126 0.488 . . . . 0.0 110.309 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 47' ' ' GLN . 8.2 mt-10 -99.34 -173.14 2.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.817 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 t -147.29 46.19 1.14 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.908 0.385 . . . . 0.0 111.62 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 19.0 mtt-85 -98.02 174.54 6.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.535 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.491 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 1.7 mptp? -75.2 -38.12 60.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.012 0.434 . . . . 0.0 110.08 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -127.72 158.29 38.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.064 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -133.96 115.8 14.81 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.388 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.471 ' HG2' ' CD2' ' A' ' 20' ' ' HIS . 31.4 mtmt -74.14 94.53 2.44 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.499 HD11 HG21 ' A' ' 62' ' ' ILE . 5.8 mm -133.49 144.89 34.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.328 -178.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.56 HG12 ' HA ' ' A' ' 20' ' ' HIS . 14.3 m -148.4 174.45 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.807 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 72.69 -151.27 0.07 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.64 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -88.87 81.26 1.54 Allowed Glycine 0 C--N 1.337 0.585 0 C-N-CA 121.472 -0.394 . . . . 0.0 112.6 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -122.05 156.06 34.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.135 0.493 . . . . 0.0 111.414 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 40.3 m -118.65 147.69 43.51 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.233 -178.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.457 HG12 ' CH2' ' A' ' 32' ' ' TRP . 0.7 OUTLIER -124.21 148.23 28.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.031 178.986 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.411 ' O ' HG11 ' A' ' 48' ' ' VAL . 58.1 m -141.7 138.46 32.44 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.631 ' HB2' ' HA ' ' A' ' 45' ' ' GLU . 2.8 t80 -152.16 127.08 9.64 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.614 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 47.55 -85.85 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.334 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -128.2 -7.92 4.29 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.039 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.452 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 1.9 m-70 -89.22 108.77 19.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.145 0.472 . . . . 0.0 111.391 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -118.99 107.45 13.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.171 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.552 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 22.0 t -130.5 152.95 38.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.039 0.447 . . . . 0.0 111.944 -178.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.544 ' N ' HG11 ' A' ' 75' ' ' VAL . 28.6 mt-30 -111.87 164.29 13.26 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.427 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.64 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 21.3 t -136.52 148.73 26.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.547 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.404 ' N ' HG13 ' A' ' 77' ' ' VAL . 27.2 m -131.63 160.05 42.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.947 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.291 -0.861 . . . . 0.0 111.144 179.978 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.207 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.7 m -113.26 -56.76 2.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.851 0.357 . . . . 0.0 110.942 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -85.81 119.75 26.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.011 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 pt -138.14 72.21 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.971 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 64.5 139.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.69 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.486 ' HD3' ' HA ' ' A' ' 6' ' ' ARG . 6.9 tpp180 -168.66 71.46 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.98 0.419 . . . . 0.0 111.037 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.48 -62.9 1.18 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.449 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 78.2 p -132.13 165.98 22.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.347 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -142.03 106.5 4.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.889 0.376 . . . . 0.0 111.37 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 36.2 mtt -93.59 128.33 39.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.58 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.446 ' O ' HG11 ' A' ' 75' ' ' VAL . . . -84.35 119.66 25.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.758 0.313 . . . . 0.0 111.045 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.462 ' HA ' HG11 ' A' ' 75' ' ' VAL . 72.1 p -137.0 129.04 29.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.185 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.631 ' HB3' HG23 ' A' ' 77' ' ' VAL . 41.6 t80 -98.36 154.48 17.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.006 0.431 . . . . 0.0 110.749 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.7 m -106.42 155.53 19.46 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.107 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.598 ' CD1' ' HA ' ' A' ' 63' ' ' VAL . 6.7 mt -122.2 -31.51 3.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.545 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.19 -111.7 3.42 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.023 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -149.84 54.72 0.94 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.306 0.574 . . . . 0.0 110.16 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.678 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 16.2 m-70 -118.98 168.6 9.5 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.766 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.678 ' HD2' ' HB3' ' A' ' 18' ' ' HIS . 7.7 Cg_endo -48.36 -44.45 29.46 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.742 2.295 . . . . 0.0 112.62 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.552 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 3.9 p80 162.75 -165.65 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.091 0.556 . . . . 0.0 109.929 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.575 HG13 HD23 ' A' ' 15' ' ' LEU . 15.5 m -134.77 147.23 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 120.959 0.409 . . . . 0.0 111.888 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.577 ' HA ' ' H ' ' A' ' 60' ' ' CYS . 1.2 mt-10 -83.93 143.54 29.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.634 179.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.519 HD13 ' N ' ' A' ' 60' ' ' CYS . 2.5 mp -39.82 -36.45 0.44 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.83 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 9.2 t -76.31 -35.51 58.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.329 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' A' ' 22' ' ' GLU . 30.1 m-20 -64.29 -62.03 1.87 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.969 0.414 . . . . 0.0 110.691 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.505 HD23 HG22 ' A' ' 68' ' ' VAL . 9.7 tt -55.05 -44.98 75.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.338 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.572 ' N ' HD11 ' A' ' 27' ' ' LEU . 5.8 mp -62.23 -54.35 42.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.698 -178.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.9 -48.89 79.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.635 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.451 HD13 ' CZ ' ' A' ' 13' ' ' PHE . 45.7 mt -58.35 -48.13 81.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.267 -0.424 . . . . 0.0 112.012 -179.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.497 ' CG ' ' HB2' ' A' ' 13' ' ' PHE . 7.4 mm-40 -70.75 -12.25 61.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.55 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.96 23.26 30.56 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.846 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.519 ' CZ3' ' HB2' ' A' ' 73' ' ' HIS . 23.1 m95 -64.63 -73.52 0.12 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.8 0.333 . . . . 0.0 110.334 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.518 ' HB2' HG21 ' A' ' 41' ' ' ILE . 24.6 t -92.91 147.27 22.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.787 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -76.75 -33.32 58.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.684 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.445 ' OG ' ' HB3' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -105.42 -28.8 10.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.112 179.71 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 115.79 -72.71 0.26 Allowed Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.445 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -120.41 -2.96 9.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.771 0.32 . . . . 0.0 111.042 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.445 ' HB3' ' OG ' ' A' ' 35' ' ' SER . 3.9 tp60 -52.63 -62.85 1.38 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.914 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.415 ' HB3' HG12 ' A' ' 41' ' ' ILE . . . -73.87 15.05 0.32 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.797 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.8 mttt 68.61 15.95 9.07 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.695 0.283 . . . . 0.0 111.046 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.518 HG21 ' HB2' ' A' ' 33' ' ' SER . 45.5 mm -58.54 -20.93 17.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.023 0.439 . . . . 0.0 110.926 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.05 -76.4 0.12 Allowed 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.93 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.6 mm -47.85 -42.52 9.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.772 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.56 ' HB3' ' CZ ' ' A' ' 70' ' ' PHE . . . -57.94 -66.6 0.45 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.383 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' A' ' 44' ' ' ALA . 9.3 tp10 -30.94 -44.83 0.06 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.56 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.93 -74.56 0.36 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.169 -1.015 . . . . 0.0 110.892 178.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.412 ' HA ' ' O ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -47.57 -11.58 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -179.787 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.471 ' CG2' ' CD1' ' A' ' 70' ' ' PHE . 39.7 t -75.32 -99.61 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 O-C-N 122.137 -0.352 . . . . 0.0 111.668 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.671 ' HD3' ' HB ' ' A' ' 54' ' ' VAL . 8.2 mmtp -161.0 138.64 9.29 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.702 0.683 . . . . 0.0 111.839 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.649 ' HB ' ' O ' ' A' ' 53' ' ' ALA . 44.1 t -127.58 147.91 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.706 ' HB2' ' HB ' ' A' ' 67' ' ' THR . 12.9 t0 -44.03 87.01 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -177.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 101.87 -19.13 50.83 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.739 -0.743 . . . . 0.0 114.821 177.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.649 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -146.77 136.68 23.31 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 118.41 1.105 . . . . 0.0 113.041 -178.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.671 ' HB ' ' HD3' ' A' ' 49' ' ' LYS . 11.3 p -107.43 108.68 25.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.238 178.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.412 ' O ' ' HA ' ' A' ' 47' ' ' GLN . 47.3 mt-10 -102.98 -170.28 1.77 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.642 0.258 . . . . 0.0 110.845 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.6 t -164.0 30.27 0.08 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.354 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.17 169.99 9.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.947 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.1 ttpp -75.86 -43.83 43.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.594 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.428 ' HA ' ' HG2' ' A' ' 22' ' ' GLU . 0.3 OUTLIER -102.31 142.63 33.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.747 179.854 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . 0.577 ' H ' ' HA ' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -100.08 116.58 32.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.805 -179.789 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.3 mtmt -103.74 78.75 1.59 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.173 0.511 . . . . 0.0 109.875 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.0 mt -138.95 148.92 23.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.172 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.598 ' HA ' ' CD1' ' A' ' 15' ' ' LEU . 1.3 m -151.11 175.09 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.698 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 78.76 -138.45 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.562 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -104.41 84.25 0.42 Allowed Glycine 0 C--N 1.339 0.695 0 C-N-CA 121.041 -0.599 . . . . 0.0 113.624 -178.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 61.9 mm-40 -122.05 163.19 19.85 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.757 0.313 . . . . 0.0 111.145 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.706 ' HB ' ' HB2' ' A' ' 51' ' ' ASP . 8.9 m -119.11 139.87 51.06 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.247 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.505 HG22 HD23 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -110.68 137.16 44.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.36 179.558 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.46 ' O ' HG11 ' A' ' 48' ' ' VAL . 2.6 m -132.0 128.18 37.83 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.919 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.56 ' CZ ' ' HB3' ' A' ' 44' ' ' ALA . 4.1 t80 -175.68 130.38 0.26 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.351 179.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.452 ' N ' ' CD1' ' A' ' 70' ' ' PHE . . . 56.99 44.91 22.08 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.393 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 70.16 1.6 35.23 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.791 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.519 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 8.3 m-70 -94.55 98.16 10.64 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.877 0.338 . . . . 0.0 111.111 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.96 101.77 11.79 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.549 ' O ' HG21 ' A' ' 67' ' ' THR . 40.8 t -120.37 147.55 24.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.569 -178.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.494 ' HG3' ' OG1' ' A' ' 67' ' ' THR . 2.0 mp0 -111.94 145.65 39.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.667 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.631 HG23 ' HB3' ' A' ' 13' ' ' PHE . 8.0 t -120.62 145.66 26.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.333 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.8 m -128.59 157.53 41.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.947 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.294 -0.86 . . . . 0.0 111.04 179.882 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 112.6 -0.2 . . . . 0.0 112.6 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.76 138.14 34.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.818 0.342 . . . . 0.0 110.954 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.35 140.96 18.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.818 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.8 mm -91.97 139.17 18.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.072 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -138.16 -59.5 0.64 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.111 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -97.79 150.78 20.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.035 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -133.55 165.56 24.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.78 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.74 112.52 6.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.074 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -142.98 -37.84 0.36 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.158 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 8.3 mtt -79.43 137.92 37.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.982 0.42 . . . . 0.0 110.989 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.523 ' O ' HG12 ' A' ' 75' ' ' VAL . . . -84.09 141.72 30.92 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.09 178.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.62 135.85 40.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.94 0.4 . . . . 0.0 110.773 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.72 ' CE2' ' HA ' ' A' ' 26' ' ' LEU . 31.7 t80 -103.98 143.11 33.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.557 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.447 ' O ' ' CE1' ' A' ' 13' ' ' PHE . 0.4 OUTLIER -106.84 132.63 52.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.389 179.471 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 63' ' ' VAL . 0.5 OUTLIER -75.51 -37.23 60.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.82 0.343 . . . . 0.0 110.845 179.868 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.66 29.48 26.62 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.306 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.19 43.18 20.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.053 0.454 . . . . 0.0 110.722 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.454 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.9 OUTLIER -114.67 168.6 7.8 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.845 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.48 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 8.8 Cg_endo -50.38 -43.68 42.92 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.694 2.263 . . . . 0.0 112.215 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.48 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 6.3 p80 172.85 -163.79 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.839 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.8 m -142.05 153.58 18.72 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.474 ' HG2' ' CB ' ' A' ' 59' ' ' ARG . 14.6 mt-10 -100.64 153.8 19.11 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.135 178.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.67 ' HB2' ' O ' ' A' ' 58' ' ' LYS . 1.5 mp -40.23 -54.85 2.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.732 0.301 . . . . 0.0 111.42 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.568 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -57.63 -33.75 68.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.748 179.791 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -72.31 -55.07 7.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.884 0.373 . . . . 0.0 110.975 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.72 ' HA ' ' CE2' ' A' ' 13' ' ' PHE . 7.6 tt -57.79 -47.93 81.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.406 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.625 ' HG ' ' CE3' ' A' ' 32' ' ' TRP . 7.5 mp -64.45 -59.14 4.69 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.568 ' HB2' ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -51.49 -59.21 4.51 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.263 -178.723 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.47 -50.62 69.4 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -178.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.532 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 2.0 mm-40 -61.85 -15.26 40.74 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.05 23.04 13.79 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.319 -0.943 . . . . 0.0 113.443 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.625 ' CE3' ' HG ' ' A' ' 27' ' ' LEU . 7.7 m0 -73.53 -66.48 0.69 Allowed 'General case' 0 C--O 1.232 0.165 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.2 t -106.83 143.25 35.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.185 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -70.24 -34.15 72.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.852 0.358 . . . . 0.0 110.692 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.469 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -105.73 -52.14 2.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.443 179.307 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 139.07 -31.82 2.33 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.432 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.98 8.7 2.1 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.469 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 3.2 tp-100 -55.25 -71.11 0.09 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.703 0.287 . . . . 0.0 111.155 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.56 15.5 0.47 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 71.44 19.44 5.21 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.045 0.45 . . . . 0.0 110.35 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.576 ' HA ' ' CE2' ' A' ' 70' ' ' PHE . 9.9 mt -61.13 -22.86 28.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.293 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.64 -77.75 0.08 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.997 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.4 ' CD1' ' HG2' ' A' ' 58' ' ' LYS . 37.1 mm -51.61 -41.78 28.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.928 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.528 ' HA ' HE21 ' A' ' 47' ' ' GLN . . . -57.74 -71.19 0.11 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.623 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.515 ' HG3' HD11 ' A' ' 27' ' ' LEU . 1.6 tm-20 -33.46 -40.13 0.06 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.013 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.454 ' C ' ' H ' ' A' ' 48' ' ' VAL . . . -60.09 -75.35 0.28 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.289 -0.957 . . . . 0.0 110.986 178.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.528 HE21 ' HA ' ' A' ' 44' ' ' ALA . 23.7 pt20 -49.15 -8.17 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.517 HG13 ' H ' ' A' ' 71' ' ' ALA . 97.7 t -75.33 -98.71 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.144 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.427 ' HG2' ' O ' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -161.87 126.15 3.29 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.973 -179.303 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.515 HG12 ' O ' ' A' ' 67' ' ' THR . 21.4 t -121.73 149.2 24.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.479 ' HB2' ' HB ' ' A' ' 67' ' ' THR . 22.2 t0 -44.96 102.48 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.864 0.364 . . . . 0.0 111.224 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 63.52 20.78 64.0 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.172 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.484 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -146.19 74.6 1.38 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.981 0.42 . . . . 0.0 111.657 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.5 p -86.25 63.72 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.983 0.42 . . . . 0.0 110.263 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.415 ' O ' ' HA ' ' A' ' 47' ' ' GLN . 21.6 mt-10 -102.29 -170.21 1.78 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.506 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.524 ' OG1' ' HB3' ' A' ' 47' ' ' GLN . 3.1 t -142.89 47.67 1.53 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.553 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 45.3 mtp85 -98.53 174.22 6.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.962 0.41 . . . . 0.0 111.3 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.67 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 24.0 mttm -79.61 -38.67 33.35 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.924 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.474 ' CB ' ' HG2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -128.34 159.36 35.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.856 -179.759 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -140.67 115.79 9.85 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.218 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.74 96.88 2.1 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.479 ' CG2' ' HG3' ' A' ' 66' ' ' GLN . 13.1 mt -133.47 136.01 55.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.809 -178.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.455 ' O ' ' HB3' ' A' ' 64' ' ' ALA . 31.1 m -141.72 175.6 5.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.535 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.455 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 71.19 -136.52 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.635 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.567 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -106.37 86.04 0.46 Allowed Glycine 0 C--N 1.339 0.702 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.192 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.479 ' HG3' ' CG2' ' A' ' 62' ' ' ILE . 8.4 mm-40 -122.05 172.25 8.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.716 0.293 . . . . 0.0 111.47 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 4.9 m -130.31 152.13 50.06 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.443 HG23 ' CD1' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -135.52 152.64 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.385 179.795 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.615 ' HA ' ' O ' ' A' ' 73' ' ' HIS . 0.4 OUTLIER -146.25 137.63 24.63 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -179.643 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.576 ' CE2' ' HA ' ' A' ' 41' ' ' ILE . 1.8 t80 -137.12 118.7 14.89 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.619 178.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.517 ' H ' HG13 ' A' ' 48' ' ' VAL . . . 38.2 30.01 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 116.39 -6.63 18.76 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.365 -0.921 . . . . 0.0 113.563 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.615 ' O ' ' HA ' ' A' ' 69' ' ' SER . 1.4 m-70 -88.13 82.98 7.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.317 0.558 . . . . 0.0 111.145 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.6 119.81 29.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.749 0.309 . . . . 0.0 110.71 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.533 ' HB ' ' HZ2' ' A' ' 32' ' ' TRP . 43.1 t -142.57 152.75 17.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.09 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.532 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 7.7 mt-30 -112.61 164.23 13.58 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.7 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.567 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 6.7 t -131.9 142.8 42.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.225 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 64' ' ' ALA . 28.1 m -138.44 169.15 18.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.184 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.118 -0.944 . . . . 0.0 111.212 179.956 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 112.621 -0.191 . . . . 0.0 112.621 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.54 161.86 14.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.801 0.334 . . . . 0.0 110.835 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -67.27 -179.52 1.02 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.958 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.1 tt -147.17 -32.16 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.478 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -130.2 153.93 48.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.733 0.302 . . . . 0.0 110.797 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -114.08 131.49 56.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.841 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 64.49 74.09 0.41 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.943 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.9 m -106.71 -53.64 2.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.703 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -127.87 -32.33 2.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.038 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 10.8 mtp -80.74 122.21 26.87 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.993 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.42 ' O ' HG13 ' A' ' 75' ' ' VAL . . . -87.01 134.72 33.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.705 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.44 131.93 43.93 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.376 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.459 ' HB3' ' CG2' ' A' ' 77' ' ' VAL . 40.8 t80 -110.39 165.3 11.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.557 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.27 140.71 35.19 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.943 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.41 ' HB2' ' CG1' ' A' ' 77' ' ' VAL . 0.4 OUTLIER -142.3 -36.03 0.42 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.944 -179.37 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.436 ' N ' ' HA ' ' A' ' 79' ' ' ALA . . . -48.58 -30.06 8.17 Favored Glycine 0 C--N 1.329 0.153 0 C-N-CA 120.98 -0.629 . . . . 0.0 113.164 -179.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.73 -34.33 65.06 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.837 0.351 . . . . 0.0 110.839 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.604 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 3.9 m-70 -117.45 163.88 21.78 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.893 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.604 ' HD2' ' HB3' ' A' ' 18' ' ' HIS . 15.8 Cg_endo -56.13 -35.14 94.69 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.569 2.179 . . . . 0.0 111.985 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.476 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 2.5 p80 174.98 -176.37 0.09 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.431 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.436 HG11 ' O ' ' A' ' 20' ' ' HIS . 13.6 m -145.32 164.21 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.422 ' CB ' ' HB3' ' A' ' 59' ' ' ARG . 1.5 pt-20 -99.83 153.17 19.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.2 178.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.1 mt -41.13 -41.84 1.87 Allowed 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 40.9 t -70.8 -38.72 73.36 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.638 0.256 . . . . 0.0 111.547 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -63.35 -60.96 2.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.947 0.403 . . . . 0.0 110.841 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.453 HD11 ' CG2' ' A' ' 77' ' ' VAL . 0.7 OUTLIER -50.86 -42.18 58.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.04 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.557 ' HG ' ' CE3' ' A' ' 32' ' ' TRP . 4.4 mp -68.01 -64.74 0.8 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.78 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.9 tmmm? -43.34 -61.45 1.35 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.66 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.412 ' HB3' ' CZ ' ' A' ' 13' ' ' PHE . 0.5 OUTLIER -54.49 -40.56 68.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.77 -179.426 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.447 ' HG2' ' CD1' ' A' ' 13' ' ' PHE . 8.7 mm-40 -69.43 -14.54 62.95 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.46 20.78 21.47 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.28 -0.962 . . . . 0.0 112.92 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.633 ' CZ3' ' HB2' ' A' ' 73' ' ' HIS . 8.3 m0 -75.63 -66.52 0.77 Allowed 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.468 ' OG ' HD12 ' A' ' 41' ' ' ILE . 30.1 t -106.86 137.03 45.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.595 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -70.75 -33.82 71.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.039 0.447 . . . . 0.0 110.295 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.485 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 0.1 OUTLIER -105.74 -55.4 2.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.314 179.223 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.403 ' N ' ' OG ' ' A' ' 33' ' ' SER . . . 126.68 -33.53 3.39 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.303 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -123.04 -5.49 8.45 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.485 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 0.8 OUTLIER -52.52 -76.34 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.839 0.352 . . . . 0.0 111.029 -179.728 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.449 ' HB3' HD13 ' A' ' 41' ' ' ILE . . . -77.15 15.77 0.67 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.249 -0.432 . . . . 0.0 112.14 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 4.5 mmtt 68.53 24.26 7.07 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.068 0.461 . . . . 0.0 110.098 -179.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.594 ' HA ' ' CE2' ' A' ' 70' ' ' PHE . 3.9 mp -57.86 -24.86 24.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.449 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.92 -77.35 0.13 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.259 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.3 mm -48.96 -42.24 14.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-O 121.017 0.437 . . . . 0.0 110.644 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.472 ' O ' ' C ' ' A' ' 45' ' ' GLU . . . -57.64 -69.05 0.18 Allowed 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.446 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.555 ' HB2' HD21 ' A' ' 27' ' ' LEU . 9.0 tp10 -29.81 -44.13 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.011 0.434 . . . . 0.0 110.672 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 55' ' ' GLU . . . -59.61 -74.89 0.31 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.115 -1.041 . . . . 0.0 110.621 178.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.528 ' N ' ' HA ' ' A' ' 56' ' ' THR . 2.3 pt20 -48.64 -12.94 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.462 HG23 ' CD1' ' A' ' 70' ' ' PHE . 47.5 t -75.06 -98.17 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.933 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -165.98 122.71 1.37 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 118.37 0.532 . . . . 0.0 111.921 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.46 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 31.7 t -117.33 152.29 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.53 ' HB2' ' O ' ' A' ' 67' ' ' THR . 3.7 t0 -44.72 101.29 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.909 0.385 . . . . 0.0 111.492 -179.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 62.63 21.89 63.3 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.415 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.46 ' HB1' ' HB ' ' A' ' 50' ' ' VAL . . . -145.83 75.57 1.43 Allowed 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 121.037 0.446 . . . . 0.0 111.67 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.1 p -87.13 67.37 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.961 0.41 . . . . 0.0 110.485 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.447 ' O ' ' O ' ' A' ' 46' ' ' GLY . 0.2 OUTLIER -102.56 -166.25 1.26 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.062 -179.356 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.528 ' HA ' ' N ' ' A' ' 47' ' ' GLN . 3.4 t -145.8 37.99 1.09 Allowed 'General case' 0 C--O 1.232 0.154 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.09 174.79 7.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.825 0.345 . . . . 0.0 111.041 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.4 tttt -78.68 -41.6 30.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.738 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.422 ' HB3' ' CB ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -124.49 154.59 40.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.62 179.796 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -136.74 115.38 12.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.394 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.6 mttt -69.48 99.09 1.19 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 17.1 mt -133.46 144.04 37.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.633 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.411 HG12 ' O ' ' A' ' 19' ' ' PRO . 7.8 m -149.5 175.3 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.862 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.453 ' HA ' ' HB2' ' A' ' 79' ' ' ALA . . . 72.31 -149.73 0.07 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 178.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.562 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -92.33 81.3 1.16 Allowed Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 116.298 -0.41 . . . . 0.0 112.953 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.92 157.47 31.13 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.208 0.528 . . . . 0.0 111.378 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.611 HG21 ' O ' ' A' ' 75' ' ' VAL . 2.9 m -113.72 150.86 32.71 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.836 -178.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.515 HG11 ' CH2' ' A' ' 32' ' ' TRP . 1.2 t -128.27 145.15 35.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.023 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.527 ' HA ' ' O ' ' A' ' 73' ' ' HIS . 1.1 m -136.07 132.21 35.86 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.594 ' CE2' ' HA ' ' A' ' 41' ' ' ILE . 2.6 t80 -147.14 123.34 10.86 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.232 178.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.409 ' N ' ' CD1' ' A' ' 70' ' ' PHE . . . 41.57 30.66 0.15 Allowed 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.2 -4.06 38.06 Favored Glycine 0 C--N 1.329 0.171 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.422 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.633 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 2.7 m-70 -90.47 98.53 11.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.853 0.327 . . . . 0.0 110.829 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -108.99 114.16 27.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.853 0.359 . . . . 0.0 111.424 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.611 ' O ' HG21 ' A' ' 67' ' ' THR . 17.6 t -138.21 156.32 30.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.761 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 9.5 mt-30 -112.6 165.61 12.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.136 0.493 . . . . 0.0 111.709 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.562 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 21.3 t -141.4 150.4 19.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.587 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.42 ' N ' HG13 ' A' ' 77' ' ' VAL . 18.2 m -130.52 166.13 28.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.886 0.374 . . . . 0.0 111.759 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.453 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . . . . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.238 -0.887 . . . . 0.0 111.096 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 112.778 -0.129 . . . . 0.0 112.778 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.6 t 58.16 175.77 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.883 0.373 . . . . 0.0 110.829 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.2 ttt -138.25 -38.98 0.54 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.215 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 pt -84.03 86.5 2.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.231 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -155.2 133.31 11.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.768 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.4 mmt85 64.31 32.57 12.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.759 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.44 140.68 24.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.4 t -133.97 -47.63 0.79 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.984 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -179.24 154.02 0.63 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.807 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 5.8 ttp -77.62 127.81 33.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.997 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.18 97.67 6.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.826 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.55 119.03 22.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.865 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.506 ' CD2' HD13 ' A' ' 26' ' ' LEU . 29.5 t80 -98.66 149.9 22.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.542 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.3 m -105.33 147.69 27.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.979 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.6 mt -127.44 -36.28 2.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.955 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.09 -111.67 3.49 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.688 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.9 tttt -136.72 52.89 1.93 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.875 0.369 . . . . 0.0 110.903 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -103.89 155.62 36.79 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.972 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.618 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 8.1 Cg_endo -50.56 -44.56 39.42 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.789 2.326 . . . . 0.0 112.235 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.618 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 12.6 p80 164.64 -166.98 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.491 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.482 ' O ' ' O ' ' A' ' 60' ' ' CYS . 14.9 m -143.58 155.92 16.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.474 ' HG2' ' HA ' ' A' ' 59' ' ' ARG . 1.4 mt-10 -87.01 141.07 28.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.03 178.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.426 HD13 ' N ' ' A' ' 24' ' ' CYS . 4.1 pp -40.94 -38.35 0.95 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.716 0.293 . . . . 0.0 111.381 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.426 ' N ' HD13 ' A' ' 23' ' ' LEU . 3.7 t -69.37 -39.51 78.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.89 0.376 . . . . 0.0 110.742 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 22' ' ' GLU . 87.8 m-20 -61.03 -59.21 5.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.629 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.506 HD13 ' CD2' ' A' ' 13' ' ' PHE . 8.2 tp -50.3 -46.99 55.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.616 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.464 ' HG ' ' CE3' ' A' ' 32' ' ' TRP . 6.8 mp -66.45 -60.91 2.31 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.865 -179.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -50.92 -55.47 17.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.317 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.78 -42.39 71.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.716 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.43 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 1.5 mm-40 -74.36 -13.83 60.79 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.0 24.75 14.23 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.251 -0.976 . . . . 0.0 113.281 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.586 ' HZ2' ' HB ' ' A' ' 75' ' ' VAL . 9.7 m95 -74.68 -63.42 1.25 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 117.003 0.401 . . . . 0.0 110.07 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 39.4 t -106.85 142.92 35.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.344 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -77.94 -34.48 51.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.837 0.351 . . . . 0.0 110.739 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.415 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 31.0 p -106.07 -41.72 5.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.309 178.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 115.82 -33.94 4.98 Favored Glycine 0 CA--C 1.52 0.36 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.771 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -129.56 8.55 5.41 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.415 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 10.4 tp60 -60.48 -74.57 0.07 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.909 0.385 . . . . 0.0 110.541 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.7 15.16 1.43 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.725 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 64.61 27.54 13.27 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.994 0.426 . . . . 0.0 110.201 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.6 mp -62.67 -16.87 17.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.085 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.68 -80.68 0.05 Allowed 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.456 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 36.4 mm -52.05 -34.31 17.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.859 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.433 ' HB1' ' CE1' ' A' ' 70' ' ' PHE . . . -61.33 -72.31 0.12 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.62 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.597 ' HA ' ' HB2' ' A' ' 70' ' ' PHE . 4.9 tm-20 -35.08 -41.17 0.14 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.263 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.433 ' C ' ' H ' ' A' ' 48' ' ' VAL . . . -60.91 -74.16 0.41 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.177 -1.011 . . . . 0.0 110.972 178.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -48.49 -9.35 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.452 HG23 ' CD1' ' A' ' 70' ' ' PHE . 58.2 t -74.66 -89.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.352 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.41 ' HG2' ' O ' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -170.31 120.97 0.62 Allowed 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 120.011 -0.676 . . . . 0.0 112.534 179.763 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.588 ' HB ' ' O ' ' A' ' 53' ' ' ALA . 40.9 t -114.29 147.47 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.457 ' N ' HG12 ' A' ' 50' ' ' VAL . 3.3 t70 -44.99 98.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.053 0.454 . . . . 0.0 111.498 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.44 15.71 73.09 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.727 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.588 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -145.86 78.03 1.52 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.976 0.417 . . . . 0.0 112.004 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.9 p -88.57 62.39 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.977 0.418 . . . . 0.0 110.465 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -99.8 -170.77 1.94 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.063 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.7 t -150.85 36.81 0.63 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.427 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.7 mtt180 -81.08 168.79 18.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.519 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.1 -44.93 44.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.046 0.451 . . . . 0.0 109.924 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.474 ' HA ' ' HG2' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -103.66 150.43 24.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.77 179.615 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . 0.482 ' O ' ' O ' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -116.95 118.13 31.59 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.01 0.433 . . . . 0.0 111.434 -179.43 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.3 mttm -96.11 71.51 2.87 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.037 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.415 ' CG2' ' HG3' ' A' ' 66' ' ' GLN . 33.2 mt -136.05 147.4 28.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.702 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.489 HG12 ' HA ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -152.51 175.14 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.776 179.52 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 77.96 -149.2 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.916 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.508 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -84.93 78.27 2.02 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 121.285 -0.484 . . . . 0.0 112.578 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.415 ' HG3' ' CG2' ' A' ' 62' ' ' ILE . 20.6 mm-40 -121.66 155.62 34.77 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.066 0.46 . . . . 0.0 111.108 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 59.3 m -116.79 152.91 33.41 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.585 -178.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.469 ' CG1' ' CH2' ' A' ' 32' ' ' TRP . 1.1 t -127.9 145.58 34.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.668 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 49' ' ' LYS . 22.2 m -143.05 135.87 27.8 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.597 ' HB2' ' HA ' ' A' ' 45' ' ' GLU . 2.2 t80 -148.48 124.06 10.41 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.195 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 51.99 -85.12 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.353 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -129.97 -3.22 4.98 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.912 -0.661 . . . . 0.0 113.012 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.453 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 2.1 m-70 -92.63 108.38 19.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.929 0.365 . . . . 0.0 111.44 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.91 102.66 8.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.338 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.586 ' HB ' ' HZ2' ' A' ' 32' ' ' TRP . 99.4 t -125.19 151.94 31.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.347 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.515 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 13.0 mt-30 -112.97 160.62 17.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.995 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.508 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 21.8 t -131.25 148.66 32.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.503 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.8 m -140.02 171.65 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.792 0.33 . . . . 0.0 111.497 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.506 -0.759 . . . . 0.0 111.059 179.933 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.112 0 CA-C-O 120.55 -0.028 . . . . 0.0 113.034 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 61.02 17.11 7.65 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 14.8 mmt -154.9 29.7 0.41 Allowed 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.654 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 pp -145.25 111.07 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.833 0.349 . . . . 0.0 111.104 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -95.14 126.72 40.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.825 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.5 mtm180 -62.38 108.44 1.11 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.722 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.05 165.11 27.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.918 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.8 t -146.39 143.04 28.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.217 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -130.76 -25.2 2.35 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.349 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 64.3 mtt -67.4 135.76 53.69 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.785 0.326 . . . . 0.0 110.895 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -100.49 136.18 40.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.86 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.53 134.14 39.14 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.405 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.511 ' CZ ' ' HB3' ' A' ' 29' ' ' LEU . 19.2 t80 -105.61 90.11 3.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.864 0.364 . . . . 0.0 110.827 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 38.6 t -73.38 95.14 2.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.904 0.383 . . . . 0.0 110.897 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.41 HD12 ' CG1' ' A' ' 21' ' ' VAL . 1.0 OUTLIER -55.63 -35.28 65.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.933 179.789 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.67 48.24 3.01 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.403 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.6 tttt 58.56 54.89 5.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.939 0.4 . . . . 0.0 110.934 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.66 166.79 10.71 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.157 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.5 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 28.2 Cg_endo -62.51 -48.8 6.78 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.617 2.211 . . . . 0.0 112.091 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.5 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 3.1 p80 173.86 -173.67 0.06 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.327 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.463 ' N ' ' ND1' ' A' ' 20' ' ' HIS . 4.1 m -142.12 158.3 20.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.441 0.639 . . . . 0.0 112.723 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.554 ' HG2' ' HG2' ' A' ' 59' ' ' ARG . 1.1 mp0 -100.81 149.96 23.3 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.002 178.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.477 HD23 ' CD ' ' A' ' 45' ' ' GLU . 0.1 OUTLIER -39.64 -53.65 2.13 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.232 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 37.5 t -60.93 -32.2 71.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.89 0.376 . . . . 0.0 110.77 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.574 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 0.9 OUTLIER -68.94 -58.83 3.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.98 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.501 HD13 ' CG2' ' A' ' 77' ' ' VAL . 3.2 tp -52.52 -48.09 66.24 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.882 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.579 HD22 ' HG3' ' A' ' 45' ' ' GLU . 4.1 mt -64.77 -58.75 5.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.699 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.72 -57.36 12.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.803 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.574 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.3 OUTLIER -50.81 -39.34 52.83 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.026 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.43 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 2.5 mm-40 -79.2 -8.09 58.74 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.75 25.28 32.87 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.313 -0.946 . . . . 0.0 113.168 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.735 ' CZ3' ' HB2' ' A' ' 73' ' ' HIS . 19.6 m95 -71.17 -65.52 0.73 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.869 0.366 . . . . 0.0 110.485 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.452 ' HB2' ' CG2' ' A' ' 41' ' ' ILE . 8.3 t -100.53 147.61 25.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.51 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -71.01 -34.81 71.68 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.668 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.3 p -106.68 -59.29 1.82 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.012 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 131.69 -19.28 4.76 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.406 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.46 -2.58 0.86 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.415 ' C ' ' H ' ' A' ' 40' ' ' LYS . 23.4 tp60 -60.13 -74.71 0.07 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.866 0.365 . . . . 0.0 110.41 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.41 14.11 0.37 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.497 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.415 ' H ' ' C ' ' A' ' 38' ' ' GLN . 3.7 mttt 66.92 20.18 10.54 Favored 'General case' 0 C--O 1.23 0.057 0 CA-C-O 120.776 0.322 . . . . 0.0 110.702 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.452 ' CG2' ' HB2' ' A' ' 33' ' ' SER . 48.0 mm -51.0 -29.62 8.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.753 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.38 -78.68 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.77 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.424 ' CD1' ' HG3' ' A' ' 58' ' ' LYS . 25.1 mm -49.81 -38.4 13.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.072 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.455 ' O ' ' HG2' ' A' ' 47' ' ' GLN . . . -61.21 -71.68 0.14 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.122 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.579 ' HG3' HD22 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -33.41 -40.48 0.07 Allowed 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 120.859 0.361 . . . . 0.0 110.594 -179.41 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.463 ' CA ' HD22 ' A' ' 23' ' ' LEU . . . -58.24 -76.12 0.23 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 119.718 -1.229 . . . . 0.0 110.531 177.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 44' ' ' ALA . 5.5 pt20 -50.24 -9.46 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.528 HG22 ' HA ' ' A' ' 45' ' ' GLU . 38.9 t -75.45 -101.24 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.007 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.5 ' HD3' ' HB ' ' A' ' 54' ' ' VAL . 1.5 mmtm -163.15 120.02 1.86 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 119.117 0.871 . . . . 0.0 112.657 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.502 ' HB ' ' O ' ' A' ' 53' ' ' ALA . 13.7 t -112.85 142.82 24.0 Favored 'Isoleucine or valine' 0 C--N 1.338 0.081 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.455 ' HB2' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -48.6 95.74 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.916 0.388 . . . . 0.0 111.023 -179.461 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.7 15.68 80.38 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.498 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.502 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -146.1 75.78 1.43 Allowed 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.078 0.465 . . . . 0.0 111.627 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.5 ' HB ' ' HD3' ' A' ' 49' ' ' LYS . 10.9 p -90.58 65.91 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.907 0.384 . . . . 0.0 110.74 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.442 ' O ' ' O ' ' A' ' 46' ' ' GLY . 44.1 mm-40 -102.08 -174.66 2.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.087 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.4 ' HA ' ' N ' ' A' ' 47' ' ' GLN . 1.7 t -143.95 41.4 1.41 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.945 0.402 . . . . 0.0 111.373 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.53 175.22 6.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.983 0.421 . . . . 0.0 110.808 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -81.04 -25.68 36.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.776 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.554 ' HG2' ' HG2' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -140.77 148.97 41.49 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.893 179.806 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -137.24 116.52 12.65 Favored 'General case' 0 CA--C 1.523 -0.078 0 CA-C-O 120.803 0.335 . . . . 0.0 110.892 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.5 mttm -74.66 102.89 4.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.526 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.4 mt -132.93 133.59 58.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.023 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.45 ' CG1' ' O ' ' A' ' 19' ' ' PRO . 35.4 m -140.46 174.96 7.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.696 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 72.27 -133.77 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.68 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.488 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -109.25 84.82 0.38 Allowed Glycine 0 C--N 1.338 0.691 0 C-N-CA 121.031 -0.604 . . . . 0.0 113.609 -178.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -122.92 167.23 13.83 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.599 0.238 . . . . 0.0 111.242 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.613 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 5.2 m -126.01 153.52 44.26 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.084 0.469 . . . . 0.0 111.866 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.641 HG12 ' CH2' ' A' ' 32' ' ' TRP . 1.2 t -132.23 147.11 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.978 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.404 ' O ' HG13 ' A' ' 48' ' ' VAL . 13.8 m -134.64 136.59 42.97 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.84 0.352 . . . . 0.0 111.703 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.482 ' CD1' ' CG2' ' A' ' 48' ' ' VAL . 6.2 t80 -176.13 137.21 0.31 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.632 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.48 ' N ' ' CD1' ' A' ' 70' ' ' PHE . . . 50.24 37.01 13.85 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.732 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.44 -4.74 66.74 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.434 -0.889 . . . . 0.0 112.823 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.735 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 5.0 m-70 -89.92 107.64 19.23 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.75 0.309 . . . . 0.0 111.189 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.17 103.81 12.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.214 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.541 ' HB ' ' HZ2' ' A' ' 32' ' ' TRP . 64.9 t -132.5 154.36 39.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.63 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.613 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 20.3 mt-30 -112.96 168.81 9.39 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.013 0.435 . . . . 0.0 111.161 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.501 ' CG2' HD13 ' A' ' 26' ' ' LEU . 20.4 t -124.34 137.81 55.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.674 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.4 m -126.84 147.87 31.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.876 0.37 . . . . 0.0 111.208 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.433 -179.586 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.144 0 N-CA-C 112.605 -0.198 . . . . 0.0 112.605 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.1 p -79.14 -164.89 0.67 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.818 0.342 . . . . 0.0 110.956 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.5 mtt -153.64 175.91 12.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.718 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.9 mt -133.72 -63.23 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.269 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.98 167.08 15.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.006 0.431 . . . . 0.0 111.343 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.64 -169.3 2.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.115 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -91.72 -42.75 9.96 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.532 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -169.74 119.61 0.64 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.766 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 60.6 t-20 -122.71 -71.32 0.73 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.998 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -66.18 116.18 6.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.992 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.507 ' O ' HG13 ' A' ' 75' ' ' VAL . . . -70.47 116.29 10.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.576 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.14 128.33 53.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.904 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.582 ' O ' HG11 ' A' ' 77' ' ' VAL . 34.2 t80 -108.05 95.94 6.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.762 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.03 104.7 1.82 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.847 0.356 . . . . 0.0 110.972 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.469 ' CD2' HG13 ' A' ' 21' ' ' VAL . 6.2 mt -72.9 -38.19 67.0 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.947 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.24 -82.46 0.31 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.519 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.4 53.47 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.951 0.405 . . . . 0.0 110.948 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.498 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 33.3 m170 -103.57 160.49 25.95 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.84 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.599 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 18.2 Cg_endo -58.83 -35.35 98.75 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.382 2.055 . . . . 0.0 111.875 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.599 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 4.5 p80 167.15 -173.57 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.117 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.475 HG23 ' CD1' ' A' ' 26' ' ' LEU . 2.8 m -146.03 164.17 10.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.255 0.55 . . . . 0.0 112.04 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.446 ' CB ' ' HB3' ' A' ' 59' ' ' ARG . 12.0 pt-20 -102.15 150.08 23.63 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.815 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.577 ' O ' HD11 ' A' ' 27' ' ' LEU . 96.0 mt -40.82 -45.64 2.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.818 0.342 . . . . 0.0 111.543 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 4.9 t -59.7 -36.26 76.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.553 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.52 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 14.8 m-20 -71.13 -63.12 1.17 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.778 0.323 . . . . 0.0 111.515 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.484 HD11 ' CG2' ' A' ' 77' ' ' VAL . 3.6 tp -46.65 -45.66 19.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.009 0.433 . . . . 0.0 111.374 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.705 ' HG ' ' CE3' ' A' ' 32' ' ' TRP . 9.7 mp -67.69 -66.63 0.54 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.28 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 24' ' ' CYS . 9.9 ttmt -50.1 -51.3 44.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.764 0.316 . . . . 0.0 111.222 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.52 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.1 OUTLIER -56.99 -34.9 68.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.203 -179.728 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 5.0 mm-40 -84.22 -8.77 58.95 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.91 22.95 24.3 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.272 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.705 ' CE3' ' HG ' ' A' ' 27' ' ' LEU . 8.6 m0 -74.99 -62.84 1.41 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.006 0.431 . . . . 0.0 109.909 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.461 ' CB ' HD13 ' A' ' 41' ' ' ILE . 0.3 OUTLIER -107.28 143.58 35.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.759 179.621 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.2 tp10 -78.28 -34.37 48.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.818 0.342 . . . . 0.0 111.261 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.423 ' OG ' ' CB ' ' A' ' 38' ' ' GLN . 42.2 p -105.72 -39.5 6.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.075 0.464 . . . . 0.0 110.525 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 108.15 -25.05 21.45 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.167 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.3 -15.43 2.51 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.423 ' CB ' ' OG ' ' A' ' 35' ' ' SER . 17.9 tp60 -52.52 -73.71 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.804 0.335 . . . . 0.0 111.362 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.12 14.96 0.18 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.39 23.38 12.93 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.803 0.335 . . . . 0.0 110.709 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.536 HG23 ' O ' ' A' ' 41' ' ' ILE . 1.9 mt -60.19 -19.6 18.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.884 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.29 -76.56 0.14 Allowed 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.82 0.343 . . . . 0.0 110.781 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 45.6 mm -47.33 -45.32 9.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-O 121.083 0.468 . . . . 0.0 110.618 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.472 ' O ' ' C ' ' A' ' 45' ' ' GLU . . . -55.39 -67.71 0.26 Allowed 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.877 178.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.472 ' C ' ' O ' ' A' ' 44' ' ' ALA . 11.5 tp10 -28.31 -47.75 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.089 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 55' ' ' GLU . . . -58.34 -74.14 0.38 Allowed Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.172 -1.014 . . . . 0.0 110.824 178.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.552 ' N ' ' HA ' ' A' ' 56' ' ' THR . 1.2 pt20 -44.57 -16.21 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.49 HG11 ' H ' ' A' ' 71' ' ' ALA . 46.6 t -76.01 -95.43 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.592 ' HD3' ' HB ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -162.82 120.08 1.97 Allowed 'General case' 0 C--N 1.339 0.149 0 O-C-N 122.1 -0.375 . . . . 0.0 111.866 -179.294 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.416 HG13 HG23 ' A' ' 68' ' ' VAL . 42.6 t -118.96 157.0 20.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.193 178.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.493 ' HB3' ' H ' ' A' ' 67' ' ' THR . 4.7 p-10 -43.62 99.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.015 0.436 . . . . 0.0 111.603 -178.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 59.76 24.35 59.94 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.175 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -145.79 76.48 1.47 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.592 ' HB ' ' HD3' ' A' ' 49' ' ' LYS . 7.6 p -84.88 58.08 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.151 0.501 . . . . 0.0 110.327 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.436 ' O ' ' O ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -100.42 -162.72 0.96 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.809 -179.547 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.552 ' HA ' ' N ' ' A' ' 47' ' ' GLN . 2.1 t -144.43 53.11 1.26 Allowed 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.525 ' HG3' ' O ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -99.25 172.66 7.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.903 0.382 . . . . 0.0 111.306 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -77.35 -48.47 17.26 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.795 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.525 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 0.3 OUTLIER -120.52 142.79 48.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.314 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . 0.507 ' HB3' HD13 ' A' ' 62' ' ' ILE . 3.3 t -124.26 118.53 27.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.975 0.417 . . . . 0.0 110.972 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.53 99.87 2.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.331 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.507 HD13 ' HB3' ' A' ' 60' ' ' CYS . 2.7 mp -138.34 142.45 35.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.769 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.566 HG13 ' O ' ' A' ' 19' ' ' PRO . 12.8 m -145.66 175.63 2.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.433 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 72.58 -138.17 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.741 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -106.32 84.75 0.41 Allowed Glycine 0 C--N 1.34 0.798 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.14 -178.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.484 ' HB3' ' CG ' ' A' ' 51' ' ' ASP . 56.5 mm-40 -123.02 167.48 13.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.975 0.417 . . . . 0.0 112.082 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.493 ' H ' ' HB3' ' A' ' 51' ' ' ASP . 3.5 m -118.18 140.84 49.2 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.076 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.605 HG12 ' CH2' ' A' ' 32' ' ' TRP . 1.2 t -123.49 146.53 28.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.794 178.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.58 ' HA ' ' O ' ' A' ' 73' ' ' HIS . 32.0 p -140.01 136.1 33.36 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -179.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.516 ' CE2' ' HA ' ' A' ' 41' ' ' ILE . 1.9 t80 -140.17 121.21 14.67 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.332 178.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.49 ' H ' HG11 ' A' ' 48' ' ' VAL . . . 40.82 28.23 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 179.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 113.16 -5.81 25.27 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.323 -0.941 . . . . 0.0 113.674 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.6 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 1.1 m-70 -88.01 91.33 8.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 117.166 0.483 . . . . 0.0 110.934 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -98.02 118.01 33.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.848 0.356 . . . . 0.0 111.443 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.594 ' HB ' ' HZ2' ' A' ' 32' ' ' TRP . 96.8 t -143.5 152.74 16.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.391 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.46 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 24.8 mt-30 -112.89 156.1 23.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.231 0.539 . . . . 0.0 111.609 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.741 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 38.3 t -121.5 145.05 28.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.129 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.8 m -134.18 165.94 30.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.872 0.367 . . . . 0.0 111.699 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.194 -179.873 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.195 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.9 m 58.6 86.47 0.08 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.764 0.316 . . . . 0.0 111.08 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 58.7 170.78 0.06 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.014 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -111.92 110.85 33.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.115 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -162.6 137.95 7.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.721 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.6 127.77 0.78 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.023 0.44 . . . . 0.0 111.033 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 17.3 ptt? -132.51 124.84 29.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.516 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.1 p -143.56 140.76 30.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.759 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -112.67 129.84 56.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.808 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 5.0 mtt -82.24 168.05 18.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.824 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.493 ' HB1' ' CG1' ' A' ' 75' ' ' VAL . . . -92.47 115.52 28.17 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.135 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.87 129.04 37.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.537 ' HD2' ' HG2' ' A' ' 30' ' ' GLU . 56.5 t80 -102.48 149.23 24.59 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.855 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.93 123.33 48.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.394 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.74 -37.59 76.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.714 0.292 . . . . 0.0 110.958 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.29 26.79 13.11 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.832 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.3 mtmt 59.58 51.52 6.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.909 0.385 . . . . 0.0 110.833 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.426 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 2.9 m-70 -119.43 168.25 10.43 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.61 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.545 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 10.3 Cg_endo -52.64 -37.96 75.56 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.396 2.064 . . . . 0.0 111.741 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.545 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 5.6 p80 167.94 -168.5 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.009 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.484 ' O ' ' O ' ' A' ' 60' ' ' CYS . 28.8 m -143.58 157.04 16.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.898 0.38 . . . . 0.0 111.77 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.511 ' HA ' ' H ' ' A' ' 60' ' ' CYS . 1.5 pt-20 -103.48 152.21 21.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.583 178.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.432 HD13 ' HB2' ' A' ' 42' ' ' ALA . 0.2 OUTLIER -37.93 -46.54 0.98 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.919 -179.372 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.0 t -62.2 -38.4 89.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.606 0.241 . . . . 0.0 111.608 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -67.73 -58.81 3.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.119 0.485 . . . . 0.0 111.122 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.492 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 3.2 tp -55.27 -49.54 71.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.8 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.623 ' HG ' ' CE3' ' A' ' 32' ' ' TRP . 6.2 mp -62.61 -59.16 5.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.159 -179.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -50.28 -59.79 3.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.98 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.474 ' HB3' ' HE2' ' A' ' 13' ' ' PHE . 3.8 mm? -55.89 -43.31 77.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.482 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.542 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 0.1 OUTLIER -66.83 -15.7 63.79 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.045 -179.943 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.92 23.9 19.02 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.096 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.623 ' CE3' ' HG ' ' A' ' 27' ' ' LEU . 8.8 m0 -74.84 -66.05 0.8 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.202 0.525 . . . . 0.0 110.119 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.478 ' CB ' HD12 ' A' ' 41' ' ' ILE . 2.1 t -106.68 139.19 41.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.135 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -82.31 -33.48 29.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.574 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.418 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -105.16 -27.54 11.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.959 179.645 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.79 0.75 88.68 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.855 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.88 -15.32 0.31 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.681 0.277 . . . . 0.0 111.468 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.418 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 1.0 OUTLIER -54.29 -77.31 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.374 -179.682 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.96 15.05 1.56 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.3 mttt 61.71 26.53 16.16 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.98 0.419 . . . . 0.0 110.406 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.539 ' HA ' ' CE2' ' A' ' 70' ' ' PHE . 11.7 mt -58.1 -22.27 18.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.708 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.432 ' HB2' HD13 ' A' ' 23' ' ' LEU . . . -74.92 -77.67 0.12 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.099 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 44.3 mm -52.31 -36.81 21.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.778 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' ' 45' ' ' GLU . . . -59.62 -69.29 0.21 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.351 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.502 ' HG3' HD12 ' A' ' 27' ' ' LEU . 3.0 tm-20 -34.28 -42.05 0.13 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.839 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.428 ' C ' ' H ' ' A' ' 48' ' ' VAL . . . -59.14 -75.43 0.27 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.109 -1.044 . . . . 0.0 111.184 178.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.51 ' HA ' ' HB ' ' A' ' 56' ' ' THR . 20.7 pt20 -48.82 -9.37 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.475 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 68.7 t -75.02 -97.28 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.166 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 48' ' ' VAL . 1.9 mmtm -163.02 124.63 2.51 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.549 0.613 . . . . 0.0 112.269 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.59 ' HB ' ' O ' ' A' ' 53' ' ' ALA . 26.3 t -116.76 151.76 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.093 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 177.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.532 ' HB2' ' HB ' ' A' ' 67' ' ' THR . 0.9 OUTLIER -44.67 99.95 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.971 0.415 . . . . 0.0 110.937 -179.269 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 60.12 24.84 61.39 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.089 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.59 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -145.78 80.49 1.59 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.436 ' HB ' ' HD3' ' A' ' 49' ' ' LYS . 8.7 p -89.24 78.92 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.896 0.379 . . . . 0.0 110.425 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -113.13 -172.77 2.12 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.69 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.51 ' HB ' ' HA ' ' A' ' 47' ' ' GLN . 2.8 t -158.62 42.77 0.26 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.52 -179.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.9 172.81 8.21 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.814 0.34 . . . . 0.0 110.991 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.9 mmmm -75.35 -55.74 5.4 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.033 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.4 mtm180 -100.46 141.66 33.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.011 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . 0.511 ' H ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -106.59 131.62 53.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.1 0.476 . . . . 0.0 111.318 -178.957 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.414 ' HA ' ' CG ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -110.07 74.71 0.9 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.245 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.417 HG22 ' N ' ' A' ' 63' ' ' VAL . 12.6 mt -134.26 144.07 36.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.16 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.417 ' N ' HG22 ' A' ' 62' ' ' ILE . 8.0 m -146.97 175.41 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.254 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 78.18 -144.64 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.542 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.621 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -100.22 83.47 0.55 Allowed Glycine 0 C--N 1.335 0.499 0 C-N-CA 121.17 -0.538 . . . . 0.0 113.382 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -122.27 163.41 19.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.664 0.269 . . . . 0.0 111.037 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.532 ' HB ' ' HB2' ' A' ' 51' ' ' ASP . 86.3 m -119.89 150.72 40.01 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.053 0.454 . . . . 0.0 112.043 -178.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.564 HG12 ' CH2' ' A' ' 32' ' ' TRP . 1.1 t -129.99 149.08 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.102 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -137.78 133.69 34.34 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -178.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.539 ' CE2' ' HA ' ' A' ' 41' ' ' ILE . 5.0 t80 -138.42 115.22 10.72 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.384 179.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 36.47 32.95 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 178.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 116.77 -13.2 14.93 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.361 -0.923 . . . . 0.0 113.531 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.406 ' O ' ' CH2' ' A' ' 32' ' ' TRP . 2.2 m-70 -88.25 82.51 7.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.955 0.378 . . . . 0.0 110.952 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.8 m -95.2 101.0 12.71 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.942 0.401 . . . . 0.0 110.943 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.497 ' HB ' ' HZ2' ' A' ' 32' ' ' TRP . 46.5 t -120.27 155.71 23.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.721 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 25.5 mt-30 -111.57 161.21 16.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.94 0.4 . . . . 0.0 110.421 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.621 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 13.1 t -133.38 146.85 31.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.424 -178.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.0 m -131.47 157.24 43.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.985 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.253 -0.88 . . . . 0.0 111.147 -179.929 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.183 0 N-CA-C 112.742 -0.143 . . . . 0.0 112.742 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.77 139.84 33.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.91 0.386 . . . . 0.0 111.197 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 56.66 -179.73 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.056 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 pp -93.2 12.53 2.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.481 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 3.6 p-80 -147.32 164.43 33.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.799 0.333 . . . . 0.0 110.843 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.0 mtt-85 -117.18 90.93 3.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.999 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -97.83 140.91 31.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.648 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.23 81.25 3.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.826 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 75.6 m-80 59.08 176.34 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.745 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 5.1 mtt -99.21 149.38 23.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.781 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.425 ' O ' HG12 ' A' ' 75' ' ' VAL . . . -88.71 135.07 33.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.394 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.46 132.47 29.49 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.85 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.419 ' CD2' ' CD1' ' A' ' 26' ' ' LEU . 36.8 t80 -102.33 147.49 26.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.896 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.8 m -106.25 147.89 28.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.399 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.0 mt -118.61 -38.12 3.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.063 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.13 -103.75 2.9 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.397 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.0 mttt -143.58 41.87 1.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.019 0.437 . . . . 0.0 110.894 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.4 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 8.0 m170 -95.5 163.91 20.3 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.446 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.591 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 17.9 Cg_endo -58.59 -43.02 48.53 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.322 2.015 . . . . 0.0 112.008 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.591 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 19.9 p80 166.08 -163.96 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.203 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.8 m -139.47 154.23 24.57 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-O 121.09 0.471 . . . . 0.0 112.144 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.491 ' HG2' ' CB ' ' A' ' 59' ' ' ARG . 13.8 mt-10 -90.81 148.09 22.76 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.593 178.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.465 HD12 ' O ' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -41.27 -50.34 3.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.795 0.331 . . . . 0.0 111.656 -179.656 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 17.9 t -65.64 -32.72 74.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.884 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 2.9 m-20 -64.57 -59.38 4.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.776 0.322 . . . . 0.0 110.323 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.599 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 12.5 tp -51.78 -40.48 60.43 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.891 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.477 HD23 ' CE3' ' A' ' 32' ' ' TRP . 12.6 mt -66.74 -67.87 0.42 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.111 0.482 . . . . 0.0 110.788 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.461 ' HE2' ' O ' ' A' ' 35' ' ' SER . 4.1 ttmt -50.15 -55.92 13.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.79 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.1 OUTLIER -53.83 -40.14 66.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.117 -178.991 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.599 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 1.1 mm-40 -80.35 -10.05 59.75 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.838 0.311 . . . . 0.0 111.838 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.68 25.13 21.56 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.249 -0.977 . . . . 0.0 113.342 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.701 ' CZ3' ' HB2' ' A' ' 73' ' ' HIS . 13.0 m95 -72.94 -61.99 1.62 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 117.133 0.466 . . . . 0.0 110.2 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.464 ' HB2' ' CB ' ' A' ' 41' ' ' ILE . 39.2 t -100.18 156.22 17.32 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.453 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -85.74 -35.15 20.97 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.186 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.461 ' O ' ' HE2' ' A' ' 28' ' ' LYS . 1.1 p -106.94 -46.21 3.99 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.524 178.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 120.81 -28.5 6.14 Favored Glycine 0 C--N 1.333 0.374 0 CA-C-N 115.745 -0.662 . . . . 0.0 112.882 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.98 1.74 3.31 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -60.91 -76.46 0.05 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.865 0.364 . . . . 0.0 111.105 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.15 15.4 0.57 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.928 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.3 mttp 66.1 24.93 10.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.983 0.421 . . . . 0.0 110.004 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.515 ' HA ' ' CE2' ' A' ' 70' ' ' PHE . 40.8 mm -52.99 -26.96 12.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.61 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.81 -78.33 0.08 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.928 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 34.4 mm -49.49 -34.34 8.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.856 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.605 ' O ' ' HG3' ' A' ' 47' ' ' GLN . . . -63.5 -72.23 0.15 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.718 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.496 ' HA ' ' HB2' ' A' ' 70' ' ' PHE . 0.6 OUTLIER -32.79 -41.71 0.07 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.95 0.405 . . . . 0.0 110.879 -179.845 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.446 ' C ' ' H ' ' A' ' 48' ' ' VAL . . . -59.68 -77.02 0.19 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.268 -0.967 . . . . 0.0 110.848 178.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.605 ' HG3' ' O ' ' A' ' 44' ' ' ALA . 1.4 pt20 -46.52 -10.42 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.481 HG23 ' CD1' ' A' ' 70' ' ' PHE . 58.4 t -74.9 -92.86 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.906 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' A' ' 48' ' ' VAL . 0.1 OUTLIER -168.12 125.73 1.13 Allowed 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.894 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.8 t -122.15 158.01 26.2 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -44.05 101.75 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.053 0.454 . . . . 0.0 111.71 -178.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 57.29 23.13 46.76 Favored Glycine 0 C--N 1.333 0.386 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.489 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -146.15 82.64 1.61 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.869 0.366 . . . . 0.0 111.787 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.442 ' O ' HG12 ' A' ' 54' ' ' VAL . 10.7 p -88.39 61.47 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.073 0.463 . . . . 0.0 110.824 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -101.14 -164.41 1.1 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.221 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.486 ' HB ' ' HA ' ' A' ' 47' ' ' GLN . 9.7 t -153.18 45.15 0.65 Allowed 'General case' 0 C--O 1.232 0.164 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.465 ' O ' HD12 ' A' ' 23' ' ' LEU . 52.3 mtt180 -87.77 174.98 8.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.067 0.46 . . . . 0.0 111.104 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -85.35 -38.72 18.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.086 179.395 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.491 ' CB ' ' HG2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -120.65 134.06 55.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.822 179.664 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -119.9 115.39 23.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.875 0.369 . . . . 0.0 110.73 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.477 ' HG3' ' CD2' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -74.15 89.85 2.01 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.033 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.531 HG21 ' HG3' ' A' ' 66' ' ' GLN . 6.9 mm -133.11 138.22 51.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.207 0.527 . . . . 0.0 112.153 -178.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.5 m -146.26 175.29 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.125 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.466 ' HA ' ' HB2' ' A' ' 79' ' ' ALA . . . 76.52 -143.14 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.64 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -99.91 83.44 0.57 Allowed Glycine 0 C--N 1.336 0.546 0 C-N-CA 121.308 -0.472 . . . . 0.0 112.129 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.531 ' HG3' HG21 ' A' ' 62' ' ' ILE . 6.1 mm100 -122.36 159.63 27.08 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.887 0.375 . . . . 0.0 111.753 -178.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 7.3 m -120.37 144.46 47.87 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.458 -178.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.612 HG11 ' CH2' ' A' ' 32' ' ' TRP . 1.2 t -118.67 143.14 30.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.451 178.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -134.07 133.37 41.09 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.516 ' CE1' ' HB3' ' A' ' 44' ' ' ALA . 1.4 t80 -146.19 122.48 10.91 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.611 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.469 ' H ' HG13 ' A' ' 48' ' ' VAL . . . 49.52 -85.47 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.343 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -129.14 -5.6 4.67 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.722 -0.751 . . . . 0.0 113.026 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.701 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 0.9 OUTLIER -90.61 113.07 25.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.967 0.384 . . . . 0.0 111.441 -179.269 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 72.1 m -120.48 115.54 23.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.178 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.576 ' HB ' ' HZ2' ' A' ' 32' ' ' TRP . 59.4 t -138.59 155.23 27.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.803 0.335 . . . . 0.0 111.328 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.508 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 2.8 mt-30 -112.78 169.96 8.53 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.104 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.64 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 21.6 t -136.36 146.0 29.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.82 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.96 150.49 34.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.952 0.406 . . . . 0.0 111.665 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.466 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.336 -0.84 . . . . 0.0 110.964 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.192 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.9 m -131.6 -65.18 0.77 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.799 0.333 . . . . 0.0 110.847 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 7.5 mtm 66.33 -73.5 0.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.009 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.1 tt -132.83 -2.08 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.781 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 51.2 m-70 -100.26 177.35 5.08 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.791 0.329 . . . . 0.0 111.059 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.45 122.75 32.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.957 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.7 ttt -131.27 30.35 4.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.728 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 p -173.44 176.9 2.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.703 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -134.28 121.19 20.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.929 0.395 . . . . 0.0 111.052 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -78.89 107.62 11.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.745 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.518 ' HB3' HG12 ' A' ' 75' ' ' VAL . . . -67.25 99.8 0.74 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.037 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.58 121.55 16.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.999 0.428 . . . . 0.0 111.168 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.53 ' CD2' HD12 ' A' ' 26' ' ' LEU . 37.1 t80 -99.02 155.28 17.52 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.945 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.5 m -106.63 148.73 27.97 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.272 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.1 mt -117.92 -28.74 5.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.851 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.09 40.06 62.34 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.972 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 56.93 68.46 0.86 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.974 0.416 . . . . 0.0 110.829 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.486 ' O ' HG13 ' A' ' 63' ' ' VAL . 1.8 m170 -115.28 170.02 6.08 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.903 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.464 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 32.7 Cg_endo -64.86 -51.5 1.68 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.406 2.07 . . . . 0.0 112.356 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.559 ' HA ' HG11 ' A' ' 63' ' ' VAL . 7.4 p80 177.94 -179.72 0.28 Allowed 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.333 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.464 HG23 HD11 ' A' ' 26' ' ' LEU . 4.5 m -142.11 161.01 20.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -179.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.468 ' HG2' ' HA ' ' A' ' 59' ' ' ARG . 8.3 mt-10 -98.89 144.42 28.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.192 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 58' ' ' LYS . 0.9 OUTLIER -39.7 -38.02 0.59 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.629 -0.259 . . . . 0.0 111.561 -179.67 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 48.9 t -73.38 -39.71 64.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.606 0.241 . . . . 0.0 111.189 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -62.86 -57.42 10.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.069 0.461 . . . . 0.0 110.358 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.53 HD12 ' CD2' ' A' ' 13' ' ' PHE . 12.6 tp -55.27 -45.97 76.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.268 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.555 ' HB3' ' HB2' ' A' ' 32' ' ' TRP . 4.0 mp -66.73 -59.95 3.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.885 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -49.31 -56.12 10.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.446 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.3 -38.42 71.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.089 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.449 ' CG ' ' HB2' ' A' ' 13' ' ' PHE . 5.2 mm-40 -79.87 -10.95 59.83 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.82 24.02 18.9 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.257 -0.973 . . . . 0.0 113.155 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.594 ' HZ2' ' HB ' ' A' ' 75' ' ' VAL . 11.2 m95 -75.92 -62.55 1.56 Allowed 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.5 t -106.38 138.54 42.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.339 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.67 -34.41 60.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.963 0.411 . . . . 0.0 110.408 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.9 -48.12 3.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.057 178.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.401 ' O ' ' HB3' ' A' ' 42' ' ' ALA . . . 118.63 -22.85 9.18 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.231 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.47 -1.78 3.12 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -59.3 -77.95 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.611 0.243 . . . . 0.0 111.249 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.423 ' HB3' HG13 ' A' ' 41' ' ' ILE . . . -75.15 15.13 0.45 Allowed 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.425 ' O ' ' HB3' ' A' ' 44' ' ' ALA . 34.9 mttt 61.85 25.34 15.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.765 0.317 . . . . 0.0 110.76 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.468 ' HA ' ' CE2' ' A' ' 70' ' ' PHE . 14.4 mt -61.37 -16.43 14.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.608 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . -72.68 -79.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.314 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 43.4 mm -53.9 -33.72 24.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.806 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.456 ' HB2' ' CE1' ' A' ' 70' ' ' PHE . . . -61.0 -72.2 0.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.232 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.533 ' HA ' ' HB2' ' A' ' 70' ' ' PHE . 2.4 tm-20 -34.76 -40.97 0.12 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.22 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.19 -73.93 0.4 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.156 -1.021 . . . . 0.0 110.628 178.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.551 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 15.8 pt20 -48.9 -11.55 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.505 HG21 ' HA ' ' A' ' 45' ' ' GLU . 47.2 t -75.0 -90.92 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.102 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.428 ' HD3' ' HB ' ' A' ' 54' ' ' VAL . 6.4 mmtp -165.43 124.84 1.75 Allowed 'General case' 0 C--O 1.232 0.153 0 C-N-CA 120.193 -0.603 . . . . 0.0 112.284 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.523 ' HB ' ' O ' ' A' ' 53' ' ' ALA . 34.2 t -119.08 142.77 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 178.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.447 ' HB2' ' O ' ' A' ' 67' ' ' THR . 0.8 OUTLIER -45.29 97.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.924 0.392 . . . . 0.0 111.567 -179.102 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.25 11.02 85.76 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.976 -0.631 . . . . 0.0 113.001 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.523 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -146.03 82.44 1.61 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 117.073 0.436 . . . . 0.0 112.033 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.439 HG11 ' O ' ' A' ' 54' ' ' VAL . 7.4 p -86.99 56.2 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.075 0.464 . . . . 0.0 110.081 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -99.65 179.72 4.45 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.628 -178.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.551 ' HB ' ' HB3' ' A' ' 47' ' ' GLN . 1.7 p -134.39 36.97 3.16 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.684 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.38 171.23 12.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.873 0.368 . . . . 0.0 111.189 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.443 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 38.6 mttm -75.57 -46.46 31.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.682 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.468 ' HA ' ' HG2' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -116.61 137.65 52.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.633 179.862 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . 0.435 ' HB3' HD13 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -115.24 115.28 26.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.77 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.436 ' HG2' ' CD2' ' A' ' 20' ' ' HIS . 11.5 mtpt -78.46 82.26 4.74 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.369 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.467 ' CD1' HG11 ' A' ' 50' ' ' VAL . 26.8 mt -133.61 147.97 30.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.261 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.559 HG11 ' HA ' ' A' ' 20' ' ' HIS . 1.9 m -154.99 175.87 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.245 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 76.22 -150.66 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.301 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -83.9 78.54 2.0 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.292 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.401 ' HG3' ' CG2' ' A' ' 62' ' ' ILE . 10.0 mm100 -122.26 154.91 36.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.112 0.482 . . . . 0.0 110.956 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.617 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 87.6 m -114.46 156.28 24.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.375 -178.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.54 HG11 ' CH2' ' A' ' 32' ' ' TRP . 1.0 OUTLIER -133.01 148.97 31.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.672 179.34 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 76.8 p -143.12 139.86 30.6 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.533 ' HB2' ' HA ' ' A' ' 45' ' ' GLU . 2.3 t80 -150.82 124.36 9.02 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 114.902 -1.044 . . . . 0.0 110.323 179.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 49.52 -85.46 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.59 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -126.18 -6.99 5.61 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.972 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.499 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 1.7 m-70 -89.5 107.11 18.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.791 0.329 . . . . 0.0 111.54 -179.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.76 95.29 4.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.175 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.594 ' HB ' ' HZ2' ' A' ' 32' ' ' TRP . 97.0 t -123.23 155.32 29.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.517 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.617 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 3.2 mp0 -113.26 165.1 12.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.971 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.441 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 11.0 t -139.76 150.57 22.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.974 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.43 ' N ' HG12 ' A' ' 77' ' ' VAL . 34.0 m -129.17 165.5 28.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.973 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.215 -0.897 . . . . 0.0 111.191 179.892 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.181 0 N-CA-C 112.748 -0.141 . . . . 0.0 112.748 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.561 ' HB3' ' O ' ' A' ' 5' ' ' HIS . 5.5 m -102.3 117.98 35.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.728 0.299 . . . . 0.0 111.059 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.9 mmt -94.66 -59.43 1.93 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.126 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.452 HG21 ' N ' ' A' ' 5' ' ' HIS . 5.8 tt -117.0 -30.37 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.615 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.561 ' O ' ' HB3' ' A' ' 2' ' ' SER . 21.3 m-70 -91.25 140.81 29.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.456 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.95 106.05 0.81 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.995 0.426 . . . . 0.0 111.183 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.41 130.01 47.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.552 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.7 t -148.96 -60.22 0.23 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.097 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -105.38 -39.18 6.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.895 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -82.34 82.35 7.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.954 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.431 ' O ' HG13 ' A' ' 75' ' ' VAL . . . -86.59 130.83 34.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.698 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.97 133.82 34.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.56 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.469 ' CD2' HD12 ' A' ' 26' ' ' LEU . 58.4 t80 -105.35 156.58 18.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.1 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.2 m -107.16 142.7 36.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.963 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.63 HD21 ' HB2' ' A' ' 18' ' ' HIS . 0.5 OUTLIER -104.67 -40.62 5.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.445 179.375 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.22 42.95 6.82 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.702 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 50.18 59.31 4.64 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.93 0.395 . . . . 0.0 111.248 179.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.63 ' HB2' HD21 ' A' ' 15' ' ' LEU . 30.7 m170 -115.66 165.27 14.88 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.398 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.647 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 18.3 Cg_endo -57.75 -38.43 93.06 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.557 2.171 . . . . 0.0 112.386 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.647 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 12.0 p80 164.38 -173.7 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.72 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.866 HG23 HD11 ' A' ' 26' ' ' LEU . 2.4 m -145.79 166.47 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.217 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.483 ' HG2' ' HB2' ' A' ' 59' ' ' ARG . 70.4 mt-10 -95.97 141.03 29.87 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.818 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.446 HD21 ' N ' ' A' ' 59' ' ' ARG . 2.0 pp -44.12 -30.59 0.78 Allowed 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 -178.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.584 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -69.63 -40.71 76.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.78 0.324 . . . . 0.0 110.396 179.361 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -63.44 -60.63 3.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.049 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.866 HD11 HG23 ' A' ' 21' ' ' VAL . 2.6 tp -49.46 -49.25 46.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.652 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.755 ' HG ' ' CE3' ' A' ' 32' ' ' TRP . 9.5 mp -65.1 -61.76 1.95 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.445 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.584 ' HB2' ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -48.82 -55.59 11.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.348 -179.718 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.2 mt -55.33 -42.49 73.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.533 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.448 ' CG ' ' HB2' ' A' ' 13' ' ' PHE . 1.3 mm-40 -71.19 -15.28 62.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.728 -0.214 . . . . 0.0 111.555 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.07 24.77 12.17 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.268 -0.968 . . . . 0.0 113.071 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.755 ' CE3' ' HG ' ' A' ' 27' ' ' LEU . 7.8 m0 -76.33 -66.28 0.82 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.959 0.38 . . . . 0.0 109.999 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 25.0 t -106.12 140.04 39.7 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.353 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -75.74 -34.96 60.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.898 0.38 . . . . 0.0 110.73 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.485 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 0.2 OUTLIER -106.45 -48.0 3.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.365 178.848 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.4 -26.25 8.72 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.201 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -127.58 -2.67 6.09 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.485 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 4.2 tp-100 -59.74 -76.56 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.674 0.273 . . . . 0.0 110.962 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.91 15.11 0.93 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.725 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.7 mttm 61.93 27.83 16.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.084 0.469 . . . . 0.0 110.401 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.44 ' HA ' ' CE2' ' A' ' 70' ' ' PHE . 12.7 mt -59.29 -25.0 29.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.554 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.07 -77.69 0.08 Allowed 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.144 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 31.6 mm -48.62 -36.29 7.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 120.896 0.379 . . . . 0.0 110.599 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.567 ' HB1' ' CE1' ' A' ' 70' ' ' PHE . . . -61.46 -67.06 0.44 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.519 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.521 ' HB2' HD21 ' A' ' 27' ' ' LEU . 5.9 tp10 -33.96 -45.73 0.21 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.852 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' A' ' 48' ' ' VAL . . . -59.23 -75.94 0.24 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.238 -0.982 . . . . 0.0 111.04 178.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.54 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 12.4 pt20 -44.5 -15.86 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.624 HG11 ' H ' ' A' ' 71' ' ' ALA . 93.6 t -75.05 -91.7 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 O-C-N 122.212 -0.305 . . . . 0.0 110.575 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -171.18 136.88 1.09 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.956 0.408 . . . . 0.0 111.146 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.485 ' O ' ' N ' ' A' ' 52' ' ' GLY . 58.5 t -131.7 144.95 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.951 179.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.461 ' HB3' ' H ' ' A' ' 67' ' ' THR . 37.6 t70 -60.61 77.23 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.055 0.455 . . . . 0.0 110.46 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 120.96 -12.46 9.89 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.408 -179.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.469 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . . . -132.37 133.69 44.27 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.892 0.377 . . . . 0.0 110.8 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.6 p -125.2 31.98 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.714 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -107.49 160.21 15.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.283 0.563 . . . . 0.0 112.433 -178.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.54 ' HB ' ' HB3' ' A' ' 47' ' ' GLN . 14.8 t -108.66 50.12 0.79 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.556 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 10.0 mtp180 -84.24 173.38 11.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.746 0.308 . . . . 0.0 111.018 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.1 ttmm -81.68 -0.69 43.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.991 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.483 ' HB2' ' HG2' ' A' ' 22' ' ' GLU . 0.3 OUTLIER -160.86 157.3 26.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.616 179.708 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.6 t -134.93 114.99 13.08 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.463 ' HG2' ' CD2' ' A' ' 20' ' ' HIS . 3.6 mttm -76.0 94.62 3.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.36 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.459 HD12 ' CG1' ' A' ' 50' ' ' VAL . 16.2 mt -135.41 141.17 43.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.696 -179.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.59 HG11 ' HA ' ' A' ' 20' ' ' HIS . 0.8 OUTLIER -144.24 175.18 3.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.927 179.3 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 66.21 -150.17 0.21 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.716 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.598 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -86.79 79.13 1.84 Allowed Glycine 0 C--N 1.336 0.565 0 C-N-CA 121.451 -0.404 . . . . 0.0 113.498 -178.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.515 ' HG3' ' O ' ' A' ' 63' ' ' VAL . 2.3 mm100 -122.18 158.95 28.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.935 0.397 . . . . 0.0 111.347 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.59 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 0.3 OUTLIER -114.53 157.66 22.69 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.529 -178.71 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.467 ' CG1' ' CH2' ' A' ' 32' ' ' TRP . 1.2 t -133.96 147.51 30.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.829 179.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.637 ' HA ' ' O ' ' A' ' 73' ' ' HIS . 0.5 OUTLIER -137.7 132.15 32.44 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -178.939 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.567 ' CE1' ' HB1' ' A' ' 44' ' ' ALA . 1.7 t80 -139.32 117.9 12.2 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.347 178.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.624 ' H ' HG11 ' A' ' 48' ' ' VAL . . . 38.01 30.0 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 117.17 -7.26 16.69 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.211 -0.995 . . . . 0.0 113.512 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.637 ' O ' ' HA ' ' A' ' 69' ' ' SER . 2.6 m-70 -87.9 89.79 8.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 117.242 0.521 . . . . 0.0 110.834 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 58.2 m -100.59 102.02 13.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.858 0.361 . . . . 0.0 111.008 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.554 ' HB ' ' HZ2' ' A' ' 32' ' ' TRP . 46.9 t -127.19 153.61 36.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.843 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.59 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -112.95 165.04 12.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.031 0.443 . . . . 0.0 111.122 179.538 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.598 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 45.3 t -138.11 154.86 28.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.48 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.483 ' O ' ' HB2' ' A' ' 15' ' ' LEU . 16.1 m -131.77 161.47 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.865 0.364 . . . . 0.0 111.417 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.321 -0.847 . . . . 0.0 111.429 179.624 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.153 0 N-CA-C 112.557 -0.217 . . . . 0.0 112.557 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 62.98 34.47 13.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.802 0.334 . . . . 0.0 110.994 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -91.98 120.97 33.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.965 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -106.19 119.84 56.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.33 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.4 m170 -76.13 138.35 40.69 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.817 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 9.6 mmm-85 -109.14 151.27 26.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.004 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.3 mtp -102.52 -45.66 4.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.998 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.92 136.95 57.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.069 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -110.39 103.31 11.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.116 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -67.64 143.05 56.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.566 179.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.425 ' HB1' ' HA ' ' A' ' 75' ' ' VAL . . . -64.14 84.7 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.141 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.62 109.42 6.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.781 0.324 . . . . 0.0 110.78 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.597 ' O ' HG11 ' A' ' 77' ' ' VAL . 28.2 t80 -98.64 170.59 8.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.975 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.9 m -106.82 138.1 43.62 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.356 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.837 ' HB2' HG12 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -131.49 -37.99 1.19 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.221 179.337 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -44.09 -27.69 1.14 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 121.213 -0.518 . . . . 0.0 113.002 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -55.46 -40.86 72.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.663 0.268 . . . . 0.0 111.257 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.575 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 42.4 m80 -119.64 163.06 29.48 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.319 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.575 ' HD2' ' HB3' ' A' ' 18' ' ' HIS . 18.2 Cg_endo -59.74 -27.87 85.96 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.658 2.239 . . . . 0.0 112.496 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.462 ' HA ' ' CG1' ' A' ' 63' ' ' VAL . 4.7 p80 177.05 178.17 0.27 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.12 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.426 HG11 ' O ' ' A' ' 20' ' ' HIS . 15.4 m -145.93 167.15 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.576 ' HG3' ' HA ' ' A' ' 59' ' ' ARG . 17.3 tt0 -100.35 144.2 29.64 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.08 178.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.45 ' HB2' ' OE1' ' A' ' 45' ' ' GLU . 1.6 pp -40.86 -46.84 2.83 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.655 0.264 . . . . 0.0 111.625 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 5.6 t -62.31 -38.05 87.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.751 0.31 . . . . 0.0 110.927 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -66.06 -57.61 7.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.885 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.2 tt -56.64 -42.05 78.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.053 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.613 HD11 ' HG3' ' A' ' 45' ' ' GLU . 6.7 mp -65.77 -62.29 1.59 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.972 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.04 -55.55 11.69 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.383 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 13' ' ' PHE . 6.6 mt -53.48 -40.16 65.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.265 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.48 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 0.4 OUTLIER -73.45 -15.17 61.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.605 -179.702 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.5 23.82 17.84 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.425 -0.893 . . . . 0.0 113.294 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.594 ' HZ2' ' HB ' ' A' ' 75' ' ' VAL . 9.3 m0 -72.62 -59.04 2.91 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 117.215 0.508 . . . . 0.0 110.137 179.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.0 t -104.87 138.72 40.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.426 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -69.28 -33.77 73.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.905 0.383 . . . . 0.0 110.761 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.9 p -105.16 -42.44 5.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.064 0.459 . . . . 0.0 110.573 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 128.67 -43.34 1.33 Allowed Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.107 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.52 4.37 3.95 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -53.07 -70.38 0.09 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.838 0.352 . . . . 0.0 110.831 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.31 15.49 0.44 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.967 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.2 mttt 64.35 23.3 12.99 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 120.913 0.387 . . . . 0.0 110.163 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.584 ' HA ' ' CE2' ' A' ' 70' ' ' PHE . 29.8 mt -61.83 -19.63 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.617 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.29 -78.92 0.09 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.916 0.389 . . . . 0.0 110.961 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 43.6 mm -52.41 -37.98 24.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.734 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.413 ' O ' ' C ' ' A' ' 45' ' ' GLU . . . -58.42 -69.38 0.19 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.155 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.613 ' HG3' HD11 ' A' ' 27' ' ' LEU . 12.3 tm-20 -34.53 -44.92 0.22 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.107 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.01 -73.14 0.44 Allowed Glycine 0 C--N 1.332 0.314 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.576 ' HG2' ' HB ' ' A' ' 56' ' ' THR . 0.0 OUTLIER -45.63 -15.44 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 179.614 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.517 HG23 ' HA ' ' A' ' 45' ' ' GLU . 46.2 t -74.92 -91.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 121.053 -0.259 . . . . 0.0 111.124 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 69' ' ' SER . 0.3 OUTLIER -175.74 130.13 0.25 Allowed 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.292 -0.563 . . . . 0.0 112.029 179.826 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.609 ' HB ' ' HB3' ' A' ' 53' ' ' ALA . 21.3 t -116.91 148.01 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.587 ' HB2' ' HB ' ' A' ' 67' ' ' THR . 14.0 t0 -44.85 99.21 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.934 0.397 . . . . 0.0 111.594 -179.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.37 17.67 70.68 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.225 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.609 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . . . -145.79 73.09 1.33 Allowed 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.249 0.547 . . . . 0.0 111.586 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.422 HG21 ' HG2' ' A' ' 49' ' ' LYS . 3.0 p -84.33 69.25 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.419 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.414 ' C ' HG21 ' A' ' 56' ' ' THR . 31.7 mm-40 -100.48 -178.62 3.86 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.83 -179.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.576 ' HB ' ' HG2' ' A' ' 47' ' ' GLN . 3.0 p -142.45 37.74 1.52 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.172 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.15 172.71 7.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.765 0.316 . . . . 0.0 111.256 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.412 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -75.3 -41.77 56.18 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.45 179.713 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.576 ' HA ' ' HG3' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -123.8 145.56 48.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.645 179.424 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . 0.411 ' HB3' HD12 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -130.85 116.16 17.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.926 0.393 . . . . 0.0 111.439 -179.469 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.24 86.46 1.09 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.278 179.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.539 ' O ' HG13 ' A' ' 63' ' ' VAL . 20.8 mt -133.37 139.94 47.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.224 -179.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.539 HG13 ' O ' ' A' ' 62' ' ' ILE . 34.4 m -148.83 175.88 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.92 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.62 ' HA ' ' HB2' ' A' ' 79' ' ' ALA . . . 76.96 -147.94 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 178.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.704 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -84.36 75.62 2.34 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.25 -179.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.426 ' OE1' ' HB3' ' A' ' 51' ' ' ASP . 16.7 mm-40 -122.17 152.73 39.64 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.099 0.476 . . . . 0.0 111.285 -179.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.623 HG23 ' O ' ' A' ' 75' ' ' VAL . 21.9 m -115.93 152.75 32.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.787 -178.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.423 ' CG1' ' CH2' ' A' ' 32' ' ' TRP . 0.8 OUTLIER -128.03 144.53 37.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.222 179.241 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' ' 49' ' ' LYS . 25.7 m -136.74 136.42 38.94 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.119 0.485 . . . . 0.0 112.246 -178.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.584 ' CE2' ' HA ' ' A' ' 41' ' ' ILE . 2.1 t80 -144.65 121.85 11.52 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.21 179.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 51.08 -81.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.981 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -131.75 -4.14 3.92 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.85 -0.69 . . . . 0.0 113.337 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.472 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 1.8 m-70 -91.48 112.62 24.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.087 0.444 . . . . 0.0 111.691 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.4 109.37 15.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.863 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.623 ' O ' HG23 ' A' ' 67' ' ' THR . 27.6 t -132.14 150.68 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 120.579 0.228 . . . . 0.0 111.468 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.601 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 1.5 mt-30 -112.29 172.4 6.93 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.008 0.432 . . . . 0.0 111.351 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.837 HG12 ' HB2' ' A' ' 15' ' ' LEU . 12.1 t -142.64 150.52 18.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.233 -178.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.1 m -127.49 158.78 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-O 120.746 0.307 . . . . 0.0 111.81 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.62 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.304 -0.855 . . . . 0.0 111.04 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.121 0 N-CA-C 112.383 -0.287 . . . . 0.0 112.383 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.41 -40.89 11.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.798 0.332 . . . . 0.0 110.826 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.452 ' O ' HG22 ' A' ' 4' ' ' ILE . 0.4 OUTLIER -88.89 -171.64 3.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.101 179.946 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.516 HG22 ' O ' ' A' ' 4' ' ' ILE . 0.8 OUTLIER 35.52 93.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 121.171 0.51 . . . . 0.0 112.226 -179.909 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 34.3 m-70 -100.87 106.75 18.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.763 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -147.08 31.58 0.93 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.171 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.6 mtp -118.89 124.46 47.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.773 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 p -91.27 161.33 15.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.06 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -153.13 -36.67 0.11 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.158 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -71.72 121.93 19.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.026 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.4 ' CB ' HG12 ' A' ' 75' ' ' VAL . . . -99.84 137.06 38.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.021 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.55 135.24 53.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.28 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.516 ' CG ' HD12 ' A' ' 26' ' ' LEU . 1.1 t80 -101.07 95.59 6.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.309 179.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.05 111.26 8.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.855 0.359 . . . . 0.0 110.58 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.512 HD21 ' HB2' ' A' ' 18' ' ' HIS . 1.4 mt -82.46 -33.7 28.37 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.033 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.4 -73.86 0.67 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.715 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.44 52.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.129 0.49 . . . . 0.0 110.847 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.688 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 32.2 m170 -109.02 166.83 10.08 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.648 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.688 ' HD2' ' HB3' ' A' ' 18' ' ' HIS . 18.6 Cg_endo -57.97 -41.48 68.18 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.317 2.011 . . . . 0.0 111.831 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.595 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 9.0 p80 165.69 -164.71 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.256 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.426 ' CG1' HD22 ' A' ' 15' ' ' LEU . 22.6 m -142.73 156.91 18.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.354 0.597 . . . . 0.0 112.248 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.697 ' HG2' ' HA ' ' A' ' 59' ' ' ARG . 12.6 mt-10 -92.56 142.93 26.85 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.639 178.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -40.14 -40.05 1.02 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.726 0.298 . . . . 0.0 111.171 -179.61 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 54.0 t -67.1 -40.24 86.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.058 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -65.29 -57.15 9.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.023 179.667 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.516 HD12 ' CG ' ' A' ' 13' ' ' PHE . 9.9 tp -57.16 -47.77 80.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.436 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.525 ' HG ' ' CE3' ' A' ' 32' ' ' TRP . 4.6 mp -62.69 -57.34 11.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.785 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -50.76 -59.12 4.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.953 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 18.7 mt -56.83 -44.04 81.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.583 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 10.9 mm-40 -67.99 -14.99 63.4 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 121.117 -0.233 . . . . 0.0 111.165 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.24 22.54 26.97 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.359 -0.924 . . . . 0.0 113.209 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.551 ' HZ2' ' HB ' ' A' ' 75' ' ' VAL . 9.3 m0 -68.84 -64.08 0.94 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.71 152.63 23.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.016 178.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -70.38 -34.56 72.72 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.28 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.559 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -106.13 -57.23 2.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.103 0.478 . . . . 0.0 110.568 179.241 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 152.63 -33.88 0.82 Allowed Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.972 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.37 7.53 1.33 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.559 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 2.1 tp60 -54.36 -70.33 0.1 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.701 0.286 . . . . 0.0 110.902 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.72 15.35 0.2 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.575 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.601 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 0.0 OUTLIER 69.11 16.26 8.63 Favored 'General case' 0 CA--C 1.523 -0.067 0 CA-C-O 120.734 0.302 . . . . 0.0 110.723 -179.378 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.542 ' HA ' ' CE2' ' A' ' 70' ' ' PHE . 22.9 mm -56.34 -26.5 22.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.299 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.75 -79.43 0.06 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.407 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.2 mm -48.04 -42.77 10.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.689 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.601 ' HB2' ' O ' ' A' ' 40' ' ' LYS . . . -57.99 -64.21 0.99 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.506 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.521 ' HA ' ' HB2' ' A' ' 70' ' ' PHE . 3.1 tm-20 -35.94 -40.78 0.21 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.709 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' A' ' 48' ' ' VAL . . . -60.07 -75.07 0.3 Allowed Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 178.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.609 ' HG2' ' HB ' ' A' ' 56' ' ' THR . 0.0 OUTLIER -46.49 -12.59 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 179.891 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.49 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 57.7 t -74.99 -89.32 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.103 -179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 48' ' ' VAL . 5.8 mmmt -167.44 144.46 4.44 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.982 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.599 ' HB ' ' O ' ' A' ' 53' ' ' ALA . 14.0 t -131.04 145.7 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.5 ' HB2' ' HB ' ' A' ' 67' ' ' THR . 8.8 t0 -43.89 90.27 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -178.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 108.98 -31.93 7.31 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.712 -0.756 . . . . 0.0 114.03 178.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.599 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -147.58 145.59 29.08 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 117.851 0.825 . . . . 0.0 112.549 -179.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.412 ' CG2' ' O ' ' A' ' 48' ' ' VAL . 4.8 p -109.38 101.5 12.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.053 178.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -99.75 -165.05 1.18 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.966 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.609 ' HB ' ' HG2' ' A' ' 47' ' ' GLN . 5.2 t -165.24 31.06 0.06 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.775 0.322 . . . . 0.0 111.371 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.3 mtt180 -89.07 167.85 12.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.023 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 58.3 mmtt -78.32 -35.61 47.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.237 0.542 . . . . 0.0 109.953 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.697 ' HA ' ' HG2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -106.93 135.08 49.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.563 179.592 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . 0.41 ' H ' ' HA ' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -104.39 118.29 36.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.879 0.371 . . . . 0.0 110.793 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.423 ' HA ' ' CD2' ' A' ' 20' ' ' HIS . 5.4 mtmt -98.99 74.06 1.98 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.11 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.449 ' O ' ' HB2' ' A' ' 20' ' ' HIS . 29.6 mt -137.88 145.26 29.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.657 -179.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.443 ' CG1' ' HA ' ' A' ' 20' ' ' HIS . 0.5 OUTLIER -151.26 175.39 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.867 179.696 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 74.88 -148.89 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.424 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.435 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -85.13 74.76 2.43 Favored Glycine 0 C--N 1.335 0.513 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.732 -179.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.421 ' O ' ' N ' ' A' ' 77' ' ' VAL . 27.9 mm-40 -122.35 150.0 42.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.955 0.407 . . . . 0.0 110.8 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 77.1 m -114.83 150.38 35.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.384 -178.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.504 HG13 ' CH2' ' A' ' 32' ' ' TRP . 0.7 OUTLIER -125.77 145.57 32.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.523 178.774 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 28.4 p -139.32 138.8 37.0 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -178.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.577 ' O ' ' N ' ' A' ' 72' ' ' GLY . 1.9 t80 -143.04 122.2 12.93 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.21 179.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.443 ' H ' HG12 ' A' ' 48' ' ' VAL . . . 48.04 -81.38 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.796 0.332 . . . . 0.0 111.396 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -130.7 -1.29 5.11 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.877 -0.678 . . . . 0.0 113.053 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -93.41 98.93 11.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.134 0.467 . . . . 0.0 111.624 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.3 m -109.82 108.28 18.55 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.405 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.551 ' HB ' ' HZ2' ' A' ' 32' ' ' TRP . 25.1 t -128.55 156.44 40.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.819 -179.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.507 ' N ' HG13 ' A' ' 75' ' ' VAL . 2.7 mp0 -112.05 161.55 16.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.815 0.34 . . . . 0.0 110.716 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.435 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 23.2 t -125.7 141.14 46.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.059 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.3 m -129.77 152.23 37.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.866 0.365 . . . . 0.0 111.124 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.279 -0.867 . . . . 0.0 111.236 -179.776 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.192 0 N-CA-C 112.559 -0.217 . . . . 0.0 112.559 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 m -153.5 -57.78 0.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.82 0.343 . . . . 0.0 110.947 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 62.88 166.54 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 38.7 pt -118.23 131.08 72.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.435 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -142.55 -16.48 0.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.953 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -90.7 128.4 36.64 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.899 0.381 . . . . 0.0 111.332 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.9 tpt -91.95 172.48 8.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.5 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.3 m 59.83 -175.14 0.1 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.777 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -73.78 133.57 43.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.911 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.6 mtp -66.15 96.52 0.33 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.874 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.61 131.05 35.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.38 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -139.62 132.83 29.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.792 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.445 ' CE1' ' HB3' ' A' ' 29' ' ' LEU . 19.1 t80 -107.54 149.28 28.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.927 0.394 . . . . 0.0 111.294 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.63 150.63 26.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.738 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.5 mt -128.08 -40.47 1.67 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.144 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.91 -100.49 2.65 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.671 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.3 tppt? -148.83 53.62 0.98 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.992 0.425 . . . . 0.0 111.003 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.589 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 69.6 m-70 -106.12 163.95 15.98 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.898 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.589 ' HD2' ' HB3' ' A' ' 18' ' ' HIS . 18.3 Cg_endo -57.74 -45.18 34.87 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.615 2.21 . . . . 0.0 112.277 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.546 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 13.8 p80 170.91 -166.67 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.941 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.41 ' O ' ' O ' ' A' ' 60' ' ' CYS . 19.5 m -147.08 159.03 9.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.408 ' O ' ' N ' ' A' ' 25' ' ' ASP . 1.2 mt-10 -88.56 139.29 30.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.959 178.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.469 ' HB2' ' OE1' ' A' ' 45' ' ' GLU . 0.9 OUTLIER -43.47 -32.5 0.9 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.884 0.374 . . . . 0.0 111.28 -179.653 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 26.3 t -73.1 -38.23 66.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.816 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.408 ' N ' ' O ' ' A' ' 22' ' ' GLU . 6.5 m-20 -62.5 -55.31 28.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.743 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.406 HD11 ' CG2' ' A' ' 77' ' ' VAL . 0.4 OUTLIER -54.89 -44.22 73.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.143 -179.913 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.556 ' HG ' ' CE3' ' A' ' 32' ' ' TRP . 5.2 mp -62.16 -64.31 0.97 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.45 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.6 ttmm -47.66 -52.46 18.08 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.974 -179.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.445 ' HB3' ' CE1' ' A' ' 13' ' ' PHE . 3.5 mm? -58.96 -46.51 87.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.322 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -70.52 -14.93 62.71 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.53 26.03 14.43 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.39 -0.91 . . . . 0.0 113.498 179.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.579 ' CH2' HG11 ' A' ' 68' ' ' VAL . 9.6 m0 -74.39 -64.89 0.93 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.015 0.436 . . . . 0.0 110.15 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.9 t -106.31 138.51 42.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.663 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.23 -33.66 37.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.707 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.42 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -105.33 -33.79 8.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.529 179.621 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.32 -20.42 50.34 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.792 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.97 -8.18 3.07 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.42 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 63.8 tp60 -55.51 -76.06 0.03 OUTLIER 'General case' 0 C--O 1.232 0.134 0 CA-C-O 120.724 0.297 . . . . 0.0 111.277 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.32 15.0 2.63 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.75 29.65 19.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.041 0.448 . . . . 0.0 110.44 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.483 ' HA ' ' CE2' ' A' ' 70' ' ' PHE . 18.6 mt -60.49 -23.89 29.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.982 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.62 -78.67 0.07 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.242 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.9 mm -51.8 -40.8 28.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.954 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.36 -68.65 0.19 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.617 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.501 ' HA ' HG23 ' A' ' 48' ' ' VAL . 3.7 tm-20 -35.82 -44.57 0.35 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.909 0.385 . . . . 0.0 110.965 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.47 -76.38 0.19 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.13 -1.033 . . . . 0.0 110.912 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.46 ' HA ' ' HB ' ' A' ' 56' ' ' THR . 14.7 pt20 -47.5 -12.07 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.501 HG23 ' HA ' ' A' ' 45' ' ' GLU . 43.6 t -74.96 -90.83 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.285 -179.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -162.39 124.23 2.71 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 119.903 -0.719 . . . . 0.0 112.916 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.644 ' HB ' ' O ' ' A' ' 53' ' ' ALA . 45.2 t -117.13 148.1 20.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 177.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -44.68 96.1 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.912 0.387 . . . . 0.0 111.343 -179.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.34 17.86 74.66 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.627 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.644 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -146.03 82.56 1.61 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.017 0.437 . . . . 0.0 112.063 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.476 HG13 ' O ' ' A' ' 54' ' ' VAL . 12.5 p -86.85 59.08 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 0.0 110.874 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.16 -168.64 1.56 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.684 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.46 ' HB ' ' HA ' ' A' ' 47' ' ' GLN . 12.2 t -151.66 44.12 0.75 Allowed 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.607 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -87.52 165.08 15.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.91 0.386 . . . . 0.0 111.292 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.2 -40.07 59.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.791 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -111.67 134.38 53.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.918 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . 0.41 ' O ' ' O ' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -107.44 115.17 29.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.36 179.782 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.53 76.49 5.07 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.129 0.49 . . . . 0.0 109.754 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.437 ' CG2' ' HG3' ' A' ' 66' ' ' GLN . 46.5 mt -139.2 153.32 24.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.43 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.44 ' CG1' ' HA ' ' A' ' 20' ' ' HIS . 4.3 m -155.26 175.42 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.663 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 78.33 -150.52 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 178.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.707 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -84.87 77.41 2.11 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.939 -179.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.437 ' HG3' ' CG2' ' A' ' 62' ' ' ILE . 22.0 mm100 -122.18 157.72 30.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.913 0.387 . . . . 0.0 111.491 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 25.1 m -118.58 156.72 28.66 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.673 0.619 . . . . 0.0 112.673 -178.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.579 HG11 ' CH2' ' A' ' 32' ' ' TRP . 1.2 t -137.34 149.37 25.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.891 179.11 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.582 ' HA ' ' O ' ' A' ' 73' ' ' HIS . 43.2 p -140.57 138.08 34.21 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.483 ' CE2' ' HA ' ' A' ' 41' ' ' ILE . 2.4 t80 -138.4 115.58 11.02 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.701 178.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 38.29 31.6 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 179.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 116.67 -7.61 17.58 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.334 -0.936 . . . . 0.0 113.619 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.582 ' O ' ' HA ' ' A' ' 69' ' ' SER . 0.9 OUTLIER -88.14 83.83 6.95 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 117.252 0.526 . . . . 0.0 110.882 -179.427 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.2 m -92.58 111.47 23.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.979 0.419 . . . . 0.0 110.942 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.51 ' HB ' ' HZ2' ' A' ' 32' ' ' TRP . 64.5 t -131.65 151.07 34.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.485 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.536 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 49.3 mt-30 -112.0 171.45 7.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.463 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.707 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 2.8 t -144.13 146.76 20.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.162 -178.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.0 m -136.38 170.44 18.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.838 0.351 . . . . 0.0 111.01 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.117 0 CA-C-O 118.214 -0.898 . . . . 0.0 111.068 179.881 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.167 0 N-CA-C 112.533 -0.227 . . . . 0.0 112.533 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.9 166.73 11.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.79 0.328 . . . . 0.0 110.853 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -103.99 -171.59 1.96 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.095 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.7 pp -138.39 25.81 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.335 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -90.56 -83.48 0.26 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.879 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -75.18 164.36 26.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.816 0.341 . . . . 0.0 110.725 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 65.44 88.87 0.1 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.734 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.4 m -63.48 145.97 54.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -90.03 139.29 30.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.803 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 8.3 mtt -89.88 176.9 6.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.342 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.492 ' O ' HG13 ' A' ' 75' ' ' VAL . . . -97.04 142.94 28.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.042 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.55 130.55 51.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.146 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.541 ' HZ ' HD11 ' A' ' 29' ' ' LEU . 15.2 t80 -106.78 96.65 6.59 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.106 -179.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.403 ' HA ' ' CG2' ' A' ' 78' ' ' VAL . 7.7 t -70.95 110.56 5.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.94 0.4 . . . . 0.0 111.083 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.438 HD11 HG11 ' A' ' 77' ' ' VAL . 13.8 mt -83.27 -31.55 26.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.555 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.05 -88.66 0.63 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.892 -0.671 . . . . 0.0 111.897 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.02 71.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.011 0.434 . . . . 0.0 110.886 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.446 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -117.43 172.18 4.24 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.38 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.592 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 38.0 Cg_endo -66.92 -41.56 9.97 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.054 1.836 . . . . 0.0 111.789 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.776 ' HA ' HG12 ' A' ' 63' ' ' VAL . 7.0 p80 170.68 -178.22 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.057 179.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.47 HG12 ' O ' ' A' ' 20' ' ' HIS . 10.8 m -149.17 169.23 2.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.604 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -97.62 146.99 24.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.988 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.529 HD12 ' N ' ' A' ' 24' ' ' CYS . 4.3 pp -42.65 -34.0 0.81 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.46 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.529 ' N ' HD12 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -65.74 -43.58 88.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.85 0.357 . . . . 0.0 110.566 179.928 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.552 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 0.5 OUTLIER -61.82 -60.11 4.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.195 179.33 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.462 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 1.9 tp -50.08 -47.92 53.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.404 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.716 HD12 ' HG2' ' A' ' 45' ' ' GLU . 9.2 mp -67.5 -61.9 1.68 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.683 -179.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -50.45 -54.43 22.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.002 -179.714 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.552 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 2.2 mt -56.8 -34.65 67.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.192 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 7.4 mm-40 -78.83 -15.13 58.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.408 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.33 22.23 22.68 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.421 -0.895 . . . . 0.0 113.104 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.627 ' CZ3' ' HB2' ' A' ' 73' ' ' HIS . 9.2 m95 -72.81 -70.49 0.35 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 117.09 0.445 . . . . 0.0 109.896 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.6 t -95.05 138.9 32.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.956 178.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -75.7 -34.17 60.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.885 0.374 . . . . 0.0 110.792 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.3 -28.8 10.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.045 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.47 -37.5 3.79 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.49 179.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.32 5.27 2.97 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 43.4 tp60 -58.45 -72.6 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.712 0.292 . . . . 0.0 111.716 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.75 15.5 0.5 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.5 mtmm 64.49 24.53 13.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.053 0.454 . . . . 0.0 110.479 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.417 HG23 HD23 ' A' ' 27' ' ' LEU . 51.4 mt -59.56 -17.83 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.698 179.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.446 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . . . -76.0 -77.91 0.12 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.042 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 13.1 mm -45.33 -45.7 3.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 121.078 0.466 . . . . 0.0 110.724 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.659 ' O ' ' HG3' ' A' ' 47' ' ' GLN . . . -57.82 -61.12 2.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.839 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.716 ' HG2' HD12 ' A' ' 27' ' ' LEU . 9.9 tp10 -35.9 -35.6 0.07 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.143 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.459 ' O ' ' N ' ' A' ' 48' ' ' VAL . . . -72.16 -72.68 0.91 Allowed Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.24 -0.981 . . . . 0.0 111.743 178.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.662 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 0.0 OUTLIER -39.93 -18.96 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -178.905 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.615 HG22 ' HA ' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -75.34 -85.74 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.763 -179.55 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -176.56 130.55 0.2 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.467 -0.493 . . . . 0.0 112.112 179.723 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.429 ' O ' ' N ' ' A' ' 52' ' ' GLY . 49.6 t -125.04 150.83 30.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.721 178.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.486 ' HB2' ' H ' ' A' ' 67' ' ' THR . 1.2 m-20 -65.96 70.65 0.06 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.944 0.402 . . . . 0.0 110.601 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 135.92 -18.51 3.79 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.387 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.66 135.02 47.43 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.009 0.433 . . . . 0.0 111.123 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.4 p -124.43 29.95 2.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.273 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -115.04 158.05 22.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.206 0.527 . . . . 0.0 111.495 -179.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.662 ' HB ' ' HB3' ' A' ' 47' ' ' GLN . 13.3 t -99.65 58.23 1.04 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.445 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 57' ' ' ARG . 14.6 mtt180 -89.13 171.81 9.54 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.785 0.326 . . . . 0.0 111.214 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.407 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -76.19 -48.24 21.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.23 179.655 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -122.4 154.82 37.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.035 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -136.91 119.19 15.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.899 0.38 . . . . 0.0 111.472 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.488 ' HG2' ' CD2' ' A' ' 20' ' ' HIS . 18.6 mttt -68.61 86.9 0.32 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.93 179.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 25.6 mt -134.54 139.98 46.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.955 0.407 . . . . 0.0 111.695 -179.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.776 HG12 ' HA ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -152.58 176.29 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.191 -179.649 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.497 ' HB1' ' O ' ' A' ' 63' ' ' VAL . . . 75.26 -154.38 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.55 179.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.575 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -84.5 78.65 1.99 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.826 -178.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -122.3 157.07 32.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.092 0.472 . . . . 0.0 111.268 -179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.554 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 1.9 m -113.25 155.5 24.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.311 -178.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.401 ' CG1' ' CH2' ' A' ' 32' ' ' TRP . 0.9 OUTLIER -125.33 139.72 50.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.55 179.228 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.406 ' O ' ' HB ' ' A' ' 48' ' ' VAL . 0.7 OUTLIER -133.99 128.88 35.29 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.232 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.615 ' HA ' HG22 ' A' ' 48' ' ' VAL . 2.9 t80 -146.77 126.5 13.44 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.641 179.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 46.13 -87.1 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.301 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -127.02 -8.73 4.5 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.889 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.627 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 1.8 m-70 -89.64 109.02 20.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.941 0.371 . . . . 0.0 111.471 -179.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.1 m -120.32 117.28 27.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.356 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.492 HG13 ' O ' ' A' ' 11' ' ' ALA . 19.5 t -140.54 159.49 24.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.58 -179.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.554 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 19.5 mt-30 -112.66 163.15 14.89 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.028 0.442 . . . . 0.0 111.485 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.575 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 15.0 t -132.08 147.78 32.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.266 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.403 ' CG2' ' HA ' ' A' ' 14' ' ' SER . 24.5 m -129.12 162.45 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 CA-C-O 120.864 0.364 . . . . 0.0 111.291 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.299 -0.858 . . . . 0.0 111.079 179.901 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.6 m -144.39 121.75 11.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.861 0.363 . . . . 0.0 110.983 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -163.67 149.75 11.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.707 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.415 ' N ' ' CD1' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -134.72 154.29 36.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.963 0.411 . . . . 0.0 111.454 -179.784 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -142.31 34.6 1.5 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.517 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.431 ' HD2' ' N ' ' A' ' 6' ' ' ARG . 1.7 mpt_? -67.79 104.51 1.69 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.311 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.2 ptp -83.31 -169.45 2.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.693 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.421 ' O ' ' CB ' ' A' ' 9' ' ' ASN . 1.4 t 59.92 170.93 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.726 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.421 ' CB ' ' O ' ' A' ' 8' ' ' SER . 1.7 m-20 83.33 -47.53 0.13 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.71 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -103.72 140.19 37.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.603 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.412 ' HB2' ' CG1' ' A' ' 75' ' ' VAL . . . -84.83 123.68 30.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.383 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.11 130.3 35.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.973 0.416 . . . . 0.0 111.046 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.484 ' HB2' ' CG ' ' A' ' 30' ' ' GLU . 13.6 t80 -107.07 144.66 33.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.312 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 74.7 m -106.82 149.82 26.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.46 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.464 ' HG ' HG13 ' A' ' 77' ' ' VAL . 55.2 mt -118.25 -40.06 2.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.833 0.349 . . . . 0.0 110.866 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.32 -102.93 2.99 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.245 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.7 pttt -143.1 43.65 1.55 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.964 0.411 . . . . 0.0 111.227 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.644 ' CG ' ' HD2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -101.64 154.45 37.27 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.194 179.536 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.644 ' HD2' ' CG ' ' A' ' 18' ' ' HIS . 9.3 Cg_endo -50.91 -32.4 37.67 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.581 2.187 . . . . 0.0 112.008 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.56 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 10.4 p80 159.62 -165.38 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.809 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.1 m -133.52 141.94 43.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.989 0.423 . . . . 0.0 111.233 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.619 ' HA ' ' H ' ' A' ' 60' ' ' CYS . 1.3 mp0 -81.28 148.07 29.61 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.822 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.485 ' O ' HD11 ' A' ' 27' ' ' LEU . 4.0 mp -38.7 -54.8 1.54 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.766 0.317 . . . . 0.0 111.39 -179.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.3 t -60.68 -29.06 69.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.417 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 22' ' ' GLU . 1.0 OUTLIER -72.74 -62.38 1.47 Allowed 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.76 0.314 . . . . 0.0 111.382 -179.716 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.441 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 4.9 tt -51.97 -48.84 64.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.266 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.526 HD12 ' HB3' ' A' ' 45' ' ' GLU . 5.4 mt -60.51 -57.76 11.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.556 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.6 ttpt -55.66 -54.46 43.99 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.769 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.25 -51.22 68.91 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -178.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.484 ' CG ' ' HB2' ' A' ' 13' ' ' PHE . 3.1 mm-40 -63.71 -15.44 58.49 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.56 25.54 15.47 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.267 -0.968 . . . . 0.0 113.341 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.599 ' CH2' HG12 ' A' ' 68' ' ' VAL . 12.4 m95 -74.14 -61.27 1.91 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-N 117.417 0.608 . . . . 0.0 109.552 178.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.0 t -106.79 140.52 39.51 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.495 179.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.61 -34.1 67.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.978 0.418 . . . . 0.0 110.171 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.54 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -105.77 -47.05 3.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.466 179.354 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 129.29 -30.82 3.57 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.303 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.96 6.7 3.4 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.54 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 19.1 tp60 -52.25 -75.01 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.857 0.361 . . . . 0.0 110.69 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.591 ' HB3' HD11 ' A' ' 41' ' ' ILE . . . -79.96 15.35 1.48 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.562 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.1 mmtt 64.61 29.4 13.06 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 121.142 0.496 . . . . 0.0 110.283 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.624 ' HA ' ' CE2' ' A' ' 70' ' ' PHE . 2.5 mp -63.4 -24.31 35.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.0 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.56 -78.97 0.05 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.383 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.4 mm -50.54 -42.64 22.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.946 0.403 . . . . 0.0 110.832 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.506 ' HA ' HE21 ' A' ' 47' ' ' GLN . . . -58.06 -68.86 0.21 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.165 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.526 ' HB3' HD12 ' A' ' 27' ' ' LEU . 1.6 tm-20 -33.88 -42.18 0.11 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.944 0.402 . . . . 0.0 111.087 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.451 ' C ' ' H ' ' A' ' 48' ' ' VAL . . . -60.15 -72.64 0.59 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.348 178.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.547 ' CA ' ' HB ' ' A' ' 56' ' ' THR . 9.3 pt20 -49.84 -8.57 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.515 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 60.0 t -74.87 -90.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.293 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.515 ' HG2' ' O ' ' A' ' 48' ' ' VAL . 0.5 OUTLIER -171.18 133.97 0.89 Allowed 'General case' 0 C--O 1.232 0.132 0 C-N-CA 120.432 -0.507 . . . . 0.0 111.744 179.559 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.516 HG22 HG23 ' A' ' 68' ' ' VAL . 21.9 t -130.41 147.44 33.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.819 178.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.413 ' HB2' ' H ' ' A' ' 67' ' ' THR . 0.5 OUTLIER -63.53 79.83 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.08 0.466 . . . . 0.0 110.51 -179.888 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 125.52 -13.68 7.33 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.583 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -135.96 135.45 39.58 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.965 0.412 . . . . 0.0 111.17 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.451 HG22 ' O ' ' A' ' 54' ' ' VAL . 10.5 p -125.55 31.19 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.886 178.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -104.71 -150.46 0.43 Allowed 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.799 -178.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.547 ' HB ' ' CA ' ' A' ' 47' ' ' GLN . 4.5 t -169.89 67.4 0.05 Allowed 'General case' 0 C--O 1.232 0.147 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.95 174.15 7.23 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.46 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -75.12 -46.43 34.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.014 0.435 . . . . 0.0 110.224 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.431 ' O ' ' HG2' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -101.87 131.9 47.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.045 179.167 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . 0.619 ' H ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -100.08 115.61 30.18 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.979 0.419 . . . . 0.0 111.217 -179.449 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.458 ' HG3' ' NE2' ' A' ' 20' ' ' HIS . 0.1 OUTLIER -94.55 74.86 3.78 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.783 179.207 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.402 HG22 ' N ' ' A' ' 63' ' ' VAL . 36.6 mt -133.65 142.09 42.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.061 0.458 . . . . 0.0 111.578 -178.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.429 HG11 ' O ' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -150.77 175.96 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.606 -179.908 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.416 ' CB ' ' O ' ' A' ' 63' ' ' VAL . . . 81.09 -154.29 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.513 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -93.7 79.02 1.03 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.631 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -122.63 162.22 22.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.147 0.498 . . . . 0.0 111.34 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.651 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 25.8 m -113.85 156.57 23.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.851 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.599 HG12 ' CH2' ' A' ' 32' ' ' TRP . 0.9 OUTLIER -131.75 146.04 34.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.005 179.335 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 60.0 p -143.66 139.13 29.41 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 120.907 0.384 . . . . 0.0 111.727 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.624 ' CE2' ' HA ' ' A' ' 41' ' ' ILE . 0.8 OUTLIER -128.48 -86.24 0.56 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.28 179.983 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -139.63 88.56 2.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.743 0.306 . . . . 0.0 110.464 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.17 -25.5 6.93 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.441 -0.885 . . . . 0.0 111.444 -178.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.593 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 0.9 OUTLIER -93.06 109.02 20.49 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 120.791 0.329 . . . . 0.0 110.914 -179.758 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.9 m -120.23 98.48 6.08 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.579 ' HB ' ' HZ2' ' A' ' 32' ' ' TRP . 38.9 t -120.32 151.16 23.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.475 -178.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.651 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 30.0 mt-30 -112.45 164.38 13.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.642 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.464 HG13 ' HG ' ' A' ' 15' ' ' LEU . 10.7 t -132.47 146.52 32.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.065 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 17.9 m -139.89 169.5 16.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.886 0.374 . . . . 0.0 111.144 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.181 -0.914 . . . . 0.0 111.071 179.863 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 112.843 -0.103 . . . . 0.0 112.843 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 m -155.73 124.46 6.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.758 0.313 . . . . 0.0 110.834 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.4 mtm -163.9 72.85 0.27 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.959 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.42 ' O ' HG13 ' A' ' 4' ' ' ILE . 1.1 tp -116.49 -22.93 4.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.523 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 71.57 96.19 0.07 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.886 0.374 . . . . 0.0 110.876 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.8 mtm180 59.1 110.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.02 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.54 -42.28 16.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.661 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.8 m -132.55 164.5 26.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.735 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -130.35 119.41 22.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.95 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 36.9 mtt -79.5 112.83 17.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.944 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.507 ' O ' HG12 ' A' ' 75' ' ' VAL . . . -85.01 138.46 32.43 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.65 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.69 135.46 53.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.464 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -124.83 98.57 5.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.886 0.374 . . . . 0.0 110.87 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.75 141.5 57.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.721 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -90.93 -36.89 13.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.633 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.26 -81.3 1.06 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.574 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.7 ttmm -171.44 39.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.887 0.375 . . . . 0.0 110.85 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.629 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 6.1 m-70 -98.67 165.1 15.7 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.713 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.629 ' HD2' ' HB3' ' A' ' 18' ' ' HIS . 42.2 Cg_endo -66.79 -37.3 21.07 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.272 1.982 . . . . 0.0 111.935 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.525 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 6.3 p80 172.71 -172.14 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.022 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.491 ' CG2' HD11 ' A' ' 26' ' ' LEU . 2.5 m -136.26 151.9 29.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.091 0.472 . . . . 0.0 112.255 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.423 ' O ' ' N ' ' A' ' 25' ' ' ASP . 2.5 mp0 -95.01 148.3 22.48 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.464 178.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.424 HD22 ' HA2' ' A' ' 46' ' ' GLY . 0.5 OUTLIER -40.7 -47.94 2.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.743 0.306 . . . . 0.0 111.636 -179.492 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -62.78 -34.72 77.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.877 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 22' ' ' GLU . 8.7 m-20 -64.75 -62.2 1.72 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.046 0.45 . . . . 0.0 110.433 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.633 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 0.9 OUTLIER -50.64 -46.0 58.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.148 179.909 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.491 ' HA ' ' CG ' ' A' ' 32' ' ' TRP . 9.8 mt -67.07 -59.37 3.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.915 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.18 -58.59 7.31 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.423 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.2 OUTLIER -53.9 -45.49 71.12 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.677 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.633 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 4.3 mm-40 -72.55 -14.62 61.68 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.09 25.34 12.93 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.192 -1.004 . . . . 0.0 113.332 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.627 ' CH2' HG12 ' A' ' 68' ' ' VAL . 12.4 m95 -73.47 -58.6 3.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.041 0.448 . . . . 0.0 110.013 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.415 ' HA ' HD13 ' A' ' 41' ' ' ILE . 2.1 t -106.1 133.7 50.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.513 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -64.67 -34.12 77.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.608 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.412 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 56.2 p -105.83 -49.2 3.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.734 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 133.91 -32.54 2.66 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.764 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.23 6.57 1.73 Allowed 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.412 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 69.7 tp60 -54.61 -71.83 0.07 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.956 0.408 . . . . 0.0 110.852 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.05 15.22 1.17 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.465 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.457 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 0.0 OUTLIER 65.38 20.84 11.86 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.629 -179.53 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.536 ' HA ' ' CE2' ' A' ' 70' ' ' PHE . 37.5 mt -54.88 -25.89 16.4 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-O 121.01 0.433 . . . . 0.0 110.712 179.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.479 ' HA ' ' CD1' ' A' ' 27' ' ' LEU . . . -67.72 -79.34 0.05 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.164 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 44.6 mm -51.2 -39.17 20.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.199 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.457 ' HB1' ' O ' ' A' ' 40' ' ' LYS . . . -58.04 -68.88 0.21 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.238 179.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.482 ' HA ' ' HB2' ' A' ' 70' ' ' PHE . 0.9 OUTLIER -33.42 -41.9 0.09 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.749 179.741 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.424 ' HA2' HD22 ' A' ' 23' ' ' LEU . . . -57.44 -74.72 0.31 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.034 -1.079 . . . . 0.0 110.553 178.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.51 ' HA ' HG21 ' A' ' 56' ' ' THR . 13.8 pt20 -48.06 -12.84 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.464 HG23 ' CD1' ' A' ' 70' ' ' PHE . 58.7 t -75.02 -93.63 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.969 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.468 ' HD3' ' HB ' ' A' ' 54' ' ' VAL . 4.6 mmtt -166.92 124.89 1.32 Allowed 'General case' 0 C--O 1.23 0.065 0 C-N-CA 120.151 -0.619 . . . . 0.0 112.368 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.494 ' HB ' ' O ' ' A' ' 53' ' ' ALA . 12.8 t -118.11 149.17 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 177.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -45.07 100.47 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.025 0.44 . . . . 0.0 111.534 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 66.95 17.3 67.43 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.857 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.494 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -145.98 82.71 1.62 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.922 0.391 . . . . 0.0 111.945 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.468 ' HB ' ' HD3' ' A' ' 49' ' ' LYS . 14.0 p -90.66 65.44 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.912 0.387 . . . . 0.0 110.582 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -99.83 -173.5 2.47 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.511 -179.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.51 HG21 ' HA ' ' A' ' 47' ' ' GLN . 0.8 OUTLIER -140.83 32.59 1.79 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.149 -179.708 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 19.4 mtp180 -84.74 169.13 14.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.062 0.458 . . . . 0.0 111.503 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.17 -32.01 55.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.915 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.2 mtt85 -131.76 146.54 52.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.654 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -129.51 115.89 18.13 Favored 'General case' 0 C--O 1.23 0.078 0 CA-C-O 120.89 0.376 . . . . 0.0 111.328 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.412 ' HG2' ' CD2' ' A' ' 20' ' ' HIS . 6.3 mttt -76.1 91.91 3.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.352 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 39.8 mt -133.77 139.72 48.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.265 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.476 HG11 ' O ' ' A' ' 19' ' ' PRO . 2.5 m -146.23 175.2 2.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.119 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 74.98 -143.51 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.965 178.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -93.13 80.49 1.08 Allowed Glycine 0 C--N 1.336 0.552 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.766 -179.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -121.92 175.17 6.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.819 0.342 . . . . 0.0 111.228 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.415 ' OG1' ' HG3' ' A' ' 76' ' ' GLN . 27.1 m -135.85 151.14 49.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.008 -178.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.627 HG12 ' CH2' ' A' ' 32' ' ' TRP . 1.2 t -130.5 144.13 38.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.309 179.135 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 67.8 m -140.99 141.23 34.4 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -178.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.536 ' CE2' ' HA ' ' A' ' 41' ' ' ILE . 1.9 t80 -146.08 122.28 10.85 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.273 179.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 49.78 -83.47 0.01 OUTLIER 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.481 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -127.46 -5.09 5.62 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.963 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.527 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 0.8 OUTLIER -89.46 113.79 25.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 117.01 0.405 . . . . 0.0 111.592 -179.027 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.61 111.35 17.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.285 178.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.568 ' HB ' ' HZ2' ' A' ' 32' ' ' TRP . 41.1 t -132.39 151.61 35.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.817 0.342 . . . . 0.0 111.488 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.415 ' HG3' ' OG1' ' A' ' 67' ' ' THR . 24.5 mp0 -113.2 159.53 19.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.423 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.452 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 6.3 t -125.07 138.7 53.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.084 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.1 m -133.88 154.54 38.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.014 0.435 . . . . 0.0 111.871 -179.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.058 179.948 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.152 0 N-CA-C 112.565 -0.214 . . . . 0.0 112.565 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 p -154.89 140.94 18.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.793 0.33 . . . . 0.0 110.911 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.26 -33.59 16.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.886 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.6 mt -79.32 125.99 38.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.072 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -168.68 -169.97 1.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.626 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 24.2 mtp180 -82.13 -31.4 30.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.84 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.18 175.4 9.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.834 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 m -139.59 123.18 17.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.037 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -71.38 84.64 0.8 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.553 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -93.35 77.19 4.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.705 -179.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.28 129.62 34.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.296 179.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.63 132.99 41.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.021 0.439 . . . . 0.0 110.902 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.521 ' CG ' HD13 ' A' ' 26' ' ' LEU . 16.8 t80 -99.72 98.24 9.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.967 179.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.411 ' HA ' HG21 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -77.18 98.98 5.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.764 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.9 mt -55.83 -34.14 65.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.985 0.421 . . . . 0.0 110.542 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.54 42.49 7.82 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.005 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt 61.3 39.38 15.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.981 0.419 . . . . 0.0 110.631 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.417 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 3.6 m170 -95.15 165.73 16.3 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.897 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.425 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 14.8 Cg_endo -56.99 -63.63 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.672 2.248 . . . . 0.0 112.612 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.425 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 8.5 p80 178.51 -174.05 0.16 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.241 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.579 HG22 HD12 ' A' ' 26' ' ' LEU . 17.8 m -149.93 167.07 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -103.71 153.39 20.72 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.253 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 81.6 mt -41.65 -45.55 3.44 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.0 t -65.37 -39.12 91.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.721 0.296 . . . . 0.0 111.671 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -62.12 -62.31 1.86 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.593 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.579 HD12 HG22 ' A' ' 21' ' ' VAL . 2.3 tp -53.69 -41.92 67.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.474 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.519 ' HG ' ' CE3' ' A' ' 32' ' ' TRP . 8.0 mp -66.81 -64.7 0.8 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.382 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -51.26 -57.0 10.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.988 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 24.9 mt -53.65 -31.02 45.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.079 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.45 ' HB2' ' CD1' ' A' ' 32' ' ' TRP . 2.4 mm-40 -84.05 -13.61 52.71 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.55 18.0 34.36 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.365 -0.922 . . . . 0.0 112.685 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.519 ' CE3' ' HG ' ' A' ' 27' ' ' LEU . 9.4 m0 -69.58 -60.81 2.09 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.1 t -106.83 134.04 50.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.99 179.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -63.95 -34.83 78.87 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.856 0.36 . . . . 0.0 111.048 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.536 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 79.0 p -106.25 -51.56 2.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.138 0.494 . . . . 0.0 110.225 178.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 139.29 -37.62 1.74 Allowed Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.3 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.03 11.25 3.33 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.536 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 3.4 tp-100 -63.11 -66.65 0.51 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.761 0.315 . . . . 0.0 110.777 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.29 14.41 0.94 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.727 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 46.0 mmtt 65.4 25.48 11.99 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.832 0.349 . . . . 0.0 110.745 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.506 ' HA ' ' CE2' ' A' ' 70' ' ' PHE . 5.3 mt -63.09 -27.12 42.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.267 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.84 -78.51 0.06 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.836 0.35 . . . . 0.0 110.577 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.6 mm -46.51 -35.81 2.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 121.104 0.478 . . . . 0.0 110.249 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.521 ' O ' ' HG3' ' A' ' 47' ' ' GLN . . . -63.8 -62.61 1.54 Allowed 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.657 178.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.464 ' HB2' ' CD2' ' A' ' 27' ' ' LEU . 16.3 tp10 -32.35 -41.84 0.06 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.823 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.8 -71.6 0.92 Allowed Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.355 -0.926 . . . . 0.0 111.743 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.521 ' HG3' ' O ' ' A' ' 44' ' ' ALA . 0.7 OUTLIER -43.69 -19.54 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.726 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.468 HG23 ' CD1' ' A' ' 70' ' ' PHE . 21.5 t -75.85 -85.05 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.945 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -170.36 133.17 1.05 Allowed 'General case' 0 C--O 1.23 0.055 0 CA-C-O 120.804 0.335 . . . . 0.0 111.138 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.428 ' O ' ' N ' ' A' ' 52' ' ' GLY . 4.4 t -134.62 144.19 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.056 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 67' ' ' THR . 6.0 t70 -48.74 91.25 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.75 0.31 . . . . 0.0 111.442 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 94.27 -7.4 72.3 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.875 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.0 131.33 47.39 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 117.323 0.562 . . . . 0.0 111.187 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.5 p -124.84 32.51 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.861 178.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -101.99 154.64 18.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.936 -178.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.504 ' HB ' ' HB3' ' A' ' 47' ' ' GLN . 12.1 t -92.88 46.84 1.24 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.643 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.68 169.98 17.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.187 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.09 -32.25 20.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.125 0.488 . . . . 0.0 109.819 178.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 36.2 mtm180 -128.38 151.94 48.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.991 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . 0.404 ' HB3' HD12 ' A' ' 62' ' ' ILE . 18.4 t -136.94 117.29 13.62 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.827 0.346 . . . . 0.0 111.105 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.02 99.0 2.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.394 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.404 HD12 ' HB3' ' A' ' 60' ' ' CYS . 1.5 mt -133.36 142.65 41.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.151 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.6 m -147.54 170.71 3.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.39 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 72.34 -155.5 0.09 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.387 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.547 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -87.17 82.96 1.59 Allowed Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 121.516 -0.373 . . . . 0.0 112.285 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.442 ' HB3' ' CB ' ' A' ' 51' ' ' ASP . 5.0 mm100 -121.48 160.91 23.21 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.972 0.415 . . . . 0.0 111.577 -178.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 0.2 OUTLIER -116.23 149.07 39.76 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.551 -178.498 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.46 HG12 ' CH2' ' A' ' 32' ' ' TRP . 1.1 t -125.88 142.47 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.651 179.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.2 m -138.14 133.53 33.47 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -178.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.52 ' O ' ' N ' ' A' ' 72' ' ' GLY . 1.9 t80 -144.05 122.57 12.45 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.1 178.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 47.21 -85.5 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.724 0.297 . . . . 0.0 111.535 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -127.31 -4.89 5.75 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.037 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.462 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 1.8 m-70 -92.75 110.1 21.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.025 0.413 . . . . 0.0 111.3 -179.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.0 m -120.69 125.16 46.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.278 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.0 t -147.23 160.64 8.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.808 0.337 . . . . 0.0 111.564 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.485 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 35.8 mt-30 -112.41 164.02 13.75 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.949 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.547 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 16.9 t -137.13 147.12 27.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.658 -179.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.417 ' N ' HG12 ' A' ' 77' ' ' VAL . 17.0 m -134.22 178.01 6.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 120.718 0.294 . . . . 0.0 110.624 178.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.331 -0.842 . . . . 0.0 111.098 -179.978 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.602 ' HB1' HG13 ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.456 -0.174 0 CA-C-O 120.687 0.28 . . . . 0.0 111.095 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.3 123.23 26.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.895 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.896 ' HB3' HG22 ' A' ' 77' ' ' VAL . 50.0 t80 -100.87 152.82 20.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.911 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.83 153.46 21.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.101 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.925 ' HB2' ' HB2' ' A' ' 79' ' ' ALA . 9.3 mt -129.32 -40.16 1.47 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.785 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.44 -111.54 3.63 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.73 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.86 57.4 1.35 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.114 0.483 . . . . 0.0 110.624 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.671 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 2.3 m-70 -110.04 165.84 11.9 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.567 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.671 ' HD2' ' HB3' ' A' ' 18' ' ' HIS . 31.2 Cg_endo -62.64 -41.25 32.53 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.098 1.866 . . . . 0.0 111.863 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.572 ' HA ' ' CG1' ' A' ' 63' ' ' VAL . 21.5 p80 171.38 -170.36 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.721 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.6 m -145.78 158.99 12.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.236 0.541 . . . . 0.0 112.365 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.574 ' HG3' ' HA ' ' A' ' 59' ' ' ARG . 8.2 tt0 -88.78 139.21 30.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.848 178.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.781 HD12 ' N ' ' A' ' 24' ' ' CYS . 4.1 pp -42.45 -30.48 0.34 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.781 0.324 . . . . 0.0 111.404 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.781 ' N ' HD12 ' A' ' 23' ' ' LEU . 3.5 t -72.47 -40.17 67.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.977 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.401 ' N ' ' O ' ' A' ' 22' ' ' GLU . 1.9 m-20 -65.74 -53.73 36.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.938 0.399 . . . . 0.0 110.702 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.871 HD11 HG21 ' A' ' 77' ' ' VAL . 10.1 tt -54.75 -48.72 72.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.825 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.872 HD23 HG22 ' A' ' 41' ' ' ILE . 8.9 mp -65.76 -63.03 1.18 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.648 -178.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.0 tmmm? -43.84 -59.43 2.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.023 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.483 ' HB3' ' CE1' ' A' ' 13' ' ' PHE . 0.5 OUTLIER -56.13 -47.5 78.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.226 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.629 ' CD ' HG11 ' A' ' 75' ' ' VAL . 2.3 mm-40 -62.11 -15.21 43.84 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.681 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.04 24.68 14.34 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.321 -0.942 . . . . 0.0 113.253 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.649 ' CH2' HG12 ' A' ' 68' ' ' VAL . 7.8 m0 -79.09 -63.88 1.32 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.248 0.524 . . . . 0.0 109.988 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.54 ' CB ' HD12 ' A' ' 41' ' ' ILE . 3.9 t -106.72 135.37 48.37 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.778 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.41 -33.36 71.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.827 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.7 p -104.67 -40.46 5.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.493 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 121.83 -30.74 5.2 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.027 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -138.31 5.93 2.53 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.701 0.259 . . . . 0.0 111.701 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 21.5 tp60 -54.91 -74.69 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.859 0.362 . . . . 0.0 110.952 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.464 ' HB3' HG13 ' A' ' 41' ' ' ILE . . . -74.62 15.68 0.34 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.77 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.4 mttm 64.48 24.57 13.15 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 120.961 0.41 . . . . 0.0 110.073 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.872 HG22 HD23 ' A' ' 27' ' ' LEU . 16.9 mt -63.71 -18.92 23.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.708 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.659 ' HB1' HD11 ' A' ' 23' ' ' LEU . . . -74.11 -79.14 0.09 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.93 0.395 . . . . 0.0 110.663 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 29.4 mm -46.61 -45.01 6.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.674 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.658 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -54.33 -68.14 0.21 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.91 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.617 ' HA ' ' HB2' ' A' ' 70' ' ' PHE . 6.6 tp10 -32.66 -45.14 0.12 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.604 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 55' ' ' GLU . . . -57.84 -74.37 0.35 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 119.875 -1.155 . . . . 0.0 110.637 178.051 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.564 ' CA ' ' HB ' ' A' ' 56' ' ' THR . 4.4 pt20 -46.33 -14.62 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.755 HG21 ' HD1' ' A' ' 70' ' ' PHE . 56.0 t -74.92 -88.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.116 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -172.84 128.87 0.5 Allowed 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.828 0.346 . . . . 0.0 111.019 179.221 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.574 ' HB ' ' HB3' ' A' ' 53' ' ' ALA . 44.7 t -124.29 149.48 28.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.591 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -55.66 85.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.132 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 106.78 -6.15 37.62 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.115 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.574 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . . . -133.75 135.42 43.92 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 117.148 0.474 . . . . 0.0 111.267 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.497 HG22 ' O ' ' A' ' 54' ' ' VAL . 12.1 p -125.42 38.13 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.306 178.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.488 ' HB3' ' H ' ' A' ' 56' ' ' THR . 7.6 mt-10 -106.94 -151.39 0.46 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.211 -0.449 . . . . 0.0 112.171 -178.12 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.564 ' HB ' ' CA ' ' A' ' 47' ' ' GLN . 3.5 t -166.96 57.3 0.08 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.927 0.394 . . . . 0.0 111.469 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.2 mtt-85 -86.29 175.29 8.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.019 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.21 -47.53 27.82 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.574 ' HA ' ' HG3' ' A' ' 22' ' ' GLU . 3.8 mtm180 -115.21 153.09 31.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.237 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -125.68 137.22 53.84 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.928 0.394 . . . . 0.0 111.231 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.508 ' HG3' ' CD2' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -99.98 77.59 2.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.441 179.485 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.3 mt -133.9 144.49 35.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.42 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.572 ' CG1' ' HA ' ' A' ' 20' ' ' HIS . 6.5 m -150.28 175.64 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.183 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.676 ' HA ' ' HB3' ' A' ' 79' ' ' ALA . . . 74.4 -150.39 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.082 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.641 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -84.93 77.74 2.08 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.319 -0.467 . . . . 0.0 112.963 -178.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 18.3 mm100 -122.09 158.71 28.66 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.859 0.361 . . . . 0.0 110.979 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.624 HG23 ' O ' ' A' ' 75' ' ' VAL . 26.9 m -117.15 154.64 30.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.141 0.496 . . . . 0.0 112.251 -178.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.649 HG12 ' CH2' ' A' ' 32' ' ' TRP . 0.7 OUTLIER -127.37 143.25 41.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.44 178.995 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 36.8 m -136.66 132.82 35.5 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -178.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.755 ' HD1' HG21 ' A' ' 48' ' ' VAL . 1.4 t80 -141.95 122.77 14.39 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.336 178.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 46.67 -87.01 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.687 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -126.66 -6.06 5.69 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.858 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.403 ' O ' ' CH2' ' A' ' 32' ' ' TRP . 1.0 OUTLIER -90.61 103.59 16.27 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.793 0.33 . . . . 0.0 111.042 -179.464 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.3 m -114.65 125.57 53.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.602 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.641 ' HB ' ' HZ2' ' A' ' 32' ' ' TRP . 47.0 t -145.59 153.58 13.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.23 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.487 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 3.1 mp0 -112.25 158.28 19.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.813 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.896 HG22 ' HB3' ' A' ' 13' ' ' PHE . 46.9 t -129.2 152.22 36.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.813 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.2 m -130.89 148.97 33.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.921 0.391 . . . . 0.0 111.53 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.925 ' HB2' ' HB2' ' A' ' 15' ' ' LEU . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.077 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.534 ' HB3' HG13 ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.456 -0.132 0 CA-C-O 120.898 0.38 . . . . 0.0 111.166 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.64 132.26 48.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.592 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.813 ' HB3' HG22 ' A' ' 77' ' ' VAL . 77.8 t80 -110.04 148.57 31.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.923 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.5 146.9 30.02 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.809 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.663 HD21 HG11 ' A' ' 77' ' ' VAL . 27.8 mt -114.23 -40.45 3.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.921 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.65 -103.75 2.89 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.585 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.06 56.62 0.9 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.995 0.426 . . . . 0.0 111.011 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.421 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 1.0 OUTLIER -113.36 167.33 9.49 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.578 179.863 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.59 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 19.4 Cg_endo -59.8 -33.55 96.12 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.3 2.0 . . . . 0.0 111.665 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.59 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 14.1 p80 163.01 -164.32 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.989 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.579 HG21 HD13 ' A' ' 26' ' ' LEU . 4.9 m -142.92 153.91 17.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.139 0.495 . . . . 0.0 112.004 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.459 ' HG3' ' CB ' ' A' ' 59' ' ' ARG . 0.7 OUTLIER -83.53 138.34 33.46 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.907 179.019 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.718 HD12 ' N ' ' A' ' 24' ' ' CYS . 4.6 pp -41.03 -33.27 0.31 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.764 0.316 . . . . 0.0 111.478 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.718 ' N ' HD12 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -71.3 -39.15 71.63 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.988 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 22' ' ' GLU . 78.8 m-20 -62.73 -52.27 63.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.05 0.452 . . . . 0.0 110.442 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.754 HD21 HG21 ' A' ' 77' ' ' VAL . 8.4 tp -58.23 -46.5 85.8 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.893 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.803 HD23 HG22 ' A' ' 41' ' ' ILE . 5.6 mp -67.33 -60.69 2.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.651 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -46.53 -65.26 0.58 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.752 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.57 -41.61 63.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.212 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 2.9 mm-40 -72.27 -15.3 61.91 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.19 26.26 12.71 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.475 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.561 ' CH2' HG12 ' A' ' 68' ' ' VAL . 9.4 m95 -76.39 -66.04 0.85 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 117.094 0.447 . . . . 0.0 110.079 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.0 t -101.0 149.29 24.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.315 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.32 -34.08 36.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.04 0.448 . . . . 0.0 110.489 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.78 -31.95 8.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.585 179.231 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 126.08 -60.22 0.65 Allowed Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.346 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -129.32 7.59 5.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.789 0.328 . . . . 0.0 111.281 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -54.21 -64.38 0.85 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.872 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.514 ' HB3' ' CD1' ' A' ' 41' ' ' ILE . . . -74.19 15.08 0.35 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -179.202 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.1 mmmt 72.24 14.14 5.58 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.622 0.249 . . . . 0.0 111.206 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.803 HG22 HD23 ' A' ' 27' ' ' LEU . 6.8 mt -65.5 -14.99 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-O 120.969 0.414 . . . . 0.0 110.739 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.533 ' HA ' HD13 ' A' ' 23' ' ' LEU . . . -72.21 -79.81 0.07 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.047 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 19.8 mm -52.33 -33.13 16.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.985 0.421 . . . . 0.0 110.51 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.789 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -63.09 -72.18 0.14 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.683 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.747 ' HG3' HD11 ' A' ' 27' ' ' LEU . 3.6 tm-20 -35.35 -41.09 0.16 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.838 0.352 . . . . 0.0 111.157 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.41 ' C ' ' H ' ' A' ' 48' ' ' VAL . . . -63.04 -73.8 0.49 Allowed Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.277 -0.964 . . . . 0.0 110.928 178.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.458 ' HG3' ' O ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -47.96 -9.52 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -179.62 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.789 HG23 ' O ' ' A' ' 44' ' ' ALA . 57.4 t -74.66 -90.67 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.644 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.625 ' HD3' ' HB ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -167.02 119.37 0.95 Allowed 'General case' 0 CA--C 1.527 0.08 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.73 179.694 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.544 ' HB ' ' O ' ' A' ' 53' ' ' ALA . 19.2 t -113.62 154.98 14.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.098 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.644 ' HB2' ' H ' ' A' ' 67' ' ' THR . 16.8 t0 -44.7 98.2 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.017 0.437 . . . . 0.0 111.611 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.93 21.43 61.18 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.339 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.544 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -145.79 79.87 1.57 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.021 0.439 . . . . 0.0 111.766 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.625 ' HB ' ' HD3' ' A' ' 49' ' ' LYS . 14.9 p -88.21 62.76 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.926 0.393 . . . . 0.0 111.044 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.42 178.4 4.65 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.297 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.8 t -139.31 40.59 2.08 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.801 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -86.91 174.39 8.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.693 0.282 . . . . 0.0 111.01 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.1 mttp -75.18 -50.27 16.8 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.965 0.412 . . . . 0.0 110.806 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.459 ' CB ' ' HG3' ' A' ' 22' ' ' GLU . 0.3 OUTLIER -106.4 136.88 45.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.27 179.402 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -100.04 115.58 30.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.949 0.404 . . . . 0.0 111.031 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.586 ' O ' HD13 ' A' ' 62' ' ' ILE . 4.7 mtmt -87.12 76.01 9.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.881 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.586 HD13 ' O ' ' A' ' 61' ' ' LYS . 3.5 mm -133.44 142.39 41.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.981 -179.06 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.534 ' O ' ' HB3' ' A' ' 64' ' ' ALA . 1.4 m -146.85 175.2 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.724 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 74.48 -155.01 0.05 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.313 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.528 ' HA2' HG12 ' A' ' 78' ' ' VAL . . . -84.73 81.13 1.77 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 121.329 -0.462 . . . . 0.0 112.515 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.508 ' HG3' HG22 ' A' ' 62' ' ' ILE . 7.9 mm-40 -122.05 156.46 33.49 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.111 0.481 . . . . 0.0 111.264 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.644 ' H ' ' HB2' ' A' ' 51' ' ' ASP . 0.8 OUTLIER -113.55 152.9 29.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.752 -179.109 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.561 HG12 ' CH2' ' A' ' 32' ' ' TRP . 0.8 OUTLIER -127.34 147.07 32.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.645 179.237 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.4 m -143.16 137.8 29.31 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -178.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.783 ' CD1' HG21 ' A' ' 48' ' ' VAL . 1.6 t80 -144.91 121.66 11.2 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.084 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 48.72 -85.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.689 0.28 . . . . 0.0 111.347 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -126.77 -5.72 5.75 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.786 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.438 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 1.1 m-70 -88.39 104.4 16.74 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.888 0.344 . . . . 0.0 111.084 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -116.9 106.72 13.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.838 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.534 HG13 ' HB3' ' A' ' 11' ' ' ALA . 38.6 t -126.17 155.94 36.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.017 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.542 ' CG ' HG23 ' A' ' 67' ' ' THR . 1.3 mt-30 -112.33 158.02 20.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.012 0.434 . . . . 0.0 111.058 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.813 HG22 ' HB3' ' A' ' 13' ' ' PHE . 29.0 t -140.39 148.0 22.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.329 -179.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.528 HG12 ' HA2' ' A' ' 65' ' ' GLY . 17.0 m -139.92 178.03 3.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.707 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.073 -179.902 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.874 ' HB1' HG13 ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.452 -0.34 0 CA-C-O 120.754 0.312 . . . . 0.0 111.036 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.5 112.23 7.88 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.474 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.848 ' HB3' HG22 ' A' ' 77' ' ' VAL . 73.8 t80 -98.67 144.13 28.28 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.002 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.4 m -107.02 135.72 48.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.478 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.729 HD22 ' HB2' ' A' ' 18' ' ' HIS . 0.5 OUTLIER -84.91 -33.18 22.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.849 0.357 . . . . 0.0 110.529 179.698 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.59 33.07 28.83 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.291 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 25.5 mttm 58.73 56.14 4.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.069 0.461 . . . . 0.0 110.764 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.729 ' HB2' HD22 ' A' ' 15' ' ' LEU . 12.9 m170 -115.36 166.14 12.68 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.867 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.577 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 23.8 Cg_endo -60.97 -36.94 80.48 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.386 2.057 . . . . 0.0 112.151 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.577 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 22.4 p80 168.14 -174.6 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.406 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.551 HG13 HD21 ' A' ' 15' ' ' LEU . 2.5 m -140.96 160.44 23.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.189 0.519 . . . . 0.0 111.975 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.42 ' O ' ' N ' ' A' ' 25' ' ' ASP . 0.5 OUTLIER -94.26 141.76 28.19 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.038 179.351 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.621 ' O ' HD13 ' A' ' 27' ' ' LEU . 8.1 mt -38.08 -39.28 0.39 Allowed 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -73.4 -37.59 65.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.387 -179.396 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 22' ' ' GLU . 56.6 m-20 -61.62 -54.52 41.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.06 0.457 . . . . 0.0 111.074 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.049 HD11 HG21 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -60.06 -43.31 95.52 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.658 -179.546 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.902 HD23 HG22 ' A' ' 41' ' ' ILE . 6.7 mp -68.33 -56.87 7.05 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.701 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -56.95 -55.87 29.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.859 0.362 . . . . 0.0 111.216 -179.597 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 81.9 mt -53.41 -37.73 62.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.685 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.487 ' OE1' HG11 ' A' ' 75' ' ' VAL . 8.7 mm-40 -79.08 -11.33 59.99 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.12 22.9 23.92 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.366 -0.921 . . . . 0.0 113.226 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.528 ' CH2' HG12 ' A' ' 68' ' ' VAL . 11.9 m95 -73.97 -63.21 1.27 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.008 0.432 . . . . 0.0 109.96 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.1 t -106.95 135.19 48.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.915 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -74.43 -34.69 63.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.022 0.439 . . . . 0.0 110.247 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.0 p -106.4 -44.76 4.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.268 178.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 112.74 -21.82 17.94 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.987 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -128.63 -1.24 5.47 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 111.709 0.262 . . . . 0.0 111.709 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.4 tp60 -61.11 -79.42 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.79 0.329 . . . . 0.0 110.611 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.32 11.28 2.47 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.562 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.3 mttm 59.44 29.81 19.42 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 120.798 0.332 . . . . 0.0 110.297 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.902 HG22 HD23 ' A' ' 27' ' ' LEU . 8.0 mt -60.06 -17.67 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.613 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.4 -79.09 0.09 Allowed 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.822 0.344 . . . . 0.0 111.111 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 44.2 mm -47.38 -36.54 4.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.97 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.797 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -61.81 -67.24 0.43 Allowed 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.346 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.781 ' HG2' HD11 ' A' ' 27' ' ' LEU . 12.3 tp10 -33.62 -42.08 0.1 Allowed 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 120.902 0.382 . . . . 0.0 110.466 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.1 -77.4 0.18 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 119.936 -1.126 . . . . 0.0 110.938 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.52 ' HG3' ' O ' ' A' ' 44' ' ' ALA . 0.6 OUTLIER -48.26 -10.88 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -179.645 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.922 HG11 ' HA ' ' A' ' 70' ' ' PHE . 47.5 t -75.33 -96.66 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.033 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -164.86 120.96 1.45 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 118.404 0.547 . . . . 0.0 111.576 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.613 HG13 HG23 ' A' ' 68' ' ' VAL . 16.5 t -114.05 150.39 16.09 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.257 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.432 ' HB2' ' HB ' ' A' ' 67' ' ' THR . 20.7 t70 -44.79 97.05 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.972 0.415 . . . . 0.0 111.441 -178.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.98 16.7 70.87 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.759 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.57 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -145.91 81.14 1.59 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.122 0.487 . . . . 0.0 112.09 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.501 HG13 ' O ' ' A' ' 54' ' ' VAL . 7.0 p -90.3 71.95 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.126 0.488 . . . . 0.0 110.309 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 47' ' ' GLN . 8.2 mt-10 -99.34 -173.14 2.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.817 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 t -147.29 46.19 1.14 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.908 0.385 . . . . 0.0 111.62 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 19.0 mtt-85 -98.02 174.54 6.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.535 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.506 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 1.7 mptp? -75.2 -38.12 60.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.012 0.434 . . . . 0.0 110.08 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -127.72 158.29 38.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.064 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' CYS . . . . . 0.419 ' HB2' ' HG ' ' A' ' 23' ' ' LEU . 0.5 OUTLIER -133.96 115.8 14.81 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.388 -179.605 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.482 ' HG2' ' CD2' ' A' ' 20' ' ' HIS . 31.4 mtmt -74.14 94.53 2.44 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.068 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.44 HD13 ' O ' ' A' ' 61' ' ' LYS . 5.8 mm -133.49 144.89 34.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.328 -178.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.566 HG11 ' O ' ' A' ' 19' ' ' PRO . 14.3 m -148.4 174.45 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.807 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.498 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 72.69 -151.27 0.07 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.646 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -88.87 81.26 1.54 Allowed Glycine 0 C--N 1.337 0.585 0 C-N-CA 121.472 -0.394 . . . . 0.0 112.6 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -122.05 156.06 34.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.135 0.493 . . . . 0.0 111.414 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.52 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 40.3 m -118.65 147.69 43.51 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.233 -178.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.613 HG23 HG13 ' A' ' 50' ' ' VAL . 0.7 OUTLIER -124.21 148.23 28.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.031 178.986 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 49' ' ' LYS . 58.1 m -141.7 138.46 32.44 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.922 ' HA ' HG11 ' A' ' 48' ' ' VAL . 2.8 t80 -152.16 127.08 9.64 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.614 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 47.55 -85.85 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.334 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -128.2 -7.92 4.29 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.039 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.476 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 1.9 m-70 -89.22 108.77 19.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.145 0.472 . . . . 0.0 111.391 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -118.99 107.45 13.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.171 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.874 HG13 ' HB1' ' A' ' 11' ' ' ALA . 22.0 t -130.5 152.95 38.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.039 0.447 . . . . 0.0 111.944 -178.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.52 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 28.6 mt-30 -111.87 164.29 13.26 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.427 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 1.049 HG21 HD11 ' A' ' 26' ' ' LEU . 21.3 t -136.52 148.73 26.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.547 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.2 m -131.63 160.05 42.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.947 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.291 -0.861 . . . . 0.0 111.144 179.978 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.659 ' O ' HG13 ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.456 -0.141 0 CA-C-O 120.758 0.313 . . . . 0.0 111.045 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.1 p -137.0 129.04 29.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.185 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.749 ' HB3' HG22 ' A' ' 77' ' ' VAL . 41.6 t80 -98.36 154.48 17.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.006 0.431 . . . . 0.0 110.749 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.7 m -106.42 155.53 19.46 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.107 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.605 ' CD1' ' HA ' ' A' ' 63' ' ' VAL . 6.7 mt -122.2 -31.51 3.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.545 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.19 -111.7 3.42 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.023 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -149.84 54.72 0.94 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.306 0.574 . . . . 0.0 110.16 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.671 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 16.2 m-70 -118.98 168.6 9.5 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.766 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.671 ' HD2' ' HB3' ' A' ' 18' ' ' HIS . 7.7 Cg_endo -48.36 -44.45 29.46 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.742 2.295 . . . . 0.0 112.62 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.55 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 3.9 p80 162.75 -165.65 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.091 0.556 . . . . 0.0 109.929 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.518 ' O ' ' O ' ' A' ' 60' ' ' CYS . 15.5 m -134.77 147.23 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 120.959 0.409 . . . . 0.0 111.888 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.65 ' HA ' ' H ' ' A' ' 60' ' ' CYS . 1.2 mt-10 -83.93 143.54 29.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.634 179.118 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.704 ' O ' HD13 ' A' ' 27' ' ' LEU . 2.5 mp -39.82 -36.45 0.44 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.83 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 9.2 t -76.31 -35.51 58.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.329 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' A' ' 22' ' ' GLU . 30.1 m-20 -64.29 -62.03 1.87 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.969 0.414 . . . . 0.0 110.691 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.51 HD11 HG21 ' A' ' 77' ' ' VAL . 9.7 tt -55.05 -44.98 75.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.338 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.797 HD23 HG22 ' A' ' 41' ' ' ILE . 5.8 mp -62.23 -54.35 42.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.698 -178.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.9 -48.89 79.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.635 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 45.7 mt -58.35 -48.13 81.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.267 -0.424 . . . . 0.0 112.012 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.506 ' CG ' ' HB2' ' A' ' 13' ' ' PHE . 7.4 mm-40 -70.75 -12.25 61.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.55 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.96 23.26 30.56 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.846 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.545 ' CZ3' ' HB2' ' A' ' 73' ' ' HIS . 23.1 m95 -64.63 -73.52 0.12 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.8 0.333 . . . . 0.0 110.334 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.585 ' HB2' HG21 ' A' ' 41' ' ' ILE . 24.6 t -92.91 147.27 22.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.787 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -76.75 -33.32 58.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.684 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.462 ' OG ' ' HB3' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -105.42 -28.8 10.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.112 179.71 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 115.79 -72.71 0.26 Allowed Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.445 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -120.41 -2.96 9.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.771 0.32 . . . . 0.0 111.042 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.462 ' HB3' ' OG ' ' A' ' 35' ' ' SER . 3.9 tp60 -52.63 -62.85 1.38 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.914 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.481 ' HB3' HG12 ' A' ' 41' ' ' ILE . . . -73.87 15.05 0.32 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.797 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.8 mttt 68.61 15.95 9.07 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.695 0.283 . . . . 0.0 111.046 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.797 HG22 HD23 ' A' ' 27' ' ' LEU . 45.5 mm -58.54 -20.93 17.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.023 0.439 . . . . 0.0 110.926 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.05 -76.4 0.12 Allowed 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.93 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.6 mm -47.85 -42.52 9.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.772 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.783 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -57.94 -66.6 0.45 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.383 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.718 ' HB2' HD21 ' A' ' 27' ' ' LEU . 9.3 tp10 -30.94 -44.83 0.06 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.56 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.93 -74.56 0.36 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.169 -1.015 . . . . 0.0 110.892 178.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.447 ' HA ' ' O ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -47.57 -11.58 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -179.787 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.983 HG21 ' CD1' ' A' ' 70' ' ' PHE . 39.7 t -75.32 -99.61 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 O-C-N 122.137 -0.352 . . . . 0.0 111.668 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.7 ' HD3' ' HB ' ' A' ' 54' ' ' VAL . 8.2 mmtp -161.0 138.64 9.29 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.702 0.683 . . . . 0.0 111.839 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.663 ' HB ' ' O ' ' A' ' 53' ' ' ALA . 44.1 t -127.58 147.91 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.306 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.74 ' HB2' ' HB ' ' A' ' 67' ' ' THR . 12.9 t0 -44.03 87.01 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -177.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 101.87 -19.13 50.83 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.739 -0.743 . . . . 0.0 114.821 177.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.663 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -146.77 136.68 23.31 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 118.41 1.105 . . . . 0.0 113.041 -178.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.7 ' HB ' ' HD3' ' A' ' 49' ' ' LYS . 11.3 p -107.43 108.68 25.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.238 178.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' A' ' 47' ' ' GLN . 47.3 mt-10 -102.98 -170.28 1.77 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.642 0.258 . . . . 0.0 110.845 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.6 t -164.0 30.27 0.08 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.354 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.17 169.99 9.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.947 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.1 ttpp -75.86 -43.83 43.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.594 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.455 ' HA ' ' HG2' ' A' ' 22' ' ' GLU . 0.3 OUTLIER -102.31 142.63 33.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.747 179.854 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' CYS . . . . . 0.65 ' H ' ' HA ' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -100.08 116.58 32.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.805 -179.789 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.414 ' HA ' ' CD2' ' A' ' 20' ' ' HIS . 11.3 mtmt -103.74 78.75 1.59 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.173 0.511 . . . . 0.0 109.875 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.436 HD12 ' SG ' ' A' ' 60' ' ' CYS . 22.0 mt -138.95 148.92 23.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.172 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.605 ' HA ' ' CD1' ' A' ' 15' ' ' LEU . 1.3 m -151.11 175.09 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.698 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.577 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 78.76 -138.45 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.569 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -104.41 84.25 0.42 Allowed Glycine 0 C--N 1.339 0.695 0 C-N-CA 121.041 -0.599 . . . . 0.0 113.624 -178.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 61.9 mm-40 -122.05 163.19 19.85 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.757 0.313 . . . . 0.0 111.145 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.74 ' HB ' ' HB2' ' A' ' 51' ' ' ASP . 8.9 m -119.11 139.87 51.06 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.247 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.68 137.16 44.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.36 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.6 m -132.0 128.18 37.83 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.919 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.983 ' CD1' HG21 ' A' ' 48' ' ' VAL . 4.1 t80 -175.68 130.38 0.26 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.351 179.013 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.452 ' N ' ' CD1' ' A' ' 70' ' ' PHE . . . 56.99 44.91 22.08 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.393 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 70.16 1.6 35.23 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.791 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.545 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 8.3 m-70 -94.55 98.16 10.64 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.877 0.338 . . . . 0.0 111.111 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.96 101.77 11.79 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.659 HG13 ' O ' ' A' ' 11' ' ' ALA . 40.8 t -120.37 147.55 24.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.569 -178.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.545 ' HG3' HG23 ' A' ' 67' ' ' THR . 2.0 mp0 -111.94 145.65 39.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.667 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.749 HG22 ' HB3' ' A' ' 13' ' ' PHE . 8.0 t -120.62 145.66 26.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.333 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.8 m -128.59 157.53 41.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.947 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.568 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . . . . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.294 -0.86 . . . . 0.0 111.04 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.712 ' HB3' HG22 ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.452 -0.356 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.62 135.85 40.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.94 0.4 . . . . 0.0 110.773 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.738 ' CE2' ' HA ' ' A' ' 26' ' ' LEU . 31.7 t80 -103.98 143.11 33.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.557 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.447 ' O ' ' CE1' ' A' ' 13' ' ' PHE . 0.4 OUTLIER -106.84 132.63 52.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.389 179.471 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.739 HD11 HG12 ' A' ' 63' ' ' VAL . 0.5 OUTLIER -75.51 -37.23 60.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.82 0.343 . . . . 0.0 110.845 179.868 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.66 29.48 26.62 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.306 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.19 43.18 20.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.053 0.454 . . . . 0.0 110.722 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.452 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 1.2 m-70 -114.67 168.6 7.8 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.845 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.517 ' O ' HG11 ' A' ' 63' ' ' VAL . 8.8 Cg_endo -50.38 -43.68 42.92 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.694 2.263 . . . . 0.0 112.215 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.528 ' CA ' HD21 ' A' ' 15' ' ' LEU . 6.3 p80 172.85 -163.79 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.839 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.403 HG11 ' CE1' ' A' ' 13' ' ' PHE . 9.8 m -142.05 153.58 18.72 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.489 ' HG2' ' CB ' ' A' ' 59' ' ' ARG . 14.6 mt-10 -100.64 153.8 19.11 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.135 178.113 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.686 ' HB2' ' O ' ' A' ' 58' ' ' LYS . 1.5 mp -40.23 -54.85 2.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.732 0.301 . . . . 0.0 111.42 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.596 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -57.63 -33.75 68.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.748 179.791 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -72.31 -55.07 7.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.884 0.373 . . . . 0.0 110.975 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.738 ' HA ' ' CE2' ' A' ' 13' ' ' PHE . 7.6 tt -57.79 -47.93 81.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.406 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.999 HD23 HG22 ' A' ' 41' ' ' ILE . 7.5 mp -64.45 -59.14 4.69 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.218 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.596 ' HB2' ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -51.49 -59.21 4.51 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.263 -178.723 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.47 -50.62 69.4 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -178.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.561 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 2.0 mm-40 -61.85 -15.26 40.74 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.05 23.04 13.79 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.319 -0.943 . . . . 0.0 113.443 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.637 ' CE3' ' HG ' ' A' ' 27' ' ' LEU . 7.7 m0 -73.53 -66.48 0.69 Allowed 'General case' 0 C--O 1.232 0.165 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.7 ' CB ' HD12 ' A' ' 41' ' ' ILE . 6.2 t -106.83 143.25 35.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.185 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -70.24 -34.15 72.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.852 0.358 . . . . 0.0 110.692 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.493 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -105.73 -52.14 2.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.443 179.307 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 139.07 -31.82 2.33 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.432 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.98 8.7 2.1 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.493 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 3.2 tp-100 -55.25 -71.11 0.09 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.703 0.287 . . . . 0.0 111.155 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.56 15.5 0.47 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 71.44 19.44 5.21 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.045 0.45 . . . . 0.0 110.35 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.999 HG22 HD23 ' A' ' 27' ' ' LEU . 9.9 mt -61.13 -22.86 28.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.293 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.64 -77.75 0.08 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.997 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.412 ' CD1' ' HG2' ' A' ' 58' ' ' LYS . 37.1 mm -51.61 -41.78 28.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.928 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.609 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -57.74 -71.19 0.11 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.623 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.743 ' CB ' HD21 ' A' ' 27' ' ' LEU . 1.6 tm-20 -33.46 -40.13 0.06 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.013 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.419 ' C ' ' H ' ' A' ' 48' ' ' VAL . . . -60.09 -75.35 0.28 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.289 -0.957 . . . . 0.0 110.986 178.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.537 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 3.8 pt20 -49.15 -8.17 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.847 HG21 ' HD1' ' A' ' 70' ' ' PHE . 97.7 t -75.33 -98.71 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.144 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.554 ' N ' HG12 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -161.87 126.15 3.29 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.973 -179.303 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.795 HG13 HG13 ' A' ' 68' ' ' VAL . 21.4 t -121.73 149.2 24.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.516 ' HB2' ' HB ' ' A' ' 67' ' ' THR . 22.2 t0 -44.96 102.48 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.864 0.364 . . . . 0.0 111.224 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 63.52 20.78 64.0 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.172 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.555 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . . . -146.19 74.6 1.38 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.981 0.42 . . . . 0.0 111.657 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.54 HG13 ' O ' ' A' ' 54' ' ' VAL . 7.5 p -86.25 63.72 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.983 0.42 . . . . 0.0 110.263 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.445 ' O ' ' HA ' ' A' ' 47' ' ' GLN . 21.6 mt-10 -102.29 -170.21 1.78 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.506 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.537 ' OG1' ' HB3' ' A' ' 47' ' ' GLN . 3.1 t -142.89 47.67 1.53 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.553 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 45.3 mtp85 -98.53 174.22 6.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.962 0.41 . . . . 0.0 111.3 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.686 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 24.0 mttm -79.61 -38.67 33.35 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.924 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.489 ' CB ' ' HG2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -128.34 159.36 35.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.856 -179.759 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -140.67 115.79 9.85 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.218 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.74 96.88 2.1 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.484 ' CG2' ' HG3' ' A' ' 66' ' ' GLN . 13.1 mt -133.47 136.01 55.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.809 -178.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.739 HG12 HD11 ' A' ' 15' ' ' LEU . 31.1 m -141.72 175.6 5.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.535 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.429 ' O ' ' HA ' ' A' ' 78' ' ' VAL . . . 71.19 -136.52 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.635 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.573 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -106.37 86.04 0.46 Allowed Glycine 0 C--N 1.339 0.702 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.192 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.484 ' HG3' ' CG2' ' A' ' 62' ' ' ILE . 8.4 mm-40 -122.05 172.25 8.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.716 0.293 . . . . 0.0 111.47 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 4.9 m -130.31 152.13 50.06 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.795 HG13 HG13 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -135.52 152.64 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.385 179.795 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.634 ' HA ' ' O ' ' A' ' 73' ' ' HIS . 0.4 OUTLIER -146.25 137.63 24.63 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -179.643 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.936 ' CE2' HG23 ' A' ' 41' ' ' ILE . 1.8 t80 -137.12 118.7 14.89 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.619 178.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 38.2 30.01 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 116.39 -6.63 18.76 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.365 -0.921 . . . . 0.0 113.563 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.634 ' O ' ' HA ' ' A' ' 69' ' ' SER . 1.4 m-70 -88.13 82.98 7.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.317 0.558 . . . . 0.0 111.145 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.6 119.81 29.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.749 0.309 . . . . 0.0 110.71 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.712 HG22 ' HB3' ' A' ' 11' ' ' ALA . 43.1 t -142.57 152.75 17.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.09 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.55 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 7.7 mt-30 -112.61 164.23 13.58 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.7 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.628 HG13 ' HD1' ' A' ' 13' ' ' PHE . 6.7 t -131.9 142.8 42.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.225 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 64' ' ' ALA . 28.1 m -138.44 169.15 18.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.184 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.118 -0.944 . . . . 0.0 111.212 179.956 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.939 ' HB3' HG13 ' A' ' 75' ' ' VAL . . . . . . . . 0 CA--C 1.523 -0.089 0 CA-C-O 120.89 0.376 . . . . 0.0 110.705 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.44 131.93 43.93 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.376 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.863 ' HB3' HG22 ' A' ' 77' ' ' VAL . 40.8 t80 -110.39 165.3 11.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.557 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.27 140.71 35.19 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.943 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.678 HD21 HG22 ' A' ' 21' ' ' VAL . 0.4 OUTLIER -142.3 -36.03 0.42 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.944 -179.37 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.506 ' H ' ' HA ' ' A' ' 79' ' ' ALA . . . -48.58 -30.06 8.17 Favored Glycine 0 C--N 1.329 0.153 0 C-N-CA 120.98 -0.629 . . . . 0.0 113.164 -179.178 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.73 -34.33 65.06 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.837 0.351 . . . . 0.0 110.839 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.614 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 3.9 m-70 -117.45 163.88 21.78 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.893 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.614 ' HD2' ' HB3' ' A' ' 18' ' ' HIS . 15.8 Cg_endo -56.13 -35.14 94.69 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.569 2.179 . . . . 0.0 111.985 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.484 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 2.5 p80 174.98 -176.37 0.09 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.431 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.678 HG22 HD21 ' A' ' 15' ' ' LEU . 13.6 m -145.32 164.21 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.414 ' CB ' ' HB3' ' A' ' 59' ' ' ARG . 1.5 pt-20 -99.83 153.17 19.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.2 178.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.781 HD22 ' HG3' ' A' ' 45' ' ' GLU . 8.1 mt -41.13 -41.84 1.87 Allowed 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 40.9 t -70.8 -38.72 73.36 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.638 0.256 . . . . 0.0 111.547 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -63.35 -60.96 2.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.947 0.403 . . . . 0.0 110.841 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.035 HD11 HG21 ' A' ' 77' ' ' VAL . 0.7 OUTLIER -50.86 -42.18 58.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.04 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.838 HD23 HG22 ' A' ' 41' ' ' ILE . 4.4 mp -68.01 -64.74 0.8 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.78 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.9 tmmm? -43.34 -61.45 1.35 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.66 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 13' ' ' PHE . 0.5 OUTLIER -54.49 -40.56 68.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.77 -179.426 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.485 ' OE1' HG11 ' A' ' 75' ' ' VAL . 8.7 mm-40 -69.43 -14.54 62.95 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.46 20.78 21.47 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.28 -0.962 . . . . 0.0 112.92 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.887 ' CH2' HG12 ' A' ' 68' ' ' VAL . 8.3 m0 -75.63 -66.52 0.77 Allowed 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.811 ' OG ' HD13 ' A' ' 41' ' ' ILE . 30.1 t -106.86 137.03 45.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.595 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -70.75 -33.82 71.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.039 0.447 . . . . 0.0 110.295 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.513 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 0.1 OUTLIER -105.74 -55.4 2.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.314 179.223 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 126.68 -33.53 3.39 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.303 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -123.04 -5.49 8.45 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.513 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 0.8 OUTLIER -52.52 -76.34 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.839 0.352 . . . . 0.0 111.029 -179.728 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.695 ' HB3' HD11 ' A' ' 41' ' ' ILE . . . -77.15 15.77 0.67 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.249 -0.432 . . . . 0.0 112.14 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 4.5 mmtt 68.53 24.26 7.07 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.068 0.461 . . . . 0.0 110.098 -179.014 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.838 HG22 HD23 ' A' ' 27' ' ' LEU . 3.9 mp -57.86 -24.86 24.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.449 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.92 -77.35 0.13 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.259 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.3 mm -48.96 -42.24 14.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-O 121.017 0.437 . . . . 0.0 110.644 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.699 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -57.64 -69.05 0.18 Allowed 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.446 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.781 ' HG3' HD22 ' A' ' 23' ' ' LEU . 9.0 tp10 -29.81 -44.13 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.011 0.434 . . . . 0.0 110.672 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 55' ' ' GLU . . . -59.61 -74.89 0.31 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.115 -1.041 . . . . 0.0 110.621 178.225 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.535 ' N ' ' HA ' ' A' ' 56' ' ' THR . 2.3 pt20 -48.64 -12.94 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.855 HG11 ' HA ' ' A' ' 70' ' ' PHE . 47.5 t -75.06 -98.17 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.933 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.406 ' CD ' ' HB ' ' A' ' 54' ' ' VAL . 0.8 OUTLIER -165.98 122.71 1.37 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 118.37 0.532 . . . . 0.0 111.921 -179.825 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.462 ' HB ' ' HB3' ' A' ' 53' ' ' ALA . 31.7 t -117.33 152.29 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.542 ' HB2' ' O ' ' A' ' 67' ' ' THR . 3.7 t0 -44.72 101.29 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.909 0.385 . . . . 0.0 111.492 -179.025 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 62.63 21.89 63.3 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.415 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.462 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . . . -145.83 75.57 1.43 Allowed 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 121.037 0.446 . . . . 0.0 111.67 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.608 HG13 ' O ' ' A' ' 54' ' ' VAL . 10.1 p -87.13 67.37 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.961 0.41 . . . . 0.0 110.485 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.447 ' O ' ' O ' ' A' ' 46' ' ' GLY . 0.2 OUTLIER -102.56 -166.25 1.26 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.062 -179.356 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.535 ' HA ' ' N ' ' A' ' 47' ' ' GLN . 3.4 t -145.8 37.99 1.09 Allowed 'General case' 0 C--O 1.232 0.154 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.09 174.79 7.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.825 0.345 . . . . 0.0 111.041 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.4 tttt -78.68 -41.6 30.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.738 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.414 ' HB3' ' CB ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -124.49 154.59 40.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.62 179.796 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -136.74 115.38 12.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.394 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.6 mttt -69.48 99.09 1.19 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 17.1 mt -133.46 144.04 37.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.633 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.51 ' O ' ' HB3' ' A' ' 64' ' ' ALA . 7.8 m -149.5 175.3 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.862 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.51 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 72.31 -149.73 0.07 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 178.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.567 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -92.33 81.3 1.16 Allowed Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 116.298 -0.41 . . . . 0.0 112.953 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.92 157.47 31.13 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.208 0.528 . . . . 0.0 111.378 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.542 ' O ' ' HB2' ' A' ' 51' ' ' ASP . 2.9 m -113.72 150.86 32.71 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.836 -178.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.887 HG12 ' CH2' ' A' ' 32' ' ' TRP . 1.2 t -128.27 145.15 35.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.023 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.55 ' HA ' ' O ' ' A' ' 73' ' ' HIS . 1.1 m -136.07 132.21 35.86 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.855 ' HA ' HG11 ' A' ' 48' ' ' VAL . 2.6 t80 -147.14 123.34 10.86 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.232 178.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.409 ' N ' ' CD1' ' A' ' 70' ' ' PHE . . . 41.57 30.66 0.15 Allowed 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.2 -4.06 38.06 Favored Glycine 0 C--N 1.329 0.171 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.422 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.661 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 2.7 m-70 -90.47 98.53 11.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.853 0.327 . . . . 0.0 110.829 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -108.99 114.16 27.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.853 0.359 . . . . 0.0 111.424 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.939 HG13 ' HB3' ' A' ' 11' ' ' ALA . 17.6 t -138.21 156.32 30.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.761 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.539 ' HG3' HG23 ' A' ' 67' ' ' THR . 9.5 mt-30 -112.6 165.61 12.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.136 0.493 . . . . 0.0 111.709 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 1.035 HG21 HD11 ' A' ' 26' ' ' LEU . 21.3 t -141.4 150.4 19.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.587 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 18.2 m -130.52 166.13 28.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.886 0.374 . . . . 0.0 111.759 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.506 ' HA ' ' H ' ' A' ' 16' ' ' GLY . . . . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.238 -0.887 . . . . 0.0 111.096 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.699 ' HB1' HG13 ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.455 -0.177 0 CA-C-O 120.78 0.324 . . . . 0.0 110.826 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.55 119.03 22.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.865 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.817 ' HB3' HG22 ' A' ' 77' ' ' VAL . 29.5 t80 -98.66 149.9 22.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.542 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.3 m -105.33 147.69 27.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.979 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.506 HD21 ' CG1' ' A' ' 21' ' ' VAL . 9.6 mt -127.44 -36.28 2.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.955 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.09 -111.67 3.49 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.688 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.9 tttt -136.72 52.89 1.93 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.875 0.369 . . . . 0.0 110.903 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -103.89 155.62 36.79 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.972 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.624 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 8.1 Cg_endo -50.56 -44.56 39.42 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.789 2.326 . . . . 0.0 112.235 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.645 ' HA ' HG13 ' A' ' 63' ' ' VAL . 12.6 p80 164.64 -166.98 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.491 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.856 HG21 HD13 ' A' ' 26' ' ' LEU . 14.9 m -143.58 155.92 16.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.147 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.508 ' HG2' ' HA ' ' A' ' 59' ' ' ARG . 1.4 mt-10 -87.01 141.07 28.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.03 178.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.51 HD13 ' O ' ' A' ' 42' ' ' ALA . 4.1 pp -40.94 -38.35 0.95 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.716 0.293 . . . . 0.0 111.381 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.498 ' N ' HD12 ' A' ' 23' ' ' LEU . 3.7 t -69.37 -39.51 78.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.89 0.376 . . . . 0.0 110.742 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 22' ' ' GLU . 87.8 m-20 -61.03 -59.21 5.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.629 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.856 HD13 HG21 ' A' ' 21' ' ' VAL . 8.2 tp -50.3 -46.99 55.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.616 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.965 HD23 HG22 ' A' ' 41' ' ' ILE . 6.8 mp -66.45 -60.91 2.31 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.865 -179.16 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -50.92 -55.47 17.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.317 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.78 -42.39 71.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.716 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 1.5 mm-40 -74.36 -13.83 60.79 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.0 24.75 14.23 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.251 -0.976 . . . . 0.0 113.281 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.731 ' CH2' HG12 ' A' ' 68' ' ' VAL . 9.7 m95 -74.68 -63.42 1.25 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 117.003 0.401 . . . . 0.0 110.07 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 39.4 t -106.85 142.92 35.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.344 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -77.94 -34.48 51.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.837 0.351 . . . . 0.0 110.739 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.437 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 31.0 p -106.07 -41.72 5.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.309 178.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 115.82 -33.94 4.98 Favored Glycine 0 CA--C 1.52 0.36 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.771 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -129.56 8.55 5.41 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.437 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 10.4 tp60 -60.48 -74.57 0.07 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.909 0.385 . . . . 0.0 110.541 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.724 ' HB3' ' CD1' ' A' ' 41' ' ' ILE . . . -79.7 15.16 1.43 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.725 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 64.61 27.54 13.27 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.994 0.426 . . . . 0.0 110.201 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.965 HG22 HD23 ' A' ' 27' ' ' LEU . 2.6 mp -62.67 -16.87 17.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.085 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.51 ' O ' HD13 ' A' ' 23' ' ' LEU . . . -70.68 -80.68 0.05 Allowed 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.456 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 36.4 mm -52.05 -34.31 17.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.859 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.722 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -61.33 -72.31 0.12 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.62 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.81 ' CB ' HD21 ' A' ' 27' ' ' LEU . 4.9 tm-20 -35.08 -41.17 0.14 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.263 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.402 ' C ' ' H ' ' A' ' 48' ' ' VAL . . . -60.91 -74.16 0.41 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.177 -1.011 . . . . 0.0 110.972 178.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -48.49 -9.35 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.842 HG11 ' HA ' ' A' ' 70' ' ' PHE . 58.2 t -74.66 -89.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.352 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.418 ' HG2' ' O ' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -170.31 120.97 0.62 Allowed 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 120.011 -0.676 . . . . 0.0 112.534 179.763 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.599 ' HB ' ' O ' ' A' ' 53' ' ' ALA . 40.9 t -114.29 147.47 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.484 ' HB2' ' H ' ' A' ' 67' ' ' THR . 3.3 t70 -44.99 98.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.053 0.454 . . . . 0.0 111.498 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.44 15.71 73.09 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.727 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.599 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -145.86 78.03 1.52 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.976 0.417 . . . . 0.0 112.004 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.561 HG13 ' O ' ' A' ' 54' ' ' VAL . 9.9 p -88.57 62.39 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.977 0.418 . . . . 0.0 110.465 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -99.8 -170.77 1.94 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.063 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.7 t -150.85 36.81 0.63 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.427 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 57' ' ' ARG . 12.7 mtt180 -81.08 168.79 18.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.519 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.1 -44.93 44.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.046 0.451 . . . . 0.0 109.924 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.508 ' HA ' ' HG2' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -103.66 150.43 24.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.77 179.615 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' CYS . . . . . 0.482 ' O ' ' O ' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -116.95 118.13 31.59 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.01 0.433 . . . . 0.0 111.434 -179.43 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.4 ' HG2' ' NE2' ' A' ' 20' ' ' HIS . 14.3 mttm -96.11 71.51 2.87 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.037 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.431 HD12 ' SG ' ' A' ' 60' ' ' CYS . 33.2 mt -136.05 147.4 28.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.702 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.645 HG13 ' HA ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -152.51 175.14 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.776 179.52 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 77.96 -149.2 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.916 179.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.514 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -84.93 78.27 2.02 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 121.285 -0.484 . . . . 0.0 112.578 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.405 ' HG3' ' CG2' ' A' ' 62' ' ' ILE . 20.6 mm-40 -121.66 155.62 34.77 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.066 0.46 . . . . 0.0 111.108 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 59.3 m -116.79 152.91 33.41 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.585 -178.296 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.731 HG12 ' CH2' ' A' ' 32' ' ' TRP . 1.1 t -127.9 145.58 34.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.668 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.406 ' HB2' ' O ' ' A' ' 49' ' ' LYS . 22.2 m -143.05 135.87 27.8 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.842 ' HA ' HG11 ' A' ' 48' ' ' VAL . 2.2 t80 -148.48 124.06 10.41 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.195 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 51.99 -85.12 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.353 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -129.97 -3.22 4.98 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.912 -0.661 . . . . 0.0 113.012 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.478 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 2.1 m-70 -92.63 108.38 19.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.929 0.365 . . . . 0.0 111.44 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.91 102.66 8.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.338 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.699 HG13 ' HB1' ' A' ' 11' ' ' ALA . 99.4 t -125.19 151.94 31.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.347 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.531 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 13.0 mt-30 -112.97 160.62 17.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.995 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.817 HG22 ' HB3' ' A' ' 13' ' ' PHE . 21.8 t -131.25 148.66 32.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.503 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.8 m -140.02 171.65 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.792 0.33 . . . . 0.0 111.497 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.506 -0.759 . . . . 0.0 111.059 179.933 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.647 ' HB3' HG22 ' A' ' 75' ' ' VAL . . . . . . . . 0 CA--C 1.522 -0.119 0 CA-C-O 120.848 0.356 . . . . 0.0 110.86 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.53 134.14 39.14 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.405 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.524 ' CZ ' ' HB3' ' A' ' 29' ' ' LEU . 19.2 t80 -105.61 90.11 3.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.864 0.364 . . . . 0.0 110.827 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.685 ' HA ' HG23 ' A' ' 78' ' ' VAL . 38.6 t -73.38 95.14 2.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.904 0.383 . . . . 0.0 110.897 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.932 HD11 HG13 ' A' ' 21' ' ' VAL . 1.0 OUTLIER -55.63 -35.28 65.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.933 179.789 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.67 48.24 3.01 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.403 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.6 tttt 58.56 54.89 5.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.939 0.4 . . . . 0.0 110.934 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.409 ' HB2' HD22 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -105.66 166.79 10.71 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.157 -179.74 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.786 ' O ' HG11 ' A' ' 63' ' ' VAL . 28.2 Cg_endo -62.51 -48.8 6.78 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.617 2.211 . . . . 0.0 112.091 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.657 ' HA ' HG12 ' A' ' 63' ' ' VAL . 3.1 p80 173.86 -173.67 0.06 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.327 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.932 HG13 HD11 ' A' ' 15' ' ' LEU . 4.1 m -142.12 158.3 20.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.441 0.639 . . . . 0.0 112.723 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.549 ' HG2' ' HG2' ' A' ' 59' ' ' ARG . 1.1 mp0 -100.81 149.96 23.3 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.002 178.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.488 ' H ' ' HA ' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -39.64 -53.65 2.13 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.232 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 37.5 t -60.93 -32.2 71.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.89 0.376 . . . . 0.0 110.77 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.585 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 0.9 OUTLIER -68.94 -58.83 3.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.98 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.888 HD11 HG21 ' A' ' 77' ' ' VAL . 3.2 tp -52.52 -48.09 66.24 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.882 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.878 HD21 ' HG3' ' A' ' 45' ' ' GLU . 4.1 mt -64.77 -58.75 5.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.699 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.72 -57.36 12.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.803 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.585 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.3 OUTLIER -50.81 -39.34 52.83 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.026 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.475 ' OE1' HG11 ' A' ' 75' ' ' VAL . 2.5 mm-40 -79.2 -8.09 58.74 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.75 25.28 32.87 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.313 -0.946 . . . . 0.0 113.168 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.769 ' CZ3' ' HB2' ' A' ' 73' ' ' HIS . 19.6 m95 -71.17 -65.52 0.73 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.869 0.366 . . . . 0.0 110.485 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.663 ' HB2' HG21 ' A' ' 41' ' ' ILE . 8.3 t -100.53 147.61 25.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.51 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -71.01 -34.81 71.68 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.668 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.3 p -106.68 -59.29 1.82 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.012 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.417 ' O ' ' HB2' ' A' ' 42' ' ' ALA . . . 131.69 -19.28 4.76 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.406 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.46 -2.58 0.86 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.4 ' C ' ' H ' ' A' ' 40' ' ' LYS . 23.4 tp60 -60.13 -74.71 0.07 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.866 0.365 . . . . 0.0 110.41 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.41 14.11 0.37 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.497 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.4 ' H ' ' C ' ' A' ' 38' ' ' GLN . 3.7 mttt 66.92 20.18 10.54 Favored 'General case' 0 C--O 1.23 0.057 0 CA-C-O 120.776 0.322 . . . . 0.0 110.702 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.71 HG23 ' HE2' ' A' ' 70' ' ' PHE . 48.0 mm -51.0 -29.62 8.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.753 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 36' ' ' GLY . . . -65.38 -78.68 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.77 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.474 HD12 ' HG3' ' A' ' 58' ' ' LYS . 25.1 mm -49.81 -38.4 13.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.072 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.74 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -61.21 -71.68 0.14 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.122 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.878 ' HG3' HD21 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -33.41 -40.48 0.07 Allowed 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 120.859 0.361 . . . . 0.0 110.594 -179.41 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 55' ' ' GLU . . . -58.24 -76.12 0.23 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 119.718 -1.229 . . . . 0.0 110.531 177.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.48 ' HG2' ' O ' ' A' ' 44' ' ' ALA . 17.0 pt20 -50.24 -9.46 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.989 HG21 ' CD1' ' A' ' 70' ' ' PHE . 38.9 t -75.45 -101.24 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.007 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.519 ' HD3' ' HB ' ' A' ' 54' ' ' VAL . 1.5 mmtm -163.15 120.02 1.86 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 119.117 0.871 . . . . 0.0 112.657 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.764 HG13 HG23 ' A' ' 68' ' ' VAL . 13.7 t -112.85 142.82 24.0 Favored 'Isoleucine or valine' 0 C--N 1.338 0.081 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.135 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.494 ' HB2' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -48.6 95.74 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.916 0.388 . . . . 0.0 111.023 -179.461 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.7 15.68 80.38 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.498 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.759 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . . . -146.1 75.78 1.43 Allowed 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.078 0.465 . . . . 0.0 111.627 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.613 HG13 ' O ' ' A' ' 54' ' ' VAL . 10.9 p -90.58 65.91 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.907 0.384 . . . . 0.0 110.74 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.442 ' O ' ' O ' ' A' ' 46' ' ' GLY . 44.1 mm-40 -102.08 -174.66 2.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.087 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.407 ' HA ' ' N ' ' A' ' 47' ' ' GLN . 1.7 t -143.95 41.4 1.41 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.945 0.402 . . . . 0.0 111.373 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.53 175.22 6.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.983 0.421 . . . . 0.0 110.808 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.483 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -81.04 -25.68 36.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.776 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.549 ' HG2' ' HG2' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -140.77 148.97 41.49 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.893 179.806 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -137.24 116.52 12.65 Favored 'General case' 0 CA--C 1.523 -0.078 0 CA-C-O 120.803 0.335 . . . . 0.0 110.892 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.5 mttm -74.66 102.89 4.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.526 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.4 mt -132.93 133.59 58.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.023 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.786 HG11 ' O ' ' A' ' 19' ' ' PRO . 35.4 m -140.46 174.96 7.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.696 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.486 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 72.27 -133.77 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.68 179.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.497 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -109.25 84.82 0.38 Allowed Glycine 0 C--N 1.338 0.691 0 C-N-CA 121.031 -0.604 . . . . 0.0 113.609 -178.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -122.92 167.23 13.83 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.599 0.238 . . . . 0.0 111.242 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.698 HG23 ' HG2' ' A' ' 76' ' ' GLN . 5.2 m -126.01 153.52 44.26 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.084 0.469 . . . . 0.0 111.866 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.764 HG23 HG13 ' A' ' 50' ' ' VAL . 1.2 t -132.23 147.11 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.978 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.8 m -134.64 136.59 42.97 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.84 0.352 . . . . 0.0 111.703 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.989 ' CD1' HG21 ' A' ' 48' ' ' VAL . 6.2 t80 -176.13 137.21 0.31 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.632 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.48 ' N ' ' CD1' ' A' ' 70' ' ' PHE . . . 50.24 37.01 13.85 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.732 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.44 -4.74 66.74 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.434 -0.889 . . . . 0.0 112.823 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.769 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 5.0 m-70 -89.92 107.64 19.23 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.75 0.309 . . . . 0.0 111.189 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.17 103.81 12.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.214 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.647 HG22 ' HB3' ' A' ' 11' ' ' ALA . 64.9 t -132.5 154.36 39.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.63 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.698 ' HG2' HG23 ' A' ' 67' ' ' THR . 20.3 mt-30 -112.96 168.81 9.39 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.013 0.435 . . . . 0.0 111.161 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.888 HG21 HD11 ' A' ' 26' ' ' LEU . 20.4 t -124.34 137.81 55.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.674 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.685 HG23 ' HA ' ' A' ' 14' ' ' SER . 10.4 m -126.84 147.87 31.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.876 0.37 . . . . 0.0 111.208 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.433 -179.586 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.667 ' CB ' HG13 ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.454 -0.248 0 CA-C-O 120.838 0.352 . . . . 0.0 110.576 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.14 128.33 53.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.904 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.542 ' O ' HG13 ' A' ' 77' ' ' VAL . 34.2 t80 -108.05 95.94 6.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.762 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.03 104.7 1.82 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.847 0.356 . . . . 0.0 110.972 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.519 HD21 HG11 ' A' ' 21' ' ' VAL . 6.2 mt -72.9 -38.19 67.0 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.947 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.24 -82.46 0.31 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.519 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.4 53.47 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.951 0.405 . . . . 0.0 110.948 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.5 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 33.3 m170 -103.57 160.49 25.95 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.84 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.613 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 18.2 Cg_endo -58.83 -35.35 98.75 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.382 2.055 . . . . 0.0 111.875 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.613 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 4.5 p80 167.15 -173.57 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.117 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.652 HG21 HD13 ' A' ' 26' ' ' LEU . 2.8 m -146.03 164.17 10.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.255 0.55 . . . . 0.0 112.04 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.457 ' HB2' ' CG ' ' A' ' 59' ' ' ARG . 12.0 pt-20 -102.15 150.08 23.63 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.815 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.786 HD22 ' HG3' ' A' ' 45' ' ' GLU . 96.0 mt -40.82 -45.64 2.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.818 0.342 . . . . 0.0 111.543 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.43 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 4.9 t -59.7 -36.26 76.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.553 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.535 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 14.8 m-20 -71.13 -63.12 1.17 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.778 0.323 . . . . 0.0 111.515 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.86 HD11 HG21 ' A' ' 77' ' ' VAL . 3.6 tp -46.65 -45.66 19.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.009 0.433 . . . . 0.0 111.374 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.013 HD23 HG22 ' A' ' 41' ' ' ILE . 9.7 mp -67.69 -66.63 0.54 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.28 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 24' ' ' CYS . 9.9 ttmt -50.1 -51.3 44.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.764 0.316 . . . . 0.0 111.222 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.535 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.1 OUTLIER -56.99 -34.9 68.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.203 -179.728 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 5.0 mm-40 -84.22 -8.77 58.95 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.91 22.95 24.3 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.272 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.72 ' CE3' ' HG ' ' A' ' 27' ' ' LEU . 8.6 m0 -74.99 -62.84 1.41 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.006 0.431 . . . . 0.0 109.909 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.472 ' CB ' HD12 ' A' ' 41' ' ' ILE . 0.3 OUTLIER -107.28 143.58 35.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.759 179.621 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.2 tp10 -78.28 -34.37 48.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.818 0.342 . . . . 0.0 111.261 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.423 ' OG ' ' CB ' ' A' ' 38' ' ' GLN . 42.2 p -105.72 -39.5 6.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.075 0.464 . . . . 0.0 110.525 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 108.15 -25.05 21.45 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.167 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.3 -15.43 2.51 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.423 ' CB ' ' OG ' ' A' ' 35' ' ' SER . 17.9 tp60 -52.52 -73.71 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.804 0.335 . . . . 0.0 111.362 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.481 ' HB3' HG13 ' A' ' 41' ' ' ILE . . . -72.12 14.96 0.18 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.39 23.38 12.93 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.803 0.335 . . . . 0.0 110.709 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 1.013 HG22 HD23 ' A' ' 27' ' ' LEU . 1.9 mt -60.19 -19.6 18.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.884 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.29 -76.56 0.14 Allowed 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.82 0.343 . . . . 0.0 110.781 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 45.6 mm -47.33 -45.32 9.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-O 121.083 0.468 . . . . 0.0 110.618 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.6 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -55.39 -67.71 0.26 Allowed 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.877 178.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.786 ' HG3' HD22 ' A' ' 23' ' ' LEU . 11.5 tp10 -28.31 -47.75 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.089 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 55' ' ' GLU . . . -58.34 -74.14 0.38 Allowed Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.172 -1.014 . . . . 0.0 110.824 178.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.555 ' N ' ' HA ' ' A' ' 56' ' ' THR . 1.2 pt20 -44.57 -16.21 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.902 HG21 ' HD1' ' A' ' 70' ' ' PHE . 46.6 t -76.01 -95.43 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.606 ' HD3' ' HB ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -162.82 120.08 1.97 Allowed 'General case' 0 C--N 1.339 0.149 0 O-C-N 122.1 -0.375 . . . . 0.0 111.866 -179.294 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.578 HG13 ' CG2' ' A' ' 68' ' ' VAL . 42.6 t -118.96 157.0 20.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.193 178.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.579 ' HB3' ' H ' ' A' ' 67' ' ' THR . 4.7 p-10 -43.62 99.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.015 0.436 . . . . 0.0 111.603 -178.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 59.76 24.35 59.94 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.175 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -145.79 76.48 1.47 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.606 ' HB ' ' HD3' ' A' ' 49' ' ' LYS . 7.6 p -84.88 58.08 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.151 0.501 . . . . 0.0 110.327 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.436 ' O ' ' O ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -100.42 -162.72 0.96 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.809 -179.547 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.555 ' HA ' ' N ' ' A' ' 47' ' ' GLN . 2.1 t -144.43 53.11 1.26 Allowed 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.544 ' HG3' ' O ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -99.25 172.66 7.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.903 0.382 . . . . 0.0 111.306 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -77.35 -48.47 17.26 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.795 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.544 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 0.3 OUTLIER -120.52 142.79 48.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.314 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' CYS . . . . . 0.773 ' SG ' HD11 ' A' ' 62' ' ' ILE . 3.3 t -124.26 118.53 27.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.975 0.417 . . . . 0.0 110.972 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.53 99.87 2.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.331 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.773 HD11 ' SG ' ' A' ' 60' ' ' CYS . 2.7 mp -138.34 142.45 35.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.769 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.546 HG11 ' O ' ' A' ' 19' ' ' PRO . 12.8 m -145.66 175.63 2.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.433 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.492 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 72.58 -138.17 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 178.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.754 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -106.32 84.75 0.41 Allowed Glycine 0 C--N 1.34 0.798 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.14 -178.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.51 ' HG3' HG23 ' A' ' 62' ' ' ILE . 13.4 mm100 -123.02 167.48 13.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.975 0.417 . . . . 0.0 112.082 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.619 HG23 ' HG2' ' A' ' 76' ' ' GLN . 3.5 m -118.18 140.84 49.2 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.076 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.641 HG12 ' CH2' ' A' ' 32' ' ' TRP . 1.2 t -123.49 146.53 28.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.794 178.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.603 ' HA ' ' O ' ' A' ' 73' ' ' HIS . 32.0 p -140.01 136.1 33.36 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -179.019 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.902 ' HD1' HG21 ' A' ' 48' ' ' VAL . 1.9 t80 -140.17 121.21 14.67 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.332 178.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 40.82 28.23 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 113.16 -5.81 25.27 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.323 -0.941 . . . . 0.0 113.674 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.628 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 1.1 m-70 -88.01 91.33 8.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 117.166 0.483 . . . . 0.0 110.934 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -98.02 118.01 33.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.848 0.356 . . . . 0.0 111.443 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.667 HG13 ' CB ' ' A' ' 11' ' ' ALA . 96.8 t -143.5 152.74 16.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.391 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.619 ' HG2' HG23 ' A' ' 67' ' ' THR . 24.8 mt-30 -112.89 156.1 23.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.231 0.539 . . . . 0.0 111.609 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.86 HG21 HD11 ' A' ' 26' ' ' LEU . 38.3 t -121.5 145.05 28.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.129 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.8 m -134.18 165.94 30.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.872 0.367 . . . . 0.0 111.699 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.194 -179.873 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.558 ' HB1' HG13 ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.455 -0.191 0 CA-C-O 120.86 0.362 . . . . 0.0 111.135 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.87 129.04 37.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.548 ' HD2' ' HG2' ' A' ' 30' ' ' GLU . 56.5 t80 -102.48 149.23 24.59 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.855 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.93 123.33 48.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.394 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.803 ' CD1' HG12 ' A' ' 63' ' ' VAL . 1.0 OUTLIER -69.74 -37.59 76.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.714 0.292 . . . . 0.0 110.958 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.29 26.79 13.11 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.832 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.3 mtmt 59.58 51.52 6.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.909 0.385 . . . . 0.0 110.833 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.428 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 2.9 m-70 -119.43 168.25 10.43 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.61 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.551 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 10.3 Cg_endo -52.64 -37.96 75.56 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.396 2.064 . . . . 0.0 111.741 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.585 ' HA ' HD11 ' A' ' 15' ' ' LEU . 5.6 p80 167.94 -168.5 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.009 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.557 HG21 HD13 ' A' ' 26' ' ' LEU . 28.8 m -143.58 157.04 16.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.898 0.38 . . . . 0.0 111.77 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.595 ' HA ' ' H ' ' A' ' 60' ' ' CYS . 1.5 pt-20 -103.48 152.21 21.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.583 178.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.621 HD13 ' C ' ' A' ' 42' ' ' ALA . 0.2 OUTLIER -37.93 -46.54 0.98 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.919 -179.372 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.0 t -62.2 -38.4 89.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.606 0.241 . . . . 0.0 111.608 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -67.73 -58.81 3.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.119 0.485 . . . . 0.0 111.122 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.557 HD13 HG21 ' A' ' 21' ' ' VAL . 3.2 tp -55.27 -49.54 71.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.8 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.891 HD23 HG22 ' A' ' 41' ' ' ILE . 6.2 mp -62.61 -59.16 5.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.159 -179.003 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -50.28 -59.79 3.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.98 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.507 ' HB3' ' HE2' ' A' ' 13' ' ' PHE . 3.8 mm? -55.89 -43.31 77.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.482 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.575 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 0.1 OUTLIER -66.83 -15.7 63.79 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.045 -179.943 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.92 23.9 19.02 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.096 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.634 ' CE3' ' HG ' ' A' ' 27' ' ' LEU . 8.8 m0 -74.84 -66.05 0.8 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.202 0.525 . . . . 0.0 110.119 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.42 ' HA ' HD12 ' A' ' 41' ' ' ILE . 2.1 t -106.68 139.19 41.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.135 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -82.31 -33.48 29.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.574 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.444 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -105.16 -27.54 11.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.959 179.645 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.79 0.75 88.68 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.855 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.88 -15.32 0.31 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.681 0.277 . . . . 0.0 111.468 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.444 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 1.0 OUTLIER -54.29 -77.31 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.374 -179.682 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.42 ' HB3' HG13 ' A' ' 41' ' ' ILE . . . -79.96 15.05 1.56 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.3 mttt 61.71 26.53 16.16 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.98 0.419 . . . . 0.0 110.406 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.891 HG22 HD23 ' A' ' 27' ' ' LEU . 11.7 mt -58.1 -22.27 18.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.708 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.621 ' C ' HD13 ' A' ' 23' ' ' LEU . . . -74.92 -77.67 0.12 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.099 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 44.3 mm -52.31 -36.81 21.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.778 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.731 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -59.62 -69.29 0.21 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.351 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.778 ' CB ' HD21 ' A' ' 27' ' ' LEU . 3.0 tm-20 -34.28 -42.05 0.13 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.839 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.402 ' C ' ' H ' ' A' ' 48' ' ' VAL . . . -59.14 -75.43 0.27 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.109 -1.044 . . . . 0.0 111.184 178.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.531 ' HA ' ' HB ' ' A' ' 56' ' ' THR . 20.7 pt20 -48.82 -9.37 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.85 HG21 ' HD1' ' A' ' 70' ' ' PHE . 68.7 t -75.02 -97.28 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.166 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' A' ' 48' ' ' VAL . 1.9 mmtm -163.02 124.63 2.51 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.549 0.613 . . . . 0.0 112.269 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.661 HG22 HG22 ' A' ' 68' ' ' VAL . 26.3 t -116.76 151.76 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.093 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 177.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.588 ' HB2' ' HB ' ' A' ' 67' ' ' THR . 0.9 OUTLIER -44.67 99.95 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.971 0.415 . . . . 0.0 110.937 -179.269 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 60.12 24.84 61.39 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.089 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.605 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -145.78 80.49 1.59 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.642 HG13 ' O ' ' A' ' 54' ' ' VAL . 8.7 p -89.24 78.92 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.896 0.379 . . . . 0.0 110.425 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 47' ' ' GLN . 3.1 mt-10 -113.13 -172.77 2.12 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.69 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.531 ' HB ' ' HA ' ' A' ' 47' ' ' GLN . 2.8 t -158.62 42.77 0.26 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.52 -179.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.525 ' O ' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -91.9 172.81 8.21 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.814 0.34 . . . . 0.0 110.991 179.95 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.9 mmmm -75.35 -55.74 5.4 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.033 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.4 mtm180 -100.46 141.66 33.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.011 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' CYS . . . . . 0.595 ' H ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -106.59 131.62 53.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.1 0.476 . . . . 0.0 111.318 -178.957 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.428 ' HA ' ' CG ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -110.07 74.71 0.9 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.245 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.6 mt -134.26 144.07 36.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.16 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.803 HG12 ' CD1' ' A' ' 15' ' ' LEU . 8.0 m -146.97 175.41 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.254 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.591 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 78.18 -144.64 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.542 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.633 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -100.22 83.47 0.55 Allowed Glycine 0 C--N 1.335 0.499 0 C-N-CA 121.17 -0.538 . . . . 0.0 113.382 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -122.27 163.41 19.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.664 0.269 . . . . 0.0 111.037 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.588 ' HB ' ' HB2' ' A' ' 51' ' ' ASP . 86.3 m -119.89 150.72 40.01 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.053 0.454 . . . . 0.0 112.043 -178.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.661 HG22 HG22 ' A' ' 50' ' ' VAL . 1.1 t -129.99 149.08 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.102 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -137.78 133.69 34.34 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -178.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.85 ' HD1' HG21 ' A' ' 48' ' ' VAL . 5.0 t80 -138.42 115.22 10.72 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.384 179.125 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 36.47 32.95 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 178.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 116.77 -13.2 14.93 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.361 -0.923 . . . . 0.0 113.531 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.406 ' O ' ' CH2' ' A' ' 32' ' ' TRP . 2.2 m-70 -88.25 82.51 7.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.955 0.378 . . . . 0.0 110.952 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.8 m -95.2 101.0 12.71 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.942 0.401 . . . . 0.0 110.943 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.558 HG13 ' HB1' ' A' ' 11' ' ' ALA . 46.5 t -120.27 155.71 23.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.721 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.502 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 25.5 mt-30 -111.57 161.21 16.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.94 0.4 . . . . 0.0 110.421 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.633 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 13.1 t -133.38 146.85 31.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.424 -178.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.0 m -131.47 157.24 43.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.985 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.253 -0.88 . . . . 0.0 111.147 -179.929 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.656 ' HB3' HG22 ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.455 -0.204 0 CA-C-O 120.645 0.26 . . . . 0.0 110.394 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.46 132.47 29.49 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.85 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.576 ' HB3' HG22 ' A' ' 77' ' ' VAL . 36.8 t80 -102.33 147.49 26.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.896 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.8 m -106.25 147.89 28.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.399 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.618 HD21 HG13 ' A' ' 21' ' ' VAL . 12.0 mt -118.61 -38.12 3.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.063 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.13 -103.75 2.9 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.397 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.0 mttt -143.58 41.87 1.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.019 0.437 . . . . 0.0 110.894 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -95.5 163.91 20.3 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.446 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.593 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 17.9 Cg_endo -58.59 -43.02 48.53 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.322 2.015 . . . . 0.0 112.008 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.593 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 19.9 p80 166.08 -163.96 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.203 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.618 HG13 HD21 ' A' ' 15' ' ' LEU . 3.8 m -139.47 154.23 24.57 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-O 121.09 0.471 . . . . 0.0 112.144 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.492 ' HG2' ' CB ' ' A' ' 59' ' ' ARG . 13.8 mt-10 -90.81 148.09 22.76 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.593 178.429 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.607 HD23 ' CD ' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -41.27 -50.34 3.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.795 0.331 . . . . 0.0 111.656 -179.656 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 17.9 t -65.64 -32.72 74.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.884 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.493 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 2.9 m-20 -64.57 -59.38 4.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.776 0.322 . . . . 0.0 110.323 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.606 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 12.5 tp -51.78 -40.48 60.43 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.891 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.835 HD21 ' HG3' ' A' ' 45' ' ' GLU . 12.6 mt -66.74 -67.87 0.42 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.111 0.482 . . . . 0.0 110.788 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.483 ' HE2' ' O ' ' A' ' 35' ' ' SER . 4.1 ttmt -50.15 -55.92 13.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.79 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.493 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.1 OUTLIER -53.83 -40.14 66.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.117 -178.991 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.606 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 1.1 mm-40 -80.35 -10.05 59.75 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.838 0.311 . . . . 0.0 111.838 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.68 25.13 21.56 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.249 -0.977 . . . . 0.0 113.342 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.73 ' CZ3' ' HB2' ' A' ' 73' ' ' HIS . 13.0 m95 -72.94 -61.99 1.62 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 117.133 0.466 . . . . 0.0 110.2 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.498 ' HB2' HG21 ' A' ' 41' ' ' ILE . 39.2 t -100.18 156.22 17.32 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.453 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -85.74 -35.15 20.97 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.186 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.483 ' O ' ' HE2' ' A' ' 28' ' ' LYS . 1.1 p -106.94 -46.21 3.99 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.524 178.262 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 120.81 -28.5 6.14 Favored Glycine 0 C--N 1.333 0.374 0 CA-C-N 115.745 -0.662 . . . . 0.0 112.882 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.98 1.74 3.31 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -60.91 -76.46 0.05 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.865 0.364 . . . . 0.0 111.105 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.15 15.4 0.57 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.928 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.3 mttp 66.1 24.93 10.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.983 0.421 . . . . 0.0 110.004 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.599 HG23 ' HE2' ' A' ' 70' ' ' PHE . 40.8 mm -52.99 -26.96 12.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.61 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.81 -78.33 0.08 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.928 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 34.4 mm -49.49 -34.34 8.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.856 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.692 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -63.5 -72.23 0.15 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.718 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.835 ' HG3' HD21 ' A' ' 27' ' ' LEU . 0.6 OUTLIER -32.79 -41.71 0.07 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.95 0.405 . . . . 0.0 110.879 -179.845 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.542 ' HA2' HD21 ' A' ' 23' ' ' LEU . . . -59.68 -77.02 0.19 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.268 -0.967 . . . . 0.0 110.848 178.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.629 ' HG3' ' O ' ' A' ' 44' ' ' ALA . 1.4 pt20 -46.52 -10.42 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.81 HG11 ' HA ' ' A' ' 70' ' ' PHE . 58.4 t -74.9 -92.86 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.906 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 48' ' ' VAL . 0.1 OUTLIER -168.12 125.73 1.13 Allowed 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.894 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.8 t -122.15 158.01 26.2 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -44.05 101.75 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.053 0.454 . . . . 0.0 111.71 -178.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 57.29 23.13 46.76 Favored Glycine 0 C--N 1.333 0.386 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.489 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -146.15 82.64 1.61 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.869 0.366 . . . . 0.0 111.787 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.523 HG13 ' O ' ' A' ' 54' ' ' VAL . 10.7 p -88.39 61.47 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.073 0.463 . . . . 0.0 110.824 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -101.14 -164.41 1.1 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.221 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.5 ' HB ' ' HA ' ' A' ' 47' ' ' GLN . 9.7 t -153.18 45.15 0.65 Allowed 'General case' 0 C--O 1.232 0.164 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.494 ' O ' HD13 ' A' ' 23' ' ' LEU . 52.3 mtt180 -87.77 174.98 8.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.067 0.46 . . . . 0.0 111.104 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -85.35 -38.72 18.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.086 179.395 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.492 ' CB ' ' HG2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -120.65 134.06 55.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.822 179.664 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -119.9 115.39 23.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.875 0.369 . . . . 0.0 110.73 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.657 ' O ' HD13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -74.15 89.85 2.01 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.033 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.657 HD13 ' O ' ' A' ' 61' ' ' LYS . 6.9 mm -133.11 138.22 51.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.207 0.527 . . . . 0.0 112.153 -178.171 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.563 ' O ' ' HB3' ' A' ' 64' ' ' ALA . 4.5 m -146.26 175.29 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.125 179.412 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 76.52 -143.14 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.649 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -99.91 83.44 0.57 Allowed Glycine 0 C--N 1.336 0.546 0 C-N-CA 121.308 -0.472 . . . . 0.0 112.129 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.507 ' HG3' HG22 ' A' ' 62' ' ' ILE . 2.3 mm-40 -122.36 159.63 27.08 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.887 0.375 . . . . 0.0 111.753 -178.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 7.3 m -120.37 144.46 47.87 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.458 -178.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.643 HG12 ' CH2' ' A' ' 32' ' ' TRP . 1.2 t -118.67 143.14 30.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.451 178.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -134.07 133.37 41.09 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.81 ' HA ' HG11 ' A' ' 48' ' ' VAL . 1.4 t80 -146.19 122.48 10.91 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.611 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 49.52 -85.47 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.343 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -129.14 -5.6 4.67 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.722 -0.751 . . . . 0.0 113.026 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.73 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 0.9 OUTLIER -90.61 113.07 25.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.967 0.384 . . . . 0.0 111.441 -179.269 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 72.1 m -120.48 115.54 23.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.178 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.656 HG22 ' HB3' ' A' ' 11' ' ' ALA . 59.4 t -138.59 155.23 27.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.803 0.335 . . . . 0.0 111.328 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.514 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 2.8 mt-30 -112.78 169.96 8.53 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.104 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.649 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 21.6 t -136.36 146.0 29.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.82 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.96 150.49 34.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.952 0.406 . . . . 0.0 111.665 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.336 -0.84 . . . . 0.0 110.964 179.727 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.769 ' HB1' HG22 ' A' ' 75' ' ' VAL . . . . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.597 0.237 . . . . 0.0 111.037 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.58 121.55 16.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.999 0.428 . . . . 0.0 111.168 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.871 ' HB3' HG22 ' A' ' 77' ' ' VAL . 37.1 t80 -99.02 155.28 17.52 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.945 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.5 m -106.63 148.73 27.97 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.272 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.516 HD21 ' CG1' ' A' ' 21' ' ' VAL . 5.1 mt -117.92 -28.74 5.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.851 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.09 40.06 62.34 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.972 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 56.93 68.46 0.86 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.974 0.416 . . . . 0.0 110.829 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.429 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 1.8 m170 -115.28 170.02 6.08 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.903 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.477 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 32.7 Cg_endo -64.86 -51.5 1.68 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.406 2.07 . . . . 0.0 112.356 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.641 ' HA ' HG13 ' A' ' 63' ' ' VAL . 7.4 p80 177.94 -179.72 0.28 Allowed 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.333 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.768 HG21 HD13 ' A' ' 26' ' ' LEU . 4.5 m -142.11 161.01 20.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -179.264 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.501 ' HG2' ' HA ' ' A' ' 59' ' ' ARG . 8.3 mt-10 -98.89 144.42 28.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.192 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.721 HD12 ' N ' ' A' ' 24' ' ' CYS . 0.9 OUTLIER -39.7 -38.02 0.59 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.629 -0.259 . . . . 0.0 111.561 -179.67 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.721 ' N ' HD12 ' A' ' 23' ' ' LEU . 48.9 t -73.38 -39.71 64.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.606 0.241 . . . . 0.0 111.189 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -62.86 -57.42 10.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.069 0.461 . . . . 0.0 110.358 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.079 HD11 HG21 ' A' ' 77' ' ' VAL . 12.6 tp -55.27 -45.97 76.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.268 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.849 HD23 HG22 ' A' ' 41' ' ' ILE . 4.0 mp -66.73 -59.95 3.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.885 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -49.31 -56.12 10.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.446 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.612 HD22 ' CE1' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -56.3 -38.42 71.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.089 -179.213 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.445 ' CG ' ' HB2' ' A' ' 13' ' ' PHE . 5.2 mm-40 -79.87 -10.95 59.83 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.097 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.82 24.02 18.9 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.257 -0.973 . . . . 0.0 113.155 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.654 ' CH2' HG12 ' A' ' 68' ' ' VAL . 11.2 m95 -75.92 -62.55 1.56 Allowed 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.299 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.409 ' CB ' HD12 ' A' ' 41' ' ' ILE . 7.5 t -106.38 138.54 42.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.339 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.67 -34.41 60.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.963 0.411 . . . . 0.0 110.408 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.9 -48.12 3.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.057 178.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 118.63 -22.85 9.18 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.231 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.47 -1.78 3.12 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -59.3 -77.95 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.611 0.243 . . . . 0.0 111.249 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.424 ' HB3' HG13 ' A' ' 41' ' ' ILE . . . -75.15 15.13 0.45 Allowed 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.9 mttt 61.85 25.34 15.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.765 0.317 . . . . 0.0 110.76 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.849 HG22 HD23 ' A' ' 27' ' ' LEU . 14.4 mt -61.37 -16.43 14.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.608 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.519 ' CA ' HD13 ' A' ' 23' ' ' LEU . . . -72.68 -79.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.314 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.441 HD11 ' NZ ' ' A' ' 58' ' ' LYS . 43.4 mm -53.9 -33.72 24.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.806 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.715 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -61.0 -72.2 0.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.232 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.749 ' CB ' HD21 ' A' ' 27' ' ' LEU . 2.4 tm-20 -34.76 -40.97 0.12 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.22 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.19 -73.93 0.4 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.156 -1.021 . . . . 0.0 110.628 178.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.827 ' HA ' HG22 ' A' ' 56' ' ' THR . 15.8 pt20 -48.9 -11.55 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.875 HG11 ' HA ' ' A' ' 70' ' ' PHE . 47.2 t -75.0 -90.92 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.102 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.432 ' HD3' ' HB ' ' A' ' 54' ' ' VAL . 6.4 mmtp -165.43 124.84 1.75 Allowed 'General case' 0 C--O 1.232 0.153 0 C-N-CA 120.193 -0.603 . . . . 0.0 112.284 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.542 HG11 ' CD1' ' A' ' 62' ' ' ILE . 34.2 t -119.08 142.77 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 178.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.539 ' HB2' ' H ' ' A' ' 67' ' ' THR . 0.8 OUTLIER -45.29 97.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.924 0.392 . . . . 0.0 111.567 -179.102 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.25 11.02 85.76 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.976 -0.631 . . . . 0.0 113.001 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.534 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -146.03 82.44 1.61 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 117.073 0.436 . . . . 0.0 112.033 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.517 HG22 ' O ' ' A' ' 54' ' ' VAL . 7.4 p -86.99 56.2 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.075 0.464 . . . . 0.0 110.081 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -99.65 179.72 4.45 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.628 -178.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.827 HG22 ' HA ' ' A' ' 47' ' ' GLN . 1.7 p -134.39 36.97 3.16 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.684 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.38 171.23 12.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.873 0.368 . . . . 0.0 111.189 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.441 ' NZ ' HD11 ' A' ' 43' ' ' ILE . 38.6 mttm -75.57 -46.46 31.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.682 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.501 ' HA ' ' HG2' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -116.61 137.65 52.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.633 179.862 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.24 115.28 26.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.77 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.441 ' HG2' ' CD2' ' A' ' 20' ' ' HIS . 11.5 mtpt -78.46 82.26 4.74 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.369 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.542 ' CD1' HG11 ' A' ' 50' ' ' VAL . 26.8 mt -133.61 147.97 30.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.261 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.641 HG13 ' HA ' ' A' ' 20' ' ' HIS . 1.9 m -154.99 175.87 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.245 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 76.22 -150.66 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.301 179.11 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -83.9 78.54 2.0 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.292 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -122.26 154.91 36.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.112 0.482 . . . . 0.0 110.956 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.627 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 87.6 m -114.46 156.28 24.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.375 -178.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.654 HG12 ' CH2' ' A' ' 32' ' ' TRP . 1.0 OUTLIER -133.01 148.97 31.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.672 179.34 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 76.8 p -143.12 139.86 30.6 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.875 ' HA ' HG11 ' A' ' 48' ' ' VAL . 2.3 t80 -150.82 124.36 9.02 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 114.902 -1.044 . . . . 0.0 110.323 179.29 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 49.52 -85.46 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.59 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -126.18 -6.99 5.61 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.972 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.526 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 1.7 m-70 -89.5 107.11 18.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.791 0.329 . . . . 0.0 111.54 -179.276 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.76 95.29 4.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.175 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.769 HG22 ' HB1' ' A' ' 11' ' ' ALA . 97.0 t -123.23 155.32 29.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.517 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.627 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 3.2 mp0 -113.26 165.1 12.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.971 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 1.079 HG21 HD11 ' A' ' 26' ' ' LEU . 11.0 t -139.76 150.57 22.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.974 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.0 m -129.17 165.5 28.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.973 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.215 -0.897 . . . . 0.0 111.191 179.892 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.075 0 CA-C-O 120.68 0.276 . . . . 0.0 110.698 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.97 133.82 34.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.56 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.875 ' HB3' HG22 ' A' ' 77' ' ' VAL . 58.4 t80 -105.35 156.58 18.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.1 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.2 m -107.16 142.7 36.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.963 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.802 HD22 ' HB2' ' A' ' 18' ' ' HIS . 0.5 OUTLIER -104.67 -40.62 5.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.445 179.375 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.22 42.95 6.82 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.702 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 50.18 59.31 4.64 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.93 0.395 . . . . 0.0 111.248 179.424 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.802 ' HB2' HD22 ' A' ' 15' ' ' LEU . 30.7 m170 -115.66 165.27 14.88 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.398 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.656 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 18.3 Cg_endo -57.75 -38.43 93.06 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.557 2.171 . . . . 0.0 112.386 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.656 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 12.0 p80 164.38 -173.7 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.72 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.628 HG13 HD21 ' A' ' 15' ' ' LEU . 2.4 m -145.79 166.47 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.217 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.507 ' HG2' ' HB2' ' A' ' 59' ' ' ARG . 70.4 mt-10 -95.97 141.03 29.87 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.818 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.613 HD21 ' O ' ' A' ' 57' ' ' ARG . 2.0 pp -44.12 -30.59 0.78 Allowed 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 -178.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.605 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -69.63 -40.71 76.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.78 0.324 . . . . 0.0 110.396 179.361 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -63.44 -60.63 3.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.049 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.993 HD11 HG21 ' A' ' 77' ' ' VAL . 2.6 tp -49.46 -49.25 46.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.652 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.835 HD21 ' HB2' ' A' ' 45' ' ' GLU . 9.5 mp -65.1 -61.76 1.95 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.445 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.605 ' HB2' ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -48.82 -55.59 11.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.348 -179.718 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.645 HD13 ' HZ ' ' A' ' 13' ' ' PHE . 1.2 mt -55.33 -42.49 73.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.533 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.521 ' OE2' HG11 ' A' ' 75' ' ' VAL . 1.3 mm-40 -71.19 -15.28 62.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.728 -0.214 . . . . 0.0 111.555 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.07 24.77 12.17 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.268 -0.968 . . . . 0.0 113.071 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.86 ' CH2' HG12 ' A' ' 68' ' ' VAL . 7.8 m0 -76.33 -66.28 0.82 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.959 0.38 . . . . 0.0 109.999 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.765 ' CB ' HD12 ' A' ' 41' ' ' ILE . 25.0 t -106.12 140.04 39.7 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.353 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -75.74 -34.96 60.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.898 0.38 . . . . 0.0 110.73 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.514 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 0.2 OUTLIER -106.45 -48.0 3.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.365 178.848 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.4 -26.25 8.72 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.201 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -127.58 -2.67 6.09 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.514 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 4.2 tp-100 -59.74 -76.56 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.674 0.273 . . . . 0.0 110.962 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.91 15.11 0.93 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.725 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.7 mttm 61.93 27.83 16.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.084 0.469 . . . . 0.0 110.401 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.799 HG23 ' CE2' ' A' ' 70' ' ' PHE . 12.7 mt -59.29 -25.0 29.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.554 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.07 -77.69 0.08 Allowed 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.144 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 31.6 mm -48.62 -36.29 7.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 120.896 0.379 . . . . 0.0 110.599 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.747 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -61.46 -67.06 0.44 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.519 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.835 ' HB2' HD21 ' A' ' 27' ' ' LEU . 5.9 tp10 -33.96 -45.73 0.21 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.852 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' A' ' 48' ' ' VAL . . . -59.23 -75.94 0.24 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.238 -0.982 . . . . 0.0 111.04 178.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.528 ' HG2' ' O ' ' A' ' 44' ' ' ALA . 12.4 pt20 -44.5 -15.86 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.815 HG21 ' HD1' ' A' ' 70' ' ' PHE . 93.6 t -75.05 -91.7 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 O-C-N 122.212 -0.305 . . . . 0.0 110.575 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -171.18 136.88 1.09 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.956 0.408 . . . . 0.0 111.146 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.566 HG11 HD11 ' A' ' 62' ' ' ILE . 58.5 t -131.7 144.95 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.951 179.306 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.551 ' HB3' ' H ' ' A' ' 67' ' ' THR . 37.6 t70 -60.61 77.23 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.055 0.455 . . . . 0.0 110.46 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 120.96 -12.46 9.89 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.408 -179.324 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.563 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . . . -132.37 133.69 44.27 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.892 0.377 . . . . 0.0 110.8 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.583 HG22 ' O ' ' A' ' 54' ' ' VAL . 12.6 p -125.2 31.98 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.714 179.441 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -107.49 160.21 15.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.283 0.563 . . . . 0.0 112.433 -178.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.51 HG23 ' O ' ' A' ' 56' ' ' THR . 14.8 t -108.66 50.12 0.79 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.556 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.613 ' O ' HD21 ' A' ' 23' ' ' LEU . 10.0 mtp180 -84.24 173.38 11.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.746 0.308 . . . . 0.0 111.018 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.1 ttmm -81.68 -0.69 43.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.991 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.507 ' HB2' ' HG2' ' A' ' 22' ' ' GLU . 0.3 OUTLIER -160.86 157.3 26.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.616 179.708 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' CYS . . . . . 0.636 ' SG ' HD11 ' A' ' 62' ' ' ILE . 1.6 t -134.93 114.99 13.08 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.484 ' HG2' ' CD2' ' A' ' 20' ' ' HIS . 3.6 mttm -76.0 94.62 3.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.36 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.636 HD11 ' SG ' ' A' ' 60' ' ' CYS . 16.2 mt -135.41 141.17 43.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.696 -179.274 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.661 HG12 HD13 ' A' ' 15' ' ' LEU . 0.8 OUTLIER -144.24 175.18 3.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.927 179.3 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 66.21 -150.17 0.21 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.716 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.605 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -86.79 79.13 1.84 Allowed Glycine 0 C--N 1.336 0.565 0 C-N-CA 121.451 -0.404 . . . . 0.0 113.498 -178.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.545 ' HG3' ' O ' ' A' ' 63' ' ' VAL . 0.7 OUTLIER -122.18 158.95 28.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.935 0.397 . . . . 0.0 111.347 179.775 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.611 HG23 ' HG3' ' A' ' 76' ' ' GLN . 0.3 OUTLIER -114.53 157.66 22.69 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.529 -178.71 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.86 HG12 ' CH2' ' A' ' 32' ' ' TRP . 1.2 t -133.96 147.51 30.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.829 179.042 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.661 ' HA ' ' O ' ' A' ' 73' ' ' HIS . 0.5 OUTLIER -137.7 132.15 32.44 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -178.939 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.815 ' HD1' HG21 ' A' ' 48' ' ' VAL . 1.7 t80 -139.32 117.9 12.2 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.347 178.217 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 38.01 30.0 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 179.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 117.17 -7.26 16.69 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.211 -0.995 . . . . 0.0 113.512 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.661 ' O ' ' HA ' ' A' ' 69' ' ' SER . 2.6 m-70 -87.9 89.79 8.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 117.242 0.521 . . . . 0.0 110.834 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 58.2 m -100.59 102.02 13.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.858 0.361 . . . . 0.0 111.008 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.565 ' HB ' ' HZ2' ' A' ' 32' ' ' TRP . 46.9 t -127.19 153.61 36.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.843 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.611 ' HG3' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -112.95 165.04 12.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.031 0.443 . . . . 0.0 111.122 179.538 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.993 HG21 HD11 ' A' ' 26' ' ' LEU . 45.3 t -138.11 154.86 28.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.48 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.498 ' O ' ' HB2' ' A' ' 15' ' ' LEU . 16.1 m -131.77 161.47 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.865 0.364 . . . . 0.0 111.417 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.321 -0.847 . . . . 0.0 111.429 179.624 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.982 ' HB1' HG13 ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.457 -0.098 0 CA-C-O 120.711 0.291 . . . . 0.0 111.141 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.62 109.42 6.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.781 0.324 . . . . 0.0 110.78 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.843 ' HB3' HG22 ' A' ' 77' ' ' VAL . 28.2 t80 -98.64 170.59 8.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.975 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.9 m -106.82 138.1 43.62 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.356 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.868 HD23 HG11 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -131.49 -37.99 1.19 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.221 179.337 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.406 ' H ' ' HA ' ' A' ' 79' ' ' ALA . . . -44.09 -27.69 1.14 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 121.213 -0.518 . . . . 0.0 113.002 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -55.46 -40.86 72.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.663 0.268 . . . . 0.0 111.257 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.588 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 42.4 m80 -119.64 163.06 29.48 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.319 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.734 ' O ' HG11 ' A' ' 63' ' ' VAL . 18.2 Cg_endo -59.74 -27.87 85.96 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.658 2.239 . . . . 0.0 112.496 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.555 ' HA ' HG12 ' A' ' 63' ' ' VAL . 4.7 p80 177.05 178.17 0.27 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.12 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.669 HG21 HD21 ' A' ' 15' ' ' LEU . 15.4 m -145.93 167.15 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.614 ' HG3' ' HA ' ' A' ' 59' ' ' ARG . 17.3 tt0 -100.35 144.2 29.64 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.08 178.428 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.671 HD13 ' O ' ' A' ' 42' ' ' ALA . 1.6 pp -40.86 -46.84 2.83 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.655 0.264 . . . . 0.0 111.625 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.659 ' N ' HD12 ' A' ' 23' ' ' LEU . 5.6 t -62.31 -38.05 87.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.751 0.31 . . . . 0.0 110.927 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -66.06 -57.61 7.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.885 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.881 HD11 HG21 ' A' ' 77' ' ' VAL . 7.2 tt -56.64 -42.05 78.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.053 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.959 HD23 HG22 ' A' ' 41' ' ' ILE . 6.7 mp -65.77 -62.29 1.59 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.972 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.04 -55.55 11.69 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.383 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.486 ' HB3' ' CZ ' ' A' ' 13' ' ' PHE . 6.6 mt -53.48 -40.16 65.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.265 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.66 ' CD ' HG11 ' A' ' 75' ' ' VAL . 0.4 OUTLIER -73.45 -15.17 61.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.605 -179.702 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.5 23.82 17.84 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.425 -0.893 . . . . 0.0 113.294 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.759 ' CH2' HG12 ' A' ' 68' ' ' VAL . 9.3 m0 -72.62 -59.04 2.91 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 117.215 0.508 . . . . 0.0 110.137 179.581 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.805 ' CB ' HD12 ' A' ' 41' ' ' ILE . 6.0 t -104.87 138.72 40.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.426 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -69.28 -33.77 73.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.905 0.383 . . . . 0.0 110.761 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.9 p -105.16 -42.44 5.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.064 0.459 . . . . 0.0 110.573 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 128.67 -43.34 1.33 Allowed Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.107 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.52 4.37 3.95 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -53.07 -70.38 0.09 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.838 0.352 . . . . 0.0 110.831 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.497 ' HB3' HG13 ' A' ' 41' ' ' ILE . . . -75.31 15.49 0.44 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.967 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.2 mttt 64.35 23.3 12.99 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 120.913 0.387 . . . . 0.0 110.163 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.959 HG22 HD23 ' A' ' 27' ' ' LEU . 29.8 mt -61.83 -19.63 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.617 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.671 ' O ' HD13 ' A' ' 23' ' ' LEU . . . -73.29 -78.92 0.09 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.916 0.389 . . . . 0.0 110.961 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.411 HD11 ' HD3' ' A' ' 58' ' ' LYS . 43.6 mm -52.41 -37.98 24.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.734 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.619 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -58.42 -69.38 0.19 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.155 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.677 ' HG3' HD21 ' A' ' 27' ' ' LEU . 12.3 tm-20 -34.53 -44.92 0.22 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.107 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.01 -73.14 0.44 Allowed Glycine 0 C--N 1.332 0.314 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.599 ' HG2' ' HB ' ' A' ' 56' ' ' THR . 0.0 OUTLIER -45.63 -15.44 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 179.614 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.818 HG21 ' HD1' ' A' ' 70' ' ' PHE . 46.2 t -74.92 -91.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 121.053 -0.259 . . . . 0.0 111.124 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.475 ' O ' ' HB2' ' A' ' 69' ' ' SER . 0.3 OUTLIER -175.74 130.13 0.25 Allowed 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.292 -0.563 . . . . 0.0 112.029 179.826 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.581 HG13 HG23 ' A' ' 68' ' ' VAL . 21.3 t -116.91 148.01 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.638 ' HB2' ' HB ' ' A' ' 67' ' ' THR . 14.0 t0 -44.85 99.21 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.934 0.397 . . . . 0.0 111.594 -179.128 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.37 17.67 70.68 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.225 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.533 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . . . -145.79 73.09 1.33 Allowed 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.249 0.547 . . . . 0.0 111.586 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.542 HG22 ' O ' ' A' ' 54' ' ' VAL . 3.0 p -84.33 69.25 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.419 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -100.48 -178.62 3.86 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.83 -179.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.599 ' HB ' ' HG2' ' A' ' 47' ' ' GLN . 3.0 p -142.45 37.74 1.52 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.172 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.458 ' O ' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -98.15 172.71 7.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.765 0.316 . . . . 0.0 111.256 -179.649 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.411 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -75.3 -41.77 56.18 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.45 179.713 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.614 ' HA ' ' HG3' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -123.8 145.56 48.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.645 179.424 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 60' ' ' CYS . . . . . 0.505 ' SG ' HD11 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -130.85 116.16 17.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.926 0.393 . . . . 0.0 111.439 -179.469 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.24 86.46 1.09 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.278 179.453 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.505 HD11 ' SG ' ' A' ' 60' ' ' CYS . 20.8 mt -133.37 139.94 47.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.224 -179.316 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.787 HG12 HD12 ' A' ' 15' ' ' LEU . 34.4 m -148.83 175.88 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.92 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.617 ' HA ' ' HB2' ' A' ' 79' ' ' ALA . . . 76.96 -147.94 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 178.274 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.712 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -84.36 75.62 2.34 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.25 -179.26 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.434 ' OE1' ' HB3' ' A' ' 51' ' ' ASP . 16.7 mm-40 -122.17 152.73 39.64 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.099 0.476 . . . . 0.0 111.285 -179.234 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.638 ' HB ' ' HB2' ' A' ' 51' ' ' ASP . 21.9 m -115.93 152.75 32.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.787 -178.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.759 HG12 ' CH2' ' A' ' 32' ' ' TRP . 0.8 OUTLIER -128.03 144.53 37.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.222 179.241 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' ' 49' ' ' LYS . 25.7 m -136.74 136.42 38.94 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.119 0.485 . . . . 0.0 112.246 -178.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.818 ' HD1' HG21 ' A' ' 48' ' ' VAL . 2.1 t80 -144.65 121.85 11.52 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.21 179.076 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 51.08 -81.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.981 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -131.75 -4.14 3.92 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.85 -0.69 . . . . 0.0 113.337 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.499 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 1.8 m-70 -91.48 112.62 24.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.087 0.444 . . . . 0.0 111.691 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.4 109.37 15.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.863 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.982 HG13 ' HB1' ' A' ' 11' ' ' ALA . 27.6 t -132.14 150.68 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 120.579 0.228 . . . . 0.0 111.468 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.612 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 1.5 mt-30 -112.29 172.4 6.93 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.008 0.432 . . . . 0.0 111.351 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.881 HG21 HD11 ' A' ' 26' ' ' LEU . 12.1 t -142.64 150.52 18.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.233 -178.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.1 m -127.49 158.78 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-O 120.746 0.307 . . . . 0.0 111.81 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.617 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.304 -0.855 . . . . 0.0 111.04 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.543 ' HB3' HG13 ' A' ' 75' ' ' VAL . . . . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.713 0.292 . . . . 0.0 111.021 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.55 135.24 53.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.28 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.721 ' CD2' HD12 ' A' ' 26' ' ' LEU . 1.1 t80 -101.07 95.59 6.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.309 179.228 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.56 ' HA ' HG23 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -73.05 111.26 8.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.855 0.359 . . . . 0.0 110.58 179.864 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.635 HD11 HG13 ' A' ' 21' ' ' VAL . 1.4 mt -82.46 -33.7 28.37 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.033 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.4 -73.86 0.67 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.715 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.44 52.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.129 0.49 . . . . 0.0 110.847 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.7 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 32.2 m170 -109.02 166.83 10.08 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.648 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.7 ' HD2' ' HB3' ' A' ' 18' ' ' HIS . 18.6 Cg_endo -57.97 -41.48 68.18 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.317 2.011 . . . . 0.0 111.831 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.601 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 9.0 p80 165.69 -164.71 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.256 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.795 HG21 HD13 ' A' ' 26' ' ' LEU . 22.6 m -142.73 156.91 18.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.354 0.597 . . . . 0.0 112.248 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.709 ' HG2' ' HA ' ' A' ' 59' ' ' ARG . 12.6 mt-10 -92.56 142.93 26.85 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.639 178.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.588 HD12 ' HB1' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -40.14 -40.05 1.02 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.726 0.298 . . . . 0.0 111.171 -179.61 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 54.0 t -67.1 -40.24 86.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.058 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -65.29 -57.15 9.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.023 179.667 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.795 HD13 HG21 ' A' ' 21' ' ' VAL . 9.9 tp -57.16 -47.77 80.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.436 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.702 HD23 HG22 ' A' ' 41' ' ' ILE . 4.6 mp -62.69 -57.34 11.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.785 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -50.76 -59.12 4.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.953 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 29' ' ' LEU . 18.7 mt -56.83 -44.04 81.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.583 -179.024 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.453 ' HG2' ' HD2' ' A' ' 13' ' ' PHE . 10.9 mm-40 -67.99 -14.99 63.4 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 121.117 -0.233 . . . . 0.0 111.165 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.24 22.54 26.97 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.359 -0.924 . . . . 0.0 113.209 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.59 ' CH2' HG12 ' A' ' 68' ' ' VAL . 9.3 m0 -68.84 -64.08 0.94 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.389 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.71 152.63 23.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.016 178.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -70.38 -34.56 72.72 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.28 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.587 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -106.13 -57.23 2.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.103 0.478 . . . . 0.0 110.568 179.241 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' A' ' 42' ' ' ALA . . . 152.63 -33.88 0.82 Allowed Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.972 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.37 7.53 1.33 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.587 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 2.1 tp60 -54.36 -70.33 0.1 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.701 0.286 . . . . 0.0 110.902 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.72 15.35 0.2 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.575 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.411 ' H ' ' C ' ' A' ' 38' ' ' GLN . 0.0 OUTLIER 69.11 16.26 8.63 Favored 'General case' 0 CA--C 1.523 -0.067 0 CA-C-O 120.734 0.302 . . . . 0.0 110.723 -179.378 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.702 HG22 HD23 ' A' ' 27' ' ' LEU . 22.9 mm -56.34 -26.5 22.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.299 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.588 ' HB1' HD12 ' A' ' 23' ' ' LEU . . . -70.75 -79.43 0.06 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.407 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.436 HD12 ' HD3' ' A' ' 58' ' ' LYS . 6.2 mm -48.04 -42.77 10.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.689 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.74 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -57.99 -64.21 0.99 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.506 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.569 ' HB2' HD21 ' A' ' 27' ' ' LEU . 3.1 tm-20 -35.94 -40.78 0.21 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.709 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' A' ' 48' ' ' VAL . . . -60.07 -75.07 0.3 Allowed Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 178.04 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.581 ' HG2' ' HB ' ' A' ' 56' ' ' THR . 0.0 OUTLIER -46.49 -12.59 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 179.891 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.798 HG21 ' HD1' ' A' ' 70' ' ' PHE . 57.7 t -74.99 -89.32 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.103 -179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.494 ' HG2' ' O ' ' A' ' 48' ' ' VAL . 5.8 mmmt -167.44 144.46 4.44 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.982 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.613 ' HB ' ' O ' ' A' ' 53' ' ' ALA . 14.0 t -131.04 145.7 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.547 ' HB2' ' HB ' ' A' ' 67' ' ' THR . 8.8 t0 -43.89 90.27 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -178.018 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 108.98 -31.93 7.31 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.712 -0.756 . . . . 0.0 114.03 178.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.613 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -147.58 145.59 29.08 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 117.851 0.825 . . . . 0.0 112.549 -179.128 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 54' ' ' VAL . 4.8 p -109.38 101.5 12.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.053 178.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -99.75 -165.05 1.18 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.966 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.581 ' HB ' ' HG2' ' A' ' 47' ' ' GLN . 5.2 t -165.24 31.06 0.06 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.775 0.322 . . . . 0.0 111.371 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.53 ' O ' HD21 ' A' ' 23' ' ' LEU . 6.3 mtt180 -89.07 167.85 12.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.023 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.436 ' HD3' HD12 ' A' ' 43' ' ' ILE . 58.3 mmtt -78.32 -35.61 47.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.237 0.542 . . . . 0.0 109.953 179.303 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.709 ' HA ' ' HG2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -106.93 135.08 49.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.563 179.592 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 60' ' ' CYS . . . . . 0.496 ' H ' ' HA ' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -104.39 118.29 36.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.879 0.371 . . . . 0.0 110.793 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.441 ' HA ' ' CD2' ' A' ' 20' ' ' HIS . 5.4 mtmt -98.99 74.06 1.98 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.11 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.48 ' O ' ' HB2' ' A' ' 20' ' ' HIS . 29.6 mt -137.88 145.26 29.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.657 -179.256 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.527 ' O ' ' HB3' ' A' ' 64' ' ' ALA . 0.5 OUTLIER -151.26 175.39 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.867 179.696 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 74.88 -148.89 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.424 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.438 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -85.13 74.76 2.43 Favored Glycine 0 C--N 1.335 0.513 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.732 -179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.437 ' O ' ' N ' ' A' ' 77' ' ' VAL . 27.9 mm-40 -122.35 150.0 42.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.955 0.407 . . . . 0.0 110.8 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.733 HG23 ' O ' ' A' ' 75' ' ' VAL . 77.1 m -114.83 150.38 35.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.384 -178.622 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.59 HG12 ' CH2' ' A' ' 32' ' ' TRP . 0.7 OUTLIER -125.77 145.57 32.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.523 178.774 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 28.4 p -139.32 138.8 37.0 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -178.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.798 ' HD1' HG21 ' A' ' 48' ' ' VAL . 1.9 t80 -143.04 122.2 12.93 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.21 179.175 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 48.04 -81.38 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.796 0.332 . . . . 0.0 111.396 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -130.7 -1.29 5.11 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.877 -0.678 . . . . 0.0 113.053 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -93.41 98.93 11.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.134 0.467 . . . . 0.0 111.624 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.3 m -109.82 108.28 18.55 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.405 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.733 ' O ' HG23 ' A' ' 67' ' ' THR . 25.1 t -128.55 156.44 40.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.819 -179.181 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.507 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 0.8 OUTLIER -112.05 161.55 16.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.815 0.34 . . . . 0.0 110.716 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.438 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 23.2 t -125.7 141.14 46.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.059 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.56 HG23 ' HA ' ' A' ' 14' ' ' SER . 29.3 m -129.77 152.23 37.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.866 0.365 . . . . 0.0 111.124 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.279 -0.867 . . . . 0.0 111.236 -179.776 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.738 ' HB3' HG22 ' A' ' 75' ' ' VAL . . . . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.779 0.323 . . . . 0.0 111.38 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -139.62 132.83 29.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.792 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.461 ' CE1' ' HB3' ' A' ' 29' ' ' LEU . 19.1 t80 -107.54 149.28 28.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.927 0.394 . . . . 0.0 111.294 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.63 150.63 26.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.738 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.5 mt -128.08 -40.47 1.67 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.144 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.91 -100.49 2.65 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.671 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.3 tppt? -148.83 53.62 0.98 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.992 0.425 . . . . 0.0 111.003 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.588 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 69.6 m-70 -106.12 163.95 15.98 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.898 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.588 ' HD2' ' HB3' ' A' ' 18' ' ' HIS . 18.3 Cg_endo -57.74 -45.18 34.87 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.615 2.21 . . . . 0.0 112.277 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.554 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 13.8 p80 170.91 -166.67 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.941 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.51 HG21 HD12 ' A' ' 26' ' ' LEU . 19.5 m -147.08 159.03 9.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.423 ' HG2' ' HA ' ' A' ' 59' ' ' ARG . 1.2 mt-10 -88.56 139.29 30.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.959 178.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.767 HD12 ' N ' ' A' ' 24' ' ' CYS . 0.9 OUTLIER -43.47 -32.5 0.9 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.884 0.374 . . . . 0.0 111.28 -179.653 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.767 ' N ' HD12 ' A' ' 23' ' ' LEU . 26.3 t -73.1 -38.23 66.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.816 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.408 ' N ' ' O ' ' A' ' 22' ' ' GLU . 6.5 m-20 -62.5 -55.31 28.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.743 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.708 HD11 HG21 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -54.89 -44.22 73.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.143 -179.913 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.705 HD23 HG22 ' A' ' 41' ' ' ILE . 5.2 mp -62.16 -64.31 0.97 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.45 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.6 ttmm -47.66 -52.46 18.08 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.974 -179.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.461 ' HB3' ' CE1' ' A' ' 13' ' ' PHE . 3.5 mm? -58.96 -46.51 87.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.322 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -70.52 -14.93 62.71 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.53 26.03 14.43 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.39 -0.91 . . . . 0.0 113.498 179.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.704 ' CH2' HG12 ' A' ' 68' ' ' VAL . 9.6 m0 -74.39 -64.89 0.93 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.015 0.436 . . . . 0.0 110.15 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.656 ' CB ' HD12 ' A' ' 41' ' ' ILE . 3.9 t -106.31 138.51 42.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.663 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.23 -33.66 37.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.707 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.447 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -105.33 -33.79 8.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.529 179.621 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.32 -20.42 50.34 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.792 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.97 -8.18 3.07 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.447 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 63.8 tp60 -55.51 -76.06 0.03 OUTLIER 'General case' 0 C--O 1.232 0.134 0 CA-C-O 120.724 0.297 . . . . 0.0 111.277 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.32 15.0 2.63 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.75 29.65 19.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.041 0.448 . . . . 0.0 110.44 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.852 HG23 ' CE2' ' A' ' 70' ' ' PHE . 18.6 mt -60.49 -23.89 29.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.982 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.62 -78.67 0.07 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.242 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.9 mm -51.8 -40.8 28.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.954 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.826 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -56.36 -68.65 0.19 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.617 179.553 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.565 ' HG3' HD11 ' A' ' 27' ' ' LEU . 3.7 tm-20 -35.82 -44.57 0.35 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.909 0.385 . . . . 0.0 110.965 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.47 -76.38 0.19 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.13 -1.033 . . . . 0.0 110.912 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.464 ' HA ' ' HB ' ' A' ' 56' ' ' THR . 14.7 pt20 -47.5 -12.07 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.826 HG23 ' O ' ' A' ' 44' ' ' ALA . 43.6 t -74.96 -90.83 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.285 -179.357 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -162.39 124.23 2.71 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 119.903 -0.719 . . . . 0.0 112.916 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.658 ' HB ' ' O ' ' A' ' 53' ' ' ALA . 45.2 t -117.13 148.1 20.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 177.479 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -44.68 96.1 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.912 0.387 . . . . 0.0 111.343 -179.024 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.34 17.86 74.66 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.627 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.658 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -146.03 82.56 1.61 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.017 0.437 . . . . 0.0 112.063 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.544 HG13 ' O ' ' A' ' 54' ' ' VAL . 12.5 p -86.85 59.08 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 0.0 110.874 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.16 -168.64 1.56 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.684 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.464 ' HB ' ' HA ' ' A' ' 47' ' ' GLN . 12.2 t -151.66 44.12 0.75 Allowed 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.607 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.676 ' O ' HD21 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -87.52 165.08 15.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.91 0.386 . . . . 0.0 111.292 -179.774 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.2 -40.07 59.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.791 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.423 ' HA ' ' HG2' ' A' ' 22' ' ' GLU . 2.6 mpt_? -111.67 134.38 53.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.918 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' CYS . . . . . 0.41 ' O ' ' O ' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -107.44 115.17 29.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.36 179.782 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.411 ' HA ' ' CG ' ' A' ' 20' ' ' HIS . 0.1 OUTLIER -92.53 76.49 5.07 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.129 0.49 . . . . 0.0 109.754 179.662 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.445 ' CG2' ' HG3' ' A' ' 66' ' ' GLN . 46.5 mt -139.2 153.32 24.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.43 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.577 ' O ' ' HB3' ' A' ' 64' ' ' ALA . 4.3 m -155.26 175.42 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.663 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.577 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 78.33 -150.52 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 178.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.712 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -84.87 77.41 2.11 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.939 -179.055 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.445 ' HG3' ' CG2' ' A' ' 62' ' ' ILE . 22.0 mm100 -122.18 157.72 30.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.913 0.387 . . . . 0.0 111.491 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.618 HG23 ' O ' ' A' ' 75' ' ' VAL . 25.1 m -118.58 156.72 28.66 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.673 0.619 . . . . 0.0 112.673 -178.173 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.704 HG12 ' CH2' ' A' ' 32' ' ' TRP . 1.2 t -137.34 149.37 25.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.891 179.11 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.602 ' HA ' ' O ' ' A' ' 73' ' ' HIS . 43.2 p -140.57 138.08 34.21 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.852 ' CE2' HG23 ' A' ' 41' ' ' ILE . 2.4 t80 -138.4 115.58 11.02 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.701 178.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.56 ' H ' HG11 ' A' ' 48' ' ' VAL . . . 38.29 31.6 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 116.67 -7.61 17.58 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.334 -0.936 . . . . 0.0 113.619 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.602 ' O ' ' HA ' ' A' ' 69' ' ' SER . 0.9 OUTLIER -88.14 83.83 6.95 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 117.252 0.526 . . . . 0.0 110.882 -179.427 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.2 m -92.58 111.47 23.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.979 0.419 . . . . 0.0 110.942 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.738 HG22 ' HB3' ' A' ' 11' ' ' ALA . 64.5 t -131.65 151.07 34.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.485 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.536 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 49.3 mt-30 -112.0 171.45 7.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.463 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.712 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 2.8 t -144.13 146.76 20.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.162 -178.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.0 m -136.38 170.44 18.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.838 0.351 . . . . 0.0 111.01 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.117 0 CA-C-O 118.214 -0.898 . . . . 0.0 111.068 179.881 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.626 ' HB3' HG13 ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.455 -0.209 0 CA-C-O 120.797 0.332 . . . . 0.0 111.042 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.55 130.55 51.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.146 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.614 ' O ' HG13 ' A' ' 77' ' ' VAL . 15.2 t80 -106.78 96.65 6.59 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.106 -179.289 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.411 ' HA ' ' CG2' ' A' ' 78' ' ' VAL . 7.7 t -70.95 110.56 5.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.94 0.4 . . . . 0.0 111.083 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 15' ' ' LEU . 13.8 mt -83.27 -31.55 26.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.555 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.05 -88.66 0.63 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.892 -0.671 . . . . 0.0 111.897 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.02 71.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.011 0.434 . . . . 0.0 110.886 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.432 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -117.43 172.18 4.24 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.38 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.606 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 38.0 Cg_endo -66.92 -41.56 9.97 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.054 1.836 . . . . 0.0 111.789 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.809 ' HA ' HG13 ' A' ' 63' ' ' VAL . 7.0 p80 170.68 -178.22 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.057 179.135 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.8 m -149.17 169.23 2.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.604 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -97.62 146.99 24.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.988 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.683 HD12 ' N ' ' A' ' 24' ' ' CYS . 4.3 pp -42.65 -34.0 0.81 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.46 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.683 ' N ' HD12 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -65.74 -43.58 88.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.85 0.357 . . . . 0.0 110.566 179.928 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.56 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 0.5 OUTLIER -61.82 -60.11 4.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.195 179.33 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.783 HD21 HG21 ' A' ' 77' ' ' VAL . 1.9 tp -50.08 -47.92 53.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.404 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.791 HD23 HG22 ' A' ' 41' ' ' ILE . 9.2 mp -67.5 -61.9 1.68 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.683 -179.339 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.509 ' HB2' ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -50.45 -54.43 22.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.002 -179.714 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.56 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 2.2 mt -56.8 -34.65 67.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.192 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.546 ' OE1' HG11 ' A' ' 75' ' ' VAL . 7.4 mm-40 -78.83 -15.13 58.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.408 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.33 22.23 22.68 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.421 -0.895 . . . . 0.0 113.104 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.675 ' CH2' HG12 ' A' ' 68' ' ' VAL . 9.2 m95 -72.81 -70.49 0.35 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 117.09 0.445 . . . . 0.0 109.896 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.736 ' CB ' HD12 ' A' ' 41' ' ' ILE . 8.6 t -95.05 138.9 32.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.956 178.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -75.7 -34.17 60.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.885 0.374 . . . . 0.0 110.792 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.407 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -105.3 -28.8 10.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.045 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.47 -37.5 3.79 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.49 179.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.32 5.27 2.97 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.407 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 43.4 tp60 -58.45 -72.6 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.712 0.292 . . . . 0.0 111.716 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.75 15.5 0.5 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.5 mtmm 64.49 24.53 13.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.053 0.454 . . . . 0.0 110.479 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.791 HG22 HD23 ' A' ' 27' ' ' LEU . 51.4 mt -59.56 -17.83 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.698 179.391 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.643 ' HB1' HD11 ' A' ' 23' ' ' LEU . . . -76.0 -77.91 0.12 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.042 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 13.1 mm -45.33 -45.7 3.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 121.078 0.466 . . . . 0.0 110.724 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.675 ' O ' ' HG3' ' A' ' 47' ' ' GLN . . . -57.82 -61.12 2.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.839 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.598 ' O ' HG23 ' A' ' 48' ' ' VAL . 9.9 tp10 -35.9 -35.6 0.07 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.143 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.459 ' O ' ' N ' ' A' ' 48' ' ' VAL . . . -72.16 -72.68 0.91 Allowed Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.24 -0.981 . . . . 0.0 111.743 178.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.675 ' HG3' ' O ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -39.93 -18.96 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -178.905 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.796 HG11 ' H ' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -75.34 -85.74 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.763 -179.55 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -176.56 130.55 0.2 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.467 -0.493 . . . . 0.0 112.112 179.723 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.628 HG11 ' CD1' ' A' ' 62' ' ' ILE . 49.6 t -125.04 150.83 30.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.721 178.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.58 ' HB2' ' H ' ' A' ' 67' ' ' THR . 1.2 m-20 -65.96 70.65 0.06 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.944 0.402 . . . . 0.0 110.601 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 135.92 -18.51 3.79 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.387 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.66 135.02 47.43 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.009 0.433 . . . . 0.0 111.123 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 54' ' ' VAL . 11.4 p -124.43 29.95 2.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.273 179.059 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -115.04 158.05 22.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.206 0.527 . . . . 0.0 111.495 -179.11 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.618 ' HB ' ' HB3' ' A' ' 47' ' ' GLN . 13.3 t -99.65 58.23 1.04 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.445 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 57' ' ' ARG . 14.6 mtt180 -89.13 171.81 9.54 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.785 0.326 . . . . 0.0 111.214 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.405 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -76.19 -48.24 21.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.23 179.655 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -122.4 154.82 37.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.035 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -136.91 119.19 15.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.899 0.38 . . . . 0.0 111.472 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.515 ' HG2' ' CD2' ' A' ' 20' ' ' HIS . 18.6 mttt -68.61 86.9 0.32 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.93 179.154 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.628 ' CD1' HG11 ' A' ' 50' ' ' VAL . 25.6 mt -134.54 139.98 46.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.955 0.407 . . . . 0.0 111.695 -179.049 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.809 HG13 ' HA ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -152.58 176.29 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.191 -179.649 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.602 ' HA ' ' HB3' ' A' ' 79' ' ' ALA . . . 75.26 -154.38 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.55 179.124 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.584 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -84.5 78.65 1.99 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.826 -178.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -122.3 157.07 32.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.092 0.472 . . . . 0.0 111.268 -179.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.58 ' H ' ' HB2' ' A' ' 51' ' ' ASP . 1.9 m -113.25 155.5 24.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.311 -178.56 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.675 HG12 ' CH2' ' A' ' 32' ' ' TRP . 0.9 OUTLIER -125.33 139.72 50.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.55 179.228 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.423 ' O ' ' HB ' ' A' ' 48' ' ' VAL . 0.7 OUTLIER -133.99 128.88 35.29 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.232 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.644 ' HA ' HG21 ' A' ' 48' ' ' VAL . 2.9 t80 -146.77 126.5 13.44 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.641 179.18 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.796 ' H ' HG11 ' A' ' 48' ' ' VAL . . . 46.13 -87.1 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.301 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -127.02 -8.73 4.5 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.889 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.658 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 1.8 m-70 -89.64 109.02 20.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.941 0.371 . . . . 0.0 111.471 -179.223 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.1 m -120.32 117.28 27.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.356 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.626 HG13 ' HB3' ' A' ' 11' ' ' ALA . 19.5 t -140.54 159.49 24.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.58 -179.257 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.569 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 19.5 mt-30 -112.66 163.15 14.89 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.028 0.442 . . . . 0.0 111.485 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.783 HG21 HD21 ' A' ' 26' ' ' LEU . 15.0 t -132.08 147.78 32.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.266 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.411 ' CG2' ' HA ' ' A' ' 14' ' ' SER . 24.5 m -129.12 162.45 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 CA-C-O 120.864 0.364 . . . . 0.0 111.291 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.602 ' HB3' ' HA ' ' A' ' 64' ' ' ALA . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.299 -0.858 . . . . 0.0 111.079 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.511 ' HB3' HG22 ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.456 -0.167 0 N-CA-C 110.383 -0.229 . . . . 0.0 110.383 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.11 130.3 35.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.973 0.416 . . . . 0.0 111.046 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.49 ' HB2' ' CG ' ' A' ' 30' ' ' GLU . 13.6 t80 -107.07 144.66 33.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.312 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 74.7 m -106.82 149.82 26.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.46 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.552 HD21 HG11 ' A' ' 77' ' ' VAL . 55.2 mt -118.25 -40.06 2.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.833 0.349 . . . . 0.0 110.866 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.32 -102.93 2.99 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.245 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.7 pttt -143.1 43.65 1.55 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.964 0.411 . . . . 0.0 111.227 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.655 ' CG ' ' HD2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -101.64 154.45 37.27 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.194 179.536 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.655 ' HD2' ' CG ' ' A' ' 18' ' ' HIS . 9.3 Cg_endo -50.91 -32.4 37.67 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.581 2.187 . . . . 0.0 112.008 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.555 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 10.4 p80 159.62 -165.38 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.809 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.698 HG21 HD12 ' A' ' 26' ' ' LEU . 15.1 m -133.52 141.94 43.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.989 0.423 . . . . 0.0 111.233 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.691 ' HA ' ' H ' ' A' ' 60' ' ' CYS . 1.3 mp0 -81.28 148.07 29.61 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.822 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.593 ' O ' HD12 ' A' ' 27' ' ' LEU . 4.0 mp -38.7 -54.8 1.54 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.766 0.317 . . . . 0.0 111.39 -179.429 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.3 t -60.68 -29.06 69.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.417 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 22' ' ' GLU . 1.0 OUTLIER -72.74 -62.38 1.47 Allowed 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.76 0.314 . . . . 0.0 111.382 -179.716 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.949 HD11 HG21 ' A' ' 77' ' ' VAL . 4.9 tt -51.97 -48.84 64.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.266 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.872 HD21 ' HG3' ' A' ' 45' ' ' GLU . 5.4 mt -60.51 -57.76 11.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.556 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.6 ttpt -55.66 -54.46 43.99 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.769 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.25 -51.22 68.91 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -178.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.501 ' CD ' HG11 ' A' ' 75' ' ' VAL . 3.1 mm-40 -63.71 -15.44 58.49 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.212 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.56 25.54 15.47 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.267 -0.968 . . . . 0.0 113.341 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.681 ' CH2' HG12 ' A' ' 68' ' ' VAL . 12.4 m95 -74.14 -61.27 1.91 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-N 117.417 0.608 . . . . 0.0 109.552 178.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.715 ' CB ' HD13 ' A' ' 41' ' ' ILE . 47.0 t -106.79 140.52 39.51 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.495 179.337 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.61 -34.1 67.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.978 0.418 . . . . 0.0 110.171 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.566 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -105.77 -47.05 3.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.466 179.354 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 129.29 -30.82 3.57 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.303 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.96 6.7 3.4 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.566 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 19.1 tp60 -52.25 -75.01 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.857 0.361 . . . . 0.0 110.69 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.506 ' HB3' HD11 ' A' ' 41' ' ' ILE . . . -79.96 15.35 1.48 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.562 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.1 mmtt 64.61 29.4 13.06 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 121.142 0.496 . . . . 0.0 110.283 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.92 HG23 ' CD2' ' A' ' 70' ' ' PHE . 2.5 mp -63.4 -24.31 35.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.0 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.56 -78.97 0.05 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.383 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.4 mm -50.54 -42.64 22.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.946 0.403 . . . . 0.0 110.832 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.676 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -58.06 -68.86 0.21 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.165 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.872 ' HG3' HD21 ' A' ' 27' ' ' LEU . 1.6 tm-20 -33.88 -42.18 0.11 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.944 0.402 . . . . 0.0 111.087 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.415 ' C ' ' H ' ' A' ' 48' ' ' VAL . . . -60.15 -72.64 0.59 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.348 178.624 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.539 ' CA ' ' HB ' ' A' ' 56' ' ' THR . 9.3 pt20 -49.84 -8.57 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.871 HG21 ' HD1' ' A' ' 70' ' ' PHE . 60.0 t -74.87 -90.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.293 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.519 ' HG2' ' O ' ' A' ' 48' ' ' VAL . 0.5 OUTLIER -171.18 133.97 0.89 Allowed 'General case' 0 C--O 1.232 0.132 0 C-N-CA 120.432 -0.507 . . . . 0.0 111.744 179.559 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.508 HG11 ' CD1' ' A' ' 62' ' ' ILE . 21.9 t -130.41 147.44 33.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.819 178.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.531 ' HB2' ' H ' ' A' ' 67' ' ' THR . 0.5 OUTLIER -63.53 79.83 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.08 0.466 . . . . 0.0 110.51 -179.888 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 125.52 -13.68 7.33 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.583 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.407 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . . . -135.96 135.45 39.58 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.965 0.412 . . . . 0.0 111.17 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 54' ' ' VAL . 10.5 p -125.55 31.19 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.886 178.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -104.71 -150.46 0.43 Allowed 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.799 -178.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.539 ' HB ' ' CA ' ' A' ' 47' ' ' GLN . 4.5 t -169.89 67.4 0.05 Allowed 'General case' 0 C--O 1.232 0.147 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.589 ' O ' HD13 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -94.95 174.15 7.23 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.46 179.192 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -75.12 -46.43 34.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.014 0.435 . . . . 0.0 110.224 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.436 ' O ' ' HG2' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -101.87 131.9 47.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.045 179.167 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 60' ' ' CYS . . . . . 0.691 ' H ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -100.08 115.61 30.18 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.979 0.419 . . . . 0.0 111.217 -179.449 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.466 ' HG3' ' NE2' ' A' ' 20' ' ' HIS . 0.1 OUTLIER -94.55 74.86 3.78 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.783 179.207 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.508 ' CD1' HG11 ' A' ' 50' ' ' VAL . 36.6 mt -133.65 142.09 42.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.061 0.458 . . . . 0.0 111.578 -178.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.603 ' O ' ' HB3' ' A' ' 64' ' ' ALA . 0.2 OUTLIER -150.77 175.96 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.606 -179.908 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.603 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 81.09 -154.29 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.513 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -93.7 79.02 1.03 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.631 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -122.63 162.22 22.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.147 0.498 . . . . 0.0 111.34 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.67 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 25.8 m -113.85 156.57 23.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.851 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.681 HG12 ' CH2' ' A' ' 32' ' ' TRP . 0.9 OUTLIER -131.75 146.04 34.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.005 179.335 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 60.0 p -143.66 139.13 29.41 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 120.907 0.384 . . . . 0.0 111.727 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.92 ' CD2' HG23 ' A' ' 41' ' ' ILE . 0.8 OUTLIER -128.48 -86.24 0.56 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.28 179.983 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -139.63 88.56 2.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.743 0.306 . . . . 0.0 110.464 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.17 -25.5 6.93 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.441 -0.885 . . . . 0.0 111.444 -178.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.625 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 0.9 OUTLIER -93.06 109.02 20.49 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 120.791 0.329 . . . . 0.0 110.914 -179.758 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.9 m -120.23 98.48 6.08 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.595 ' HB ' ' HZ2' ' A' ' 32' ' ' TRP . 38.9 t -120.32 151.16 23.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.475 -178.518 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.67 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 22.5 mt-30 -112.45 164.38 13.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.642 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.949 HG21 HD11 ' A' ' 26' ' ' LEU . 10.7 t -132.47 146.52 32.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.065 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 17.9 m -139.89 169.5 16.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.886 0.374 . . . . 0.0 111.144 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.181 -0.914 . . . . 0.0 111.071 179.863 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.476 ' HB3' HG13 ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.453 -0.275 0 CA-C-O 120.813 0.339 . . . . 0.0 110.65 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.69 135.46 53.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.464 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.71 ' O ' HG13 ' A' ' 77' ' ' VAL . 40.2 t80 -124.83 98.57 5.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.886 0.374 . . . . 0.0 110.87 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.75 141.5 57.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.721 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.575 ' CD1' HG12 ' A' ' 63' ' ' VAL . 0.6 OUTLIER -90.93 -36.89 13.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.633 179.906 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.26 -81.3 1.06 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.574 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.7 ttmm -171.44 39.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.887 0.375 . . . . 0.0 110.85 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.651 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 6.1 m-70 -98.67 165.1 15.7 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.713 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.651 ' HD2' ' HB3' ' A' ' 18' ' ' HIS . 42.2 Cg_endo -66.79 -37.3 21.07 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.272 1.982 . . . . 0.0 111.935 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.533 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 6.3 p80 172.71 -172.14 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.022 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.555 HG21 ' CD1' ' A' ' 26' ' ' LEU . 2.5 m -136.26 151.9 29.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.091 0.472 . . . . 0.0 112.255 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.423 ' O ' ' N ' ' A' ' 25' ' ' ASP . 2.5 mp0 -95.01 148.3 22.48 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.464 178.61 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.567 ' O ' HD12 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -40.7 -47.94 2.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.743 0.306 . . . . 0.0 111.636 -179.492 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -62.78 -34.72 77.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.877 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.436 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 8.7 m-20 -64.75 -62.2 1.72 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.046 0.45 . . . . 0.0 110.433 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.793 HD11 HG21 ' A' ' 77' ' ' VAL . 0.9 OUTLIER -50.64 -46.0 58.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.148 179.909 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.769 HD21 ' HG3' ' A' ' 45' ' ' GLU . 9.8 mt -67.07 -59.37 3.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.915 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.18 -58.59 7.31 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.436 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.2 OUTLIER -53.9 -45.49 71.12 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.677 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.641 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 4.3 mm-40 -72.55 -14.62 61.68 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.187 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.09 25.34 12.93 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.192 -1.004 . . . . 0.0 113.332 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.712 ' CD2' HD23 ' A' ' 27' ' ' LEU . 12.4 m95 -73.47 -58.6 3.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.041 0.448 . . . . 0.0 110.013 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.699 ' HA ' HD12 ' A' ' 41' ' ' ILE . 2.1 t -106.1 133.7 50.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.513 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -64.67 -34.12 77.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.608 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.434 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 56.2 p -105.83 -49.2 3.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.734 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 133.91 -32.54 2.66 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.764 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.23 6.57 1.73 Allowed 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.434 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 69.7 tp60 -54.61 -71.83 0.07 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.956 0.408 . . . . 0.0 110.852 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.05 15.22 1.17 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.465 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.38 20.84 11.86 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.629 -179.53 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.71 HG23 ' CD2' ' A' ' 70' ' ' PHE . 37.5 mt -54.88 -25.89 16.4 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-O 121.01 0.433 . . . . 0.0 110.712 179.6 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.492 ' HA ' ' CD1' ' A' ' 27' ' ' LEU . . . -67.72 -79.34 0.05 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.164 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 44.6 mm -51.2 -39.17 20.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.199 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.624 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -58.04 -68.88 0.21 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.238 179.182 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.769 ' HG3' HD21 ' A' ' 27' ' ' LEU . 0.9 OUTLIER -33.42 -41.9 0.09 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.749 179.741 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.475 ' HA2' HD21 ' A' ' 23' ' ' LEU . . . -57.44 -74.72 0.31 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.034 -1.079 . . . . 0.0 110.553 178.047 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.529 ' HA ' HG22 ' A' ' 56' ' ' THR . 13.8 pt20 -48.06 -12.84 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.762 HG21 ' HD1' ' A' ' 70' ' ' PHE . 58.7 t -75.02 -93.63 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.969 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.48 ' HD3' ' HB ' ' A' ' 54' ' ' VAL . 4.6 mmtt -166.92 124.89 1.32 Allowed 'General case' 0 C--O 1.23 0.065 0 C-N-CA 120.151 -0.619 . . . . 0.0 112.368 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.602 HG13 HG23 ' A' ' 68' ' ' VAL . 12.8 t -118.11 149.17 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 177.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.445 ' HB2' ' H ' ' A' ' 67' ' ' THR . 9.9 t0 -45.07 100.47 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.025 0.44 . . . . 0.0 111.534 -178.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 66.95 17.3 67.43 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.857 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.507 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -145.98 82.71 1.62 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.922 0.391 . . . . 0.0 111.945 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.635 HG13 ' O ' ' A' ' 54' ' ' VAL . 14.0 p -90.66 65.44 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.912 0.387 . . . . 0.0 110.582 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -99.83 -173.5 2.47 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.511 -179.173 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.529 HG22 ' HA ' ' A' ' 47' ' ' GLN . 0.8 OUTLIER -140.83 32.59 1.79 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.149 -179.708 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 19.4 mtp180 -84.74 169.13 14.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.062 0.458 . . . . 0.0 111.503 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.17 -32.01 55.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.915 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.2 mtt85 -131.76 146.54 52.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.654 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -129.51 115.89 18.13 Favored 'General case' 0 C--O 1.23 0.078 0 CA-C-O 120.89 0.376 . . . . 0.0 111.328 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.436 ' HG2' ' CD2' ' A' ' 20' ' ' HIS . 6.3 mttt -76.1 91.91 3.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.352 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.466 ' CD1' HG11 ' A' ' 50' ' ' VAL . 39.8 mt -133.77 139.72 48.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.265 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.575 HG12 ' CD1' ' A' ' 15' ' ' LEU . 2.5 m -146.23 175.2 2.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.119 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.533 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 74.98 -143.51 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.965 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -93.13 80.49 1.08 Allowed Glycine 0 C--N 1.336 0.552 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.766 -179.329 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -121.92 175.17 6.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.819 0.342 . . . . 0.0 111.228 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.445 ' H ' ' HB2' ' A' ' 51' ' ' ASP . 27.1 m -135.85 151.14 49.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.008 -178.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.712 HG12 ' CH2' ' A' ' 32' ' ' TRP . 1.2 t -130.5 144.13 38.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.309 179.135 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 67.8 m -140.99 141.23 34.4 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -178.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.762 ' HD1' HG21 ' A' ' 48' ' ' VAL . 1.9 t80 -146.08 122.28 10.85 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.273 179.096 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 49.78 -83.47 0.01 OUTLIER 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.481 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -127.46 -5.09 5.62 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.963 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.551 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 0.8 OUTLIER -89.46 113.79 25.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 117.01 0.405 . . . . 0.0 111.592 -179.027 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.61 111.35 17.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.285 178.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.587 ' HB ' ' HZ2' ' A' ' 32' ' ' TRP . 41.1 t -132.39 151.61 35.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.817 0.342 . . . . 0.0 111.488 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.438 ' HG3' ' OG1' ' A' ' 67' ' ' THR . 24.5 mp0 -113.2 159.53 19.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.423 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.793 HG21 HD11 ' A' ' 26' ' ' LEU . 6.3 t -125.07 138.7 53.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.084 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.1 m -133.88 154.54 38.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.014 0.435 . . . . 0.0 111.871 -179.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.431 ' HB2' ' HB2' ' A' ' 15' ' ' LEU . . . . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.058 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.15 0 CA-C-O 120.652 0.263 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.63 132.99 41.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.021 0.439 . . . . 0.0 110.902 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.486 ' HE1' HD23 ' A' ' 15' ' ' LEU . 16.8 t80 -99.72 98.24 9.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.967 179.745 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.416 ' HA ' HG23 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -77.18 98.98 5.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.764 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.486 HD23 ' HE1' ' A' ' 13' ' ' PHE . 17.9 mt -55.83 -34.14 65.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.985 0.421 . . . . 0.0 110.542 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.54 42.49 7.82 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.005 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt 61.3 39.38 15.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.981 0.419 . . . . 0.0 110.631 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.402 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 3.6 m170 -95.15 165.73 16.3 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.897 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.434 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 14.8 Cg_endo -56.99 -63.63 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.672 2.248 . . . . 0.0 112.612 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.434 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 8.5 p80 178.51 -174.05 0.16 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.241 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.421 ' N ' ' ND1' ' A' ' 20' ' ' HIS . 17.8 m -149.93 167.07 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.409 ' HB2' ' CB ' ' A' ' 59' ' ' ARG . 1.5 pt-20 -103.71 153.39 20.72 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.253 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.543 ' O ' HD13 ' A' ' 27' ' ' LEU . 81.6 mt -41.65 -45.55 3.44 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.534 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.0 t -65.37 -39.12 91.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.721 0.296 . . . . 0.0 111.671 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -62.12 -62.31 1.86 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.593 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.672 HD21 ' CG2' ' A' ' 77' ' ' VAL . 2.3 tp -53.69 -41.92 67.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.474 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.001 HD23 HG22 ' A' ' 41' ' ' ILE . 8.0 mp -66.81 -64.7 0.8 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.382 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -51.26 -57.0 10.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.988 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 24.9 mt -53.65 -31.02 45.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.079 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.556 ' OE2' HG11 ' A' ' 75' ' ' VAL . 2.4 mm-40 -84.05 -13.61 52.71 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.55 18.0 34.36 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.365 -0.922 . . . . 0.0 112.685 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.529 ' CE3' ' HG ' ' A' ' 27' ' ' LEU . 9.4 m0 -69.58 -60.81 2.09 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.279 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.64 ' CB ' HD12 ' A' ' 41' ' ' ILE . 2.1 t -106.83 134.04 50.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.99 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -63.95 -34.83 78.87 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.856 0.36 . . . . 0.0 111.048 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.559 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 79.0 p -106.25 -51.56 2.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.138 0.494 . . . . 0.0 110.225 178.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 139.29 -37.62 1.74 Allowed Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.3 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.03 11.25 3.33 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.559 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 3.4 tp-100 -63.11 -66.65 0.51 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.761 0.315 . . . . 0.0 110.777 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.29 14.41 0.94 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.727 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 46.0 mmtt 65.4 25.48 11.99 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.832 0.349 . . . . 0.0 110.745 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 1.001 HG22 HD23 ' A' ' 27' ' ' LEU . 5.3 mt -63.09 -27.12 42.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.267 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.84 -78.51 0.06 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.836 0.35 . . . . 0.0 110.577 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.6 mm -46.51 -35.81 2.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 121.104 0.478 . . . . 0.0 110.249 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.722 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -63.8 -62.61 1.54 Allowed 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.657 178.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.759 ' HB2' HD21 ' A' ' 27' ' ' LEU . 16.3 tp10 -32.35 -41.84 0.06 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.823 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.8 -71.6 0.92 Allowed Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.355 -0.926 . . . . 0.0 111.743 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.522 ' HG3' ' O ' ' A' ' 44' ' ' ALA . 0.7 OUTLIER -43.69 -19.54 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.726 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.84 HG21 ' HD1' ' A' ' 70' ' ' PHE . 21.5 t -75.85 -85.05 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.945 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -170.36 133.17 1.05 Allowed 'General case' 0 C--O 1.23 0.055 0 CA-C-O 120.804 0.335 . . . . 0.0 111.138 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.665 ' HB ' ' HB3' ' A' ' 53' ' ' ALA . 4.4 t -134.62 144.19 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.056 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 67' ' ' THR . 6.0 t70 -48.74 91.25 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.75 0.31 . . . . 0.0 111.442 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 94.27 -7.4 72.3 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.875 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.665 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . . . -129.0 131.33 47.39 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 117.323 0.562 . . . . 0.0 111.187 -179.623 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 54' ' ' VAL . 7.5 p -124.84 32.51 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.861 178.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -101.99 154.64 18.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.936 -178.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.47 ' HA ' ' N ' ' A' ' 47' ' ' GLN . 12.1 t -92.88 46.84 1.24 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.643 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.68 169.98 17.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.187 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.09 -32.25 20.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.125 0.488 . . . . 0.0 109.819 178.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.409 ' CB ' ' HB2' ' A' ' 22' ' ' GLU . 36.2 mtm180 -128.38 151.94 48.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.991 179.339 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' CYS . . . . . 0.616 ' SG ' HD11 ' A' ' 62' ' ' ILE . 18.4 t -136.94 117.29 13.62 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.827 0.346 . . . . 0.0 111.105 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.02 99.0 2.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.394 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.616 HD11 ' SG ' ' A' ' 60' ' ' CYS . 1.5 mt -133.36 142.65 41.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.151 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.513 ' O ' ' HB3' ' A' ' 64' ' ' ALA . 25.6 m -147.54 170.71 3.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.39 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 72.34 -155.5 0.09 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.387 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.551 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -87.17 82.96 1.59 Allowed Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 121.516 -0.373 . . . . 0.0 112.285 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.454 ' HB3' ' CB ' ' A' ' 51' ' ' ASP . 5.0 mm100 -121.48 160.91 23.21 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.972 0.415 . . . . 0.0 111.577 -178.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.821 HG23 ' HG3' ' A' ' 76' ' ' GLN . 0.2 OUTLIER -116.23 149.07 39.76 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.551 -178.498 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.548 HG13 ' OE2' ' A' ' 45' ' ' GLU . 1.1 t -125.88 142.47 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.651 179.121 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.407 ' O ' ' HB ' ' A' ' 48' ' ' VAL . 13.2 m -138.14 133.53 33.47 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -178.494 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.858 ' CE2' HG23 ' A' ' 41' ' ' ILE . 1.9 t80 -144.05 122.57 12.45 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.1 178.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 47.21 -85.5 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.724 0.297 . . . . 0.0 111.535 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -127.31 -4.89 5.75 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.037 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.487 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 1.8 m-70 -92.75 110.1 21.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.025 0.413 . . . . 0.0 111.3 -179.323 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.0 m -120.69 125.16 46.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.278 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.556 HG11 ' OE2' ' A' ' 30' ' ' GLU . 47.0 t -147.23 160.64 8.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.808 0.337 . . . . 0.0 111.564 -179.293 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.821 ' HG3' HG23 ' A' ' 67' ' ' THR . 35.8 mt-30 -112.41 164.02 13.75 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.949 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.672 ' CG2' HD21 ' A' ' 26' ' ' LEU . 16.9 t -137.13 147.12 27.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.658 -179.274 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.416 HG23 ' HA ' ' A' ' 14' ' ' SER . 17.0 m -134.22 178.01 6.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 120.718 0.294 . . . . 0.0 110.624 178.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.331 -0.842 . . . . 0.0 111.098 -179.978 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.168 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.58 80.29 1.28 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.88 0.371 . . . . 0.0 110.736 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.1 ttt -168.58 72.91 0.1 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.309 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 34.8 pt -99.49 148.47 6.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.885 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 33.6 m80 -84.43 -174.88 5.52 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.725 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.427 ' C ' ' H ' ' A' ' 8' ' ' SER . 1.5 mtt180 -147.57 109.92 4.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.74 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.404 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 74.43 -31.32 0.21 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.294 -179.548 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.427 ' H ' ' C ' ' A' ' 6' ' ' ARG . 0.6 OUTLIER 67.72 115.99 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.864 0.364 . . . . 0.0 110.9 179.667 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -108.75 83.88 1.84 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.868 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.57 71.78 2.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.037 0.446 . . . . 0.0 110.414 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.602 ' HB1' HG13 ' A' ' 75' ' ' VAL . . . -77.16 102.55 6.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.095 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.3 123.23 26.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.895 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.896 ' HB3' HG22 ' A' ' 77' ' ' VAL . 50.0 t80 -100.87 152.82 20.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.911 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.83 153.46 21.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.101 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.925 ' HB2' ' HB2' ' A' ' 79' ' ' ALA . 9.3 mt -129.32 -40.16 1.47 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.785 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.44 -111.54 3.63 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.73 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.86 57.4 1.35 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.114 0.483 . . . . 0.0 110.624 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.671 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 2.3 m-70 -110.04 165.84 11.9 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.567 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.671 ' HD2' ' HB3' ' A' ' 18' ' ' HIS . 31.2 Cg_endo -62.64 -41.25 32.53 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.098 1.866 . . . . 0.0 111.863 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.572 ' HA ' ' CG1' ' A' ' 63' ' ' VAL . 21.5 p80 171.38 -170.36 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.721 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.6 m -145.78 158.99 12.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.236 0.541 . . . . 0.0 112.365 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.574 ' HG3' ' HA ' ' A' ' 59' ' ' ARG . 8.2 tt0 -88.78 139.21 30.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.848 178.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.781 HD12 ' N ' ' A' ' 24' ' ' CYS . 4.1 pp -42.45 -30.48 0.34 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.781 0.324 . . . . 0.0 111.404 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.781 ' N ' HD12 ' A' ' 23' ' ' LEU . 3.5 t -72.47 -40.17 67.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.977 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.401 ' N ' ' O ' ' A' ' 22' ' ' GLU . 1.9 m-20 -65.74 -53.73 36.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.938 0.399 . . . . 0.0 110.702 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.871 HD11 HG21 ' A' ' 77' ' ' VAL . 10.1 tt -54.75 -48.72 72.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.825 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.872 HD23 HG22 ' A' ' 41' ' ' ILE . 8.9 mp -65.76 -63.03 1.18 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.648 -178.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.0 tmmm? -43.84 -59.43 2.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.023 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.483 ' HB3' ' CE1' ' A' ' 13' ' ' PHE . 0.5 OUTLIER -56.13 -47.5 78.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.226 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.629 ' CD ' HG11 ' A' ' 75' ' ' VAL . 2.3 mm-40 -62.11 -15.21 43.84 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.681 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.04 24.68 14.34 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.321 -0.942 . . . . 0.0 113.253 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.649 ' CH2' HG12 ' A' ' 68' ' ' VAL . 7.8 m0 -79.09 -63.88 1.32 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.248 0.524 . . . . 0.0 109.988 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.54 ' CB ' HD12 ' A' ' 41' ' ' ILE . 3.9 t -106.72 135.37 48.37 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.778 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.41 -33.36 71.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.827 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.7 p -104.67 -40.46 5.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.493 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 121.83 -30.74 5.2 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.027 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -138.31 5.93 2.53 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.701 0.259 . . . . 0.0 111.701 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 21.5 tp60 -54.91 -74.69 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.859 0.362 . . . . 0.0 110.952 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.464 ' HB3' HG13 ' A' ' 41' ' ' ILE . . . -74.62 15.68 0.34 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.77 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.4 mttm 64.48 24.57 13.15 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 120.961 0.41 . . . . 0.0 110.073 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.872 HG22 HD23 ' A' ' 27' ' ' LEU . 16.9 mt -63.71 -18.92 23.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.708 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.659 ' HB1' HD11 ' A' ' 23' ' ' LEU . . . -74.11 -79.14 0.09 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.93 0.395 . . . . 0.0 110.663 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 29.4 mm -46.61 -45.01 6.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.674 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.658 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -54.33 -68.14 0.21 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.91 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.617 ' HA ' ' HB2' ' A' ' 70' ' ' PHE . 6.6 tp10 -32.66 -45.14 0.12 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.604 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 55' ' ' GLU . . . -57.84 -74.37 0.35 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 119.875 -1.155 . . . . 0.0 110.637 178.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.564 ' CA ' ' HB ' ' A' ' 56' ' ' THR . 4.4 pt20 -46.33 -14.62 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.755 HG21 ' HD1' ' A' ' 70' ' ' PHE . 56.0 t -74.92 -88.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.116 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -172.84 128.87 0.5 Allowed 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.828 0.346 . . . . 0.0 111.019 179.221 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.574 ' HB ' ' HB3' ' A' ' 53' ' ' ALA . 44.7 t -124.29 149.48 28.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.591 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -55.66 85.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.132 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 106.78 -6.15 37.62 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.115 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.574 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . . . -133.75 135.42 43.92 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 117.148 0.474 . . . . 0.0 111.267 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.497 HG22 ' O ' ' A' ' 54' ' ' VAL . 12.1 p -125.42 38.13 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.306 178.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.488 ' HB3' ' H ' ' A' ' 56' ' ' THR . 7.6 mt-10 -106.94 -151.39 0.46 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.211 -0.449 . . . . 0.0 112.171 -178.12 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.564 ' HB ' ' CA ' ' A' ' 47' ' ' GLN . 3.5 t -166.96 57.3 0.08 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.927 0.394 . . . . 0.0 111.469 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.2 mtt-85 -86.29 175.29 8.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.019 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.21 -47.53 27.82 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.574 ' HA ' ' HG3' ' A' ' 22' ' ' GLU . 3.8 mtm180 -115.21 153.09 31.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.237 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -125.68 137.22 53.84 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.928 0.394 . . . . 0.0 111.231 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.508 ' HG3' ' CD2' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -99.98 77.59 2.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.441 179.485 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.3 mt -133.9 144.49 35.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.42 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.572 ' CG1' ' HA ' ' A' ' 20' ' ' HIS . 6.5 m -150.28 175.64 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.183 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.676 ' HA ' ' HB3' ' A' ' 79' ' ' ALA . . . 74.4 -150.39 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.082 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.641 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -84.93 77.74 2.08 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.319 -0.467 . . . . 0.0 112.963 -178.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 18.3 mm100 -122.09 158.71 28.66 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.859 0.361 . . . . 0.0 110.979 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.624 HG23 ' O ' ' A' ' 75' ' ' VAL . 26.9 m -117.15 154.64 30.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.141 0.496 . . . . 0.0 112.251 -178.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.649 HG12 ' CH2' ' A' ' 32' ' ' TRP . 0.7 OUTLIER -127.37 143.25 41.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.44 178.995 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 36.8 m -136.66 132.82 35.5 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -178.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.755 ' HD1' HG21 ' A' ' 48' ' ' VAL . 1.4 t80 -141.95 122.77 14.39 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.336 178.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 46.67 -87.01 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.687 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -126.66 -6.06 5.69 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.858 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.403 ' O ' ' CH2' ' A' ' 32' ' ' TRP . 1.0 OUTLIER -90.61 103.59 16.27 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.793 0.33 . . . . 0.0 111.042 -179.464 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.3 m -114.65 125.57 53.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.602 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.641 ' HB ' ' HZ2' ' A' ' 32' ' ' TRP . 47.0 t -145.59 153.58 13.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.23 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.487 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 3.1 mp0 -112.25 158.28 19.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.813 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.896 HG22 ' HB3' ' A' ' 13' ' ' PHE . 46.9 t -129.2 152.22 36.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.813 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.2 m -130.89 148.97 33.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.921 0.391 . . . . 0.0 111.53 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.925 ' HB2' ' HB2' ' A' ' 15' ' ' LEU . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.077 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 112.554 -0.218 . . . . 0.0 112.554 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 63.43 103.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.828 0.347 . . . . 0.0 110.987 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.3 mtt -80.39 -48.42 12.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.721 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.584 HG22 ' O ' ' A' ' 4' ' ' ILE . 26.7 mt 65.7 41.14 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.124 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 14.4 t-160 -71.54 -20.82 61.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.138 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.5 ttt180 61.65 94.51 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.827 0.346 . . . . 0.0 110.781 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -114.15 -69.43 0.86 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.881 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.7 t -105.61 104.63 14.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.015 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -88.72 154.33 20.37 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.911 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -71.56 156.39 39.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.665 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.534 ' HB3' HG13 ' A' ' 75' ' ' VAL . . . -98.73 134.28 41.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.166 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.64 132.26 48.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.592 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.813 ' HB3' HG22 ' A' ' 77' ' ' VAL . 77.8 t80 -110.04 148.57 31.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.923 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.5 146.9 30.02 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.809 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.663 HD21 HG11 ' A' ' 77' ' ' VAL . 27.8 mt -114.23 -40.45 3.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.921 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.65 -103.75 2.89 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.585 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.06 56.62 0.9 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.995 0.426 . . . . 0.0 111.011 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.421 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 1.0 OUTLIER -113.36 167.33 9.49 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.578 179.863 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.59 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 19.4 Cg_endo -59.8 -33.55 96.12 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.3 2.0 . . . . 0.0 111.665 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.59 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 14.1 p80 163.01 -164.32 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.989 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.579 HG21 HD13 ' A' ' 26' ' ' LEU . 4.9 m -142.92 153.91 17.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.139 0.495 . . . . 0.0 112.004 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.459 ' HG3' ' CB ' ' A' ' 59' ' ' ARG . 0.7 OUTLIER -83.53 138.34 33.46 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.907 179.019 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.718 HD12 ' N ' ' A' ' 24' ' ' CYS . 4.6 pp -41.03 -33.27 0.31 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.764 0.316 . . . . 0.0 111.478 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.718 ' N ' HD12 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -71.3 -39.15 71.63 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.988 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 22' ' ' GLU . 78.8 m-20 -62.73 -52.27 63.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.05 0.452 . . . . 0.0 110.442 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.754 HD21 HG21 ' A' ' 77' ' ' VAL . 8.4 tp -58.23 -46.5 85.8 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.893 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.803 HD23 HG22 ' A' ' 41' ' ' ILE . 5.6 mp -67.33 -60.69 2.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.651 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -46.53 -65.26 0.58 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.752 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.57 -41.61 63.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.212 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 2.9 mm-40 -72.27 -15.3 61.91 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.19 26.26 12.71 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.475 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.561 ' CH2' HG12 ' A' ' 68' ' ' VAL . 9.4 m95 -76.39 -66.04 0.85 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 117.094 0.447 . . . . 0.0 110.079 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.0 t -101.0 149.29 24.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.315 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.32 -34.08 36.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.04 0.448 . . . . 0.0 110.489 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.78 -31.95 8.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.585 179.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 126.08 -60.22 0.65 Allowed Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.346 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -129.32 7.59 5.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.789 0.328 . . . . 0.0 111.281 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -54.21 -64.38 0.85 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.872 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.514 ' HB3' ' CD1' ' A' ' 41' ' ' ILE . . . -74.19 15.08 0.35 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -179.202 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.1 mmmt 72.24 14.14 5.58 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.622 0.249 . . . . 0.0 111.206 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.803 HG22 HD23 ' A' ' 27' ' ' LEU . 6.8 mt -65.5 -14.99 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-O 120.969 0.414 . . . . 0.0 110.739 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.533 ' HA ' HD13 ' A' ' 23' ' ' LEU . . . -72.21 -79.81 0.07 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.047 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 19.8 mm -52.33 -33.13 16.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.985 0.421 . . . . 0.0 110.51 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.789 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -63.09 -72.18 0.14 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.683 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.747 ' HG3' HD11 ' A' ' 27' ' ' LEU . 3.6 tm-20 -35.35 -41.09 0.16 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.838 0.352 . . . . 0.0 111.157 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.41 ' C ' ' H ' ' A' ' 48' ' ' VAL . . . -63.04 -73.8 0.49 Allowed Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.277 -0.964 . . . . 0.0 110.928 178.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.458 ' HG3' ' O ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -47.96 -9.52 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -179.62 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.789 HG23 ' O ' ' A' ' 44' ' ' ALA . 57.4 t -74.66 -90.67 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.644 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.625 ' HD3' ' HB ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -167.02 119.37 0.95 Allowed 'General case' 0 CA--C 1.527 0.08 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.73 179.694 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.544 ' HB ' ' O ' ' A' ' 53' ' ' ALA . 19.2 t -113.62 154.98 14.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.098 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.644 ' HB2' ' H ' ' A' ' 67' ' ' THR . 16.8 t0 -44.7 98.2 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.017 0.437 . . . . 0.0 111.611 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.93 21.43 61.18 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.339 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.544 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -145.79 79.87 1.57 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.021 0.439 . . . . 0.0 111.766 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.625 ' HB ' ' HD3' ' A' ' 49' ' ' LYS . 14.9 p -88.21 62.76 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.926 0.393 . . . . 0.0 111.044 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.42 178.4 4.65 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.297 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.8 t -139.31 40.59 2.08 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.801 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -86.91 174.39 8.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.693 0.282 . . . . 0.0 111.01 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.1 mttp -75.18 -50.27 16.8 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.965 0.412 . . . . 0.0 110.806 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.459 ' CB ' ' HG3' ' A' ' 22' ' ' GLU . 0.3 OUTLIER -106.4 136.88 45.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.27 179.402 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -100.04 115.58 30.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.949 0.404 . . . . 0.0 111.031 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.586 ' O ' HD13 ' A' ' 62' ' ' ILE . 4.7 mtmt -87.12 76.01 9.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.881 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.586 HD13 ' O ' ' A' ' 61' ' ' LYS . 3.5 mm -133.44 142.39 41.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.981 -179.06 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.534 ' O ' ' HB3' ' A' ' 64' ' ' ALA . 1.4 m -146.85 175.2 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.724 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 74.48 -155.01 0.05 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.313 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.528 ' HA2' HG12 ' A' ' 78' ' ' VAL . . . -84.73 81.13 1.77 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 121.329 -0.462 . . . . 0.0 112.515 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.508 ' HG3' HG22 ' A' ' 62' ' ' ILE . 7.9 mm-40 -122.05 156.46 33.49 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.111 0.481 . . . . 0.0 111.264 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.644 ' H ' ' HB2' ' A' ' 51' ' ' ASP . 0.8 OUTLIER -113.55 152.9 29.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.752 -179.109 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.561 HG12 ' CH2' ' A' ' 32' ' ' TRP . 0.8 OUTLIER -127.34 147.07 32.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.645 179.237 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.4 m -143.16 137.8 29.31 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -178.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.783 ' CD1' HG21 ' A' ' 48' ' ' VAL . 1.6 t80 -144.91 121.66 11.2 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.084 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 48.72 -85.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.689 0.28 . . . . 0.0 111.347 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -126.77 -5.72 5.75 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.786 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.438 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 1.1 m-70 -88.39 104.4 16.74 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.888 0.344 . . . . 0.0 111.084 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -116.9 106.72 13.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.838 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.534 HG13 ' HB3' ' A' ' 11' ' ' ALA . 38.6 t -126.17 155.94 36.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.017 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.542 ' CG ' HG23 ' A' ' 67' ' ' THR . 1.3 mt-30 -112.33 158.02 20.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.012 0.434 . . . . 0.0 111.058 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.813 HG22 ' HB3' ' A' ' 13' ' ' PHE . 29.0 t -140.39 148.0 22.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.329 -179.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.528 HG12 ' HA2' ' A' ' 65' ' ' GLY . 17.0 m -139.92 178.03 3.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.707 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.073 -179.902 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.301 0 N-CA-C 112.565 -0.214 . . . . 0.0 112.565 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.7 m 65.68 -171.44 0.19 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.656 0.265 . . . . 0.0 110.786 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 8.3 ttt -67.05 152.7 45.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.138 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 23.5 mt 60.36 117.89 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.56 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -172.82 -60.45 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.831 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 16.8 mtt180 58.4 167.66 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.051 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 17.9 mmt 58.28 -172.3 0.1 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.612 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.3 m 67.55 161.59 0.18 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.878 0.37 . . . . 0.0 110.702 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -165.46 -62.38 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.475 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -95.72 -176.09 3.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.768 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.874 ' HB1' HG13 ' A' ' 75' ' ' VAL . . . -92.71 83.34 4.83 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.754 0.312 . . . . 0.0 111.036 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.5 112.23 7.88 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.474 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.848 ' HB3' HG22 ' A' ' 77' ' ' VAL . 73.8 t80 -98.67 144.13 28.28 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.002 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.4 m -107.02 135.72 48.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.478 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.729 HD22 ' HB2' ' A' ' 18' ' ' HIS . 0.5 OUTLIER -84.91 -33.18 22.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.849 0.357 . . . . 0.0 110.529 179.698 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.59 33.07 28.83 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.291 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 25.5 mttm 58.73 56.14 4.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.069 0.461 . . . . 0.0 110.764 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.729 ' HB2' HD22 ' A' ' 15' ' ' LEU . 12.9 m170 -115.36 166.14 12.68 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.867 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.577 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 23.8 Cg_endo -60.97 -36.94 80.48 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.386 2.057 . . . . 0.0 112.151 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.577 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 22.4 p80 168.14 -174.6 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.406 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.551 HG13 HD21 ' A' ' 15' ' ' LEU . 2.5 m -140.96 160.44 23.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.189 0.519 . . . . 0.0 111.975 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.42 ' O ' ' N ' ' A' ' 25' ' ' ASP . 0.5 OUTLIER -94.26 141.76 28.19 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.038 179.351 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.621 ' O ' HD13 ' A' ' 27' ' ' LEU . 8.1 mt -38.08 -39.28 0.39 Allowed 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -73.4 -37.59 65.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.387 -179.396 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 22' ' ' GLU . 56.6 m-20 -61.62 -54.52 41.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.06 0.457 . . . . 0.0 111.074 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.049 HD11 HG21 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -60.06 -43.31 95.52 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.658 -179.546 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.902 HD23 HG22 ' A' ' 41' ' ' ILE . 6.7 mp -68.33 -56.87 7.05 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.701 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -56.95 -55.87 29.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.859 0.362 . . . . 0.0 111.216 -179.597 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 81.9 mt -53.41 -37.73 62.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.685 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.487 ' OE1' HG11 ' A' ' 75' ' ' VAL . 8.7 mm-40 -79.08 -11.33 59.99 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.12 22.9 23.92 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.366 -0.921 . . . . 0.0 113.226 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.528 ' CH2' HG12 ' A' ' 68' ' ' VAL . 11.9 m95 -73.97 -63.21 1.27 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.008 0.432 . . . . 0.0 109.96 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.1 t -106.95 135.19 48.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.915 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -74.43 -34.69 63.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.022 0.439 . . . . 0.0 110.247 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.0 p -106.4 -44.76 4.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.268 178.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 112.74 -21.82 17.94 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.987 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -128.63 -1.24 5.47 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 111.709 0.262 . . . . 0.0 111.709 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.4 tp60 -61.11 -79.42 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.79 0.329 . . . . 0.0 110.611 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.32 11.28 2.47 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.562 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.3 mttm 59.44 29.81 19.42 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 120.798 0.332 . . . . 0.0 110.297 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.902 HG22 HD23 ' A' ' 27' ' ' LEU . 8.0 mt -60.06 -17.67 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.613 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.4 -79.09 0.09 Allowed 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.822 0.344 . . . . 0.0 111.111 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 44.2 mm -47.38 -36.54 4.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.97 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.797 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -61.81 -67.24 0.43 Allowed 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.346 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.781 ' HG2' HD11 ' A' ' 27' ' ' LEU . 12.3 tp10 -33.62 -42.08 0.1 Allowed 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 120.902 0.382 . . . . 0.0 110.466 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.1 -77.4 0.18 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 119.936 -1.126 . . . . 0.0 110.938 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.52 ' HG3' ' O ' ' A' ' 44' ' ' ALA . 0.6 OUTLIER -48.26 -10.88 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -179.645 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.922 HG11 ' HA ' ' A' ' 70' ' ' PHE . 47.5 t -75.33 -96.66 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.033 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -164.86 120.96 1.45 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 118.404 0.547 . . . . 0.0 111.576 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.613 HG13 HG23 ' A' ' 68' ' ' VAL . 16.5 t -114.05 150.39 16.09 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.432 ' HB2' ' HB ' ' A' ' 67' ' ' THR . 20.7 t70 -44.79 97.05 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.972 0.415 . . . . 0.0 111.441 -178.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.98 16.7 70.87 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.759 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.57 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -145.91 81.14 1.59 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.122 0.487 . . . . 0.0 112.09 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.501 HG13 ' O ' ' A' ' 54' ' ' VAL . 7.0 p -90.3 71.95 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.126 0.488 . . . . 0.0 110.309 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 47' ' ' GLN . 8.2 mt-10 -99.34 -173.14 2.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.817 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 t -147.29 46.19 1.14 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.908 0.385 . . . . 0.0 111.62 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 19.0 mtt-85 -98.02 174.54 6.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.535 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.506 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 1.7 mptp? -75.2 -38.12 60.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.012 0.434 . . . . 0.0 110.08 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -127.72 158.29 38.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.064 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' CYS . . . . . 0.419 ' HB2' ' HG ' ' A' ' 23' ' ' LEU . 0.5 OUTLIER -133.96 115.8 14.81 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.388 -179.605 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.482 ' HG2' ' CD2' ' A' ' 20' ' ' HIS . 31.4 mtmt -74.14 94.53 2.44 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.068 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.44 HD13 ' O ' ' A' ' 61' ' ' LYS . 5.8 mm -133.49 144.89 34.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.328 -178.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.566 HG11 ' O ' ' A' ' 19' ' ' PRO . 14.3 m -148.4 174.45 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.807 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.498 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 72.69 -151.27 0.07 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.646 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -88.87 81.26 1.54 Allowed Glycine 0 C--N 1.337 0.585 0 C-N-CA 121.472 -0.394 . . . . 0.0 112.6 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -122.05 156.06 34.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.135 0.493 . . . . 0.0 111.414 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.52 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 40.3 m -118.65 147.69 43.51 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.233 -178.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.613 HG23 HG13 ' A' ' 50' ' ' VAL . 0.7 OUTLIER -124.21 148.23 28.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.031 178.986 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 49' ' ' LYS . 58.1 m -141.7 138.46 32.44 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.922 ' HA ' HG11 ' A' ' 48' ' ' VAL . 2.8 t80 -152.16 127.08 9.64 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.614 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 47.55 -85.85 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.334 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -128.2 -7.92 4.29 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.039 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.476 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 1.9 m-70 -89.22 108.77 19.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.145 0.472 . . . . 0.0 111.391 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -118.99 107.45 13.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.171 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.874 HG13 ' HB1' ' A' ' 11' ' ' ALA . 22.0 t -130.5 152.95 38.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.039 0.447 . . . . 0.0 111.944 -178.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.52 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 28.6 mt-30 -111.87 164.29 13.26 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.427 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 1.049 HG21 HD11 ' A' ' 26' ' ' LEU . 21.3 t -136.52 148.73 26.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.547 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.2 m -131.63 160.05 42.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.947 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.291 -0.861 . . . . 0.0 111.144 179.978 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.207 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.7 m -113.26 -56.76 2.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.851 0.357 . . . . 0.0 110.942 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -85.81 119.75 26.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.011 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 pt -138.14 72.21 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.971 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 64.5 139.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.69 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.487 ' HD3' ' HA ' ' A' ' 6' ' ' ARG . 6.9 tpp180 -168.66 71.46 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.98 0.419 . . . . 0.0 111.037 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.48 -62.9 1.18 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.449 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 78.2 p -132.13 165.98 22.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.347 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -142.03 106.5 4.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.889 0.376 . . . . 0.0 111.37 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 36.2 mtt -93.59 128.33 39.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.58 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.659 ' O ' HG13 ' A' ' 75' ' ' VAL . . . -84.35 119.66 25.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.758 0.313 . . . . 0.0 111.045 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.1 p -137.0 129.04 29.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.185 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.749 ' HB3' HG22 ' A' ' 77' ' ' VAL . 41.6 t80 -98.36 154.48 17.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.006 0.431 . . . . 0.0 110.749 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.7 m -106.42 155.53 19.46 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.107 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.605 ' CD1' ' HA ' ' A' ' 63' ' ' VAL . 6.7 mt -122.2 -31.51 3.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.545 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.19 -111.7 3.42 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.023 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -149.84 54.72 0.94 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.306 0.574 . . . . 0.0 110.16 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.671 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 16.2 m-70 -118.98 168.6 9.5 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.766 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.671 ' HD2' ' HB3' ' A' ' 18' ' ' HIS . 7.7 Cg_endo -48.36 -44.45 29.46 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.742 2.295 . . . . 0.0 112.62 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.55 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 3.9 p80 162.75 -165.65 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.091 0.556 . . . . 0.0 109.929 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.518 ' O ' ' O ' ' A' ' 60' ' ' CYS . 15.5 m -134.77 147.23 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 120.959 0.409 . . . . 0.0 111.888 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.65 ' HA ' ' H ' ' A' ' 60' ' ' CYS . 1.2 mt-10 -83.93 143.54 29.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.634 179.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.704 ' O ' HD13 ' A' ' 27' ' ' LEU . 2.5 mp -39.82 -36.45 0.44 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.83 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 9.2 t -76.31 -35.51 58.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.329 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' A' ' 22' ' ' GLU . 30.1 m-20 -64.29 -62.03 1.87 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.969 0.414 . . . . 0.0 110.691 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.51 HD11 HG21 ' A' ' 77' ' ' VAL . 9.7 tt -55.05 -44.98 75.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.338 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.797 HD23 HG22 ' A' ' 41' ' ' ILE . 5.8 mp -62.23 -54.35 42.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.698 -178.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.9 -48.89 79.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.635 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 45.7 mt -58.35 -48.13 81.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.267 -0.424 . . . . 0.0 112.012 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.506 ' CG ' ' HB2' ' A' ' 13' ' ' PHE . 7.4 mm-40 -70.75 -12.25 61.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.55 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.96 23.26 30.56 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.846 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.545 ' CZ3' ' HB2' ' A' ' 73' ' ' HIS . 23.1 m95 -64.63 -73.52 0.12 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.8 0.333 . . . . 0.0 110.334 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.585 ' HB2' HG21 ' A' ' 41' ' ' ILE . 24.6 t -92.91 147.27 22.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.787 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -76.75 -33.32 58.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.684 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.462 ' OG ' ' HB3' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -105.42 -28.8 10.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.112 179.71 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 115.79 -72.71 0.26 Allowed Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.445 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -120.41 -2.96 9.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.771 0.32 . . . . 0.0 111.042 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.462 ' HB3' ' OG ' ' A' ' 35' ' ' SER . 3.9 tp60 -52.63 -62.85 1.38 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.914 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.481 ' HB3' HG12 ' A' ' 41' ' ' ILE . . . -73.87 15.05 0.32 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.797 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.8 mttt 68.61 15.95 9.07 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.695 0.283 . . . . 0.0 111.046 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.797 HG22 HD23 ' A' ' 27' ' ' LEU . 45.5 mm -58.54 -20.93 17.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.023 0.439 . . . . 0.0 110.926 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.05 -76.4 0.12 Allowed 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.93 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.6 mm -47.85 -42.52 9.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.772 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.783 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -57.94 -66.6 0.45 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.383 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.718 ' HB2' HD21 ' A' ' 27' ' ' LEU . 9.3 tp10 -30.94 -44.83 0.06 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.56 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.93 -74.56 0.36 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.169 -1.015 . . . . 0.0 110.892 178.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.447 ' HA ' ' O ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -47.57 -11.58 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -179.787 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.983 HG21 ' CD1' ' A' ' 70' ' ' PHE . 39.7 t -75.32 -99.61 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 O-C-N 122.137 -0.352 . . . . 0.0 111.668 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.7 ' HD3' ' HB ' ' A' ' 54' ' ' VAL . 8.2 mmtp -161.0 138.64 9.29 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.702 0.683 . . . . 0.0 111.839 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.663 ' HB ' ' O ' ' A' ' 53' ' ' ALA . 44.1 t -127.58 147.91 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.306 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.74 ' HB2' ' HB ' ' A' ' 67' ' ' THR . 12.9 t0 -44.03 87.01 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -177.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 101.87 -19.13 50.83 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.739 -0.743 . . . . 0.0 114.821 177.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.663 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -146.77 136.68 23.31 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 118.41 1.105 . . . . 0.0 113.041 -178.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.7 ' HB ' ' HD3' ' A' ' 49' ' ' LYS . 11.3 p -107.43 108.68 25.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.238 178.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' A' ' 47' ' ' GLN . 47.3 mt-10 -102.98 -170.28 1.77 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.642 0.258 . . . . 0.0 110.845 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.6 t -164.0 30.27 0.08 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.354 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.17 169.99 9.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.947 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.1 ttpp -75.86 -43.83 43.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.594 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.455 ' HA ' ' HG2' ' A' ' 22' ' ' GLU . 0.3 OUTLIER -102.31 142.63 33.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.747 179.854 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' CYS . . . . . 0.65 ' H ' ' HA ' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -100.08 116.58 32.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.805 -179.789 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.414 ' HA ' ' CD2' ' A' ' 20' ' ' HIS . 11.3 mtmt -103.74 78.75 1.59 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.173 0.511 . . . . 0.0 109.875 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.436 HD12 ' SG ' ' A' ' 60' ' ' CYS . 22.0 mt -138.95 148.92 23.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.172 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.605 ' HA ' ' CD1' ' A' ' 15' ' ' LEU . 1.3 m -151.11 175.09 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.698 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.577 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 78.76 -138.45 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.569 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -104.41 84.25 0.42 Allowed Glycine 0 C--N 1.339 0.695 0 C-N-CA 121.041 -0.599 . . . . 0.0 113.624 -178.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 61.9 mm-40 -122.05 163.19 19.85 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.757 0.313 . . . . 0.0 111.145 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.74 ' HB ' ' HB2' ' A' ' 51' ' ' ASP . 8.9 m -119.11 139.87 51.06 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.247 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.68 137.16 44.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.36 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.6 m -132.0 128.18 37.83 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.919 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.983 ' CD1' HG21 ' A' ' 48' ' ' VAL . 4.1 t80 -175.68 130.38 0.26 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.351 179.013 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.452 ' N ' ' CD1' ' A' ' 70' ' ' PHE . . . 56.99 44.91 22.08 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.393 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 70.16 1.6 35.23 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.791 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.545 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 8.3 m-70 -94.55 98.16 10.64 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.877 0.338 . . . . 0.0 111.111 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.96 101.77 11.79 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.659 HG13 ' O ' ' A' ' 11' ' ' ALA . 40.8 t -120.37 147.55 24.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.569 -178.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.545 ' HG3' HG23 ' A' ' 67' ' ' THR . 2.0 mp0 -111.94 145.65 39.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.667 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.749 HG22 ' HB3' ' A' ' 13' ' ' PHE . 8.0 t -120.62 145.66 26.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.333 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.8 m -128.59 157.53 41.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.947 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.568 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . . . . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.294 -0.86 . . . . 0.0 111.04 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 112.6 -0.2 . . . . 0.0 112.6 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.76 138.14 34.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.818 0.342 . . . . 0.0 110.954 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.35 140.96 18.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.818 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.8 mm -91.97 139.17 18.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.072 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -138.16 -59.5 0.64 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.111 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -97.79 150.78 20.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.035 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -133.55 165.56 24.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.78 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.74 112.52 6.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.074 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -142.98 -37.84 0.36 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.158 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 8.3 mtt -79.43 137.92 37.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.982 0.42 . . . . 0.0 110.989 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.712 ' HB3' HG22 ' A' ' 75' ' ' VAL . . . -84.09 141.72 30.92 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.09 178.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.62 135.85 40.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.94 0.4 . . . . 0.0 110.773 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.738 ' CE2' ' HA ' ' A' ' 26' ' ' LEU . 31.7 t80 -103.98 143.11 33.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.557 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.447 ' O ' ' CE1' ' A' ' 13' ' ' PHE . 0.4 OUTLIER -106.84 132.63 52.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.389 179.471 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.739 HD11 HG12 ' A' ' 63' ' ' VAL . 0.5 OUTLIER -75.51 -37.23 60.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.82 0.343 . . . . 0.0 110.845 179.868 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.66 29.48 26.62 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.306 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.19 43.18 20.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.053 0.454 . . . . 0.0 110.722 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.452 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 1.2 m-70 -114.67 168.6 7.8 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.845 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.517 ' O ' HG11 ' A' ' 63' ' ' VAL . 8.8 Cg_endo -50.38 -43.68 42.92 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.694 2.263 . . . . 0.0 112.215 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.528 ' CA ' HD21 ' A' ' 15' ' ' LEU . 6.3 p80 172.85 -163.79 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.839 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.403 HG11 ' CE1' ' A' ' 13' ' ' PHE . 9.8 m -142.05 153.58 18.72 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.489 ' HG2' ' CB ' ' A' ' 59' ' ' ARG . 14.6 mt-10 -100.64 153.8 19.11 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.135 178.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.686 ' HB2' ' O ' ' A' ' 58' ' ' LYS . 1.5 mp -40.23 -54.85 2.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.732 0.301 . . . . 0.0 111.42 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.596 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -57.63 -33.75 68.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.748 179.791 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -72.31 -55.07 7.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.884 0.373 . . . . 0.0 110.975 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.738 ' HA ' ' CE2' ' A' ' 13' ' ' PHE . 7.6 tt -57.79 -47.93 81.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.406 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.999 HD23 HG22 ' A' ' 41' ' ' ILE . 7.5 mp -64.45 -59.14 4.69 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.596 ' HB2' ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -51.49 -59.21 4.51 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.263 -178.723 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.47 -50.62 69.4 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -178.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.561 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 2.0 mm-40 -61.85 -15.26 40.74 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.05 23.04 13.79 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.319 -0.943 . . . . 0.0 113.443 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.637 ' CE3' ' HG ' ' A' ' 27' ' ' LEU . 7.7 m0 -73.53 -66.48 0.69 Allowed 'General case' 0 C--O 1.232 0.165 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.7 ' CB ' HD12 ' A' ' 41' ' ' ILE . 6.2 t -106.83 143.25 35.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.185 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -70.24 -34.15 72.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.852 0.358 . . . . 0.0 110.692 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.493 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -105.73 -52.14 2.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.443 179.307 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 139.07 -31.82 2.33 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.432 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.98 8.7 2.1 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.493 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 3.2 tp-100 -55.25 -71.11 0.09 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.703 0.287 . . . . 0.0 111.155 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.56 15.5 0.47 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 71.44 19.44 5.21 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.045 0.45 . . . . 0.0 110.35 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.999 HG22 HD23 ' A' ' 27' ' ' LEU . 9.9 mt -61.13 -22.86 28.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.293 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.64 -77.75 0.08 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.997 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.412 ' CD1' ' HG2' ' A' ' 58' ' ' LYS . 37.1 mm -51.61 -41.78 28.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.928 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.609 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -57.74 -71.19 0.11 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.623 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.743 ' CB ' HD21 ' A' ' 27' ' ' LEU . 1.6 tm-20 -33.46 -40.13 0.06 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.013 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.419 ' C ' ' H ' ' A' ' 48' ' ' VAL . . . -60.09 -75.35 0.28 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.289 -0.957 . . . . 0.0 110.986 178.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.537 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 3.8 pt20 -49.15 -8.17 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.847 HG21 ' HD1' ' A' ' 70' ' ' PHE . 97.7 t -75.33 -98.71 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.144 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.554 ' N ' HG12 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -161.87 126.15 3.29 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.973 -179.303 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.795 HG13 HG13 ' A' ' 68' ' ' VAL . 21.4 t -121.73 149.2 24.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.516 ' HB2' ' HB ' ' A' ' 67' ' ' THR . 22.2 t0 -44.96 102.48 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.864 0.364 . . . . 0.0 111.224 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 63.52 20.78 64.0 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.172 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.555 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . . . -146.19 74.6 1.38 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.981 0.42 . . . . 0.0 111.657 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.54 HG13 ' O ' ' A' ' 54' ' ' VAL . 7.5 p -86.25 63.72 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.983 0.42 . . . . 0.0 110.263 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.445 ' O ' ' HA ' ' A' ' 47' ' ' GLN . 21.6 mt-10 -102.29 -170.21 1.78 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.506 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.537 ' OG1' ' HB3' ' A' ' 47' ' ' GLN . 3.1 t -142.89 47.67 1.53 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.553 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 45.3 mtp85 -98.53 174.22 6.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.962 0.41 . . . . 0.0 111.3 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.686 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 24.0 mttm -79.61 -38.67 33.35 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.924 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.489 ' CB ' ' HG2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -128.34 159.36 35.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.856 -179.759 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -140.67 115.79 9.85 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.218 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.74 96.88 2.1 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.484 ' CG2' ' HG3' ' A' ' 66' ' ' GLN . 13.1 mt -133.47 136.01 55.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.809 -178.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.739 HG12 HD11 ' A' ' 15' ' ' LEU . 31.1 m -141.72 175.6 5.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.535 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.429 ' O ' ' HA ' ' A' ' 78' ' ' VAL . . . 71.19 -136.52 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.635 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.573 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -106.37 86.04 0.46 Allowed Glycine 0 C--N 1.339 0.702 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.192 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.484 ' HG3' ' CG2' ' A' ' 62' ' ' ILE . 8.4 mm-40 -122.05 172.25 8.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.716 0.293 . . . . 0.0 111.47 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 4.9 m -130.31 152.13 50.06 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.795 HG13 HG13 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -135.52 152.64 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.385 179.795 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.634 ' HA ' ' O ' ' A' ' 73' ' ' HIS . 0.4 OUTLIER -146.25 137.63 24.63 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -179.643 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.936 ' CE2' HG23 ' A' ' 41' ' ' ILE . 1.8 t80 -137.12 118.7 14.89 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.619 178.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 38.2 30.01 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 116.39 -6.63 18.76 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.365 -0.921 . . . . 0.0 113.563 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.634 ' O ' ' HA ' ' A' ' 69' ' ' SER . 1.4 m-70 -88.13 82.98 7.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.317 0.558 . . . . 0.0 111.145 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.6 119.81 29.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.749 0.309 . . . . 0.0 110.71 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.712 HG22 ' HB3' ' A' ' 11' ' ' ALA . 43.1 t -142.57 152.75 17.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.09 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.55 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 7.7 mt-30 -112.61 164.23 13.58 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.7 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.628 HG13 ' HD1' ' A' ' 13' ' ' PHE . 6.7 t -131.9 142.8 42.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.225 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 64' ' ' ALA . 28.1 m -138.44 169.15 18.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.184 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.118 -0.944 . . . . 0.0 111.212 179.956 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 112.621 -0.191 . . . . 0.0 112.621 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.54 161.86 14.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.801 0.334 . . . . 0.0 110.835 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -67.27 -179.52 1.02 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.958 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.1 tt -147.17 -32.16 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.478 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -130.2 153.93 48.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.733 0.302 . . . . 0.0 110.797 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -114.08 131.49 56.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.841 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 64.49 74.09 0.41 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.943 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.9 m -106.71 -53.64 2.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.703 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -127.87 -32.33 2.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.038 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 10.8 mtp -80.74 122.21 26.87 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.993 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.939 ' HB3' HG13 ' A' ' 75' ' ' VAL . . . -87.01 134.72 33.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.705 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.44 131.93 43.93 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.376 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.863 ' HB3' HG22 ' A' ' 77' ' ' VAL . 40.8 t80 -110.39 165.3 11.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.557 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.27 140.71 35.19 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.943 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.678 HD21 HG22 ' A' ' 21' ' ' VAL . 0.4 OUTLIER -142.3 -36.03 0.42 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.944 -179.37 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.506 ' H ' ' HA ' ' A' ' 79' ' ' ALA . . . -48.58 -30.06 8.17 Favored Glycine 0 C--N 1.329 0.153 0 C-N-CA 120.98 -0.629 . . . . 0.0 113.164 -179.178 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.73 -34.33 65.06 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.837 0.351 . . . . 0.0 110.839 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.614 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 3.9 m-70 -117.45 163.88 21.78 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.893 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.614 ' HD2' ' HB3' ' A' ' 18' ' ' HIS . 15.8 Cg_endo -56.13 -35.14 94.69 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.569 2.179 . . . . 0.0 111.985 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.484 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 2.5 p80 174.98 -176.37 0.09 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.431 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.678 HG22 HD21 ' A' ' 15' ' ' LEU . 13.6 m -145.32 164.21 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.414 ' CB ' ' HB3' ' A' ' 59' ' ' ARG . 1.5 pt-20 -99.83 153.17 19.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.2 178.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.781 HD22 ' HG3' ' A' ' 45' ' ' GLU . 8.1 mt -41.13 -41.84 1.87 Allowed 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 40.9 t -70.8 -38.72 73.36 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.638 0.256 . . . . 0.0 111.547 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -63.35 -60.96 2.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.947 0.403 . . . . 0.0 110.841 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.035 HD11 HG21 ' A' ' 77' ' ' VAL . 0.7 OUTLIER -50.86 -42.18 58.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.04 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.838 HD23 HG22 ' A' ' 41' ' ' ILE . 4.4 mp -68.01 -64.74 0.8 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.78 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.9 tmmm? -43.34 -61.45 1.35 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.66 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 13' ' ' PHE . 0.5 OUTLIER -54.49 -40.56 68.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.77 -179.426 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.485 ' OE1' HG11 ' A' ' 75' ' ' VAL . 8.7 mm-40 -69.43 -14.54 62.95 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.46 20.78 21.47 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.28 -0.962 . . . . 0.0 112.92 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.887 ' CH2' HG12 ' A' ' 68' ' ' VAL . 8.3 m0 -75.63 -66.52 0.77 Allowed 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.811 ' OG ' HD13 ' A' ' 41' ' ' ILE . 30.1 t -106.86 137.03 45.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.595 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -70.75 -33.82 71.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.039 0.447 . . . . 0.0 110.295 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.513 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 0.1 OUTLIER -105.74 -55.4 2.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.314 179.223 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 126.68 -33.53 3.39 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.303 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -123.04 -5.49 8.45 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.513 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 0.8 OUTLIER -52.52 -76.34 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.839 0.352 . . . . 0.0 111.029 -179.728 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.695 ' HB3' HD11 ' A' ' 41' ' ' ILE . . . -77.15 15.77 0.67 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.249 -0.432 . . . . 0.0 112.14 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 4.5 mmtt 68.53 24.26 7.07 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.068 0.461 . . . . 0.0 110.098 -179.014 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.838 HG22 HD23 ' A' ' 27' ' ' LEU . 3.9 mp -57.86 -24.86 24.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.449 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.92 -77.35 0.13 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.259 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.3 mm -48.96 -42.24 14.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-O 121.017 0.437 . . . . 0.0 110.644 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.699 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -57.64 -69.05 0.18 Allowed 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.446 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.781 ' HG3' HD22 ' A' ' 23' ' ' LEU . 9.0 tp10 -29.81 -44.13 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.011 0.434 . . . . 0.0 110.672 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 55' ' ' GLU . . . -59.61 -74.89 0.31 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.115 -1.041 . . . . 0.0 110.621 178.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.535 ' N ' ' HA ' ' A' ' 56' ' ' THR . 2.3 pt20 -48.64 -12.94 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.855 HG11 ' HA ' ' A' ' 70' ' ' PHE . 47.5 t -75.06 -98.17 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.933 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.406 ' CD ' ' HB ' ' A' ' 54' ' ' VAL . 0.8 OUTLIER -165.98 122.71 1.37 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 118.37 0.532 . . . . 0.0 111.921 -179.825 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.462 ' HB ' ' HB3' ' A' ' 53' ' ' ALA . 31.7 t -117.33 152.29 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.542 ' HB2' ' O ' ' A' ' 67' ' ' THR . 3.7 t0 -44.72 101.29 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.909 0.385 . . . . 0.0 111.492 -179.025 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 62.63 21.89 63.3 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.415 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.462 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . . . -145.83 75.57 1.43 Allowed 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 121.037 0.446 . . . . 0.0 111.67 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.608 HG13 ' O ' ' A' ' 54' ' ' VAL . 10.1 p -87.13 67.37 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.961 0.41 . . . . 0.0 110.485 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.447 ' O ' ' O ' ' A' ' 46' ' ' GLY . 0.2 OUTLIER -102.56 -166.25 1.26 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.062 -179.356 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.535 ' HA ' ' N ' ' A' ' 47' ' ' GLN . 3.4 t -145.8 37.99 1.09 Allowed 'General case' 0 C--O 1.232 0.154 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.09 174.79 7.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.825 0.345 . . . . 0.0 111.041 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.4 tttt -78.68 -41.6 30.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.738 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.414 ' HB3' ' CB ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -124.49 154.59 40.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.62 179.796 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -136.74 115.38 12.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.394 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.6 mttt -69.48 99.09 1.19 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 17.1 mt -133.46 144.04 37.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.633 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.51 ' O ' ' HB3' ' A' ' 64' ' ' ALA . 7.8 m -149.5 175.3 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.862 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.51 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 72.31 -149.73 0.07 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 178.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.567 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -92.33 81.3 1.16 Allowed Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 116.298 -0.41 . . . . 0.0 112.953 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.92 157.47 31.13 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.208 0.528 . . . . 0.0 111.378 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.542 ' O ' ' HB2' ' A' ' 51' ' ' ASP . 2.9 m -113.72 150.86 32.71 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.836 -178.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.887 HG12 ' CH2' ' A' ' 32' ' ' TRP . 1.2 t -128.27 145.15 35.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.023 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.55 ' HA ' ' O ' ' A' ' 73' ' ' HIS . 1.1 m -136.07 132.21 35.86 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.855 ' HA ' HG11 ' A' ' 48' ' ' VAL . 2.6 t80 -147.14 123.34 10.86 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.232 178.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.409 ' N ' ' CD1' ' A' ' 70' ' ' PHE . . . 41.57 30.66 0.15 Allowed 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.2 -4.06 38.06 Favored Glycine 0 C--N 1.329 0.171 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.422 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.661 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 2.7 m-70 -90.47 98.53 11.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.853 0.327 . . . . 0.0 110.829 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -108.99 114.16 27.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.853 0.359 . . . . 0.0 111.424 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.939 HG13 ' HB3' ' A' ' 11' ' ' ALA . 17.6 t -138.21 156.32 30.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.761 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.539 ' HG3' HG23 ' A' ' 67' ' ' THR . 9.5 mt-30 -112.6 165.61 12.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.136 0.493 . . . . 0.0 111.709 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 1.035 HG21 HD11 ' A' ' 26' ' ' LEU . 21.3 t -141.4 150.4 19.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.587 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 18.2 m -130.52 166.13 28.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.886 0.374 . . . . 0.0 111.759 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.506 ' HA ' ' H ' ' A' ' 16' ' ' GLY . . . . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.238 -0.887 . . . . 0.0 111.096 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 112.778 -0.129 . . . . 0.0 112.778 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.6 t 58.16 175.77 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.883 0.373 . . . . 0.0 110.829 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.2 ttt -138.25 -38.98 0.54 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.215 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 pt -84.03 86.5 2.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.231 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -155.2 133.31 11.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.768 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.4 mmt85 64.31 32.57 12.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.759 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.44 140.68 24.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.4 t -133.97 -47.63 0.79 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.984 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -179.24 154.02 0.63 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.807 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 5.8 ttp -77.62 127.81 33.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.997 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.699 ' HB1' HG13 ' A' ' 75' ' ' VAL . . . -79.18 97.67 6.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.826 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.55 119.03 22.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.865 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.817 ' HB3' HG22 ' A' ' 77' ' ' VAL . 29.5 t80 -98.66 149.9 22.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.542 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.3 m -105.33 147.69 27.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.979 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.506 HD21 ' CG1' ' A' ' 21' ' ' VAL . 9.6 mt -127.44 -36.28 2.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.955 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.09 -111.67 3.49 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.688 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.9 tttt -136.72 52.89 1.93 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.875 0.369 . . . . 0.0 110.903 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -103.89 155.62 36.79 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.972 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.624 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 8.1 Cg_endo -50.56 -44.56 39.42 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.789 2.326 . . . . 0.0 112.235 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.645 ' HA ' HG13 ' A' ' 63' ' ' VAL . 12.6 p80 164.64 -166.98 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.491 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.856 HG21 HD13 ' A' ' 26' ' ' LEU . 14.9 m -143.58 155.92 16.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.508 ' HG2' ' HA ' ' A' ' 59' ' ' ARG . 1.4 mt-10 -87.01 141.07 28.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.03 178.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.51 HD13 ' O ' ' A' ' 42' ' ' ALA . 4.1 pp -40.94 -38.35 0.95 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.716 0.293 . . . . 0.0 111.381 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.498 ' N ' HD12 ' A' ' 23' ' ' LEU . 3.7 t -69.37 -39.51 78.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.89 0.376 . . . . 0.0 110.742 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 22' ' ' GLU . 87.8 m-20 -61.03 -59.21 5.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.629 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.856 HD13 HG21 ' A' ' 21' ' ' VAL . 8.2 tp -50.3 -46.99 55.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.616 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.965 HD23 HG22 ' A' ' 41' ' ' ILE . 6.8 mp -66.45 -60.91 2.31 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.865 -179.16 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -50.92 -55.47 17.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.317 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.78 -42.39 71.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.716 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 1.5 mm-40 -74.36 -13.83 60.79 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.0 24.75 14.23 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.251 -0.976 . . . . 0.0 113.281 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.731 ' CH2' HG12 ' A' ' 68' ' ' VAL . 9.7 m95 -74.68 -63.42 1.25 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 117.003 0.401 . . . . 0.0 110.07 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 39.4 t -106.85 142.92 35.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.344 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -77.94 -34.48 51.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.837 0.351 . . . . 0.0 110.739 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.437 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 31.0 p -106.07 -41.72 5.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.309 178.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 115.82 -33.94 4.98 Favored Glycine 0 CA--C 1.52 0.36 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.771 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -129.56 8.55 5.41 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.437 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 10.4 tp60 -60.48 -74.57 0.07 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.909 0.385 . . . . 0.0 110.541 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.724 ' HB3' ' CD1' ' A' ' 41' ' ' ILE . . . -79.7 15.16 1.43 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.725 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 64.61 27.54 13.27 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.994 0.426 . . . . 0.0 110.201 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.965 HG22 HD23 ' A' ' 27' ' ' LEU . 2.6 mp -62.67 -16.87 17.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.085 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.51 ' O ' HD13 ' A' ' 23' ' ' LEU . . . -70.68 -80.68 0.05 Allowed 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.456 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 36.4 mm -52.05 -34.31 17.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.859 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.722 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -61.33 -72.31 0.12 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.62 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.81 ' CB ' HD21 ' A' ' 27' ' ' LEU . 4.9 tm-20 -35.08 -41.17 0.14 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.263 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.402 ' C ' ' H ' ' A' ' 48' ' ' VAL . . . -60.91 -74.16 0.41 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.177 -1.011 . . . . 0.0 110.972 178.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -48.49 -9.35 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.842 HG11 ' HA ' ' A' ' 70' ' ' PHE . 58.2 t -74.66 -89.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.352 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.418 ' HG2' ' O ' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -170.31 120.97 0.62 Allowed 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 120.011 -0.676 . . . . 0.0 112.534 179.763 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.599 ' HB ' ' O ' ' A' ' 53' ' ' ALA . 40.9 t -114.29 147.47 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.484 ' HB2' ' H ' ' A' ' 67' ' ' THR . 3.3 t70 -44.99 98.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.053 0.454 . . . . 0.0 111.498 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.44 15.71 73.09 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.727 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.599 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -145.86 78.03 1.52 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.976 0.417 . . . . 0.0 112.004 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.561 HG13 ' O ' ' A' ' 54' ' ' VAL . 9.9 p -88.57 62.39 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.977 0.418 . . . . 0.0 110.465 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -99.8 -170.77 1.94 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.063 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.7 t -150.85 36.81 0.63 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.427 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 57' ' ' ARG . 12.7 mtt180 -81.08 168.79 18.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.519 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.1 -44.93 44.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.046 0.451 . . . . 0.0 109.924 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.508 ' HA ' ' HG2' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -103.66 150.43 24.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.77 179.615 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' CYS . . . . . 0.482 ' O ' ' O ' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -116.95 118.13 31.59 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.01 0.433 . . . . 0.0 111.434 -179.43 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.4 ' HG2' ' NE2' ' A' ' 20' ' ' HIS . 14.3 mttm -96.11 71.51 2.87 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.037 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.431 HD12 ' SG ' ' A' ' 60' ' ' CYS . 33.2 mt -136.05 147.4 28.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.702 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.645 HG13 ' HA ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -152.51 175.14 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.776 179.52 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 77.96 -149.2 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.916 179.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.514 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -84.93 78.27 2.02 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 121.285 -0.484 . . . . 0.0 112.578 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.405 ' HG3' ' CG2' ' A' ' 62' ' ' ILE . 20.6 mm-40 -121.66 155.62 34.77 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.066 0.46 . . . . 0.0 111.108 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 59.3 m -116.79 152.91 33.41 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.585 -178.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.731 HG12 ' CH2' ' A' ' 32' ' ' TRP . 1.1 t -127.9 145.58 34.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.668 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.406 ' HB2' ' O ' ' A' ' 49' ' ' LYS . 22.2 m -143.05 135.87 27.8 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.842 ' HA ' HG11 ' A' ' 48' ' ' VAL . 2.2 t80 -148.48 124.06 10.41 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.195 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 51.99 -85.12 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.353 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -129.97 -3.22 4.98 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.912 -0.661 . . . . 0.0 113.012 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.478 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 2.1 m-70 -92.63 108.38 19.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.929 0.365 . . . . 0.0 111.44 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.91 102.66 8.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.338 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.699 HG13 ' HB1' ' A' ' 11' ' ' ALA . 99.4 t -125.19 151.94 31.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.347 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.531 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 13.0 mt-30 -112.97 160.62 17.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.995 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.817 HG22 ' HB3' ' A' ' 13' ' ' PHE . 21.8 t -131.25 148.66 32.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.503 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.8 m -140.02 171.65 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.792 0.33 . . . . 0.0 111.497 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.506 -0.759 . . . . 0.0 111.059 179.933 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.112 0 CA-C-O 120.55 -0.028 . . . . 0.0 113.034 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 61.02 17.11 7.65 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 14.8 mmt -154.9 29.7 0.41 Allowed 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.654 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 pp -145.25 111.07 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.833 0.349 . . . . 0.0 111.104 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -95.14 126.72 40.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.825 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.5 mtm180 -62.38 108.44 1.11 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.722 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.05 165.11 27.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.918 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.8 t -146.39 143.04 28.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.217 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -130.76 -25.2 2.35 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.349 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 64.3 mtt -67.4 135.76 53.69 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.785 0.326 . . . . 0.0 110.895 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.647 ' HB3' HG22 ' A' ' 75' ' ' VAL . . . -100.49 136.18 40.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.86 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.53 134.14 39.14 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.405 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.524 ' CZ ' ' HB3' ' A' ' 29' ' ' LEU . 19.2 t80 -105.61 90.11 3.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.864 0.364 . . . . 0.0 110.827 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.685 ' HA ' HG23 ' A' ' 78' ' ' VAL . 38.6 t -73.38 95.14 2.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.904 0.383 . . . . 0.0 110.897 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.932 HD11 HG13 ' A' ' 21' ' ' VAL . 1.0 OUTLIER -55.63 -35.28 65.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.933 179.789 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.67 48.24 3.01 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.403 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.6 tttt 58.56 54.89 5.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.939 0.4 . . . . 0.0 110.934 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.409 ' HB2' HD22 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -105.66 166.79 10.71 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.157 -179.74 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.786 ' O ' HG11 ' A' ' 63' ' ' VAL . 28.2 Cg_endo -62.51 -48.8 6.78 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.617 2.211 . . . . 0.0 112.091 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.657 ' HA ' HG12 ' A' ' 63' ' ' VAL . 3.1 p80 173.86 -173.67 0.06 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.327 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.932 HG13 HD11 ' A' ' 15' ' ' LEU . 4.1 m -142.12 158.3 20.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.441 0.639 . . . . 0.0 112.723 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.549 ' HG2' ' HG2' ' A' ' 59' ' ' ARG . 1.1 mp0 -100.81 149.96 23.3 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.002 178.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.488 ' H ' ' HA ' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -39.64 -53.65 2.13 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.232 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 37.5 t -60.93 -32.2 71.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.89 0.376 . . . . 0.0 110.77 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.585 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 0.9 OUTLIER -68.94 -58.83 3.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.98 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.888 HD11 HG21 ' A' ' 77' ' ' VAL . 3.2 tp -52.52 -48.09 66.24 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.882 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.878 HD21 ' HG3' ' A' ' 45' ' ' GLU . 4.1 mt -64.77 -58.75 5.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.699 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.72 -57.36 12.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.803 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.585 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.3 OUTLIER -50.81 -39.34 52.83 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.026 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.475 ' OE1' HG11 ' A' ' 75' ' ' VAL . 2.5 mm-40 -79.2 -8.09 58.74 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.75 25.28 32.87 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.313 -0.946 . . . . 0.0 113.168 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.769 ' CZ3' ' HB2' ' A' ' 73' ' ' HIS . 19.6 m95 -71.17 -65.52 0.73 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.869 0.366 . . . . 0.0 110.485 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.663 ' HB2' HG21 ' A' ' 41' ' ' ILE . 8.3 t -100.53 147.61 25.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.51 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -71.01 -34.81 71.68 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.668 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.3 p -106.68 -59.29 1.82 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.012 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.417 ' O ' ' HB2' ' A' ' 42' ' ' ALA . . . 131.69 -19.28 4.76 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.406 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.46 -2.58 0.86 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.4 ' C ' ' H ' ' A' ' 40' ' ' LYS . 23.4 tp60 -60.13 -74.71 0.07 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.866 0.365 . . . . 0.0 110.41 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.41 14.11 0.37 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.497 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.4 ' H ' ' C ' ' A' ' 38' ' ' GLN . 3.7 mttt 66.92 20.18 10.54 Favored 'General case' 0 C--O 1.23 0.057 0 CA-C-O 120.776 0.322 . . . . 0.0 110.702 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.71 HG23 ' HE2' ' A' ' 70' ' ' PHE . 48.0 mm -51.0 -29.62 8.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.753 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 36' ' ' GLY . . . -65.38 -78.68 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.77 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.474 HD12 ' HG3' ' A' ' 58' ' ' LYS . 25.1 mm -49.81 -38.4 13.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.072 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.74 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -61.21 -71.68 0.14 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.122 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.878 ' HG3' HD21 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -33.41 -40.48 0.07 Allowed 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 120.859 0.361 . . . . 0.0 110.594 -179.41 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 55' ' ' GLU . . . -58.24 -76.12 0.23 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 119.718 -1.229 . . . . 0.0 110.531 177.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.48 ' HG2' ' O ' ' A' ' 44' ' ' ALA . 17.0 pt20 -50.24 -9.46 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.989 HG21 ' CD1' ' A' ' 70' ' ' PHE . 38.9 t -75.45 -101.24 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.007 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.519 ' HD3' ' HB ' ' A' ' 54' ' ' VAL . 1.5 mmtm -163.15 120.02 1.86 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 119.117 0.871 . . . . 0.0 112.657 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.764 HG13 HG23 ' A' ' 68' ' ' VAL . 13.7 t -112.85 142.82 24.0 Favored 'Isoleucine or valine' 0 C--N 1.338 0.081 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.494 ' HB2' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -48.6 95.74 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.916 0.388 . . . . 0.0 111.023 -179.461 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.7 15.68 80.38 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.498 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.759 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . . . -146.1 75.78 1.43 Allowed 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.078 0.465 . . . . 0.0 111.627 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.613 HG13 ' O ' ' A' ' 54' ' ' VAL . 10.9 p -90.58 65.91 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.907 0.384 . . . . 0.0 110.74 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.442 ' O ' ' O ' ' A' ' 46' ' ' GLY . 44.1 mm-40 -102.08 -174.66 2.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.087 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.407 ' HA ' ' N ' ' A' ' 47' ' ' GLN . 1.7 t -143.95 41.4 1.41 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.945 0.402 . . . . 0.0 111.373 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.53 175.22 6.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.983 0.421 . . . . 0.0 110.808 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.483 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -81.04 -25.68 36.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.776 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.549 ' HG2' ' HG2' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -140.77 148.97 41.49 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.893 179.806 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -137.24 116.52 12.65 Favored 'General case' 0 CA--C 1.523 -0.078 0 CA-C-O 120.803 0.335 . . . . 0.0 110.892 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.5 mttm -74.66 102.89 4.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.526 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.4 mt -132.93 133.59 58.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.023 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.786 HG11 ' O ' ' A' ' 19' ' ' PRO . 35.4 m -140.46 174.96 7.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.696 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.486 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 72.27 -133.77 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.68 179.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.497 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -109.25 84.82 0.38 Allowed Glycine 0 C--N 1.338 0.691 0 C-N-CA 121.031 -0.604 . . . . 0.0 113.609 -178.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -122.92 167.23 13.83 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.599 0.238 . . . . 0.0 111.242 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.698 HG23 ' HG2' ' A' ' 76' ' ' GLN . 5.2 m -126.01 153.52 44.26 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.084 0.469 . . . . 0.0 111.866 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.764 HG23 HG13 ' A' ' 50' ' ' VAL . 1.2 t -132.23 147.11 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.978 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.8 m -134.64 136.59 42.97 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.84 0.352 . . . . 0.0 111.703 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.989 ' CD1' HG21 ' A' ' 48' ' ' VAL . 6.2 t80 -176.13 137.21 0.31 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.632 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.48 ' N ' ' CD1' ' A' ' 70' ' ' PHE . . . 50.24 37.01 13.85 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.732 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.44 -4.74 66.74 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.434 -0.889 . . . . 0.0 112.823 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.769 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 5.0 m-70 -89.92 107.64 19.23 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.75 0.309 . . . . 0.0 111.189 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.17 103.81 12.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.214 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.647 HG22 ' HB3' ' A' ' 11' ' ' ALA . 64.9 t -132.5 154.36 39.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.63 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.698 ' HG2' HG23 ' A' ' 67' ' ' THR . 20.3 mt-30 -112.96 168.81 9.39 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.013 0.435 . . . . 0.0 111.161 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.888 HG21 HD11 ' A' ' 26' ' ' LEU . 20.4 t -124.34 137.81 55.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.674 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.685 HG23 ' HA ' ' A' ' 14' ' ' SER . 10.4 m -126.84 147.87 31.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.876 0.37 . . . . 0.0 111.208 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.433 -179.586 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.144 0 N-CA-C 112.605 -0.198 . . . . 0.0 112.605 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.1 p -79.14 -164.89 0.67 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.818 0.342 . . . . 0.0 110.956 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.5 mtt -153.64 175.91 12.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.718 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.9 mt -133.72 -63.23 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.269 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.98 167.08 15.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.006 0.431 . . . . 0.0 111.343 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.64 -169.3 2.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.115 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -91.72 -42.75 9.96 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.532 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -169.74 119.61 0.64 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.766 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 60.6 t-20 -122.71 -71.32 0.73 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.998 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -66.18 116.18 6.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.992 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.667 ' CB ' HG13 ' A' ' 75' ' ' VAL . . . -70.47 116.29 10.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.576 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.14 128.33 53.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.904 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.542 ' O ' HG13 ' A' ' 77' ' ' VAL . 34.2 t80 -108.05 95.94 6.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.762 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.03 104.7 1.82 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.847 0.356 . . . . 0.0 110.972 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.519 HD21 HG11 ' A' ' 21' ' ' VAL . 6.2 mt -72.9 -38.19 67.0 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.947 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.24 -82.46 0.31 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.519 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.4 53.47 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.951 0.405 . . . . 0.0 110.948 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.5 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 33.3 m170 -103.57 160.49 25.95 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.84 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.613 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 18.2 Cg_endo -58.83 -35.35 98.75 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.382 2.055 . . . . 0.0 111.875 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.613 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 4.5 p80 167.15 -173.57 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.117 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.652 HG21 HD13 ' A' ' 26' ' ' LEU . 2.8 m -146.03 164.17 10.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.255 0.55 . . . . 0.0 112.04 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.457 ' HB2' ' CG ' ' A' ' 59' ' ' ARG . 12.0 pt-20 -102.15 150.08 23.63 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.815 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.786 HD22 ' HG3' ' A' ' 45' ' ' GLU . 96.0 mt -40.82 -45.64 2.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.818 0.342 . . . . 0.0 111.543 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.43 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 4.9 t -59.7 -36.26 76.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.553 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.535 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 14.8 m-20 -71.13 -63.12 1.17 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.778 0.323 . . . . 0.0 111.515 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.86 HD11 HG21 ' A' ' 77' ' ' VAL . 3.6 tp -46.65 -45.66 19.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.009 0.433 . . . . 0.0 111.374 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.013 HD23 HG22 ' A' ' 41' ' ' ILE . 9.7 mp -67.69 -66.63 0.54 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.28 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 24' ' ' CYS . 9.9 ttmt -50.1 -51.3 44.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.764 0.316 . . . . 0.0 111.222 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.535 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.1 OUTLIER -56.99 -34.9 68.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.203 -179.728 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 5.0 mm-40 -84.22 -8.77 58.95 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.91 22.95 24.3 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.272 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.72 ' CE3' ' HG ' ' A' ' 27' ' ' LEU . 8.6 m0 -74.99 -62.84 1.41 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.006 0.431 . . . . 0.0 109.909 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.472 ' CB ' HD12 ' A' ' 41' ' ' ILE . 0.3 OUTLIER -107.28 143.58 35.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.759 179.621 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.2 tp10 -78.28 -34.37 48.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.818 0.342 . . . . 0.0 111.261 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.423 ' OG ' ' CB ' ' A' ' 38' ' ' GLN . 42.2 p -105.72 -39.5 6.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.075 0.464 . . . . 0.0 110.525 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 108.15 -25.05 21.45 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.167 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.3 -15.43 2.51 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.423 ' CB ' ' OG ' ' A' ' 35' ' ' SER . 17.9 tp60 -52.52 -73.71 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.804 0.335 . . . . 0.0 111.362 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.481 ' HB3' HG13 ' A' ' 41' ' ' ILE . . . -72.12 14.96 0.18 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.39 23.38 12.93 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.803 0.335 . . . . 0.0 110.709 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 1.013 HG22 HD23 ' A' ' 27' ' ' LEU . 1.9 mt -60.19 -19.6 18.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.884 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.29 -76.56 0.14 Allowed 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.82 0.343 . . . . 0.0 110.781 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 45.6 mm -47.33 -45.32 9.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-O 121.083 0.468 . . . . 0.0 110.618 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.6 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -55.39 -67.71 0.26 Allowed 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.877 178.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.786 ' HG3' HD22 ' A' ' 23' ' ' LEU . 11.5 tp10 -28.31 -47.75 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.089 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 55' ' ' GLU . . . -58.34 -74.14 0.38 Allowed Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.172 -1.014 . . . . 0.0 110.824 178.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.555 ' N ' ' HA ' ' A' ' 56' ' ' THR . 1.2 pt20 -44.57 -16.21 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.902 HG21 ' HD1' ' A' ' 70' ' ' PHE . 46.6 t -76.01 -95.43 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.606 ' HD3' ' HB ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -162.82 120.08 1.97 Allowed 'General case' 0 C--N 1.339 0.149 0 O-C-N 122.1 -0.375 . . . . 0.0 111.866 -179.294 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.578 HG13 ' CG2' ' A' ' 68' ' ' VAL . 42.6 t -118.96 157.0 20.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.193 178.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.579 ' HB3' ' H ' ' A' ' 67' ' ' THR . 4.7 p-10 -43.62 99.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.015 0.436 . . . . 0.0 111.603 -178.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 59.76 24.35 59.94 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.175 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -145.79 76.48 1.47 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.606 ' HB ' ' HD3' ' A' ' 49' ' ' LYS . 7.6 p -84.88 58.08 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.151 0.501 . . . . 0.0 110.327 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.436 ' O ' ' O ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -100.42 -162.72 0.96 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.809 -179.547 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.555 ' HA ' ' N ' ' A' ' 47' ' ' GLN . 2.1 t -144.43 53.11 1.26 Allowed 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.544 ' HG3' ' O ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -99.25 172.66 7.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.903 0.382 . . . . 0.0 111.306 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -77.35 -48.47 17.26 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.795 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.544 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 0.3 OUTLIER -120.52 142.79 48.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.314 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' CYS . . . . . 0.773 ' SG ' HD11 ' A' ' 62' ' ' ILE . 3.3 t -124.26 118.53 27.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.975 0.417 . . . . 0.0 110.972 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.53 99.87 2.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.331 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.773 HD11 ' SG ' ' A' ' 60' ' ' CYS . 2.7 mp -138.34 142.45 35.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.769 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.546 HG11 ' O ' ' A' ' 19' ' ' PRO . 12.8 m -145.66 175.63 2.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.433 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.492 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 72.58 -138.17 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 178.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.754 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -106.32 84.75 0.41 Allowed Glycine 0 C--N 1.34 0.798 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.14 -178.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.51 ' HG3' HG23 ' A' ' 62' ' ' ILE . 13.4 mm100 -123.02 167.48 13.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.975 0.417 . . . . 0.0 112.082 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.619 HG23 ' HG2' ' A' ' 76' ' ' GLN . 3.5 m -118.18 140.84 49.2 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.076 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.641 HG12 ' CH2' ' A' ' 32' ' ' TRP . 1.2 t -123.49 146.53 28.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.794 178.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.603 ' HA ' ' O ' ' A' ' 73' ' ' HIS . 32.0 p -140.01 136.1 33.36 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -179.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.902 ' HD1' HG21 ' A' ' 48' ' ' VAL . 1.9 t80 -140.17 121.21 14.67 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.332 178.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 40.82 28.23 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 113.16 -5.81 25.27 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.323 -0.941 . . . . 0.0 113.674 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.628 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 1.1 m-70 -88.01 91.33 8.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 117.166 0.483 . . . . 0.0 110.934 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -98.02 118.01 33.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.848 0.356 . . . . 0.0 111.443 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.667 HG13 ' CB ' ' A' ' 11' ' ' ALA . 96.8 t -143.5 152.74 16.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.391 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.619 ' HG2' HG23 ' A' ' 67' ' ' THR . 24.8 mt-30 -112.89 156.1 23.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.231 0.539 . . . . 0.0 111.609 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.86 HG21 HD11 ' A' ' 26' ' ' LEU . 38.3 t -121.5 145.05 28.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.129 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.8 m -134.18 165.94 30.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.872 0.367 . . . . 0.0 111.699 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.194 -179.873 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.195 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.9 m 58.6 86.47 0.08 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.764 0.316 . . . . 0.0 111.08 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 58.7 170.78 0.06 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.014 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -111.92 110.85 33.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.115 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -162.6 137.95 7.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.721 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.6 127.77 0.78 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.023 0.44 . . . . 0.0 111.033 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 17.3 ptt? -132.51 124.84 29.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.516 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.1 p -143.56 140.76 30.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.759 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -112.67 129.84 56.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.808 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 5.0 mtt -82.24 168.05 18.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.824 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.558 ' HB1' HG13 ' A' ' 75' ' ' VAL . . . -92.47 115.52 28.17 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.135 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.87 129.04 37.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.548 ' HD2' ' HG2' ' A' ' 30' ' ' GLU . 56.5 t80 -102.48 149.23 24.59 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.855 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.93 123.33 48.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.394 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.803 ' CD1' HG12 ' A' ' 63' ' ' VAL . 1.0 OUTLIER -69.74 -37.59 76.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.714 0.292 . . . . 0.0 110.958 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.29 26.79 13.11 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.832 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.3 mtmt 59.58 51.52 6.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.909 0.385 . . . . 0.0 110.833 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.428 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 2.9 m-70 -119.43 168.25 10.43 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.61 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.551 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 10.3 Cg_endo -52.64 -37.96 75.56 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.396 2.064 . . . . 0.0 111.741 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.585 ' HA ' HD11 ' A' ' 15' ' ' LEU . 5.6 p80 167.94 -168.5 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.009 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.557 HG21 HD13 ' A' ' 26' ' ' LEU . 28.8 m -143.58 157.04 16.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.898 0.38 . . . . 0.0 111.77 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.595 ' HA ' ' H ' ' A' ' 60' ' ' CYS . 1.5 pt-20 -103.48 152.21 21.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.583 178.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.621 HD13 ' C ' ' A' ' 42' ' ' ALA . 0.2 OUTLIER -37.93 -46.54 0.98 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.919 -179.372 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.0 t -62.2 -38.4 89.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.606 0.241 . . . . 0.0 111.608 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -67.73 -58.81 3.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.119 0.485 . . . . 0.0 111.122 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.557 HD13 HG21 ' A' ' 21' ' ' VAL . 3.2 tp -55.27 -49.54 71.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.8 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.891 HD23 HG22 ' A' ' 41' ' ' ILE . 6.2 mp -62.61 -59.16 5.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.159 -179.003 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -50.28 -59.79 3.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.98 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.507 ' HB3' ' HE2' ' A' ' 13' ' ' PHE . 3.8 mm? -55.89 -43.31 77.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.482 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.575 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 0.1 OUTLIER -66.83 -15.7 63.79 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.045 -179.943 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.92 23.9 19.02 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.096 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.634 ' CE3' ' HG ' ' A' ' 27' ' ' LEU . 8.8 m0 -74.84 -66.05 0.8 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.202 0.525 . . . . 0.0 110.119 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.42 ' HA ' HD12 ' A' ' 41' ' ' ILE . 2.1 t -106.68 139.19 41.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.135 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -82.31 -33.48 29.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.574 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.444 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -105.16 -27.54 11.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.959 179.645 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.79 0.75 88.68 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.855 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.88 -15.32 0.31 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.681 0.277 . . . . 0.0 111.468 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.444 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 1.0 OUTLIER -54.29 -77.31 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.374 -179.682 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.42 ' HB3' HG13 ' A' ' 41' ' ' ILE . . . -79.96 15.05 1.56 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.3 mttt 61.71 26.53 16.16 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.98 0.419 . . . . 0.0 110.406 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.891 HG22 HD23 ' A' ' 27' ' ' LEU . 11.7 mt -58.1 -22.27 18.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.708 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.621 ' C ' HD13 ' A' ' 23' ' ' LEU . . . -74.92 -77.67 0.12 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.099 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 44.3 mm -52.31 -36.81 21.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.778 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.731 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -59.62 -69.29 0.21 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.351 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.778 ' CB ' HD21 ' A' ' 27' ' ' LEU . 3.0 tm-20 -34.28 -42.05 0.13 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.839 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.402 ' C ' ' H ' ' A' ' 48' ' ' VAL . . . -59.14 -75.43 0.27 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.109 -1.044 . . . . 0.0 111.184 178.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.531 ' HA ' ' HB ' ' A' ' 56' ' ' THR . 20.7 pt20 -48.82 -9.37 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.85 HG21 ' HD1' ' A' ' 70' ' ' PHE . 68.7 t -75.02 -97.28 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.166 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' A' ' 48' ' ' VAL . 1.9 mmtm -163.02 124.63 2.51 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.549 0.613 . . . . 0.0 112.269 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.661 HG22 HG22 ' A' ' 68' ' ' VAL . 26.3 t -116.76 151.76 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.093 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 177.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.588 ' HB2' ' HB ' ' A' ' 67' ' ' THR . 0.9 OUTLIER -44.67 99.95 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.971 0.415 . . . . 0.0 110.937 -179.269 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 60.12 24.84 61.39 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.089 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.605 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -145.78 80.49 1.59 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.642 HG13 ' O ' ' A' ' 54' ' ' VAL . 8.7 p -89.24 78.92 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.896 0.379 . . . . 0.0 110.425 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 47' ' ' GLN . 3.1 mt-10 -113.13 -172.77 2.12 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.69 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.531 ' HB ' ' HA ' ' A' ' 47' ' ' GLN . 2.8 t -158.62 42.77 0.26 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.52 -179.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.525 ' O ' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -91.9 172.81 8.21 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.814 0.34 . . . . 0.0 110.991 179.95 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.9 mmmm -75.35 -55.74 5.4 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.033 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.4 mtm180 -100.46 141.66 33.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.011 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' CYS . . . . . 0.595 ' H ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -106.59 131.62 53.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.1 0.476 . . . . 0.0 111.318 -178.957 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.428 ' HA ' ' CG ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -110.07 74.71 0.9 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.245 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.6 mt -134.26 144.07 36.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.16 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.803 HG12 ' CD1' ' A' ' 15' ' ' LEU . 8.0 m -146.97 175.41 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.254 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.591 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 78.18 -144.64 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.542 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.633 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -100.22 83.47 0.55 Allowed Glycine 0 C--N 1.335 0.499 0 C-N-CA 121.17 -0.538 . . . . 0.0 113.382 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -122.27 163.41 19.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.664 0.269 . . . . 0.0 111.037 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.588 ' HB ' ' HB2' ' A' ' 51' ' ' ASP . 86.3 m -119.89 150.72 40.01 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.053 0.454 . . . . 0.0 112.043 -178.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.661 HG22 HG22 ' A' ' 50' ' ' VAL . 1.1 t -129.99 149.08 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.102 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -137.78 133.69 34.34 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -178.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.85 ' HD1' HG21 ' A' ' 48' ' ' VAL . 5.0 t80 -138.42 115.22 10.72 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.384 179.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 36.47 32.95 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 178.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 116.77 -13.2 14.93 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.361 -0.923 . . . . 0.0 113.531 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.406 ' O ' ' CH2' ' A' ' 32' ' ' TRP . 2.2 m-70 -88.25 82.51 7.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.955 0.378 . . . . 0.0 110.952 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.8 m -95.2 101.0 12.71 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.942 0.401 . . . . 0.0 110.943 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.558 HG13 ' HB1' ' A' ' 11' ' ' ALA . 46.5 t -120.27 155.71 23.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.721 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.502 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 25.5 mt-30 -111.57 161.21 16.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.94 0.4 . . . . 0.0 110.421 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.633 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 13.1 t -133.38 146.85 31.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.424 -178.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.0 m -131.47 157.24 43.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.985 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.253 -0.88 . . . . 0.0 111.147 -179.929 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.183 0 N-CA-C 112.742 -0.143 . . . . 0.0 112.742 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.77 139.84 33.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.91 0.386 . . . . 0.0 111.197 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 56.66 -179.73 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.056 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.418 ' H ' HG13 ' A' ' 4' ' ' ILE . 2.0 pp -93.2 12.53 2.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.481 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -147.32 164.43 33.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.799 0.333 . . . . 0.0 110.843 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.0 mtt-85 -117.18 90.93 3.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.999 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -97.83 140.91 31.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.648 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.23 81.25 3.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.826 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 75.6 m-80 59.08 176.34 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.745 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 5.1 mtt -99.21 149.38 23.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.781 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.656 ' HB3' HG22 ' A' ' 75' ' ' VAL . . . -88.71 135.07 33.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.394 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.46 132.47 29.49 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.85 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.576 ' HB3' HG22 ' A' ' 77' ' ' VAL . 36.8 t80 -102.33 147.49 26.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.896 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.8 m -106.25 147.89 28.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.399 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.618 HD21 HG13 ' A' ' 21' ' ' VAL . 12.0 mt -118.61 -38.12 3.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.063 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.13 -103.75 2.9 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.397 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.0 mttt -143.58 41.87 1.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.019 0.437 . . . . 0.0 110.894 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -95.5 163.91 20.3 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.446 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.593 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 17.9 Cg_endo -58.59 -43.02 48.53 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.322 2.015 . . . . 0.0 112.008 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.593 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 19.9 p80 166.08 -163.96 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.203 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.618 HG13 HD21 ' A' ' 15' ' ' LEU . 3.8 m -139.47 154.23 24.57 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-O 121.09 0.471 . . . . 0.0 112.144 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.492 ' HG2' ' CB ' ' A' ' 59' ' ' ARG . 13.8 mt-10 -90.81 148.09 22.76 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.593 178.429 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.607 HD23 ' CD ' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -41.27 -50.34 3.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.795 0.331 . . . . 0.0 111.656 -179.656 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 17.9 t -65.64 -32.72 74.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.884 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.493 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 2.9 m-20 -64.57 -59.38 4.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.776 0.322 . . . . 0.0 110.323 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.606 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 12.5 tp -51.78 -40.48 60.43 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.891 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.835 HD21 ' HG3' ' A' ' 45' ' ' GLU . 12.6 mt -66.74 -67.87 0.42 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.111 0.482 . . . . 0.0 110.788 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.483 ' HE2' ' O ' ' A' ' 35' ' ' SER . 4.1 ttmt -50.15 -55.92 13.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.79 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.493 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.1 OUTLIER -53.83 -40.14 66.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.117 -178.991 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.606 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 1.1 mm-40 -80.35 -10.05 59.75 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.838 0.311 . . . . 0.0 111.838 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.68 25.13 21.56 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.249 -0.977 . . . . 0.0 113.342 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.73 ' CZ3' ' HB2' ' A' ' 73' ' ' HIS . 13.0 m95 -72.94 -61.99 1.62 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 117.133 0.466 . . . . 0.0 110.2 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.498 ' HB2' HG21 ' A' ' 41' ' ' ILE . 39.2 t -100.18 156.22 17.32 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.453 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -85.74 -35.15 20.97 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.186 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.483 ' O ' ' HE2' ' A' ' 28' ' ' LYS . 1.1 p -106.94 -46.21 3.99 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.524 178.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 120.81 -28.5 6.14 Favored Glycine 0 C--N 1.333 0.374 0 CA-C-N 115.745 -0.662 . . . . 0.0 112.882 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.98 1.74 3.31 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -60.91 -76.46 0.05 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.865 0.364 . . . . 0.0 111.105 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.15 15.4 0.57 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.928 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.3 mttp 66.1 24.93 10.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.983 0.421 . . . . 0.0 110.004 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.599 HG23 ' HE2' ' A' ' 70' ' ' PHE . 40.8 mm -52.99 -26.96 12.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.61 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.81 -78.33 0.08 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.928 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 34.4 mm -49.49 -34.34 8.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.856 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.692 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -63.5 -72.23 0.15 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.718 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.835 ' HG3' HD21 ' A' ' 27' ' ' LEU . 0.6 OUTLIER -32.79 -41.71 0.07 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.95 0.405 . . . . 0.0 110.879 -179.845 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.542 ' HA2' HD21 ' A' ' 23' ' ' LEU . . . -59.68 -77.02 0.19 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.268 -0.967 . . . . 0.0 110.848 178.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.629 ' HG3' ' O ' ' A' ' 44' ' ' ALA . 1.4 pt20 -46.52 -10.42 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.81 HG11 ' HA ' ' A' ' 70' ' ' PHE . 58.4 t -74.9 -92.86 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.906 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 48' ' ' VAL . 0.1 OUTLIER -168.12 125.73 1.13 Allowed 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.894 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.8 t -122.15 158.01 26.2 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -44.05 101.75 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.053 0.454 . . . . 0.0 111.71 -178.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 57.29 23.13 46.76 Favored Glycine 0 C--N 1.333 0.386 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.489 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -146.15 82.64 1.61 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.869 0.366 . . . . 0.0 111.787 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.523 HG13 ' O ' ' A' ' 54' ' ' VAL . 10.7 p -88.39 61.47 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.073 0.463 . . . . 0.0 110.824 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -101.14 -164.41 1.1 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.221 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.5 ' HB ' ' HA ' ' A' ' 47' ' ' GLN . 9.7 t -153.18 45.15 0.65 Allowed 'General case' 0 C--O 1.232 0.164 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.494 ' O ' HD13 ' A' ' 23' ' ' LEU . 52.3 mtt180 -87.77 174.98 8.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.067 0.46 . . . . 0.0 111.104 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -85.35 -38.72 18.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.086 179.395 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.492 ' CB ' ' HG2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -120.65 134.06 55.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.822 179.664 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -119.9 115.39 23.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.875 0.369 . . . . 0.0 110.73 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.657 ' O ' HD13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -74.15 89.85 2.01 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.033 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.657 HD13 ' O ' ' A' ' 61' ' ' LYS . 6.9 mm -133.11 138.22 51.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.207 0.527 . . . . 0.0 112.153 -178.171 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.563 ' O ' ' HB3' ' A' ' 64' ' ' ALA . 4.5 m -146.26 175.29 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.125 179.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 76.52 -143.14 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.649 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -99.91 83.44 0.57 Allowed Glycine 0 C--N 1.336 0.546 0 C-N-CA 121.308 -0.472 . . . . 0.0 112.129 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.507 ' HG3' HG22 ' A' ' 62' ' ' ILE . 2.3 mm-40 -122.36 159.63 27.08 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.887 0.375 . . . . 0.0 111.753 -178.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 7.3 m -120.37 144.46 47.87 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.458 -178.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.643 HG12 ' CH2' ' A' ' 32' ' ' TRP . 1.2 t -118.67 143.14 30.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.451 178.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -134.07 133.37 41.09 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.81 ' HA ' HG11 ' A' ' 48' ' ' VAL . 1.4 t80 -146.19 122.48 10.91 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.611 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 49.52 -85.47 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.343 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -129.14 -5.6 4.67 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.722 -0.751 . . . . 0.0 113.026 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.73 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 0.9 OUTLIER -90.61 113.07 25.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.967 0.384 . . . . 0.0 111.441 -179.269 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 72.1 m -120.48 115.54 23.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.178 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.656 HG22 ' HB3' ' A' ' 11' ' ' ALA . 59.4 t -138.59 155.23 27.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.803 0.335 . . . . 0.0 111.328 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.514 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 2.8 mt-30 -112.78 169.96 8.53 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.104 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.649 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 21.6 t -136.36 146.0 29.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.82 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.96 150.49 34.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.952 0.406 . . . . 0.0 111.665 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.336 -0.84 . . . . 0.0 110.964 179.727 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.192 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.9 m -131.6 -65.18 0.77 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.799 0.333 . . . . 0.0 110.847 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 7.5 mtm 66.33 -73.5 0.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.009 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.1 tt -132.83 -2.08 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.781 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 51.2 m-70 -100.26 177.35 5.08 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.791 0.329 . . . . 0.0 111.059 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.45 122.75 32.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.957 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.7 ttt -131.27 30.35 4.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.728 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 p -173.44 176.9 2.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.703 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -134.28 121.19 20.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.929 0.395 . . . . 0.0 111.052 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -78.89 107.62 11.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.745 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.769 ' HB1' HG22 ' A' ' 75' ' ' VAL . . . -67.25 99.8 0.74 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.037 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.58 121.55 16.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.999 0.428 . . . . 0.0 111.168 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.871 ' HB3' HG22 ' A' ' 77' ' ' VAL . 37.1 t80 -99.02 155.28 17.52 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.945 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.5 m -106.63 148.73 27.97 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.272 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.516 HD21 ' CG1' ' A' ' 21' ' ' VAL . 5.1 mt -117.92 -28.74 5.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.851 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.09 40.06 62.34 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.972 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 56.93 68.46 0.86 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.974 0.416 . . . . 0.0 110.829 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.429 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 1.8 m170 -115.28 170.02 6.08 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.903 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.477 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 32.7 Cg_endo -64.86 -51.5 1.68 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.406 2.07 . . . . 0.0 112.356 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.641 ' HA ' HG13 ' A' ' 63' ' ' VAL . 7.4 p80 177.94 -179.72 0.28 Allowed 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.333 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.768 HG21 HD13 ' A' ' 26' ' ' LEU . 4.5 m -142.11 161.01 20.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -179.264 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.501 ' HG2' ' HA ' ' A' ' 59' ' ' ARG . 8.3 mt-10 -98.89 144.42 28.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.192 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.721 HD12 ' N ' ' A' ' 24' ' ' CYS . 0.9 OUTLIER -39.7 -38.02 0.59 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.629 -0.259 . . . . 0.0 111.561 -179.67 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.721 ' N ' HD12 ' A' ' 23' ' ' LEU . 48.9 t -73.38 -39.71 64.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.606 0.241 . . . . 0.0 111.189 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -62.86 -57.42 10.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.069 0.461 . . . . 0.0 110.358 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.079 HD11 HG21 ' A' ' 77' ' ' VAL . 12.6 tp -55.27 -45.97 76.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.268 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.849 HD23 HG22 ' A' ' 41' ' ' ILE . 4.0 mp -66.73 -59.95 3.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.885 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -49.31 -56.12 10.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.446 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.612 HD22 ' CE1' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -56.3 -38.42 71.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.089 -179.213 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.445 ' CG ' ' HB2' ' A' ' 13' ' ' PHE . 5.2 mm-40 -79.87 -10.95 59.83 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.097 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.82 24.02 18.9 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.257 -0.973 . . . . 0.0 113.155 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.654 ' CH2' HG12 ' A' ' 68' ' ' VAL . 11.2 m95 -75.92 -62.55 1.56 Allowed 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.299 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.409 ' CB ' HD12 ' A' ' 41' ' ' ILE . 7.5 t -106.38 138.54 42.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.339 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.67 -34.41 60.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.963 0.411 . . . . 0.0 110.408 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.9 -48.12 3.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.057 178.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 118.63 -22.85 9.18 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.231 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.47 -1.78 3.12 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -59.3 -77.95 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.611 0.243 . . . . 0.0 111.249 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.424 ' HB3' HG13 ' A' ' 41' ' ' ILE . . . -75.15 15.13 0.45 Allowed 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.9 mttt 61.85 25.34 15.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.765 0.317 . . . . 0.0 110.76 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.849 HG22 HD23 ' A' ' 27' ' ' LEU . 14.4 mt -61.37 -16.43 14.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.608 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.519 ' CA ' HD13 ' A' ' 23' ' ' LEU . . . -72.68 -79.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.314 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.441 HD11 ' NZ ' ' A' ' 58' ' ' LYS . 43.4 mm -53.9 -33.72 24.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.806 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.715 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -61.0 -72.2 0.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.232 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.749 ' CB ' HD21 ' A' ' 27' ' ' LEU . 2.4 tm-20 -34.76 -40.97 0.12 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.22 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.19 -73.93 0.4 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.156 -1.021 . . . . 0.0 110.628 178.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.827 ' HA ' HG22 ' A' ' 56' ' ' THR . 15.8 pt20 -48.9 -11.55 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.875 HG11 ' HA ' ' A' ' 70' ' ' PHE . 47.2 t -75.0 -90.92 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.102 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.432 ' HD3' ' HB ' ' A' ' 54' ' ' VAL . 6.4 mmtp -165.43 124.84 1.75 Allowed 'General case' 0 C--O 1.232 0.153 0 C-N-CA 120.193 -0.603 . . . . 0.0 112.284 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.542 HG11 ' CD1' ' A' ' 62' ' ' ILE . 34.2 t -119.08 142.77 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 178.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.539 ' HB2' ' H ' ' A' ' 67' ' ' THR . 0.8 OUTLIER -45.29 97.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.924 0.392 . . . . 0.0 111.567 -179.102 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.25 11.02 85.76 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.976 -0.631 . . . . 0.0 113.001 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.534 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -146.03 82.44 1.61 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 117.073 0.436 . . . . 0.0 112.033 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.517 HG22 ' O ' ' A' ' 54' ' ' VAL . 7.4 p -86.99 56.2 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.075 0.464 . . . . 0.0 110.081 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -99.65 179.72 4.45 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.628 -178.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.827 HG22 ' HA ' ' A' ' 47' ' ' GLN . 1.7 p -134.39 36.97 3.16 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.684 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.38 171.23 12.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.873 0.368 . . . . 0.0 111.189 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.441 ' NZ ' HD11 ' A' ' 43' ' ' ILE . 38.6 mttm -75.57 -46.46 31.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.682 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.501 ' HA ' ' HG2' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -116.61 137.65 52.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.633 179.862 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.24 115.28 26.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.77 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.441 ' HG2' ' CD2' ' A' ' 20' ' ' HIS . 11.5 mtpt -78.46 82.26 4.74 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.369 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.542 ' CD1' HG11 ' A' ' 50' ' ' VAL . 26.8 mt -133.61 147.97 30.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.261 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.641 HG13 ' HA ' ' A' ' 20' ' ' HIS . 1.9 m -154.99 175.87 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.245 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 76.22 -150.66 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.301 179.11 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -83.9 78.54 2.0 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.292 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -122.26 154.91 36.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.112 0.482 . . . . 0.0 110.956 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.627 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 87.6 m -114.46 156.28 24.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.375 -178.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.654 HG12 ' CH2' ' A' ' 32' ' ' TRP . 1.0 OUTLIER -133.01 148.97 31.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.672 179.34 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 76.8 p -143.12 139.86 30.6 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.875 ' HA ' HG11 ' A' ' 48' ' ' VAL . 2.3 t80 -150.82 124.36 9.02 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 114.902 -1.044 . . . . 0.0 110.323 179.29 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 49.52 -85.46 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.59 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -126.18 -6.99 5.61 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.972 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.526 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 1.7 m-70 -89.5 107.11 18.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.791 0.329 . . . . 0.0 111.54 -179.276 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.76 95.29 4.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.175 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.769 HG22 ' HB1' ' A' ' 11' ' ' ALA . 97.0 t -123.23 155.32 29.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.517 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.627 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 3.2 mp0 -113.26 165.1 12.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.971 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 1.079 HG21 HD11 ' A' ' 26' ' ' LEU . 11.0 t -139.76 150.57 22.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.974 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.0 m -129.17 165.5 28.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.973 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.215 -0.897 . . . . 0.0 111.191 179.892 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.181 0 N-CA-C 112.748 -0.141 . . . . 0.0 112.748 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.573 ' HB3' ' O ' ' A' ' 5' ' ' HIS . 5.5 m -102.3 117.98 35.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.728 0.299 . . . . 0.0 111.059 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.9 mmt -94.66 -59.43 1.93 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.126 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.8 tt -117.0 -30.37 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.615 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.573 ' O ' ' HB3' ' A' ' 2' ' ' SER . 29.6 m80 -91.25 140.81 29.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.456 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.95 106.05 0.81 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.995 0.426 . . . . 0.0 111.183 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.41 130.01 47.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.552 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.7 t -148.96 -60.22 0.23 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.097 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -105.38 -39.18 6.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.895 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -82.34 82.35 7.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.954 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.59 130.83 34.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.698 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.97 133.82 34.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.56 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.875 ' HB3' HG22 ' A' ' 77' ' ' VAL . 58.4 t80 -105.35 156.58 18.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.1 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.2 m -107.16 142.7 36.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.963 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.802 HD22 ' HB2' ' A' ' 18' ' ' HIS . 0.5 OUTLIER -104.67 -40.62 5.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.445 179.375 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.22 42.95 6.82 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.702 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 50.18 59.31 4.64 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.93 0.395 . . . . 0.0 111.248 179.424 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.802 ' HB2' HD22 ' A' ' 15' ' ' LEU . 30.7 m170 -115.66 165.27 14.88 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.398 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.656 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 18.3 Cg_endo -57.75 -38.43 93.06 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.557 2.171 . . . . 0.0 112.386 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.656 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 12.0 p80 164.38 -173.7 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.72 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.628 HG13 HD21 ' A' ' 15' ' ' LEU . 2.4 m -145.79 166.47 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.217 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.507 ' HG2' ' HB2' ' A' ' 59' ' ' ARG . 70.4 mt-10 -95.97 141.03 29.87 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.818 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.613 HD21 ' O ' ' A' ' 57' ' ' ARG . 2.0 pp -44.12 -30.59 0.78 Allowed 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 -178.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.605 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -69.63 -40.71 76.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.78 0.324 . . . . 0.0 110.396 179.361 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -63.44 -60.63 3.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.049 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.993 HD11 HG21 ' A' ' 77' ' ' VAL . 2.6 tp -49.46 -49.25 46.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.652 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.835 HD21 ' HB2' ' A' ' 45' ' ' GLU . 9.5 mp -65.1 -61.76 1.95 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.445 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.605 ' HB2' ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -48.82 -55.59 11.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.348 -179.718 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.645 HD13 ' HZ ' ' A' ' 13' ' ' PHE . 1.2 mt -55.33 -42.49 73.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.533 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.521 ' OE2' HG11 ' A' ' 75' ' ' VAL . 1.3 mm-40 -71.19 -15.28 62.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.728 -0.214 . . . . 0.0 111.555 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.07 24.77 12.17 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.268 -0.968 . . . . 0.0 113.071 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.86 ' CH2' HG12 ' A' ' 68' ' ' VAL . 7.8 m0 -76.33 -66.28 0.82 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.959 0.38 . . . . 0.0 109.999 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.765 ' CB ' HD12 ' A' ' 41' ' ' ILE . 25.0 t -106.12 140.04 39.7 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.353 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -75.74 -34.96 60.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.898 0.38 . . . . 0.0 110.73 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.514 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 0.2 OUTLIER -106.45 -48.0 3.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.365 178.848 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.4 -26.25 8.72 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.201 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -127.58 -2.67 6.09 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.514 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 4.2 tp-100 -59.74 -76.56 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.674 0.273 . . . . 0.0 110.962 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.91 15.11 0.93 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.725 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.7 mttm 61.93 27.83 16.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.084 0.469 . . . . 0.0 110.401 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.799 HG23 ' CE2' ' A' ' 70' ' ' PHE . 12.7 mt -59.29 -25.0 29.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.554 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.07 -77.69 0.08 Allowed 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.144 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 31.6 mm -48.62 -36.29 7.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 120.896 0.379 . . . . 0.0 110.599 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.747 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -61.46 -67.06 0.44 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.519 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.835 ' HB2' HD21 ' A' ' 27' ' ' LEU . 5.9 tp10 -33.96 -45.73 0.21 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.852 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' A' ' 48' ' ' VAL . . . -59.23 -75.94 0.24 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.238 -0.982 . . . . 0.0 111.04 178.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.528 ' HG2' ' O ' ' A' ' 44' ' ' ALA . 12.4 pt20 -44.5 -15.86 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.815 HG21 ' HD1' ' A' ' 70' ' ' PHE . 93.6 t -75.05 -91.7 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 O-C-N 122.212 -0.305 . . . . 0.0 110.575 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -171.18 136.88 1.09 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.956 0.408 . . . . 0.0 111.146 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.566 HG11 HD11 ' A' ' 62' ' ' ILE . 58.5 t -131.7 144.95 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.951 179.306 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.551 ' HB3' ' H ' ' A' ' 67' ' ' THR . 37.6 t70 -60.61 77.23 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.055 0.455 . . . . 0.0 110.46 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 120.96 -12.46 9.89 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.408 -179.324 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.563 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . . . -132.37 133.69 44.27 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.892 0.377 . . . . 0.0 110.8 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.583 HG22 ' O ' ' A' ' 54' ' ' VAL . 12.6 p -125.2 31.98 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.714 179.441 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -107.49 160.21 15.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.283 0.563 . . . . 0.0 112.433 -178.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.51 HG23 ' O ' ' A' ' 56' ' ' THR . 14.8 t -108.66 50.12 0.79 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.556 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.613 ' O ' HD21 ' A' ' 23' ' ' LEU . 10.0 mtp180 -84.24 173.38 11.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.746 0.308 . . . . 0.0 111.018 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.1 ttmm -81.68 -0.69 43.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.991 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.507 ' HB2' ' HG2' ' A' ' 22' ' ' GLU . 0.3 OUTLIER -160.86 157.3 26.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.616 179.708 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' CYS . . . . . 0.636 ' SG ' HD11 ' A' ' 62' ' ' ILE . 1.6 t -134.93 114.99 13.08 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.484 ' HG2' ' CD2' ' A' ' 20' ' ' HIS . 3.6 mttm -76.0 94.62 3.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.36 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.636 HD11 ' SG ' ' A' ' 60' ' ' CYS . 16.2 mt -135.41 141.17 43.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.696 -179.274 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.661 HG12 HD13 ' A' ' 15' ' ' LEU . 0.8 OUTLIER -144.24 175.18 3.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.927 179.3 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 66.21 -150.17 0.21 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.716 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.605 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -86.79 79.13 1.84 Allowed Glycine 0 C--N 1.336 0.565 0 C-N-CA 121.451 -0.404 . . . . 0.0 113.498 -178.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.545 ' HG3' ' O ' ' A' ' 63' ' ' VAL . 0.7 OUTLIER -122.18 158.95 28.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.935 0.397 . . . . 0.0 111.347 179.775 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.611 HG23 ' HG3' ' A' ' 76' ' ' GLN . 0.3 OUTLIER -114.53 157.66 22.69 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.529 -178.71 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.86 HG12 ' CH2' ' A' ' 32' ' ' TRP . 1.2 t -133.96 147.51 30.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.829 179.042 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.661 ' HA ' ' O ' ' A' ' 73' ' ' HIS . 0.5 OUTLIER -137.7 132.15 32.44 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -178.939 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.815 ' HD1' HG21 ' A' ' 48' ' ' VAL . 1.7 t80 -139.32 117.9 12.2 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.347 178.217 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 38.01 30.0 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 179.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 117.17 -7.26 16.69 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.211 -0.995 . . . . 0.0 113.512 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.661 ' O ' ' HA ' ' A' ' 69' ' ' SER . 2.6 m-70 -87.9 89.79 8.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 117.242 0.521 . . . . 0.0 110.834 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 58.2 m -100.59 102.02 13.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.858 0.361 . . . . 0.0 111.008 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.565 ' HB ' ' HZ2' ' A' ' 32' ' ' TRP . 46.9 t -127.19 153.61 36.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.843 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.611 ' HG3' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -112.95 165.04 12.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.031 0.443 . . . . 0.0 111.122 179.538 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.993 HG21 HD11 ' A' ' 26' ' ' LEU . 45.3 t -138.11 154.86 28.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.48 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.498 ' O ' ' HB2' ' A' ' 15' ' ' LEU . 16.1 m -131.77 161.47 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.865 0.364 . . . . 0.0 111.417 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.321 -0.847 . . . . 0.0 111.429 179.624 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.153 0 N-CA-C 112.557 -0.217 . . . . 0.0 112.557 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 62.98 34.47 13.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.802 0.334 . . . . 0.0 110.994 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -91.98 120.97 33.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.965 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -106.19 119.84 56.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.33 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.4 m170 -76.13 138.35 40.69 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.817 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 9.6 mmm-85 -109.14 151.27 26.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.004 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.3 mtp -102.52 -45.66 4.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.998 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.92 136.95 57.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.069 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -110.39 103.31 11.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.116 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -67.64 143.05 56.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.566 179.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.982 ' HB1' HG13 ' A' ' 75' ' ' VAL . . . -64.14 84.7 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.141 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.62 109.42 6.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.781 0.324 . . . . 0.0 110.78 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.843 ' HB3' HG22 ' A' ' 77' ' ' VAL . 28.2 t80 -98.64 170.59 8.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.975 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.9 m -106.82 138.1 43.62 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.356 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.868 HD23 HG11 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -131.49 -37.99 1.19 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.221 179.337 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.406 ' H ' ' HA ' ' A' ' 79' ' ' ALA . . . -44.09 -27.69 1.14 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 121.213 -0.518 . . . . 0.0 113.002 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -55.46 -40.86 72.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.663 0.268 . . . . 0.0 111.257 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.588 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 42.4 m80 -119.64 163.06 29.48 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.319 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.734 ' O ' HG11 ' A' ' 63' ' ' VAL . 18.2 Cg_endo -59.74 -27.87 85.96 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.658 2.239 . . . . 0.0 112.496 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.555 ' HA ' HG12 ' A' ' 63' ' ' VAL . 4.7 p80 177.05 178.17 0.27 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.12 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.669 HG21 HD21 ' A' ' 15' ' ' LEU . 15.4 m -145.93 167.15 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.614 ' HG3' ' HA ' ' A' ' 59' ' ' ARG . 17.3 tt0 -100.35 144.2 29.64 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.08 178.428 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.671 HD13 ' O ' ' A' ' 42' ' ' ALA . 1.6 pp -40.86 -46.84 2.83 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.655 0.264 . . . . 0.0 111.625 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.659 ' N ' HD12 ' A' ' 23' ' ' LEU . 5.6 t -62.31 -38.05 87.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.751 0.31 . . . . 0.0 110.927 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -66.06 -57.61 7.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.885 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.881 HD11 HG21 ' A' ' 77' ' ' VAL . 7.2 tt -56.64 -42.05 78.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.053 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.959 HD23 HG22 ' A' ' 41' ' ' ILE . 6.7 mp -65.77 -62.29 1.59 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.972 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.04 -55.55 11.69 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.383 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.486 ' HB3' ' CZ ' ' A' ' 13' ' ' PHE . 6.6 mt -53.48 -40.16 65.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.265 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.66 ' CD ' HG11 ' A' ' 75' ' ' VAL . 0.4 OUTLIER -73.45 -15.17 61.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.605 -179.702 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.5 23.82 17.84 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.425 -0.893 . . . . 0.0 113.294 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.759 ' CH2' HG12 ' A' ' 68' ' ' VAL . 9.3 m0 -72.62 -59.04 2.91 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 117.215 0.508 . . . . 0.0 110.137 179.581 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.805 ' CB ' HD12 ' A' ' 41' ' ' ILE . 6.0 t -104.87 138.72 40.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.426 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -69.28 -33.77 73.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.905 0.383 . . . . 0.0 110.761 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.9 p -105.16 -42.44 5.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.064 0.459 . . . . 0.0 110.573 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 128.67 -43.34 1.33 Allowed Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.107 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.52 4.37 3.95 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -53.07 -70.38 0.09 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.838 0.352 . . . . 0.0 110.831 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.497 ' HB3' HG13 ' A' ' 41' ' ' ILE . . . -75.31 15.49 0.44 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.967 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.2 mttt 64.35 23.3 12.99 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 120.913 0.387 . . . . 0.0 110.163 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.959 HG22 HD23 ' A' ' 27' ' ' LEU . 29.8 mt -61.83 -19.63 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.617 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.671 ' O ' HD13 ' A' ' 23' ' ' LEU . . . -73.29 -78.92 0.09 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.916 0.389 . . . . 0.0 110.961 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.411 HD11 ' HD3' ' A' ' 58' ' ' LYS . 43.6 mm -52.41 -37.98 24.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.734 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.619 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -58.42 -69.38 0.19 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.155 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.677 ' HG3' HD21 ' A' ' 27' ' ' LEU . 12.3 tm-20 -34.53 -44.92 0.22 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.107 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.01 -73.14 0.44 Allowed Glycine 0 C--N 1.332 0.314 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.599 ' HG2' ' HB ' ' A' ' 56' ' ' THR . 0.0 OUTLIER -45.63 -15.44 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 179.614 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.818 HG21 ' HD1' ' A' ' 70' ' ' PHE . 46.2 t -74.92 -91.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 121.053 -0.259 . . . . 0.0 111.124 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.475 ' O ' ' HB2' ' A' ' 69' ' ' SER . 0.3 OUTLIER -175.74 130.13 0.25 Allowed 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.292 -0.563 . . . . 0.0 112.029 179.826 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.581 HG13 HG23 ' A' ' 68' ' ' VAL . 21.3 t -116.91 148.01 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.638 ' HB2' ' HB ' ' A' ' 67' ' ' THR . 14.0 t0 -44.85 99.21 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.934 0.397 . . . . 0.0 111.594 -179.128 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.37 17.67 70.68 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.225 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.533 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . . . -145.79 73.09 1.33 Allowed 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.249 0.547 . . . . 0.0 111.586 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.542 HG22 ' O ' ' A' ' 54' ' ' VAL . 3.0 p -84.33 69.25 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.419 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -100.48 -178.62 3.86 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.83 -179.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.599 ' HB ' ' HG2' ' A' ' 47' ' ' GLN . 3.0 p -142.45 37.74 1.52 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.172 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.458 ' O ' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -98.15 172.71 7.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.765 0.316 . . . . 0.0 111.256 -179.649 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.411 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -75.3 -41.77 56.18 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.45 179.713 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.614 ' HA ' ' HG3' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -123.8 145.56 48.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.645 179.424 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' CYS . . . . . 0.505 ' SG ' HD11 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -130.85 116.16 17.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.926 0.393 . . . . 0.0 111.439 -179.469 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.24 86.46 1.09 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.278 179.453 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.505 HD11 ' SG ' ' A' ' 60' ' ' CYS . 20.8 mt -133.37 139.94 47.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.224 -179.316 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.787 HG12 HD12 ' A' ' 15' ' ' LEU . 34.4 m -148.83 175.88 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.92 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.617 ' HA ' ' HB2' ' A' ' 79' ' ' ALA . . . 76.96 -147.94 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 178.274 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.712 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -84.36 75.62 2.34 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.25 -179.26 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.434 ' OE1' ' HB3' ' A' ' 51' ' ' ASP . 16.7 mm-40 -122.17 152.73 39.64 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.099 0.476 . . . . 0.0 111.285 -179.234 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.638 ' HB ' ' HB2' ' A' ' 51' ' ' ASP . 21.9 m -115.93 152.75 32.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.787 -178.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.759 HG12 ' CH2' ' A' ' 32' ' ' TRP . 0.8 OUTLIER -128.03 144.53 37.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.222 179.241 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' ' 49' ' ' LYS . 25.7 m -136.74 136.42 38.94 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.119 0.485 . . . . 0.0 112.246 -178.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.818 ' HD1' HG21 ' A' ' 48' ' ' VAL . 2.1 t80 -144.65 121.85 11.52 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.21 179.076 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 51.08 -81.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.981 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -131.75 -4.14 3.92 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.85 -0.69 . . . . 0.0 113.337 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.499 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 1.8 m-70 -91.48 112.62 24.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.087 0.444 . . . . 0.0 111.691 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.4 109.37 15.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.863 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.982 HG13 ' HB1' ' A' ' 11' ' ' ALA . 27.6 t -132.14 150.68 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 120.579 0.228 . . . . 0.0 111.468 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.612 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 1.5 mt-30 -112.29 172.4 6.93 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.008 0.432 . . . . 0.0 111.351 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.881 HG21 HD11 ' A' ' 26' ' ' LEU . 12.1 t -142.64 150.52 18.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.233 -178.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.1 m -127.49 158.78 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-O 120.746 0.307 . . . . 0.0 111.81 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.617 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.304 -0.855 . . . . 0.0 111.04 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.121 0 N-CA-C 112.383 -0.287 . . . . 0.0 112.383 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.41 -40.89 11.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.798 0.332 . . . . 0.0 110.826 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -88.89 -171.64 3.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.101 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.553 HG23 ' O ' ' A' ' 4' ' ' ILE . 0.8 OUTLIER 35.52 93.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 121.171 0.51 . . . . 0.0 112.226 -179.909 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 34.3 m-70 -100.87 106.75 18.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.763 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 6' ' ' ARG . 0.4 OUTLIER -147.08 31.58 0.93 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.171 -179.922 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.6 mtp -118.89 124.46 47.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.773 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 p -91.27 161.33 15.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.06 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -153.13 -36.67 0.11 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.158 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -71.72 121.93 19.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.026 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.543 ' HB3' HG13 ' A' ' 75' ' ' VAL . . . -99.84 137.06 38.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.021 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.55 135.24 53.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.28 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.721 ' CD2' HD12 ' A' ' 26' ' ' LEU . 1.1 t80 -101.07 95.59 6.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.309 179.228 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.56 ' HA ' HG23 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -73.05 111.26 8.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.855 0.359 . . . . 0.0 110.58 179.864 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.635 HD11 HG13 ' A' ' 21' ' ' VAL . 1.4 mt -82.46 -33.7 28.37 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.033 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.4 -73.86 0.67 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.715 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.44 52.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.129 0.49 . . . . 0.0 110.847 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.7 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 32.2 m170 -109.02 166.83 10.08 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.648 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.7 ' HD2' ' HB3' ' A' ' 18' ' ' HIS . 18.6 Cg_endo -57.97 -41.48 68.18 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.317 2.011 . . . . 0.0 111.831 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.601 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 9.0 p80 165.69 -164.71 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.256 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.795 HG21 HD13 ' A' ' 26' ' ' LEU . 22.6 m -142.73 156.91 18.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.354 0.597 . . . . 0.0 112.248 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.709 ' HG2' ' HA ' ' A' ' 59' ' ' ARG . 12.6 mt-10 -92.56 142.93 26.85 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.639 178.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.588 HD12 ' HB1' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -40.14 -40.05 1.02 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.726 0.298 . . . . 0.0 111.171 -179.61 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 54.0 t -67.1 -40.24 86.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.058 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -65.29 -57.15 9.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.023 179.667 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.795 HD13 HG21 ' A' ' 21' ' ' VAL . 9.9 tp -57.16 -47.77 80.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.436 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.702 HD23 HG22 ' A' ' 41' ' ' ILE . 4.6 mp -62.69 -57.34 11.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.785 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -50.76 -59.12 4.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.953 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 29' ' ' LEU . 18.7 mt -56.83 -44.04 81.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.583 -179.024 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.453 ' HG2' ' HD2' ' A' ' 13' ' ' PHE . 10.9 mm-40 -67.99 -14.99 63.4 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 121.117 -0.233 . . . . 0.0 111.165 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.24 22.54 26.97 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.359 -0.924 . . . . 0.0 113.209 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.59 ' CH2' HG12 ' A' ' 68' ' ' VAL . 9.3 m0 -68.84 -64.08 0.94 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.389 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.71 152.63 23.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.016 178.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -70.38 -34.56 72.72 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.28 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.587 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -106.13 -57.23 2.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.103 0.478 . . . . 0.0 110.568 179.241 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' A' ' 42' ' ' ALA . . . 152.63 -33.88 0.82 Allowed Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.972 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.37 7.53 1.33 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.587 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 2.1 tp60 -54.36 -70.33 0.1 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.701 0.286 . . . . 0.0 110.902 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.72 15.35 0.2 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.575 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.411 ' H ' ' C ' ' A' ' 38' ' ' GLN . 0.0 OUTLIER 69.11 16.26 8.63 Favored 'General case' 0 CA--C 1.523 -0.067 0 CA-C-O 120.734 0.302 . . . . 0.0 110.723 -179.378 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.702 HG22 HD23 ' A' ' 27' ' ' LEU . 22.9 mm -56.34 -26.5 22.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.299 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.588 ' HB1' HD12 ' A' ' 23' ' ' LEU . . . -70.75 -79.43 0.06 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.407 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.436 HD12 ' HD3' ' A' ' 58' ' ' LYS . 6.2 mm -48.04 -42.77 10.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.689 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.74 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -57.99 -64.21 0.99 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.506 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.569 ' HB2' HD21 ' A' ' 27' ' ' LEU . 3.1 tm-20 -35.94 -40.78 0.21 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.709 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' A' ' 48' ' ' VAL . . . -60.07 -75.07 0.3 Allowed Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 178.04 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.581 ' HG2' ' HB ' ' A' ' 56' ' ' THR . 0.0 OUTLIER -46.49 -12.59 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 179.891 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.798 HG21 ' HD1' ' A' ' 70' ' ' PHE . 57.7 t -74.99 -89.32 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.103 -179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.494 ' HG2' ' O ' ' A' ' 48' ' ' VAL . 5.8 mmmt -167.44 144.46 4.44 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.982 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.613 ' HB ' ' O ' ' A' ' 53' ' ' ALA . 14.0 t -131.04 145.7 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.547 ' HB2' ' HB ' ' A' ' 67' ' ' THR . 8.8 t0 -43.89 90.27 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -178.018 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 108.98 -31.93 7.31 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.712 -0.756 . . . . 0.0 114.03 178.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.613 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -147.58 145.59 29.08 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 117.851 0.825 . . . . 0.0 112.549 -179.128 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 54' ' ' VAL . 4.8 p -109.38 101.5 12.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.053 178.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -99.75 -165.05 1.18 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.966 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.581 ' HB ' ' HG2' ' A' ' 47' ' ' GLN . 5.2 t -165.24 31.06 0.06 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.775 0.322 . . . . 0.0 111.371 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.53 ' O ' HD21 ' A' ' 23' ' ' LEU . 6.3 mtt180 -89.07 167.85 12.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.023 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.436 ' HD3' HD12 ' A' ' 43' ' ' ILE . 58.3 mmtt -78.32 -35.61 47.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.237 0.542 . . . . 0.0 109.953 179.303 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.709 ' HA ' ' HG2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -106.93 135.08 49.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.563 179.592 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' CYS . . . . . 0.496 ' H ' ' HA ' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -104.39 118.29 36.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.879 0.371 . . . . 0.0 110.793 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.441 ' HA ' ' CD2' ' A' ' 20' ' ' HIS . 5.4 mtmt -98.99 74.06 1.98 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.11 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.48 ' O ' ' HB2' ' A' ' 20' ' ' HIS . 29.6 mt -137.88 145.26 29.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.657 -179.256 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.527 ' O ' ' HB3' ' A' ' 64' ' ' ALA . 0.5 OUTLIER -151.26 175.39 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.867 179.696 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 74.88 -148.89 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.424 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.438 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -85.13 74.76 2.43 Favored Glycine 0 C--N 1.335 0.513 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.732 -179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.437 ' O ' ' N ' ' A' ' 77' ' ' VAL . 27.9 mm-40 -122.35 150.0 42.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.955 0.407 . . . . 0.0 110.8 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.733 HG23 ' O ' ' A' ' 75' ' ' VAL . 77.1 m -114.83 150.38 35.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.384 -178.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.59 HG12 ' CH2' ' A' ' 32' ' ' TRP . 0.7 OUTLIER -125.77 145.57 32.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.523 178.774 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 28.4 p -139.32 138.8 37.0 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -178.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.798 ' HD1' HG21 ' A' ' 48' ' ' VAL . 1.9 t80 -143.04 122.2 12.93 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.21 179.175 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 48.04 -81.38 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.796 0.332 . . . . 0.0 111.396 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -130.7 -1.29 5.11 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.877 -0.678 . . . . 0.0 113.053 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -93.41 98.93 11.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.134 0.467 . . . . 0.0 111.624 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.3 m -109.82 108.28 18.55 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.405 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.733 ' O ' HG23 ' A' ' 67' ' ' THR . 25.1 t -128.55 156.44 40.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.819 -179.181 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.507 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 2.7 mp0 -112.05 161.55 16.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.815 0.34 . . . . 0.0 110.716 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.438 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 23.2 t -125.7 141.14 46.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.059 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.56 HG23 ' HA ' ' A' ' 14' ' ' SER . 29.3 m -129.77 152.23 37.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.866 0.365 . . . . 0.0 111.124 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.279 -0.867 . . . . 0.0 111.236 -179.776 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.192 0 N-CA-C 112.559 -0.217 . . . . 0.0 112.559 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 m -153.5 -57.78 0.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.82 0.343 . . . . 0.0 110.947 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 62.88 166.54 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 38.7 pt -118.23 131.08 72.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.435 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -142.55 -16.48 0.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.953 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -90.7 128.4 36.64 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.899 0.381 . . . . 0.0 111.332 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.9 tpt -91.95 172.48 8.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.5 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.3 m 59.83 -175.14 0.1 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.777 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -73.78 133.57 43.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.911 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.6 mtp -66.15 96.52 0.33 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.874 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.738 ' HB3' HG22 ' A' ' 75' ' ' VAL . . . -81.61 131.05 35.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.38 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -139.62 132.83 29.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.792 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.461 ' CE1' ' HB3' ' A' ' 29' ' ' LEU . 19.1 t80 -107.54 149.28 28.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.927 0.394 . . . . 0.0 111.294 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.63 150.63 26.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.738 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.5 mt -128.08 -40.47 1.67 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.144 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.91 -100.49 2.65 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.671 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.3 tppt? -148.83 53.62 0.98 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.992 0.425 . . . . 0.0 111.003 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.588 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 69.6 m-70 -106.12 163.95 15.98 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.898 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.588 ' HD2' ' HB3' ' A' ' 18' ' ' HIS . 18.3 Cg_endo -57.74 -45.18 34.87 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.615 2.21 . . . . 0.0 112.277 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.554 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 13.8 p80 170.91 -166.67 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.941 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.51 HG21 HD12 ' A' ' 26' ' ' LEU . 19.5 m -147.08 159.03 9.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.423 ' HG2' ' HA ' ' A' ' 59' ' ' ARG . 1.2 mt-10 -88.56 139.29 30.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.959 178.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.767 HD12 ' N ' ' A' ' 24' ' ' CYS . 0.9 OUTLIER -43.47 -32.5 0.9 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.884 0.374 . . . . 0.0 111.28 -179.653 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.767 ' N ' HD12 ' A' ' 23' ' ' LEU . 26.3 t -73.1 -38.23 66.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.816 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.408 ' N ' ' O ' ' A' ' 22' ' ' GLU . 6.5 m-20 -62.5 -55.31 28.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.743 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.708 HD11 HG21 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -54.89 -44.22 73.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.143 -179.913 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.705 HD23 HG22 ' A' ' 41' ' ' ILE . 5.2 mp -62.16 -64.31 0.97 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.45 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.6 ttmm -47.66 -52.46 18.08 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.974 -179.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.461 ' HB3' ' CE1' ' A' ' 13' ' ' PHE . 3.5 mm? -58.96 -46.51 87.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.322 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -70.52 -14.93 62.71 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.53 26.03 14.43 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.39 -0.91 . . . . 0.0 113.498 179.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.704 ' CH2' HG12 ' A' ' 68' ' ' VAL . 9.6 m0 -74.39 -64.89 0.93 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.015 0.436 . . . . 0.0 110.15 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.656 ' CB ' HD12 ' A' ' 41' ' ' ILE . 3.9 t -106.31 138.51 42.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.663 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.23 -33.66 37.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.707 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.447 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -105.33 -33.79 8.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.529 179.621 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.32 -20.42 50.34 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.792 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.97 -8.18 3.07 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.447 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 63.8 tp60 -55.51 -76.06 0.03 OUTLIER 'General case' 0 C--O 1.232 0.134 0 CA-C-O 120.724 0.297 . . . . 0.0 111.277 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.32 15.0 2.63 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.75 29.65 19.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.041 0.448 . . . . 0.0 110.44 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.852 HG23 ' CE2' ' A' ' 70' ' ' PHE . 18.6 mt -60.49 -23.89 29.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.982 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.62 -78.67 0.07 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.242 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.9 mm -51.8 -40.8 28.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.954 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.826 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -56.36 -68.65 0.19 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.617 179.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.565 ' HG3' HD11 ' A' ' 27' ' ' LEU . 3.7 tm-20 -35.82 -44.57 0.35 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.909 0.385 . . . . 0.0 110.965 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.47 -76.38 0.19 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.13 -1.033 . . . . 0.0 110.912 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.464 ' HA ' ' HB ' ' A' ' 56' ' ' THR . 14.7 pt20 -47.5 -12.07 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.826 HG23 ' O ' ' A' ' 44' ' ' ALA . 43.6 t -74.96 -90.83 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.285 -179.357 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -162.39 124.23 2.71 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 119.903 -0.719 . . . . 0.0 112.916 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.658 ' HB ' ' O ' ' A' ' 53' ' ' ALA . 45.2 t -117.13 148.1 20.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 177.479 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -44.68 96.1 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.912 0.387 . . . . 0.0 111.343 -179.024 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.34 17.86 74.66 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.627 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.658 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -146.03 82.56 1.61 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.017 0.437 . . . . 0.0 112.063 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.544 HG13 ' O ' ' A' ' 54' ' ' VAL . 12.5 p -86.85 59.08 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 0.0 110.874 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.16 -168.64 1.56 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.684 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.464 ' HB ' ' HA ' ' A' ' 47' ' ' GLN . 12.2 t -151.66 44.12 0.75 Allowed 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.607 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.676 ' O ' HD21 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -87.52 165.08 15.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.91 0.386 . . . . 0.0 111.292 -179.774 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.2 -40.07 59.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.791 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.423 ' HA ' ' HG2' ' A' ' 22' ' ' GLU . 2.6 mpt_? -111.67 134.38 53.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.918 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' CYS . . . . . 0.41 ' O ' ' O ' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -107.44 115.17 29.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.36 179.782 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.411 ' HA ' ' CG ' ' A' ' 20' ' ' HIS . 0.1 OUTLIER -92.53 76.49 5.07 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.129 0.49 . . . . 0.0 109.754 179.662 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.445 ' CG2' ' HG3' ' A' ' 66' ' ' GLN . 46.5 mt -139.2 153.32 24.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.43 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.577 ' O ' ' HB3' ' A' ' 64' ' ' ALA . 4.3 m -155.26 175.42 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.663 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.577 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 78.33 -150.52 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 178.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.712 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -84.87 77.41 2.11 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.939 -179.055 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.445 ' HG3' ' CG2' ' A' ' 62' ' ' ILE . 22.0 mm100 -122.18 157.72 30.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.913 0.387 . . . . 0.0 111.491 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.618 HG23 ' O ' ' A' ' 75' ' ' VAL . 25.1 m -118.58 156.72 28.66 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.673 0.619 . . . . 0.0 112.673 -178.173 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.704 HG12 ' CH2' ' A' ' 32' ' ' TRP . 1.2 t -137.34 149.37 25.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.891 179.11 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.602 ' HA ' ' O ' ' A' ' 73' ' ' HIS . 43.2 p -140.57 138.08 34.21 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.852 ' CE2' HG23 ' A' ' 41' ' ' ILE . 2.4 t80 -138.4 115.58 11.02 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.701 178.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.56 ' H ' HG11 ' A' ' 48' ' ' VAL . . . 38.29 31.6 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 116.67 -7.61 17.58 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.334 -0.936 . . . . 0.0 113.619 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.602 ' O ' ' HA ' ' A' ' 69' ' ' SER . 0.9 OUTLIER -88.14 83.83 6.95 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 117.252 0.526 . . . . 0.0 110.882 -179.427 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.2 m -92.58 111.47 23.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.979 0.419 . . . . 0.0 110.942 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.738 HG22 ' HB3' ' A' ' 11' ' ' ALA . 64.5 t -131.65 151.07 34.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.485 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.536 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 49.3 mt-30 -112.0 171.45 7.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.463 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.712 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 2.8 t -144.13 146.76 20.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.162 -178.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.0 m -136.38 170.44 18.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.838 0.351 . . . . 0.0 111.01 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.117 0 CA-C-O 118.214 -0.898 . . . . 0.0 111.068 179.881 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.167 0 N-CA-C 112.533 -0.227 . . . . 0.0 112.533 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.9 166.73 11.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.79 0.328 . . . . 0.0 110.853 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -103.99 -171.59 1.96 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.095 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.7 pp -138.39 25.81 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.335 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -90.56 -83.48 0.26 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.879 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -75.18 164.36 26.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.816 0.341 . . . . 0.0 110.725 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 65.44 88.87 0.1 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.734 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.4 m -63.48 145.97 54.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -90.03 139.29 30.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.803 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 8.3 mtt -89.88 176.9 6.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.342 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.626 ' HB3' HG13 ' A' ' 75' ' ' VAL . . . -97.04 142.94 28.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.042 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.55 130.55 51.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.146 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.614 ' O ' HG13 ' A' ' 77' ' ' VAL . 15.2 t80 -106.78 96.65 6.59 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.106 -179.289 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.411 ' HA ' ' CG2' ' A' ' 78' ' ' VAL . 7.7 t -70.95 110.56 5.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.94 0.4 . . . . 0.0 111.083 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 15' ' ' LEU . 13.8 mt -83.27 -31.55 26.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.555 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.05 -88.66 0.63 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.892 -0.671 . . . . 0.0 111.897 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.02 71.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.011 0.434 . . . . 0.0 110.886 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.432 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -117.43 172.18 4.24 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.38 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.606 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 38.0 Cg_endo -66.92 -41.56 9.97 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.054 1.836 . . . . 0.0 111.789 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.809 ' HA ' HG13 ' A' ' 63' ' ' VAL . 7.0 p80 170.68 -178.22 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.057 179.135 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.8 m -149.17 169.23 2.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.604 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -97.62 146.99 24.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.988 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.683 HD12 ' N ' ' A' ' 24' ' ' CYS . 4.3 pp -42.65 -34.0 0.81 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.46 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.683 ' N ' HD12 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -65.74 -43.58 88.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.85 0.357 . . . . 0.0 110.566 179.928 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.56 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 0.5 OUTLIER -61.82 -60.11 4.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.195 179.33 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.783 HD21 HG21 ' A' ' 77' ' ' VAL . 1.9 tp -50.08 -47.92 53.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.404 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.791 HD23 HG22 ' A' ' 41' ' ' ILE . 9.2 mp -67.5 -61.9 1.68 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.683 -179.339 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.509 ' HB2' ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -50.45 -54.43 22.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.002 -179.714 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.56 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 2.2 mt -56.8 -34.65 67.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.192 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.546 ' OE1' HG11 ' A' ' 75' ' ' VAL . 7.4 mm-40 -78.83 -15.13 58.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.408 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.33 22.23 22.68 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.421 -0.895 . . . . 0.0 113.104 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.675 ' CH2' HG12 ' A' ' 68' ' ' VAL . 9.2 m95 -72.81 -70.49 0.35 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 117.09 0.445 . . . . 0.0 109.896 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.736 ' CB ' HD12 ' A' ' 41' ' ' ILE . 8.6 t -95.05 138.9 32.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.956 178.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -75.7 -34.17 60.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.885 0.374 . . . . 0.0 110.792 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.407 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -105.3 -28.8 10.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.045 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.47 -37.5 3.79 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.49 179.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.32 5.27 2.97 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.407 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 43.4 tp60 -58.45 -72.6 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.712 0.292 . . . . 0.0 111.716 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.75 15.5 0.5 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.5 mtmm 64.49 24.53 13.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.053 0.454 . . . . 0.0 110.479 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.791 HG22 HD23 ' A' ' 27' ' ' LEU . 51.4 mt -59.56 -17.83 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.698 179.391 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.643 ' HB1' HD11 ' A' ' 23' ' ' LEU . . . -76.0 -77.91 0.12 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.042 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 13.1 mm -45.33 -45.7 3.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 121.078 0.466 . . . . 0.0 110.724 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.675 ' O ' ' HG3' ' A' ' 47' ' ' GLN . . . -57.82 -61.12 2.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.839 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.598 ' O ' HG23 ' A' ' 48' ' ' VAL . 9.9 tp10 -35.9 -35.6 0.07 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.143 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.459 ' O ' ' N ' ' A' ' 48' ' ' VAL . . . -72.16 -72.68 0.91 Allowed Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.24 -0.981 . . . . 0.0 111.743 178.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.675 ' HG3' ' O ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -39.93 -18.96 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -178.905 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.796 HG11 ' H ' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -75.34 -85.74 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.763 -179.55 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -176.56 130.55 0.2 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.467 -0.493 . . . . 0.0 112.112 179.723 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.628 HG11 ' CD1' ' A' ' 62' ' ' ILE . 49.6 t -125.04 150.83 30.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.721 178.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.58 ' HB2' ' H ' ' A' ' 67' ' ' THR . 1.2 m-20 -65.96 70.65 0.06 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.944 0.402 . . . . 0.0 110.601 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 135.92 -18.51 3.79 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.387 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.66 135.02 47.43 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.009 0.433 . . . . 0.0 111.123 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 54' ' ' VAL . 11.4 p -124.43 29.95 2.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.273 179.059 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -115.04 158.05 22.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.206 0.527 . . . . 0.0 111.495 -179.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.618 ' HB ' ' HB3' ' A' ' 47' ' ' GLN . 13.3 t -99.65 58.23 1.04 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.445 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 57' ' ' ARG . 14.6 mtt180 -89.13 171.81 9.54 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.785 0.326 . . . . 0.0 111.214 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.405 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -76.19 -48.24 21.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.23 179.655 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -122.4 154.82 37.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.035 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -136.91 119.19 15.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.899 0.38 . . . . 0.0 111.472 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.515 ' HG2' ' CD2' ' A' ' 20' ' ' HIS . 18.6 mttt -68.61 86.9 0.32 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.93 179.154 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.628 ' CD1' HG11 ' A' ' 50' ' ' VAL . 25.6 mt -134.54 139.98 46.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.955 0.407 . . . . 0.0 111.695 -179.049 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.809 HG13 ' HA ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -152.58 176.29 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.191 -179.649 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.602 ' HA ' ' HB3' ' A' ' 79' ' ' ALA . . . 75.26 -154.38 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.55 179.124 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.584 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -84.5 78.65 1.99 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.826 -178.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -122.3 157.07 32.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.092 0.472 . . . . 0.0 111.268 -179.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.58 ' H ' ' HB2' ' A' ' 51' ' ' ASP . 1.9 m -113.25 155.5 24.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.311 -178.56 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.675 HG12 ' CH2' ' A' ' 32' ' ' TRP . 0.9 OUTLIER -125.33 139.72 50.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.55 179.228 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.423 ' O ' ' HB ' ' A' ' 48' ' ' VAL . 0.7 OUTLIER -133.99 128.88 35.29 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.232 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.644 ' HA ' HG21 ' A' ' 48' ' ' VAL . 2.9 t80 -146.77 126.5 13.44 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.641 179.18 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.796 ' H ' HG11 ' A' ' 48' ' ' VAL . . . 46.13 -87.1 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.301 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -127.02 -8.73 4.5 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.889 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.658 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 1.8 m-70 -89.64 109.02 20.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.941 0.371 . . . . 0.0 111.471 -179.223 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.1 m -120.32 117.28 27.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.356 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.626 HG13 ' HB3' ' A' ' 11' ' ' ALA . 19.5 t -140.54 159.49 24.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.58 -179.257 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.569 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 19.5 mt-30 -112.66 163.15 14.89 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.028 0.442 . . . . 0.0 111.485 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.783 HG21 HD21 ' A' ' 26' ' ' LEU . 15.0 t -132.08 147.78 32.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.266 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.411 ' CG2' ' HA ' ' A' ' 14' ' ' SER . 24.5 m -129.12 162.45 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 CA-C-O 120.864 0.364 . . . . 0.0 111.291 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.602 ' HB3' ' HA ' ' A' ' 64' ' ' ALA . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.299 -0.858 . . . . 0.0 111.079 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.6 m -144.39 121.75 11.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.861 0.363 . . . . 0.0 110.983 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -163.67 149.75 11.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.707 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.67 ' H ' HD13 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -134.72 154.29 36.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.963 0.411 . . . . 0.0 111.454 -179.784 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -142.31 34.6 1.5 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.517 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.45 ' HD2' ' N ' ' A' ' 6' ' ' ARG . 1.7 mpt_? -67.79 104.51 1.69 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.311 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.2 ptp -83.31 -169.45 2.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.693 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.421 ' O ' ' CB ' ' A' ' 9' ' ' ASN . 1.4 t 59.92 170.93 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.726 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.421 ' CB ' ' O ' ' A' ' 8' ' ' SER . 1.7 m-20 83.33 -47.53 0.13 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.71 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -103.72 140.19 37.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.603 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.511 ' HB3' HG22 ' A' ' 75' ' ' VAL . . . -84.83 123.68 30.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.383 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.11 130.3 35.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.973 0.416 . . . . 0.0 111.046 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.49 ' HB2' ' CG ' ' A' ' 30' ' ' GLU . 13.6 t80 -107.07 144.66 33.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.312 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 74.7 m -106.82 149.82 26.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.46 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.552 HD21 HG11 ' A' ' 77' ' ' VAL . 55.2 mt -118.25 -40.06 2.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.833 0.349 . . . . 0.0 110.866 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.32 -102.93 2.99 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.245 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.7 pttt -143.1 43.65 1.55 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.964 0.411 . . . . 0.0 111.227 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.655 ' CG ' ' HD2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -101.64 154.45 37.27 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.194 179.536 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.655 ' HD2' ' CG ' ' A' ' 18' ' ' HIS . 9.3 Cg_endo -50.91 -32.4 37.67 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.581 2.187 . . . . 0.0 112.008 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.555 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 10.4 p80 159.62 -165.38 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.809 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.698 HG21 HD12 ' A' ' 26' ' ' LEU . 15.1 m -133.52 141.94 43.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.989 0.423 . . . . 0.0 111.233 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.691 ' HA ' ' H ' ' A' ' 60' ' ' CYS . 1.3 mp0 -81.28 148.07 29.61 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.822 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.593 ' O ' HD12 ' A' ' 27' ' ' LEU . 4.0 mp -38.7 -54.8 1.54 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.766 0.317 . . . . 0.0 111.39 -179.429 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.3 t -60.68 -29.06 69.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.417 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 22' ' ' GLU . 1.0 OUTLIER -72.74 -62.38 1.47 Allowed 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.76 0.314 . . . . 0.0 111.382 -179.716 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.949 HD11 HG21 ' A' ' 77' ' ' VAL . 4.9 tt -51.97 -48.84 64.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.266 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.872 HD21 ' HG3' ' A' ' 45' ' ' GLU . 5.4 mt -60.51 -57.76 11.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.556 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.6 ttpt -55.66 -54.46 43.99 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.769 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.25 -51.22 68.91 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -178.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.501 ' CD ' HG11 ' A' ' 75' ' ' VAL . 3.1 mm-40 -63.71 -15.44 58.49 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.212 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.56 25.54 15.47 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.267 -0.968 . . . . 0.0 113.341 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.681 ' CH2' HG12 ' A' ' 68' ' ' VAL . 12.4 m95 -74.14 -61.27 1.91 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-N 117.417 0.608 . . . . 0.0 109.552 178.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.715 ' CB ' HD13 ' A' ' 41' ' ' ILE . 47.0 t -106.79 140.52 39.51 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.495 179.337 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.61 -34.1 67.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.978 0.418 . . . . 0.0 110.171 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.566 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -105.77 -47.05 3.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.466 179.354 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 129.29 -30.82 3.57 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.303 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.96 6.7 3.4 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.566 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 19.1 tp60 -52.25 -75.01 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.857 0.361 . . . . 0.0 110.69 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.506 ' HB3' HD11 ' A' ' 41' ' ' ILE . . . -79.96 15.35 1.48 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.562 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.1 mmtt 64.61 29.4 13.06 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 121.142 0.496 . . . . 0.0 110.283 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.92 HG23 ' CD2' ' A' ' 70' ' ' PHE . 2.5 mp -63.4 -24.31 35.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.0 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.56 -78.97 0.05 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.383 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.4 mm -50.54 -42.64 22.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.946 0.403 . . . . 0.0 110.832 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.676 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -58.06 -68.86 0.21 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.165 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.872 ' HG3' HD21 ' A' ' 27' ' ' LEU . 1.6 tm-20 -33.88 -42.18 0.11 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.944 0.402 . . . . 0.0 111.087 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.415 ' C ' ' H ' ' A' ' 48' ' ' VAL . . . -60.15 -72.64 0.59 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.348 178.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.539 ' CA ' ' HB ' ' A' ' 56' ' ' THR . 9.3 pt20 -49.84 -8.57 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.871 HG21 ' HD1' ' A' ' 70' ' ' PHE . 60.0 t -74.87 -90.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.293 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.519 ' HG2' ' O ' ' A' ' 48' ' ' VAL . 0.5 OUTLIER -171.18 133.97 0.89 Allowed 'General case' 0 C--O 1.232 0.132 0 C-N-CA 120.432 -0.507 . . . . 0.0 111.744 179.559 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.508 HG11 ' CD1' ' A' ' 62' ' ' ILE . 21.9 t -130.41 147.44 33.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.819 178.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.531 ' HB2' ' H ' ' A' ' 67' ' ' THR . 0.5 OUTLIER -63.53 79.83 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.08 0.466 . . . . 0.0 110.51 -179.888 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 125.52 -13.68 7.33 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.583 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.407 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . . . -135.96 135.45 39.58 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.965 0.412 . . . . 0.0 111.17 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 54' ' ' VAL . 10.5 p -125.55 31.19 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.886 178.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -104.71 -150.46 0.43 Allowed 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.799 -178.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.539 ' HB ' ' CA ' ' A' ' 47' ' ' GLN . 4.5 t -169.89 67.4 0.05 Allowed 'General case' 0 C--O 1.232 0.147 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.589 ' O ' HD13 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -94.95 174.15 7.23 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.46 179.192 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -75.12 -46.43 34.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.014 0.435 . . . . 0.0 110.224 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.436 ' O ' ' HG2' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -101.87 131.9 47.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.045 179.167 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' CYS . . . . . 0.691 ' H ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -100.08 115.61 30.18 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.979 0.419 . . . . 0.0 111.217 -179.449 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.466 ' HG3' ' NE2' ' A' ' 20' ' ' HIS . 0.1 OUTLIER -94.55 74.86 3.78 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.783 179.207 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.508 ' CD1' HG11 ' A' ' 50' ' ' VAL . 36.6 mt -133.65 142.09 42.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.061 0.458 . . . . 0.0 111.578 -178.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.603 ' O ' ' HB3' ' A' ' 64' ' ' ALA . 0.2 OUTLIER -150.77 175.96 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.606 -179.908 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.603 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 81.09 -154.29 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.513 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -93.7 79.02 1.03 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.631 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -122.63 162.22 22.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.147 0.498 . . . . 0.0 111.34 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.67 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 25.8 m -113.85 156.57 23.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.851 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.681 HG12 ' CH2' ' A' ' 32' ' ' TRP . 0.9 OUTLIER -131.75 146.04 34.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.005 179.335 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 60.0 p -143.66 139.13 29.41 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 120.907 0.384 . . . . 0.0 111.727 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.92 ' CD2' HG23 ' A' ' 41' ' ' ILE . 0.8 OUTLIER -128.48 -86.24 0.56 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.28 179.983 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -139.63 88.56 2.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.743 0.306 . . . . 0.0 110.464 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.17 -25.5 6.93 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.441 -0.885 . . . . 0.0 111.444 -178.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.625 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 0.9 OUTLIER -93.06 109.02 20.49 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 120.791 0.329 . . . . 0.0 110.914 -179.758 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.9 m -120.23 98.48 6.08 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.595 ' HB ' ' HZ2' ' A' ' 32' ' ' TRP . 38.9 t -120.32 151.16 23.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.475 -178.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.67 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 22.5 mt-30 -112.45 164.38 13.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.642 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.949 HG21 HD11 ' A' ' 26' ' ' LEU . 10.7 t -132.47 146.52 32.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.065 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 17.9 m -139.89 169.5 16.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.886 0.374 . . . . 0.0 111.144 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.181 -0.914 . . . . 0.0 111.071 179.863 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 112.843 -0.103 . . . . 0.0 112.843 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 m -155.73 124.46 6.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.758 0.313 . . . . 0.0 110.834 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.4 mtm -163.9 72.85 0.27 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.959 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.438 ' O ' HG13 ' A' ' 4' ' ' ILE . 1.1 tp -116.49 -22.93 4.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.523 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 71.57 96.19 0.07 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.886 0.374 . . . . 0.0 110.876 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.8 mtm180 59.1 110.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.02 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.54 -42.28 16.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.661 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.8 m -132.55 164.5 26.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.735 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -130.35 119.41 22.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.95 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 36.9 mtt -79.5 112.83 17.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.944 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.476 ' HB3' HG13 ' A' ' 75' ' ' VAL . . . -85.01 138.46 32.43 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.65 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.69 135.46 53.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.464 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.71 ' O ' HG13 ' A' ' 77' ' ' VAL . 40.2 t80 -124.83 98.57 5.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.886 0.374 . . . . 0.0 110.87 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.75 141.5 57.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.721 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.575 ' CD1' HG12 ' A' ' 63' ' ' VAL . 0.6 OUTLIER -90.93 -36.89 13.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.633 179.906 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.26 -81.3 1.06 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.574 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.7 ttmm -171.44 39.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.887 0.375 . . . . 0.0 110.85 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.651 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 6.1 m-70 -98.67 165.1 15.7 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.713 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.651 ' HD2' ' HB3' ' A' ' 18' ' ' HIS . 42.2 Cg_endo -66.79 -37.3 21.07 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.272 1.982 . . . . 0.0 111.935 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.533 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 6.3 p80 172.71 -172.14 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.022 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.555 HG21 ' CD1' ' A' ' 26' ' ' LEU . 2.5 m -136.26 151.9 29.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.091 0.472 . . . . 0.0 112.255 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.423 ' O ' ' N ' ' A' ' 25' ' ' ASP . 2.5 mp0 -95.01 148.3 22.48 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.464 178.61 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.567 ' O ' HD12 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -40.7 -47.94 2.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.743 0.306 . . . . 0.0 111.636 -179.492 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -62.78 -34.72 77.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.877 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.436 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 8.7 m-20 -64.75 -62.2 1.72 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.046 0.45 . . . . 0.0 110.433 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.793 HD11 HG21 ' A' ' 77' ' ' VAL . 0.9 OUTLIER -50.64 -46.0 58.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.148 179.909 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.769 HD21 ' HG3' ' A' ' 45' ' ' GLU . 9.8 mt -67.07 -59.37 3.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.915 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.18 -58.59 7.31 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.436 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.2 OUTLIER -53.9 -45.49 71.12 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.677 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.641 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 4.3 mm-40 -72.55 -14.62 61.68 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.187 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.09 25.34 12.93 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.192 -1.004 . . . . 0.0 113.332 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.712 ' CD2' HD23 ' A' ' 27' ' ' LEU . 12.4 m95 -73.47 -58.6 3.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.041 0.448 . . . . 0.0 110.013 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.699 ' HA ' HD12 ' A' ' 41' ' ' ILE . 2.1 t -106.1 133.7 50.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.513 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -64.67 -34.12 77.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.608 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.434 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 56.2 p -105.83 -49.2 3.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.734 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 133.91 -32.54 2.66 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.764 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.23 6.57 1.73 Allowed 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.434 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 69.7 tp60 -54.61 -71.83 0.07 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.956 0.408 . . . . 0.0 110.852 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.05 15.22 1.17 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.465 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.38 20.84 11.86 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.629 -179.53 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.71 HG23 ' CD2' ' A' ' 70' ' ' PHE . 37.5 mt -54.88 -25.89 16.4 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-O 121.01 0.433 . . . . 0.0 110.712 179.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.492 ' HA ' ' CD1' ' A' ' 27' ' ' LEU . . . -67.72 -79.34 0.05 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.164 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 44.6 mm -51.2 -39.17 20.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.199 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.624 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -58.04 -68.88 0.21 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.238 179.182 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.769 ' HG3' HD21 ' A' ' 27' ' ' LEU . 0.9 OUTLIER -33.42 -41.9 0.09 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.749 179.741 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.475 ' HA2' HD21 ' A' ' 23' ' ' LEU . . . -57.44 -74.72 0.31 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.034 -1.079 . . . . 0.0 110.553 178.047 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.529 ' HA ' HG22 ' A' ' 56' ' ' THR . 13.8 pt20 -48.06 -12.84 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.762 HG21 ' HD1' ' A' ' 70' ' ' PHE . 58.7 t -75.02 -93.63 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.969 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.48 ' HD3' ' HB ' ' A' ' 54' ' ' VAL . 4.6 mmtt -166.92 124.89 1.32 Allowed 'General case' 0 C--O 1.23 0.065 0 C-N-CA 120.151 -0.619 . . . . 0.0 112.368 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.602 HG13 HG23 ' A' ' 68' ' ' VAL . 12.8 t -118.11 149.17 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 177.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.445 ' HB2' ' H ' ' A' ' 67' ' ' THR . 9.9 t0 -45.07 100.47 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.025 0.44 . . . . 0.0 111.534 -178.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 66.95 17.3 67.43 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.857 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.507 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -145.98 82.71 1.62 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.922 0.391 . . . . 0.0 111.945 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.635 HG13 ' O ' ' A' ' 54' ' ' VAL . 14.0 p -90.66 65.44 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.912 0.387 . . . . 0.0 110.582 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -99.83 -173.5 2.47 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.511 -179.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.529 HG22 ' HA ' ' A' ' 47' ' ' GLN . 0.8 OUTLIER -140.83 32.59 1.79 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.149 -179.708 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 19.4 mtp180 -84.74 169.13 14.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.062 0.458 . . . . 0.0 111.503 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.17 -32.01 55.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.915 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.2 mtt85 -131.76 146.54 52.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.654 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -129.51 115.89 18.13 Favored 'General case' 0 C--O 1.23 0.078 0 CA-C-O 120.89 0.376 . . . . 0.0 111.328 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.436 ' HG2' ' CD2' ' A' ' 20' ' ' HIS . 6.3 mttt -76.1 91.91 3.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.352 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.466 ' CD1' HG11 ' A' ' 50' ' ' VAL . 39.8 mt -133.77 139.72 48.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.265 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.575 HG12 ' CD1' ' A' ' 15' ' ' LEU . 2.5 m -146.23 175.2 2.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.119 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.533 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 74.98 -143.51 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.965 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -93.13 80.49 1.08 Allowed Glycine 0 C--N 1.336 0.552 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.766 -179.329 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -121.92 175.17 6.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.819 0.342 . . . . 0.0 111.228 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.445 ' H ' ' HB2' ' A' ' 51' ' ' ASP . 27.1 m -135.85 151.14 49.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.008 -178.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.712 HG12 ' CH2' ' A' ' 32' ' ' TRP . 1.2 t -130.5 144.13 38.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.309 179.135 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 67.8 m -140.99 141.23 34.4 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -178.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.762 ' HD1' HG21 ' A' ' 48' ' ' VAL . 1.9 t80 -146.08 122.28 10.85 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.273 179.096 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 49.78 -83.47 0.01 OUTLIER 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.481 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -127.46 -5.09 5.62 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.963 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.551 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 0.8 OUTLIER -89.46 113.79 25.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 117.01 0.405 . . . . 0.0 111.592 -179.027 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.61 111.35 17.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.285 178.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.587 ' HB ' ' HZ2' ' A' ' 32' ' ' TRP . 41.1 t -132.39 151.61 35.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.817 0.342 . . . . 0.0 111.488 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.438 ' HG3' ' OG1' ' A' ' 67' ' ' THR . 24.5 mp0 -113.2 159.53 19.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.423 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.793 HG21 HD11 ' A' ' 26' ' ' LEU . 6.3 t -125.07 138.7 53.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.084 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.1 m -133.88 154.54 38.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.014 0.435 . . . . 0.0 111.871 -179.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.431 ' HB2' ' HB2' ' A' ' 15' ' ' LEU . . . . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.058 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.152 0 N-CA-C 112.565 -0.214 . . . . 0.0 112.565 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 p -154.89 140.94 18.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.793 0.33 . . . . 0.0 110.911 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.26 -33.59 16.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.886 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.6 mt -79.32 125.99 38.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.072 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -168.68 -169.97 1.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.626 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 24.2 mtp180 -82.13 -31.4 30.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.84 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.18 175.4 9.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.834 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 m -139.59 123.18 17.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.037 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -71.38 84.64 0.8 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.553 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -93.35 77.19 4.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.705 -179.375 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.28 129.62 34.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.296 179.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.63 132.99 41.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.021 0.439 . . . . 0.0 110.902 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.486 ' HE1' HD23 ' A' ' 15' ' ' LEU . 16.8 t80 -99.72 98.24 9.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.967 179.745 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.416 ' HA ' HG23 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -77.18 98.98 5.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.764 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.486 HD23 ' HE1' ' A' ' 13' ' ' PHE . 17.9 mt -55.83 -34.14 65.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.985 0.421 . . . . 0.0 110.542 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.54 42.49 7.82 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.005 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt 61.3 39.38 15.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.981 0.419 . . . . 0.0 110.631 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.402 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 3.6 m170 -95.15 165.73 16.3 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.897 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.434 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 14.8 Cg_endo -56.99 -63.63 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.672 2.248 . . . . 0.0 112.612 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.434 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 8.5 p80 178.51 -174.05 0.16 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.241 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.421 ' N ' ' ND1' ' A' ' 20' ' ' HIS . 17.8 m -149.93 167.07 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.409 ' HB2' ' CB ' ' A' ' 59' ' ' ARG . 1.5 pt-20 -103.71 153.39 20.72 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.253 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.543 ' O ' HD13 ' A' ' 27' ' ' LEU . 81.6 mt -41.65 -45.55 3.44 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.534 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.0 t -65.37 -39.12 91.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.721 0.296 . . . . 0.0 111.671 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -62.12 -62.31 1.86 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.593 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.672 HD21 ' CG2' ' A' ' 77' ' ' VAL . 2.3 tp -53.69 -41.92 67.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.474 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.001 HD23 HG22 ' A' ' 41' ' ' ILE . 8.0 mp -66.81 -64.7 0.8 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.382 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -51.26 -57.0 10.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.988 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 24.9 mt -53.65 -31.02 45.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.079 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.556 ' OE2' HG11 ' A' ' 75' ' ' VAL . 2.4 mm-40 -84.05 -13.61 52.71 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.55 18.0 34.36 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.365 -0.922 . . . . 0.0 112.685 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.529 ' CE3' ' HG ' ' A' ' 27' ' ' LEU . 9.4 m0 -69.58 -60.81 2.09 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.279 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.64 ' CB ' HD12 ' A' ' 41' ' ' ILE . 2.1 t -106.83 134.04 50.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.99 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -63.95 -34.83 78.87 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.856 0.36 . . . . 0.0 111.048 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.559 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 79.0 p -106.25 -51.56 2.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.138 0.494 . . . . 0.0 110.225 178.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 139.29 -37.62 1.74 Allowed Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.3 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.03 11.25 3.33 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.559 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 3.4 tp-100 -63.11 -66.65 0.51 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.761 0.315 . . . . 0.0 110.777 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.29 14.41 0.94 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.727 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 46.0 mmtt 65.4 25.48 11.99 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.832 0.349 . . . . 0.0 110.745 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 1.001 HG22 HD23 ' A' ' 27' ' ' LEU . 5.3 mt -63.09 -27.12 42.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.267 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.84 -78.51 0.06 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.836 0.35 . . . . 0.0 110.577 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.6 mm -46.51 -35.81 2.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 121.104 0.478 . . . . 0.0 110.249 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.722 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -63.8 -62.61 1.54 Allowed 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.657 178.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.759 ' HB2' HD21 ' A' ' 27' ' ' LEU . 16.3 tp10 -32.35 -41.84 0.06 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.823 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.8 -71.6 0.92 Allowed Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.355 -0.926 . . . . 0.0 111.743 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.522 ' HG3' ' O ' ' A' ' 44' ' ' ALA . 0.7 OUTLIER -43.69 -19.54 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.726 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.84 HG21 ' HD1' ' A' ' 70' ' ' PHE . 21.5 t -75.85 -85.05 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.945 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -170.36 133.17 1.05 Allowed 'General case' 0 C--O 1.23 0.055 0 CA-C-O 120.804 0.335 . . . . 0.0 111.138 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.665 ' HB ' ' HB3' ' A' ' 53' ' ' ALA . 4.4 t -134.62 144.19 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.056 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 67' ' ' THR . 6.0 t70 -48.74 91.25 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.75 0.31 . . . . 0.0 111.442 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 94.27 -7.4 72.3 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.875 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.665 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . . . -129.0 131.33 47.39 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 117.323 0.562 . . . . 0.0 111.187 -179.623 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 54' ' ' VAL . 7.5 p -124.84 32.51 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.861 178.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -101.99 154.64 18.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.936 -178.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.47 ' HA ' ' N ' ' A' ' 47' ' ' GLN . 12.1 t -92.88 46.84 1.24 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.643 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.68 169.98 17.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.187 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.09 -32.25 20.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.125 0.488 . . . . 0.0 109.819 178.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.409 ' CB ' ' HB2' ' A' ' 22' ' ' GLU . 36.2 mtm180 -128.38 151.94 48.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.991 179.339 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' CYS . . . . . 0.616 ' SG ' HD11 ' A' ' 62' ' ' ILE . 18.4 t -136.94 117.29 13.62 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.827 0.346 . . . . 0.0 111.105 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.02 99.0 2.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.394 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.616 HD11 ' SG ' ' A' ' 60' ' ' CYS . 1.5 mt -133.36 142.65 41.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.151 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.513 ' O ' ' HB3' ' A' ' 64' ' ' ALA . 25.6 m -147.54 170.71 3.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.39 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 72.34 -155.5 0.09 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.387 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.551 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -87.17 82.96 1.59 Allowed Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 121.516 -0.373 . . . . 0.0 112.285 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.454 ' HB3' ' CB ' ' A' ' 51' ' ' ASP . 5.0 mm100 -121.48 160.91 23.21 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.972 0.415 . . . . 0.0 111.577 -178.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.821 HG23 ' HG3' ' A' ' 76' ' ' GLN . 0.2 OUTLIER -116.23 149.07 39.76 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.551 -178.498 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.548 HG13 ' OE2' ' A' ' 45' ' ' GLU . 1.1 t -125.88 142.47 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.651 179.121 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.407 ' O ' ' HB ' ' A' ' 48' ' ' VAL . 13.2 m -138.14 133.53 33.47 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -178.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.858 ' CE2' HG23 ' A' ' 41' ' ' ILE . 1.9 t80 -144.05 122.57 12.45 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.1 178.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 47.21 -85.5 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.724 0.297 . . . . 0.0 111.535 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -127.31 -4.89 5.75 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.037 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.487 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 1.8 m-70 -92.75 110.1 21.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.025 0.413 . . . . 0.0 111.3 -179.323 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.0 m -120.69 125.16 46.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.278 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.556 HG11 ' OE2' ' A' ' 30' ' ' GLU . 47.0 t -147.23 160.64 8.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.808 0.337 . . . . 0.0 111.564 -179.293 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.821 ' HG3' HG23 ' A' ' 67' ' ' THR . 35.8 mt-30 -112.41 164.02 13.75 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.949 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.672 ' CG2' HD21 ' A' ' 26' ' ' LEU . 16.9 t -137.13 147.12 27.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.658 -179.274 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.416 HG23 ' HA ' ' A' ' 14' ' ' SER . 17.0 m -134.22 178.01 6.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 120.718 0.294 . . . . 0.0 110.624 178.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.331 -0.842 . . . . 0.0 111.098 -179.978 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.602 ' HB1' HG13 ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.456 -0.174 0 CA-C-O 120.687 0.28 . . . . 0.0 111.095 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.3 123.23 26.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.895 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.896 ' HB3' HG22 ' A' ' 77' ' ' VAL . 50.0 t80 -100.87 152.82 20.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.911 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.83 153.46 21.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.101 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.925 ' HB2' ' HB2' ' A' ' 79' ' ' ALA . 9.3 mt -129.32 -40.16 1.47 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.785 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.44 -111.54 3.63 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.73 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.86 57.4 1.35 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.114 0.483 . . . . 0.0 110.624 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.671 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 2.3 m-70 -110.04 165.84 11.9 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.567 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.671 ' HD2' ' HB3' ' A' ' 18' ' ' HIS . 31.2 Cg_endo -62.64 -41.25 32.53 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.098 1.866 . . . . 0.0 111.863 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.572 ' HA ' ' CG1' ' A' ' 63' ' ' VAL . 21.5 p80 171.38 -170.36 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.721 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.6 m -145.78 158.99 12.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.236 0.541 . . . . 0.0 112.365 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.574 ' HG3' ' HA ' ' A' ' 59' ' ' ARG . 8.2 tt0 -88.78 139.21 30.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.848 178.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.781 HD12 ' N ' ' A' ' 24' ' ' CYS . 4.1 pp -42.45 -30.48 0.34 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.781 0.324 . . . . 0.0 111.404 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.781 ' N ' HD12 ' A' ' 23' ' ' LEU . 3.5 t -72.47 -40.17 67.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.977 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.401 ' N ' ' O ' ' A' ' 22' ' ' GLU . 1.9 m-20 -65.74 -53.73 36.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.938 0.399 . . . . 0.0 110.702 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.871 HD11 HG21 ' A' ' 77' ' ' VAL . 10.1 tt -54.75 -48.72 72.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.825 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.872 HD23 HG22 ' A' ' 41' ' ' ILE . 8.9 mp -65.76 -63.03 1.18 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.648 -178.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.0 tmmm? -43.84 -59.43 2.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.023 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.483 ' HB3' ' CE1' ' A' ' 13' ' ' PHE . 0.5 OUTLIER -56.13 -47.5 78.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.226 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.629 ' CD ' HG11 ' A' ' 75' ' ' VAL . 2.3 mm-40 -62.11 -15.21 43.84 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.681 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.04 24.68 14.34 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.321 -0.942 . . . . 0.0 113.253 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.649 ' CH2' HG12 ' A' ' 68' ' ' VAL . 7.8 m0 -79.09 -63.88 1.32 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.248 0.524 . . . . 0.0 109.988 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.54 ' CB ' HD12 ' A' ' 41' ' ' ILE . 3.9 t -106.72 135.37 48.37 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.778 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.41 -33.36 71.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.827 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.7 p -104.67 -40.46 5.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.493 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 121.83 -30.74 5.2 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.027 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -138.31 5.93 2.53 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.701 0.259 . . . . 0.0 111.701 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 21.5 tp60 -54.91 -74.69 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.859 0.362 . . . . 0.0 110.952 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.464 ' HB3' HG13 ' A' ' 41' ' ' ILE . . . -74.62 15.68 0.34 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.77 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.4 mttm 64.48 24.57 13.15 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 120.961 0.41 . . . . 0.0 110.073 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.872 HG22 HD23 ' A' ' 27' ' ' LEU . 16.9 mt -63.71 -18.92 23.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.708 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.659 ' HB1' HD11 ' A' ' 23' ' ' LEU . . . -74.11 -79.14 0.09 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.93 0.395 . . . . 0.0 110.663 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 29.4 mm -46.61 -45.01 6.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.674 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.658 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -54.33 -68.14 0.21 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.91 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.617 ' HA ' ' HB2' ' A' ' 70' ' ' PHE . 6.6 tp10 -32.66 -45.14 0.12 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.604 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 55' ' ' GLU . . . -57.84 -74.37 0.35 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 119.875 -1.155 . . . . 0.0 110.637 178.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.564 ' CA ' ' HB ' ' A' ' 56' ' ' THR . 14.6 pt20 -46.33 -14.62 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.755 HG21 ' HD1' ' A' ' 70' ' ' PHE . 56.0 t -74.92 -88.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.116 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -172.84 128.87 0.5 Allowed 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.828 0.346 . . . . 0.0 111.019 179.221 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.574 ' HB ' ' HB3' ' A' ' 53' ' ' ALA . 44.7 t -124.29 149.48 28.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.591 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -55.66 85.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.132 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 106.78 -6.15 37.62 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.115 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.574 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . . . -133.75 135.42 43.92 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 117.148 0.474 . . . . 0.0 111.267 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.497 HG22 ' O ' ' A' ' 54' ' ' VAL . 12.1 p -125.42 38.13 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.306 178.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.488 ' HB3' ' H ' ' A' ' 56' ' ' THR . 7.6 mt-10 -106.94 -151.39 0.46 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.211 -0.449 . . . . 0.0 112.171 -178.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.564 ' HB ' ' CA ' ' A' ' 47' ' ' GLN . 3.5 t -166.96 57.3 0.08 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.927 0.394 . . . . 0.0 111.469 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.2 mtt-85 -86.29 175.29 8.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.019 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.21 -47.53 27.82 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.574 ' HA ' ' HG3' ' A' ' 22' ' ' GLU . 3.8 mtm180 -115.21 153.09 31.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.237 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -125.68 137.22 53.84 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.928 0.394 . . . . 0.0 111.231 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.508 ' HG3' ' CD2' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -99.98 77.59 2.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.441 179.485 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.3 mt -133.9 144.49 35.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.42 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.572 ' CG1' ' HA ' ' A' ' 20' ' ' HIS . 6.5 m -150.28 175.64 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.183 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.676 ' HA ' ' HB3' ' A' ' 79' ' ' ALA . . . 74.4 -150.39 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.082 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.641 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -84.93 77.74 2.08 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.319 -0.467 . . . . 0.0 112.963 -178.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 18.3 mm100 -122.09 158.71 28.66 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.859 0.361 . . . . 0.0 110.979 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.624 HG23 ' O ' ' A' ' 75' ' ' VAL . 26.9 m -117.15 154.64 30.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.141 0.496 . . . . 0.0 112.251 -178.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.649 HG12 ' CH2' ' A' ' 32' ' ' TRP . 0.7 OUTLIER -127.37 143.25 41.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.44 178.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 36.8 m -136.66 132.82 35.5 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -178.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.755 ' HD1' HG21 ' A' ' 48' ' ' VAL . 1.4 t80 -141.95 122.77 14.39 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.336 178.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 46.67 -87.01 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.687 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -126.66 -6.06 5.69 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.858 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.403 ' O ' ' CH2' ' A' ' 32' ' ' TRP . 1.0 OUTLIER -90.61 103.59 16.27 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.793 0.33 . . . . 0.0 111.042 -179.464 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.3 m -114.65 125.57 53.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.602 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.641 ' HB ' ' HZ2' ' A' ' 32' ' ' TRP . 47.0 t -145.59 153.58 13.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.23 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.487 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 3.1 mp0 -112.25 158.28 19.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.813 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.896 HG22 ' HB3' ' A' ' 13' ' ' PHE . 46.9 t -129.2 152.22 36.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.813 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.2 m -130.89 148.97 33.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.921 0.391 . . . . 0.0 111.53 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.925 ' HB2' ' HB2' ' A' ' 15' ' ' LEU . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.077 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.534 ' HB3' HG13 ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.456 -0.132 0 CA-C-O 120.898 0.38 . . . . 0.0 111.166 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.64 132.26 48.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.592 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.813 ' HB3' HG22 ' A' ' 77' ' ' VAL . 77.8 t80 -110.04 148.57 31.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.923 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.5 146.9 30.02 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.809 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.663 HD21 HG11 ' A' ' 77' ' ' VAL . 27.8 mt -114.23 -40.45 3.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.921 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.65 -103.75 2.89 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.585 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.06 56.62 0.9 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.995 0.426 . . . . 0.0 111.011 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.421 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 1.0 OUTLIER -113.36 167.33 9.49 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.578 179.863 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.59 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 19.4 Cg_endo -59.8 -33.55 96.12 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.3 2.0 . . . . 0.0 111.665 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.59 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 14.1 p80 163.01 -164.32 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.989 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.579 HG21 HD13 ' A' ' 26' ' ' LEU . 4.9 m -142.92 153.91 17.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.139 0.495 . . . . 0.0 112.004 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.459 ' HG3' ' CB ' ' A' ' 59' ' ' ARG . 0.7 OUTLIER -83.53 138.34 33.46 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.907 179.019 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.718 HD12 ' N ' ' A' ' 24' ' ' CYS . 4.6 pp -41.03 -33.27 0.31 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.764 0.316 . . . . 0.0 111.478 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.718 ' N ' HD12 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -71.3 -39.15 71.63 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.988 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 22' ' ' GLU . 78.8 m-20 -62.73 -52.27 63.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.05 0.452 . . . . 0.0 110.442 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.754 HD21 HG21 ' A' ' 77' ' ' VAL . 8.4 tp -58.23 -46.5 85.8 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.893 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.803 HD23 HG22 ' A' ' 41' ' ' ILE . 5.6 mp -67.33 -60.69 2.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.651 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -46.53 -65.26 0.58 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.752 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.57 -41.61 63.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.212 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 2.9 mm-40 -72.27 -15.3 61.91 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.19 26.26 12.71 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.475 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.561 ' CH2' HG12 ' A' ' 68' ' ' VAL . 9.4 m95 -76.39 -66.04 0.85 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 117.094 0.447 . . . . 0.0 110.079 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.0 t -101.0 149.29 24.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.315 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.32 -34.08 36.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.04 0.448 . . . . 0.0 110.489 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.78 -31.95 8.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.585 179.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 126.08 -60.22 0.65 Allowed Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.346 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -129.32 7.59 5.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.789 0.328 . . . . 0.0 111.281 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -54.21 -64.38 0.85 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.872 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.514 ' HB3' ' CD1' ' A' ' 41' ' ' ILE . . . -74.19 15.08 0.35 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -179.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.1 mmmt 72.24 14.14 5.58 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.622 0.249 . . . . 0.0 111.206 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.803 HG22 HD23 ' A' ' 27' ' ' LEU . 6.8 mt -65.5 -14.99 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-O 120.969 0.414 . . . . 0.0 110.739 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.533 ' HA ' HD13 ' A' ' 23' ' ' LEU . . . -72.21 -79.81 0.07 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.047 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 19.8 mm -52.33 -33.13 16.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.985 0.421 . . . . 0.0 110.51 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.789 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -63.09 -72.18 0.14 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.683 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.747 ' HG3' HD11 ' A' ' 27' ' ' LEU . 3.6 tm-20 -35.35 -41.09 0.16 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.838 0.352 . . . . 0.0 111.157 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.41 ' C ' ' H ' ' A' ' 48' ' ' VAL . . . -63.04 -73.8 0.49 Allowed Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.277 -0.964 . . . . 0.0 110.928 178.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.458 ' HG3' ' O ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -47.96 -9.52 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -179.62 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.789 HG23 ' O ' ' A' ' 44' ' ' ALA . 57.4 t -74.66 -90.67 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.644 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.625 ' HD3' ' HB ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -167.02 119.37 0.95 Allowed 'General case' 0 CA--C 1.527 0.08 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.73 179.694 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.544 ' HB ' ' O ' ' A' ' 53' ' ' ALA . 19.2 t -113.62 154.98 14.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.644 ' HB2' ' H ' ' A' ' 67' ' ' THR . 16.8 t0 -44.7 98.2 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.017 0.437 . . . . 0.0 111.611 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.93 21.43 61.18 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.339 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.544 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -145.79 79.87 1.57 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.021 0.439 . . . . 0.0 111.766 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.625 ' HB ' ' HD3' ' A' ' 49' ' ' LYS . 14.9 p -88.21 62.76 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.926 0.393 . . . . 0.0 111.044 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.42 178.4 4.65 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.297 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.8 t -139.31 40.59 2.08 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.801 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -86.91 174.39 8.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.693 0.282 . . . . 0.0 111.01 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.1 mttp -75.18 -50.27 16.8 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.965 0.412 . . . . 0.0 110.806 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.459 ' CB ' ' HG3' ' A' ' 22' ' ' GLU . 0.3 OUTLIER -106.4 136.88 45.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.27 179.402 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -100.04 115.58 30.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.949 0.404 . . . . 0.0 111.031 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.586 ' O ' HD13 ' A' ' 62' ' ' ILE . 4.7 mtmt -87.12 76.01 9.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.881 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.586 HD13 ' O ' ' A' ' 61' ' ' LYS . 3.5 mm -133.44 142.39 41.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.981 -179.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.534 ' O ' ' HB3' ' A' ' 64' ' ' ALA . 1.4 m -146.85 175.2 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.724 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 74.48 -155.01 0.05 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.313 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.528 ' HA2' HG12 ' A' ' 78' ' ' VAL . . . -84.73 81.13 1.77 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 121.329 -0.462 . . . . 0.0 112.515 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.508 ' HG3' HG22 ' A' ' 62' ' ' ILE . 7.9 mm-40 -122.05 156.46 33.49 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.111 0.481 . . . . 0.0 111.264 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.644 ' H ' ' HB2' ' A' ' 51' ' ' ASP . 0.8 OUTLIER -113.55 152.9 29.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.752 -179.109 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.561 HG12 ' CH2' ' A' ' 32' ' ' TRP . 0.8 OUTLIER -127.34 147.07 32.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.645 179.237 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.4 m -143.16 137.8 29.31 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -178.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.783 ' CD1' HG21 ' A' ' 48' ' ' VAL . 1.6 t80 -144.91 121.66 11.2 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.084 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 48.72 -85.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.689 0.28 . . . . 0.0 111.347 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -126.77 -5.72 5.75 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.786 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.438 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 1.1 m-70 -88.39 104.4 16.74 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.888 0.344 . . . . 0.0 111.084 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -116.9 106.72 13.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.838 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.534 HG13 ' HB3' ' A' ' 11' ' ' ALA . 38.6 t -126.17 155.94 36.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.017 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.542 ' CG ' HG23 ' A' ' 67' ' ' THR . 1.3 mt-30 -112.33 158.02 20.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.012 0.434 . . . . 0.0 111.058 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.813 HG22 ' HB3' ' A' ' 13' ' ' PHE . 29.0 t -140.39 148.0 22.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.329 -179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.528 HG12 ' HA2' ' A' ' 65' ' ' GLY . 17.0 m -139.92 178.03 3.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.707 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.073 -179.902 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.874 ' HB1' HG13 ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.452 -0.34 0 CA-C-O 120.754 0.312 . . . . 0.0 111.036 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.5 112.23 7.88 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.474 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.848 ' HB3' HG22 ' A' ' 77' ' ' VAL . 73.8 t80 -98.67 144.13 28.28 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.002 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.4 m -107.02 135.72 48.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.478 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.729 HD22 ' HB2' ' A' ' 18' ' ' HIS . 0.5 OUTLIER -84.91 -33.18 22.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.849 0.357 . . . . 0.0 110.529 179.698 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.59 33.07 28.83 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.291 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 25.5 mttm 58.73 56.14 4.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.069 0.461 . . . . 0.0 110.764 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.729 ' HB2' HD22 ' A' ' 15' ' ' LEU . 12.9 m170 -115.36 166.14 12.68 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.867 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.577 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 23.8 Cg_endo -60.97 -36.94 80.48 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.386 2.057 . . . . 0.0 112.151 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.577 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 22.4 p80 168.14 -174.6 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.406 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.551 HG13 HD21 ' A' ' 15' ' ' LEU . 2.5 m -140.96 160.44 23.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.189 0.519 . . . . 0.0 111.975 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.42 ' O ' ' N ' ' A' ' 25' ' ' ASP . 0.5 OUTLIER -94.26 141.76 28.19 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.038 179.351 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.621 ' O ' HD13 ' A' ' 27' ' ' LEU . 8.1 mt -38.08 -39.28 0.39 Allowed 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -73.4 -37.59 65.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.387 -179.396 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 22' ' ' GLU . 56.6 m-20 -61.62 -54.52 41.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.06 0.457 . . . . 0.0 111.074 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.049 HD11 HG21 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -60.06 -43.31 95.52 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.658 -179.546 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.902 HD23 HG22 ' A' ' 41' ' ' ILE . 6.7 mp -68.33 -56.87 7.05 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.701 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -56.95 -55.87 29.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.859 0.362 . . . . 0.0 111.216 -179.597 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 81.9 mt -53.41 -37.73 62.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.685 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.487 ' OE1' HG11 ' A' ' 75' ' ' VAL . 8.7 mm-40 -79.08 -11.33 59.99 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.12 22.9 23.92 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.366 -0.921 . . . . 0.0 113.226 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.528 ' CH2' HG12 ' A' ' 68' ' ' VAL . 11.9 m95 -73.97 -63.21 1.27 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.008 0.432 . . . . 0.0 109.96 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.1 t -106.95 135.19 48.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.915 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -74.43 -34.69 63.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.022 0.439 . . . . 0.0 110.247 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.0 p -106.4 -44.76 4.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.268 178.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 112.74 -21.82 17.94 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.987 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -128.63 -1.24 5.47 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 111.709 0.262 . . . . 0.0 111.709 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.4 tp60 -61.11 -79.42 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.79 0.329 . . . . 0.0 110.611 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.32 11.28 2.47 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.562 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.3 mttm 59.44 29.81 19.42 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 120.798 0.332 . . . . 0.0 110.297 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.902 HG22 HD23 ' A' ' 27' ' ' LEU . 8.0 mt -60.06 -17.67 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.613 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.4 -79.09 0.09 Allowed 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.822 0.344 . . . . 0.0 111.111 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 44.2 mm -47.38 -36.54 4.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.97 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.797 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -61.81 -67.24 0.43 Allowed 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.346 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.781 ' HG2' HD11 ' A' ' 27' ' ' LEU . 12.3 tp10 -33.62 -42.08 0.1 Allowed 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 120.902 0.382 . . . . 0.0 110.466 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.1 -77.4 0.18 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 119.936 -1.126 . . . . 0.0 110.938 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.52 ' HG3' ' O ' ' A' ' 44' ' ' ALA . 0.6 OUTLIER -48.26 -10.88 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -179.645 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.922 HG11 ' HA ' ' A' ' 70' ' ' PHE . 47.5 t -75.33 -96.66 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.033 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -164.86 120.96 1.45 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 118.404 0.547 . . . . 0.0 111.576 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.613 HG13 HG23 ' A' ' 68' ' ' VAL . 16.5 t -114.05 150.39 16.09 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.432 ' HB2' ' HB ' ' A' ' 67' ' ' THR . 20.7 t70 -44.79 97.05 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.972 0.415 . . . . 0.0 111.441 -178.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.98 16.7 70.87 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.759 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.57 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -145.91 81.14 1.59 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.122 0.487 . . . . 0.0 112.09 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.501 HG13 ' O ' ' A' ' 54' ' ' VAL . 7.0 p -90.3 71.95 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.126 0.488 . . . . 0.0 110.309 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 47' ' ' GLN . 8.2 mt-10 -99.34 -173.14 2.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.817 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 t -147.29 46.19 1.14 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.908 0.385 . . . . 0.0 111.62 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 19.0 mtt-85 -98.02 174.54 6.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.535 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.506 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 1.7 mptp? -75.2 -38.12 60.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.012 0.434 . . . . 0.0 110.08 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -127.72 158.29 38.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.064 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . 0.419 ' HB2' ' HG ' ' A' ' 23' ' ' LEU . 0.5 OUTLIER -133.96 115.8 14.81 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.388 -179.605 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.482 ' HG2' ' CD2' ' A' ' 20' ' ' HIS . 31.4 mtmt -74.14 94.53 2.44 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.44 HD13 ' O ' ' A' ' 61' ' ' LYS . 5.8 mm -133.49 144.89 34.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.328 -178.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.566 HG11 ' O ' ' A' ' 19' ' ' PRO . 14.3 m -148.4 174.45 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.807 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.498 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 72.69 -151.27 0.07 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.646 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -88.87 81.26 1.54 Allowed Glycine 0 C--N 1.337 0.585 0 C-N-CA 121.472 -0.394 . . . . 0.0 112.6 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -122.05 156.06 34.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.135 0.493 . . . . 0.0 111.414 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.52 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 40.3 m -118.65 147.69 43.51 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.233 -178.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.613 HG23 HG13 ' A' ' 50' ' ' VAL . 0.7 OUTLIER -124.21 148.23 28.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.031 178.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 49' ' ' LYS . 58.1 m -141.7 138.46 32.44 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.922 ' HA ' HG11 ' A' ' 48' ' ' VAL . 2.8 t80 -152.16 127.08 9.64 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.614 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 47.55 -85.85 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.334 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -128.2 -7.92 4.29 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.039 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.476 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 1.9 m-70 -89.22 108.77 19.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.145 0.472 . . . . 0.0 111.391 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -118.99 107.45 13.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.171 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.874 HG13 ' HB1' ' A' ' 11' ' ' ALA . 22.0 t -130.5 152.95 38.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.039 0.447 . . . . 0.0 111.944 -178.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.52 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 28.6 mt-30 -111.87 164.29 13.26 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.427 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 1.049 HG21 HD11 ' A' ' 26' ' ' LEU . 21.3 t -136.52 148.73 26.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.547 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.2 m -131.63 160.05 42.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.947 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.291 -0.861 . . . . 0.0 111.144 179.978 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.659 ' O ' HG13 ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.456 -0.141 0 CA-C-O 120.758 0.313 . . . . 0.0 111.045 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.1 p -137.0 129.04 29.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.185 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.749 ' HB3' HG22 ' A' ' 77' ' ' VAL . 41.6 t80 -98.36 154.48 17.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.006 0.431 . . . . 0.0 110.749 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.7 m -106.42 155.53 19.46 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.107 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.605 ' CD1' ' HA ' ' A' ' 63' ' ' VAL . 6.7 mt -122.2 -31.51 3.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.545 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.19 -111.7 3.42 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.023 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -149.84 54.72 0.94 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.306 0.574 . . . . 0.0 110.16 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.671 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 16.2 m-70 -118.98 168.6 9.5 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.766 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.671 ' HD2' ' HB3' ' A' ' 18' ' ' HIS . 7.7 Cg_endo -48.36 -44.45 29.46 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.742 2.295 . . . . 0.0 112.62 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.55 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 3.9 p80 162.75 -165.65 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.091 0.556 . . . . 0.0 109.929 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.518 ' O ' ' O ' ' A' ' 60' ' ' CYS . 15.5 m -134.77 147.23 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 120.959 0.409 . . . . 0.0 111.888 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.65 ' HA ' ' H ' ' A' ' 60' ' ' CYS . 1.2 mt-10 -83.93 143.54 29.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.634 179.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.704 ' O ' HD13 ' A' ' 27' ' ' LEU . 2.5 mp -39.82 -36.45 0.44 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.83 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 9.2 t -76.31 -35.51 58.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.329 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' A' ' 22' ' ' GLU . 30.1 m-20 -64.29 -62.03 1.87 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.969 0.414 . . . . 0.0 110.691 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.51 HD11 HG21 ' A' ' 77' ' ' VAL . 9.7 tt -55.05 -44.98 75.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.338 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.797 HD23 HG22 ' A' ' 41' ' ' ILE . 5.8 mp -62.23 -54.35 42.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.698 -178.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.9 -48.89 79.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.635 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 45.7 mt -58.35 -48.13 81.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.267 -0.424 . . . . 0.0 112.012 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.506 ' CG ' ' HB2' ' A' ' 13' ' ' PHE . 7.4 mm-40 -70.75 -12.25 61.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.55 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.96 23.26 30.56 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.846 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.545 ' CZ3' ' HB2' ' A' ' 73' ' ' HIS . 23.1 m95 -64.63 -73.52 0.12 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.8 0.333 . . . . 0.0 110.334 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.585 ' HB2' HG21 ' A' ' 41' ' ' ILE . 24.6 t -92.91 147.27 22.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.787 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -76.75 -33.32 58.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.684 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.462 ' OG ' ' HB3' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -105.42 -28.8 10.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.112 179.71 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 115.79 -72.71 0.26 Allowed Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.445 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -120.41 -2.96 9.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.771 0.32 . . . . 0.0 111.042 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.462 ' HB3' ' OG ' ' A' ' 35' ' ' SER . 3.9 tp60 -52.63 -62.85 1.38 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.914 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.481 ' HB3' HG12 ' A' ' 41' ' ' ILE . . . -73.87 15.05 0.32 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.797 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.8 mttt 68.61 15.95 9.07 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.695 0.283 . . . . 0.0 111.046 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.797 HG22 HD23 ' A' ' 27' ' ' LEU . 45.5 mm -58.54 -20.93 17.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.023 0.439 . . . . 0.0 110.926 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.05 -76.4 0.12 Allowed 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.93 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.6 mm -47.85 -42.52 9.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.772 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.783 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -57.94 -66.6 0.45 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.383 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.718 ' HB2' HD21 ' A' ' 27' ' ' LEU . 9.3 tp10 -30.94 -44.83 0.06 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.56 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.93 -74.56 0.36 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.169 -1.015 . . . . 0.0 110.892 178.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.447 ' HA ' ' O ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -47.57 -11.58 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -179.787 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.983 HG21 ' CD1' ' A' ' 70' ' ' PHE . 39.7 t -75.32 -99.61 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 O-C-N 122.137 -0.352 . . . . 0.0 111.668 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.7 ' HD3' ' HB ' ' A' ' 54' ' ' VAL . 8.2 mmtp -161.0 138.64 9.29 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.702 0.683 . . . . 0.0 111.839 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.663 ' HB ' ' O ' ' A' ' 53' ' ' ALA . 44.1 t -127.58 147.91 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.74 ' HB2' ' HB ' ' A' ' 67' ' ' THR . 12.9 t0 -44.03 87.01 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -177.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 101.87 -19.13 50.83 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.739 -0.743 . . . . 0.0 114.821 177.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.663 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -146.77 136.68 23.31 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 118.41 1.105 . . . . 0.0 113.041 -178.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.7 ' HB ' ' HD3' ' A' ' 49' ' ' LYS . 11.3 p -107.43 108.68 25.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.238 178.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' A' ' 47' ' ' GLN . 47.3 mt-10 -102.98 -170.28 1.77 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.642 0.258 . . . . 0.0 110.845 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.6 t -164.0 30.27 0.08 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.354 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.17 169.99 9.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.947 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.1 ttpp -75.86 -43.83 43.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.594 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.455 ' HA ' ' HG2' ' A' ' 22' ' ' GLU . 0.3 OUTLIER -102.31 142.63 33.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.747 179.854 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . 0.65 ' H ' ' HA ' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -100.08 116.58 32.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.805 -179.789 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.414 ' HA ' ' CD2' ' A' ' 20' ' ' HIS . 11.3 mtmt -103.74 78.75 1.59 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.173 0.511 . . . . 0.0 109.875 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.436 HD12 ' SG ' ' A' ' 60' ' ' CYS . 22.0 mt -138.95 148.92 23.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.172 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.605 ' HA ' ' CD1' ' A' ' 15' ' ' LEU . 1.3 m -151.11 175.09 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.698 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.577 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 78.76 -138.45 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.569 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -104.41 84.25 0.42 Allowed Glycine 0 C--N 1.339 0.695 0 C-N-CA 121.041 -0.599 . . . . 0.0 113.624 -178.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 61.9 mm-40 -122.05 163.19 19.85 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.757 0.313 . . . . 0.0 111.145 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.74 ' HB ' ' HB2' ' A' ' 51' ' ' ASP . 8.9 m -119.11 139.87 51.06 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.247 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.68 137.16 44.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.36 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.6 m -132.0 128.18 37.83 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.919 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.983 ' CD1' HG21 ' A' ' 48' ' ' VAL . 4.1 t80 -175.68 130.38 0.26 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.351 179.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.452 ' N ' ' CD1' ' A' ' 70' ' ' PHE . . . 56.99 44.91 22.08 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.393 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 70.16 1.6 35.23 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.791 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.545 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 8.3 m-70 -94.55 98.16 10.64 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.877 0.338 . . . . 0.0 111.111 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.96 101.77 11.79 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.659 HG13 ' O ' ' A' ' 11' ' ' ALA . 40.8 t -120.37 147.55 24.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.569 -178.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.545 ' HG3' HG23 ' A' ' 67' ' ' THR . 2.0 mp0 -111.94 145.65 39.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.667 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.749 HG22 ' HB3' ' A' ' 13' ' ' PHE . 8.0 t -120.62 145.66 26.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.333 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.8 m -128.59 157.53 41.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.947 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.568 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . . . . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.294 -0.86 . . . . 0.0 111.04 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.712 ' HB3' HG22 ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.452 -0.356 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.62 135.85 40.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.94 0.4 . . . . 0.0 110.773 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.738 ' CE2' ' HA ' ' A' ' 26' ' ' LEU . 31.7 t80 -103.98 143.11 33.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.557 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.447 ' O ' ' CE1' ' A' ' 13' ' ' PHE . 0.4 OUTLIER -106.84 132.63 52.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.389 179.471 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.739 HD11 HG12 ' A' ' 63' ' ' VAL . 0.5 OUTLIER -75.51 -37.23 60.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.82 0.343 . . . . 0.0 110.845 179.868 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.66 29.48 26.62 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.306 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.19 43.18 20.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.053 0.454 . . . . 0.0 110.722 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.452 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.9 OUTLIER -114.67 168.6 7.8 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.845 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.517 ' O ' HG11 ' A' ' 63' ' ' VAL . 8.8 Cg_endo -50.38 -43.68 42.92 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.694 2.263 . . . . 0.0 112.215 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.528 ' CA ' HD21 ' A' ' 15' ' ' LEU . 6.3 p80 172.85 -163.79 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.839 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.403 HG11 ' CE1' ' A' ' 13' ' ' PHE . 9.8 m -142.05 153.58 18.72 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.489 ' HG2' ' CB ' ' A' ' 59' ' ' ARG . 14.6 mt-10 -100.64 153.8 19.11 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.135 178.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.686 ' HB2' ' O ' ' A' ' 58' ' ' LYS . 1.5 mp -40.23 -54.85 2.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.732 0.301 . . . . 0.0 111.42 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.596 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -57.63 -33.75 68.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.748 179.791 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -72.31 -55.07 7.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.884 0.373 . . . . 0.0 110.975 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.738 ' HA ' ' CE2' ' A' ' 13' ' ' PHE . 7.6 tt -57.79 -47.93 81.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.406 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.999 HD23 HG22 ' A' ' 41' ' ' ILE . 7.5 mp -64.45 -59.14 4.69 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.596 ' HB2' ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -51.49 -59.21 4.51 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.263 -178.723 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.47 -50.62 69.4 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -178.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.561 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 2.0 mm-40 -61.85 -15.26 40.74 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.05 23.04 13.79 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.319 -0.943 . . . . 0.0 113.443 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.637 ' CE3' ' HG ' ' A' ' 27' ' ' LEU . 7.7 m0 -73.53 -66.48 0.69 Allowed 'General case' 0 C--O 1.232 0.165 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.7 ' CB ' HD12 ' A' ' 41' ' ' ILE . 6.2 t -106.83 143.25 35.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.185 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -70.24 -34.15 72.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.852 0.358 . . . . 0.0 110.692 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.493 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -105.73 -52.14 2.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.443 179.307 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 139.07 -31.82 2.33 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.432 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.98 8.7 2.1 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.493 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 3.2 tp-100 -55.25 -71.11 0.09 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.703 0.287 . . . . 0.0 111.155 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.56 15.5 0.47 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 71.44 19.44 5.21 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.045 0.45 . . . . 0.0 110.35 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.999 HG22 HD23 ' A' ' 27' ' ' LEU . 9.9 mt -61.13 -22.86 28.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.293 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.64 -77.75 0.08 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.997 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.412 ' CD1' ' HG2' ' A' ' 58' ' ' LYS . 37.1 mm -51.61 -41.78 28.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.928 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.609 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -57.74 -71.19 0.11 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.623 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.743 ' CB ' HD21 ' A' ' 27' ' ' LEU . 1.6 tm-20 -33.46 -40.13 0.06 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.013 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.419 ' C ' ' H ' ' A' ' 48' ' ' VAL . . . -60.09 -75.35 0.28 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.289 -0.957 . . . . 0.0 110.986 178.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.551 HE21 ' HA ' ' A' ' 44' ' ' ALA . 23.7 pt20 -49.15 -8.17 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.847 HG21 ' HD1' ' A' ' 70' ' ' PHE . 97.7 t -75.33 -98.71 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.144 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.554 ' N ' HG12 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -161.87 126.15 3.29 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.973 -179.303 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.795 HG13 HG13 ' A' ' 68' ' ' VAL . 21.4 t -121.73 149.2 24.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.516 ' HB2' ' HB ' ' A' ' 67' ' ' THR . 22.2 t0 -44.96 102.48 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.864 0.364 . . . . 0.0 111.224 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 63.52 20.78 64.0 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.172 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.555 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . . . -146.19 74.6 1.38 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.981 0.42 . . . . 0.0 111.657 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.54 HG13 ' O ' ' A' ' 54' ' ' VAL . 7.5 p -86.25 63.72 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.983 0.42 . . . . 0.0 110.263 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.445 ' O ' ' HA ' ' A' ' 47' ' ' GLN . 21.6 mt-10 -102.29 -170.21 1.78 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.506 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.537 ' OG1' ' HB3' ' A' ' 47' ' ' GLN . 3.1 t -142.89 47.67 1.53 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.553 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 45.3 mtp85 -98.53 174.22 6.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.962 0.41 . . . . 0.0 111.3 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.686 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 24.0 mttm -79.61 -38.67 33.35 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.924 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.489 ' CB ' ' HG2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -128.34 159.36 35.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.856 -179.759 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -140.67 115.79 9.85 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.218 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.74 96.88 2.1 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.484 ' CG2' ' HG3' ' A' ' 66' ' ' GLN . 13.1 mt -133.47 136.01 55.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.809 -178.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.739 HG12 HD11 ' A' ' 15' ' ' LEU . 31.1 m -141.72 175.6 5.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.535 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.429 ' O ' ' HA ' ' A' ' 78' ' ' VAL . . . 71.19 -136.52 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.635 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.573 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -106.37 86.04 0.46 Allowed Glycine 0 C--N 1.339 0.702 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.192 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.484 ' HG3' ' CG2' ' A' ' 62' ' ' ILE . 8.4 mm-40 -122.05 172.25 8.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.716 0.293 . . . . 0.0 111.47 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 4.9 m -130.31 152.13 50.06 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.795 HG13 HG13 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -135.52 152.64 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.385 179.795 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.634 ' HA ' ' O ' ' A' ' 73' ' ' HIS . 0.4 OUTLIER -146.25 137.63 24.63 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -179.643 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.936 ' CE2' HG23 ' A' ' 41' ' ' ILE . 1.8 t80 -137.12 118.7 14.89 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.619 178.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 38.2 30.01 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 116.39 -6.63 18.76 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.365 -0.921 . . . . 0.0 113.563 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.634 ' O ' ' HA ' ' A' ' 69' ' ' SER . 1.4 m-70 -88.13 82.98 7.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.317 0.558 . . . . 0.0 111.145 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.6 119.81 29.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.749 0.309 . . . . 0.0 110.71 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.712 HG22 ' HB3' ' A' ' 11' ' ' ALA . 43.1 t -142.57 152.75 17.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.09 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.55 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 7.7 mt-30 -112.61 164.23 13.58 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.7 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.628 HG13 ' HD1' ' A' ' 13' ' ' PHE . 6.7 t -131.9 142.8 42.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.225 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 64' ' ' ALA . 28.1 m -138.44 169.15 18.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.184 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.118 -0.944 . . . . 0.0 111.212 179.956 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.939 ' HB3' HG13 ' A' ' 75' ' ' VAL . . . . . . . . 0 CA--C 1.523 -0.089 0 CA-C-O 120.89 0.376 . . . . 0.0 110.705 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.44 131.93 43.93 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.376 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.863 ' HB3' HG22 ' A' ' 77' ' ' VAL . 40.8 t80 -110.39 165.3 11.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.557 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.27 140.71 35.19 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.943 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.678 HD21 HG22 ' A' ' 21' ' ' VAL . 0.4 OUTLIER -142.3 -36.03 0.42 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.944 -179.37 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.506 ' H ' ' HA ' ' A' ' 79' ' ' ALA . . . -48.58 -30.06 8.17 Favored Glycine 0 C--N 1.329 0.153 0 C-N-CA 120.98 -0.629 . . . . 0.0 113.164 -179.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.73 -34.33 65.06 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.837 0.351 . . . . 0.0 110.839 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.614 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 3.9 m-70 -117.45 163.88 21.78 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.893 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.614 ' HD2' ' HB3' ' A' ' 18' ' ' HIS . 15.8 Cg_endo -56.13 -35.14 94.69 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.569 2.179 . . . . 0.0 111.985 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.484 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 2.5 p80 174.98 -176.37 0.09 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.431 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.678 HG22 HD21 ' A' ' 15' ' ' LEU . 13.6 m -145.32 164.21 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.414 ' CB ' ' HB3' ' A' ' 59' ' ' ARG . 1.5 pt-20 -99.83 153.17 19.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.2 178.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.781 HD22 ' HG3' ' A' ' 45' ' ' GLU . 8.1 mt -41.13 -41.84 1.87 Allowed 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 40.9 t -70.8 -38.72 73.36 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.638 0.256 . . . . 0.0 111.547 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -63.35 -60.96 2.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.947 0.403 . . . . 0.0 110.841 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.035 HD11 HG21 ' A' ' 77' ' ' VAL . 0.7 OUTLIER -50.86 -42.18 58.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.04 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.838 HD23 HG22 ' A' ' 41' ' ' ILE . 4.4 mp -68.01 -64.74 0.8 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.78 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.9 tmmm? -43.34 -61.45 1.35 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.66 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 13' ' ' PHE . 0.5 OUTLIER -54.49 -40.56 68.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.77 -179.426 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.485 ' OE1' HG11 ' A' ' 75' ' ' VAL . 8.7 mm-40 -69.43 -14.54 62.95 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.46 20.78 21.47 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.28 -0.962 . . . . 0.0 112.92 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.887 ' CH2' HG12 ' A' ' 68' ' ' VAL . 8.3 m0 -75.63 -66.52 0.77 Allowed 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.811 ' OG ' HD13 ' A' ' 41' ' ' ILE . 30.1 t -106.86 137.03 45.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.595 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -70.75 -33.82 71.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.039 0.447 . . . . 0.0 110.295 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.513 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 0.1 OUTLIER -105.74 -55.4 2.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.314 179.223 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 126.68 -33.53 3.39 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.303 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -123.04 -5.49 8.45 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.513 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 0.8 OUTLIER -52.52 -76.34 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.839 0.352 . . . . 0.0 111.029 -179.728 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.695 ' HB3' HD11 ' A' ' 41' ' ' ILE . . . -77.15 15.77 0.67 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.249 -0.432 . . . . 0.0 112.14 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 4.5 mmtt 68.53 24.26 7.07 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.068 0.461 . . . . 0.0 110.098 -179.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.838 HG22 HD23 ' A' ' 27' ' ' LEU . 3.9 mp -57.86 -24.86 24.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.449 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.92 -77.35 0.13 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.259 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.3 mm -48.96 -42.24 14.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-O 121.017 0.437 . . . . 0.0 110.644 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.699 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -57.64 -69.05 0.18 Allowed 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.446 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.781 ' HG3' HD22 ' A' ' 23' ' ' LEU . 9.0 tp10 -29.81 -44.13 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.011 0.434 . . . . 0.0 110.672 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 55' ' ' GLU . . . -59.61 -74.89 0.31 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.115 -1.041 . . . . 0.0 110.621 178.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.535 ' N ' ' HA ' ' A' ' 56' ' ' THR . 2.3 pt20 -48.64 -12.94 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.855 HG11 ' HA ' ' A' ' 70' ' ' PHE . 47.5 t -75.06 -98.17 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.933 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.406 ' CD ' ' HB ' ' A' ' 54' ' ' VAL . 0.8 OUTLIER -165.98 122.71 1.37 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 118.37 0.532 . . . . 0.0 111.921 -179.825 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.462 ' HB ' ' HB3' ' A' ' 53' ' ' ALA . 31.7 t -117.33 152.29 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.542 ' HB2' ' O ' ' A' ' 67' ' ' THR . 3.7 t0 -44.72 101.29 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.909 0.385 . . . . 0.0 111.492 -179.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 62.63 21.89 63.3 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.415 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.462 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . . . -145.83 75.57 1.43 Allowed 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 121.037 0.446 . . . . 0.0 111.67 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.608 HG13 ' O ' ' A' ' 54' ' ' VAL . 10.1 p -87.13 67.37 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.961 0.41 . . . . 0.0 110.485 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.447 ' O ' ' O ' ' A' ' 46' ' ' GLY . 0.2 OUTLIER -102.56 -166.25 1.26 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.062 -179.356 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.535 ' HA ' ' N ' ' A' ' 47' ' ' GLN . 3.4 t -145.8 37.99 1.09 Allowed 'General case' 0 C--O 1.232 0.154 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.09 174.79 7.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.825 0.345 . . . . 0.0 111.041 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.4 tttt -78.68 -41.6 30.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.738 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.414 ' HB3' ' CB ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -124.49 154.59 40.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.62 179.796 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -136.74 115.38 12.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.394 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.6 mttt -69.48 99.09 1.19 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 17.1 mt -133.46 144.04 37.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.633 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.51 ' O ' ' HB3' ' A' ' 64' ' ' ALA . 7.8 m -149.5 175.3 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.862 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.51 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 72.31 -149.73 0.07 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 178.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.567 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -92.33 81.3 1.16 Allowed Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 116.298 -0.41 . . . . 0.0 112.953 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.92 157.47 31.13 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.208 0.528 . . . . 0.0 111.378 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.542 ' O ' ' HB2' ' A' ' 51' ' ' ASP . 2.9 m -113.72 150.86 32.71 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.836 -178.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.887 HG12 ' CH2' ' A' ' 32' ' ' TRP . 1.2 t -128.27 145.15 35.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.023 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.55 ' HA ' ' O ' ' A' ' 73' ' ' HIS . 1.1 m -136.07 132.21 35.86 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.855 ' HA ' HG11 ' A' ' 48' ' ' VAL . 2.6 t80 -147.14 123.34 10.86 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.232 178.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.409 ' N ' ' CD1' ' A' ' 70' ' ' PHE . . . 41.57 30.66 0.15 Allowed 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.2 -4.06 38.06 Favored Glycine 0 C--N 1.329 0.171 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.422 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.661 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 2.7 m-70 -90.47 98.53 11.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.853 0.327 . . . . 0.0 110.829 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -108.99 114.16 27.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.853 0.359 . . . . 0.0 111.424 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.939 HG13 ' HB3' ' A' ' 11' ' ' ALA . 17.6 t -138.21 156.32 30.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.761 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.539 ' HG3' HG23 ' A' ' 67' ' ' THR . 9.5 mt-30 -112.6 165.61 12.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.136 0.493 . . . . 0.0 111.709 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 1.035 HG21 HD11 ' A' ' 26' ' ' LEU . 21.3 t -141.4 150.4 19.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.587 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 18.2 m -130.52 166.13 28.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.886 0.374 . . . . 0.0 111.759 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.506 ' HA ' ' H ' ' A' ' 16' ' ' GLY . . . . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.238 -0.887 . . . . 0.0 111.096 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.699 ' HB1' HG13 ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.455 -0.177 0 CA-C-O 120.78 0.324 . . . . 0.0 110.826 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.55 119.03 22.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.865 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.817 ' HB3' HG22 ' A' ' 77' ' ' VAL . 29.5 t80 -98.66 149.9 22.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.542 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.3 m -105.33 147.69 27.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.979 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.506 HD21 ' CG1' ' A' ' 21' ' ' VAL . 9.6 mt -127.44 -36.28 2.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.955 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.09 -111.67 3.49 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.688 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.9 tttt -136.72 52.89 1.93 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.875 0.369 . . . . 0.0 110.903 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -103.89 155.62 36.79 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.972 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.624 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 8.1 Cg_endo -50.56 -44.56 39.42 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.789 2.326 . . . . 0.0 112.235 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.645 ' HA ' HG13 ' A' ' 63' ' ' VAL . 12.6 p80 164.64 -166.98 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.491 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.856 HG21 HD13 ' A' ' 26' ' ' LEU . 14.9 m -143.58 155.92 16.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.508 ' HG2' ' HA ' ' A' ' 59' ' ' ARG . 1.4 mt-10 -87.01 141.07 28.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.03 178.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.51 HD13 ' O ' ' A' ' 42' ' ' ALA . 4.1 pp -40.94 -38.35 0.95 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.716 0.293 . . . . 0.0 111.381 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.498 ' N ' HD12 ' A' ' 23' ' ' LEU . 3.7 t -69.37 -39.51 78.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.89 0.376 . . . . 0.0 110.742 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 22' ' ' GLU . 87.8 m-20 -61.03 -59.21 5.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.629 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.856 HD13 HG21 ' A' ' 21' ' ' VAL . 8.2 tp -50.3 -46.99 55.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.616 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.965 HD23 HG22 ' A' ' 41' ' ' ILE . 6.8 mp -66.45 -60.91 2.31 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.865 -179.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -50.92 -55.47 17.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.317 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.78 -42.39 71.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.716 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 1.5 mm-40 -74.36 -13.83 60.79 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.0 24.75 14.23 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.251 -0.976 . . . . 0.0 113.281 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.731 ' CH2' HG12 ' A' ' 68' ' ' VAL . 9.7 m95 -74.68 -63.42 1.25 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 117.003 0.401 . . . . 0.0 110.07 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 39.4 t -106.85 142.92 35.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.344 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -77.94 -34.48 51.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.837 0.351 . . . . 0.0 110.739 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.437 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 31.0 p -106.07 -41.72 5.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.309 178.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 115.82 -33.94 4.98 Favored Glycine 0 CA--C 1.52 0.36 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.771 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -129.56 8.55 5.41 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.437 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 10.4 tp60 -60.48 -74.57 0.07 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.909 0.385 . . . . 0.0 110.541 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.724 ' HB3' ' CD1' ' A' ' 41' ' ' ILE . . . -79.7 15.16 1.43 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.725 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 64.61 27.54 13.27 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.994 0.426 . . . . 0.0 110.201 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.965 HG22 HD23 ' A' ' 27' ' ' LEU . 2.6 mp -62.67 -16.87 17.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.085 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.51 ' O ' HD13 ' A' ' 23' ' ' LEU . . . -70.68 -80.68 0.05 Allowed 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.456 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 36.4 mm -52.05 -34.31 17.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.859 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.722 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -61.33 -72.31 0.12 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.62 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.81 ' CB ' HD21 ' A' ' 27' ' ' LEU . 4.9 tm-20 -35.08 -41.17 0.14 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.263 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.402 ' C ' ' H ' ' A' ' 48' ' ' VAL . . . -60.91 -74.16 0.41 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.177 -1.011 . . . . 0.0 110.972 178.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -48.49 -9.35 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.842 HG11 ' HA ' ' A' ' 70' ' ' PHE . 58.2 t -74.66 -89.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.352 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.418 ' HG2' ' O ' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -170.31 120.97 0.62 Allowed 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 120.011 -0.676 . . . . 0.0 112.534 179.763 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.599 ' HB ' ' O ' ' A' ' 53' ' ' ALA . 40.9 t -114.29 147.47 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.484 ' HB2' ' H ' ' A' ' 67' ' ' THR . 3.3 t70 -44.99 98.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.053 0.454 . . . . 0.0 111.498 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.44 15.71 73.09 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.727 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.599 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -145.86 78.03 1.52 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.976 0.417 . . . . 0.0 112.004 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.561 HG13 ' O ' ' A' ' 54' ' ' VAL . 9.9 p -88.57 62.39 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.977 0.418 . . . . 0.0 110.465 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -99.8 -170.77 1.94 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.063 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.7 t -150.85 36.81 0.63 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.427 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 57' ' ' ARG . 12.7 mtt180 -81.08 168.79 18.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.519 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.1 -44.93 44.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.046 0.451 . . . . 0.0 109.924 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.508 ' HA ' ' HG2' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -103.66 150.43 24.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.77 179.615 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . 0.482 ' O ' ' O ' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -116.95 118.13 31.59 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.01 0.433 . . . . 0.0 111.434 -179.43 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.4 ' HG2' ' NE2' ' A' ' 20' ' ' HIS . 14.3 mttm -96.11 71.51 2.87 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.037 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.431 HD12 ' SG ' ' A' ' 60' ' ' CYS . 33.2 mt -136.05 147.4 28.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.702 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.645 HG13 ' HA ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -152.51 175.14 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.776 179.52 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 77.96 -149.2 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.916 179.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.514 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -84.93 78.27 2.02 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 121.285 -0.484 . . . . 0.0 112.578 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.405 ' HG3' ' CG2' ' A' ' 62' ' ' ILE . 20.6 mm-40 -121.66 155.62 34.77 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.066 0.46 . . . . 0.0 111.108 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 59.3 m -116.79 152.91 33.41 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.585 -178.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.731 HG12 ' CH2' ' A' ' 32' ' ' TRP . 1.1 t -127.9 145.58 34.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.668 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.406 ' HB2' ' O ' ' A' ' 49' ' ' LYS . 22.2 m -143.05 135.87 27.8 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.842 ' HA ' HG11 ' A' ' 48' ' ' VAL . 2.2 t80 -148.48 124.06 10.41 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.195 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 51.99 -85.12 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.353 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -129.97 -3.22 4.98 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.912 -0.661 . . . . 0.0 113.012 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.478 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 2.1 m-70 -92.63 108.38 19.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.929 0.365 . . . . 0.0 111.44 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.91 102.66 8.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.338 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.699 HG13 ' HB1' ' A' ' 11' ' ' ALA . 99.4 t -125.19 151.94 31.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.347 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.531 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 13.0 mt-30 -112.97 160.62 17.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.995 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.817 HG22 ' HB3' ' A' ' 13' ' ' PHE . 21.8 t -131.25 148.66 32.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.503 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.8 m -140.02 171.65 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.792 0.33 . . . . 0.0 111.497 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.506 -0.759 . . . . 0.0 111.059 179.933 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.647 ' HB3' HG22 ' A' ' 75' ' ' VAL . . . . . . . . 0 CA--C 1.522 -0.119 0 CA-C-O 120.848 0.356 . . . . 0.0 110.86 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.53 134.14 39.14 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.405 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.524 ' CZ ' ' HB3' ' A' ' 29' ' ' LEU . 19.2 t80 -105.61 90.11 3.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.864 0.364 . . . . 0.0 110.827 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.685 ' HA ' HG23 ' A' ' 78' ' ' VAL . 38.6 t -73.38 95.14 2.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.904 0.383 . . . . 0.0 110.897 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.932 HD11 HG13 ' A' ' 21' ' ' VAL . 1.0 OUTLIER -55.63 -35.28 65.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.933 179.789 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.67 48.24 3.01 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.403 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.6 tttt 58.56 54.89 5.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.939 0.4 . . . . 0.0 110.934 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.409 ' HB2' HD22 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -105.66 166.79 10.71 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.157 -179.74 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.786 ' O ' HG11 ' A' ' 63' ' ' VAL . 28.2 Cg_endo -62.51 -48.8 6.78 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.617 2.211 . . . . 0.0 112.091 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.657 ' HA ' HG12 ' A' ' 63' ' ' VAL . 3.1 p80 173.86 -173.67 0.06 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.327 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.932 HG13 HD11 ' A' ' 15' ' ' LEU . 4.1 m -142.12 158.3 20.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.441 0.639 . . . . 0.0 112.723 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.549 ' HG2' ' HG2' ' A' ' 59' ' ' ARG . 1.1 mp0 -100.81 149.96 23.3 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.002 178.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.488 ' H ' ' HA ' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -39.64 -53.65 2.13 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.232 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 37.5 t -60.93 -32.2 71.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.89 0.376 . . . . 0.0 110.77 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.585 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 0.9 OUTLIER -68.94 -58.83 3.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.98 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.888 HD11 HG21 ' A' ' 77' ' ' VAL . 3.2 tp -52.52 -48.09 66.24 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.882 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.878 HD21 ' HG3' ' A' ' 45' ' ' GLU . 4.1 mt -64.77 -58.75 5.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.699 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.72 -57.36 12.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.803 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.585 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.3 OUTLIER -50.81 -39.34 52.83 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.026 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.475 ' OE1' HG11 ' A' ' 75' ' ' VAL . 2.5 mm-40 -79.2 -8.09 58.74 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.75 25.28 32.87 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.313 -0.946 . . . . 0.0 113.168 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.769 ' CZ3' ' HB2' ' A' ' 73' ' ' HIS . 19.6 m95 -71.17 -65.52 0.73 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.869 0.366 . . . . 0.0 110.485 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.663 ' HB2' HG21 ' A' ' 41' ' ' ILE . 8.3 t -100.53 147.61 25.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.51 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -71.01 -34.81 71.68 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.668 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.3 p -106.68 -59.29 1.82 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.012 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.417 ' O ' ' HB2' ' A' ' 42' ' ' ALA . . . 131.69 -19.28 4.76 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.406 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.46 -2.58 0.86 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.4 ' C ' ' H ' ' A' ' 40' ' ' LYS . 23.4 tp60 -60.13 -74.71 0.07 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.866 0.365 . . . . 0.0 110.41 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.41 14.11 0.37 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.497 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.4 ' H ' ' C ' ' A' ' 38' ' ' GLN . 3.7 mttt 66.92 20.18 10.54 Favored 'General case' 0 C--O 1.23 0.057 0 CA-C-O 120.776 0.322 . . . . 0.0 110.702 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.71 HG23 ' HE2' ' A' ' 70' ' ' PHE . 48.0 mm -51.0 -29.62 8.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.753 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 36' ' ' GLY . . . -65.38 -78.68 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.77 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.474 HD12 ' HG3' ' A' ' 58' ' ' LYS . 25.1 mm -49.81 -38.4 13.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.072 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.74 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -61.21 -71.68 0.14 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.122 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.878 ' HG3' HD21 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -33.41 -40.48 0.07 Allowed 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 120.859 0.361 . . . . 0.0 110.594 -179.41 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 55' ' ' GLU . . . -58.24 -76.12 0.23 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 119.718 -1.229 . . . . 0.0 110.531 177.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.48 ' HG2' ' O ' ' A' ' 44' ' ' ALA . 5.5 pt20 -50.24 -9.46 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.989 HG21 ' CD1' ' A' ' 70' ' ' PHE . 38.9 t -75.45 -101.24 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.007 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.519 ' HD3' ' HB ' ' A' ' 54' ' ' VAL . 1.5 mmtm -163.15 120.02 1.86 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 119.117 0.871 . . . . 0.0 112.657 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.764 HG13 HG23 ' A' ' 68' ' ' VAL . 13.7 t -112.85 142.82 24.0 Favored 'Isoleucine or valine' 0 C--N 1.338 0.081 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.494 ' HB2' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -48.6 95.74 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.916 0.388 . . . . 0.0 111.023 -179.461 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.7 15.68 80.38 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.498 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.759 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . . . -146.1 75.78 1.43 Allowed 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.078 0.465 . . . . 0.0 111.627 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.613 HG13 ' O ' ' A' ' 54' ' ' VAL . 10.9 p -90.58 65.91 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.907 0.384 . . . . 0.0 110.74 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.442 ' O ' ' O ' ' A' ' 46' ' ' GLY . 44.1 mm-40 -102.08 -174.66 2.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.087 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.407 ' HA ' ' N ' ' A' ' 47' ' ' GLN . 1.7 t -143.95 41.4 1.41 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.945 0.402 . . . . 0.0 111.373 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.53 175.22 6.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.983 0.421 . . . . 0.0 110.808 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.483 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -81.04 -25.68 36.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.776 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.549 ' HG2' ' HG2' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -140.77 148.97 41.49 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.893 179.806 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -137.24 116.52 12.65 Favored 'General case' 0 CA--C 1.523 -0.078 0 CA-C-O 120.803 0.335 . . . . 0.0 110.892 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.5 mttm -74.66 102.89 4.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.526 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.4 mt -132.93 133.59 58.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.023 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.786 HG11 ' O ' ' A' ' 19' ' ' PRO . 35.4 m -140.46 174.96 7.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.696 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.486 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 72.27 -133.77 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.68 179.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.497 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -109.25 84.82 0.38 Allowed Glycine 0 C--N 1.338 0.691 0 C-N-CA 121.031 -0.604 . . . . 0.0 113.609 -178.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -122.92 167.23 13.83 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.599 0.238 . . . . 0.0 111.242 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.698 HG23 ' HG2' ' A' ' 76' ' ' GLN . 5.2 m -126.01 153.52 44.26 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.084 0.469 . . . . 0.0 111.866 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.764 HG23 HG13 ' A' ' 50' ' ' VAL . 1.2 t -132.23 147.11 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.978 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.8 m -134.64 136.59 42.97 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.84 0.352 . . . . 0.0 111.703 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.989 ' CD1' HG21 ' A' ' 48' ' ' VAL . 6.2 t80 -176.13 137.21 0.31 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.632 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.48 ' N ' ' CD1' ' A' ' 70' ' ' PHE . . . 50.24 37.01 13.85 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.732 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.44 -4.74 66.74 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.434 -0.889 . . . . 0.0 112.823 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.769 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 5.0 m-70 -89.92 107.64 19.23 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.75 0.309 . . . . 0.0 111.189 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.17 103.81 12.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.214 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.647 HG22 ' HB3' ' A' ' 11' ' ' ALA . 64.9 t -132.5 154.36 39.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.63 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.698 ' HG2' HG23 ' A' ' 67' ' ' THR . 20.3 mt-30 -112.96 168.81 9.39 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.013 0.435 . . . . 0.0 111.161 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.888 HG21 HD11 ' A' ' 26' ' ' LEU . 20.4 t -124.34 137.81 55.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.674 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.685 HG23 ' HA ' ' A' ' 14' ' ' SER . 10.4 m -126.84 147.87 31.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.876 0.37 . . . . 0.0 111.208 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.433 -179.586 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.667 ' CB ' HG13 ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.454 -0.248 0 CA-C-O 120.838 0.352 . . . . 0.0 110.576 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.14 128.33 53.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.904 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.542 ' O ' HG13 ' A' ' 77' ' ' VAL . 34.2 t80 -108.05 95.94 6.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.762 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.03 104.7 1.82 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.847 0.356 . . . . 0.0 110.972 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.519 HD21 HG11 ' A' ' 21' ' ' VAL . 6.2 mt -72.9 -38.19 67.0 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.947 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.24 -82.46 0.31 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.519 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.4 53.47 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.951 0.405 . . . . 0.0 110.948 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.5 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 33.3 m170 -103.57 160.49 25.95 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.84 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.613 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 18.2 Cg_endo -58.83 -35.35 98.75 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.382 2.055 . . . . 0.0 111.875 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.613 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 4.5 p80 167.15 -173.57 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.117 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.652 HG21 HD13 ' A' ' 26' ' ' LEU . 2.8 m -146.03 164.17 10.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.255 0.55 . . . . 0.0 112.04 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.457 ' HB2' ' CG ' ' A' ' 59' ' ' ARG . 12.0 pt-20 -102.15 150.08 23.63 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.815 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.786 HD22 ' HG3' ' A' ' 45' ' ' GLU . 96.0 mt -40.82 -45.64 2.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.818 0.342 . . . . 0.0 111.543 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.43 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 4.9 t -59.7 -36.26 76.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.553 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.535 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 14.8 m-20 -71.13 -63.12 1.17 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.778 0.323 . . . . 0.0 111.515 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.86 HD11 HG21 ' A' ' 77' ' ' VAL . 3.6 tp -46.65 -45.66 19.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.009 0.433 . . . . 0.0 111.374 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.013 HD23 HG22 ' A' ' 41' ' ' ILE . 9.7 mp -67.69 -66.63 0.54 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.28 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 24' ' ' CYS . 9.9 ttmt -50.1 -51.3 44.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.764 0.316 . . . . 0.0 111.222 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.535 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.1 OUTLIER -56.99 -34.9 68.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.203 -179.728 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 5.0 mm-40 -84.22 -8.77 58.95 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.91 22.95 24.3 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.272 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.72 ' CE3' ' HG ' ' A' ' 27' ' ' LEU . 8.6 m0 -74.99 -62.84 1.41 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.006 0.431 . . . . 0.0 109.909 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.472 ' CB ' HD12 ' A' ' 41' ' ' ILE . 0.3 OUTLIER -107.28 143.58 35.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.759 179.621 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.2 tp10 -78.28 -34.37 48.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.818 0.342 . . . . 0.0 111.261 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.423 ' OG ' ' CB ' ' A' ' 38' ' ' GLN . 42.2 p -105.72 -39.5 6.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.075 0.464 . . . . 0.0 110.525 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 108.15 -25.05 21.45 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.167 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.3 -15.43 2.51 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.423 ' CB ' ' OG ' ' A' ' 35' ' ' SER . 17.9 tp60 -52.52 -73.71 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.804 0.335 . . . . 0.0 111.362 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.481 ' HB3' HG13 ' A' ' 41' ' ' ILE . . . -72.12 14.96 0.18 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.39 23.38 12.93 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.803 0.335 . . . . 0.0 110.709 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 1.013 HG22 HD23 ' A' ' 27' ' ' LEU . 1.9 mt -60.19 -19.6 18.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.884 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.29 -76.56 0.14 Allowed 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.82 0.343 . . . . 0.0 110.781 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 45.6 mm -47.33 -45.32 9.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-O 121.083 0.468 . . . . 0.0 110.618 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.6 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -55.39 -67.71 0.26 Allowed 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.877 178.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.786 ' HG3' HD22 ' A' ' 23' ' ' LEU . 11.5 tp10 -28.31 -47.75 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.089 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 55' ' ' GLU . . . -58.34 -74.14 0.38 Allowed Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.172 -1.014 . . . . 0.0 110.824 178.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.555 ' N ' ' HA ' ' A' ' 56' ' ' THR . 1.2 pt20 -44.57 -16.21 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.902 HG21 ' HD1' ' A' ' 70' ' ' PHE . 46.6 t -76.01 -95.43 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.606 ' HD3' ' HB ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -162.82 120.08 1.97 Allowed 'General case' 0 C--N 1.339 0.149 0 O-C-N 122.1 -0.375 . . . . 0.0 111.866 -179.294 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.578 HG13 ' CG2' ' A' ' 68' ' ' VAL . 42.6 t -118.96 157.0 20.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.193 178.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.579 ' HB3' ' H ' ' A' ' 67' ' ' THR . 4.7 p-10 -43.62 99.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.015 0.436 . . . . 0.0 111.603 -178.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 59.76 24.35 59.94 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.175 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -145.79 76.48 1.47 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.606 ' HB ' ' HD3' ' A' ' 49' ' ' LYS . 7.6 p -84.88 58.08 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.151 0.501 . . . . 0.0 110.327 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.436 ' O ' ' O ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -100.42 -162.72 0.96 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.809 -179.547 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.555 ' HA ' ' N ' ' A' ' 47' ' ' GLN . 2.1 t -144.43 53.11 1.26 Allowed 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.544 ' HG3' ' O ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -99.25 172.66 7.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.903 0.382 . . . . 0.0 111.306 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -77.35 -48.47 17.26 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.795 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.544 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 0.3 OUTLIER -120.52 142.79 48.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.314 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . 0.773 ' SG ' HD11 ' A' ' 62' ' ' ILE . 3.3 t -124.26 118.53 27.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.975 0.417 . . . . 0.0 110.972 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.53 99.87 2.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.331 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.773 HD11 ' SG ' ' A' ' 60' ' ' CYS . 2.7 mp -138.34 142.45 35.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.769 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.546 HG11 ' O ' ' A' ' 19' ' ' PRO . 12.8 m -145.66 175.63 2.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.433 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.492 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 72.58 -138.17 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 178.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.754 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -106.32 84.75 0.41 Allowed Glycine 0 C--N 1.34 0.798 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.14 -178.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.51 ' HG3' HG23 ' A' ' 62' ' ' ILE . 56.5 mm-40 -123.02 167.48 13.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.975 0.417 . . . . 0.0 112.082 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.619 HG23 ' HG2' ' A' ' 76' ' ' GLN . 3.5 m -118.18 140.84 49.2 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.076 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.641 HG12 ' CH2' ' A' ' 32' ' ' TRP . 1.2 t -123.49 146.53 28.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.794 178.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.603 ' HA ' ' O ' ' A' ' 73' ' ' HIS . 32.0 p -140.01 136.1 33.36 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -179.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.902 ' HD1' HG21 ' A' ' 48' ' ' VAL . 1.9 t80 -140.17 121.21 14.67 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.332 178.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 40.82 28.23 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 113.16 -5.81 25.27 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.323 -0.941 . . . . 0.0 113.674 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.628 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 1.1 m-70 -88.01 91.33 8.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 117.166 0.483 . . . . 0.0 110.934 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -98.02 118.01 33.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.848 0.356 . . . . 0.0 111.443 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.667 HG13 ' CB ' ' A' ' 11' ' ' ALA . 96.8 t -143.5 152.74 16.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.391 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.619 ' HG2' HG23 ' A' ' 67' ' ' THR . 24.8 mt-30 -112.89 156.1 23.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.231 0.539 . . . . 0.0 111.609 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.86 HG21 HD11 ' A' ' 26' ' ' LEU . 38.3 t -121.5 145.05 28.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.129 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.8 m -134.18 165.94 30.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.872 0.367 . . . . 0.0 111.699 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.194 -179.873 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.558 ' HB1' HG13 ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.455 -0.191 0 CA-C-O 120.86 0.362 . . . . 0.0 111.135 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.87 129.04 37.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.548 ' HD2' ' HG2' ' A' ' 30' ' ' GLU . 56.5 t80 -102.48 149.23 24.59 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.855 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.93 123.33 48.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.394 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.803 ' CD1' HG12 ' A' ' 63' ' ' VAL . 1.0 OUTLIER -69.74 -37.59 76.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.714 0.292 . . . . 0.0 110.958 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.29 26.79 13.11 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.832 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.3 mtmt 59.58 51.52 6.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.909 0.385 . . . . 0.0 110.833 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.428 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 2.9 m-70 -119.43 168.25 10.43 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.61 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.551 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 10.3 Cg_endo -52.64 -37.96 75.56 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.396 2.064 . . . . 0.0 111.741 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.585 ' HA ' HD11 ' A' ' 15' ' ' LEU . 5.6 p80 167.94 -168.5 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.009 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.557 HG21 HD13 ' A' ' 26' ' ' LEU . 28.8 m -143.58 157.04 16.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.898 0.38 . . . . 0.0 111.77 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.595 ' HA ' ' H ' ' A' ' 60' ' ' CYS . 1.5 pt-20 -103.48 152.21 21.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.583 178.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.621 HD13 ' C ' ' A' ' 42' ' ' ALA . 0.2 OUTLIER -37.93 -46.54 0.98 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.919 -179.372 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.0 t -62.2 -38.4 89.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.606 0.241 . . . . 0.0 111.608 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -67.73 -58.81 3.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.119 0.485 . . . . 0.0 111.122 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.557 HD13 HG21 ' A' ' 21' ' ' VAL . 3.2 tp -55.27 -49.54 71.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.8 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.891 HD23 HG22 ' A' ' 41' ' ' ILE . 6.2 mp -62.61 -59.16 5.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.159 -179.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -50.28 -59.79 3.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.98 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.507 ' HB3' ' HE2' ' A' ' 13' ' ' PHE . 3.8 mm? -55.89 -43.31 77.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.482 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.575 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 0.1 OUTLIER -66.83 -15.7 63.79 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.045 -179.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.92 23.9 19.02 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.096 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.634 ' CE3' ' HG ' ' A' ' 27' ' ' LEU . 8.8 m0 -74.84 -66.05 0.8 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.202 0.525 . . . . 0.0 110.119 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.42 ' HA ' HD12 ' A' ' 41' ' ' ILE . 2.1 t -106.68 139.19 41.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.135 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -82.31 -33.48 29.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.574 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.444 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -105.16 -27.54 11.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.959 179.645 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.79 0.75 88.68 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.855 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.88 -15.32 0.31 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.681 0.277 . . . . 0.0 111.468 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.444 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 1.0 OUTLIER -54.29 -77.31 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.374 -179.682 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.42 ' HB3' HG13 ' A' ' 41' ' ' ILE . . . -79.96 15.05 1.56 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.3 mttt 61.71 26.53 16.16 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.98 0.419 . . . . 0.0 110.406 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.891 HG22 HD23 ' A' ' 27' ' ' LEU . 11.7 mt -58.1 -22.27 18.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.708 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.621 ' C ' HD13 ' A' ' 23' ' ' LEU . . . -74.92 -77.67 0.12 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.099 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 44.3 mm -52.31 -36.81 21.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.778 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.731 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -59.62 -69.29 0.21 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.351 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.778 ' CB ' HD21 ' A' ' 27' ' ' LEU . 3.0 tm-20 -34.28 -42.05 0.13 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.839 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.402 ' C ' ' H ' ' A' ' 48' ' ' VAL . . . -59.14 -75.43 0.27 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.109 -1.044 . . . . 0.0 111.184 178.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.531 ' HA ' ' HB ' ' A' ' 56' ' ' THR . 20.7 pt20 -48.82 -9.37 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.85 HG21 ' HD1' ' A' ' 70' ' ' PHE . 68.7 t -75.02 -97.28 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.166 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' A' ' 48' ' ' VAL . 1.9 mmtm -163.02 124.63 2.51 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.549 0.613 . . . . 0.0 112.269 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.661 HG22 HG22 ' A' ' 68' ' ' VAL . 26.3 t -116.76 151.76 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.093 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 177.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.588 ' HB2' ' HB ' ' A' ' 67' ' ' THR . 0.9 OUTLIER -44.67 99.95 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.971 0.415 . . . . 0.0 110.937 -179.269 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 60.12 24.84 61.39 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.089 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.605 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -145.78 80.49 1.59 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.642 HG13 ' O ' ' A' ' 54' ' ' VAL . 8.7 p -89.24 78.92 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.896 0.379 . . . . 0.0 110.425 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 47' ' ' GLN . 3.1 mt-10 -113.13 -172.77 2.12 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.69 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.531 ' HB ' ' HA ' ' A' ' 47' ' ' GLN . 2.8 t -158.62 42.77 0.26 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.52 -179.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.525 ' O ' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -91.9 172.81 8.21 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.814 0.34 . . . . 0.0 110.991 179.95 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.9 mmmm -75.35 -55.74 5.4 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.033 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.4 mtm180 -100.46 141.66 33.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.011 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . 0.595 ' H ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -106.59 131.62 53.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.1 0.476 . . . . 0.0 111.318 -178.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.428 ' HA ' ' CG ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -110.07 74.71 0.9 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.245 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.6 mt -134.26 144.07 36.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.16 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.803 HG12 ' CD1' ' A' ' 15' ' ' LEU . 8.0 m -146.97 175.41 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.254 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.591 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 78.18 -144.64 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.542 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.633 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -100.22 83.47 0.55 Allowed Glycine 0 C--N 1.335 0.499 0 C-N-CA 121.17 -0.538 . . . . 0.0 113.382 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -122.27 163.41 19.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.664 0.269 . . . . 0.0 111.037 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.588 ' HB ' ' HB2' ' A' ' 51' ' ' ASP . 86.3 m -119.89 150.72 40.01 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.053 0.454 . . . . 0.0 112.043 -178.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.661 HG22 HG22 ' A' ' 50' ' ' VAL . 1.1 t -129.99 149.08 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.102 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -137.78 133.69 34.34 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -178.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.85 ' HD1' HG21 ' A' ' 48' ' ' VAL . 5.0 t80 -138.42 115.22 10.72 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.384 179.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 36.47 32.95 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 178.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 116.77 -13.2 14.93 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.361 -0.923 . . . . 0.0 113.531 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.406 ' O ' ' CH2' ' A' ' 32' ' ' TRP . 2.2 m-70 -88.25 82.51 7.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.955 0.378 . . . . 0.0 110.952 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.8 m -95.2 101.0 12.71 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.942 0.401 . . . . 0.0 110.943 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.558 HG13 ' HB1' ' A' ' 11' ' ' ALA . 46.5 t -120.27 155.71 23.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.721 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.502 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 25.5 mt-30 -111.57 161.21 16.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.94 0.4 . . . . 0.0 110.421 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.633 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 13.1 t -133.38 146.85 31.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.424 -178.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.0 m -131.47 157.24 43.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.985 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.253 -0.88 . . . . 0.0 111.147 -179.929 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.656 ' HB3' HG22 ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.455 -0.204 0 CA-C-O 120.645 0.26 . . . . 0.0 110.394 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.46 132.47 29.49 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.85 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.576 ' HB3' HG22 ' A' ' 77' ' ' VAL . 36.8 t80 -102.33 147.49 26.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.896 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.8 m -106.25 147.89 28.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.399 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.618 HD21 HG13 ' A' ' 21' ' ' VAL . 12.0 mt -118.61 -38.12 3.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.063 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.13 -103.75 2.9 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.397 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.0 mttt -143.58 41.87 1.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.019 0.437 . . . . 0.0 110.894 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -95.5 163.91 20.3 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.446 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.593 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 17.9 Cg_endo -58.59 -43.02 48.53 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.322 2.015 . . . . 0.0 112.008 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.593 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 19.9 p80 166.08 -163.96 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.203 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.618 HG13 HD21 ' A' ' 15' ' ' LEU . 3.8 m -139.47 154.23 24.57 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-O 121.09 0.471 . . . . 0.0 112.144 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.492 ' HG2' ' CB ' ' A' ' 59' ' ' ARG . 13.8 mt-10 -90.81 148.09 22.76 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.593 178.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.607 HD23 ' CD ' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -41.27 -50.34 3.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.795 0.331 . . . . 0.0 111.656 -179.656 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 17.9 t -65.64 -32.72 74.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.884 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.493 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 2.9 m-20 -64.57 -59.38 4.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.776 0.322 . . . . 0.0 110.323 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.606 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 12.5 tp -51.78 -40.48 60.43 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.891 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.835 HD21 ' HG3' ' A' ' 45' ' ' GLU . 12.6 mt -66.74 -67.87 0.42 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.111 0.482 . . . . 0.0 110.788 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.483 ' HE2' ' O ' ' A' ' 35' ' ' SER . 4.1 ttmt -50.15 -55.92 13.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.79 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.493 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.1 OUTLIER -53.83 -40.14 66.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.117 -178.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.606 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 1.1 mm-40 -80.35 -10.05 59.75 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.838 0.311 . . . . 0.0 111.838 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.68 25.13 21.56 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.249 -0.977 . . . . 0.0 113.342 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.73 ' CZ3' ' HB2' ' A' ' 73' ' ' HIS . 13.0 m95 -72.94 -61.99 1.62 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 117.133 0.466 . . . . 0.0 110.2 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.498 ' HB2' HG21 ' A' ' 41' ' ' ILE . 39.2 t -100.18 156.22 17.32 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.453 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -85.74 -35.15 20.97 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.186 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.483 ' O ' ' HE2' ' A' ' 28' ' ' LYS . 1.1 p -106.94 -46.21 3.99 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.524 178.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 120.81 -28.5 6.14 Favored Glycine 0 C--N 1.333 0.374 0 CA-C-N 115.745 -0.662 . . . . 0.0 112.882 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.98 1.74 3.31 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -60.91 -76.46 0.05 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.865 0.364 . . . . 0.0 111.105 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.15 15.4 0.57 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.928 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.3 mttp 66.1 24.93 10.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.983 0.421 . . . . 0.0 110.004 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.599 HG23 ' HE2' ' A' ' 70' ' ' PHE . 40.8 mm -52.99 -26.96 12.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.61 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.81 -78.33 0.08 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.928 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 34.4 mm -49.49 -34.34 8.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.856 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.692 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -63.5 -72.23 0.15 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.718 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.835 ' HG3' HD21 ' A' ' 27' ' ' LEU . 0.6 OUTLIER -32.79 -41.71 0.07 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.95 0.405 . . . . 0.0 110.879 -179.845 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.542 ' HA2' HD21 ' A' ' 23' ' ' LEU . . . -59.68 -77.02 0.19 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.268 -0.967 . . . . 0.0 110.848 178.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.629 ' HG3' ' O ' ' A' ' 44' ' ' ALA . 1.4 pt20 -46.52 -10.42 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.81 HG11 ' HA ' ' A' ' 70' ' ' PHE . 58.4 t -74.9 -92.86 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.906 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 48' ' ' VAL . 0.1 OUTLIER -168.12 125.73 1.13 Allowed 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.894 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.8 t -122.15 158.01 26.2 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -44.05 101.75 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.053 0.454 . . . . 0.0 111.71 -178.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 57.29 23.13 46.76 Favored Glycine 0 C--N 1.333 0.386 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.489 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -146.15 82.64 1.61 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.869 0.366 . . . . 0.0 111.787 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.523 HG13 ' O ' ' A' ' 54' ' ' VAL . 10.7 p -88.39 61.47 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.073 0.463 . . . . 0.0 110.824 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -101.14 -164.41 1.1 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.221 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.5 ' HB ' ' HA ' ' A' ' 47' ' ' GLN . 9.7 t -153.18 45.15 0.65 Allowed 'General case' 0 C--O 1.232 0.164 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.494 ' O ' HD13 ' A' ' 23' ' ' LEU . 52.3 mtt180 -87.77 174.98 8.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.067 0.46 . . . . 0.0 111.104 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -85.35 -38.72 18.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.086 179.395 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.492 ' CB ' ' HG2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -120.65 134.06 55.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.822 179.664 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -119.9 115.39 23.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.875 0.369 . . . . 0.0 110.73 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.657 ' O ' HD13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -74.15 89.85 2.01 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.033 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.657 HD13 ' O ' ' A' ' 61' ' ' LYS . 6.9 mm -133.11 138.22 51.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.207 0.527 . . . . 0.0 112.153 -178.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.563 ' O ' ' HB3' ' A' ' 64' ' ' ALA . 4.5 m -146.26 175.29 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.125 179.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 76.52 -143.14 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.649 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -99.91 83.44 0.57 Allowed Glycine 0 C--N 1.336 0.546 0 C-N-CA 121.308 -0.472 . . . . 0.0 112.129 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.507 ' HG3' HG22 ' A' ' 62' ' ' ILE . 6.1 mm100 -122.36 159.63 27.08 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.887 0.375 . . . . 0.0 111.753 -178.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 7.3 m -120.37 144.46 47.87 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.458 -178.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.643 HG12 ' CH2' ' A' ' 32' ' ' TRP . 1.2 t -118.67 143.14 30.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.451 178.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -134.07 133.37 41.09 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.81 ' HA ' HG11 ' A' ' 48' ' ' VAL . 1.4 t80 -146.19 122.48 10.91 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.611 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 49.52 -85.47 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.343 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -129.14 -5.6 4.67 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.722 -0.751 . . . . 0.0 113.026 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.73 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 0.9 OUTLIER -90.61 113.07 25.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.967 0.384 . . . . 0.0 111.441 -179.269 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 72.1 m -120.48 115.54 23.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.178 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.656 HG22 ' HB3' ' A' ' 11' ' ' ALA . 59.4 t -138.59 155.23 27.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.803 0.335 . . . . 0.0 111.328 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.514 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 2.8 mt-30 -112.78 169.96 8.53 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.104 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.649 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 21.6 t -136.36 146.0 29.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.82 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.96 150.49 34.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.952 0.406 . . . . 0.0 111.665 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.336 -0.84 . . . . 0.0 110.964 179.727 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.769 ' HB1' HG22 ' A' ' 75' ' ' VAL . . . . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.597 0.237 . . . . 0.0 111.037 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.58 121.55 16.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.999 0.428 . . . . 0.0 111.168 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.871 ' HB3' HG22 ' A' ' 77' ' ' VAL . 37.1 t80 -99.02 155.28 17.52 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.945 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.5 m -106.63 148.73 27.97 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.272 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.516 HD21 ' CG1' ' A' ' 21' ' ' VAL . 5.1 mt -117.92 -28.74 5.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.851 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.09 40.06 62.34 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.972 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 56.93 68.46 0.86 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.974 0.416 . . . . 0.0 110.829 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.429 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 1.8 m170 -115.28 170.02 6.08 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.903 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.477 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 32.7 Cg_endo -64.86 -51.5 1.68 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.406 2.07 . . . . 0.0 112.356 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.641 ' HA ' HG13 ' A' ' 63' ' ' VAL . 7.4 p80 177.94 -179.72 0.28 Allowed 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.333 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.768 HG21 HD13 ' A' ' 26' ' ' LEU . 4.5 m -142.11 161.01 20.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -179.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.501 ' HG2' ' HA ' ' A' ' 59' ' ' ARG . 8.3 mt-10 -98.89 144.42 28.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.192 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.721 HD12 ' N ' ' A' ' 24' ' ' CYS . 0.9 OUTLIER -39.7 -38.02 0.59 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.629 -0.259 . . . . 0.0 111.561 -179.67 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.721 ' N ' HD12 ' A' ' 23' ' ' LEU . 48.9 t -73.38 -39.71 64.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.606 0.241 . . . . 0.0 111.189 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -62.86 -57.42 10.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.069 0.461 . . . . 0.0 110.358 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.079 HD11 HG21 ' A' ' 77' ' ' VAL . 12.6 tp -55.27 -45.97 76.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.268 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.849 HD23 HG22 ' A' ' 41' ' ' ILE . 4.0 mp -66.73 -59.95 3.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.885 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -49.31 -56.12 10.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.446 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.612 HD22 ' CE1' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -56.3 -38.42 71.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.089 -179.213 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.445 ' CG ' ' HB2' ' A' ' 13' ' ' PHE . 5.2 mm-40 -79.87 -10.95 59.83 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.82 24.02 18.9 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.257 -0.973 . . . . 0.0 113.155 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.654 ' CH2' HG12 ' A' ' 68' ' ' VAL . 11.2 m95 -75.92 -62.55 1.56 Allowed 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.409 ' CB ' HD12 ' A' ' 41' ' ' ILE . 7.5 t -106.38 138.54 42.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.339 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.67 -34.41 60.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.963 0.411 . . . . 0.0 110.408 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.9 -48.12 3.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.057 178.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 118.63 -22.85 9.18 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.231 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.47 -1.78 3.12 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -59.3 -77.95 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.611 0.243 . . . . 0.0 111.249 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.424 ' HB3' HG13 ' A' ' 41' ' ' ILE . . . -75.15 15.13 0.45 Allowed 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.9 mttt 61.85 25.34 15.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.765 0.317 . . . . 0.0 110.76 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.849 HG22 HD23 ' A' ' 27' ' ' LEU . 14.4 mt -61.37 -16.43 14.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.608 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.519 ' CA ' HD13 ' A' ' 23' ' ' LEU . . . -72.68 -79.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.314 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.441 HD11 ' NZ ' ' A' ' 58' ' ' LYS . 43.4 mm -53.9 -33.72 24.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.806 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.715 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -61.0 -72.2 0.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.232 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.749 ' CB ' HD21 ' A' ' 27' ' ' LEU . 2.4 tm-20 -34.76 -40.97 0.12 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.22 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.19 -73.93 0.4 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.156 -1.021 . . . . 0.0 110.628 178.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.827 ' HA ' HG22 ' A' ' 56' ' ' THR . 15.8 pt20 -48.9 -11.55 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.875 HG11 ' HA ' ' A' ' 70' ' ' PHE . 47.2 t -75.0 -90.92 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.102 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.432 ' HD3' ' HB ' ' A' ' 54' ' ' VAL . 6.4 mmtp -165.43 124.84 1.75 Allowed 'General case' 0 C--O 1.232 0.153 0 C-N-CA 120.193 -0.603 . . . . 0.0 112.284 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.542 HG11 ' CD1' ' A' ' 62' ' ' ILE . 34.2 t -119.08 142.77 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 178.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.539 ' HB2' ' H ' ' A' ' 67' ' ' THR . 0.8 OUTLIER -45.29 97.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.924 0.392 . . . . 0.0 111.567 -179.102 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.25 11.02 85.76 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.976 -0.631 . . . . 0.0 113.001 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.534 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -146.03 82.44 1.61 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 117.073 0.436 . . . . 0.0 112.033 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.517 HG22 ' O ' ' A' ' 54' ' ' VAL . 7.4 p -86.99 56.2 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.075 0.464 . . . . 0.0 110.081 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -99.65 179.72 4.45 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.628 -178.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.827 HG22 ' HA ' ' A' ' 47' ' ' GLN . 1.7 p -134.39 36.97 3.16 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.684 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.38 171.23 12.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.873 0.368 . . . . 0.0 111.189 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.441 ' NZ ' HD11 ' A' ' 43' ' ' ILE . 38.6 mttm -75.57 -46.46 31.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.682 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.501 ' HA ' ' HG2' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -116.61 137.65 52.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.633 179.862 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.24 115.28 26.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.77 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.441 ' HG2' ' CD2' ' A' ' 20' ' ' HIS . 11.5 mtpt -78.46 82.26 4.74 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.369 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.542 ' CD1' HG11 ' A' ' 50' ' ' VAL . 26.8 mt -133.61 147.97 30.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.261 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.641 HG13 ' HA ' ' A' ' 20' ' ' HIS . 1.9 m -154.99 175.87 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.245 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 76.22 -150.66 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.301 179.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -83.9 78.54 2.0 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.292 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -122.26 154.91 36.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.112 0.482 . . . . 0.0 110.956 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.627 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 87.6 m -114.46 156.28 24.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.375 -178.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.654 HG12 ' CH2' ' A' ' 32' ' ' TRP . 1.0 OUTLIER -133.01 148.97 31.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.672 179.34 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 76.8 p -143.12 139.86 30.6 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.875 ' HA ' HG11 ' A' ' 48' ' ' VAL . 2.3 t80 -150.82 124.36 9.02 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 114.902 -1.044 . . . . 0.0 110.323 179.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 49.52 -85.46 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.59 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -126.18 -6.99 5.61 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.972 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.526 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 1.7 m-70 -89.5 107.11 18.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.791 0.329 . . . . 0.0 111.54 -179.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.76 95.29 4.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.175 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.769 HG22 ' HB1' ' A' ' 11' ' ' ALA . 97.0 t -123.23 155.32 29.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.517 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.627 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 3.2 mp0 -113.26 165.1 12.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.971 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 1.079 HG21 HD11 ' A' ' 26' ' ' LEU . 11.0 t -139.76 150.57 22.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.974 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.0 m -129.17 165.5 28.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.973 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.215 -0.897 . . . . 0.0 111.191 179.892 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.075 0 CA-C-O 120.68 0.276 . . . . 0.0 110.698 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.97 133.82 34.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.56 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.875 ' HB3' HG22 ' A' ' 77' ' ' VAL . 58.4 t80 -105.35 156.58 18.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.1 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.2 m -107.16 142.7 36.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.963 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.802 HD22 ' HB2' ' A' ' 18' ' ' HIS . 0.5 OUTLIER -104.67 -40.62 5.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.445 179.375 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.22 42.95 6.82 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.702 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 50.18 59.31 4.64 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.93 0.395 . . . . 0.0 111.248 179.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.802 ' HB2' HD22 ' A' ' 15' ' ' LEU . 30.7 m170 -115.66 165.27 14.88 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.398 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.656 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 18.3 Cg_endo -57.75 -38.43 93.06 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.557 2.171 . . . . 0.0 112.386 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.656 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 12.0 p80 164.38 -173.7 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.72 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.628 HG13 HD21 ' A' ' 15' ' ' LEU . 2.4 m -145.79 166.47 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.217 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.507 ' HG2' ' HB2' ' A' ' 59' ' ' ARG . 70.4 mt-10 -95.97 141.03 29.87 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.818 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.613 HD21 ' O ' ' A' ' 57' ' ' ARG . 2.0 pp -44.12 -30.59 0.78 Allowed 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 -178.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.605 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -69.63 -40.71 76.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.78 0.324 . . . . 0.0 110.396 179.361 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -63.44 -60.63 3.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.049 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.993 HD11 HG21 ' A' ' 77' ' ' VAL . 2.6 tp -49.46 -49.25 46.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.652 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.835 HD21 ' HB2' ' A' ' 45' ' ' GLU . 9.5 mp -65.1 -61.76 1.95 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.445 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.605 ' HB2' ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -48.82 -55.59 11.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.348 -179.718 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.645 HD13 ' HZ ' ' A' ' 13' ' ' PHE . 1.2 mt -55.33 -42.49 73.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.533 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.521 ' OE2' HG11 ' A' ' 75' ' ' VAL . 1.3 mm-40 -71.19 -15.28 62.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.728 -0.214 . . . . 0.0 111.555 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.07 24.77 12.17 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.268 -0.968 . . . . 0.0 113.071 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.86 ' CH2' HG12 ' A' ' 68' ' ' VAL . 7.8 m0 -76.33 -66.28 0.82 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.959 0.38 . . . . 0.0 109.999 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.765 ' CB ' HD12 ' A' ' 41' ' ' ILE . 25.0 t -106.12 140.04 39.7 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.353 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -75.74 -34.96 60.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.898 0.38 . . . . 0.0 110.73 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.514 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 0.2 OUTLIER -106.45 -48.0 3.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.365 178.848 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.4 -26.25 8.72 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.201 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -127.58 -2.67 6.09 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.514 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 4.2 tp-100 -59.74 -76.56 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.674 0.273 . . . . 0.0 110.962 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.91 15.11 0.93 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.725 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.7 mttm 61.93 27.83 16.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.084 0.469 . . . . 0.0 110.401 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.799 HG23 ' CE2' ' A' ' 70' ' ' PHE . 12.7 mt -59.29 -25.0 29.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.554 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.07 -77.69 0.08 Allowed 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.144 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 31.6 mm -48.62 -36.29 7.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 120.896 0.379 . . . . 0.0 110.599 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.747 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -61.46 -67.06 0.44 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.519 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.835 ' HB2' HD21 ' A' ' 27' ' ' LEU . 5.9 tp10 -33.96 -45.73 0.21 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.852 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' A' ' 48' ' ' VAL . . . -59.23 -75.94 0.24 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.238 -0.982 . . . . 0.0 111.04 178.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.528 ' HG2' ' O ' ' A' ' 44' ' ' ALA . 12.4 pt20 -44.5 -15.86 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.815 HG21 ' HD1' ' A' ' 70' ' ' PHE . 93.6 t -75.05 -91.7 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 O-C-N 122.212 -0.305 . . . . 0.0 110.575 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -171.18 136.88 1.09 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.956 0.408 . . . . 0.0 111.146 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.566 HG11 HD11 ' A' ' 62' ' ' ILE . 58.5 t -131.7 144.95 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.951 179.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.551 ' HB3' ' H ' ' A' ' 67' ' ' THR . 37.6 t70 -60.61 77.23 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.055 0.455 . . . . 0.0 110.46 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 120.96 -12.46 9.89 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.408 -179.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.563 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . . . -132.37 133.69 44.27 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.892 0.377 . . . . 0.0 110.8 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.583 HG22 ' O ' ' A' ' 54' ' ' VAL . 12.6 p -125.2 31.98 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.714 179.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -107.49 160.21 15.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.283 0.563 . . . . 0.0 112.433 -178.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.51 HG23 ' O ' ' A' ' 56' ' ' THR . 14.8 t -108.66 50.12 0.79 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.556 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.613 ' O ' HD21 ' A' ' 23' ' ' LEU . 10.0 mtp180 -84.24 173.38 11.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.746 0.308 . . . . 0.0 111.018 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.1 ttmm -81.68 -0.69 43.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.991 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.507 ' HB2' ' HG2' ' A' ' 22' ' ' GLU . 0.3 OUTLIER -160.86 157.3 26.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.616 179.708 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . 0.636 ' SG ' HD11 ' A' ' 62' ' ' ILE . 1.6 t -134.93 114.99 13.08 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.484 ' HG2' ' CD2' ' A' ' 20' ' ' HIS . 3.6 mttm -76.0 94.62 3.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.36 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.636 HD11 ' SG ' ' A' ' 60' ' ' CYS . 16.2 mt -135.41 141.17 43.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.696 -179.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.661 HG12 HD13 ' A' ' 15' ' ' LEU . 0.8 OUTLIER -144.24 175.18 3.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.927 179.3 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 66.21 -150.17 0.21 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.716 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.605 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -86.79 79.13 1.84 Allowed Glycine 0 C--N 1.336 0.565 0 C-N-CA 121.451 -0.404 . . . . 0.0 113.498 -178.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.545 ' HG3' ' O ' ' A' ' 63' ' ' VAL . 2.3 mm100 -122.18 158.95 28.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.935 0.397 . . . . 0.0 111.347 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.611 HG23 ' HG3' ' A' ' 76' ' ' GLN . 0.3 OUTLIER -114.53 157.66 22.69 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.529 -178.71 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.86 HG12 ' CH2' ' A' ' 32' ' ' TRP . 1.2 t -133.96 147.51 30.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.829 179.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.661 ' HA ' ' O ' ' A' ' 73' ' ' HIS . 0.5 OUTLIER -137.7 132.15 32.44 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -178.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.815 ' HD1' HG21 ' A' ' 48' ' ' VAL . 1.7 t80 -139.32 117.9 12.2 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.347 178.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 38.01 30.0 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 179.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 117.17 -7.26 16.69 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.211 -0.995 . . . . 0.0 113.512 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.661 ' O ' ' HA ' ' A' ' 69' ' ' SER . 2.6 m-70 -87.9 89.79 8.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 117.242 0.521 . . . . 0.0 110.834 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 58.2 m -100.59 102.02 13.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.858 0.361 . . . . 0.0 111.008 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.565 ' HB ' ' HZ2' ' A' ' 32' ' ' TRP . 46.9 t -127.19 153.61 36.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.843 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.611 ' HG3' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -112.95 165.04 12.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.031 0.443 . . . . 0.0 111.122 179.538 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.993 HG21 HD11 ' A' ' 26' ' ' LEU . 45.3 t -138.11 154.86 28.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.48 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.498 ' O ' ' HB2' ' A' ' 15' ' ' LEU . 16.1 m -131.77 161.47 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.865 0.364 . . . . 0.0 111.417 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.321 -0.847 . . . . 0.0 111.429 179.624 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.982 ' HB1' HG13 ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.457 -0.098 0 CA-C-O 120.711 0.291 . . . . 0.0 111.141 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.62 109.42 6.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.781 0.324 . . . . 0.0 110.78 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.843 ' HB3' HG22 ' A' ' 77' ' ' VAL . 28.2 t80 -98.64 170.59 8.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.975 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.9 m -106.82 138.1 43.62 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.356 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.868 HD23 HG11 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -131.49 -37.99 1.19 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.221 179.337 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.406 ' H ' ' HA ' ' A' ' 79' ' ' ALA . . . -44.09 -27.69 1.14 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 121.213 -0.518 . . . . 0.0 113.002 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -55.46 -40.86 72.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.663 0.268 . . . . 0.0 111.257 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.588 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 42.4 m80 -119.64 163.06 29.48 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.319 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.734 ' O ' HG11 ' A' ' 63' ' ' VAL . 18.2 Cg_endo -59.74 -27.87 85.96 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.658 2.239 . . . . 0.0 112.496 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.555 ' HA ' HG12 ' A' ' 63' ' ' VAL . 4.7 p80 177.05 178.17 0.27 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.12 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.669 HG21 HD21 ' A' ' 15' ' ' LEU . 15.4 m -145.93 167.15 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.614 ' HG3' ' HA ' ' A' ' 59' ' ' ARG . 17.3 tt0 -100.35 144.2 29.64 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.08 178.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.671 HD13 ' O ' ' A' ' 42' ' ' ALA . 1.6 pp -40.86 -46.84 2.83 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.655 0.264 . . . . 0.0 111.625 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.659 ' N ' HD12 ' A' ' 23' ' ' LEU . 5.6 t -62.31 -38.05 87.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.751 0.31 . . . . 0.0 110.927 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -66.06 -57.61 7.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.885 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.881 HD11 HG21 ' A' ' 77' ' ' VAL . 7.2 tt -56.64 -42.05 78.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.053 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.959 HD23 HG22 ' A' ' 41' ' ' ILE . 6.7 mp -65.77 -62.29 1.59 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.972 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.04 -55.55 11.69 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.383 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.486 ' HB3' ' CZ ' ' A' ' 13' ' ' PHE . 6.6 mt -53.48 -40.16 65.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.265 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.66 ' CD ' HG11 ' A' ' 75' ' ' VAL . 0.4 OUTLIER -73.45 -15.17 61.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.605 -179.702 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.5 23.82 17.84 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.425 -0.893 . . . . 0.0 113.294 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.759 ' CH2' HG12 ' A' ' 68' ' ' VAL . 9.3 m0 -72.62 -59.04 2.91 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 117.215 0.508 . . . . 0.0 110.137 179.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.805 ' CB ' HD12 ' A' ' 41' ' ' ILE . 6.0 t -104.87 138.72 40.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.426 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -69.28 -33.77 73.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.905 0.383 . . . . 0.0 110.761 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.9 p -105.16 -42.44 5.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.064 0.459 . . . . 0.0 110.573 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 128.67 -43.34 1.33 Allowed Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.107 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.52 4.37 3.95 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -53.07 -70.38 0.09 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.838 0.352 . . . . 0.0 110.831 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.497 ' HB3' HG13 ' A' ' 41' ' ' ILE . . . -75.31 15.49 0.44 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.967 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.2 mttt 64.35 23.3 12.99 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 120.913 0.387 . . . . 0.0 110.163 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.959 HG22 HD23 ' A' ' 27' ' ' LEU . 29.8 mt -61.83 -19.63 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.617 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.671 ' O ' HD13 ' A' ' 23' ' ' LEU . . . -73.29 -78.92 0.09 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.916 0.389 . . . . 0.0 110.961 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.411 HD11 ' HD3' ' A' ' 58' ' ' LYS . 43.6 mm -52.41 -37.98 24.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.734 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.619 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -58.42 -69.38 0.19 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.155 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.677 ' HG3' HD21 ' A' ' 27' ' ' LEU . 12.3 tm-20 -34.53 -44.92 0.22 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.107 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.01 -73.14 0.44 Allowed Glycine 0 C--N 1.332 0.314 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.599 ' HG2' ' HB ' ' A' ' 56' ' ' THR . 0.0 OUTLIER -45.63 -15.44 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 179.614 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.818 HG21 ' HD1' ' A' ' 70' ' ' PHE . 46.2 t -74.92 -91.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 121.053 -0.259 . . . . 0.0 111.124 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.475 ' O ' ' HB2' ' A' ' 69' ' ' SER . 0.3 OUTLIER -175.74 130.13 0.25 Allowed 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.292 -0.563 . . . . 0.0 112.029 179.826 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.581 HG13 HG23 ' A' ' 68' ' ' VAL . 21.3 t -116.91 148.01 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.638 ' HB2' ' HB ' ' A' ' 67' ' ' THR . 14.0 t0 -44.85 99.21 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.934 0.397 . . . . 0.0 111.594 -179.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.37 17.67 70.68 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.225 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.533 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . . . -145.79 73.09 1.33 Allowed 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.249 0.547 . . . . 0.0 111.586 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.542 HG22 ' O ' ' A' ' 54' ' ' VAL . 3.0 p -84.33 69.25 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.419 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -100.48 -178.62 3.86 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.83 -179.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.599 ' HB ' ' HG2' ' A' ' 47' ' ' GLN . 3.0 p -142.45 37.74 1.52 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.172 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.458 ' O ' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -98.15 172.71 7.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.765 0.316 . . . . 0.0 111.256 -179.649 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.411 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -75.3 -41.77 56.18 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.45 179.713 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.614 ' HA ' ' HG3' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -123.8 145.56 48.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.645 179.424 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . 0.505 ' SG ' HD11 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -130.85 116.16 17.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.926 0.393 . . . . 0.0 111.439 -179.469 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.24 86.46 1.09 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.278 179.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.505 HD11 ' SG ' ' A' ' 60' ' ' CYS . 20.8 mt -133.37 139.94 47.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.224 -179.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.787 HG12 HD12 ' A' ' 15' ' ' LEU . 34.4 m -148.83 175.88 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.92 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.617 ' HA ' ' HB2' ' A' ' 79' ' ' ALA . . . 76.96 -147.94 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 178.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.712 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -84.36 75.62 2.34 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.25 -179.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.434 ' OE1' ' HB3' ' A' ' 51' ' ' ASP . 16.7 mm-40 -122.17 152.73 39.64 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.099 0.476 . . . . 0.0 111.285 -179.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.638 ' HB ' ' HB2' ' A' ' 51' ' ' ASP . 21.9 m -115.93 152.75 32.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.787 -178.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.759 HG12 ' CH2' ' A' ' 32' ' ' TRP . 0.8 OUTLIER -128.03 144.53 37.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.222 179.241 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' ' 49' ' ' LYS . 25.7 m -136.74 136.42 38.94 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.119 0.485 . . . . 0.0 112.246 -178.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.818 ' HD1' HG21 ' A' ' 48' ' ' VAL . 2.1 t80 -144.65 121.85 11.52 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.21 179.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 51.08 -81.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.981 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -131.75 -4.14 3.92 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.85 -0.69 . . . . 0.0 113.337 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.499 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 1.8 m-70 -91.48 112.62 24.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.087 0.444 . . . . 0.0 111.691 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.4 109.37 15.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.863 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.982 HG13 ' HB1' ' A' ' 11' ' ' ALA . 27.6 t -132.14 150.68 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 120.579 0.228 . . . . 0.0 111.468 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.612 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 1.5 mt-30 -112.29 172.4 6.93 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.008 0.432 . . . . 0.0 111.351 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.881 HG21 HD11 ' A' ' 26' ' ' LEU . 12.1 t -142.64 150.52 18.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.233 -178.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.1 m -127.49 158.78 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-O 120.746 0.307 . . . . 0.0 111.81 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.617 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.304 -0.855 . . . . 0.0 111.04 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.543 ' HB3' HG13 ' A' ' 75' ' ' VAL . . . . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.713 0.292 . . . . 0.0 111.021 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.55 135.24 53.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.28 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.721 ' CD2' HD12 ' A' ' 26' ' ' LEU . 1.1 t80 -101.07 95.59 6.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.309 179.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.56 ' HA ' HG23 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -73.05 111.26 8.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.855 0.359 . . . . 0.0 110.58 179.864 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.635 HD11 HG13 ' A' ' 21' ' ' VAL . 1.4 mt -82.46 -33.7 28.37 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.033 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.4 -73.86 0.67 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.715 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.44 52.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.129 0.49 . . . . 0.0 110.847 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.7 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 32.2 m170 -109.02 166.83 10.08 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.648 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.7 ' HD2' ' HB3' ' A' ' 18' ' ' HIS . 18.6 Cg_endo -57.97 -41.48 68.18 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.317 2.011 . . . . 0.0 111.831 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.601 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 9.0 p80 165.69 -164.71 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.256 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.795 HG21 HD13 ' A' ' 26' ' ' LEU . 22.6 m -142.73 156.91 18.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.354 0.597 . . . . 0.0 112.248 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.709 ' HG2' ' HA ' ' A' ' 59' ' ' ARG . 12.6 mt-10 -92.56 142.93 26.85 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.639 178.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.588 HD12 ' HB1' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -40.14 -40.05 1.02 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.726 0.298 . . . . 0.0 111.171 -179.61 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 54.0 t -67.1 -40.24 86.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.058 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -65.29 -57.15 9.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.023 179.667 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.795 HD13 HG21 ' A' ' 21' ' ' VAL . 9.9 tp -57.16 -47.77 80.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.436 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.702 HD23 HG22 ' A' ' 41' ' ' ILE . 4.6 mp -62.69 -57.34 11.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.785 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -50.76 -59.12 4.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.953 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 29' ' ' LEU . 18.7 mt -56.83 -44.04 81.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.583 -179.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.453 ' HG2' ' HD2' ' A' ' 13' ' ' PHE . 10.9 mm-40 -67.99 -14.99 63.4 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 121.117 -0.233 . . . . 0.0 111.165 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.24 22.54 26.97 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.359 -0.924 . . . . 0.0 113.209 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.59 ' CH2' HG12 ' A' ' 68' ' ' VAL . 9.3 m0 -68.84 -64.08 0.94 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.71 152.63 23.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.016 178.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -70.38 -34.56 72.72 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.28 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.587 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -106.13 -57.23 2.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.103 0.478 . . . . 0.0 110.568 179.241 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' A' ' 42' ' ' ALA . . . 152.63 -33.88 0.82 Allowed Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.972 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.37 7.53 1.33 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.587 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 2.1 tp60 -54.36 -70.33 0.1 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.701 0.286 . . . . 0.0 110.902 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.72 15.35 0.2 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.575 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.411 ' H ' ' C ' ' A' ' 38' ' ' GLN . 0.0 OUTLIER 69.11 16.26 8.63 Favored 'General case' 0 CA--C 1.523 -0.067 0 CA-C-O 120.734 0.302 . . . . 0.0 110.723 -179.378 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.702 HG22 HD23 ' A' ' 27' ' ' LEU . 22.9 mm -56.34 -26.5 22.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.299 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.588 ' HB1' HD12 ' A' ' 23' ' ' LEU . . . -70.75 -79.43 0.06 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.407 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.436 HD12 ' HD3' ' A' ' 58' ' ' LYS . 6.2 mm -48.04 -42.77 10.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.689 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.74 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -57.99 -64.21 0.99 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.506 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.569 ' HB2' HD21 ' A' ' 27' ' ' LEU . 3.1 tm-20 -35.94 -40.78 0.21 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.709 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' A' ' 48' ' ' VAL . . . -60.07 -75.07 0.3 Allowed Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 178.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.581 ' HG2' ' HB ' ' A' ' 56' ' ' THR . 0.0 OUTLIER -46.49 -12.59 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 179.891 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.798 HG21 ' HD1' ' A' ' 70' ' ' PHE . 57.7 t -74.99 -89.32 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.103 -179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.494 ' HG2' ' O ' ' A' ' 48' ' ' VAL . 5.8 mmmt -167.44 144.46 4.44 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.982 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.613 ' HB ' ' O ' ' A' ' 53' ' ' ALA . 14.0 t -131.04 145.7 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.547 ' HB2' ' HB ' ' A' ' 67' ' ' THR . 8.8 t0 -43.89 90.27 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -178.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 108.98 -31.93 7.31 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.712 -0.756 . . . . 0.0 114.03 178.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.613 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -147.58 145.59 29.08 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 117.851 0.825 . . . . 0.0 112.549 -179.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 54' ' ' VAL . 4.8 p -109.38 101.5 12.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.053 178.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -99.75 -165.05 1.18 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.966 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.581 ' HB ' ' HG2' ' A' ' 47' ' ' GLN . 5.2 t -165.24 31.06 0.06 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.775 0.322 . . . . 0.0 111.371 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.53 ' O ' HD21 ' A' ' 23' ' ' LEU . 6.3 mtt180 -89.07 167.85 12.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.023 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.436 ' HD3' HD12 ' A' ' 43' ' ' ILE . 58.3 mmtt -78.32 -35.61 47.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.237 0.542 . . . . 0.0 109.953 179.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.709 ' HA ' ' HG2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -106.93 135.08 49.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.563 179.592 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . 0.496 ' H ' ' HA ' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -104.39 118.29 36.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.879 0.371 . . . . 0.0 110.793 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.441 ' HA ' ' CD2' ' A' ' 20' ' ' HIS . 5.4 mtmt -98.99 74.06 1.98 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.11 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.48 ' O ' ' HB2' ' A' ' 20' ' ' HIS . 29.6 mt -137.88 145.26 29.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.657 -179.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.527 ' O ' ' HB3' ' A' ' 64' ' ' ALA . 0.5 OUTLIER -151.26 175.39 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.867 179.696 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 74.88 -148.89 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.424 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.438 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -85.13 74.76 2.43 Favored Glycine 0 C--N 1.335 0.513 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.732 -179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.437 ' O ' ' N ' ' A' ' 77' ' ' VAL . 27.9 mm-40 -122.35 150.0 42.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.955 0.407 . . . . 0.0 110.8 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.733 HG23 ' O ' ' A' ' 75' ' ' VAL . 77.1 m -114.83 150.38 35.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.384 -178.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.59 HG12 ' CH2' ' A' ' 32' ' ' TRP . 0.7 OUTLIER -125.77 145.57 32.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.523 178.774 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 28.4 p -139.32 138.8 37.0 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -178.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.798 ' HD1' HG21 ' A' ' 48' ' ' VAL . 1.9 t80 -143.04 122.2 12.93 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.21 179.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 48.04 -81.38 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.796 0.332 . . . . 0.0 111.396 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -130.7 -1.29 5.11 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.877 -0.678 . . . . 0.0 113.053 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -93.41 98.93 11.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.134 0.467 . . . . 0.0 111.624 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.3 m -109.82 108.28 18.55 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.405 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.733 ' O ' HG23 ' A' ' 67' ' ' THR . 25.1 t -128.55 156.44 40.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.819 -179.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.507 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 2.7 mp0 -112.05 161.55 16.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.815 0.34 . . . . 0.0 110.716 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.438 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 23.2 t -125.7 141.14 46.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.059 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.56 HG23 ' HA ' ' A' ' 14' ' ' SER . 29.3 m -129.77 152.23 37.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.866 0.365 . . . . 0.0 111.124 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.279 -0.867 . . . . 0.0 111.236 -179.776 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.738 ' HB3' HG22 ' A' ' 75' ' ' VAL . . . . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.779 0.323 . . . . 0.0 111.38 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -139.62 132.83 29.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.792 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.461 ' CE1' ' HB3' ' A' ' 29' ' ' LEU . 19.1 t80 -107.54 149.28 28.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.927 0.394 . . . . 0.0 111.294 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.63 150.63 26.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.738 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.5 mt -128.08 -40.47 1.67 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.144 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.91 -100.49 2.65 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.671 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.3 tppt? -148.83 53.62 0.98 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.992 0.425 . . . . 0.0 111.003 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.588 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 69.6 m-70 -106.12 163.95 15.98 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.898 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.588 ' HD2' ' HB3' ' A' ' 18' ' ' HIS . 18.3 Cg_endo -57.74 -45.18 34.87 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.615 2.21 . . . . 0.0 112.277 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.554 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 13.8 p80 170.91 -166.67 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.941 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.51 HG21 HD12 ' A' ' 26' ' ' LEU . 19.5 m -147.08 159.03 9.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.423 ' HG2' ' HA ' ' A' ' 59' ' ' ARG . 1.2 mt-10 -88.56 139.29 30.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.959 178.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.767 HD12 ' N ' ' A' ' 24' ' ' CYS . 0.9 OUTLIER -43.47 -32.5 0.9 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.884 0.374 . . . . 0.0 111.28 -179.653 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.767 ' N ' HD12 ' A' ' 23' ' ' LEU . 26.3 t -73.1 -38.23 66.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.816 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.408 ' N ' ' O ' ' A' ' 22' ' ' GLU . 6.5 m-20 -62.5 -55.31 28.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.743 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.708 HD11 HG21 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -54.89 -44.22 73.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.143 -179.913 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.705 HD23 HG22 ' A' ' 41' ' ' ILE . 5.2 mp -62.16 -64.31 0.97 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.45 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.6 ttmm -47.66 -52.46 18.08 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.974 -179.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.461 ' HB3' ' CE1' ' A' ' 13' ' ' PHE . 3.5 mm? -58.96 -46.51 87.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.322 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -70.52 -14.93 62.71 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.53 26.03 14.43 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.39 -0.91 . . . . 0.0 113.498 179.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.704 ' CH2' HG12 ' A' ' 68' ' ' VAL . 9.6 m0 -74.39 -64.89 0.93 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.015 0.436 . . . . 0.0 110.15 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.656 ' CB ' HD12 ' A' ' 41' ' ' ILE . 3.9 t -106.31 138.51 42.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.663 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.23 -33.66 37.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.707 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.447 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -105.33 -33.79 8.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.529 179.621 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.32 -20.42 50.34 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.792 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.97 -8.18 3.07 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.447 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 63.8 tp60 -55.51 -76.06 0.03 OUTLIER 'General case' 0 C--O 1.232 0.134 0 CA-C-O 120.724 0.297 . . . . 0.0 111.277 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.32 15.0 2.63 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.75 29.65 19.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.041 0.448 . . . . 0.0 110.44 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.852 HG23 ' CE2' ' A' ' 70' ' ' PHE . 18.6 mt -60.49 -23.89 29.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.982 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.62 -78.67 0.07 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.242 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.9 mm -51.8 -40.8 28.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.954 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.826 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -56.36 -68.65 0.19 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.617 179.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.565 ' HG3' HD11 ' A' ' 27' ' ' LEU . 3.7 tm-20 -35.82 -44.57 0.35 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.909 0.385 . . . . 0.0 110.965 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.47 -76.38 0.19 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.13 -1.033 . . . . 0.0 110.912 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.464 ' HA ' ' HB ' ' A' ' 56' ' ' THR . 14.7 pt20 -47.5 -12.07 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.826 HG23 ' O ' ' A' ' 44' ' ' ALA . 43.6 t -74.96 -90.83 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.285 -179.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -162.39 124.23 2.71 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 119.903 -0.719 . . . . 0.0 112.916 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.658 ' HB ' ' O ' ' A' ' 53' ' ' ALA . 45.2 t -117.13 148.1 20.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 177.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -44.68 96.1 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.912 0.387 . . . . 0.0 111.343 -179.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.34 17.86 74.66 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.627 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.658 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -146.03 82.56 1.61 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.017 0.437 . . . . 0.0 112.063 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.544 HG13 ' O ' ' A' ' 54' ' ' VAL . 12.5 p -86.85 59.08 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 0.0 110.874 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.16 -168.64 1.56 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.684 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.464 ' HB ' ' HA ' ' A' ' 47' ' ' GLN . 12.2 t -151.66 44.12 0.75 Allowed 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.607 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.676 ' O ' HD21 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -87.52 165.08 15.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.91 0.386 . . . . 0.0 111.292 -179.774 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.2 -40.07 59.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.791 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.423 ' HA ' ' HG2' ' A' ' 22' ' ' GLU . 2.6 mpt_? -111.67 134.38 53.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.918 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . 0.41 ' O ' ' O ' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -107.44 115.17 29.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.36 179.782 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.411 ' HA ' ' CG ' ' A' ' 20' ' ' HIS . 0.1 OUTLIER -92.53 76.49 5.07 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.129 0.49 . . . . 0.0 109.754 179.662 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.445 ' CG2' ' HG3' ' A' ' 66' ' ' GLN . 46.5 mt -139.2 153.32 24.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.43 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.577 ' O ' ' HB3' ' A' ' 64' ' ' ALA . 4.3 m -155.26 175.42 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.663 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.577 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 78.33 -150.52 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 178.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.712 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -84.87 77.41 2.11 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.939 -179.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.445 ' HG3' ' CG2' ' A' ' 62' ' ' ILE . 22.0 mm100 -122.18 157.72 30.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.913 0.387 . . . . 0.0 111.491 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.618 HG23 ' O ' ' A' ' 75' ' ' VAL . 25.1 m -118.58 156.72 28.66 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.673 0.619 . . . . 0.0 112.673 -178.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.704 HG12 ' CH2' ' A' ' 32' ' ' TRP . 1.2 t -137.34 149.37 25.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.891 179.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.602 ' HA ' ' O ' ' A' ' 73' ' ' HIS . 43.2 p -140.57 138.08 34.21 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.852 ' CE2' HG23 ' A' ' 41' ' ' ILE . 2.4 t80 -138.4 115.58 11.02 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.701 178.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.56 ' H ' HG11 ' A' ' 48' ' ' VAL . . . 38.29 31.6 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 116.67 -7.61 17.58 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.334 -0.936 . . . . 0.0 113.619 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.602 ' O ' ' HA ' ' A' ' 69' ' ' SER . 0.9 OUTLIER -88.14 83.83 6.95 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 117.252 0.526 . . . . 0.0 110.882 -179.427 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.2 m -92.58 111.47 23.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.979 0.419 . . . . 0.0 110.942 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.738 HG22 ' HB3' ' A' ' 11' ' ' ALA . 64.5 t -131.65 151.07 34.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.485 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.536 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 49.3 mt-30 -112.0 171.45 7.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.463 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.712 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 2.8 t -144.13 146.76 20.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.162 -178.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.0 m -136.38 170.44 18.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.838 0.351 . . . . 0.0 111.01 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.117 0 CA-C-O 118.214 -0.898 . . . . 0.0 111.068 179.881 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.626 ' HB3' HG13 ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.455 -0.209 0 CA-C-O 120.797 0.332 . . . . 0.0 111.042 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.55 130.55 51.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.146 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.614 ' O ' HG13 ' A' ' 77' ' ' VAL . 15.2 t80 -106.78 96.65 6.59 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.106 -179.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.411 ' HA ' ' CG2' ' A' ' 78' ' ' VAL . 7.7 t -70.95 110.56 5.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.94 0.4 . . . . 0.0 111.083 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 15' ' ' LEU . 13.8 mt -83.27 -31.55 26.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.555 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.05 -88.66 0.63 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.892 -0.671 . . . . 0.0 111.897 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.02 71.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.011 0.434 . . . . 0.0 110.886 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.432 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -117.43 172.18 4.24 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.38 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.606 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 38.0 Cg_endo -66.92 -41.56 9.97 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.054 1.836 . . . . 0.0 111.789 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.809 ' HA ' HG13 ' A' ' 63' ' ' VAL . 7.0 p80 170.68 -178.22 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.057 179.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.8 m -149.17 169.23 2.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.604 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -97.62 146.99 24.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.988 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.683 HD12 ' N ' ' A' ' 24' ' ' CYS . 4.3 pp -42.65 -34.0 0.81 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.46 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.683 ' N ' HD12 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -65.74 -43.58 88.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.85 0.357 . . . . 0.0 110.566 179.928 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.56 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 0.5 OUTLIER -61.82 -60.11 4.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.195 179.33 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.783 HD21 HG21 ' A' ' 77' ' ' VAL . 1.9 tp -50.08 -47.92 53.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.404 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.791 HD23 HG22 ' A' ' 41' ' ' ILE . 9.2 mp -67.5 -61.9 1.68 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.683 -179.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.509 ' HB2' ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -50.45 -54.43 22.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.002 -179.714 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.56 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 2.2 mt -56.8 -34.65 67.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.192 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.546 ' OE1' HG11 ' A' ' 75' ' ' VAL . 7.4 mm-40 -78.83 -15.13 58.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.408 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.33 22.23 22.68 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.421 -0.895 . . . . 0.0 113.104 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.675 ' CH2' HG12 ' A' ' 68' ' ' VAL . 9.2 m95 -72.81 -70.49 0.35 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 117.09 0.445 . . . . 0.0 109.896 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.736 ' CB ' HD12 ' A' ' 41' ' ' ILE . 8.6 t -95.05 138.9 32.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.956 178.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -75.7 -34.17 60.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.885 0.374 . . . . 0.0 110.792 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.407 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -105.3 -28.8 10.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.045 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.47 -37.5 3.79 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.49 179.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.32 5.27 2.97 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.407 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 43.4 tp60 -58.45 -72.6 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.712 0.292 . . . . 0.0 111.716 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.75 15.5 0.5 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.5 mtmm 64.49 24.53 13.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.053 0.454 . . . . 0.0 110.479 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.791 HG22 HD23 ' A' ' 27' ' ' LEU . 51.4 mt -59.56 -17.83 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.698 179.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.643 ' HB1' HD11 ' A' ' 23' ' ' LEU . . . -76.0 -77.91 0.12 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.042 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 13.1 mm -45.33 -45.7 3.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 121.078 0.466 . . . . 0.0 110.724 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.675 ' O ' ' HG3' ' A' ' 47' ' ' GLN . . . -57.82 -61.12 2.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.839 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.598 ' O ' HG23 ' A' ' 48' ' ' VAL . 9.9 tp10 -35.9 -35.6 0.07 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.143 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.459 ' O ' ' N ' ' A' ' 48' ' ' VAL . . . -72.16 -72.68 0.91 Allowed Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.24 -0.981 . . . . 0.0 111.743 178.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.675 ' HG3' ' O ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -39.93 -18.96 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -178.905 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.796 HG11 ' H ' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -75.34 -85.74 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.763 -179.55 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -176.56 130.55 0.2 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.467 -0.493 . . . . 0.0 112.112 179.723 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.628 HG11 ' CD1' ' A' ' 62' ' ' ILE . 49.6 t -125.04 150.83 30.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.721 178.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.58 ' HB2' ' H ' ' A' ' 67' ' ' THR . 1.2 m-20 -65.96 70.65 0.06 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.944 0.402 . . . . 0.0 110.601 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 135.92 -18.51 3.79 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.387 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.66 135.02 47.43 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.009 0.433 . . . . 0.0 111.123 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 54' ' ' VAL . 11.4 p -124.43 29.95 2.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.273 179.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -115.04 158.05 22.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.206 0.527 . . . . 0.0 111.495 -179.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.618 ' HB ' ' HB3' ' A' ' 47' ' ' GLN . 13.3 t -99.65 58.23 1.04 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.445 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 57' ' ' ARG . 14.6 mtt180 -89.13 171.81 9.54 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.785 0.326 . . . . 0.0 111.214 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.405 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -76.19 -48.24 21.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.23 179.655 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -122.4 154.82 37.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.035 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -136.91 119.19 15.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.899 0.38 . . . . 0.0 111.472 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.515 ' HG2' ' CD2' ' A' ' 20' ' ' HIS . 18.6 mttt -68.61 86.9 0.32 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.93 179.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.628 ' CD1' HG11 ' A' ' 50' ' ' VAL . 25.6 mt -134.54 139.98 46.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.955 0.407 . . . . 0.0 111.695 -179.049 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.809 HG13 ' HA ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -152.58 176.29 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.191 -179.649 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.602 ' HA ' ' HB3' ' A' ' 79' ' ' ALA . . . 75.26 -154.38 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.55 179.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.584 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -84.5 78.65 1.99 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.826 -178.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.62 HE21 HG23 ' A' ' 62' ' ' ILE . 2.0 mm100 -122.3 157.07 32.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.092 0.472 . . . . 0.0 111.268 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.58 ' H ' ' HB2' ' A' ' 51' ' ' ASP . 1.9 m -113.25 155.5 24.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.311 -178.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.675 HG12 ' CH2' ' A' ' 32' ' ' TRP . 0.9 OUTLIER -125.33 139.72 50.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.55 179.228 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.423 ' O ' ' HB ' ' A' ' 48' ' ' VAL . 0.7 OUTLIER -133.99 128.88 35.29 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.232 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.644 ' HA ' HG21 ' A' ' 48' ' ' VAL . 2.9 t80 -146.77 126.5 13.44 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.641 179.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.796 ' H ' HG11 ' A' ' 48' ' ' VAL . . . 46.13 -87.1 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.301 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -127.02 -8.73 4.5 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.889 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.658 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 1.8 m-70 -89.64 109.02 20.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.941 0.371 . . . . 0.0 111.471 -179.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.1 m -120.32 117.28 27.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.356 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.626 HG13 ' HB3' ' A' ' 11' ' ' ALA . 19.5 t -140.54 159.49 24.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.58 -179.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.569 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 19.5 mt-30 -112.66 163.15 14.89 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.028 0.442 . . . . 0.0 111.485 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.783 HG21 HD21 ' A' ' 26' ' ' LEU . 15.0 t -132.08 147.78 32.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.266 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.411 ' CG2' ' HA ' ' A' ' 14' ' ' SER . 24.5 m -129.12 162.45 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 CA-C-O 120.864 0.364 . . . . 0.0 111.291 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.602 ' HB3' ' HA ' ' A' ' 64' ' ' ALA . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.299 -0.858 . . . . 0.0 111.079 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.511 ' HB3' HG22 ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.456 -0.167 0 N-CA-C 110.383 -0.229 . . . . 0.0 110.383 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.11 130.3 35.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.973 0.416 . . . . 0.0 111.046 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.49 ' HB2' ' CG ' ' A' ' 30' ' ' GLU . 13.6 t80 -107.07 144.66 33.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.312 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 74.7 m -106.82 149.82 26.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.46 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.552 HD21 HG11 ' A' ' 77' ' ' VAL . 55.2 mt -118.25 -40.06 2.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.833 0.349 . . . . 0.0 110.866 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.32 -102.93 2.99 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.245 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.7 pttt -143.1 43.65 1.55 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.964 0.411 . . . . 0.0 111.227 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.655 ' CG ' ' HD2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -101.64 154.45 37.27 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.194 179.536 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.655 ' HD2' ' CG ' ' A' ' 18' ' ' HIS . 9.3 Cg_endo -50.91 -32.4 37.67 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.581 2.187 . . . . 0.0 112.008 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.555 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 10.4 p80 159.62 -165.38 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.809 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.698 HG21 HD12 ' A' ' 26' ' ' LEU . 15.1 m -133.52 141.94 43.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.989 0.423 . . . . 0.0 111.233 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.691 ' HA ' ' H ' ' A' ' 60' ' ' CYS . 1.3 mp0 -81.28 148.07 29.61 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.822 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.593 ' O ' HD12 ' A' ' 27' ' ' LEU . 4.0 mp -38.7 -54.8 1.54 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.766 0.317 . . . . 0.0 111.39 -179.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.3 t -60.68 -29.06 69.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.417 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 22' ' ' GLU . 1.0 OUTLIER -72.74 -62.38 1.47 Allowed 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.76 0.314 . . . . 0.0 111.382 -179.716 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.949 HD11 HG21 ' A' ' 77' ' ' VAL . 4.9 tt -51.97 -48.84 64.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.266 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.872 HD21 ' HG3' ' A' ' 45' ' ' GLU . 5.4 mt -60.51 -57.76 11.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.556 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.6 ttpt -55.66 -54.46 43.99 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.769 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.25 -51.22 68.91 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -178.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.501 ' CD ' HG11 ' A' ' 75' ' ' VAL . 3.1 mm-40 -63.71 -15.44 58.49 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.56 25.54 15.47 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.267 -0.968 . . . . 0.0 113.341 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.681 ' CH2' HG12 ' A' ' 68' ' ' VAL . 12.4 m95 -74.14 -61.27 1.91 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-N 117.417 0.608 . . . . 0.0 109.552 178.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.715 ' CB ' HD13 ' A' ' 41' ' ' ILE . 47.0 t -106.79 140.52 39.51 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.495 179.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.61 -34.1 67.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.978 0.418 . . . . 0.0 110.171 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.566 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -105.77 -47.05 3.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.466 179.354 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 129.29 -30.82 3.57 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.303 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.96 6.7 3.4 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.566 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 19.1 tp60 -52.25 -75.01 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.857 0.361 . . . . 0.0 110.69 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.506 ' HB3' HD11 ' A' ' 41' ' ' ILE . . . -79.96 15.35 1.48 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.562 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.1 mmtt 64.61 29.4 13.06 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 121.142 0.496 . . . . 0.0 110.283 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.92 HG23 ' CD2' ' A' ' 70' ' ' PHE . 2.5 mp -63.4 -24.31 35.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.0 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.56 -78.97 0.05 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.383 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.4 mm -50.54 -42.64 22.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.946 0.403 . . . . 0.0 110.832 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.676 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -58.06 -68.86 0.21 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.165 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.872 ' HG3' HD21 ' A' ' 27' ' ' LEU . 1.6 tm-20 -33.88 -42.18 0.11 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.944 0.402 . . . . 0.0 111.087 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.415 ' C ' ' H ' ' A' ' 48' ' ' VAL . . . -60.15 -72.64 0.59 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.348 178.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.539 ' CA ' ' HB ' ' A' ' 56' ' ' THR . 9.3 pt20 -49.84 -8.57 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.871 HG21 ' HD1' ' A' ' 70' ' ' PHE . 60.0 t -74.87 -90.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.293 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.519 ' HG2' ' O ' ' A' ' 48' ' ' VAL . 0.5 OUTLIER -171.18 133.97 0.89 Allowed 'General case' 0 C--O 1.232 0.132 0 C-N-CA 120.432 -0.507 . . . . 0.0 111.744 179.559 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.508 HG11 ' CD1' ' A' ' 62' ' ' ILE . 21.9 t -130.41 147.44 33.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.819 178.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.531 ' HB2' ' H ' ' A' ' 67' ' ' THR . 0.5 OUTLIER -63.53 79.83 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.08 0.466 . . . . 0.0 110.51 -179.888 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 125.52 -13.68 7.33 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.583 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.407 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . . . -135.96 135.45 39.58 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.965 0.412 . . . . 0.0 111.17 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 54' ' ' VAL . 10.5 p -125.55 31.19 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.886 178.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -104.71 -150.46 0.43 Allowed 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.799 -178.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.539 ' HB ' ' CA ' ' A' ' 47' ' ' GLN . 4.5 t -169.89 67.4 0.05 Allowed 'General case' 0 C--O 1.232 0.147 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.589 ' O ' HD13 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -94.95 174.15 7.23 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.46 179.192 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -75.12 -46.43 34.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.014 0.435 . . . . 0.0 110.224 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.436 ' O ' ' HG2' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -101.87 131.9 47.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.045 179.167 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . 0.691 ' H ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -100.08 115.61 30.18 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.979 0.419 . . . . 0.0 111.217 -179.449 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.466 ' HG3' ' NE2' ' A' ' 20' ' ' HIS . 0.1 OUTLIER -94.55 74.86 3.78 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.783 179.207 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.508 ' CD1' HG11 ' A' ' 50' ' ' VAL . 36.6 mt -133.65 142.09 42.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.061 0.458 . . . . 0.0 111.578 -178.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.603 ' O ' ' HB3' ' A' ' 64' ' ' ALA . 0.2 OUTLIER -150.77 175.96 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.606 -179.908 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.603 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 81.09 -154.29 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.513 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -93.7 79.02 1.03 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.631 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -122.63 162.22 22.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.147 0.498 . . . . 0.0 111.34 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.67 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 25.8 m -113.85 156.57 23.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.851 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.681 HG12 ' CH2' ' A' ' 32' ' ' TRP . 0.9 OUTLIER -131.75 146.04 34.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.005 179.335 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 60.0 p -143.66 139.13 29.41 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 120.907 0.384 . . . . 0.0 111.727 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.92 ' CD2' HG23 ' A' ' 41' ' ' ILE . 0.8 OUTLIER -128.48 -86.24 0.56 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.28 179.983 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -139.63 88.56 2.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.743 0.306 . . . . 0.0 110.464 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.17 -25.5 6.93 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.441 -0.885 . . . . 0.0 111.444 -178.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.625 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 0.9 OUTLIER -93.06 109.02 20.49 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 120.791 0.329 . . . . 0.0 110.914 -179.758 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.9 m -120.23 98.48 6.08 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.595 ' HB ' ' HZ2' ' A' ' 32' ' ' TRP . 38.9 t -120.32 151.16 23.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.475 -178.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.67 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 30.0 mt-30 -112.45 164.38 13.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.642 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.949 HG21 HD11 ' A' ' 26' ' ' LEU . 10.7 t -132.47 146.52 32.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.065 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 17.9 m -139.89 169.5 16.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.886 0.374 . . . . 0.0 111.144 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.181 -0.914 . . . . 0.0 111.071 179.863 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.476 ' HB3' HG13 ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.453 -0.275 0 CA-C-O 120.813 0.339 . . . . 0.0 110.65 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.69 135.46 53.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.464 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.71 ' O ' HG13 ' A' ' 77' ' ' VAL . 40.2 t80 -124.83 98.57 5.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.886 0.374 . . . . 0.0 110.87 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.75 141.5 57.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.721 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.575 ' CD1' HG12 ' A' ' 63' ' ' VAL . 0.6 OUTLIER -90.93 -36.89 13.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.633 179.906 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.26 -81.3 1.06 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.574 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.7 ttmm -171.44 39.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.887 0.375 . . . . 0.0 110.85 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.651 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 6.1 m-70 -98.67 165.1 15.7 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.713 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.651 ' HD2' ' HB3' ' A' ' 18' ' ' HIS . 42.2 Cg_endo -66.79 -37.3 21.07 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.272 1.982 . . . . 0.0 111.935 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.533 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 6.3 p80 172.71 -172.14 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.022 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.555 HG21 ' CD1' ' A' ' 26' ' ' LEU . 2.5 m -136.26 151.9 29.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.091 0.472 . . . . 0.0 112.255 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.423 ' O ' ' N ' ' A' ' 25' ' ' ASP . 2.5 mp0 -95.01 148.3 22.48 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.464 178.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.567 ' O ' HD12 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -40.7 -47.94 2.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.743 0.306 . . . . 0.0 111.636 -179.492 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -62.78 -34.72 77.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.877 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.436 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 8.7 m-20 -64.75 -62.2 1.72 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.046 0.45 . . . . 0.0 110.433 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.793 HD11 HG21 ' A' ' 77' ' ' VAL . 0.9 OUTLIER -50.64 -46.0 58.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.148 179.909 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.769 HD21 ' HG3' ' A' ' 45' ' ' GLU . 9.8 mt -67.07 -59.37 3.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.915 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.18 -58.59 7.31 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.436 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.2 OUTLIER -53.9 -45.49 71.12 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.677 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.641 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 4.3 mm-40 -72.55 -14.62 61.68 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.09 25.34 12.93 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.192 -1.004 . . . . 0.0 113.332 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.712 ' CD2' HD23 ' A' ' 27' ' ' LEU . 12.4 m95 -73.47 -58.6 3.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.041 0.448 . . . . 0.0 110.013 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.699 ' HA ' HD12 ' A' ' 41' ' ' ILE . 2.1 t -106.1 133.7 50.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.513 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -64.67 -34.12 77.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.608 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.434 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 56.2 p -105.83 -49.2 3.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.734 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 133.91 -32.54 2.66 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.764 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.23 6.57 1.73 Allowed 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.434 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 69.7 tp60 -54.61 -71.83 0.07 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.956 0.408 . . . . 0.0 110.852 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.05 15.22 1.17 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.465 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.38 20.84 11.86 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.629 -179.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.71 HG23 ' CD2' ' A' ' 70' ' ' PHE . 37.5 mt -54.88 -25.89 16.4 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-O 121.01 0.433 . . . . 0.0 110.712 179.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.492 ' HA ' ' CD1' ' A' ' 27' ' ' LEU . . . -67.72 -79.34 0.05 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.164 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 44.6 mm -51.2 -39.17 20.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.199 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.624 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -58.04 -68.88 0.21 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.238 179.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.769 ' HG3' HD21 ' A' ' 27' ' ' LEU . 0.9 OUTLIER -33.42 -41.9 0.09 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.749 179.741 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.475 ' HA2' HD21 ' A' ' 23' ' ' LEU . . . -57.44 -74.72 0.31 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.034 -1.079 . . . . 0.0 110.553 178.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.529 ' HA ' HG22 ' A' ' 56' ' ' THR . 13.8 pt20 -48.06 -12.84 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.762 HG21 ' HD1' ' A' ' 70' ' ' PHE . 58.7 t -75.02 -93.63 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.969 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.48 ' HD3' ' HB ' ' A' ' 54' ' ' VAL . 4.6 mmtt -166.92 124.89 1.32 Allowed 'General case' 0 C--O 1.23 0.065 0 C-N-CA 120.151 -0.619 . . . . 0.0 112.368 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.602 HG13 HG23 ' A' ' 68' ' ' VAL . 12.8 t -118.11 149.17 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 177.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.445 ' HB2' ' H ' ' A' ' 67' ' ' THR . 9.9 t0 -45.07 100.47 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.025 0.44 . . . . 0.0 111.534 -178.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 66.95 17.3 67.43 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.857 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.507 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -145.98 82.71 1.62 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.922 0.391 . . . . 0.0 111.945 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.635 HG13 ' O ' ' A' ' 54' ' ' VAL . 14.0 p -90.66 65.44 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.912 0.387 . . . . 0.0 110.582 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -99.83 -173.5 2.47 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.511 -179.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.529 HG22 ' HA ' ' A' ' 47' ' ' GLN . 0.8 OUTLIER -140.83 32.59 1.79 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.149 -179.708 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 19.4 mtp180 -84.74 169.13 14.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.062 0.458 . . . . 0.0 111.503 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.17 -32.01 55.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.915 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.2 mtt85 -131.76 146.54 52.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.654 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -129.51 115.89 18.13 Favored 'General case' 0 C--O 1.23 0.078 0 CA-C-O 120.89 0.376 . . . . 0.0 111.328 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.436 ' HG2' ' CD2' ' A' ' 20' ' ' HIS . 6.3 mttt -76.1 91.91 3.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.352 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.466 ' CD1' HG11 ' A' ' 50' ' ' VAL . 39.8 mt -133.77 139.72 48.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.265 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.575 HG12 ' CD1' ' A' ' 15' ' ' LEU . 2.5 m -146.23 175.2 2.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.119 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.533 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 74.98 -143.51 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.965 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -93.13 80.49 1.08 Allowed Glycine 0 C--N 1.336 0.552 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.766 -179.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -121.92 175.17 6.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.819 0.342 . . . . 0.0 111.228 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.445 ' H ' ' HB2' ' A' ' 51' ' ' ASP . 27.1 m -135.85 151.14 49.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.008 -178.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.712 HG12 ' CH2' ' A' ' 32' ' ' TRP . 1.2 t -130.5 144.13 38.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.309 179.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 67.8 m -140.99 141.23 34.4 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -178.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.762 ' HD1' HG21 ' A' ' 48' ' ' VAL . 1.9 t80 -146.08 122.28 10.85 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.273 179.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 49.78 -83.47 0.01 OUTLIER 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.481 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -127.46 -5.09 5.62 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.963 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.551 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 0.8 OUTLIER -89.46 113.79 25.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 117.01 0.405 . . . . 0.0 111.592 -179.027 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.61 111.35 17.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.285 178.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.587 ' HB ' ' HZ2' ' A' ' 32' ' ' TRP . 41.1 t -132.39 151.61 35.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.817 0.342 . . . . 0.0 111.488 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.438 ' HG3' ' OG1' ' A' ' 67' ' ' THR . 24.5 mp0 -113.2 159.53 19.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.423 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.793 HG21 HD11 ' A' ' 26' ' ' LEU . 6.3 t -125.07 138.7 53.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.084 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.1 m -133.88 154.54 38.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.014 0.435 . . . . 0.0 111.871 -179.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.431 ' HB2' ' HB2' ' A' ' 15' ' ' LEU . . . . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.058 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.15 0 CA-C-O 120.652 0.263 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.63 132.99 41.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.021 0.439 . . . . 0.0 110.902 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.486 ' HE1' HD23 ' A' ' 15' ' ' LEU . 16.8 t80 -99.72 98.24 9.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.967 179.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.416 ' HA ' HG23 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -77.18 98.98 5.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.764 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.486 HD23 ' HE1' ' A' ' 13' ' ' PHE . 17.9 mt -55.83 -34.14 65.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.985 0.421 . . . . 0.0 110.542 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.54 42.49 7.82 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.005 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt 61.3 39.38 15.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.981 0.419 . . . . 0.0 110.631 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.402 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 3.6 m170 -95.15 165.73 16.3 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.897 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.434 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 14.8 Cg_endo -56.99 -63.63 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.672 2.248 . . . . 0.0 112.612 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.434 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 8.5 p80 178.51 -174.05 0.16 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.241 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.421 ' N ' ' ND1' ' A' ' 20' ' ' HIS . 17.8 m -149.93 167.07 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.409 ' HB2' ' CB ' ' A' ' 59' ' ' ARG . 1.5 pt-20 -103.71 153.39 20.72 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.253 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.543 ' O ' HD13 ' A' ' 27' ' ' LEU . 81.6 mt -41.65 -45.55 3.44 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.0 t -65.37 -39.12 91.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.721 0.296 . . . . 0.0 111.671 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -62.12 -62.31 1.86 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.593 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.672 HD21 ' CG2' ' A' ' 77' ' ' VAL . 2.3 tp -53.69 -41.92 67.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.474 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.001 HD23 HG22 ' A' ' 41' ' ' ILE . 8.0 mp -66.81 -64.7 0.8 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.382 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -51.26 -57.0 10.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.988 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 24.9 mt -53.65 -31.02 45.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.079 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.556 ' OE2' HG11 ' A' ' 75' ' ' VAL . 2.4 mm-40 -84.05 -13.61 52.71 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.55 18.0 34.36 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.365 -0.922 . . . . 0.0 112.685 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.529 ' CE3' ' HG ' ' A' ' 27' ' ' LEU . 9.4 m0 -69.58 -60.81 2.09 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.64 ' CB ' HD12 ' A' ' 41' ' ' ILE . 2.1 t -106.83 134.04 50.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.99 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -63.95 -34.83 78.87 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.856 0.36 . . . . 0.0 111.048 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.559 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 79.0 p -106.25 -51.56 2.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.138 0.494 . . . . 0.0 110.225 178.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 139.29 -37.62 1.74 Allowed Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.3 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.03 11.25 3.33 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.559 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 3.4 tp-100 -63.11 -66.65 0.51 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.761 0.315 . . . . 0.0 110.777 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.29 14.41 0.94 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.727 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 46.0 mmtt 65.4 25.48 11.99 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.832 0.349 . . . . 0.0 110.745 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 1.001 HG22 HD23 ' A' ' 27' ' ' LEU . 5.3 mt -63.09 -27.12 42.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.267 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.84 -78.51 0.06 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.836 0.35 . . . . 0.0 110.577 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.6 mm -46.51 -35.81 2.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 121.104 0.478 . . . . 0.0 110.249 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.722 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -63.8 -62.61 1.54 Allowed 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.657 178.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.759 ' HB2' HD21 ' A' ' 27' ' ' LEU . 16.3 tp10 -32.35 -41.84 0.06 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.823 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.8 -71.6 0.92 Allowed Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.355 -0.926 . . . . 0.0 111.743 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.522 ' HG3' ' O ' ' A' ' 44' ' ' ALA . 0.7 OUTLIER -43.69 -19.54 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.726 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.84 HG21 ' HD1' ' A' ' 70' ' ' PHE . 21.5 t -75.85 -85.05 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.945 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -170.36 133.17 1.05 Allowed 'General case' 0 C--O 1.23 0.055 0 CA-C-O 120.804 0.335 . . . . 0.0 111.138 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.665 ' HB ' ' HB3' ' A' ' 53' ' ' ALA . 4.4 t -134.62 144.19 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.056 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 67' ' ' THR . 6.0 t70 -48.74 91.25 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.75 0.31 . . . . 0.0 111.442 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 94.27 -7.4 72.3 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.875 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.665 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . . . -129.0 131.33 47.39 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 117.323 0.562 . . . . 0.0 111.187 -179.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 54' ' ' VAL . 7.5 p -124.84 32.51 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.861 178.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -101.99 154.64 18.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.936 -178.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.47 ' HA ' ' N ' ' A' ' 47' ' ' GLN . 12.1 t -92.88 46.84 1.24 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.643 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.68 169.98 17.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.187 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.09 -32.25 20.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.125 0.488 . . . . 0.0 109.819 178.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.409 ' CB ' ' HB2' ' A' ' 22' ' ' GLU . 36.2 mtm180 -128.38 151.94 48.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.991 179.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . 0.616 ' SG ' HD11 ' A' ' 62' ' ' ILE . 18.4 t -136.94 117.29 13.62 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.827 0.346 . . . . 0.0 111.105 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.02 99.0 2.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.394 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.616 HD11 ' SG ' ' A' ' 60' ' ' CYS . 1.5 mt -133.36 142.65 41.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.151 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.513 ' O ' ' HB3' ' A' ' 64' ' ' ALA . 25.6 m -147.54 170.71 3.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.39 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 72.34 -155.5 0.09 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.387 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.551 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -87.17 82.96 1.59 Allowed Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 121.516 -0.373 . . . . 0.0 112.285 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.454 ' HB3' ' CB ' ' A' ' 51' ' ' ASP . 5.0 mm100 -121.48 160.91 23.21 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.972 0.415 . . . . 0.0 111.577 -178.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.821 HG23 ' HG3' ' A' ' 76' ' ' GLN . 0.2 OUTLIER -116.23 149.07 39.76 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.551 -178.498 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.548 HG13 ' OE2' ' A' ' 45' ' ' GLU . 1.1 t -125.88 142.47 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.651 179.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.407 ' O ' ' HB ' ' A' ' 48' ' ' VAL . 13.2 m -138.14 133.53 33.47 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -178.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.858 ' CE2' HG23 ' A' ' 41' ' ' ILE . 1.9 t80 -144.05 122.57 12.45 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.1 178.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 47.21 -85.5 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.724 0.297 . . . . 0.0 111.535 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -127.31 -4.89 5.75 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.037 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.487 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 1.8 m-70 -92.75 110.1 21.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.025 0.413 . . . . 0.0 111.3 -179.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.0 m -120.69 125.16 46.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.278 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.556 HG11 ' OE2' ' A' ' 30' ' ' GLU . 47.0 t -147.23 160.64 8.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.808 0.337 . . . . 0.0 111.564 -179.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.821 ' HG3' HG23 ' A' ' 67' ' ' THR . 35.8 mt-30 -112.41 164.02 13.75 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.949 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.672 ' CG2' HD21 ' A' ' 26' ' ' LEU . 16.9 t -137.13 147.12 27.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.658 -179.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.416 HG23 ' HA ' ' A' ' 14' ' ' SER . 17.0 m -134.22 178.01 6.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 120.718 0.294 . . . . 0.0 110.624 178.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.331 -0.842 . . . . 0.0 111.098 -179.978 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.168 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.58 80.29 1.28 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.88 0.371 . . . . 0.0 110.736 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.1 ttt -168.58 72.91 0.1 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.309 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 34.8 pt -99.49 148.47 6.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.885 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 33.6 m80 -84.43 -174.88 5.52 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.725 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.427 ' C ' ' H ' ' A' ' 8' ' ' SER . 1.5 mtt180 -147.57 109.92 4.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.74 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.404 ' HB2' ' O ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 74.43 -31.32 0.21 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.294 -179.548 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.427 ' H ' ' C ' ' A' ' 6' ' ' ARG . 0.6 OUTLIER 67.72 115.99 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.864 0.364 . . . . 0.0 110.9 179.667 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -108.75 83.88 1.84 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.868 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.57 71.78 2.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.037 0.446 . . . . 0.0 110.414 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.602 ' HB1' HG13 ' A' ' 75' ' ' VAL . . . -77.16 102.55 6.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.095 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.3 123.23 26.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.895 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.896 ' HB3' HG22 ' A' ' 77' ' ' VAL . 50.0 t80 -100.87 152.82 20.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.911 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.83 153.46 21.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.101 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.925 ' HB2' ' HB2' ' A' ' 79' ' ' ALA . 9.3 mt -129.32 -40.16 1.47 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.785 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.44 -111.54 3.63 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.73 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.86 57.4 1.35 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.114 0.483 . . . . 0.0 110.624 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.671 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 2.3 m-70 -110.04 165.84 11.9 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.567 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.671 ' HD2' ' HB3' ' A' ' 18' ' ' HIS . 31.2 Cg_endo -62.64 -41.25 32.53 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.098 1.866 . . . . 0.0 111.863 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.572 ' HA ' ' CG1' ' A' ' 63' ' ' VAL . 21.5 p80 171.38 -170.36 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.721 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.6 m -145.78 158.99 12.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.236 0.541 . . . . 0.0 112.365 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.574 ' HG3' ' HA ' ' A' ' 59' ' ' ARG . 8.2 tt0 -88.78 139.21 30.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.848 178.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.781 HD12 ' N ' ' A' ' 24' ' ' CYS . 4.1 pp -42.45 -30.48 0.34 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.781 0.324 . . . . 0.0 111.404 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.781 ' N ' HD12 ' A' ' 23' ' ' LEU . 3.5 t -72.47 -40.17 67.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.977 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.401 ' N ' ' O ' ' A' ' 22' ' ' GLU . 1.9 m-20 -65.74 -53.73 36.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.938 0.399 . . . . 0.0 110.702 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.871 HD11 HG21 ' A' ' 77' ' ' VAL . 10.1 tt -54.75 -48.72 72.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.825 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.872 HD23 HG22 ' A' ' 41' ' ' ILE . 8.9 mp -65.76 -63.03 1.18 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.648 -178.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.0 tmmm? -43.84 -59.43 2.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.023 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.483 ' HB3' ' CE1' ' A' ' 13' ' ' PHE . 0.5 OUTLIER -56.13 -47.5 78.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.226 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.629 ' CD ' HG11 ' A' ' 75' ' ' VAL . 2.3 mm-40 -62.11 -15.21 43.84 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.681 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.04 24.68 14.34 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.321 -0.942 . . . . 0.0 113.253 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.649 ' CH2' HG12 ' A' ' 68' ' ' VAL . 7.8 m0 -79.09 -63.88 1.32 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.248 0.524 . . . . 0.0 109.988 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.54 ' CB ' HD12 ' A' ' 41' ' ' ILE . 3.9 t -106.72 135.37 48.37 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.778 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.41 -33.36 71.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.827 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.7 p -104.67 -40.46 5.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.493 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 121.83 -30.74 5.2 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.027 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -138.31 5.93 2.53 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.701 0.259 . . . . 0.0 111.701 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 21.5 tp60 -54.91 -74.69 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.859 0.362 . . . . 0.0 110.952 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.464 ' HB3' HG13 ' A' ' 41' ' ' ILE . . . -74.62 15.68 0.34 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.77 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.4 mttm 64.48 24.57 13.15 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 120.961 0.41 . . . . 0.0 110.073 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.872 HG22 HD23 ' A' ' 27' ' ' LEU . 16.9 mt -63.71 -18.92 23.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.708 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.659 ' HB1' HD11 ' A' ' 23' ' ' LEU . . . -74.11 -79.14 0.09 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.93 0.395 . . . . 0.0 110.663 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 29.4 mm -46.61 -45.01 6.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.674 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.658 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -54.33 -68.14 0.21 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.91 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.617 ' HA ' ' HB2' ' A' ' 70' ' ' PHE . 6.6 tp10 -32.66 -45.14 0.12 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.604 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 55' ' ' GLU . . . -57.84 -74.37 0.35 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 119.875 -1.155 . . . . 0.0 110.637 178.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.564 ' CA ' ' HB ' ' A' ' 56' ' ' THR . 14.6 pt20 -46.33 -14.62 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.755 HG21 ' HD1' ' A' ' 70' ' ' PHE . 56.0 t -74.92 -88.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.116 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -172.84 128.87 0.5 Allowed 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.828 0.346 . . . . 0.0 111.019 179.221 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.574 ' HB ' ' HB3' ' A' ' 53' ' ' ALA . 44.7 t -124.29 149.48 28.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.591 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -55.66 85.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.132 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 106.78 -6.15 37.62 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.115 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.574 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . . . -133.75 135.42 43.92 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 117.148 0.474 . . . . 0.0 111.267 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.497 HG22 ' O ' ' A' ' 54' ' ' VAL . 12.1 p -125.42 38.13 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.306 178.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.488 ' HB3' ' H ' ' A' ' 56' ' ' THR . 7.6 mt-10 -106.94 -151.39 0.46 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.211 -0.449 . . . . 0.0 112.171 -178.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.564 ' HB ' ' CA ' ' A' ' 47' ' ' GLN . 3.5 t -166.96 57.3 0.08 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.927 0.394 . . . . 0.0 111.469 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.2 mtt-85 -86.29 175.29 8.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.019 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.21 -47.53 27.82 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.574 ' HA ' ' HG3' ' A' ' 22' ' ' GLU . 3.8 mtm180 -115.21 153.09 31.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.237 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -125.68 137.22 53.84 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.928 0.394 . . . . 0.0 111.231 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.508 ' HG3' ' CD2' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -99.98 77.59 2.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.441 179.485 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.3 mt -133.9 144.49 35.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.42 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.572 ' CG1' ' HA ' ' A' ' 20' ' ' HIS . 6.5 m -150.28 175.64 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.183 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.676 ' HA ' ' HB3' ' A' ' 79' ' ' ALA . . . 74.4 -150.39 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.082 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.641 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -84.93 77.74 2.08 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.319 -0.467 . . . . 0.0 112.963 -178.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 18.3 mm100 -122.09 158.71 28.66 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.859 0.361 . . . . 0.0 110.979 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.624 HG23 ' O ' ' A' ' 75' ' ' VAL . 26.9 m -117.15 154.64 30.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.141 0.496 . . . . 0.0 112.251 -178.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.649 HG12 ' CH2' ' A' ' 32' ' ' TRP . 0.7 OUTLIER -127.37 143.25 41.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.44 178.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 36.8 m -136.66 132.82 35.5 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -178.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.755 ' HD1' HG21 ' A' ' 48' ' ' VAL . 1.4 t80 -141.95 122.77 14.39 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.336 178.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 46.67 -87.01 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.687 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -126.66 -6.06 5.69 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.858 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.403 ' O ' ' CH2' ' A' ' 32' ' ' TRP . 1.0 OUTLIER -90.61 103.59 16.27 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.793 0.33 . . . . 0.0 111.042 -179.464 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.3 m -114.65 125.57 53.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.602 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.641 ' HB ' ' HZ2' ' A' ' 32' ' ' TRP . 47.0 t -145.59 153.58 13.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.23 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.487 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 3.1 mp0 -112.25 158.28 19.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.813 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.896 HG22 ' HB3' ' A' ' 13' ' ' PHE . 46.9 t -129.2 152.22 36.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.813 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.2 m -130.89 148.97 33.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.921 0.391 . . . . 0.0 111.53 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.925 ' HB2' ' HB2' ' A' ' 15' ' ' LEU . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.077 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 112.554 -0.218 . . . . 0.0 112.554 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 63.43 103.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.828 0.347 . . . . 0.0 110.987 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.3 mtt -80.39 -48.42 12.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.721 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.584 HG22 ' O ' ' A' ' 4' ' ' ILE . 26.7 mt 65.7 41.14 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.124 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 14.4 t-160 -71.54 -20.82 61.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.138 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.5 ttt180 61.65 94.51 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.827 0.346 . . . . 0.0 110.781 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -114.15 -69.43 0.86 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.881 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.7 t -105.61 104.63 14.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.015 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -88.72 154.33 20.37 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.911 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -71.56 156.39 39.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.665 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.534 ' HB3' HG13 ' A' ' 75' ' ' VAL . . . -98.73 134.28 41.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.166 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.64 132.26 48.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.592 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.813 ' HB3' HG22 ' A' ' 77' ' ' VAL . 77.8 t80 -110.04 148.57 31.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.923 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.5 146.9 30.02 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.809 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.663 HD21 HG11 ' A' ' 77' ' ' VAL . 27.8 mt -114.23 -40.45 3.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.921 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.65 -103.75 2.89 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.585 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.06 56.62 0.9 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.995 0.426 . . . . 0.0 111.011 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.421 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 1.0 OUTLIER -113.36 167.33 9.49 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.578 179.863 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.59 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 19.4 Cg_endo -59.8 -33.55 96.12 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.3 2.0 . . . . 0.0 111.665 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.59 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 14.1 p80 163.01 -164.32 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.989 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.579 HG21 HD13 ' A' ' 26' ' ' LEU . 4.9 m -142.92 153.91 17.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.139 0.495 . . . . 0.0 112.004 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.459 ' HG3' ' CB ' ' A' ' 59' ' ' ARG . 0.7 OUTLIER -83.53 138.34 33.46 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.907 179.019 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.718 HD12 ' N ' ' A' ' 24' ' ' CYS . 4.6 pp -41.03 -33.27 0.31 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.764 0.316 . . . . 0.0 111.478 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.718 ' N ' HD12 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -71.3 -39.15 71.63 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.988 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 22' ' ' GLU . 78.8 m-20 -62.73 -52.27 63.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.05 0.452 . . . . 0.0 110.442 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.754 HD21 HG21 ' A' ' 77' ' ' VAL . 8.4 tp -58.23 -46.5 85.8 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.893 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.803 HD23 HG22 ' A' ' 41' ' ' ILE . 5.6 mp -67.33 -60.69 2.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.651 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -46.53 -65.26 0.58 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.752 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.57 -41.61 63.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.212 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 2.9 mm-40 -72.27 -15.3 61.91 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.19 26.26 12.71 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.475 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.561 ' CH2' HG12 ' A' ' 68' ' ' VAL . 9.4 m95 -76.39 -66.04 0.85 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 117.094 0.447 . . . . 0.0 110.079 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.0 t -101.0 149.29 24.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.315 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.32 -34.08 36.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.04 0.448 . . . . 0.0 110.489 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.78 -31.95 8.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.585 179.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 126.08 -60.22 0.65 Allowed Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.346 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -129.32 7.59 5.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.789 0.328 . . . . 0.0 111.281 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -54.21 -64.38 0.85 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.872 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.514 ' HB3' ' CD1' ' A' ' 41' ' ' ILE . . . -74.19 15.08 0.35 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -179.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.1 mmmt 72.24 14.14 5.58 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.622 0.249 . . . . 0.0 111.206 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.803 HG22 HD23 ' A' ' 27' ' ' LEU . 6.8 mt -65.5 -14.99 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-O 120.969 0.414 . . . . 0.0 110.739 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.533 ' HA ' HD13 ' A' ' 23' ' ' LEU . . . -72.21 -79.81 0.07 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.047 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 19.8 mm -52.33 -33.13 16.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.985 0.421 . . . . 0.0 110.51 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.789 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -63.09 -72.18 0.14 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.683 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.747 ' HG3' HD11 ' A' ' 27' ' ' LEU . 3.6 tm-20 -35.35 -41.09 0.16 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.838 0.352 . . . . 0.0 111.157 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.41 ' C ' ' H ' ' A' ' 48' ' ' VAL . . . -63.04 -73.8 0.49 Allowed Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.277 -0.964 . . . . 0.0 110.928 178.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.458 ' HG3' ' O ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -47.96 -9.52 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -179.62 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.789 HG23 ' O ' ' A' ' 44' ' ' ALA . 57.4 t -74.66 -90.67 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.644 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.625 ' HD3' ' HB ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -167.02 119.37 0.95 Allowed 'General case' 0 CA--C 1.527 0.08 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.73 179.694 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.544 ' HB ' ' O ' ' A' ' 53' ' ' ALA . 19.2 t -113.62 154.98 14.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.644 ' HB2' ' H ' ' A' ' 67' ' ' THR . 16.8 t0 -44.7 98.2 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.017 0.437 . . . . 0.0 111.611 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.93 21.43 61.18 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.339 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.544 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -145.79 79.87 1.57 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.021 0.439 . . . . 0.0 111.766 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.625 ' HB ' ' HD3' ' A' ' 49' ' ' LYS . 14.9 p -88.21 62.76 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.926 0.393 . . . . 0.0 111.044 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.42 178.4 4.65 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.297 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.8 t -139.31 40.59 2.08 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.801 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -86.91 174.39 8.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.693 0.282 . . . . 0.0 111.01 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.1 mttp -75.18 -50.27 16.8 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.965 0.412 . . . . 0.0 110.806 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.459 ' CB ' ' HG3' ' A' ' 22' ' ' GLU . 0.3 OUTLIER -106.4 136.88 45.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.27 179.402 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -100.04 115.58 30.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.949 0.404 . . . . 0.0 111.031 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.586 ' O ' HD13 ' A' ' 62' ' ' ILE . 4.7 mtmt -87.12 76.01 9.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.881 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.586 HD13 ' O ' ' A' ' 61' ' ' LYS . 3.5 mm -133.44 142.39 41.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.981 -179.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.534 ' O ' ' HB3' ' A' ' 64' ' ' ALA . 1.4 m -146.85 175.2 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.724 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 74.48 -155.01 0.05 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.313 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.528 ' HA2' HG12 ' A' ' 78' ' ' VAL . . . -84.73 81.13 1.77 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 121.329 -0.462 . . . . 0.0 112.515 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.508 ' HG3' HG22 ' A' ' 62' ' ' ILE . 7.9 mm-40 -122.05 156.46 33.49 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.111 0.481 . . . . 0.0 111.264 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.644 ' H ' ' HB2' ' A' ' 51' ' ' ASP . 0.8 OUTLIER -113.55 152.9 29.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.752 -179.109 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.561 HG12 ' CH2' ' A' ' 32' ' ' TRP . 0.8 OUTLIER -127.34 147.07 32.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.645 179.237 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.4 m -143.16 137.8 29.31 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -178.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.783 ' CD1' HG21 ' A' ' 48' ' ' VAL . 1.6 t80 -144.91 121.66 11.2 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.084 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 48.72 -85.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.689 0.28 . . . . 0.0 111.347 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -126.77 -5.72 5.75 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.786 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.438 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 1.1 m-70 -88.39 104.4 16.74 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.888 0.344 . . . . 0.0 111.084 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -116.9 106.72 13.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.838 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.534 HG13 ' HB3' ' A' ' 11' ' ' ALA . 38.6 t -126.17 155.94 36.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.017 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.542 ' CG ' HG23 ' A' ' 67' ' ' THR . 1.3 mt-30 -112.33 158.02 20.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.012 0.434 . . . . 0.0 111.058 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.813 HG22 ' HB3' ' A' ' 13' ' ' PHE . 29.0 t -140.39 148.0 22.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.329 -179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.528 HG12 ' HA2' ' A' ' 65' ' ' GLY . 17.0 m -139.92 178.03 3.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.707 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.073 -179.902 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.301 0 N-CA-C 112.565 -0.214 . . . . 0.0 112.565 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.7 m 65.68 -171.44 0.19 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.656 0.265 . . . . 0.0 110.786 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 8.3 ttt -67.05 152.7 45.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.138 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 23.5 mt 60.36 117.89 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.56 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -172.82 -60.45 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.831 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 16.8 mtt180 58.4 167.66 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.051 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 17.9 mmt 58.28 -172.3 0.1 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.612 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.3 m 67.55 161.59 0.18 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.878 0.37 . . . . 0.0 110.702 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -165.46 -62.38 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.475 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -95.72 -176.09 3.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.768 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.874 ' HB1' HG13 ' A' ' 75' ' ' VAL . . . -92.71 83.34 4.83 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.754 0.312 . . . . 0.0 111.036 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.5 112.23 7.88 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.474 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.848 ' HB3' HG22 ' A' ' 77' ' ' VAL . 73.8 t80 -98.67 144.13 28.28 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.002 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.4 m -107.02 135.72 48.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.478 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.729 HD22 ' HB2' ' A' ' 18' ' ' HIS . 0.5 OUTLIER -84.91 -33.18 22.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.849 0.357 . . . . 0.0 110.529 179.698 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.59 33.07 28.83 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.291 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 25.5 mttm 58.73 56.14 4.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.069 0.461 . . . . 0.0 110.764 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.729 ' HB2' HD22 ' A' ' 15' ' ' LEU . 12.9 m170 -115.36 166.14 12.68 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.867 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.577 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 23.8 Cg_endo -60.97 -36.94 80.48 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.386 2.057 . . . . 0.0 112.151 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.577 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 22.4 p80 168.14 -174.6 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.406 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.551 HG13 HD21 ' A' ' 15' ' ' LEU . 2.5 m -140.96 160.44 23.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.189 0.519 . . . . 0.0 111.975 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.42 ' O ' ' N ' ' A' ' 25' ' ' ASP . 0.5 OUTLIER -94.26 141.76 28.19 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.038 179.351 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.621 ' O ' HD13 ' A' ' 27' ' ' LEU . 8.1 mt -38.08 -39.28 0.39 Allowed 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -73.4 -37.59 65.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.387 -179.396 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 22' ' ' GLU . 56.6 m-20 -61.62 -54.52 41.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.06 0.457 . . . . 0.0 111.074 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.049 HD11 HG21 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -60.06 -43.31 95.52 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.658 -179.546 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.902 HD23 HG22 ' A' ' 41' ' ' ILE . 6.7 mp -68.33 -56.87 7.05 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.701 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -56.95 -55.87 29.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.859 0.362 . . . . 0.0 111.216 -179.597 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 81.9 mt -53.41 -37.73 62.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.685 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.487 ' OE1' HG11 ' A' ' 75' ' ' VAL . 8.7 mm-40 -79.08 -11.33 59.99 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.12 22.9 23.92 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.366 -0.921 . . . . 0.0 113.226 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.528 ' CH2' HG12 ' A' ' 68' ' ' VAL . 11.9 m95 -73.97 -63.21 1.27 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.008 0.432 . . . . 0.0 109.96 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.1 t -106.95 135.19 48.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.915 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -74.43 -34.69 63.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.022 0.439 . . . . 0.0 110.247 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.0 p -106.4 -44.76 4.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.268 178.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 112.74 -21.82 17.94 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.987 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -128.63 -1.24 5.47 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 111.709 0.262 . . . . 0.0 111.709 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.4 tp60 -61.11 -79.42 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.79 0.329 . . . . 0.0 110.611 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.32 11.28 2.47 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.562 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.3 mttm 59.44 29.81 19.42 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 120.798 0.332 . . . . 0.0 110.297 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.902 HG22 HD23 ' A' ' 27' ' ' LEU . 8.0 mt -60.06 -17.67 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.613 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.4 -79.09 0.09 Allowed 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.822 0.344 . . . . 0.0 111.111 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 44.2 mm -47.38 -36.54 4.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.97 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.797 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -61.81 -67.24 0.43 Allowed 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.346 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.781 ' HG2' HD11 ' A' ' 27' ' ' LEU . 12.3 tp10 -33.62 -42.08 0.1 Allowed 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 120.902 0.382 . . . . 0.0 110.466 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.1 -77.4 0.18 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 119.936 -1.126 . . . . 0.0 110.938 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.52 ' HG3' ' O ' ' A' ' 44' ' ' ALA . 0.6 OUTLIER -48.26 -10.88 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -179.645 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.922 HG11 ' HA ' ' A' ' 70' ' ' PHE . 47.5 t -75.33 -96.66 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.033 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -164.86 120.96 1.45 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 118.404 0.547 . . . . 0.0 111.576 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.613 HG13 HG23 ' A' ' 68' ' ' VAL . 16.5 t -114.05 150.39 16.09 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.432 ' HB2' ' HB ' ' A' ' 67' ' ' THR . 20.7 t70 -44.79 97.05 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.972 0.415 . . . . 0.0 111.441 -178.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.98 16.7 70.87 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.759 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.57 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -145.91 81.14 1.59 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.122 0.487 . . . . 0.0 112.09 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.501 HG13 ' O ' ' A' ' 54' ' ' VAL . 7.0 p -90.3 71.95 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.126 0.488 . . . . 0.0 110.309 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 47' ' ' GLN . 8.2 mt-10 -99.34 -173.14 2.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.817 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 t -147.29 46.19 1.14 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.908 0.385 . . . . 0.0 111.62 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 19.0 mtt-85 -98.02 174.54 6.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.535 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.506 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 1.7 mptp? -75.2 -38.12 60.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.012 0.434 . . . . 0.0 110.08 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -127.72 158.29 38.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.064 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . 0.419 ' HB2' ' HG ' ' A' ' 23' ' ' LEU . 0.5 OUTLIER -133.96 115.8 14.81 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.388 -179.605 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.482 ' HG2' ' CD2' ' A' ' 20' ' ' HIS . 31.4 mtmt -74.14 94.53 2.44 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.44 HD13 ' O ' ' A' ' 61' ' ' LYS . 5.8 mm -133.49 144.89 34.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.328 -178.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.566 HG11 ' O ' ' A' ' 19' ' ' PRO . 14.3 m -148.4 174.45 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.807 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.498 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 72.69 -151.27 0.07 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.646 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -88.87 81.26 1.54 Allowed Glycine 0 C--N 1.337 0.585 0 C-N-CA 121.472 -0.394 . . . . 0.0 112.6 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -122.05 156.06 34.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.135 0.493 . . . . 0.0 111.414 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.52 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 40.3 m -118.65 147.69 43.51 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.233 -178.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.613 HG23 HG13 ' A' ' 50' ' ' VAL . 0.7 OUTLIER -124.21 148.23 28.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.031 178.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 49' ' ' LYS . 58.1 m -141.7 138.46 32.44 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.922 ' HA ' HG11 ' A' ' 48' ' ' VAL . 2.8 t80 -152.16 127.08 9.64 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.614 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 47.55 -85.85 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.334 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -128.2 -7.92 4.29 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.039 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.476 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 1.9 m-70 -89.22 108.77 19.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.145 0.472 . . . . 0.0 111.391 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -118.99 107.45 13.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.171 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.874 HG13 ' HB1' ' A' ' 11' ' ' ALA . 22.0 t -130.5 152.95 38.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.039 0.447 . . . . 0.0 111.944 -178.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.52 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 28.6 mt-30 -111.87 164.29 13.26 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.427 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 1.049 HG21 HD11 ' A' ' 26' ' ' LEU . 21.3 t -136.52 148.73 26.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.547 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.2 m -131.63 160.05 42.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.947 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.291 -0.861 . . . . 0.0 111.144 179.978 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.207 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.7 m -113.26 -56.76 2.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.851 0.357 . . . . 0.0 110.942 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -85.81 119.75 26.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.011 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 pt -138.14 72.21 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.971 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 64.5 139.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.69 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.487 ' HD3' ' HA ' ' A' ' 6' ' ' ARG . 6.9 tpp180 -168.66 71.46 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.98 0.419 . . . . 0.0 111.037 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.48 -62.9 1.18 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.449 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 78.2 p -132.13 165.98 22.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.347 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -142.03 106.5 4.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.889 0.376 . . . . 0.0 111.37 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 36.2 mtt -93.59 128.33 39.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.58 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.659 ' O ' HG13 ' A' ' 75' ' ' VAL . . . -84.35 119.66 25.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.758 0.313 . . . . 0.0 111.045 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.1 p -137.0 129.04 29.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.185 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.749 ' HB3' HG22 ' A' ' 77' ' ' VAL . 41.6 t80 -98.36 154.48 17.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.006 0.431 . . . . 0.0 110.749 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.7 m -106.42 155.53 19.46 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.107 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.605 ' CD1' ' HA ' ' A' ' 63' ' ' VAL . 6.7 mt -122.2 -31.51 3.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.545 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.19 -111.7 3.42 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.023 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -149.84 54.72 0.94 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.306 0.574 . . . . 0.0 110.16 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.671 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 16.2 m-70 -118.98 168.6 9.5 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.766 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.671 ' HD2' ' HB3' ' A' ' 18' ' ' HIS . 7.7 Cg_endo -48.36 -44.45 29.46 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.742 2.295 . . . . 0.0 112.62 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.55 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 3.9 p80 162.75 -165.65 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.091 0.556 . . . . 0.0 109.929 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.518 ' O ' ' O ' ' A' ' 60' ' ' CYS . 15.5 m -134.77 147.23 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 120.959 0.409 . . . . 0.0 111.888 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.65 ' HA ' ' H ' ' A' ' 60' ' ' CYS . 1.2 mt-10 -83.93 143.54 29.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.634 179.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.704 ' O ' HD13 ' A' ' 27' ' ' LEU . 2.5 mp -39.82 -36.45 0.44 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.83 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 9.2 t -76.31 -35.51 58.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.329 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' A' ' 22' ' ' GLU . 30.1 m-20 -64.29 -62.03 1.87 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.969 0.414 . . . . 0.0 110.691 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.51 HD11 HG21 ' A' ' 77' ' ' VAL . 9.7 tt -55.05 -44.98 75.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.338 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.797 HD23 HG22 ' A' ' 41' ' ' ILE . 5.8 mp -62.23 -54.35 42.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.698 -178.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.9 -48.89 79.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.635 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 45.7 mt -58.35 -48.13 81.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.267 -0.424 . . . . 0.0 112.012 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.506 ' CG ' ' HB2' ' A' ' 13' ' ' PHE . 7.4 mm-40 -70.75 -12.25 61.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.55 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.96 23.26 30.56 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.846 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.545 ' CZ3' ' HB2' ' A' ' 73' ' ' HIS . 23.1 m95 -64.63 -73.52 0.12 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.8 0.333 . . . . 0.0 110.334 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.585 ' HB2' HG21 ' A' ' 41' ' ' ILE . 24.6 t -92.91 147.27 22.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.787 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -76.75 -33.32 58.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.684 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.462 ' OG ' ' HB3' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -105.42 -28.8 10.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.112 179.71 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 115.79 -72.71 0.26 Allowed Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.445 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -120.41 -2.96 9.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.771 0.32 . . . . 0.0 111.042 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.462 ' HB3' ' OG ' ' A' ' 35' ' ' SER . 3.9 tp60 -52.63 -62.85 1.38 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.914 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.481 ' HB3' HG12 ' A' ' 41' ' ' ILE . . . -73.87 15.05 0.32 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.797 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.8 mttt 68.61 15.95 9.07 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.695 0.283 . . . . 0.0 111.046 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.797 HG22 HD23 ' A' ' 27' ' ' LEU . 45.5 mm -58.54 -20.93 17.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.023 0.439 . . . . 0.0 110.926 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.05 -76.4 0.12 Allowed 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.93 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.6 mm -47.85 -42.52 9.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.772 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.783 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -57.94 -66.6 0.45 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.383 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.718 ' HB2' HD21 ' A' ' 27' ' ' LEU . 9.3 tp10 -30.94 -44.83 0.06 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.56 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.93 -74.56 0.36 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.169 -1.015 . . . . 0.0 110.892 178.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.447 ' HA ' ' O ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -47.57 -11.58 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -179.787 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.983 HG21 ' CD1' ' A' ' 70' ' ' PHE . 39.7 t -75.32 -99.61 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 O-C-N 122.137 -0.352 . . . . 0.0 111.668 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.7 ' HD3' ' HB ' ' A' ' 54' ' ' VAL . 8.2 mmtp -161.0 138.64 9.29 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.702 0.683 . . . . 0.0 111.839 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.663 ' HB ' ' O ' ' A' ' 53' ' ' ALA . 44.1 t -127.58 147.91 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.74 ' HB2' ' HB ' ' A' ' 67' ' ' THR . 12.9 t0 -44.03 87.01 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -177.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 101.87 -19.13 50.83 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.739 -0.743 . . . . 0.0 114.821 177.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.663 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -146.77 136.68 23.31 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 118.41 1.105 . . . . 0.0 113.041 -178.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.7 ' HB ' ' HD3' ' A' ' 49' ' ' LYS . 11.3 p -107.43 108.68 25.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.238 178.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' A' ' 47' ' ' GLN . 47.3 mt-10 -102.98 -170.28 1.77 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.642 0.258 . . . . 0.0 110.845 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.6 t -164.0 30.27 0.08 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.354 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.17 169.99 9.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.947 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.1 ttpp -75.86 -43.83 43.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.594 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.455 ' HA ' ' HG2' ' A' ' 22' ' ' GLU . 0.3 OUTLIER -102.31 142.63 33.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.747 179.854 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . 0.65 ' H ' ' HA ' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -100.08 116.58 32.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.805 -179.789 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.414 ' HA ' ' CD2' ' A' ' 20' ' ' HIS . 11.3 mtmt -103.74 78.75 1.59 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.173 0.511 . . . . 0.0 109.875 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.436 HD12 ' SG ' ' A' ' 60' ' ' CYS . 22.0 mt -138.95 148.92 23.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.172 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.605 ' HA ' ' CD1' ' A' ' 15' ' ' LEU . 1.3 m -151.11 175.09 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.698 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.577 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 78.76 -138.45 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.569 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -104.41 84.25 0.42 Allowed Glycine 0 C--N 1.339 0.695 0 C-N-CA 121.041 -0.599 . . . . 0.0 113.624 -178.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 61.9 mm-40 -122.05 163.19 19.85 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.757 0.313 . . . . 0.0 111.145 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.74 ' HB ' ' HB2' ' A' ' 51' ' ' ASP . 8.9 m -119.11 139.87 51.06 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.247 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.68 137.16 44.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.36 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.6 m -132.0 128.18 37.83 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.919 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.983 ' CD1' HG21 ' A' ' 48' ' ' VAL . 4.1 t80 -175.68 130.38 0.26 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.351 179.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.452 ' N ' ' CD1' ' A' ' 70' ' ' PHE . . . 56.99 44.91 22.08 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.393 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 70.16 1.6 35.23 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.791 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.545 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 8.3 m-70 -94.55 98.16 10.64 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.877 0.338 . . . . 0.0 111.111 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.96 101.77 11.79 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.659 HG13 ' O ' ' A' ' 11' ' ' ALA . 40.8 t -120.37 147.55 24.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.569 -178.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.545 ' HG3' HG23 ' A' ' 67' ' ' THR . 2.0 mp0 -111.94 145.65 39.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.667 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.749 HG22 ' HB3' ' A' ' 13' ' ' PHE . 8.0 t -120.62 145.66 26.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.333 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.8 m -128.59 157.53 41.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.947 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.568 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . . . . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.294 -0.86 . . . . 0.0 111.04 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 112.6 -0.2 . . . . 0.0 112.6 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.76 138.14 34.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.818 0.342 . . . . 0.0 110.954 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.35 140.96 18.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.818 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.8 mm -91.97 139.17 18.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.072 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -138.16 -59.5 0.64 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.111 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -97.79 150.78 20.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.035 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -133.55 165.56 24.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.78 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.74 112.52 6.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.074 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -142.98 -37.84 0.36 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.158 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 8.3 mtt -79.43 137.92 37.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.982 0.42 . . . . 0.0 110.989 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.712 ' HB3' HG22 ' A' ' 75' ' ' VAL . . . -84.09 141.72 30.92 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.09 178.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.62 135.85 40.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.94 0.4 . . . . 0.0 110.773 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.738 ' CE2' ' HA ' ' A' ' 26' ' ' LEU . 31.7 t80 -103.98 143.11 33.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.557 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.447 ' O ' ' CE1' ' A' ' 13' ' ' PHE . 0.4 OUTLIER -106.84 132.63 52.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.389 179.471 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.739 HD11 HG12 ' A' ' 63' ' ' VAL . 0.5 OUTLIER -75.51 -37.23 60.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.82 0.343 . . . . 0.0 110.845 179.868 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.66 29.48 26.62 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.306 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.19 43.18 20.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.053 0.454 . . . . 0.0 110.722 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.452 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.9 OUTLIER -114.67 168.6 7.8 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.845 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.517 ' O ' HG11 ' A' ' 63' ' ' VAL . 8.8 Cg_endo -50.38 -43.68 42.92 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.694 2.263 . . . . 0.0 112.215 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.528 ' CA ' HD21 ' A' ' 15' ' ' LEU . 6.3 p80 172.85 -163.79 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.839 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.403 HG11 ' CE1' ' A' ' 13' ' ' PHE . 9.8 m -142.05 153.58 18.72 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.489 ' HG2' ' CB ' ' A' ' 59' ' ' ARG . 14.6 mt-10 -100.64 153.8 19.11 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.135 178.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.686 ' HB2' ' O ' ' A' ' 58' ' ' LYS . 1.5 mp -40.23 -54.85 2.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.732 0.301 . . . . 0.0 111.42 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.596 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -57.63 -33.75 68.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.748 179.791 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -72.31 -55.07 7.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.884 0.373 . . . . 0.0 110.975 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.738 ' HA ' ' CE2' ' A' ' 13' ' ' PHE . 7.6 tt -57.79 -47.93 81.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.406 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.999 HD23 HG22 ' A' ' 41' ' ' ILE . 7.5 mp -64.45 -59.14 4.69 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.596 ' HB2' ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -51.49 -59.21 4.51 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.263 -178.723 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.47 -50.62 69.4 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -178.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.561 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 2.0 mm-40 -61.85 -15.26 40.74 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.05 23.04 13.79 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.319 -0.943 . . . . 0.0 113.443 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.637 ' CE3' ' HG ' ' A' ' 27' ' ' LEU . 7.7 m0 -73.53 -66.48 0.69 Allowed 'General case' 0 C--O 1.232 0.165 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.7 ' CB ' HD12 ' A' ' 41' ' ' ILE . 6.2 t -106.83 143.25 35.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.185 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -70.24 -34.15 72.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.852 0.358 . . . . 0.0 110.692 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.493 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -105.73 -52.14 2.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.443 179.307 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 139.07 -31.82 2.33 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.432 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.98 8.7 2.1 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.493 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 3.2 tp-100 -55.25 -71.11 0.09 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.703 0.287 . . . . 0.0 111.155 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.56 15.5 0.47 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 71.44 19.44 5.21 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.045 0.45 . . . . 0.0 110.35 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.999 HG22 HD23 ' A' ' 27' ' ' LEU . 9.9 mt -61.13 -22.86 28.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.293 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.64 -77.75 0.08 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.997 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.412 ' CD1' ' HG2' ' A' ' 58' ' ' LYS . 37.1 mm -51.61 -41.78 28.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.928 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.609 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -57.74 -71.19 0.11 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.623 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.743 ' CB ' HD21 ' A' ' 27' ' ' LEU . 1.6 tm-20 -33.46 -40.13 0.06 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.013 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.419 ' C ' ' H ' ' A' ' 48' ' ' VAL . . . -60.09 -75.35 0.28 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.289 -0.957 . . . . 0.0 110.986 178.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.551 HE21 ' HA ' ' A' ' 44' ' ' ALA . 23.7 pt20 -49.15 -8.17 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.847 HG21 ' HD1' ' A' ' 70' ' ' PHE . 97.7 t -75.33 -98.71 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.144 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.554 ' N ' HG12 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -161.87 126.15 3.29 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.973 -179.303 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.795 HG13 HG13 ' A' ' 68' ' ' VAL . 21.4 t -121.73 149.2 24.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.516 ' HB2' ' HB ' ' A' ' 67' ' ' THR . 22.2 t0 -44.96 102.48 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.864 0.364 . . . . 0.0 111.224 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 63.52 20.78 64.0 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.172 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.555 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . . . -146.19 74.6 1.38 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.981 0.42 . . . . 0.0 111.657 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.54 HG13 ' O ' ' A' ' 54' ' ' VAL . 7.5 p -86.25 63.72 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.983 0.42 . . . . 0.0 110.263 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.445 ' O ' ' HA ' ' A' ' 47' ' ' GLN . 21.6 mt-10 -102.29 -170.21 1.78 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.506 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.537 ' OG1' ' HB3' ' A' ' 47' ' ' GLN . 3.1 t -142.89 47.67 1.53 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.553 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 45.3 mtp85 -98.53 174.22 6.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.962 0.41 . . . . 0.0 111.3 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.686 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 24.0 mttm -79.61 -38.67 33.35 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.924 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.489 ' CB ' ' HG2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -128.34 159.36 35.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.856 -179.759 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -140.67 115.79 9.85 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.218 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.74 96.88 2.1 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.484 ' CG2' ' HG3' ' A' ' 66' ' ' GLN . 13.1 mt -133.47 136.01 55.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.809 -178.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.739 HG12 HD11 ' A' ' 15' ' ' LEU . 31.1 m -141.72 175.6 5.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.535 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.429 ' O ' ' HA ' ' A' ' 78' ' ' VAL . . . 71.19 -136.52 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.635 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.573 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -106.37 86.04 0.46 Allowed Glycine 0 C--N 1.339 0.702 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.192 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.484 ' HG3' ' CG2' ' A' ' 62' ' ' ILE . 8.4 mm-40 -122.05 172.25 8.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.716 0.293 . . . . 0.0 111.47 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 4.9 m -130.31 152.13 50.06 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.795 HG13 HG13 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -135.52 152.64 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.385 179.795 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.634 ' HA ' ' O ' ' A' ' 73' ' ' HIS . 0.4 OUTLIER -146.25 137.63 24.63 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -179.643 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.936 ' CE2' HG23 ' A' ' 41' ' ' ILE . 1.8 t80 -137.12 118.7 14.89 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.619 178.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 38.2 30.01 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 116.39 -6.63 18.76 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.365 -0.921 . . . . 0.0 113.563 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.634 ' O ' ' HA ' ' A' ' 69' ' ' SER . 1.4 m-70 -88.13 82.98 7.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.317 0.558 . . . . 0.0 111.145 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.6 119.81 29.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.749 0.309 . . . . 0.0 110.71 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.712 HG22 ' HB3' ' A' ' 11' ' ' ALA . 43.1 t -142.57 152.75 17.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.09 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.55 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 7.7 mt-30 -112.61 164.23 13.58 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.7 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.628 HG13 ' HD1' ' A' ' 13' ' ' PHE . 6.7 t -131.9 142.8 42.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.225 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 64' ' ' ALA . 28.1 m -138.44 169.15 18.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.184 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.118 -0.944 . . . . 0.0 111.212 179.956 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 112.621 -0.191 . . . . 0.0 112.621 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.54 161.86 14.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.801 0.334 . . . . 0.0 110.835 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -67.27 -179.52 1.02 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.958 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.1 tt -147.17 -32.16 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.478 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -130.2 153.93 48.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.733 0.302 . . . . 0.0 110.797 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -114.08 131.49 56.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.841 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 64.49 74.09 0.41 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.943 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.9 m -106.71 -53.64 2.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.703 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -127.87 -32.33 2.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.038 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 10.8 mtp -80.74 122.21 26.87 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.993 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.939 ' HB3' HG13 ' A' ' 75' ' ' VAL . . . -87.01 134.72 33.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.705 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.44 131.93 43.93 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.376 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.863 ' HB3' HG22 ' A' ' 77' ' ' VAL . 40.8 t80 -110.39 165.3 11.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.557 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.27 140.71 35.19 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.943 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.678 HD21 HG22 ' A' ' 21' ' ' VAL . 0.4 OUTLIER -142.3 -36.03 0.42 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.944 -179.37 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.506 ' H ' ' HA ' ' A' ' 79' ' ' ALA . . . -48.58 -30.06 8.17 Favored Glycine 0 C--N 1.329 0.153 0 C-N-CA 120.98 -0.629 . . . . 0.0 113.164 -179.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.73 -34.33 65.06 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.837 0.351 . . . . 0.0 110.839 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.614 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 3.9 m-70 -117.45 163.88 21.78 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.893 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.614 ' HD2' ' HB3' ' A' ' 18' ' ' HIS . 15.8 Cg_endo -56.13 -35.14 94.69 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.569 2.179 . . . . 0.0 111.985 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.484 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 2.5 p80 174.98 -176.37 0.09 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.431 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.678 HG22 HD21 ' A' ' 15' ' ' LEU . 13.6 m -145.32 164.21 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.414 ' CB ' ' HB3' ' A' ' 59' ' ' ARG . 1.5 pt-20 -99.83 153.17 19.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.2 178.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.781 HD22 ' HG3' ' A' ' 45' ' ' GLU . 8.1 mt -41.13 -41.84 1.87 Allowed 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 40.9 t -70.8 -38.72 73.36 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.638 0.256 . . . . 0.0 111.547 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -63.35 -60.96 2.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.947 0.403 . . . . 0.0 110.841 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.035 HD11 HG21 ' A' ' 77' ' ' VAL . 0.7 OUTLIER -50.86 -42.18 58.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.04 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.838 HD23 HG22 ' A' ' 41' ' ' ILE . 4.4 mp -68.01 -64.74 0.8 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.78 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.9 tmmm? -43.34 -61.45 1.35 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.66 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 13' ' ' PHE . 0.5 OUTLIER -54.49 -40.56 68.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.77 -179.426 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.485 ' OE1' HG11 ' A' ' 75' ' ' VAL . 8.7 mm-40 -69.43 -14.54 62.95 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.46 20.78 21.47 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.28 -0.962 . . . . 0.0 112.92 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.887 ' CH2' HG12 ' A' ' 68' ' ' VAL . 8.3 m0 -75.63 -66.52 0.77 Allowed 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.811 ' OG ' HD13 ' A' ' 41' ' ' ILE . 30.1 t -106.86 137.03 45.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.595 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -70.75 -33.82 71.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.039 0.447 . . . . 0.0 110.295 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.513 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 0.1 OUTLIER -105.74 -55.4 2.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.314 179.223 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 126.68 -33.53 3.39 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.303 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -123.04 -5.49 8.45 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.513 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 0.8 OUTLIER -52.52 -76.34 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.839 0.352 . . . . 0.0 111.029 -179.728 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.695 ' HB3' HD11 ' A' ' 41' ' ' ILE . . . -77.15 15.77 0.67 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.249 -0.432 . . . . 0.0 112.14 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 4.5 mmtt 68.53 24.26 7.07 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.068 0.461 . . . . 0.0 110.098 -179.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.838 HG22 HD23 ' A' ' 27' ' ' LEU . 3.9 mp -57.86 -24.86 24.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.449 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.92 -77.35 0.13 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.259 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.3 mm -48.96 -42.24 14.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-O 121.017 0.437 . . . . 0.0 110.644 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.699 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -57.64 -69.05 0.18 Allowed 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.446 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.781 ' HG3' HD22 ' A' ' 23' ' ' LEU . 9.0 tp10 -29.81 -44.13 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.011 0.434 . . . . 0.0 110.672 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 55' ' ' GLU . . . -59.61 -74.89 0.31 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.115 -1.041 . . . . 0.0 110.621 178.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.535 ' N ' ' HA ' ' A' ' 56' ' ' THR . 2.3 pt20 -48.64 -12.94 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.855 HG11 ' HA ' ' A' ' 70' ' ' PHE . 47.5 t -75.06 -98.17 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.933 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.406 ' CD ' ' HB ' ' A' ' 54' ' ' VAL . 0.8 OUTLIER -165.98 122.71 1.37 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 118.37 0.532 . . . . 0.0 111.921 -179.825 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.462 ' HB ' ' HB3' ' A' ' 53' ' ' ALA . 31.7 t -117.33 152.29 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.542 ' HB2' ' O ' ' A' ' 67' ' ' THR . 3.7 t0 -44.72 101.29 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.909 0.385 . . . . 0.0 111.492 -179.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 62.63 21.89 63.3 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.415 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.462 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . . . -145.83 75.57 1.43 Allowed 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 121.037 0.446 . . . . 0.0 111.67 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.608 HG13 ' O ' ' A' ' 54' ' ' VAL . 10.1 p -87.13 67.37 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.961 0.41 . . . . 0.0 110.485 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.447 ' O ' ' O ' ' A' ' 46' ' ' GLY . 0.2 OUTLIER -102.56 -166.25 1.26 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.062 -179.356 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.535 ' HA ' ' N ' ' A' ' 47' ' ' GLN . 3.4 t -145.8 37.99 1.09 Allowed 'General case' 0 C--O 1.232 0.154 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.09 174.79 7.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.825 0.345 . . . . 0.0 111.041 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.4 tttt -78.68 -41.6 30.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.738 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.414 ' HB3' ' CB ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -124.49 154.59 40.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.62 179.796 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -136.74 115.38 12.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.394 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.6 mttt -69.48 99.09 1.19 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 17.1 mt -133.46 144.04 37.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.633 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.51 ' O ' ' HB3' ' A' ' 64' ' ' ALA . 7.8 m -149.5 175.3 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.862 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.51 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 72.31 -149.73 0.07 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 178.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.567 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -92.33 81.3 1.16 Allowed Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 116.298 -0.41 . . . . 0.0 112.953 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.92 157.47 31.13 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.208 0.528 . . . . 0.0 111.378 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.542 ' O ' ' HB2' ' A' ' 51' ' ' ASP . 2.9 m -113.72 150.86 32.71 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.836 -178.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.887 HG12 ' CH2' ' A' ' 32' ' ' TRP . 1.2 t -128.27 145.15 35.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.023 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.55 ' HA ' ' O ' ' A' ' 73' ' ' HIS . 1.1 m -136.07 132.21 35.86 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.855 ' HA ' HG11 ' A' ' 48' ' ' VAL . 2.6 t80 -147.14 123.34 10.86 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.232 178.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.409 ' N ' ' CD1' ' A' ' 70' ' ' PHE . . . 41.57 30.66 0.15 Allowed 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.2 -4.06 38.06 Favored Glycine 0 C--N 1.329 0.171 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.422 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.661 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 2.7 m-70 -90.47 98.53 11.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.853 0.327 . . . . 0.0 110.829 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -108.99 114.16 27.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.853 0.359 . . . . 0.0 111.424 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.939 HG13 ' HB3' ' A' ' 11' ' ' ALA . 17.6 t -138.21 156.32 30.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.761 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.539 ' HG3' HG23 ' A' ' 67' ' ' THR . 9.5 mt-30 -112.6 165.61 12.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.136 0.493 . . . . 0.0 111.709 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 1.035 HG21 HD11 ' A' ' 26' ' ' LEU . 21.3 t -141.4 150.4 19.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.587 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 18.2 m -130.52 166.13 28.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.886 0.374 . . . . 0.0 111.759 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.506 ' HA ' ' H ' ' A' ' 16' ' ' GLY . . . . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.238 -0.887 . . . . 0.0 111.096 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 112.778 -0.129 . . . . 0.0 112.778 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.6 t 58.16 175.77 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.883 0.373 . . . . 0.0 110.829 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.2 ttt -138.25 -38.98 0.54 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.215 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 pt -84.03 86.5 2.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.231 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -155.2 133.31 11.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.768 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.4 mmt85 64.31 32.57 12.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.759 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.44 140.68 24.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.4 t -133.97 -47.63 0.79 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.984 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -179.24 154.02 0.63 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.807 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 5.8 ttp -77.62 127.81 33.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.997 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.699 ' HB1' HG13 ' A' ' 75' ' ' VAL . . . -79.18 97.67 6.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.826 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.55 119.03 22.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.865 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.817 ' HB3' HG22 ' A' ' 77' ' ' VAL . 29.5 t80 -98.66 149.9 22.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.542 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.3 m -105.33 147.69 27.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.979 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.506 HD21 ' CG1' ' A' ' 21' ' ' VAL . 9.6 mt -127.44 -36.28 2.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.955 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.09 -111.67 3.49 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.688 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.9 tttt -136.72 52.89 1.93 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.875 0.369 . . . . 0.0 110.903 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -103.89 155.62 36.79 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.972 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.624 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 8.1 Cg_endo -50.56 -44.56 39.42 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.789 2.326 . . . . 0.0 112.235 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.645 ' HA ' HG13 ' A' ' 63' ' ' VAL . 12.6 p80 164.64 -166.98 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.491 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.856 HG21 HD13 ' A' ' 26' ' ' LEU . 14.9 m -143.58 155.92 16.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.508 ' HG2' ' HA ' ' A' ' 59' ' ' ARG . 1.4 mt-10 -87.01 141.07 28.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.03 178.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.51 HD13 ' O ' ' A' ' 42' ' ' ALA . 4.1 pp -40.94 -38.35 0.95 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.716 0.293 . . . . 0.0 111.381 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.498 ' N ' HD12 ' A' ' 23' ' ' LEU . 3.7 t -69.37 -39.51 78.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.89 0.376 . . . . 0.0 110.742 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 22' ' ' GLU . 87.8 m-20 -61.03 -59.21 5.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.629 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.856 HD13 HG21 ' A' ' 21' ' ' VAL . 8.2 tp -50.3 -46.99 55.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.616 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.965 HD23 HG22 ' A' ' 41' ' ' ILE . 6.8 mp -66.45 -60.91 2.31 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.865 -179.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -50.92 -55.47 17.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.317 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.78 -42.39 71.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.716 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 1.5 mm-40 -74.36 -13.83 60.79 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.0 24.75 14.23 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.251 -0.976 . . . . 0.0 113.281 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.731 ' CH2' HG12 ' A' ' 68' ' ' VAL . 9.7 m95 -74.68 -63.42 1.25 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 117.003 0.401 . . . . 0.0 110.07 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 39.4 t -106.85 142.92 35.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.344 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -77.94 -34.48 51.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.837 0.351 . . . . 0.0 110.739 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.437 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 31.0 p -106.07 -41.72 5.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.309 178.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 115.82 -33.94 4.98 Favored Glycine 0 CA--C 1.52 0.36 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.771 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -129.56 8.55 5.41 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.437 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 10.4 tp60 -60.48 -74.57 0.07 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.909 0.385 . . . . 0.0 110.541 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.724 ' HB3' ' CD1' ' A' ' 41' ' ' ILE . . . -79.7 15.16 1.43 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.725 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 64.61 27.54 13.27 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.994 0.426 . . . . 0.0 110.201 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.965 HG22 HD23 ' A' ' 27' ' ' LEU . 2.6 mp -62.67 -16.87 17.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.085 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.51 ' O ' HD13 ' A' ' 23' ' ' LEU . . . -70.68 -80.68 0.05 Allowed 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.456 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 36.4 mm -52.05 -34.31 17.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.859 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.722 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -61.33 -72.31 0.12 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.62 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.81 ' CB ' HD21 ' A' ' 27' ' ' LEU . 4.9 tm-20 -35.08 -41.17 0.14 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.263 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.402 ' C ' ' H ' ' A' ' 48' ' ' VAL . . . -60.91 -74.16 0.41 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.177 -1.011 . . . . 0.0 110.972 178.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -48.49 -9.35 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.842 HG11 ' HA ' ' A' ' 70' ' ' PHE . 58.2 t -74.66 -89.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.352 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.418 ' HG2' ' O ' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -170.31 120.97 0.62 Allowed 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 120.011 -0.676 . . . . 0.0 112.534 179.763 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.599 ' HB ' ' O ' ' A' ' 53' ' ' ALA . 40.9 t -114.29 147.47 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.484 ' HB2' ' H ' ' A' ' 67' ' ' THR . 3.3 t70 -44.99 98.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.053 0.454 . . . . 0.0 111.498 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.44 15.71 73.09 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.727 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.599 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -145.86 78.03 1.52 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.976 0.417 . . . . 0.0 112.004 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.561 HG13 ' O ' ' A' ' 54' ' ' VAL . 9.9 p -88.57 62.39 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.977 0.418 . . . . 0.0 110.465 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -99.8 -170.77 1.94 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.063 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.7 t -150.85 36.81 0.63 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.427 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 57' ' ' ARG . 12.7 mtt180 -81.08 168.79 18.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.519 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.1 -44.93 44.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.046 0.451 . . . . 0.0 109.924 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.508 ' HA ' ' HG2' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -103.66 150.43 24.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.77 179.615 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . 0.482 ' O ' ' O ' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -116.95 118.13 31.59 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.01 0.433 . . . . 0.0 111.434 -179.43 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.4 ' HG2' ' NE2' ' A' ' 20' ' ' HIS . 14.3 mttm -96.11 71.51 2.87 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.037 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.431 HD12 ' SG ' ' A' ' 60' ' ' CYS . 33.2 mt -136.05 147.4 28.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.702 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.645 HG13 ' HA ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -152.51 175.14 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.776 179.52 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 77.96 -149.2 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.916 179.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.514 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -84.93 78.27 2.02 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 121.285 -0.484 . . . . 0.0 112.578 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.405 ' HG3' ' CG2' ' A' ' 62' ' ' ILE . 20.6 mm-40 -121.66 155.62 34.77 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.066 0.46 . . . . 0.0 111.108 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 59.3 m -116.79 152.91 33.41 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.585 -178.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.731 HG12 ' CH2' ' A' ' 32' ' ' TRP . 1.1 t -127.9 145.58 34.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.668 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.406 ' HB2' ' O ' ' A' ' 49' ' ' LYS . 22.2 m -143.05 135.87 27.8 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.842 ' HA ' HG11 ' A' ' 48' ' ' VAL . 2.2 t80 -148.48 124.06 10.41 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.195 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 51.99 -85.12 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.353 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -129.97 -3.22 4.98 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.912 -0.661 . . . . 0.0 113.012 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.478 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 2.1 m-70 -92.63 108.38 19.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.929 0.365 . . . . 0.0 111.44 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.91 102.66 8.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.338 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.699 HG13 ' HB1' ' A' ' 11' ' ' ALA . 99.4 t -125.19 151.94 31.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.347 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.531 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 13.0 mt-30 -112.97 160.62 17.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.995 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.817 HG22 ' HB3' ' A' ' 13' ' ' PHE . 21.8 t -131.25 148.66 32.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.503 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.8 m -140.02 171.65 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.792 0.33 . . . . 0.0 111.497 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.506 -0.759 . . . . 0.0 111.059 179.933 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.112 0 CA-C-O 120.55 -0.028 . . . . 0.0 113.034 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 61.02 17.11 7.65 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 14.8 mmt -154.9 29.7 0.41 Allowed 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.654 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 pp -145.25 111.07 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.833 0.349 . . . . 0.0 111.104 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -95.14 126.72 40.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.825 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.5 mtm180 -62.38 108.44 1.11 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.722 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.05 165.11 27.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.918 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.8 t -146.39 143.04 28.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.217 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -130.76 -25.2 2.35 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.349 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 64.3 mtt -67.4 135.76 53.69 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.785 0.326 . . . . 0.0 110.895 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.647 ' HB3' HG22 ' A' ' 75' ' ' VAL . . . -100.49 136.18 40.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.86 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.53 134.14 39.14 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.405 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.524 ' CZ ' ' HB3' ' A' ' 29' ' ' LEU . 19.2 t80 -105.61 90.11 3.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.864 0.364 . . . . 0.0 110.827 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.685 ' HA ' HG23 ' A' ' 78' ' ' VAL . 38.6 t -73.38 95.14 2.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.904 0.383 . . . . 0.0 110.897 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.932 HD11 HG13 ' A' ' 21' ' ' VAL . 1.0 OUTLIER -55.63 -35.28 65.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.933 179.789 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.67 48.24 3.01 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.403 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.6 tttt 58.56 54.89 5.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.939 0.4 . . . . 0.0 110.934 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.409 ' HB2' HD22 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -105.66 166.79 10.71 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.157 -179.74 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.786 ' O ' HG11 ' A' ' 63' ' ' VAL . 28.2 Cg_endo -62.51 -48.8 6.78 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.617 2.211 . . . . 0.0 112.091 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.657 ' HA ' HG12 ' A' ' 63' ' ' VAL . 3.1 p80 173.86 -173.67 0.06 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.327 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.932 HG13 HD11 ' A' ' 15' ' ' LEU . 4.1 m -142.12 158.3 20.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.441 0.639 . . . . 0.0 112.723 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.549 ' HG2' ' HG2' ' A' ' 59' ' ' ARG . 1.1 mp0 -100.81 149.96 23.3 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.002 178.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.488 ' H ' ' HA ' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -39.64 -53.65 2.13 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.232 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 37.5 t -60.93 -32.2 71.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.89 0.376 . . . . 0.0 110.77 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.585 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 0.9 OUTLIER -68.94 -58.83 3.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.98 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.888 HD11 HG21 ' A' ' 77' ' ' VAL . 3.2 tp -52.52 -48.09 66.24 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.882 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.878 HD21 ' HG3' ' A' ' 45' ' ' GLU . 4.1 mt -64.77 -58.75 5.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.699 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.72 -57.36 12.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.803 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.585 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.3 OUTLIER -50.81 -39.34 52.83 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.026 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.475 ' OE1' HG11 ' A' ' 75' ' ' VAL . 2.5 mm-40 -79.2 -8.09 58.74 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.75 25.28 32.87 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.313 -0.946 . . . . 0.0 113.168 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.769 ' CZ3' ' HB2' ' A' ' 73' ' ' HIS . 19.6 m95 -71.17 -65.52 0.73 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.869 0.366 . . . . 0.0 110.485 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.663 ' HB2' HG21 ' A' ' 41' ' ' ILE . 8.3 t -100.53 147.61 25.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.51 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -71.01 -34.81 71.68 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.668 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.3 p -106.68 -59.29 1.82 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.012 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.417 ' O ' ' HB2' ' A' ' 42' ' ' ALA . . . 131.69 -19.28 4.76 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.406 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.46 -2.58 0.86 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.4 ' C ' ' H ' ' A' ' 40' ' ' LYS . 23.4 tp60 -60.13 -74.71 0.07 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.866 0.365 . . . . 0.0 110.41 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.41 14.11 0.37 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.497 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.4 ' H ' ' C ' ' A' ' 38' ' ' GLN . 3.7 mttt 66.92 20.18 10.54 Favored 'General case' 0 C--O 1.23 0.057 0 CA-C-O 120.776 0.322 . . . . 0.0 110.702 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.71 HG23 ' HE2' ' A' ' 70' ' ' PHE . 48.0 mm -51.0 -29.62 8.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.753 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 36' ' ' GLY . . . -65.38 -78.68 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.77 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.474 HD12 ' HG3' ' A' ' 58' ' ' LYS . 25.1 mm -49.81 -38.4 13.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.072 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.74 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -61.21 -71.68 0.14 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.122 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.878 ' HG3' HD21 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -33.41 -40.48 0.07 Allowed 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 120.859 0.361 . . . . 0.0 110.594 -179.41 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 55' ' ' GLU . . . -58.24 -76.12 0.23 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 119.718 -1.229 . . . . 0.0 110.531 177.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.48 ' HG2' ' O ' ' A' ' 44' ' ' ALA . 5.5 pt20 -50.24 -9.46 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.989 HG21 ' CD1' ' A' ' 70' ' ' PHE . 38.9 t -75.45 -101.24 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.007 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.519 ' HD3' ' HB ' ' A' ' 54' ' ' VAL . 1.5 mmtm -163.15 120.02 1.86 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 119.117 0.871 . . . . 0.0 112.657 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.764 HG13 HG23 ' A' ' 68' ' ' VAL . 13.7 t -112.85 142.82 24.0 Favored 'Isoleucine or valine' 0 C--N 1.338 0.081 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.494 ' HB2' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -48.6 95.74 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.916 0.388 . . . . 0.0 111.023 -179.461 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.7 15.68 80.38 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.498 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.759 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . . . -146.1 75.78 1.43 Allowed 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.078 0.465 . . . . 0.0 111.627 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.613 HG13 ' O ' ' A' ' 54' ' ' VAL . 10.9 p -90.58 65.91 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.907 0.384 . . . . 0.0 110.74 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.442 ' O ' ' O ' ' A' ' 46' ' ' GLY . 44.1 mm-40 -102.08 -174.66 2.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.087 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.407 ' HA ' ' N ' ' A' ' 47' ' ' GLN . 1.7 t -143.95 41.4 1.41 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.945 0.402 . . . . 0.0 111.373 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.53 175.22 6.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.983 0.421 . . . . 0.0 110.808 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.483 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -81.04 -25.68 36.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.776 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.549 ' HG2' ' HG2' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -140.77 148.97 41.49 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.893 179.806 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -137.24 116.52 12.65 Favored 'General case' 0 CA--C 1.523 -0.078 0 CA-C-O 120.803 0.335 . . . . 0.0 110.892 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.5 mttm -74.66 102.89 4.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.526 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.4 mt -132.93 133.59 58.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.023 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.786 HG11 ' O ' ' A' ' 19' ' ' PRO . 35.4 m -140.46 174.96 7.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.696 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.486 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 72.27 -133.77 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.68 179.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.497 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -109.25 84.82 0.38 Allowed Glycine 0 C--N 1.338 0.691 0 C-N-CA 121.031 -0.604 . . . . 0.0 113.609 -178.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -122.92 167.23 13.83 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.599 0.238 . . . . 0.0 111.242 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.698 HG23 ' HG2' ' A' ' 76' ' ' GLN . 5.2 m -126.01 153.52 44.26 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.084 0.469 . . . . 0.0 111.866 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.764 HG23 HG13 ' A' ' 50' ' ' VAL . 1.2 t -132.23 147.11 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.978 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.8 m -134.64 136.59 42.97 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.84 0.352 . . . . 0.0 111.703 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.989 ' CD1' HG21 ' A' ' 48' ' ' VAL . 6.2 t80 -176.13 137.21 0.31 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.632 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.48 ' N ' ' CD1' ' A' ' 70' ' ' PHE . . . 50.24 37.01 13.85 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.732 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.44 -4.74 66.74 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.434 -0.889 . . . . 0.0 112.823 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.769 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 5.0 m-70 -89.92 107.64 19.23 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.75 0.309 . . . . 0.0 111.189 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.17 103.81 12.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.214 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.647 HG22 ' HB3' ' A' ' 11' ' ' ALA . 64.9 t -132.5 154.36 39.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.63 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.698 ' HG2' HG23 ' A' ' 67' ' ' THR . 20.3 mt-30 -112.96 168.81 9.39 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.013 0.435 . . . . 0.0 111.161 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.888 HG21 HD11 ' A' ' 26' ' ' LEU . 20.4 t -124.34 137.81 55.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.674 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.685 HG23 ' HA ' ' A' ' 14' ' ' SER . 10.4 m -126.84 147.87 31.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.876 0.37 . . . . 0.0 111.208 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.433 -179.586 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.144 0 N-CA-C 112.605 -0.198 . . . . 0.0 112.605 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.1 p -79.14 -164.89 0.67 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.818 0.342 . . . . 0.0 110.956 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.5 mtt -153.64 175.91 12.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.718 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.9 mt -133.72 -63.23 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.269 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.98 167.08 15.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.006 0.431 . . . . 0.0 111.343 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.64 -169.3 2.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.115 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -91.72 -42.75 9.96 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.532 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -169.74 119.61 0.64 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.766 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 60.6 t-20 -122.71 -71.32 0.73 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.998 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -66.18 116.18 6.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.992 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.667 ' CB ' HG13 ' A' ' 75' ' ' VAL . . . -70.47 116.29 10.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.576 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.14 128.33 53.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.904 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.542 ' O ' HG13 ' A' ' 77' ' ' VAL . 34.2 t80 -108.05 95.94 6.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.762 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.03 104.7 1.82 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.847 0.356 . . . . 0.0 110.972 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.519 HD21 HG11 ' A' ' 21' ' ' VAL . 6.2 mt -72.9 -38.19 67.0 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.947 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.24 -82.46 0.31 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.519 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.4 53.47 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.951 0.405 . . . . 0.0 110.948 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.5 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 33.3 m170 -103.57 160.49 25.95 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.84 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.613 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 18.2 Cg_endo -58.83 -35.35 98.75 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.382 2.055 . . . . 0.0 111.875 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.613 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 4.5 p80 167.15 -173.57 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.117 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.652 HG21 HD13 ' A' ' 26' ' ' LEU . 2.8 m -146.03 164.17 10.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.255 0.55 . . . . 0.0 112.04 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.457 ' HB2' ' CG ' ' A' ' 59' ' ' ARG . 12.0 pt-20 -102.15 150.08 23.63 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.815 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.786 HD22 ' HG3' ' A' ' 45' ' ' GLU . 96.0 mt -40.82 -45.64 2.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.818 0.342 . . . . 0.0 111.543 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.43 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 4.9 t -59.7 -36.26 76.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.553 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.535 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 14.8 m-20 -71.13 -63.12 1.17 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.778 0.323 . . . . 0.0 111.515 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.86 HD11 HG21 ' A' ' 77' ' ' VAL . 3.6 tp -46.65 -45.66 19.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.009 0.433 . . . . 0.0 111.374 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.013 HD23 HG22 ' A' ' 41' ' ' ILE . 9.7 mp -67.69 -66.63 0.54 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.28 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 24' ' ' CYS . 9.9 ttmt -50.1 -51.3 44.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.764 0.316 . . . . 0.0 111.222 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.535 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.1 OUTLIER -56.99 -34.9 68.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.203 -179.728 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 5.0 mm-40 -84.22 -8.77 58.95 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.91 22.95 24.3 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.272 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.72 ' CE3' ' HG ' ' A' ' 27' ' ' LEU . 8.6 m0 -74.99 -62.84 1.41 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.006 0.431 . . . . 0.0 109.909 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.472 ' CB ' HD12 ' A' ' 41' ' ' ILE . 0.3 OUTLIER -107.28 143.58 35.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.759 179.621 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.2 tp10 -78.28 -34.37 48.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.818 0.342 . . . . 0.0 111.261 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.423 ' OG ' ' CB ' ' A' ' 38' ' ' GLN . 42.2 p -105.72 -39.5 6.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.075 0.464 . . . . 0.0 110.525 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 108.15 -25.05 21.45 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.167 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.3 -15.43 2.51 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.423 ' CB ' ' OG ' ' A' ' 35' ' ' SER . 17.9 tp60 -52.52 -73.71 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.804 0.335 . . . . 0.0 111.362 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.481 ' HB3' HG13 ' A' ' 41' ' ' ILE . . . -72.12 14.96 0.18 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.39 23.38 12.93 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.803 0.335 . . . . 0.0 110.709 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 1.013 HG22 HD23 ' A' ' 27' ' ' LEU . 1.9 mt -60.19 -19.6 18.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.884 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.29 -76.56 0.14 Allowed 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.82 0.343 . . . . 0.0 110.781 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 45.6 mm -47.33 -45.32 9.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-O 121.083 0.468 . . . . 0.0 110.618 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.6 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -55.39 -67.71 0.26 Allowed 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.877 178.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.786 ' HG3' HD22 ' A' ' 23' ' ' LEU . 11.5 tp10 -28.31 -47.75 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.089 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 55' ' ' GLU . . . -58.34 -74.14 0.38 Allowed Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.172 -1.014 . . . . 0.0 110.824 178.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.555 ' N ' ' HA ' ' A' ' 56' ' ' THR . 1.2 pt20 -44.57 -16.21 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.902 HG21 ' HD1' ' A' ' 70' ' ' PHE . 46.6 t -76.01 -95.43 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.606 ' HD3' ' HB ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -162.82 120.08 1.97 Allowed 'General case' 0 C--N 1.339 0.149 0 O-C-N 122.1 -0.375 . . . . 0.0 111.866 -179.294 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.578 HG13 ' CG2' ' A' ' 68' ' ' VAL . 42.6 t -118.96 157.0 20.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.193 178.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.579 ' HB3' ' H ' ' A' ' 67' ' ' THR . 4.7 p-10 -43.62 99.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.015 0.436 . . . . 0.0 111.603 -178.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 59.76 24.35 59.94 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.175 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -145.79 76.48 1.47 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.606 ' HB ' ' HD3' ' A' ' 49' ' ' LYS . 7.6 p -84.88 58.08 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.151 0.501 . . . . 0.0 110.327 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.436 ' O ' ' O ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -100.42 -162.72 0.96 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.809 -179.547 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.555 ' HA ' ' N ' ' A' ' 47' ' ' GLN . 2.1 t -144.43 53.11 1.26 Allowed 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.544 ' HG3' ' O ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -99.25 172.66 7.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.903 0.382 . . . . 0.0 111.306 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -77.35 -48.47 17.26 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.795 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.544 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 0.3 OUTLIER -120.52 142.79 48.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.314 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . 0.773 ' SG ' HD11 ' A' ' 62' ' ' ILE . 3.3 t -124.26 118.53 27.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.975 0.417 . . . . 0.0 110.972 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.53 99.87 2.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.331 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.773 HD11 ' SG ' ' A' ' 60' ' ' CYS . 2.7 mp -138.34 142.45 35.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.769 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.546 HG11 ' O ' ' A' ' 19' ' ' PRO . 12.8 m -145.66 175.63 2.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.433 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.492 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 72.58 -138.17 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 178.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.754 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -106.32 84.75 0.41 Allowed Glycine 0 C--N 1.34 0.798 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.14 -178.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.51 ' HG3' HG23 ' A' ' 62' ' ' ILE . 56.5 mm-40 -123.02 167.48 13.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.975 0.417 . . . . 0.0 112.082 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.619 HG23 ' HG2' ' A' ' 76' ' ' GLN . 3.5 m -118.18 140.84 49.2 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.076 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.641 HG12 ' CH2' ' A' ' 32' ' ' TRP . 1.2 t -123.49 146.53 28.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.794 178.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.603 ' HA ' ' O ' ' A' ' 73' ' ' HIS . 32.0 p -140.01 136.1 33.36 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -179.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.902 ' HD1' HG21 ' A' ' 48' ' ' VAL . 1.9 t80 -140.17 121.21 14.67 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.332 178.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 40.82 28.23 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 113.16 -5.81 25.27 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.323 -0.941 . . . . 0.0 113.674 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.628 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 1.1 m-70 -88.01 91.33 8.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 117.166 0.483 . . . . 0.0 110.934 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -98.02 118.01 33.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.848 0.356 . . . . 0.0 111.443 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.667 HG13 ' CB ' ' A' ' 11' ' ' ALA . 96.8 t -143.5 152.74 16.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.391 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.619 ' HG2' HG23 ' A' ' 67' ' ' THR . 24.8 mt-30 -112.89 156.1 23.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.231 0.539 . . . . 0.0 111.609 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.86 HG21 HD11 ' A' ' 26' ' ' LEU . 38.3 t -121.5 145.05 28.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.129 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.8 m -134.18 165.94 30.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.872 0.367 . . . . 0.0 111.699 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.194 -179.873 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.195 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.9 m 58.6 86.47 0.08 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.764 0.316 . . . . 0.0 111.08 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 58.7 170.78 0.06 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.014 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -111.92 110.85 33.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.115 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -162.6 137.95 7.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.721 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.6 127.77 0.78 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.023 0.44 . . . . 0.0 111.033 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 17.3 ptt? -132.51 124.84 29.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.516 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.1 p -143.56 140.76 30.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.759 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -112.67 129.84 56.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.808 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 5.0 mtt -82.24 168.05 18.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.824 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.558 ' HB1' HG13 ' A' ' 75' ' ' VAL . . . -92.47 115.52 28.17 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.135 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.87 129.04 37.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.548 ' HD2' ' HG2' ' A' ' 30' ' ' GLU . 56.5 t80 -102.48 149.23 24.59 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.855 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.93 123.33 48.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.394 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.803 ' CD1' HG12 ' A' ' 63' ' ' VAL . 1.0 OUTLIER -69.74 -37.59 76.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.714 0.292 . . . . 0.0 110.958 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.29 26.79 13.11 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.832 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.3 mtmt 59.58 51.52 6.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.909 0.385 . . . . 0.0 110.833 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.428 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 2.9 m-70 -119.43 168.25 10.43 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.61 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.551 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 10.3 Cg_endo -52.64 -37.96 75.56 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.396 2.064 . . . . 0.0 111.741 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.585 ' HA ' HD11 ' A' ' 15' ' ' LEU . 5.6 p80 167.94 -168.5 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.009 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.557 HG21 HD13 ' A' ' 26' ' ' LEU . 28.8 m -143.58 157.04 16.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.898 0.38 . . . . 0.0 111.77 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.595 ' HA ' ' H ' ' A' ' 60' ' ' CYS . 1.5 pt-20 -103.48 152.21 21.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.583 178.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.621 HD13 ' C ' ' A' ' 42' ' ' ALA . 0.2 OUTLIER -37.93 -46.54 0.98 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.919 -179.372 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.0 t -62.2 -38.4 89.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.606 0.241 . . . . 0.0 111.608 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -67.73 -58.81 3.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.119 0.485 . . . . 0.0 111.122 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.557 HD13 HG21 ' A' ' 21' ' ' VAL . 3.2 tp -55.27 -49.54 71.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.8 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.891 HD23 HG22 ' A' ' 41' ' ' ILE . 6.2 mp -62.61 -59.16 5.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.159 -179.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -50.28 -59.79 3.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.98 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.507 ' HB3' ' HE2' ' A' ' 13' ' ' PHE . 3.8 mm? -55.89 -43.31 77.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.482 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.575 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 0.1 OUTLIER -66.83 -15.7 63.79 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.045 -179.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.92 23.9 19.02 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.096 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.634 ' CE3' ' HG ' ' A' ' 27' ' ' LEU . 8.8 m0 -74.84 -66.05 0.8 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.202 0.525 . . . . 0.0 110.119 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.42 ' HA ' HD12 ' A' ' 41' ' ' ILE . 2.1 t -106.68 139.19 41.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.135 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -82.31 -33.48 29.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.574 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.444 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -105.16 -27.54 11.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.959 179.645 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.79 0.75 88.68 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.855 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.88 -15.32 0.31 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.681 0.277 . . . . 0.0 111.468 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.444 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 1.0 OUTLIER -54.29 -77.31 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.374 -179.682 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.42 ' HB3' HG13 ' A' ' 41' ' ' ILE . . . -79.96 15.05 1.56 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.3 mttt 61.71 26.53 16.16 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.98 0.419 . . . . 0.0 110.406 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.891 HG22 HD23 ' A' ' 27' ' ' LEU . 11.7 mt -58.1 -22.27 18.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.708 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.621 ' C ' HD13 ' A' ' 23' ' ' LEU . . . -74.92 -77.67 0.12 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.099 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 44.3 mm -52.31 -36.81 21.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.778 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.731 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -59.62 -69.29 0.21 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.351 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.778 ' CB ' HD21 ' A' ' 27' ' ' LEU . 3.0 tm-20 -34.28 -42.05 0.13 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.839 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.402 ' C ' ' H ' ' A' ' 48' ' ' VAL . . . -59.14 -75.43 0.27 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.109 -1.044 . . . . 0.0 111.184 178.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.531 ' HA ' ' HB ' ' A' ' 56' ' ' THR . 20.7 pt20 -48.82 -9.37 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.85 HG21 ' HD1' ' A' ' 70' ' ' PHE . 68.7 t -75.02 -97.28 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.166 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' A' ' 48' ' ' VAL . 1.9 mmtm -163.02 124.63 2.51 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.549 0.613 . . . . 0.0 112.269 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.661 HG22 HG22 ' A' ' 68' ' ' VAL . 26.3 t -116.76 151.76 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.093 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 177.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.588 ' HB2' ' HB ' ' A' ' 67' ' ' THR . 0.9 OUTLIER -44.67 99.95 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.971 0.415 . . . . 0.0 110.937 -179.269 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 60.12 24.84 61.39 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.089 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.605 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -145.78 80.49 1.59 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.642 HG13 ' O ' ' A' ' 54' ' ' VAL . 8.7 p -89.24 78.92 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.896 0.379 . . . . 0.0 110.425 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 47' ' ' GLN . 3.1 mt-10 -113.13 -172.77 2.12 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.69 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.531 ' HB ' ' HA ' ' A' ' 47' ' ' GLN . 2.8 t -158.62 42.77 0.26 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.52 -179.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.525 ' O ' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -91.9 172.81 8.21 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.814 0.34 . . . . 0.0 110.991 179.95 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.9 mmmm -75.35 -55.74 5.4 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.033 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.4 mtm180 -100.46 141.66 33.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.011 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . 0.595 ' H ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -106.59 131.62 53.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.1 0.476 . . . . 0.0 111.318 -178.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.428 ' HA ' ' CG ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -110.07 74.71 0.9 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.245 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.6 mt -134.26 144.07 36.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.16 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.803 HG12 ' CD1' ' A' ' 15' ' ' LEU . 8.0 m -146.97 175.41 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.254 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.591 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 78.18 -144.64 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.542 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.633 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -100.22 83.47 0.55 Allowed Glycine 0 C--N 1.335 0.499 0 C-N-CA 121.17 -0.538 . . . . 0.0 113.382 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -122.27 163.41 19.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.664 0.269 . . . . 0.0 111.037 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.588 ' HB ' ' HB2' ' A' ' 51' ' ' ASP . 86.3 m -119.89 150.72 40.01 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.053 0.454 . . . . 0.0 112.043 -178.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.661 HG22 HG22 ' A' ' 50' ' ' VAL . 1.1 t -129.99 149.08 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.102 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -137.78 133.69 34.34 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -178.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.85 ' HD1' HG21 ' A' ' 48' ' ' VAL . 5.0 t80 -138.42 115.22 10.72 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.384 179.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 36.47 32.95 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 178.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 116.77 -13.2 14.93 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.361 -0.923 . . . . 0.0 113.531 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.406 ' O ' ' CH2' ' A' ' 32' ' ' TRP . 2.2 m-70 -88.25 82.51 7.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.955 0.378 . . . . 0.0 110.952 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.8 m -95.2 101.0 12.71 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.942 0.401 . . . . 0.0 110.943 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.558 HG13 ' HB1' ' A' ' 11' ' ' ALA . 46.5 t -120.27 155.71 23.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.721 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.502 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 25.5 mt-30 -111.57 161.21 16.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.94 0.4 . . . . 0.0 110.421 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.633 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 13.1 t -133.38 146.85 31.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.424 -178.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.0 m -131.47 157.24 43.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.985 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.253 -0.88 . . . . 0.0 111.147 -179.929 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.183 0 N-CA-C 112.742 -0.143 . . . . 0.0 112.742 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.77 139.84 33.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.91 0.386 . . . . 0.0 111.197 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 56.66 -179.73 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.056 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.418 ' H ' HG13 ' A' ' 4' ' ' ILE . 2.0 pp -93.2 12.53 2.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.481 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 3.6 p-80 -147.32 164.43 33.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.799 0.333 . . . . 0.0 110.843 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.0 mtt-85 -117.18 90.93 3.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.999 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -97.83 140.91 31.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.648 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.23 81.25 3.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.826 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 75.6 m-80 59.08 176.34 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.745 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 5.1 mtt -99.21 149.38 23.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.781 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.656 ' HB3' HG22 ' A' ' 75' ' ' VAL . . . -88.71 135.07 33.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.394 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.46 132.47 29.49 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.85 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.576 ' HB3' HG22 ' A' ' 77' ' ' VAL . 36.8 t80 -102.33 147.49 26.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.896 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.8 m -106.25 147.89 28.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.399 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.618 HD21 HG13 ' A' ' 21' ' ' VAL . 12.0 mt -118.61 -38.12 3.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.063 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.13 -103.75 2.9 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.397 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.0 mttt -143.58 41.87 1.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.019 0.437 . . . . 0.0 110.894 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -95.5 163.91 20.3 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.446 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.593 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 17.9 Cg_endo -58.59 -43.02 48.53 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.322 2.015 . . . . 0.0 112.008 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.593 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 19.9 p80 166.08 -163.96 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.203 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.618 HG13 HD21 ' A' ' 15' ' ' LEU . 3.8 m -139.47 154.23 24.57 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-O 121.09 0.471 . . . . 0.0 112.144 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.492 ' HG2' ' CB ' ' A' ' 59' ' ' ARG . 13.8 mt-10 -90.81 148.09 22.76 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.593 178.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.607 HD23 ' CD ' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -41.27 -50.34 3.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.795 0.331 . . . . 0.0 111.656 -179.656 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 17.9 t -65.64 -32.72 74.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.884 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.493 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 2.9 m-20 -64.57 -59.38 4.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.776 0.322 . . . . 0.0 110.323 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.606 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 12.5 tp -51.78 -40.48 60.43 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.891 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.835 HD21 ' HG3' ' A' ' 45' ' ' GLU . 12.6 mt -66.74 -67.87 0.42 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.111 0.482 . . . . 0.0 110.788 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.483 ' HE2' ' O ' ' A' ' 35' ' ' SER . 4.1 ttmt -50.15 -55.92 13.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.79 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.493 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.1 OUTLIER -53.83 -40.14 66.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.117 -178.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.606 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 1.1 mm-40 -80.35 -10.05 59.75 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.838 0.311 . . . . 0.0 111.838 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.68 25.13 21.56 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.249 -0.977 . . . . 0.0 113.342 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.73 ' CZ3' ' HB2' ' A' ' 73' ' ' HIS . 13.0 m95 -72.94 -61.99 1.62 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 117.133 0.466 . . . . 0.0 110.2 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.498 ' HB2' HG21 ' A' ' 41' ' ' ILE . 39.2 t -100.18 156.22 17.32 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.453 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -85.74 -35.15 20.97 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.186 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.483 ' O ' ' HE2' ' A' ' 28' ' ' LYS . 1.1 p -106.94 -46.21 3.99 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.524 178.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 120.81 -28.5 6.14 Favored Glycine 0 C--N 1.333 0.374 0 CA-C-N 115.745 -0.662 . . . . 0.0 112.882 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.98 1.74 3.31 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -60.91 -76.46 0.05 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.865 0.364 . . . . 0.0 111.105 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.15 15.4 0.57 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.928 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.3 mttp 66.1 24.93 10.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.983 0.421 . . . . 0.0 110.004 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.599 HG23 ' HE2' ' A' ' 70' ' ' PHE . 40.8 mm -52.99 -26.96 12.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.61 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.81 -78.33 0.08 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.928 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 34.4 mm -49.49 -34.34 8.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.856 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.692 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -63.5 -72.23 0.15 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.718 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.835 ' HG3' HD21 ' A' ' 27' ' ' LEU . 0.6 OUTLIER -32.79 -41.71 0.07 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.95 0.405 . . . . 0.0 110.879 -179.845 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.542 ' HA2' HD21 ' A' ' 23' ' ' LEU . . . -59.68 -77.02 0.19 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.268 -0.967 . . . . 0.0 110.848 178.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.629 ' HG3' ' O ' ' A' ' 44' ' ' ALA . 1.4 pt20 -46.52 -10.42 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.81 HG11 ' HA ' ' A' ' 70' ' ' PHE . 58.4 t -74.9 -92.86 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.906 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 48' ' ' VAL . 0.1 OUTLIER -168.12 125.73 1.13 Allowed 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.894 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.8 t -122.15 158.01 26.2 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -44.05 101.75 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.053 0.454 . . . . 0.0 111.71 -178.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 57.29 23.13 46.76 Favored Glycine 0 C--N 1.333 0.386 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.489 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -146.15 82.64 1.61 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.869 0.366 . . . . 0.0 111.787 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.523 HG13 ' O ' ' A' ' 54' ' ' VAL . 10.7 p -88.39 61.47 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.073 0.463 . . . . 0.0 110.824 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -101.14 -164.41 1.1 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.221 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.5 ' HB ' ' HA ' ' A' ' 47' ' ' GLN . 9.7 t -153.18 45.15 0.65 Allowed 'General case' 0 C--O 1.232 0.164 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.494 ' O ' HD13 ' A' ' 23' ' ' LEU . 52.3 mtt180 -87.77 174.98 8.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.067 0.46 . . . . 0.0 111.104 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -85.35 -38.72 18.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.086 179.395 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.492 ' CB ' ' HG2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -120.65 134.06 55.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.822 179.664 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -119.9 115.39 23.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.875 0.369 . . . . 0.0 110.73 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.657 ' O ' HD13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -74.15 89.85 2.01 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.033 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.657 HD13 ' O ' ' A' ' 61' ' ' LYS . 6.9 mm -133.11 138.22 51.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.207 0.527 . . . . 0.0 112.153 -178.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.563 ' O ' ' HB3' ' A' ' 64' ' ' ALA . 4.5 m -146.26 175.29 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.125 179.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 76.52 -143.14 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.649 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -99.91 83.44 0.57 Allowed Glycine 0 C--N 1.336 0.546 0 C-N-CA 121.308 -0.472 . . . . 0.0 112.129 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.507 ' HG3' HG22 ' A' ' 62' ' ' ILE . 6.1 mm100 -122.36 159.63 27.08 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.887 0.375 . . . . 0.0 111.753 -178.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 7.3 m -120.37 144.46 47.87 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.458 -178.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.643 HG12 ' CH2' ' A' ' 32' ' ' TRP . 1.2 t -118.67 143.14 30.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.451 178.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -134.07 133.37 41.09 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.81 ' HA ' HG11 ' A' ' 48' ' ' VAL . 1.4 t80 -146.19 122.48 10.91 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.611 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 49.52 -85.47 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.343 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -129.14 -5.6 4.67 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.722 -0.751 . . . . 0.0 113.026 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.73 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 0.9 OUTLIER -90.61 113.07 25.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.967 0.384 . . . . 0.0 111.441 -179.269 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 72.1 m -120.48 115.54 23.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.178 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.656 HG22 ' HB3' ' A' ' 11' ' ' ALA . 59.4 t -138.59 155.23 27.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.803 0.335 . . . . 0.0 111.328 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.514 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 2.8 mt-30 -112.78 169.96 8.53 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.104 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.649 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 21.6 t -136.36 146.0 29.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.82 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.96 150.49 34.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.952 0.406 . . . . 0.0 111.665 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.336 -0.84 . . . . 0.0 110.964 179.727 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.192 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.9 m -131.6 -65.18 0.77 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.799 0.333 . . . . 0.0 110.847 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 7.5 mtm 66.33 -73.5 0.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.009 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.1 tt -132.83 -2.08 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.781 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 51.2 m-70 -100.26 177.35 5.08 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.791 0.329 . . . . 0.0 111.059 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.45 122.75 32.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.957 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.7 ttt -131.27 30.35 4.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.728 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 p -173.44 176.9 2.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.703 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -134.28 121.19 20.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.929 0.395 . . . . 0.0 111.052 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -78.89 107.62 11.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.745 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.769 ' HB1' HG22 ' A' ' 75' ' ' VAL . . . -67.25 99.8 0.74 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.037 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.58 121.55 16.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.999 0.428 . . . . 0.0 111.168 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.871 ' HB3' HG22 ' A' ' 77' ' ' VAL . 37.1 t80 -99.02 155.28 17.52 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.945 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.5 m -106.63 148.73 27.97 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.272 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.516 HD21 ' CG1' ' A' ' 21' ' ' VAL . 5.1 mt -117.92 -28.74 5.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.851 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.09 40.06 62.34 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.972 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 56.93 68.46 0.86 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.974 0.416 . . . . 0.0 110.829 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.429 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 1.8 m170 -115.28 170.02 6.08 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.903 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.477 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 32.7 Cg_endo -64.86 -51.5 1.68 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.406 2.07 . . . . 0.0 112.356 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.641 ' HA ' HG13 ' A' ' 63' ' ' VAL . 7.4 p80 177.94 -179.72 0.28 Allowed 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.333 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.768 HG21 HD13 ' A' ' 26' ' ' LEU . 4.5 m -142.11 161.01 20.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -179.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.501 ' HG2' ' HA ' ' A' ' 59' ' ' ARG . 8.3 mt-10 -98.89 144.42 28.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.192 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.721 HD12 ' N ' ' A' ' 24' ' ' CYS . 0.9 OUTLIER -39.7 -38.02 0.59 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.629 -0.259 . . . . 0.0 111.561 -179.67 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.721 ' N ' HD12 ' A' ' 23' ' ' LEU . 48.9 t -73.38 -39.71 64.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.606 0.241 . . . . 0.0 111.189 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -62.86 -57.42 10.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.069 0.461 . . . . 0.0 110.358 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.079 HD11 HG21 ' A' ' 77' ' ' VAL . 12.6 tp -55.27 -45.97 76.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.268 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.849 HD23 HG22 ' A' ' 41' ' ' ILE . 4.0 mp -66.73 -59.95 3.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.885 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -49.31 -56.12 10.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.446 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.612 HD22 ' CE1' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -56.3 -38.42 71.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.089 -179.213 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.445 ' CG ' ' HB2' ' A' ' 13' ' ' PHE . 5.2 mm-40 -79.87 -10.95 59.83 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.82 24.02 18.9 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.257 -0.973 . . . . 0.0 113.155 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.654 ' CH2' HG12 ' A' ' 68' ' ' VAL . 11.2 m95 -75.92 -62.55 1.56 Allowed 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.409 ' CB ' HD12 ' A' ' 41' ' ' ILE . 7.5 t -106.38 138.54 42.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.339 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.67 -34.41 60.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.963 0.411 . . . . 0.0 110.408 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.9 -48.12 3.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.057 178.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 118.63 -22.85 9.18 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.231 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.47 -1.78 3.12 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -59.3 -77.95 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.611 0.243 . . . . 0.0 111.249 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.424 ' HB3' HG13 ' A' ' 41' ' ' ILE . . . -75.15 15.13 0.45 Allowed 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.9 mttt 61.85 25.34 15.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.765 0.317 . . . . 0.0 110.76 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.849 HG22 HD23 ' A' ' 27' ' ' LEU . 14.4 mt -61.37 -16.43 14.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.608 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.519 ' CA ' HD13 ' A' ' 23' ' ' LEU . . . -72.68 -79.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.314 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.441 HD11 ' NZ ' ' A' ' 58' ' ' LYS . 43.4 mm -53.9 -33.72 24.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.806 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.715 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -61.0 -72.2 0.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.232 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.749 ' CB ' HD21 ' A' ' 27' ' ' LEU . 2.4 tm-20 -34.76 -40.97 0.12 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.22 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.19 -73.93 0.4 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.156 -1.021 . . . . 0.0 110.628 178.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.827 ' HA ' HG22 ' A' ' 56' ' ' THR . 15.8 pt20 -48.9 -11.55 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.875 HG11 ' HA ' ' A' ' 70' ' ' PHE . 47.2 t -75.0 -90.92 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.102 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.432 ' HD3' ' HB ' ' A' ' 54' ' ' VAL . 6.4 mmtp -165.43 124.84 1.75 Allowed 'General case' 0 C--O 1.232 0.153 0 C-N-CA 120.193 -0.603 . . . . 0.0 112.284 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.542 HG11 ' CD1' ' A' ' 62' ' ' ILE . 34.2 t -119.08 142.77 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 178.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.539 ' HB2' ' H ' ' A' ' 67' ' ' THR . 0.8 OUTLIER -45.29 97.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.924 0.392 . . . . 0.0 111.567 -179.102 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.25 11.02 85.76 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.976 -0.631 . . . . 0.0 113.001 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.534 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -146.03 82.44 1.61 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 117.073 0.436 . . . . 0.0 112.033 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.517 HG22 ' O ' ' A' ' 54' ' ' VAL . 7.4 p -86.99 56.2 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.075 0.464 . . . . 0.0 110.081 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -99.65 179.72 4.45 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.628 -178.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.827 HG22 ' HA ' ' A' ' 47' ' ' GLN . 1.7 p -134.39 36.97 3.16 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.684 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.38 171.23 12.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.873 0.368 . . . . 0.0 111.189 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.441 ' NZ ' HD11 ' A' ' 43' ' ' ILE . 38.6 mttm -75.57 -46.46 31.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.682 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.501 ' HA ' ' HG2' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -116.61 137.65 52.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.633 179.862 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.24 115.28 26.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.77 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.441 ' HG2' ' CD2' ' A' ' 20' ' ' HIS . 11.5 mtpt -78.46 82.26 4.74 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.369 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.542 ' CD1' HG11 ' A' ' 50' ' ' VAL . 26.8 mt -133.61 147.97 30.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.261 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.641 HG13 ' HA ' ' A' ' 20' ' ' HIS . 1.9 m -154.99 175.87 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.245 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 76.22 -150.66 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.301 179.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -83.9 78.54 2.0 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.292 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -122.26 154.91 36.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.112 0.482 . . . . 0.0 110.956 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.627 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 87.6 m -114.46 156.28 24.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.375 -178.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.654 HG12 ' CH2' ' A' ' 32' ' ' TRP . 1.0 OUTLIER -133.01 148.97 31.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.672 179.34 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 76.8 p -143.12 139.86 30.6 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.875 ' HA ' HG11 ' A' ' 48' ' ' VAL . 2.3 t80 -150.82 124.36 9.02 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 114.902 -1.044 . . . . 0.0 110.323 179.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 49.52 -85.46 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.59 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -126.18 -6.99 5.61 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.972 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.526 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 1.7 m-70 -89.5 107.11 18.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.791 0.329 . . . . 0.0 111.54 -179.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.76 95.29 4.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.175 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.769 HG22 ' HB1' ' A' ' 11' ' ' ALA . 97.0 t -123.23 155.32 29.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.517 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.627 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 3.2 mp0 -113.26 165.1 12.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.971 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 1.079 HG21 HD11 ' A' ' 26' ' ' LEU . 11.0 t -139.76 150.57 22.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.974 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.0 m -129.17 165.5 28.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.973 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.215 -0.897 . . . . 0.0 111.191 179.892 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.181 0 N-CA-C 112.748 -0.141 . . . . 0.0 112.748 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.573 ' HB3' ' O ' ' A' ' 5' ' ' HIS . 5.5 m -102.3 117.98 35.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.728 0.299 . . . . 0.0 111.059 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.9 mmt -94.66 -59.43 1.93 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.126 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.8 tt -117.0 -30.37 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.615 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.573 ' O ' ' HB3' ' A' ' 2' ' ' SER . 21.3 m-70 -91.25 140.81 29.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.456 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.95 106.05 0.81 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.995 0.426 . . . . 0.0 111.183 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.41 130.01 47.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.552 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.7 t -148.96 -60.22 0.23 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.097 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -105.38 -39.18 6.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.895 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -82.34 82.35 7.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.954 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.59 130.83 34.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.698 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.97 133.82 34.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.56 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.875 ' HB3' HG22 ' A' ' 77' ' ' VAL . 58.4 t80 -105.35 156.58 18.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.1 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.2 m -107.16 142.7 36.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.963 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.802 HD22 ' HB2' ' A' ' 18' ' ' HIS . 0.5 OUTLIER -104.67 -40.62 5.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.445 179.375 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.22 42.95 6.82 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.702 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 50.18 59.31 4.64 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.93 0.395 . . . . 0.0 111.248 179.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.802 ' HB2' HD22 ' A' ' 15' ' ' LEU . 30.7 m170 -115.66 165.27 14.88 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.398 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.656 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 18.3 Cg_endo -57.75 -38.43 93.06 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.557 2.171 . . . . 0.0 112.386 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.656 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 12.0 p80 164.38 -173.7 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.72 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.628 HG13 HD21 ' A' ' 15' ' ' LEU . 2.4 m -145.79 166.47 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.217 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.507 ' HG2' ' HB2' ' A' ' 59' ' ' ARG . 70.4 mt-10 -95.97 141.03 29.87 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.818 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.613 HD21 ' O ' ' A' ' 57' ' ' ARG . 2.0 pp -44.12 -30.59 0.78 Allowed 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 -178.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.605 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -69.63 -40.71 76.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.78 0.324 . . . . 0.0 110.396 179.361 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -63.44 -60.63 3.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.049 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.993 HD11 HG21 ' A' ' 77' ' ' VAL . 2.6 tp -49.46 -49.25 46.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.652 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.835 HD21 ' HB2' ' A' ' 45' ' ' GLU . 9.5 mp -65.1 -61.76 1.95 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.445 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.605 ' HB2' ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -48.82 -55.59 11.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.348 -179.718 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.645 HD13 ' HZ ' ' A' ' 13' ' ' PHE . 1.2 mt -55.33 -42.49 73.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.533 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.521 ' OE2' HG11 ' A' ' 75' ' ' VAL . 1.3 mm-40 -71.19 -15.28 62.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.728 -0.214 . . . . 0.0 111.555 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.07 24.77 12.17 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.268 -0.968 . . . . 0.0 113.071 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.86 ' CH2' HG12 ' A' ' 68' ' ' VAL . 7.8 m0 -76.33 -66.28 0.82 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.959 0.38 . . . . 0.0 109.999 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.765 ' CB ' HD12 ' A' ' 41' ' ' ILE . 25.0 t -106.12 140.04 39.7 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.353 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -75.74 -34.96 60.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.898 0.38 . . . . 0.0 110.73 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.514 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 0.2 OUTLIER -106.45 -48.0 3.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.365 178.848 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.4 -26.25 8.72 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.201 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -127.58 -2.67 6.09 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.514 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 4.2 tp-100 -59.74 -76.56 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.674 0.273 . . . . 0.0 110.962 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.91 15.11 0.93 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.725 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.7 mttm 61.93 27.83 16.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.084 0.469 . . . . 0.0 110.401 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.799 HG23 ' CE2' ' A' ' 70' ' ' PHE . 12.7 mt -59.29 -25.0 29.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.554 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.07 -77.69 0.08 Allowed 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.144 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 31.6 mm -48.62 -36.29 7.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 120.896 0.379 . . . . 0.0 110.599 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.747 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -61.46 -67.06 0.44 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.519 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.835 ' HB2' HD21 ' A' ' 27' ' ' LEU . 5.9 tp10 -33.96 -45.73 0.21 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.852 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' A' ' 48' ' ' VAL . . . -59.23 -75.94 0.24 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.238 -0.982 . . . . 0.0 111.04 178.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.528 ' HG2' ' O ' ' A' ' 44' ' ' ALA . 12.4 pt20 -44.5 -15.86 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.815 HG21 ' HD1' ' A' ' 70' ' ' PHE . 93.6 t -75.05 -91.7 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 O-C-N 122.212 -0.305 . . . . 0.0 110.575 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -171.18 136.88 1.09 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.956 0.408 . . . . 0.0 111.146 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.566 HG11 HD11 ' A' ' 62' ' ' ILE . 58.5 t -131.7 144.95 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.951 179.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.551 ' HB3' ' H ' ' A' ' 67' ' ' THR . 37.6 t70 -60.61 77.23 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.055 0.455 . . . . 0.0 110.46 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 120.96 -12.46 9.89 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.408 -179.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.563 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . . . -132.37 133.69 44.27 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.892 0.377 . . . . 0.0 110.8 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.583 HG22 ' O ' ' A' ' 54' ' ' VAL . 12.6 p -125.2 31.98 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.714 179.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -107.49 160.21 15.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.283 0.563 . . . . 0.0 112.433 -178.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.51 HG23 ' O ' ' A' ' 56' ' ' THR . 14.8 t -108.66 50.12 0.79 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.556 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.613 ' O ' HD21 ' A' ' 23' ' ' LEU . 10.0 mtp180 -84.24 173.38 11.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.746 0.308 . . . . 0.0 111.018 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.1 ttmm -81.68 -0.69 43.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.991 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.507 ' HB2' ' HG2' ' A' ' 22' ' ' GLU . 0.3 OUTLIER -160.86 157.3 26.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.616 179.708 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . 0.636 ' SG ' HD11 ' A' ' 62' ' ' ILE . 1.6 t -134.93 114.99 13.08 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.484 ' HG2' ' CD2' ' A' ' 20' ' ' HIS . 3.6 mttm -76.0 94.62 3.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.36 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.636 HD11 ' SG ' ' A' ' 60' ' ' CYS . 16.2 mt -135.41 141.17 43.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.696 -179.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.661 HG12 HD13 ' A' ' 15' ' ' LEU . 0.8 OUTLIER -144.24 175.18 3.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.927 179.3 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 66.21 -150.17 0.21 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.716 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.605 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -86.79 79.13 1.84 Allowed Glycine 0 C--N 1.336 0.565 0 C-N-CA 121.451 -0.404 . . . . 0.0 113.498 -178.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.545 ' HG3' ' O ' ' A' ' 63' ' ' VAL . 2.3 mm100 -122.18 158.95 28.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.935 0.397 . . . . 0.0 111.347 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.611 HG23 ' HG3' ' A' ' 76' ' ' GLN . 0.3 OUTLIER -114.53 157.66 22.69 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.529 -178.71 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.86 HG12 ' CH2' ' A' ' 32' ' ' TRP . 1.2 t -133.96 147.51 30.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.829 179.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.661 ' HA ' ' O ' ' A' ' 73' ' ' HIS . 0.5 OUTLIER -137.7 132.15 32.44 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -178.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.815 ' HD1' HG21 ' A' ' 48' ' ' VAL . 1.7 t80 -139.32 117.9 12.2 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.347 178.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 38.01 30.0 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 179.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 117.17 -7.26 16.69 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.211 -0.995 . . . . 0.0 113.512 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.661 ' O ' ' HA ' ' A' ' 69' ' ' SER . 2.6 m-70 -87.9 89.79 8.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 117.242 0.521 . . . . 0.0 110.834 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 58.2 m -100.59 102.02 13.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.858 0.361 . . . . 0.0 111.008 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.565 ' HB ' ' HZ2' ' A' ' 32' ' ' TRP . 46.9 t -127.19 153.61 36.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.843 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.611 ' HG3' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -112.95 165.04 12.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.031 0.443 . . . . 0.0 111.122 179.538 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.993 HG21 HD11 ' A' ' 26' ' ' LEU . 45.3 t -138.11 154.86 28.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.48 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.498 ' O ' ' HB2' ' A' ' 15' ' ' LEU . 16.1 m -131.77 161.47 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.865 0.364 . . . . 0.0 111.417 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.321 -0.847 . . . . 0.0 111.429 179.624 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.153 0 N-CA-C 112.557 -0.217 . . . . 0.0 112.557 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 62.98 34.47 13.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.802 0.334 . . . . 0.0 110.994 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -91.98 120.97 33.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.965 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -106.19 119.84 56.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.33 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.4 m170 -76.13 138.35 40.69 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.817 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 9.6 mmm-85 -109.14 151.27 26.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.004 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.3 mtp -102.52 -45.66 4.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.998 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.92 136.95 57.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.069 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -110.39 103.31 11.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.116 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -67.64 143.05 56.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.566 179.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.982 ' HB1' HG13 ' A' ' 75' ' ' VAL . . . -64.14 84.7 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.141 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.62 109.42 6.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.781 0.324 . . . . 0.0 110.78 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.843 ' HB3' HG22 ' A' ' 77' ' ' VAL . 28.2 t80 -98.64 170.59 8.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.975 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.9 m -106.82 138.1 43.62 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.356 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.868 HD23 HG11 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -131.49 -37.99 1.19 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.221 179.337 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.406 ' H ' ' HA ' ' A' ' 79' ' ' ALA . . . -44.09 -27.69 1.14 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 121.213 -0.518 . . . . 0.0 113.002 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -55.46 -40.86 72.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.663 0.268 . . . . 0.0 111.257 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.588 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 42.4 m80 -119.64 163.06 29.48 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.319 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.734 ' O ' HG11 ' A' ' 63' ' ' VAL . 18.2 Cg_endo -59.74 -27.87 85.96 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.658 2.239 . . . . 0.0 112.496 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.555 ' HA ' HG12 ' A' ' 63' ' ' VAL . 4.7 p80 177.05 178.17 0.27 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.12 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.669 HG21 HD21 ' A' ' 15' ' ' LEU . 15.4 m -145.93 167.15 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.614 ' HG3' ' HA ' ' A' ' 59' ' ' ARG . 17.3 tt0 -100.35 144.2 29.64 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.08 178.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.671 HD13 ' O ' ' A' ' 42' ' ' ALA . 1.6 pp -40.86 -46.84 2.83 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.655 0.264 . . . . 0.0 111.625 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.659 ' N ' HD12 ' A' ' 23' ' ' LEU . 5.6 t -62.31 -38.05 87.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.751 0.31 . . . . 0.0 110.927 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -66.06 -57.61 7.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.885 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.881 HD11 HG21 ' A' ' 77' ' ' VAL . 7.2 tt -56.64 -42.05 78.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.053 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.959 HD23 HG22 ' A' ' 41' ' ' ILE . 6.7 mp -65.77 -62.29 1.59 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.972 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.04 -55.55 11.69 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.383 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.486 ' HB3' ' CZ ' ' A' ' 13' ' ' PHE . 6.6 mt -53.48 -40.16 65.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.265 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.66 ' CD ' HG11 ' A' ' 75' ' ' VAL . 0.4 OUTLIER -73.45 -15.17 61.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.605 -179.702 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.5 23.82 17.84 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.425 -0.893 . . . . 0.0 113.294 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.759 ' CH2' HG12 ' A' ' 68' ' ' VAL . 9.3 m0 -72.62 -59.04 2.91 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 117.215 0.508 . . . . 0.0 110.137 179.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.805 ' CB ' HD12 ' A' ' 41' ' ' ILE . 6.0 t -104.87 138.72 40.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.426 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -69.28 -33.77 73.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.905 0.383 . . . . 0.0 110.761 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.9 p -105.16 -42.44 5.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.064 0.459 . . . . 0.0 110.573 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 128.67 -43.34 1.33 Allowed Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.107 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.52 4.37 3.95 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -53.07 -70.38 0.09 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.838 0.352 . . . . 0.0 110.831 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.497 ' HB3' HG13 ' A' ' 41' ' ' ILE . . . -75.31 15.49 0.44 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.967 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.2 mttt 64.35 23.3 12.99 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 120.913 0.387 . . . . 0.0 110.163 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.959 HG22 HD23 ' A' ' 27' ' ' LEU . 29.8 mt -61.83 -19.63 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.617 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.671 ' O ' HD13 ' A' ' 23' ' ' LEU . . . -73.29 -78.92 0.09 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.916 0.389 . . . . 0.0 110.961 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.411 HD11 ' HD3' ' A' ' 58' ' ' LYS . 43.6 mm -52.41 -37.98 24.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.734 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.619 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -58.42 -69.38 0.19 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.155 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.677 ' HG3' HD21 ' A' ' 27' ' ' LEU . 12.3 tm-20 -34.53 -44.92 0.22 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.107 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.01 -73.14 0.44 Allowed Glycine 0 C--N 1.332 0.314 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.599 ' HG2' ' HB ' ' A' ' 56' ' ' THR . 0.0 OUTLIER -45.63 -15.44 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 179.614 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.818 HG21 ' HD1' ' A' ' 70' ' ' PHE . 46.2 t -74.92 -91.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 121.053 -0.259 . . . . 0.0 111.124 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.475 ' O ' ' HB2' ' A' ' 69' ' ' SER . 0.3 OUTLIER -175.74 130.13 0.25 Allowed 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.292 -0.563 . . . . 0.0 112.029 179.826 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.581 HG13 HG23 ' A' ' 68' ' ' VAL . 21.3 t -116.91 148.01 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.638 ' HB2' ' HB ' ' A' ' 67' ' ' THR . 14.0 t0 -44.85 99.21 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.934 0.397 . . . . 0.0 111.594 -179.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.37 17.67 70.68 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.225 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.533 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . . . -145.79 73.09 1.33 Allowed 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.249 0.547 . . . . 0.0 111.586 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.542 HG22 ' O ' ' A' ' 54' ' ' VAL . 3.0 p -84.33 69.25 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.419 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -100.48 -178.62 3.86 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.83 -179.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.599 ' HB ' ' HG2' ' A' ' 47' ' ' GLN . 3.0 p -142.45 37.74 1.52 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.172 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.458 ' O ' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -98.15 172.71 7.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.765 0.316 . . . . 0.0 111.256 -179.649 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.411 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -75.3 -41.77 56.18 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.45 179.713 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.614 ' HA ' ' HG3' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -123.8 145.56 48.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.645 179.424 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . 0.505 ' SG ' HD11 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -130.85 116.16 17.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.926 0.393 . . . . 0.0 111.439 -179.469 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.24 86.46 1.09 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.278 179.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.505 HD11 ' SG ' ' A' ' 60' ' ' CYS . 20.8 mt -133.37 139.94 47.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.224 -179.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.787 HG12 HD12 ' A' ' 15' ' ' LEU . 34.4 m -148.83 175.88 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.92 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.617 ' HA ' ' HB2' ' A' ' 79' ' ' ALA . . . 76.96 -147.94 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 178.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.712 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -84.36 75.62 2.34 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.25 -179.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.434 ' OE1' ' HB3' ' A' ' 51' ' ' ASP . 16.7 mm-40 -122.17 152.73 39.64 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.099 0.476 . . . . 0.0 111.285 -179.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.638 ' HB ' ' HB2' ' A' ' 51' ' ' ASP . 21.9 m -115.93 152.75 32.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.787 -178.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.759 HG12 ' CH2' ' A' ' 32' ' ' TRP . 0.8 OUTLIER -128.03 144.53 37.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.222 179.241 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' ' 49' ' ' LYS . 25.7 m -136.74 136.42 38.94 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.119 0.485 . . . . 0.0 112.246 -178.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.818 ' HD1' HG21 ' A' ' 48' ' ' VAL . 2.1 t80 -144.65 121.85 11.52 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.21 179.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 51.08 -81.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.981 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -131.75 -4.14 3.92 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.85 -0.69 . . . . 0.0 113.337 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.499 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 1.8 m-70 -91.48 112.62 24.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.087 0.444 . . . . 0.0 111.691 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.4 109.37 15.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.863 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.982 HG13 ' HB1' ' A' ' 11' ' ' ALA . 27.6 t -132.14 150.68 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 120.579 0.228 . . . . 0.0 111.468 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.612 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 1.5 mt-30 -112.29 172.4 6.93 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.008 0.432 . . . . 0.0 111.351 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.881 HG21 HD11 ' A' ' 26' ' ' LEU . 12.1 t -142.64 150.52 18.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.233 -178.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.1 m -127.49 158.78 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-O 120.746 0.307 . . . . 0.0 111.81 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.617 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.304 -0.855 . . . . 0.0 111.04 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.121 0 N-CA-C 112.383 -0.287 . . . . 0.0 112.383 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.41 -40.89 11.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.798 0.332 . . . . 0.0 110.826 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -88.89 -171.64 3.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.101 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.553 HG23 ' O ' ' A' ' 4' ' ' ILE . 0.8 OUTLIER 35.52 93.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 121.171 0.51 . . . . 0.0 112.226 -179.909 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 34.3 m-70 -100.87 106.75 18.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.763 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 6' ' ' ARG . 0.4 OUTLIER -147.08 31.58 0.93 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.171 -179.922 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.6 mtp -118.89 124.46 47.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.773 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 p -91.27 161.33 15.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.06 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -153.13 -36.67 0.11 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.158 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -71.72 121.93 19.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.026 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.543 ' HB3' HG13 ' A' ' 75' ' ' VAL . . . -99.84 137.06 38.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.021 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.55 135.24 53.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.28 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.721 ' CD2' HD12 ' A' ' 26' ' ' LEU . 1.1 t80 -101.07 95.59 6.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.309 179.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.56 ' HA ' HG23 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -73.05 111.26 8.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.855 0.359 . . . . 0.0 110.58 179.864 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.635 HD11 HG13 ' A' ' 21' ' ' VAL . 1.4 mt -82.46 -33.7 28.37 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.033 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.4 -73.86 0.67 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.715 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.44 52.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.129 0.49 . . . . 0.0 110.847 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.7 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 32.2 m170 -109.02 166.83 10.08 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.648 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.7 ' HD2' ' HB3' ' A' ' 18' ' ' HIS . 18.6 Cg_endo -57.97 -41.48 68.18 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.317 2.011 . . . . 0.0 111.831 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.601 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 9.0 p80 165.69 -164.71 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.256 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.795 HG21 HD13 ' A' ' 26' ' ' LEU . 22.6 m -142.73 156.91 18.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.354 0.597 . . . . 0.0 112.248 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.709 ' HG2' ' HA ' ' A' ' 59' ' ' ARG . 12.6 mt-10 -92.56 142.93 26.85 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.639 178.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.588 HD12 ' HB1' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -40.14 -40.05 1.02 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.726 0.298 . . . . 0.0 111.171 -179.61 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 54.0 t -67.1 -40.24 86.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.058 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -65.29 -57.15 9.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.023 179.667 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.795 HD13 HG21 ' A' ' 21' ' ' VAL . 9.9 tp -57.16 -47.77 80.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.436 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.702 HD23 HG22 ' A' ' 41' ' ' ILE . 4.6 mp -62.69 -57.34 11.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.785 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -50.76 -59.12 4.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.953 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 29' ' ' LEU . 18.7 mt -56.83 -44.04 81.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.583 -179.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.453 ' HG2' ' HD2' ' A' ' 13' ' ' PHE . 10.9 mm-40 -67.99 -14.99 63.4 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 121.117 -0.233 . . . . 0.0 111.165 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.24 22.54 26.97 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.359 -0.924 . . . . 0.0 113.209 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.59 ' CH2' HG12 ' A' ' 68' ' ' VAL . 9.3 m0 -68.84 -64.08 0.94 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.71 152.63 23.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.016 178.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -70.38 -34.56 72.72 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.28 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.587 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -106.13 -57.23 2.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.103 0.478 . . . . 0.0 110.568 179.241 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' A' ' 42' ' ' ALA . . . 152.63 -33.88 0.82 Allowed Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.972 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.37 7.53 1.33 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.587 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 2.1 tp60 -54.36 -70.33 0.1 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.701 0.286 . . . . 0.0 110.902 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.72 15.35 0.2 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.575 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.411 ' H ' ' C ' ' A' ' 38' ' ' GLN . 0.0 OUTLIER 69.11 16.26 8.63 Favored 'General case' 0 CA--C 1.523 -0.067 0 CA-C-O 120.734 0.302 . . . . 0.0 110.723 -179.378 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.702 HG22 HD23 ' A' ' 27' ' ' LEU . 22.9 mm -56.34 -26.5 22.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.299 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.588 ' HB1' HD12 ' A' ' 23' ' ' LEU . . . -70.75 -79.43 0.06 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.407 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.436 HD12 ' HD3' ' A' ' 58' ' ' LYS . 6.2 mm -48.04 -42.77 10.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.689 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.74 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -57.99 -64.21 0.99 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.506 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.569 ' HB2' HD21 ' A' ' 27' ' ' LEU . 3.1 tm-20 -35.94 -40.78 0.21 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.709 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' A' ' 48' ' ' VAL . . . -60.07 -75.07 0.3 Allowed Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 178.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.581 ' HG2' ' HB ' ' A' ' 56' ' ' THR . 0.0 OUTLIER -46.49 -12.59 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 179.891 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.798 HG21 ' HD1' ' A' ' 70' ' ' PHE . 57.7 t -74.99 -89.32 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.103 -179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.494 ' HG2' ' O ' ' A' ' 48' ' ' VAL . 5.8 mmmt -167.44 144.46 4.44 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.982 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.613 ' HB ' ' O ' ' A' ' 53' ' ' ALA . 14.0 t -131.04 145.7 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.547 ' HB2' ' HB ' ' A' ' 67' ' ' THR . 8.8 t0 -43.89 90.27 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -178.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 108.98 -31.93 7.31 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.712 -0.756 . . . . 0.0 114.03 178.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.613 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -147.58 145.59 29.08 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 117.851 0.825 . . . . 0.0 112.549 -179.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 54' ' ' VAL . 4.8 p -109.38 101.5 12.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.053 178.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -99.75 -165.05 1.18 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.966 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.581 ' HB ' ' HG2' ' A' ' 47' ' ' GLN . 5.2 t -165.24 31.06 0.06 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.775 0.322 . . . . 0.0 111.371 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.53 ' O ' HD21 ' A' ' 23' ' ' LEU . 6.3 mtt180 -89.07 167.85 12.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.023 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.436 ' HD3' HD12 ' A' ' 43' ' ' ILE . 58.3 mmtt -78.32 -35.61 47.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.237 0.542 . . . . 0.0 109.953 179.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.709 ' HA ' ' HG2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -106.93 135.08 49.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.563 179.592 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . 0.496 ' H ' ' HA ' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -104.39 118.29 36.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.879 0.371 . . . . 0.0 110.793 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.441 ' HA ' ' CD2' ' A' ' 20' ' ' HIS . 5.4 mtmt -98.99 74.06 1.98 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.11 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.48 ' O ' ' HB2' ' A' ' 20' ' ' HIS . 29.6 mt -137.88 145.26 29.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.657 -179.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.527 ' O ' ' HB3' ' A' ' 64' ' ' ALA . 0.5 OUTLIER -151.26 175.39 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.867 179.696 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 74.88 -148.89 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.424 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.438 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -85.13 74.76 2.43 Favored Glycine 0 C--N 1.335 0.513 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.732 -179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.437 ' O ' ' N ' ' A' ' 77' ' ' VAL . 27.9 mm-40 -122.35 150.0 42.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.955 0.407 . . . . 0.0 110.8 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.733 HG23 ' O ' ' A' ' 75' ' ' VAL . 77.1 m -114.83 150.38 35.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.384 -178.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.59 HG12 ' CH2' ' A' ' 32' ' ' TRP . 0.7 OUTLIER -125.77 145.57 32.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.523 178.774 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 28.4 p -139.32 138.8 37.0 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -178.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.798 ' HD1' HG21 ' A' ' 48' ' ' VAL . 1.9 t80 -143.04 122.2 12.93 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.21 179.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 48.04 -81.38 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.796 0.332 . . . . 0.0 111.396 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -130.7 -1.29 5.11 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.877 -0.678 . . . . 0.0 113.053 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -93.41 98.93 11.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.134 0.467 . . . . 0.0 111.624 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.3 m -109.82 108.28 18.55 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.405 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.733 ' O ' HG23 ' A' ' 67' ' ' THR . 25.1 t -128.55 156.44 40.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.819 -179.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.507 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 2.7 mp0 -112.05 161.55 16.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.815 0.34 . . . . 0.0 110.716 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.438 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 23.2 t -125.7 141.14 46.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.059 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.56 HG23 ' HA ' ' A' ' 14' ' ' SER . 29.3 m -129.77 152.23 37.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.866 0.365 . . . . 0.0 111.124 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.279 -0.867 . . . . 0.0 111.236 -179.776 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.192 0 N-CA-C 112.559 -0.217 . . . . 0.0 112.559 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 m -153.5 -57.78 0.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.82 0.343 . . . . 0.0 110.947 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 62.88 166.54 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 38.7 pt -118.23 131.08 72.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.435 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -142.55 -16.48 0.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.953 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -90.7 128.4 36.64 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.899 0.381 . . . . 0.0 111.332 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.9 tpt -91.95 172.48 8.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.5 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.3 m 59.83 -175.14 0.1 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.777 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -73.78 133.57 43.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.911 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.6 mtp -66.15 96.52 0.33 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.874 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.738 ' HB3' HG22 ' A' ' 75' ' ' VAL . . . -81.61 131.05 35.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.38 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -139.62 132.83 29.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.792 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.461 ' CE1' ' HB3' ' A' ' 29' ' ' LEU . 19.1 t80 -107.54 149.28 28.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.927 0.394 . . . . 0.0 111.294 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.63 150.63 26.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.738 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.5 mt -128.08 -40.47 1.67 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.144 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.91 -100.49 2.65 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.671 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.3 tppt? -148.83 53.62 0.98 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.992 0.425 . . . . 0.0 111.003 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.588 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 69.6 m-70 -106.12 163.95 15.98 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.898 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.588 ' HD2' ' HB3' ' A' ' 18' ' ' HIS . 18.3 Cg_endo -57.74 -45.18 34.87 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.615 2.21 . . . . 0.0 112.277 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.554 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 13.8 p80 170.91 -166.67 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.941 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.51 HG21 HD12 ' A' ' 26' ' ' LEU . 19.5 m -147.08 159.03 9.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.423 ' HG2' ' HA ' ' A' ' 59' ' ' ARG . 1.2 mt-10 -88.56 139.29 30.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.959 178.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.767 HD12 ' N ' ' A' ' 24' ' ' CYS . 0.9 OUTLIER -43.47 -32.5 0.9 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.884 0.374 . . . . 0.0 111.28 -179.653 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.767 ' N ' HD12 ' A' ' 23' ' ' LEU . 26.3 t -73.1 -38.23 66.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.816 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.408 ' N ' ' O ' ' A' ' 22' ' ' GLU . 6.5 m-20 -62.5 -55.31 28.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.743 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.708 HD11 HG21 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -54.89 -44.22 73.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.143 -179.913 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.705 HD23 HG22 ' A' ' 41' ' ' ILE . 5.2 mp -62.16 -64.31 0.97 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.45 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.6 ttmm -47.66 -52.46 18.08 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.974 -179.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.461 ' HB3' ' CE1' ' A' ' 13' ' ' PHE . 3.5 mm? -58.96 -46.51 87.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.322 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -70.52 -14.93 62.71 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.53 26.03 14.43 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.39 -0.91 . . . . 0.0 113.498 179.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.704 ' CH2' HG12 ' A' ' 68' ' ' VAL . 9.6 m0 -74.39 -64.89 0.93 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.015 0.436 . . . . 0.0 110.15 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.656 ' CB ' HD12 ' A' ' 41' ' ' ILE . 3.9 t -106.31 138.51 42.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.663 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.23 -33.66 37.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.707 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.447 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -105.33 -33.79 8.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.529 179.621 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.32 -20.42 50.34 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.792 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.97 -8.18 3.07 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.447 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 63.8 tp60 -55.51 -76.06 0.03 OUTLIER 'General case' 0 C--O 1.232 0.134 0 CA-C-O 120.724 0.297 . . . . 0.0 111.277 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.32 15.0 2.63 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.75 29.65 19.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.041 0.448 . . . . 0.0 110.44 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.852 HG23 ' CE2' ' A' ' 70' ' ' PHE . 18.6 mt -60.49 -23.89 29.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.982 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.62 -78.67 0.07 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.242 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.9 mm -51.8 -40.8 28.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.954 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.826 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -56.36 -68.65 0.19 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.617 179.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.565 ' HG3' HD11 ' A' ' 27' ' ' LEU . 3.7 tm-20 -35.82 -44.57 0.35 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.909 0.385 . . . . 0.0 110.965 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.47 -76.38 0.19 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.13 -1.033 . . . . 0.0 110.912 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.464 ' HA ' ' HB ' ' A' ' 56' ' ' THR . 14.7 pt20 -47.5 -12.07 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.826 HG23 ' O ' ' A' ' 44' ' ' ALA . 43.6 t -74.96 -90.83 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.285 -179.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -162.39 124.23 2.71 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 119.903 -0.719 . . . . 0.0 112.916 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.658 ' HB ' ' O ' ' A' ' 53' ' ' ALA . 45.2 t -117.13 148.1 20.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 177.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -44.68 96.1 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.912 0.387 . . . . 0.0 111.343 -179.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.34 17.86 74.66 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.627 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.658 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -146.03 82.56 1.61 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.017 0.437 . . . . 0.0 112.063 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.544 HG13 ' O ' ' A' ' 54' ' ' VAL . 12.5 p -86.85 59.08 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.998 0.428 . . . . 0.0 110.874 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.16 -168.64 1.56 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.684 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.464 ' HB ' ' HA ' ' A' ' 47' ' ' GLN . 12.2 t -151.66 44.12 0.75 Allowed 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.607 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.676 ' O ' HD21 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -87.52 165.08 15.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.91 0.386 . . . . 0.0 111.292 -179.774 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.2 -40.07 59.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.791 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.423 ' HA ' ' HG2' ' A' ' 22' ' ' GLU . 2.6 mpt_? -111.67 134.38 53.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.918 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . 0.41 ' O ' ' O ' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -107.44 115.17 29.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.36 179.782 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.411 ' HA ' ' CG ' ' A' ' 20' ' ' HIS . 0.1 OUTLIER -92.53 76.49 5.07 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.129 0.49 . . . . 0.0 109.754 179.662 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.445 ' CG2' ' HG3' ' A' ' 66' ' ' GLN . 46.5 mt -139.2 153.32 24.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.43 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.577 ' O ' ' HB3' ' A' ' 64' ' ' ALA . 4.3 m -155.26 175.42 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.663 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.577 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 78.33 -150.52 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 178.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.712 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -84.87 77.41 2.11 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.939 -179.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.445 ' HG3' ' CG2' ' A' ' 62' ' ' ILE . 22.0 mm100 -122.18 157.72 30.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.913 0.387 . . . . 0.0 111.491 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.618 HG23 ' O ' ' A' ' 75' ' ' VAL . 25.1 m -118.58 156.72 28.66 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.673 0.619 . . . . 0.0 112.673 -178.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.704 HG12 ' CH2' ' A' ' 32' ' ' TRP . 1.2 t -137.34 149.37 25.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.891 179.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.602 ' HA ' ' O ' ' A' ' 73' ' ' HIS . 43.2 p -140.57 138.08 34.21 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.852 ' CE2' HG23 ' A' ' 41' ' ' ILE . 2.4 t80 -138.4 115.58 11.02 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.701 178.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.56 ' H ' HG11 ' A' ' 48' ' ' VAL . . . 38.29 31.6 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 116.67 -7.61 17.58 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.334 -0.936 . . . . 0.0 113.619 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.602 ' O ' ' HA ' ' A' ' 69' ' ' SER . 0.9 OUTLIER -88.14 83.83 6.95 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 117.252 0.526 . . . . 0.0 110.882 -179.427 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.2 m -92.58 111.47 23.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.979 0.419 . . . . 0.0 110.942 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.738 HG22 ' HB3' ' A' ' 11' ' ' ALA . 64.5 t -131.65 151.07 34.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.485 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.536 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 49.3 mt-30 -112.0 171.45 7.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.463 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.712 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 2.8 t -144.13 146.76 20.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.162 -178.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.0 m -136.38 170.44 18.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.838 0.351 . . . . 0.0 111.01 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.117 0 CA-C-O 118.214 -0.898 . . . . 0.0 111.068 179.881 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.167 0 N-CA-C 112.533 -0.227 . . . . 0.0 112.533 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.9 166.73 11.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.79 0.328 . . . . 0.0 110.853 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -103.99 -171.59 1.96 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.095 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.7 pp -138.39 25.81 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.335 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -90.56 -83.48 0.26 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.879 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -75.18 164.36 26.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.816 0.341 . . . . 0.0 110.725 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 65.44 88.87 0.1 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.734 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.4 m -63.48 145.97 54.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -90.03 139.29 30.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.803 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 8.3 mtt -89.88 176.9 6.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.342 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.626 ' HB3' HG13 ' A' ' 75' ' ' VAL . . . -97.04 142.94 28.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.042 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.55 130.55 51.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.146 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.614 ' O ' HG13 ' A' ' 77' ' ' VAL . 15.2 t80 -106.78 96.65 6.59 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.106 -179.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.411 ' HA ' ' CG2' ' A' ' 78' ' ' VAL . 7.7 t -70.95 110.56 5.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.94 0.4 . . . . 0.0 111.083 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 15' ' ' LEU . 13.8 mt -83.27 -31.55 26.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.555 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.05 -88.66 0.63 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.892 -0.671 . . . . 0.0 111.897 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.02 71.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.011 0.434 . . . . 0.0 110.886 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.432 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -117.43 172.18 4.24 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.38 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.606 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 38.0 Cg_endo -66.92 -41.56 9.97 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.054 1.836 . . . . 0.0 111.789 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.809 ' HA ' HG13 ' A' ' 63' ' ' VAL . 7.0 p80 170.68 -178.22 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.057 179.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.8 m -149.17 169.23 2.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.604 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -97.62 146.99 24.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.988 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.683 HD12 ' N ' ' A' ' 24' ' ' CYS . 4.3 pp -42.65 -34.0 0.81 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.46 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.683 ' N ' HD12 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -65.74 -43.58 88.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.85 0.357 . . . . 0.0 110.566 179.928 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.56 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 0.5 OUTLIER -61.82 -60.11 4.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.195 179.33 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.783 HD21 HG21 ' A' ' 77' ' ' VAL . 1.9 tp -50.08 -47.92 53.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.404 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.791 HD23 HG22 ' A' ' 41' ' ' ILE . 9.2 mp -67.5 -61.9 1.68 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.683 -179.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.509 ' HB2' ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -50.45 -54.43 22.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.002 -179.714 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.56 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 2.2 mt -56.8 -34.65 67.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.192 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.546 ' OE1' HG11 ' A' ' 75' ' ' VAL . 7.4 mm-40 -78.83 -15.13 58.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.408 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.33 22.23 22.68 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.421 -0.895 . . . . 0.0 113.104 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.675 ' CH2' HG12 ' A' ' 68' ' ' VAL . 9.2 m95 -72.81 -70.49 0.35 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 117.09 0.445 . . . . 0.0 109.896 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.736 ' CB ' HD12 ' A' ' 41' ' ' ILE . 8.6 t -95.05 138.9 32.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.956 178.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -75.7 -34.17 60.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.885 0.374 . . . . 0.0 110.792 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.407 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -105.3 -28.8 10.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.045 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.47 -37.5 3.79 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.49 179.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.32 5.27 2.97 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.407 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 43.4 tp60 -58.45 -72.6 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.712 0.292 . . . . 0.0 111.716 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.75 15.5 0.5 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.5 mtmm 64.49 24.53 13.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.053 0.454 . . . . 0.0 110.479 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.791 HG22 HD23 ' A' ' 27' ' ' LEU . 51.4 mt -59.56 -17.83 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.698 179.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.643 ' HB1' HD11 ' A' ' 23' ' ' LEU . . . -76.0 -77.91 0.12 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.042 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 13.1 mm -45.33 -45.7 3.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 121.078 0.466 . . . . 0.0 110.724 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.675 ' O ' ' HG3' ' A' ' 47' ' ' GLN . . . -57.82 -61.12 2.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.839 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.598 ' O ' HG23 ' A' ' 48' ' ' VAL . 9.9 tp10 -35.9 -35.6 0.07 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.143 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.459 ' O ' ' N ' ' A' ' 48' ' ' VAL . . . -72.16 -72.68 0.91 Allowed Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.24 -0.981 . . . . 0.0 111.743 178.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.675 ' HG3' ' O ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -39.93 -18.96 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -178.905 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.796 HG11 ' H ' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -75.34 -85.74 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.763 -179.55 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -176.56 130.55 0.2 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.467 -0.493 . . . . 0.0 112.112 179.723 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.628 HG11 ' CD1' ' A' ' 62' ' ' ILE . 49.6 t -125.04 150.83 30.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.721 178.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.58 ' HB2' ' H ' ' A' ' 67' ' ' THR . 1.2 m-20 -65.96 70.65 0.06 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.944 0.402 . . . . 0.0 110.601 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 135.92 -18.51 3.79 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.387 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.66 135.02 47.43 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.009 0.433 . . . . 0.0 111.123 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 54' ' ' VAL . 11.4 p -124.43 29.95 2.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.273 179.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -115.04 158.05 22.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.206 0.527 . . . . 0.0 111.495 -179.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.618 ' HB ' ' HB3' ' A' ' 47' ' ' GLN . 13.3 t -99.65 58.23 1.04 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.445 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 57' ' ' ARG . 14.6 mtt180 -89.13 171.81 9.54 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.785 0.326 . . . . 0.0 111.214 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.405 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -76.19 -48.24 21.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.23 179.655 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -122.4 154.82 37.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.035 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -136.91 119.19 15.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.899 0.38 . . . . 0.0 111.472 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.515 ' HG2' ' CD2' ' A' ' 20' ' ' HIS . 18.6 mttt -68.61 86.9 0.32 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.93 179.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.628 ' CD1' HG11 ' A' ' 50' ' ' VAL . 25.6 mt -134.54 139.98 46.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.955 0.407 . . . . 0.0 111.695 -179.049 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.809 HG13 ' HA ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -152.58 176.29 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.191 -179.649 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.602 ' HA ' ' HB3' ' A' ' 79' ' ' ALA . . . 75.26 -154.38 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.55 179.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.584 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -84.5 78.65 1.99 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.826 -178.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.62 HE21 HG23 ' A' ' 62' ' ' ILE . 2.0 mm100 -122.3 157.07 32.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.092 0.472 . . . . 0.0 111.268 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.58 ' H ' ' HB2' ' A' ' 51' ' ' ASP . 1.9 m -113.25 155.5 24.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.311 -178.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.675 HG12 ' CH2' ' A' ' 32' ' ' TRP . 0.9 OUTLIER -125.33 139.72 50.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.55 179.228 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.423 ' O ' ' HB ' ' A' ' 48' ' ' VAL . 0.7 OUTLIER -133.99 128.88 35.29 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.232 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.644 ' HA ' HG21 ' A' ' 48' ' ' VAL . 2.9 t80 -146.77 126.5 13.44 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.641 179.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.796 ' H ' HG11 ' A' ' 48' ' ' VAL . . . 46.13 -87.1 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.301 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -127.02 -8.73 4.5 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.889 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.658 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 1.8 m-70 -89.64 109.02 20.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.941 0.371 . . . . 0.0 111.471 -179.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.1 m -120.32 117.28 27.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.356 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.626 HG13 ' HB3' ' A' ' 11' ' ' ALA . 19.5 t -140.54 159.49 24.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.58 -179.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.569 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 19.5 mt-30 -112.66 163.15 14.89 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.028 0.442 . . . . 0.0 111.485 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.783 HG21 HD21 ' A' ' 26' ' ' LEU . 15.0 t -132.08 147.78 32.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.266 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.411 ' CG2' ' HA ' ' A' ' 14' ' ' SER . 24.5 m -129.12 162.45 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 CA-C-O 120.864 0.364 . . . . 0.0 111.291 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.602 ' HB3' ' HA ' ' A' ' 64' ' ' ALA . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.299 -0.858 . . . . 0.0 111.079 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.6 m -144.39 121.75 11.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.861 0.363 . . . . 0.0 110.983 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -163.67 149.75 11.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.707 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.67 ' H ' HD13 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -134.72 154.29 36.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.963 0.411 . . . . 0.0 111.454 -179.784 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -142.31 34.6 1.5 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.517 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.45 ' HD2' ' N ' ' A' ' 6' ' ' ARG . 1.7 mpt_? -67.79 104.51 1.69 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.311 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.2 ptp -83.31 -169.45 2.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.693 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.421 ' O ' ' CB ' ' A' ' 9' ' ' ASN . 1.4 t 59.92 170.93 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.726 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.421 ' CB ' ' O ' ' A' ' 8' ' ' SER . 1.7 m-20 83.33 -47.53 0.13 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.71 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -103.72 140.19 37.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.603 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.511 ' HB3' HG22 ' A' ' 75' ' ' VAL . . . -84.83 123.68 30.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.383 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.11 130.3 35.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.973 0.416 . . . . 0.0 111.046 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.49 ' HB2' ' CG ' ' A' ' 30' ' ' GLU . 13.6 t80 -107.07 144.66 33.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.312 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 74.7 m -106.82 149.82 26.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.46 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.552 HD21 HG11 ' A' ' 77' ' ' VAL . 55.2 mt -118.25 -40.06 2.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.833 0.349 . . . . 0.0 110.866 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.32 -102.93 2.99 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.245 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.7 pttt -143.1 43.65 1.55 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.964 0.411 . . . . 0.0 111.227 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.655 ' CG ' ' HD2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -101.64 154.45 37.27 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.194 179.536 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.655 ' HD2' ' CG ' ' A' ' 18' ' ' HIS . 9.3 Cg_endo -50.91 -32.4 37.67 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.581 2.187 . . . . 0.0 112.008 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.555 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 10.4 p80 159.62 -165.38 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.809 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.698 HG21 HD12 ' A' ' 26' ' ' LEU . 15.1 m -133.52 141.94 43.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.989 0.423 . . . . 0.0 111.233 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.691 ' HA ' ' H ' ' A' ' 60' ' ' CYS . 1.3 mp0 -81.28 148.07 29.61 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.822 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.593 ' O ' HD12 ' A' ' 27' ' ' LEU . 4.0 mp -38.7 -54.8 1.54 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.766 0.317 . . . . 0.0 111.39 -179.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.3 t -60.68 -29.06 69.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.417 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 22' ' ' GLU . 1.0 OUTLIER -72.74 -62.38 1.47 Allowed 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.76 0.314 . . . . 0.0 111.382 -179.716 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.949 HD11 HG21 ' A' ' 77' ' ' VAL . 4.9 tt -51.97 -48.84 64.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.266 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.872 HD21 ' HG3' ' A' ' 45' ' ' GLU . 5.4 mt -60.51 -57.76 11.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.556 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.6 ttpt -55.66 -54.46 43.99 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.769 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.25 -51.22 68.91 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -178.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.501 ' CD ' HG11 ' A' ' 75' ' ' VAL . 3.1 mm-40 -63.71 -15.44 58.49 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.56 25.54 15.47 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.267 -0.968 . . . . 0.0 113.341 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.681 ' CH2' HG12 ' A' ' 68' ' ' VAL . 12.4 m95 -74.14 -61.27 1.91 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-N 117.417 0.608 . . . . 0.0 109.552 178.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.715 ' CB ' HD13 ' A' ' 41' ' ' ILE . 47.0 t -106.79 140.52 39.51 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.495 179.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.61 -34.1 67.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.978 0.418 . . . . 0.0 110.171 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.566 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -105.77 -47.05 3.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.466 179.354 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 129.29 -30.82 3.57 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.303 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.96 6.7 3.4 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.566 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 19.1 tp60 -52.25 -75.01 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.857 0.361 . . . . 0.0 110.69 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.506 ' HB3' HD11 ' A' ' 41' ' ' ILE . . . -79.96 15.35 1.48 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.562 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.1 mmtt 64.61 29.4 13.06 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 121.142 0.496 . . . . 0.0 110.283 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.92 HG23 ' CD2' ' A' ' 70' ' ' PHE . 2.5 mp -63.4 -24.31 35.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.0 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.56 -78.97 0.05 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.383 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.4 mm -50.54 -42.64 22.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.946 0.403 . . . . 0.0 110.832 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.676 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -58.06 -68.86 0.21 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.165 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.872 ' HG3' HD21 ' A' ' 27' ' ' LEU . 1.6 tm-20 -33.88 -42.18 0.11 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.944 0.402 . . . . 0.0 111.087 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.415 ' C ' ' H ' ' A' ' 48' ' ' VAL . . . -60.15 -72.64 0.59 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.348 178.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.539 ' CA ' ' HB ' ' A' ' 56' ' ' THR . 9.3 pt20 -49.84 -8.57 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.871 HG21 ' HD1' ' A' ' 70' ' ' PHE . 60.0 t -74.87 -90.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.293 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.519 ' HG2' ' O ' ' A' ' 48' ' ' VAL . 0.5 OUTLIER -171.18 133.97 0.89 Allowed 'General case' 0 C--O 1.232 0.132 0 C-N-CA 120.432 -0.507 . . . . 0.0 111.744 179.559 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.508 HG11 ' CD1' ' A' ' 62' ' ' ILE . 21.9 t -130.41 147.44 33.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.819 178.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.531 ' HB2' ' H ' ' A' ' 67' ' ' THR . 0.5 OUTLIER -63.53 79.83 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.08 0.466 . . . . 0.0 110.51 -179.888 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 125.52 -13.68 7.33 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.583 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.407 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . . . -135.96 135.45 39.58 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.965 0.412 . . . . 0.0 111.17 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 54' ' ' VAL . 10.5 p -125.55 31.19 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.886 178.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -104.71 -150.46 0.43 Allowed 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.799 -178.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.539 ' HB ' ' CA ' ' A' ' 47' ' ' GLN . 4.5 t -169.89 67.4 0.05 Allowed 'General case' 0 C--O 1.232 0.147 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.589 ' O ' HD13 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -94.95 174.15 7.23 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.46 179.192 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -75.12 -46.43 34.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.014 0.435 . . . . 0.0 110.224 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.436 ' O ' ' HG2' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -101.87 131.9 47.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.045 179.167 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . 0.691 ' H ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -100.08 115.61 30.18 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.979 0.419 . . . . 0.0 111.217 -179.449 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.466 ' HG3' ' NE2' ' A' ' 20' ' ' HIS . 0.1 OUTLIER -94.55 74.86 3.78 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.783 179.207 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.508 ' CD1' HG11 ' A' ' 50' ' ' VAL . 36.6 mt -133.65 142.09 42.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.061 0.458 . . . . 0.0 111.578 -178.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.603 ' O ' ' HB3' ' A' ' 64' ' ' ALA . 0.2 OUTLIER -150.77 175.96 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.606 -179.908 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.603 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 81.09 -154.29 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.513 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -93.7 79.02 1.03 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.631 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -122.63 162.22 22.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.147 0.498 . . . . 0.0 111.34 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.67 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 25.8 m -113.85 156.57 23.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.851 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.681 HG12 ' CH2' ' A' ' 32' ' ' TRP . 0.9 OUTLIER -131.75 146.04 34.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.005 179.335 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 60.0 p -143.66 139.13 29.41 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 120.907 0.384 . . . . 0.0 111.727 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.92 ' CD2' HG23 ' A' ' 41' ' ' ILE . 0.8 OUTLIER -128.48 -86.24 0.56 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.28 179.983 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -139.63 88.56 2.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.743 0.306 . . . . 0.0 110.464 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.17 -25.5 6.93 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.441 -0.885 . . . . 0.0 111.444 -178.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.625 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 0.9 OUTLIER -93.06 109.02 20.49 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 120.791 0.329 . . . . 0.0 110.914 -179.758 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.9 m -120.23 98.48 6.08 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.595 ' HB ' ' HZ2' ' A' ' 32' ' ' TRP . 38.9 t -120.32 151.16 23.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.475 -178.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.67 ' HA ' ' HA ' ' A' ' 67' ' ' THR . 30.0 mt-30 -112.45 164.38 13.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.642 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.949 HG21 HD11 ' A' ' 26' ' ' LEU . 10.7 t -132.47 146.52 32.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.065 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 17.9 m -139.89 169.5 16.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.886 0.374 . . . . 0.0 111.144 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.181 -0.914 . . . . 0.0 111.071 179.863 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 112.843 -0.103 . . . . 0.0 112.843 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 m -155.73 124.46 6.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.758 0.313 . . . . 0.0 110.834 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.4 mtm -163.9 72.85 0.27 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.959 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.438 ' O ' HG13 ' A' ' 4' ' ' ILE . 1.1 tp -116.49 -22.93 4.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.523 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 71.57 96.19 0.07 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.886 0.374 . . . . 0.0 110.876 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.8 mtm180 59.1 110.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.02 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.54 -42.28 16.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.661 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.8 m -132.55 164.5 26.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.735 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -130.35 119.41 22.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.95 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 36.9 mtt -79.5 112.83 17.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.944 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.476 ' HB3' HG13 ' A' ' 75' ' ' VAL . . . -85.01 138.46 32.43 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.65 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.69 135.46 53.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.464 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.71 ' O ' HG13 ' A' ' 77' ' ' VAL . 40.2 t80 -124.83 98.57 5.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.886 0.374 . . . . 0.0 110.87 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.75 141.5 57.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.721 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.575 ' CD1' HG12 ' A' ' 63' ' ' VAL . 0.6 OUTLIER -90.93 -36.89 13.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.633 179.906 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.26 -81.3 1.06 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.574 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.7 ttmm -171.44 39.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.887 0.375 . . . . 0.0 110.85 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.651 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 6.1 m-70 -98.67 165.1 15.7 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.713 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.651 ' HD2' ' HB3' ' A' ' 18' ' ' HIS . 42.2 Cg_endo -66.79 -37.3 21.07 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.272 1.982 . . . . 0.0 111.935 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.533 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 6.3 p80 172.71 -172.14 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.022 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.555 HG21 ' CD1' ' A' ' 26' ' ' LEU . 2.5 m -136.26 151.9 29.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.091 0.472 . . . . 0.0 112.255 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.423 ' O ' ' N ' ' A' ' 25' ' ' ASP . 2.5 mp0 -95.01 148.3 22.48 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.464 178.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.567 ' O ' HD12 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -40.7 -47.94 2.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.743 0.306 . . . . 0.0 111.636 -179.492 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -62.78 -34.72 77.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.877 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.436 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 8.7 m-20 -64.75 -62.2 1.72 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.046 0.45 . . . . 0.0 110.433 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.793 HD11 HG21 ' A' ' 77' ' ' VAL . 0.9 OUTLIER -50.64 -46.0 58.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.148 179.909 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.769 HD21 ' HG3' ' A' ' 45' ' ' GLU . 9.8 mt -67.07 -59.37 3.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.915 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.18 -58.59 7.31 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.436 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.2 OUTLIER -53.9 -45.49 71.12 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.677 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.641 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 4.3 mm-40 -72.55 -14.62 61.68 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.09 25.34 12.93 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.192 -1.004 . . . . 0.0 113.332 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.712 ' CD2' HD23 ' A' ' 27' ' ' LEU . 12.4 m95 -73.47 -58.6 3.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.041 0.448 . . . . 0.0 110.013 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.699 ' HA ' HD12 ' A' ' 41' ' ' ILE . 2.1 t -106.1 133.7 50.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.513 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -64.67 -34.12 77.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.608 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.434 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 56.2 p -105.83 -49.2 3.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.734 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 133.91 -32.54 2.66 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.764 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.23 6.57 1.73 Allowed 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.434 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 69.7 tp60 -54.61 -71.83 0.07 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.956 0.408 . . . . 0.0 110.852 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.05 15.22 1.17 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.465 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.38 20.84 11.86 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.629 -179.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.71 HG23 ' CD2' ' A' ' 70' ' ' PHE . 37.5 mt -54.88 -25.89 16.4 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-O 121.01 0.433 . . . . 0.0 110.712 179.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.492 ' HA ' ' CD1' ' A' ' 27' ' ' LEU . . . -67.72 -79.34 0.05 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.164 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 44.6 mm -51.2 -39.17 20.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.199 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.624 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -58.04 -68.88 0.21 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.238 179.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.769 ' HG3' HD21 ' A' ' 27' ' ' LEU . 0.9 OUTLIER -33.42 -41.9 0.09 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.749 179.741 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.475 ' HA2' HD21 ' A' ' 23' ' ' LEU . . . -57.44 -74.72 0.31 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.034 -1.079 . . . . 0.0 110.553 178.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.529 ' HA ' HG22 ' A' ' 56' ' ' THR . 13.8 pt20 -48.06 -12.84 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.762 HG21 ' HD1' ' A' ' 70' ' ' PHE . 58.7 t -75.02 -93.63 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.969 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.48 ' HD3' ' HB ' ' A' ' 54' ' ' VAL . 4.6 mmtt -166.92 124.89 1.32 Allowed 'General case' 0 C--O 1.23 0.065 0 C-N-CA 120.151 -0.619 . . . . 0.0 112.368 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.602 HG13 HG23 ' A' ' 68' ' ' VAL . 12.8 t -118.11 149.17 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 177.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.445 ' HB2' ' H ' ' A' ' 67' ' ' THR . 9.9 t0 -45.07 100.47 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.025 0.44 . . . . 0.0 111.534 -178.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 66.95 17.3 67.43 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.857 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.507 ' O ' ' HB ' ' A' ' 50' ' ' VAL . . . -145.98 82.71 1.62 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.922 0.391 . . . . 0.0 111.945 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.635 HG13 ' O ' ' A' ' 54' ' ' VAL . 14.0 p -90.66 65.44 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.912 0.387 . . . . 0.0 110.582 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -99.83 -173.5 2.47 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.511 -179.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.529 HG22 ' HA ' ' A' ' 47' ' ' GLN . 0.8 OUTLIER -140.83 32.59 1.79 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.149 -179.708 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 19.4 mtp180 -84.74 169.13 14.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.062 0.458 . . . . 0.0 111.503 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.17 -32.01 55.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.915 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.2 mtt85 -131.76 146.54 52.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.654 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -129.51 115.89 18.13 Favored 'General case' 0 C--O 1.23 0.078 0 CA-C-O 120.89 0.376 . . . . 0.0 111.328 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.436 ' HG2' ' CD2' ' A' ' 20' ' ' HIS . 6.3 mttt -76.1 91.91 3.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.352 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.466 ' CD1' HG11 ' A' ' 50' ' ' VAL . 39.8 mt -133.77 139.72 48.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.265 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.575 HG12 ' CD1' ' A' ' 15' ' ' LEU . 2.5 m -146.23 175.2 2.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.119 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.533 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 74.98 -143.51 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.965 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -93.13 80.49 1.08 Allowed Glycine 0 C--N 1.336 0.552 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.766 -179.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -121.92 175.17 6.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.819 0.342 . . . . 0.0 111.228 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.445 ' H ' ' HB2' ' A' ' 51' ' ' ASP . 27.1 m -135.85 151.14 49.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.008 -178.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.712 HG12 ' CH2' ' A' ' 32' ' ' TRP . 1.2 t -130.5 144.13 38.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.309 179.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 67.8 m -140.99 141.23 34.4 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -178.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.762 ' HD1' HG21 ' A' ' 48' ' ' VAL . 1.9 t80 -146.08 122.28 10.85 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.273 179.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 49.78 -83.47 0.01 OUTLIER 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.481 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -127.46 -5.09 5.62 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.963 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.551 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 0.8 OUTLIER -89.46 113.79 25.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 117.01 0.405 . . . . 0.0 111.592 -179.027 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.61 111.35 17.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.285 178.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.587 ' HB ' ' HZ2' ' A' ' 32' ' ' TRP . 41.1 t -132.39 151.61 35.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.817 0.342 . . . . 0.0 111.488 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.438 ' HG3' ' OG1' ' A' ' 67' ' ' THR . 24.5 mp0 -113.2 159.53 19.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.423 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.793 HG21 HD11 ' A' ' 26' ' ' LEU . 6.3 t -125.07 138.7 53.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.084 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.1 m -133.88 154.54 38.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.014 0.435 . . . . 0.0 111.871 -179.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.431 ' HB2' ' HB2' ' A' ' 15' ' ' LEU . . . . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.058 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.152 0 N-CA-C 112.565 -0.214 . . . . 0.0 112.565 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 p -154.89 140.94 18.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.793 0.33 . . . . 0.0 110.911 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.26 -33.59 16.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.886 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.6 mt -79.32 125.99 38.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.072 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -168.68 -169.97 1.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.626 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 24.2 mtp180 -82.13 -31.4 30.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.84 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.18 175.4 9.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.834 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 m -139.59 123.18 17.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.037 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -71.38 84.64 0.8 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.553 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -93.35 77.19 4.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.705 -179.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.28 129.62 34.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.296 179.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.63 132.99 41.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.021 0.439 . . . . 0.0 110.902 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.486 ' HE1' HD23 ' A' ' 15' ' ' LEU . 16.8 t80 -99.72 98.24 9.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.967 179.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.416 ' HA ' HG23 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -77.18 98.98 5.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.764 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.486 HD23 ' HE1' ' A' ' 13' ' ' PHE . 17.9 mt -55.83 -34.14 65.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.985 0.421 . . . . 0.0 110.542 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.54 42.49 7.82 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.005 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt 61.3 39.38 15.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.981 0.419 . . . . 0.0 110.631 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.402 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 3.6 m170 -95.15 165.73 16.3 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.897 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.434 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 14.8 Cg_endo -56.99 -63.63 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.672 2.248 . . . . 0.0 112.612 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.434 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 8.5 p80 178.51 -174.05 0.16 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.241 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.421 ' N ' ' ND1' ' A' ' 20' ' ' HIS . 17.8 m -149.93 167.07 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.409 ' HB2' ' CB ' ' A' ' 59' ' ' ARG . 1.5 pt-20 -103.71 153.39 20.72 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.253 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.543 ' O ' HD13 ' A' ' 27' ' ' LEU . 81.6 mt -41.65 -45.55 3.44 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.0 t -65.37 -39.12 91.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.721 0.296 . . . . 0.0 111.671 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -62.12 -62.31 1.86 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.593 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.672 HD21 ' CG2' ' A' ' 77' ' ' VAL . 2.3 tp -53.69 -41.92 67.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.474 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.001 HD23 HG22 ' A' ' 41' ' ' ILE . 8.0 mp -66.81 -64.7 0.8 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.382 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -51.26 -57.0 10.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.988 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 24.9 mt -53.65 -31.02 45.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.079 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.556 ' OE2' HG11 ' A' ' 75' ' ' VAL . 2.4 mm-40 -84.05 -13.61 52.71 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.55 18.0 34.36 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.365 -0.922 . . . . 0.0 112.685 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.529 ' CE3' ' HG ' ' A' ' 27' ' ' LEU . 9.4 m0 -69.58 -60.81 2.09 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.64 ' CB ' HD12 ' A' ' 41' ' ' ILE . 2.1 t -106.83 134.04 50.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.99 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -63.95 -34.83 78.87 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.856 0.36 . . . . 0.0 111.048 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.559 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 79.0 p -106.25 -51.56 2.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.138 0.494 . . . . 0.0 110.225 178.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 139.29 -37.62 1.74 Allowed Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.3 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.03 11.25 3.33 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.559 ' HB2' ' OG ' ' A' ' 35' ' ' SER . 3.4 tp-100 -63.11 -66.65 0.51 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.761 0.315 . . . . 0.0 110.777 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.29 14.41 0.94 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.727 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 46.0 mmtt 65.4 25.48 11.99 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.832 0.349 . . . . 0.0 110.745 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 1.001 HG22 HD23 ' A' ' 27' ' ' LEU . 5.3 mt -63.09 -27.12 42.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.267 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.84 -78.51 0.06 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.836 0.35 . . . . 0.0 110.577 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.6 mm -46.51 -35.81 2.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 121.104 0.478 . . . . 0.0 110.249 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.722 ' O ' HG23 ' A' ' 48' ' ' VAL . . . -63.8 -62.61 1.54 Allowed 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.657 178.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.759 ' HB2' HD21 ' A' ' 27' ' ' LEU . 16.3 tp10 -32.35 -41.84 0.06 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.823 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.8 -71.6 0.92 Allowed Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.355 -0.926 . . . . 0.0 111.743 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.522 ' HG3' ' O ' ' A' ' 44' ' ' ALA . 0.7 OUTLIER -43.69 -19.54 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.726 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.84 HG21 ' HD1' ' A' ' 70' ' ' PHE . 21.5 t -75.85 -85.05 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.945 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -170.36 133.17 1.05 Allowed 'General case' 0 C--O 1.23 0.055 0 CA-C-O 120.804 0.335 . . . . 0.0 111.138 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.665 ' HB ' ' HB3' ' A' ' 53' ' ' ALA . 4.4 t -134.62 144.19 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.056 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 67' ' ' THR . 6.0 t70 -48.74 91.25 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.75 0.31 . . . . 0.0 111.442 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 50' ' ' VAL . . . 94.27 -7.4 72.3 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.875 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.665 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . . . -129.0 131.33 47.39 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 117.323 0.562 . . . . 0.0 111.187 -179.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 54' ' ' VAL . 7.5 p -124.84 32.51 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.861 178.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -101.99 154.64 18.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.936 -178.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.47 ' HA ' ' N ' ' A' ' 47' ' ' GLN . 12.1 t -92.88 46.84 1.24 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.643 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.68 169.98 17.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.187 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.09 -32.25 20.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.125 0.488 . . . . 0.0 109.819 178.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.409 ' CB ' ' HB2' ' A' ' 22' ' ' GLU . 36.2 mtm180 -128.38 151.94 48.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.991 179.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . 0.616 ' SG ' HD11 ' A' ' 62' ' ' ILE . 18.4 t -136.94 117.29 13.62 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.827 0.346 . . . . 0.0 111.105 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.02 99.0 2.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.394 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.616 HD11 ' SG ' ' A' ' 60' ' ' CYS . 1.5 mt -133.36 142.65 41.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.151 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.513 ' O ' ' HB3' ' A' ' 64' ' ' ALA . 25.6 m -147.54 170.71 3.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.39 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' A' ' 63' ' ' VAL . . . 72.34 -155.5 0.09 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.387 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.551 ' HA2' ' O ' ' A' ' 77' ' ' VAL . . . -87.17 82.96 1.59 Allowed Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 121.516 -0.373 . . . . 0.0 112.285 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.454 ' HB3' ' CB ' ' A' ' 51' ' ' ASP . 5.0 mm100 -121.48 160.91 23.21 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.972 0.415 . . . . 0.0 111.577 -178.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.821 HG23 ' HG3' ' A' ' 76' ' ' GLN . 0.2 OUTLIER -116.23 149.07 39.76 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.551 -178.498 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.548 HG13 ' OE2' ' A' ' 45' ' ' GLU . 1.1 t -125.88 142.47 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.651 179.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.407 ' O ' ' HB ' ' A' ' 48' ' ' VAL . 13.2 m -138.14 133.53 33.47 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -178.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.858 ' CE2' HG23 ' A' ' 41' ' ' ILE . 1.9 t80 -144.05 122.57 12.45 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.1 178.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 47.21 -85.5 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.724 0.297 . . . . 0.0 111.535 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 70' ' ' PHE . . . -127.31 -4.89 5.75 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.037 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.487 ' HB2' ' CZ3' ' A' ' 32' ' ' TRP . 1.8 m-70 -92.75 110.1 21.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.025 0.413 . . . . 0.0 111.3 -179.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.0 m -120.69 125.16 46.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.278 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.556 HG11 ' OE2' ' A' ' 30' ' ' GLU . 47.0 t -147.23 160.64 8.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.808 0.337 . . . . 0.0 111.564 -179.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.821 ' HG3' HG23 ' A' ' 67' ' ' THR . 35.8 mt-30 -112.41 164.02 13.75 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.949 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.672 ' CG2' HD21 ' A' ' 26' ' ' LEU . 16.9 t -137.13 147.12 27.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.658 -179.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.416 HG23 ' HA ' ' A' ' 14' ' ' SER . 17.0 m -134.22 178.01 6.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 120.718 0.294 . . . . 0.0 110.624 178.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.331 -0.842 . . . . 0.0 111.098 -179.978 . . . . . . . . 0 0 . 1 stop_ save_